[
    {
        "input": "3: HR, 114.0; 3: RR, 16.0; 3: SpO2, 100.0; 3: SBP, 126.0; 3: DBP, 63.0; 3: MAP, 84.0; 3: Temp, 98.2; 9: Pain, 0.0; 36: HR, 108.0; 36: RR, 18.0; 36: SpO2, 99.0; 36: SBP, 123.0; 36: DBP, 73.0; 36: MAP, 89.667; 38: SpO2, 99.0; 38: Perf, 0.32; 38: SBP, 123.0; 38: DBP, 73.0; 38: MAP, 89.667; 39: SpO2, 98.246; 39: Perf, 0.303; 40: SpO2, 98.941; 40: Perf, 0.264; 41: SpO2, 97.966; 41: Perf, 0.291; 42: SpO2, 99.070; 42: Perf, 0.266; 43: SpO2, 97.966; 43: Perf, 0.331; 44: SpO2, 98.254; 44: Perf, 0.302; 45: SpO2, 99.919; 45: Perf, 0.264; 46: SpO2, 100.0; 46: Perf, 0.251; 47: SpO2, 100.0; 47: Perf, 0.266; 48: SpO2, 100.0; 48: Perf, 0.286; 49: SpO2, 100.0; 49: Perf, 0.282; 50: SpO2, 100.0; 50: Perf, 0.297; 51: SpO2, 100.0; 51: Perf, 0.348; 52: SpO2, 99.655; 52: Perf, 0.328; 52: SBP, 110.0; 52: DBP, 73.0; 52: MAP, 85.333; 53: SpO2, 98.732; 53: Perf, 0.274; 54: SpO2, 100.0; 54: Perf, 0.534; 54: Pain, 0.0; 55: SpO2, 99.914; 55: Perf, 0.471; 56: SpO2, 99.136; 56: Perf, 0.417; 57: SpO2, 99.776; 57: Perf, 0.461; 58: SpO2, 99.559; 58: Perf, 0.428; 59: SpO2, 98.157; 59: Perf, 0.373; 60: SpO2, 99.897; 60: Perf, 0.304; 61: SpO2, 99.661; 61: Perf, 0.328; 62: SpO2, 99.0; 62: Perf, 0.323; 63: SpO2, 98.949; 63: Perf, 0.330; 64: SpO2, 99.655; 64: Perf, 0.363; 65: SpO2, 98.789; 65: Perf, 0.436; 66: WAM DIFTYP, AUTO; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: HEMATOCRIT (HCT), 32.6 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.11 K/uL; 66: PLATELET COUNT (PLT), 347 K/uL; 66: EOSINOPHIL % (AUTO DIFF), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: WHITE BLOOD CELLS (WBC), 12.3 K/uL; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.95 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 66: MONOCYTE % (AUTO DIFF), 9.6 %; 66: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 66: HEMOGLOBIN (HGB), 10.6 g/dL; 66: RED BLOOD CELLS (RBC), 3.92 MIL/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: BASOPHIL % (AUTO DIFF), 0.2 %; 66: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 66: MEAN CORPUSCULAR VOLUME (MCV), 83.2 fL; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 1.18 K/uL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: NEUTROPHIL % (AUTO DIFF), 82.1 %; 66: HR, 104.0; 66: RR, 16.0; 66: SpO2, 99.525; 66: Perf, 0.388; 66: SBP, 103.0; 66: DBP, 63.0; 66: MAP, 76.333; 67: SpO2, 99.138; 67: Perf, 0.552; 67: SBP, 103.0; 67: DBP, 63.0; 67: MAP, 76.333; 68: SpO2, 98.729; 68: Perf, 0.543; 69: SpO2, 98.586; 69: Perf, 0.541; 70: SpO2, 98.102; 70: Perf, 0.534; 71: SpO2, 98.0; 71: Perf, 0.458; 72: SpO2, 98.0; 72: Perf, 0.475; 73: SpO2, 98.475; 73: Perf, 0.447; 74: SpO2, 98.845; 74: Perf, 0.445; 75: SpO2, 98.712; 75: Perf, 0.485; 76: SpO2, 99.271; 76: Perf, 0.767; 77: SpO2, 98.276; 77: Perf, 0.812; 78: SpO2, 98.0; 78: Perf, 0.635; 79: SpO2, 98.655; 79: Perf, 0.639; 80: SpO2, 98.153; 80: Perf, 0.571; 81: SpO2, 98.458; 81: Perf, 0.606; 82: SpO2, 98.552; 82: Perf, 0.689; 82: SBP, 100.0; 82: DBP, 60.0; 82: MAP, 73.333; 83: SpO2, 98.068; 83: Perf, 0.686; 84: SpO2, 98.879; 84: Perf, 0.740; 85: SpO2, 98.525; 85: Perf, 0.788; 86: SpO2, 99.068; 86: Perf, 0.682; 87: SpO2, 98.552; 87: Perf, 1.312; 88: SpO2, 98.0; 88: Perf, 1.848; 89: SpO2, 97.845; 89: Perf, 1.742; 90: SpO2, 97.831; 90: Perf, 1.476; 91: SpO2, 98.0; 91: Perf, 1.267; 92: SARS-COV-2 RNA, Not Detected; 92: SpO2, 98.0; 92: Perf, 1.059; 93: SpO2, 98.0; 93: Perf, 1.031; 94: SpO2, 98.0; 94: Perf, 1.012; 95: SpO2, 98.169; 95: Perf, 0.956; 96: HR, 101.0; 96: RR, 18.0; 96: SpO2, 98.914; 96: Perf, 1.175; 96: SBP, 104.0; 96: DBP, 61.0; 96: MAP, 75.333; 97: SpO2, 98.576; 97: Perf, 1.789; 97: SBP, 104.0; 97: DBP, 61.0; 97: MAP, 75.333; 98: SpO2, 98.0; 98: Perf, 1.576; 99: SpO2, 98.0; 99: Perf, 1.743; 100: SpO2, 98.712; 100: Perf, 1.520; 101: SpO2, 98.103; 101: Perf, 1.484; 102: SpO2, 97.373; 102: Perf, 1.195; 103: SpO2, 98.153; 103: Perf, 0.925; 104: SpO2, 99.586; 104: Perf, 1.084; 105: SpO2, 99.424; 105: Perf, 1.391; 106: SpO2, 98.879; 106: Perf, 1.341; 107: SpO2, 100.0; 107: Perf, 1.634; 108: CORRECTED CALCIUM, 9.3 mg/dL; 108: ALKALINE PHOSPHATASE, 222 U/L; 108: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 108: ALT (SGPT), 138 U/L; 108: BILIRUBIN TOTAL, 1.9 mg/dL; 108: POTASSIUM, 3.8 mmol/L; 108: GLUCOSE, 134 mg/dL; 108: CALCIUM, 9.3 mg/dL; 108: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 108: SODIUM, 131 mmol/L; 108: CHLORIDE, 94 mmol/L; 108: PROTEIN TOTAL, 7.7 g/dL; 108: AST (SGOT), 61 U/L; 108: CO2, 23 mmol/L; 108: CREATININE, 0.98 mg/dL; 108: ANION GAP, 14 mmol/L; 108: ALBUMIN, 4.0 g/dL; 108: GLOBULIN, 3.7 g/dL; 0: Age, 76; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 114.0; 0: Triage RR, 16.0; 0: Triage SBP, 126.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, evaluate vital signs such as heart rate (HR), respiratory rate (RR), systolic and diastolic blood pressure (SBP and DBP), and body temperature. Initial readings show elevated HR (114 bpm) but stable RR, BP, and temperature. Next, assess trends across subsequent measurements, noting that HR trends downward and there are no deteriorations suggesting sepsis risk escalation. Then, review key lab values like white blood cell count (12.3 K/uL), which shows mild elevation but not overtly indicative of sepsis. Additionally, stable SpO2 readings and lack of alarming trends in perf values and chemistry panels suggest no high sepsis risk within the observation window.",
        "claims": [
            "Vital signs should be evaluated to assess a patient's condition.",
            "Heart rate (HR) is one of the vital signs that should be monitored.",
            "The initial heart rate reading is 114 bpm.",
            "A heart rate of 114 bpm is considered elevated.",
            "Respiratory rate (RR) should also be evaluated when assessing vital signs.",
            "The initial respiratory rate readings are stable.",
            "Systolic and diastolic blood pressure (SBP and DBP) should be monitored as part of vital signs.",
            "Initial blood pressure readings are stable.",
            "Body temperature should be evaluated along with other vital signs.",
            "The initial body temperature readings are stable.",
            "Trends in vital signs should be assessed across subsequent measurements.",
            "The heart rate trends downward in subsequent measurements.",
            "No deteriorations in vital signs are noted that suggest an escalation in sepsis risk.",
            "Key lab values, such as white blood cell count, should be reviewed when assessing sepsis risk.",
            "The white blood cell count is 12.3 K/uL.",
            "A white blood cell count of 12.3 K/uL shows mild elevation.",
            "A white blood cell count of 12.3 K/uL is not overtly indicative of sepsis.",
            "Stable SpO2 readings should be assessed in relation to sepsis risk.",
            "There are no alarming trends in perfusion values.",
            "There are no alarming trends in chemistry panels.",
            "The overall assessment suggests no high sepsis risk within the observation window."
        ],
        "relevant_claims": [
            "The initial heart rate reading is 114 bpm.",
            "A heart rate of 114 bpm is considered elevated.",
            "The white blood cell count is 12.3 K/uL.",
            "A white blood cell count of 12.3 K/uL shows mild elevation.",
            "A white blood cell count of 12.3 K/uL is not overtly indicative of sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.9,
            0.5,
            0.9,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "The claim of a heart rate of 114 bpm exceeds the SIRS criterion of heart rate >90 bpm, indicating the presence of systemic inflammation consistent with early sepsis. As the heart rate is specifically mentioned in the SIRS criteria, there is a strong alignment, but since only one criterion is met and SIRS requires \u22652 criteria, the alignment is not complete.",
            "An elevated heart rate (>90 bpm) is explicitly mentioned as one of the SIRS criteria, which indicates systemic inflammation consistent with early sepsis. The alignment is strong because the claim matches one of the criteria directly, though the complete SIRS evaluation requires at least two criteria to fully assess sepsis risk.",
            "The white blood cell count of 12.3 K/uL slightly exceeds the SIRS threshold of >12,000/\u00b5L, which is one of the criteria for systemic inflammation consistent with early sepsis. The alignment is moderate as it meets the criterion exactly but does not include additional SIRS elements to strengthen the prediction.",
            "The claim mentions a white blood cell count of 12.3 K/uL, which qualifies as elevated under the SIRS criteria (WBC\u202f>\u202f12\u202f000/\u00b5L). This aligns almost perfectly with the SIRS Positivity category, as elevated WBC is one of the systemic inflammation indicators considered under this criterion. However, since it does not mention any other SIRS criteria (\u22652 required for complete alignment), the alignment isn't absolute.",
            "The white blood cell count of 12.3 K/uL slightly exceeds the SIRS criterion of >12,000/\u00b5L, which is used to identify systemic inflammation consistent with early sepsis. While the claim suggests it's not strongly indicative of sepsis, the WBC count does meet a SIRS criterion implying relevance but with noted skepticism in the claim."
        ],
        "final_alignment_score": 0.74,
        "accuracy": 0
    },
    {
        "input": "6: HR, 72.0; 6: RR, 18.0; 6: SpO2, 95.0; 6: SBP, 140.0; 6: DBP, 96.0; 6: MAP, 110.667; 6: Pain, 8.0; 6: Temp, 98.1; 19: HR, 79.0; 19: SpO2, 92.0; 19: SBP, 140.0; 19: DBP, 96.0; 19: MAP, 110.667; 20: SpO2, 97.333; 20: SBP, 140.0; 20: DBP, 96.0; 20: MAP, 110.667; 21: SpO2, 94.026; 22: SpO2, 94.379; 22: Perf, 1.397; 23: SpO2, 95.661; 23: Perf, 1.858; 24: SpO2, 93.052; 24: Perf, 2.022; 25: SpO2, 92.220; 25: Perf, 2.138; 26: SpO2, 93.475; 26: Perf, 2.172; 27: POC PH (V) ISTAT, 7.41; 27: POC TCO2 (V) ISTAT, 26 mmol/L; 27: POC LACTATE ISTAT, 1.58 mmol/L; 27: POC PCO2 (V) ISTAT, 38.8 mmHg; 27: POC PO2 (V) ISTAT, 30 mmHg; 27: POC HCO3 (V) ISTAT, 24.6 mmol/L; 27: POC O2 SATURATION ISTAT VENOUS, 58 %; 27: POC BASE EXCESS ISTAT, 0 mmol/L; 27: SpO2, 93.879; 27: Perf, 2.195; 28: SpO2, 94.643; 28: Perf, 2.079; 29: SpO2, 93.352; 30: SpO2, 92.661; 31: SpO2, 94.458; 31: Perf, 2.148; 32: SpO2, 94.879; 32: Perf, 2.341; 33: WAM DIFTYP, AUTO; 33: WHITE BLOOD CELLS (WBC), 12.6 K/uL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 83.4 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 33: RED BLOOD CELLS (RBC), 4.41 MIL/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 33: EOSINOPHIL % (AUTO DIFF), 0.0 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.53 K/uL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 33: HEMATOCRIT (HCT), 40.2 %; 33: MONOCYTE % (AUTO DIFF), 5.5 %; 33: HEMOGLOBIN (HGB), 13.5 g/dL; 33: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 33: PLATELET COUNT (PLT), 202 K/uL; 33: SpO2, 93.881; 33: Perf, 2.597; 34: SpO2, 93.569; 34: Perf, 2.418; 35: SpO2, 93.051; 35: Perf, 2.030; 35: SBP, 82.0; 35: DBP, 71.0; 35: MAP, 74.667; 36: SpO2, 93.932; 36: Perf, 1.853; 37: SpO2, 93.707; 37: Perf, 1.826; 38: SpO2, 93.559; 38: Perf, 1.822; 39: SpO2, 93.328; 39: Perf, 1.862; 40: SpO2, 94.797; 40: Perf, 2.180; 41: SpO2, 92.729; 41: Perf, 2.138; 42: SpO2, 93.586; 42: Perf, 2.102; 43: SpO2, 93.847; 43: Perf, 2.15; 44: SpO2, 92.397; 44: Perf, 2.078; 45: SpO2, 91.271; 45: Perf, 2.132; 46: SpO2, 90.793; 46: Perf, 2.216; 47: SpO2, 91.237; 47: Perf, 2.514; 48: SpO2, 91.983; 48: Perf, 2.57; 49: HR, 70.0; 49: SpO2, 92.914; 49: Perf, 2.288; 50: SpO2, 91.746; 50: Perf, 2.022; 51: SpO2, 92.879; 51: Perf, 2.147; 52: SpO2, 93.203; 52: Perf, 2.179; 53: SpO2, 92.203; 53: Perf, 2.168; 54: SpO2, 93.672; 54: Perf, 2.118; 55: SpO2, 93.373; 55: Perf, 2.159; 56: SpO2, 92.810; 56: Perf, 2.301; 57: SpO2, 92.780; 57: Perf, 2.435; 58: SpO2, 93.441; 58: Perf, 2.373; 59: SpO2, 92.414; 59: Perf, 2.294; 60: SpO2, 93.237; 60: Perf, 2.240; 61: SpO2, 93.138; 61: Perf, 1.998; 62: SpO2, 93.017; 62: Perf, 2.243; 63: SpO2, 94.136; 63: Perf, 2.593; 64: HR, 67.0; 64: SpO2, 94.828; 64: Perf, 2.848; 64: SBP, 122.0; 64: DBP, 80.0; 64: MAP, 94.0; 65: SpO2, 93.034; 65: Perf, 2.602; 65: SBP, 122.0; 65: DBP, 80.0; 65: MAP, 94.0; 66: SpO2, 91.948; 66: Perf, 2.722; 67: SpO2, 93.973; 67: Perf, 2.708; 68: ANION GAP, 14 mmol/L; 68: ALT (SGPT), 19 U/L; 68: CO2, 22 mmol/L; 68: ALBUMIN, 4.3 g/dL; 68: ALKALINE PHOSPHATASE, 63 U/L; 68: GLOBULIN, 3.1 g/dL; 68: BLOOD UREA NITROGEN (BUN), 17 mg/dL; 68: BILIRUBIN TOTAL, 0.9 mg/dL; 68: AST (SGOT), 23 U/L; 68: CALCIUM, 9.8 mg/dL; 68: CREATININE, 1.24 mg/dL; 68: POTASSIUM, 4.0 mmol/L; 68: EGFR REFIT WITHOUT RACE (2021), 56 mL/min/1.73 m2; 68: PROTEIN TOTAL, 7.4 g/dL; 68: CORRECTED CALCIUM, 9.6 mg/dL; 68: CHLORIDE, 96 mmol/L; 68: SODIUM, 132 mmol/L; 68: GLUCOSE, 124 mg/dL; 68: LIPASE, 41 U/L; 87: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: HR:, 68.0; 94: RR, 17.0; 94: SpO2, 93.448; 94: SBP, 134.0; 94: DBP, 69.0; 94: MAP, 90.667; 94: Pain, 0.0; 95: SpO2, 93.576; 95: SBP, 134.0; 95: DBP, 69.0; 95: MAP, 90.667; 96: SpO2, 93.862; 96: Perf, 2.867; 97: SpO2, 92.644; 97: Perf, 3.977; 98: SpO2, 92.534; 98: Perf, 4.487; 99: SpO2, 92.305; 99: Perf, 4.551; 100: SpO2, 91.542; 100: Perf, 4.468; 101: SpO2, 91.603; 101: Perf, 3.958; 102: SpO2, 90.678; 102: Perf, 4.415; 103: SpO2, 90.259; 103: Perf, 4.996; 104: SpO2, 90.729; 104: Perf, 5.183; 105: SpO2, 90.847; 105: Perf, 5.788; 106: SpO2, 92.966; 106: Perf, 3.739; 107: SpO2, 92.966; 107: Perf, 2.844; 108: SpO2, 94.069; 108: Perf, 2.802; 109: SpO2, 94.610; 109: Perf, 2.876; 110: SpO2, 95.345; 110: Perf, 2.937; 111: SpO2, 95.203; 111: Perf, 2.839; 112: SpO2, 94.814; 112: Perf, 2.809; 113: SpO2, 95.586; 113: Perf, 2.783; 114: SpO2, 95.254; 114: Perf, 2.725; 115: SpO2, 93.931; 115: Perf, 2.339; 116: SpO2, 90.983; 116: Perf, 2.184; 116: LR IV BOLUS -, 500 ML; 117: SpO, 2: 91.220; 117: Perf, 2.278; 118: SpO2, 91.534; 118: Perf, 2.451; 119: SpO2, 91.763; 119: Perf, 2.482; 0: Age, 88; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 72.0; 0: Triage RR, 18.0; 0: Triage SBP, 140.0; 0: Triage DBP, 96.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To evaluate the risk of sepsis, I first examined the patient's vital signs, such as heart rate (HR), blood pressure (BP), temperature, respiration rate (RR), and oxygen saturation (SpO2) over time. The initial vitals are within normal ranges, and although there's a slight decrease in SpO2 with time, it remains above critical levels. Additionally, laboratory values like lactate (1.58 mmol/L) and white blood cell count (12.6 K/uL) don't suggest acute distress. Finally, the perfusion index remains relatively stable, not indicating circulatory shock. Combining these observations, the patient shows no high-risk indicators for developing sepsis within 12 hours.",
        "claims": [
            "To evaluate the risk of sepsis, I first examined the patient's vital signs.",
            "I examined the patient's heart rate (HR) over time.",
            "I examined the patient's blood pressure (BP) over time.",
            "I examined the patient's temperature over time.",
            "I examined the patient's respiration rate (RR) over time.",
            "I examined the patient's oxygen saturation (SpO2) over time.",
            "The initial vitals are within normal ranges.",
            "There is a slight decrease in SpO2 over time.",
            "The SpO2 remains above critical levels.",
            "Laboratory values like lactate are 1.58 mmol/L.",
            "The white blood cell count is 12.6 K/uL.",
            "The laboratory values do not suggest acute distress.",
            "The perfusion index remains relatively stable.",
            "The stable perfusion index does not indicate circulatory shock.",
            "Combining these observations, the patient shows no high-risk indicators for developing sepsis.",
            "The patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "There is a slight decrease in SpO2 over time.",
            "The white blood cell count is 12.6 K/uL."
        ],
        "alignment_scores": [
            0.5,
            0.8
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "The claim describes a decrease in SpO\u2082, which can be associated with impaired oxygenation in the body. While SpO\u2082 is not directly a SOFA metric, it relates conceptually to hypoxia and oxygenation inefficiencies. Thus, it partly aligns with the respiratory component of SOFA score, but since it does not directly match any specific SOFA component threshold, the alignment is moderate.",
            "The claim refers to a white blood cell count of 12.6 K/uL, which is just above the SIRS criterion of WBC > 12,000/\u00b5L. This directly relates to the SIRS criteria category, indicating systemic inflammation and potentially early sepsis. The alignment is strong, as the WBC count meets the threshold, but not extremely high beyond it, so the rating is slightly less than perfect."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 1
    },
    {
        "input": "7: HR, 122.0; 7: RR, 19.0; 7: SpO2, 96.0; 7: SBP, 141.0; 7: DBP, 99.0; 7: MAP, 113.0; 7: Temp, 101.7; 10: Pain, 5.0; 25: SpO2, 97.0; 28: SpO2, 95.0; 29: SpO2, 95.847; 29: Perf, 2.744; 30: SpO2, 96.0; 30: Perf, 2.426; 31: SpO2, 96.276; 31: Perf, 1.912; 32: SpO2, 95.508; 32: Perf, 2.054; 33: SpO2, 95.448; 33: Perf, 2.287; 34: SpO2, 95.0; 34: Perf, 2.120; 35: SpO2, 95.0; 35: Perf, 2.073; 36: SpO2, 94.931; 36: Perf, 2.025; 37: SpO2, 94.831; 37: Perf, 2.353; 38: SpO2, 94.948; 38: Perf, 2.507; 39: SpO2, 94.746; 39: Perf, 2.149; 40: SpO2, 94.793; 40: Perf, 2.478; 41: SpO2, 93.763; 41: Perf, 2.571; 41: SBP, 161.0; 41: DBP, 79.0; 41: MAP, 106.333; 42: SpO2, 94.458; 42: Perf, 2.453; 43: SpO2, 93.948; 43: Perf, 2.944; 44: SpO2, 93.915; 44: Perf, 3.298; 45: SpO2, 94.586; 45: Perf, 2.991; 46: SpO2, 93.441; 46: Perf, 2.730; 47: SpO2, 93.568; 47: Perf, 1.832; 48: SpO2, 94.576; 49: SpO2, 94.492; 49: Perf, 1.823; 50: SpO2, 94.259; 50: Perf, 1.940; 50: Pain, 0.0; 51: SpO2, 94.203; 51: Perf, 1.974; 52: SpO2, 93.780; 52: Perf, 1.835; 53: SpO2, 92.672; 53: Perf, 1.057; 54: SpO2, 92.034; 54: Perf, 1.235; 55: SpO2, 92.276; 55: Perf, 1.395; 56: SpO2, 93.237; 56: Perf, 1.808; 57: SpO2, 94.525; 57: Perf, 2.943; 58: SpO2, 94.190; 58: Perf, 4.109; 59: SpO2, 94.237; 59: Perf, 3.728; 60: SpO2, 94.103; 60: Perf, 3.958; 61: SpO2, 94.339; 61: Perf, 3.283; 62: SpO2, 95.085; 62: Perf, 2.947; 63: POC PH (V) ISTAT, 7.45; 63: POC O2 SATURATION ISTAT VENOUS, 73 %; 63: POC PCO2 (V) ISTAT, 36.4 mmHg; 63: POC TCO2 (V) ISTAT, 26 mmol/L; 63: POC PO2 (V) ISTAT, 37 mmHg; 63: POC HCO3 (V) ISTAT, 25.3 mmol/L; 63: POC BASE EXCESS ISTAT, 1 mmol/L; 63: POC LACTATE ISTAT, 2.11 mmol/L; 63: SpO2, 94.828; 63: Perf, 2.951; 64: SpO2, 94.729; 64: Perf, 2.876; 65: SpO2, 94.224; 65: Perf, 2.912; 66: SpO2, 94.068; 66: Perf, 2.771; 67: SpO2, 94.0; 67: Perf, 2.611; 68: SpO2, 93.793; 68: Perf, 2.431; 69: SpO2, 93.627; 69: Perf, 2.341; 70: SpO2, 93.828; 70: Perf, 2.342; 70: Pain, 10.0; 71: SpO2, 93.729; 71: Perf, 2.431; 72: SpO2, 93.879; 72: Perf, 2.424; 73: SpO2, 93.831; 73: Perf, 2.465; 74: SpO2, 94.508; 74: Perf, 2.437; 75: SpO2, 94.483; 75: Perf, 2.640; 76: SpO2, 94.407; 76: Perf, 2.442; 77: SpO2, 93.879; 77: Perf, 2.260; 78: SpO2, 93.424; 78: Perf, 2.185; 79: SpO2, 93.085; 79: Perf, 2.197; 80: SpO2, 93.517; 80: Perf, 2.056; 81: SpO2, 93.322; 81: Perf, 2.152; 82: SpO2, 93.931; 82: Perf, 2.176; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 93.831; 83: Perf, 2.772; 84: SpO2, 94.034; 84: Perf, 2.811; 85: SpO2, 93.310; 85: Perf, 1.924; 85: LR IV BOLUS -, 1000 ML; 86: SpO, 2: 92.949; 86: Perf, 1.520; 87: SpO2, 93.190; 87: Perf, 1.522; 88: SpO2, 93.492; 88: Perf, 1.592; 89: SpO2, 94.102; 89: Perf, 2.008; 90: HR, 112.263; 90: RR, 24.941; 90: SpO2, 94.241; 90: Perf, 2.526; 90: 1min HRV, 2.278; 90: 5min HRV, 2.278; 91: HR, 112.797; 91: RR, 25.695; 91: SpO2, 94.0; 91: Perf, 2.527; 91: 1min HRV, 2.096; 92: HR, 112.810; 92: RR, 25.328; 92: SpO2, 94.828; 92: Perf, 2.403; 92: 1min HRV, 1.882; 93: HR, 112.898; 93: RR, 25.864; 93: SpO2, 95.0; 93: Perf, 2.415; 93: 1min HRV, 1.685; 94: HR, 112.305; 94: RR, 24.356; 94: SpO2, 94.831; 94: Perf, 2.243; 94: 1min HRV, 3.770; 95: HR, 112.052; 95: RR, 24.569; 95: SpO2, 95.0; 95: Perf, 2.181; 95: 1min HRV, 1.974; 95: 5min HRV, 2.747; 96: HR, 112.237; 96: RR, 25.051; 96: SpO2, 94.847; 96: Perf, 2.044; 96: 1min HRV, 1.699; 97: HR, 112.172; 97: RR, 23.862; 97: SpO2, 95.672; 97: Perf, 2.615; 97: 1min HRV, 1.409; 100: 5min HRV, 1.576; 105: ALT (SGPT), 91 U/L; 105: SODIUM, 135 mmol/L; 105: ANION GAP, 13 mmol/L; 105: ALKALINE PHOSPHATASE, 48 U/L; 105: ALBUMIN, 3.4 g/dL; 105: AST (SGOT), 64 U/L; 105: PROTEIN TOTAL, 7.1 g/dL; 105: CREATININE, 1.13 mg/dL; 105: CHLORIDE, 99 mmol/L; 105: POTASSIUM, 4.3 mmol/L; 105: CO2, 23 mmol/L; 105: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 105: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 105: GLOBULIN, 3.7 g/dL; 105: CALCIUM, 9.0 mg/dL; 105: GLUCOSE, 203 mg/dL; 105: CORRECTED CALCIUM, 9.5 mg/dL; 105: BILIRUBIN TOTAL, 0.7 mg/dL; 115: C-REACTIVE PROTEIN (CRP), 7.0 mg/dL; 115: Pain, 10.0; 119: WHITE BLOOD CELLS (WBC), 5.0 K/uL; 119: HEMOGLOBIN (HGB), 12.6 g/dL; 119: MEAN CORPUSCULAR VOLUME (MCV), 91.8 fL; 119: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 119: HEMATOCRIT (HCT), 37.0 %; 119: PLATELET COUNT (PLT), 115 K/uL; 119: RED BLOOD CELLS (RBC), 4.03 MIL/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 119: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.52 K/uL; 119: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 119: METAMYELOCYTES % (MANUAL DIFF), 0.9 %; 119: BASOPHILS % (MANUAL DIFF), 0.9 %; 119: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.26 K/uL; 119: LYMPHOCYTES % (MANUAL DIFF), 3.5 %; 119: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 48.7 %; 119: EOSINOPHILS % (MANUAL DIFF), 10.4 %; 119: MONOCYTES % (MANUAL DIFF), 5.2 %; 119: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 3.98 K/uL; 119: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.05 K/uL; 119: NEUTROPHILS BANDS % (MANUAL DIFF), 30.4 %; 0: Age, 55; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.7; 0: Triage HR, 122.0; 0: Triage RR, 19.0; 0: Triage SBP, 141.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The key subquestions involve identifying clinical signs indicative of sepsis. Elevated heart rate and temperature along with low blood oxygen saturation (SpO2) suggest a potential for infection, which are present in this patient's EHR data. Additional lab results show elevated C-reactive protein (CRP), an indicator of inflammation that may suggest infection, alongside a lactate level that can indicate worsening oxygen delivery or utilization. These factors combined suggest a high risk of sepsis within the next 12 hours.",
        "claims": [
            "The key subquestions involve identifying clinical signs indicative of sepsis.",
            "Elevated heart rate suggests a potential for infection.",
            "Elevated temperature suggests a potential for infection.",
            "Low blood oxygen saturation (SpO2) suggests a potential for infection.",
            "The patient's EHR data shows elevated heart rate.",
            "The patient's EHR data shows elevated temperature.",
            "The patient's EHR data shows low blood oxygen saturation (SpO2).",
            "Additional lab results show elevated C-reactive protein (CRP).",
            "Elevated C-reactive protein (CRP) is an indicator of inflammation.",
            "Elevated C-reactive protein (CRP) may suggest infection.",
            "The patient's lab results show elevated lactate level.",
            "Elevated lactate level can indicate worsening oxygen delivery or utilization.",
            "These factors combined suggest a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Elevated heart rate suggests a potential for infection.",
            "Elevated temperature suggests a potential for infection.",
            "Low blood oxygen saturation (SpO2) suggests a potential for infection.",
            "The patient's EHR data shows elevated heart rate.",
            "The patient's EHR data shows elevated temperature.",
            "The patient's EHR data shows low blood oxygen saturation (SpO2).",
            "Additional lab results show elevated C-reactive protein (CRP).",
            "Elevated C-reactive protein (CRP) is an indicator of inflammation.",
            "Elevated C-reactive protein (CRP) may suggest infection.",
            "Elevated lactate level can indicate worsening oxygen delivery or utilization.",
            "These factors combined suggest a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.6,
            0.8,
            0.7,
            0.7,
            0.5,
            0.3,
            0.3,
            1.0,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is one of the criteria for Systemic Inflammatory Response Syndrome (SIRS), which is used to identify systemic inflammation consistent with early sepsis. The claim directly references an elevated heart rate, suggesting alignment with SIRS criteria, which are relevant for sepsis prediction. However, the claim alone doesn't confirm meeting multiple SIRS criteria, hence the slightly less than perfect alignment.",
            "Elevated temperature is explicitly part of the SIRS criteria, which includes temperature >38\u00b0C as a sign of systemic inflammation indicative of early sepsis. While the specific temperature value isn't given, the mention of \"elevated\" temperature suggests it is toward this threshold, aligning significantly with the SIRS criteria.",
            "Low blood oxygen saturation (SpO2) hints at possible hypoxia, which can relate to a decrease in PaO\u2082/FiO\u2082 ratio\u2014one of the SOFA score components. While SpO2 is not directly part of the SOFA score criteria, it conceptually aligns with assessing lung function and possible organ dysfunction due to sepsis, leading to a moderate alignment rating.",
            "An elevated heart rate (heart rate > 90 bpm) is one of the criteria listed under SIRS (Systemic Inflammatory Response Syndrome), which is used to identify systemic inflammation consistent with early sepsis. Since the claim indicates an elevated heart rate without specifying the exact value, it closely aligns with the SIRS criteria but might need further context to confirm full adherence to the criteria, like additional supporting criteria.",
            "While the claim mentions an elevated temperature, it does not specify if the temperature exceeds the SIRS criterion of >38\u00b0C (100.4\u00b0F). Thus, exact alignment of the temperature with the SIRS criteria cannot be confirmed, but it suggests a potential systemic inflammatory response, making it partially relevant.",
            "Low blood oxygen saturation (SpO2) is not directly a measure within the SOFA score, but it indicates potential respiratory impairment, which can be related to the SOFA criteria of impaired oxygenation (PaO\u2082/FiO\u2082\u202f<\u202f300). While SpO2 is not directly part of the SOFA calculation, the connection to potential respiratory dysfunction increases the patient's risk of sepsis-related organ dysfunction, thus aligning indirectly yet meaningfully with the category.",
            "Elevated C-reactive protein (CRP) is indicative of inflammation and is often used as a marker of infection or systemic inflammation, which aligns conceptually with the systemic inflammatory response syndrome (SIRS). However, CRP is not specifically listed as part of the SIRS criteria, which include more specific metrics like temperature, heart rate, respiratory rate, and white blood cell count. The alignment is partial since CRP supports the idea of inflammation but does not fulfill an explicit SIRS criterion.",
            "While elevated C-reactive protein (CRP) is indeed an indicator of inflammation, it is not one of the specific criteria listed under SIRS (Systemic Inflammatory Response Syndrome). However, it does have an indirect relevance to identifying systemic inflammation, making the alignment weak but present.",
            "Elevated C-reactive protein (CRP) is an inflammatory marker that can suggest an inflammatory or infectious process. It is not directly listed as a SIRS criterion, but it aligns with the concept of systemic inflammation, which is captured by the SIRS criteria. The alignment is indirect and less strong because CRP itself isn't used in SIRS criteria, so the alignment rating is low.",
            "The claim explicitly mentions \"elevated lactate level,\" which directly aligns with the category of Elevated Serum Lactate (\u22652 mmol/L). This category evaluates tissue hypoperfusion and elevated mortality risk associated with sepsis. The alignment is perfect since the claim directly addresses the concept described in this category.",
            "The claim mentions a high risk of sepsis within the next 12 hours, which could connect to an Elevated NEWS Score (\u22655 points) as it predicts imminent clinical deterioration, potentially compatible with sepsis. However, the claim itself is very vague and lacks any specific reference to the variables or measurements that create the NEWS score. Thus, the alignment is broad and weak, justifying a low rating."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 1
    },
    {
        "input": "7: HR, 144.0; 7: RR, 18.0; 7: SpO2, 98.0; 7: SBP, 152.0; 7: DBP, 98.0; 7: MAP, 116.0; 7: Temp, 97.7; 19: RR, 36.0; 83: HR, 133.739; 83: RR, 22.636; 83: 1min HRV, 10.734; 83: SBP, 156.0; 83: DBP, 109.0; 83: MAP, 124.667; 83: LR IV BOLUS -, 1000 ML; 84: HR:, 132.264; 84: RR, 25.761; 84: SpO2, 96.519; 84: 1min HRV, 12.989; 85: HR, 129.170; 85: SpO2, 96.674; 85: 1min HRV, 12.830; 85: 5min HRV, 13.946; 86: HR, 131.635; 86: SpO2, 96.712; 86: 1min HRV, 16.313; 87: HR, 129.811; 87: RR, 20.0; 87: SpO2, 96.075; 87: 1min HRV, 9.957; 88: HR, 128.827; 88: RR, 21.231; 88: SpO2, 96.596; 88: 1min HRV, 12.831; 89: HR, 126.340; 89: RR, 20.057; 89: SpO2, 97.302; 89: 1min HRV, 10.653; 90: HR, 128.415; 90: RR, 17.208; 90: SpO2, 96.358; 90: 1min HRV, 11.254; 90: 5min HRV, 13.239; 91: HR, 125.577; 91: RR, 20.981; 91: SpO2, 97.0; 91: 1min HRV, 12.190; 91: SBP, 167.0; 91: DBP, 108.0; 91: MAP, 127.667; 92: HR, 124.604; 92: RR, 16.547; 92: SpO2, 97.321; 92: 1min HRV, 12.536; 93: HR, 125.811; 93: RR, 20.660; 93: SpO2, 96.755; 93: 1min HRV, 7.732; 94: HR, 122.830; 94: RR, 22.811; 94: SpO2, 97.038; 94: 1min HRV, 16.489; 95: HR, 120.717; 95: RR, 22.849; 95: SpO2, 96.755; 95: 1min HRV, 16.859; 95: 5min HRV, 15.336; 95: SBP, 167.0; 95: DBP, 108.0; 95: MAP, 127.667; 96: HR, 121.692; 96: RR, 25.192; 96: SpO2, 96.712; 96: Perf, 0.877; 96: 1min HRV, 7.205; 97: HR, 121.679; 97: RR, 22.830; 97: SpO2, 96.264; 97: Perf, 0.895; 97: 1min HRV, 13.014; 98: HR, 120.462; 98: RR, 20.635; 98: SpO2, 96.019; 98: Perf, 0.886; 98: 1min HRV, 10.239; 99: HR, 120.056; 99: RR, 26.093; 99: SpO2, 96.037; 99: Perf, 0.836; 99: 1min HRV, 10.386; 100: HR, 119.925; 100: RR, 23.943; 100: SpO2, 95.0; 100: Perf, 0.802; 100: 1min HRV, 19.736; 100: 5min HRV, 13.378; 101: HR, 123.292; 101: RR, 19.422; 101: SpO2, 96.020; 101: Perf, 0.8; 101: 1min HRV, 26.040; 102: SARS-COV-2 RNA, Not Detected; 102: HR, 129.909; 102: RR, 25.833; 102: SpO2, 97.098; 102: Perf, 0.8; 102: 1min HRV, 15.681; 103: HR, 128.442; 103: RR, 28.347; 103: SpO2, 97.75; 103: Perf, 0.757; 103: 1min HRV, 12.615; 104: HR, 125.321; 104: RR, 28.0; 104: SpO2, 98.660; 104: Perf, 0.692; 104: 1min HRV, 7.775; 105: HR, 125.537; 105: RR, 49.0; 105: SpO2, 97.444; 105: Perf, 0.71; 105: 1min HRV, 12.504; 105: 5min HRV, 17.522; 106: HR, 124.577; 106: SpO2, 98.481; 106: Perf, 0.752; 106: 1min HRV, 10.585; 106: SBP, 172.0; 106: DBP, 120.0; 106: MAP, 137.333; 107: HR, 123.264; 107: SpO2, 98.566; 107: Perf, 0.76; 107: 1min HRV, 9.122; 108: WAM DIFTYP, AUTO; 108: HEMOGLOBIN (HGB), 13.5 g/dL; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 9.3 %; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.26 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.2 pg; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 80.8 %; 108: EOSINOPHIL % (AUTO DIFF), 0.2 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 108: BASOPHIL % (AUTO DIFF), 0.9 %; 108: HEMATOCRIT (HCT), 40.8 %; 108: WHITE BLOOD CELLS (WBC), 13.9 K/uL; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 108: PLATELET COUNT (PLT), 215 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.29 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 103.3 fL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: HR, 123.192; 108: SpO2, 95.923; 108: Perf, 0.761; 108: 1min HRV, 11.873; 109: HR, 124.208; 109: SpO2, 96.340; 109: Perf, 0.791; 109: 1min HRV, 4.982; 110: HR, 125.692; 110: SpO2, 96.231; 110: Perf, 0.8; 110: 1min HRV, 5.283; 110: 5min HRV, 9.970; 111: HR, 126.623; 111: SpO2, 95.642; 111: Perf, 0.8; 111: 1min HRV, 5.043; 112: HR, 126.434; 112: SpO2, 97.113; 112: Perf, 0.8; 112: 1min HRV, 11.187; 113: HR, 127.231; 113: SpO2, 97.365; 113: Perf, 0.800; 113: 1min HRV, 10.667; 114: HR, 126.415; 114: SpO2, 97.868; 114: Perf, 0.876; 114: 1min HRV, 6.807; 115: HR, 126.096; 115: SpO2, 96.65; 115: Perf, 0.883; 115: 1min HRV, 6.921; 115: 5min HRV, 8.705; 116: HR, 121.943; 116: SpO2, 95.358; 116: Perf, 0.908; 116: 1min HRV, 6.774; 117: HR, 121.593; 117: SpO2, 94.630; 117: Perf, 0.94; 117: 1min HRV, 6.756; 118: HR, 122.365; 118: SpO2, 96.283; 118: Perf, 0.94; 118: 1min HRV, 3.852; 119: HR, 123.075; 119: SpO2, 97.302; 119: Perf, 0.950; 119: 1min HRV, 5.567; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 144.0; 0: Triage RR, 18.0; 0: Triage SBP, 152.0; 0: Triage DBP, 98.0; 0: Triage acuity, 2-Emergent; 0: CC, EAR PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The subquestions to consider include analyzing vital signs, laboratory results, and overall patient context. The patient's HR is consistently high, and RR spikes at some points, but other vital signs like SBP, DBP, temperature, and SpO2 remain stable. The laboratory results show an elevated WBC count but not extremely so, and there's no indication of positive infection markers, like SARS-COV-2. The overall pattern doesn't strongly suggest an impending sepsis risk, leading to a \"No\" label.",
        "claims": [
            "The subquestions to consider include analyzing vital signs, laboratory results, and overall patient context.",
            "The patient's heart rate (HR) is consistently high.",
            "The patient's respiratory rate (RR) spikes at some points.",
            "Other vital signs such as systolic blood pressure (SBP), diastolic blood pressure (DBP), temperature, and SpO2 remain stable.",
            "The laboratory results show an elevated white blood cell (WBC) count.",
            "The elevated WBC count is not extremely high.",
            "There is no indication of positive infection markers, such as SARS-CoV-2.",
            "The overall pattern does not strongly suggest an impending sepsis risk.",
            "This analysis leads to a \"No\" label for sepsis risk."
        ],
        "relevant_claims": [
            "The patient's heart rate (HR) is consistently high.",
            "There is no indication of positive infection markers, such as SARS-CoV-2."
        ],
        "alignment_scores": [
            0.6,
            0.2
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim about a consistently high heart rate (HR) aligns with the concept of an elevated shock index, which involves heart rate as a key component (heart\u202frate\u202f\u00f7\u202fsystolic\u202fBP). Although the claim does not provide information about blood pressure to fully calculate the shock index or a rise in it, the emphasis on heart rate suggests relevance. Therefore, while there is some alignment, it is not complete due to missing parameters.",
            "The claim focuses on the absence of positive infection markers, specifically mentioning SARS-CoV-2. While this might impact the decision not to pursue early antibiotic administration or culture orders, it does not directly relate to any concrete clinical action or specific infection marker categories. The alignment is very indirect as it implies a consideration of infection risk assessment but lacks an immediate clinical correlation to sepsis prediction categories."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 0
    },
    {
        "input": "4: HR, 110.0; 4: RR, 20.0; 4: SpO2, 95.0; 4: SBP, 121.0; 4: DBP, 75.0; 4: MAP, 90.333; 4: LPM O2, 2.0; 4: Pain, 9.0; 4: Temp, 101.0; 8: HR, 110.423; 8: SpO2, 97.286; 8: 1min HRV, 6.363; 9: HR, 109.491; 9: SpO2, 95.462; 9: 1min HRV, 7.100; 9: 5min HRV, 7.163; 10: HR, 109.019; 10: SpO2, 93.042; 10: 1min HRV, 5.598; 11: HR, 108.231; 11: SpO2, 100.0; 11: 1min HRV, 6.479; 12: HR, 108.057; 12: SpO2, 97.25; 12: 1min HRV, 6.938; 13: HR, 107.808; 13: SpO2, 92.0; 13: 1min HRV, 6.788; 14: HR, 108.057; 14: 1min HRV, 6.794; 14: 5min HRV, 6.848; 15: HR, 107.642; 15: 1min HRV, 8.627; 16: HR, 106.577; 16: SpO2, 100.0; 16: 1min HRV, 5.616; 17: HR, 106.736; 17: SpO2, 100.0; 17: 1min HRV, 8.881; 18: HR, 106.404; 18: SpO2, 100.0; 18: 1min HRV, 6.987; 19: HR, 106.660; 19: SpO2, 95.0; 19: 1min HRV, 5.812; 19: 5min HRV, 7.624; 20: HR, 104.981; 20: SpO2, 93.7; 20: 1min HRV, 5.233; 21: HR, 105.113; 21: SpO2, 86.75; 21: 1min HRV, 4.250; 22: HR, 104.981; 22: 1min HRV, 6.263; 23: HR, 104.904; 23: 1min HRV, 5.129; 24: HR, 105.264; 24: 1min HRV, 6.084; 24: 5min HRV, 5.666; 25: HR, 106.077; 25: 1min HRV, 3.849; 26: HR, 106.283; 26: 1min HRV, 4.909; 27: HR, 105.660; 27: SpO2, 99.5; 27: 1min HRV, 5.928; 27: LR IV BOLUS -, 1000 ML; 28: HR:, 106.038; 28: SpO2, 100.0; 28: 1min HRV, 6.198; 28: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 29: HR:, 105.585; 29: SpO2, 100.0; 29: 1min HRV, 6.069; 29: 5min HRV, 5.721; 30: HR, 104.827; 30: 1min HRV, 6.000; 30: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 31: HR:, 104.113; 31: 1min HRV, 5.008; 32: HR, 103.811; 32: 1min HRV, 4.507; 33: HR, 103.962; 33: 1min HRV, 5.163; 34: HR, 103.302; 34: SpO2, 97.0; 34: 1min HRV, 4.079; 34: 5min HRV, 5.647; 35: HR, 103.019; 35: SpO2, 99.0; 35: 1min HRV, 4.333; 36: HR, 104.208; 36: SpO2, 98.2; 36: 1min HRV, 4.511; 37: HR, 103.283; 37: SpO2, 97.0; 37: 1min HRV, 4.111; 38: HR, 103.192; 38: SpO2, 96.591; 38: 1min HRV, 8.164; 39: HR, 102.094; 39: SpO2, 100.0; 39: 1min HRV, 4.334; 39: 5min HRV, 6.205; 40: HR, 102.769; 40: SpO2, 100.0; 40: 1min HRV, 4.169; 41: HR, 103.019; 41: SpO2, 97.667; 41: 1min HRV, 4.208; 42: HR, 103.0; 42: SpO2, 100.0; 42: 1min HRV, 3.939; 43: HR, 102.269; 43: SpO2, 100.0; 43: 1min HRV, 4.882; 44: HR, 102.811; 44: SpO2, 100.0; 44: 1min HRV, 4.287; 44: 5min HRV, 4.601; 45: HR, 102.308; 45: SpO2, 99.922; 45: Perf, 0.195; 45: 1min HRV, 4.202; 49: 5min HRV, 4.202; 53: POC PH (V) ISTAT, 7.38; 53: POC LACTATE ISTAT, 0.60 mmol/L; 53: POC HCO3 (V) ISTAT, 27.6 mmol/L; 53: POC PO2 (V) ISTAT, 31 mmHg; 53: POC PCO2 (V) ISTAT, 46.3 mmHg; 53: POC BASE EXCESS ISTAT, 3 mmol/L; 53: POC O2 SATURATION ISTAT VENOUS, 59 %; 53: POC TCO2 (V) ISTAT, 29 mmol/L; 64: RSV, Not Detected; 64: SARS-COV-2 RNA, Not Detected; 64: INFLUENZA A, Not Detected; 64: INFLUENZA B, Not Detected; 65: WAM DIFTYP, AUTO; 65: LYMPHOCYTE % (AUTO DIFF), 4.8 %; 65: PLATELET COUNT (PLT), 100 K/uL; 65: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 65: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 65: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 65: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 65: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 65: BASOPHIL % (AUTO DIFF), 0.1 %; 65: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.39 K/uL; 65: HEMATOCRIT (HCT), 27.9 %; 65: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.41 K/uL; 65: MONOCYTE % (AUTO DIFF), 3.8 %; 65: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 65: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.0 pg; 65: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 65: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 65: HEMOGLOBIN (HGB), 9.3 g/dL; 65: MEAN CORPUSCULAR VOLUME (MCV), 95.9 fL; 65: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 65: EOSINOPHIL % (AUTO DIFF), 0.0 %; 65: NEUTROPHIL % (AUTO DIFF), 90.9 %; 65: NRBC PERCENT (HEMATOLOGY), 0.0 %; 65: WHITE BLOOD CELLS (WBC), 8.2 K/uL; 78: INR, 1.1; 78: PROTHROMBIN TIME, 14.0 seconds; 79: PART. THROMBOPLASTIN TIME, 35.6 seconds; 99: CALCIUM, 8.6 mg/dL; 99: AST (SGOT), 47 U/L; 99: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 99: PROTEIN TOTAL, 6.5 g/dL; 99: BILIRUBIN TOTAL, 0.3 mg/dL; 99: POTASSIUM, 3.5 mmol/L; 99: CORRECTED CALCIUM, 8.9 mg/dL; 99: GLOBULIN, 2.9 g/dL; 99: ANION GAP, 11 mmol/L; 99: ALKALINE PHOSPHATASE, 134 U/L; 99: GLUCOSE, 156 mg/dL; 99: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 99: CREATININE, 0.56 mg/dL; 99: SODIUM, 133 mmol/L; 99: CHLORIDE, 97 mmol/L; 99: CO2, 25 mmol/L; 99: LIPASE, 19 U/L; 99: ALT (SGPT), 45 U/L; 99: ALBUMIN, 3.6 g/dL; 103: HR, 95.0; 103: SpO2, 100.0; 103: SBP, 97.0; 103: DBP, 66.0; 103: MAP, 76.333; 103: LPM O2, 2.0; 103: Pain, 8.0; 103: Temp, 99.3; 104: KETAMINE, IVPB (ED/CDU PAIN INDICATION); 119: HR:, 91.0; 119: SpO2, 100.0; 119: SBP, 96.0; 119: DBP, 65.0; 119: MAP, 75.333; 119: LPM O2, 2.0; 119: Pain, 3.0; 0: Age, 65; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 121.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, VOMITING",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To predict sepsis risk, first evaluate vital signs, lab results, and symptoms common in sepsis, like high heart rate, fever, low blood pressure, or abnormal lab values. This patient presents with a high heart rate and fever initially but maintains stable oxygen levels and blood pressure without signs of organ dysfunction. Labs are largely within normal limits or slightly outside without indicating sepsis. There's no significant deterioration, indicating the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To predict sepsis risk, first evaluate vital signs, lab results, and symptoms common in sepsis.",
            "Vital signs, lab results, and symptoms common in sepsis include high heart rate, fever, low blood pressure, and abnormal lab values.",
            "This patient presents with a high heart rate initially.",
            "This patient presents with a fever initially.",
            "The patient maintains stable oxygen levels.",
            "The patient maintains stable blood pressure.",
            "There are no signs of organ dysfunction in this patient.",
            "Lab results for this patient are largely within normal limits.",
            "Some lab results are slightly outside normal limits but do not indicate sepsis.",
            "There has been no significant deterioration in the patient's condition.",
            "The patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "This patient presents with a high heart rate initially.",
            "This patient presents with a fever initially."
        ],
        "alignment_scores": [
            0.7,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "A high heart rate is one of the criteria for SIRS, which relates to systemic inflammation and could indicate early sepsis. While the claim only specifies one elevated parameter (heart rate), it still aligns strongly with the SIRS category, though not fully, as it doesn't specify \u22652 criteria required for complete SIRS positivity.",
            "The claim mentions the presence of a fever, which aligns with one of the SIRS criteria of having a temperature >38\u00b0C. However, the claim does not specify the exact temperature, leaving some ambiguity about whether the specific temperature criterion is met. Therefore, while fever suggests the presence of inflammation, it is not explicit enough to fully satisfy the criteria, resulting in a partial alignment."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 0
    },
    {
        "input": "2: HR, 130.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 150.0; 2: DBP, 80.0; 2: MAP, 103.333; 2: Temp, 100.8; 49: POC PH (V) ISTAT, 7.43; 49: POC TCO2 (V) ISTAT, 28 mmol/L; 49: POC PO2 (V) ISTAT, 32 mmHg; 49: POC BASE EXCESS ISTAT, 2 mmol/L; 49: POC LACTATE ISTAT, 1.79 mmol/L; 49: POC O2 SATURATION ISTAT VENOUS, 63 %; 49: POC HCO3 (V) ISTAT, 26.6 mmol/L; 49: POC PCO2 (V) ISTAT, 40.5 mmHg; 57: SpO2, 98.706; 58: HR, 115.429; 58: RR, 34.846; 58: SpO2, 98.917; 58: Perf, 0.15; 58: 1min HRV, 7.583; 59: HR, 114.293; 59: RR, 21.190; 59: SpO2, 98.792; 59: Perf, 0.15; 59: 1min HRV, 10.194; 60: HR, 111.712; 60: RR, 19.220; 60: SpO2, 98.419; 60: 1min HRV, 7.770; 60: 5min HRV, 10.260; 60: Temp, 99.8; 61: HR, 113.948; 61: RR, 20.172; 61: SpO2, 97.979; 61: 1min HRV, 12.083; 62: HR, 111.25; 62: RR, 19.85; 62: SpO2, 99.909; 62: Perf, 0.12; 62: 1min HRV, 8.237; 63: HR, 112.828; 63: RR, 19.5; 63: SpO2, 100.0; 63: Perf, 0.08; 63: 1min HRV, 9.478; 64: HR, 115.017; 64: RR, 21.339; 64: SpO2, 99.333; 64: Perf, 0.087; 64: 1min HRV, 9.341; 65: HR, 113.879; 65: RR, 18.155; 65: SpO2, 98.75; 65: Perf, 0.1; 65: 1min HRV, 9.050; 65: 5min HRV, 11.233; 66: HR, 112.610; 66: RR, 19.169; 66: SpO2, 93.7; 66: 1min HRV, 7.226; 67: HR, 109.241; 67: RR, 20.914; 67: SpO2, 97.846; 67: 1min HRV, 16.590; 68: HR, 109.780; 68: RR, 25.322; 68: SpO2, 100.0; 68: 1min HRV, 6.405; 69: HR, 115.678; 69: RR, 21.390; 69: SpO2, 97.6; 69: 1min HRV, 13.991; 70: HR, 119.172; 70: RR, 24.172; 70: 1min HRV, 12.028; 70: 5min HRV, 20.794; 71: HR, 114.431; 71: RR, 19.983; 71: SpO2, 99.190; 71: 1min HRV, 6.842; 72: WAM DIFTYP, AUTO; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 72: EOSINOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 21.7 pg; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 72: HEMOGLOBIN (HGB), 11.2 g/dL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 72: MEAN CORPUSCULAR VOLUME (MCV), 69.1 fL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.16 K/uL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 72: PLATELET COUNT (PLT), 284 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 72: HEMATOCRIT (HCT), 35.6 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: NEUTROPHIL % (AUTO DIFF), 81.5 %; 72: RED BLOOD CELLS (RBC), 5.15 MIL/uL; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: MONOCYTE % (AUTO DIFF), 6.9 %; 72: WHITE BLOOD CELLS (WBC), 11.1 K/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.02 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 10.5 %; 72: HR, 114.797; 72: RR, 16.220; 72: SpO2, 99.0; 72: 1min HRV, 12.736; 73: HR, 116.593; 73: RR, 22.322; 73: SpO2, 99.667; 73: 1min HRV, 10.852; 74: INR, 1.1; 74: PROTHROMBIN TIME, 13.7 seconds; 74: HR, 114.271; 74: RR, 15.136; 74: SpO2, 99.158; 74: 1min HRV, 13.033; 75: PART. THROMBOPLASTIN TIME, 26.9 seconds; 75: HR, 115.983; 75: RR, 18.569; 75: SpO2, 99.172; 75: Perf, 0.335; 75: 1min HRV, 9.179; 75: 5min HRV, 11.055; 76: HR, 117.833; 76: RR, 20.333; 76: SpO2, 98.857; 76: Perf, 0.339; 76: 1min HRV, 20.298; 77: HR, 119.635; 77: RR, 18.315; 77: SpO2, 97.810; 77: 1min HRV, 11.138; 78: HR, 118.458; 78: RR, 15.915; 78: SpO2, 98.906; 78: 1min HRV, 7.851; 78: SBP, 136.0; 78: DBP, 86.0; 78: MAP, 102.667; 79: HR, 118.390; 79: RR, 21.864; 79: SpO2, 97.0; 79: 1min HRV, 10.976; 80: HR, 116.345; 80: RR, 19.190; 80: SpO2, 92.25; 80: 1min HRV, 6.229; 80: 5min HRV, 12.280; 81: HR, 117.068; 81: RR, 16.475; 81: SpO2, 100.0; 81: 1min HRV, 9.360; 82: HR, 114.948; 82: RR, 13.672; 82: SpO2, 99.0; 82: 1min HRV, 8.781; 83: HR, 113.831; 83: RR, 17.407; 83: SpO2, 98.0; 83: 1min HRV, 9.350; 84: SPECIFIC GRAVITY, URINE (UA): 1.014; 84: PROTEIN, URINE (UA): Negative; 84: GLUCOSE, URINE (UA): Negative; 84: PH, URINE (UA): 7.0; 84: NITRITE, URINE (UA): Negative; 84: LEUKOCYTE ESTERASE, URINE (UA): Negative; 84: KETONE, URINE (UA): Negative; 84: BLOOD, URINE (UA): Negative; 84: HR, 114.525; 84: RR, 19.186; 84: SpO2, 99.111; 84: 1min HRV, 12.467; 85: HR, 112.828; 85: RR, 16.103; 85: SpO2, 98.0; 85: 1min HRV, 8.069; 85: 5min HRV, 11.248; 85: SBP, 141.0; 85: DBP, 83.0; 85: MAP, 102.333; 85: Temp, 102.6; 86: HR, 119.357; 86: RR, 19.462; 86: SpO2, 87.762; 86: 1min HRV, 11.205; 87: HR, 114.0; 87: 1min HRV, 2.966; 90: POTASSIUM, 3.7 mmol/L; 90: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 90: PROTEIN TOTAL, 7.5 g/dL; 90: ALKALINE PHOSPHATASE, 167 U/L; 90: BILIRUBIN TOTAL, 0.7 mg/dL; 90: CO2, 23 mmol/L; 90: SODIUM, 138 mmol/L; 90: CREATININE, 0.82 mg/dL; 90: ALBUMIN, 4.7 g/dL; 90: CORRECTED CALCIUM, 9.0 mg/dL; 90: ALT (SGPT), 25 U/L; 90: AST (SGOT), 14 U/L; 90: CHLORIDE, 101 mmol/L; 90: GLOBULIN, 2.8 g/dL; 90: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 90: ANION GAP, 14 mmol/L; 90: GLUCOSE, 111 mg/dL; 90: CALCIUM, 9.6 mg/dL; 90: 5min HRV, 15.033; 92: RSV, Not Detected; 92: INFLUENZA B, Not Detected; 92: INFLUENZA A, Not Detected; 92: SARS-COV-2 RNA, Not Detected; 95: LR IV BOLUS -, 1000 ML; 96: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 100: HR, 103.0; 100: RR, 25.0; 100: SpO2, 97.0; 100: SBP, 126.0; 100: DBP, 80.0; 100: MAP, 95.333; 0: Age, 44; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 130.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, HIP PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To predict sepsis risk, I considered key clinical indicators. The patient's initial HR and RR are elevated, and the temperature remains high, suggesting possible infection. However, lactate levels are within normal range, SpO2 remains adequate, and the differential WBC count does not show marked deviation indicative of sepsis. Additionally, vital signs remain relatively stable throughout, and laboratory tests do not suggest significant organ dysfunction. Therefore, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To predict sepsis risk, key clinical indicators were considered.",
            "The patient's initial heart rate (HR) is elevated.",
            "The patient's initial respiratory rate (RR) is elevated.",
            "The patient's temperature remains high.",
            "An elevated temperature suggests possible infection.",
            "Lactate levels are within normal range.",
            "SpO2 remains adequate.",
            "The differential white blood cell (WBC) count does not show marked deviation indicative of sepsis.",
            "Vital signs remain relatively stable throughout.",
            "Laboratory tests do not suggest significant organ dysfunction.",
            "The patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's initial heart rate (HR) is elevated.",
            "The patient's initial respiratory rate (RR) is elevated.",
            "The patient's temperature remains high.",
            "An elevated temperature suggests possible infection."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.7,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is one of the criteria for SIRS, which can indicate systemic inflammation consistent with early sepsis. While the claim mentions an elevated heart rate, it does not specify if the heart rate exceeds 90 bpm, but it strongly suggests that the criteria could be met if additional context were given; hence the high alignment rating.",
            "An elevated respiratory rate is one of the components of the qSOFA score (specifically, a respiratory rate \u226522/min). This directly ties to assessing the risk of sepsis-related organ dysfunction and mortality. However, without knowing the exact value of the respiratory rate or other qSOFA criteria, this alignment is not complete but still significant.",
            "The claim refers to a high temperature, a component of the SIRS criteria (temperature >38\u00b0C). While it doesn't specify the exact temperature, a persistently high temperature strongly suggests systemic inflammation, consistent with early sepsis as identified by SIRS criteria. Since it aligns well but lacks precise detail, I rated it 0.7.",
            "An elevated temperature is one of the SIRS criteria used to identify systemic inflammation and early sepsis. However, the claim does not specify if the temperature exceeds the critical threshold (>38\u00b0C), thus alignment is strong but not complete due to lack of specific numerical detail."
        ],
        "final_alignment_score": 0.7250000000000001,
        "accuracy": 1
    },
    {
        "input": "4: HR, 95.0; 4: RR, 14.0; 4: SpO2, 100.0; 4: SBP, 142.0; 4: DBP, 87.0; 4: MAP, 105.333; 4: Pain, 5.0; 4: Temp, 99.8; 38: POC PH (V) ISTAT, 7.40; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC O2 SATURATION ISTAT VENOUS, 33 %; 38: POC HCO3 (V) ISTAT, 30.1 mmol/L; 38: POC PO2 (V) ISTAT, 21 mmHg; 38: POC LACTATE ISTAT, 0.78 mmol/L; 38: POC PCO2 (V) ISTAT, 48.5 mmHg; 42: SpO2, 95.429; 42: SBP, 132.0; 42: DBP, 79.0; 42: MAP, 96.667; 43: SpO2, 97.695; 43: Perf, 1.460; 44: SpO2, 97.655; 44: Perf, 1.709; 45: SpO2, 97.847; 45: Perf, 1.616; 46: SpO2, 97.431; 46: Perf, 1.456; 47: SpO2, 97.831; 47: Perf, 1.534; 48: SpO2, 97.729; 48: Perf, 1.598; 49: SpO2, 97.690; 49: Perf, 1.836; 50: SpO2, 96.966; 50: Perf, 1.689; 51: SpO2, 96.862; 51: Perf, 1.797; 52: SpO2, 98.153; 52: Perf, 1.553; 53: SpO2, 97.085; 53: Perf, 1.476; 54: SpO2, 96.828; 54: Perf, 1.469; 55: SpO2, 97.695; 55: Perf, 1.439; 56: SpO2, 97.276; 56: Perf, 1.384; 57: SpO2, 97.237; 57: Perf, 1.219; 58: SpO2, 96.508; 58: Perf, 1.283; 59: SpO2, 96.655; 59: Perf, 1.297; 59: Pain, 5.0; 60: SpO2, 98.153; 60: Perf, 1.605; 61: SpO2, 97.793; 61: Perf, 1.55; 62: SpO2, 98.559; 62: Perf, 1.715; 63: SpO2, 97.119; 63: Perf, 1.324; 64: SpO2, 97.5; 64: Perf, 1.432; 65: SpO2, 96.983; 65: Perf, 1.462; 66: SpO2, 96.931; 66: Perf, 1.344; 67: SpO2, 95.898; 67: Perf, 1.367; 68: SpO2, 97.932; 68: Perf, 2.006; 69: SpO2, 97.828; 69: Perf, 2.007; 70: SpO2, 97.322; 70: Perf, 1.516; 70: ACETAMINOPHEN, 325 MG PO TABS; 71: SpO, 2: 98.293; 71: Perf, 2.057; 71: LR IV BOLUS -, 1000 ML; 72: SpO, 2: 96.864; 72: Perf, 1.716; 73: SpO2, 97.525; 73: Perf, 1.641; 74: SpO2, 96.810; 74: Perf, 1.119; 75: SpO2, 96.576; 75: Perf, 1.097; 76: SpO2, 96.828; 76: Perf, 0.97; 77: SpO2, 96.729; 77: Perf, 0.978; 78: SpO2, 97.103; 78: Perf, 1.133; 79: SpO2, 97.746; 79: Perf, 0.817; 80: SpO2, 97.780; 80: Perf, 0.655; 81: SpO2, 98.121; 81: Perf, 0.556; 82: SpO2, 97.407; 82: Perf, 0.713; 83: SpO2, 97.845; 83: Perf, 0.911; 84: SpO2, 97.322; 84: Perf, 1.002; 85: SpO2, 96.763; 85: Perf, 0.847; 86: SpO2, 97.310; 86: Perf, 0.828; 87: SpO2, 97.542; 87: Perf, 0.783; 88: SpO2, 97.121; 88: Perf, 0.765; 89: HR, 87.0; 89: RR, 16.0; 89: SpO2, 97.763; 89: Perf, 1.317; 89: SBP, 137.0; 89: DBP, 80.0; 89: MAP, 99.0; 90: SpO2, 98.458; 90: Perf, 1.344; 90: SBP, 137.0; 90: DBP, 80.0; 90: MAP, 99.0; 91: SpO2, 97.586; 91: Perf, 1.229; 92: SpO2, 98.424; 92: Perf, 1.203; 93: WAM DIFTYP, AUTO; 93: BASOPHIL % (AUTO DIFF), 0.0 %; 93: MEAN CORPUSCULAR VOLUME (MCV), 90.7 fL; 93: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 93: MONOCYTE % (AUTO DIFF), 9.4 %; 93: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 93: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 93: NEUTROPHIL % (AUTO DIFF), 62.1 %; 93: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.65 K/uL; 93: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 93: NRBC PERCENT (HEMATOLOGY), 0.0 %; 93: EOSINOPHIL % (AUTO DIFF), 0.2 %; 93: PLATELET COUNT (PLT), 140 K/uL; 93: BASOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 93: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 93: RED BLOOD CELLS (RBC), 4.85 MIL/uL; 93: WHITE BLOOD CELLS (WBC), 4.3 K/uL; 93: HEMATOCRIT (HCT), 44.0 %; 93: LYMPHOCYTE % (AUTO DIFF), 28.1 %; 93: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 93: RED CELL DISTRIBUTION WIDTH (RDW), 12.1 %; 93: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 93: HEMOGLOBIN (HGB), 14.2 g/dL; 93: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 93: SpO2, 97.776; 93: Perf, 1.051; 94: SpO2, 98.390; 94: Perf, 1.286; 95: SpO2, 97.458; 95: Perf, 1.696; 96: SpO2, 97.552; 96: Perf, 1.981; 97: SpO2, 98.136; 97: Perf, 2.354; 98: SpO2, 97.741; 98: Perf, 3.455; 99: SpO2, 97.525; 99: Perf, 3.604; 100: CORRECTED CALCIUM, 8.1 mg/dL; 100: AST (SGOT), 55 U/L; 100: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 100: CREATININE, 0.83 mg/dL; 100: BILIRUBIN TOTAL, 0.4 mg/dL; 100: CALCIUM, 8.5 mg/dL; 100: CO2, 26 mmol/L; 100: PROTEIN TOTAL, 7.4 g/dL; 100: SODIUM, 136 mmol/L; 100: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 100: CHLORIDE, 99 mmol/L; 100: GLUCOSE, 97 mg/dL; 100: ALT (SGPT), 47 U/L; 100: POTASSIUM, 3.7 mmol/L; 100: ANION GAP, 11 mmol/L; 100: ALKALINE PHOSPHATASE, 67 U/L; 100: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 100: GLOBULIN, 2.9 g/dL; 100: ALBUMIN, 4.5 g/dL; 100: SpO2, 98.0; 100: Perf, 2.318; 101: SpO2, 97.431; 101: Perf, 3.629; 102: SpO2, 97.441; 102: Perf, 3.987; 103: SpO2, 97.655; 103: Perf, 4.155; 104: SpO2, 97.644; 104: Perf, 5.328; 105: SpO2, 97.627; 105: Perf, 5.882; 106: SpO2, 98.069; 106: Perf, 4.651; 107: SpO2, 98.034; 107: Perf, 3.996; 108: SpO2, 97.224; 108: Perf, 4.485; 109: SpO2, 96.847; 109: Perf, 6.229; 110: SpO2, 97.241; 110: Perf, 5.401; 111: SpO2, 97.424; 111: Perf, 5.043; 112: SpO2, 97.695; 112: Perf, 4.544; 113: SpO2, 97.897; 113: Perf, 4.034; 114: SpO2, 97.898; 114: Perf, 3.892; 115: SpO2, 97.914; 115: Perf, 3.896; 116: SpO2, 97.983; 116: Perf, 3.929; 117: SpO2, 97.593; 117: Perf, 3.813; 118: SpO2, 97.845; 118: Perf, 3.414; 119: SpO2, 98.424; 119: Perf, 2.615; 0: Age, 30; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 95.0; 0: Triage RR, 14.0; 0: Triage SBP, 142.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERALIZED BODY ACHES,FEVER,HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To predict the risk of sepsis, I first examined the vital signs for abnormalities such as high heart rate, abnormal body temperature, or low blood oxygen saturation. The heart rate, temperature, and SpO2 were within normal ranges and showed stability over time. Next, I checked laboratory values such as lactate levels, which were normal. I also reviewed treatments, such as LR bolus, which may indicate fluid resuscitation, but given the overall stable and normal clinical parameters, the risk of sepsis is low. The absence of troubling signs like a high WBC count or significant hemodynamic instability also supports a low sepsis risk assessment.",
        "claims": [
            "I examined the vital signs for abnormalities to predict the risk of sepsis.",
            "I looked for high heart rate as a possible indicator of sepsis.",
            "I considered abnormal body temperature as a potential sign of sepsis.",
            "I assessed low blood oxygen saturation when predicting sepsis risk.",
            "The heart rate was within normal ranges.",
            "The temperature was within normal ranges.",
            "The SpO2 levels showed stability over time.",
            "I checked laboratory values such as lactate levels.",
            "The lactate levels were normal.",
            "I reviewed treatments administered to the patient.",
            "The patient received an LR bolus, which may indicate fluid resuscitation.",
            "The overall clinical parameters were stable and normal.",
            "Given the stable clinical parameters, the risk of sepsis is low.",
            "The absence of a high WBC count supports a low risk of sepsis.",
            "The presence of no significant hemodynamic instability supports a low risk of sepsis."
        ],
        "relevant_claims": [
            "The presence of no significant hemodynamic instability supports a low risk of sepsis."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)"
        ],
        "alignment_reasonings": [
            "The claim references \"no significant hemodynamic instability,\" which is closely related to the category of Elevated Shock Index, as hemodynamic instability affects the shock index calculation. Since the claim suggests stability, it implies a low shock index, reducing the risk of severe sepsis. However, the alignment isn't perfect because the claim is about absence of instability rather than directly stating shock index values."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 119.0; 5: DBP, 63.0; 5: MAP, 81.667; 5: Temp, 97.9; 48: HR, 107.171; 48: RR, 21.667; 48: 1min HRV, 7.060; 48: SBP, 132.0; 48: DBP, 86.0; 48: MAP, 101.333; 49: HR, 103.707; 49: RR, 15.017; 49: 1min HRV, 7.922; 50: HR, 101.559; 50: RR, 13.593; 50: 1min HRV, 13.327; 50: 5min HRV, 15.889; 51: HR, 104.948; 51: RR, 18.052; 51: 1min HRV, 12.539; 52: HR, 108.780; 52: RR, 13.593; 52: 1min HRV, 9.291; 53: HR, 107.305; 53: RR, 16.288; 53: 1min HRV, 21.887; 54: HR, 107.741; 54: RR, 17.103; 54: 1min HRV, 9.699; 55: HR, 104.525; 55: RR, 13.729; 55: 1min HRV, 16.064; 55: 5min HRV, 16.311; 56: HR, 103.672; 56: RR, 16.586; 56: 1min HRV, 11.985; 57: HR, 98.949; 57: RR, 16.254; 57: 1min HRV, 18.393; 58: HR, 102.288; 58: RR, 15.847; 58: 1min HRV, 24.567; 59: HR, 101.603; 59: RR, 16.172; 59: 1min HRV, 14.703; 60: HR, 99.780; 60: RR, 19.017; 60: 1min HRV, 11.709; 60: 5min HRV, 18.947; 61: HR, 99.810; 61: RR, 20.776; 61: 1min HRV, 5.400; 62: HR, 100.475; 62: RR, 17.441; 62: 1min HRV, 4.773; 63: HR, 101.138; 63: RR, 17.345; 63: 1min HRV, 24.163; 64: HR, 100.864; 64: RR, 19.864; 64: 1min HRV, 14.177; 65: HR, 99.373; 65: RR, 19.254; 65: 1min HRV, 5.808; 65: 5min HRV, 13.977; 66: HR, 99.138; 66: RR, 18.052; 66: 1min HRV, 6.775; 67: HR, 101.780; 67: RR, 18.068; 67: 1min HRV, 6.950; 68: HR, 103.224; 68: RR, 16.897; 68: 1min HRV, 11.861; 69: HR, 102.525; 69: RR, 18.661; 69: 1min HRV, 25.985; 70: HR, 100.695; 70: RR, 18.576; 70: 1min HRV, 6.207; 70: 5min HRV, 16.112; 71: HR, 101.224; 71: RR, 18.5; 71: 1min HRV, 5.814; 72: HR, 101.203; 72: RR, 18.339; 72: 1min HRV, 30.666; 73: HR, 100.517; 73: RR, 18.086; 73: 1min HRV, 4.284; 74: HR, 101.390; 74: RR, 18.661; 74: 1min HRV, 4.836; 75: HR, 100.153; 75: RR, 18.356; 75: SpO2, 100.0; 75: 1min HRV, 5.396; 75: 5min HRV, 14.719; 75: SBP, 125.0; 75: DBP, 78.0; 75: MAP, 93.667; 76: HR, 100.586; 76: RR, 19.707; 76: 1min HRV, 6.736; 76: SBP, 125.0; 76: DBP, 78.0; 76: MAP, 93.667; 77: HR, 101.0; 77: RR, 19.915; 77: 1min HRV, 25.271; 78: HR, 102.207; 78: RR, 18.776; 78: 1min HRV, 7.651; 79: HR, 104.186; 79: RR, 19.339; 79: 1min HRV, 23.564; 80: HR, 99.559; 80: RR, 18.339; 80: 1min HRV, 5.302; 80: 5min HRV, 18.504; 81: HR, 99.276; 81: RR, 16.224; 81: 1min HRV, 10.391; 81: LR IV BOLUS -, 1000 ML; 82: HR:, 100.0; 82: RR, 14.407; 82: 1min HRV, 21.803; 83: POC PH (V) ISTAT, 7.41; 83: POC PCO2 (V) ISTAT, 35.4 mmHg; 83: POC TCO2 (V) ISTAT, 24 mmol/L; 83: POC HCO3 (V) ISTAT, 22.5 mmol/L; 83: POC BASE EXCESS ISTAT, -2 mmol/L; 83: POC PO2 (V) ISTAT, 37 mmHg; 83: POC O2 SATURATION ISTAT VENOUS, 72 %; 83: POC LACTATE ISTAT, 2.36 mmol/L; 83: HR, 99.948; 83: RR, 15.759; 83: 1min HRV, 10.178; 84: HR, 103.169; 84: RR, 16.407; 84: 1min HRV, 7.486; 85: HR, 100.627; 85: RR, 17.203; 85: 1min HRV, 18.625; 85: 5min HRV, 16.917; 86: HR, 100.121; 86: RR, 17.862; 86: 1min HRV, 14.181; 87: HR, 104.373; 87: RR, 16.220; 87: 1min HRV, 31.188; 88: HR, 106.397; 88: RR, 17.448; 88: 1min HRV, 25.171; 89: HR, 105.441; 89: RR, 20.017; 89: 1min HRV, 20.929; 90: HR, 103.661; 90: RR, 19.424; 90: 1min HRV, 12.967; 90: 5min HRV, 24.426; 91: HR, 102.724; 91: RR, 20.190; 91: 1min HRV, 10.363; 92: HR, 103.864; 92: RR, 19.576; 92: 1min HRV, 16.807; 93: HR, 103.259; 93: RR, 16.793; 93: 1min HRV, 26.245; 94: HR, 105.390; 94: RR, 19.475; 94: 1min HRV, 25.257; 95: SARS-COV-2 RNA, Not Detected; 95: HR, 101.914; 95: RR, 19.966; 95: 1min HRV, 6.939; 95: 5min HRV, 19.694; 96: HR, 101.814; 96: RR, 19.458; 96: 1min HRV, 6.218; 97: HR, 103.153; 97: RR, 19.356; 97: 1min HRV, 15.343; 98: HR, 103.741; 98: RR, 19.431; 98: 1min HRV, 11.374; 99: HR, 105.475; 99: RR, 18.034; 99: 1min HRV, 18.055; 100: HR, 101.655; 100: RR, 20.897; 100: 1min HRV, 14.612; 100: 5min HRV, 16.578; 101: ALKALINE PHOSPHATASE, 156 U/L; 101: GLOBULIN, 1.7 g/dL; 101: POTASSIUM, 4.1 mmol/L; 101: CHLORIDE, 102 mmol/L; 101: LIPASE, 70 U/L; 101: AST (SGOT), 36 U/L; 101: EGFR REFIT WITHOUT RACE (2021), 65 mL/min/1.73 m2; 101: ANION GAP, 13 mmol/L; 101: PROTEIN TOTAL, 5.7 g/dL; 101: CO2, 21 mmol/L; 101: ALBUMIN, 4.0 g/dL; 101: CALCIUM, 9.7 mg/dL; 101: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 101: ALT (SGPT), 14 U/L; 101: BILIRUBIN TOTAL, 0.3 mg/dL; 101: SODIUM, 136 mmol/L; 101: CORRECTED CALCIUM, 9.7 mg/dL; 101: CREATININE, 1.23 mg/dL; 101: GLUCOSE, 169 mg/dL; 101: HR, 104.136; 101: RR, 22.610; 101: 1min HRV, 22.822; 102: HR, 109.593; 102: RR, 18.373; 102: 1min HRV, 24.401; 103: HR, 106.448; 103: RR, 19.793; 103: 1min HRV, 68.019; 104: HR, 106.407; 104: RR, 17.610; 104: 1min HRV, 13.481; 105: HIGH SENSITIVITY TROPONIN, 7 ng/L; 105: HR, 104.328; 105: RR, 20.259; 105: SpO2, 100.0; 105: 1min HRV, 10.131; 105: 5min HRV, 35.905; 106: HR, 107.525; 106: RR, 18.576; 106: 1min HRV, 13.288; 107: HR, 106.458; 107: RR, 18.542; 107: 1min HRV, 9.333; 108: HR, 103.862; 108: RR, 24.103; 108: 1min HRV, 5.588; 109: HR, 103.831; 109: RR, 22.441; 109: 1min HRV, 5.072; 110: HR, 105.603; 110: RR, 21.655; 110: 1min HRV, 14.536; 110: 5min HRV, 12.758; 111: HR, 108.847; 111: RR, 19.763; 111: 1min HRV, 18.562; 112: HR, 106.695; 112: RR, 21.356; 112: 1min HRV, 23.629; 113: HR, 107.224; 113: RR, 18.172; 113: 1min HRV, 12.075; 114: HR, 106.678; 114: RR, 20.932; 114: 1min HRV, 20.000; 115: HR, 106.810; 115: RR, 18.948; 115: 1min HRV, 24.795; 115: 5min HRV, 21.082; 116: HR, 108.983; 116: RR, 22.593; 116: 1min HRV, 24.284; 117: HR, 115.508; 117: RR, 21.136; 117: 1min HRV, 18.287; 118: HR, 109.741; 118: RR, 20.052; 118: 1min HRV, 14.957; 119: HR, 105.932; 119: RR, 21.271; 119: 1min HRV, 22.043; 0: Age, 65; 0: Gender, M; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 119.0; 0: Triage DBP, 63.0; 0: Triage acuity, 3-Urgent; 0: CC, PALPITATIONS,ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The subquestions to determine sepsis risk include: 1) Are there any signs of hemodynamic instability? 2) Are there indications of infection from vital signs or lab results, such as elevated temperature or white blood cell count? 3) Does the heart rate variability (HRV) or respiratory rate suggest autonomic nervous system dysfunction? The patient exhibits tachycardia with heart rates consistently high and some variations in HRV, and there's a minor presence of lactic acid (2.36 mmol/L), but there is no fever, low blood pressure, or significant abnormalities in lab results that typically signify sepsis risk. Therefore, the patient is deemed not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The subquestions to determine sepsis risk include signs of hemodynamic instability.",
            "The subquestions to determine sepsis risk include indications of infection from vital signs or lab results.",
            "The subquestions to determine sepsis risk include heart rate variability (HRV) or respiratory rate suggesting autonomic nervous system dysfunction.",
            "The patient exhibits tachycardia with heart rates consistently high.",
            "The patient shows some variations in heart rate variability (HRV).",
            "There is a minor presence of lactic acid at 2.36 mmol/L.",
            "There is no fever in the patient.",
            "There is low blood pressure in the patient.",
            "There are no significant abnormalities in lab results that typically signify sepsis risk.",
            "The patient is deemed not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient exhibits tachycardia with heart rates consistently high.",
            "There is a minor presence of lactic acid at 2.36 mmol/L.",
            "There is no fever in the patient."
        ],
        "alignment_scores": [
            0.8,
            1.0,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is listed as one of the SIRS criteria. Although the claim does not provide exact numerical values or if any other SIRS criteria are met, the presence of consistent tachycardia strongly aligns with the systemic inflammation signaled by SIRS, indicating potential early sepsis. The alignment is not completely certain due to the absence of additional criteria fulfillment, so a rating of 0.8 is justified.",
            "The claim references elevated serum lactate at 2.36 mmol/L, which exceeds the threshold of \u22652 mmol/L. This is directly aligned with the Elevated Serum Lactate category, as serum lactate levels above this threshold signal tissue hypoperfusion and increase the risk of sepsis mortality. The alignment is perfect because the claim meets and exceeds the specified criterion.",
            "The absence of fever relates to the SIRS criteria since a significantly high temperature is part of the SIRS indicators. However, the claim is about the lack of a specific symptom (fever) rather than meeting any SIRS criteria or indicating systemic inflammation. Therefore, the alignment is weak but slightly relevant to assessing SIRS criteria."
        ],
        "final_alignment_score": 0.7000000000000001,
        "accuracy": 0
    },
    {
        "input": "6: HR, 91.0; 6: RR, 20.0; 6: SpO2, 100.0; 6: SBP, 140.0; 6: DBP, 119.0; 6: MAP, 126.0; 6: Temp, 97.7; 89: HR, 86.122; 89: RR, 14.545; 89: SpO2, 99.611; 89: Perf, 1.259; 89: 1min HRV, 64.115; 90: HR, 83.644; 90: RR, 13.949; 90: SpO2, 99.034; 90: Perf, 1.051; 90: 1min HRV, 101.623; 90: 5min HRV, 86.748; 91: HR, 85.712; 91: RR, 16.102; 91: SpO2, 99.475; 91: Perf, 0.914; 91: 1min HRV, 87.323; 91: SBP, 136.0; 91: DBP, 51.0; 91: MAP, 79.333; 92: HR, 86.0; 92: RR, 14.638; 92: SpO2, 99.155; 92: Perf, 0.880; 92: 1min HRV, 90.021; 93: HR, 83.678; 93: RR, 14.0; 93: SpO2, 99.0; 93: Perf, 0.866; 93: 1min HRV, 74.305; 94: HR, 83.5; 94: RR, 14.431; 94: SpO2, 99.0; 94: Perf, 0.86; 94: 1min HRV, 58.107; 95: HR, 84.559; 95: RR, 15.898; 95: SpO2, 99.0; 95: Perf, 0.831; 95: 1min HRV, 54.349; 95: 5min HRV, 74.663; 96: HR, 83.569; 96: RR, 14.552; 96: SpO2, 99.0; 96: Perf, 0.846; 96: 1min HRV, 75.772; 96: SBP, 135.0; 96: DBP, 64.0; 96: MAP, 87.667; 97: HR, 82.254; 97: RR, 15.220; 97: SpO2, 99.0; 97: Perf, 0.851; 97: 1min HRV, 69.625; 98: HR, 84.271; 98: RR, 15.678; 98: SpO2, 98.831; 98: Perf, 0.818; 98: 1min HRV, 71.319; 99: HR, 83.069; 99: RR, 21.138; 99: SpO2, 99.121; 99: Perf, 0.781; 99: 1min HRV, 69.271; 100: HR, 83.983; 100: RR, 16.475; 100: SpO2, 98.831; 100: Perf, 0.745; 100: 1min HRV, 64.848; 100: 5min HRV, 70.448; 101: HR, 84.966; 101: RR, 15.661; 101: SpO2, 98.898; 101: Perf, 0.710; 101: 1min HRV, 70.236; 102: HR, 81.534; 102: RR, 15.879; 102: SpO2, 98.759; 102: Perf, 0.722; 102: 1min HRV, 64.743; 103: HR, 82.0; 103: RR, 14.424; 103: SpO2, 98.712; 103: Perf, 0.696; 103: 1min HRV, 60.270; 104: HR, 81.293; 104: RR, 13.224; 104: SpO2, 98.759; 104: Perf, 0.694; 104: 1min HRV, 75.829; 105: HR, 83.356; 105: RR, 14.746; 105: SpO2, 99.136; 105: Perf, 0.688; 105: 1min HRV, 64.337; 105: 5min HRV, 68.181; 106: HR, 82.763; 106: RR, 14.780; 106: SpO2, 98.644; 106: Perf, 0.685; 106: 1min HRV, 68.190; 107: HR, 81.603; 107: RR, 14.655; 107: SpO2, 99.0; 107: Perf, 0.680; 107: 1min HRV, 59.350; 108: HR, 81.220; 108: RR, 21.627; 108: SpO2, 98.932; 108: Perf, 0.709; 108: 1min HRV, 76.786; 109: HR, 80.966; 109: RR, 19.362; 109: SpO2, 99.0; 109: Perf, 0.725; 109: 1min HRV, 76.180; 110: HR, 80.661; 110: RR, 16.288; 110: SpO2, 99.0; 110: Perf, 0.707; 110: 1min HRV, 66.222; 110: 5min HRV, 70.035; 111: HR, 81.220; 111: RR, 23.169; 111: SpO2, 99.0; 111: Perf, 0.679; 111: 1min HRV, 77.056; 111: SBP, 136.0; 111: DBP, 64.0; 111: MAP, 88.0; 112: HR, 81.983; 112: RR, 18.586; 112: SpO2, 99.0; 112: Perf, 0.652; 112: 1min HRV, 60.951; 113: WAM DIFTYP, AUTO; 113: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 113: LYMPHOCYTE % (AUTO DIFF), 14.9 %; 113: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 113: HEMATOCRIT (HCT), 35.1 %; 113: HEMOGLOBIN (HGB), 10.9 g/dL; 113: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 113: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 113: NRBC PERCENT (HEMATOLOGY), 0.0 %; 113: RED BLOOD CELLS (RBC), 3.62 MIL/uL; 113: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.1 pg; 113: NEUTROPHIL % (AUTO DIFF), 75.4 %; 113: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 113: BASOPHIL % (AUTO DIFF), 0.5 %; 113: PLATELET COUNT (PLT), 252 K/uL; 113: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 113: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 113: EOSINOPHIL % (AUTO DIFF), 1.9 %; 113: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.25 K/uL; 113: WHITE BLOOD CELLS (WBC), 13.0 K/uL; 113: MONOCYTE % (AUTO DIFF), 6.7 %; 113: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 113: MEAN CORPUSCULAR VOLUME (MCV), 97.0 fL; 113: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 113: HR, 82.797; 113: RR, 14.271; 113: SpO2, 99.0; 113: Perf, 0.625; 113: 1min HRV, 70.045; 114: HR, 82.190; 114: RR, 19.414; 114: SpO2, 98.828; 114: Perf, 0.61; 114: 1min HRV, 61.600; 115: HR, 82.508; 115: RR, 13.017; 115: SpO2, 99.508; 115: Perf, 0.654; 115: 1min HRV, 63.268; 115: 5min HRV, 66.921; 116: HR, 82.155; 116: RR, 12.103; 116: SpO2, 99.397; 116: Perf, 0.662; 116: 1min HRV, 73.993; 117: HR, 81.576; 117: RR, 13.119; 117: SpO2, 99.0; 117: Perf, 0.662; 117: 1min HRV, 64.195; 118: HR, 81.763; 118: RR, 11.136; 118: SpO2, 99.0; 118: Perf, 0.653; 118: 1min HRV, 60.004; 119: HR, 79.017; 119: RR, 10.286; 119: SpO2, 99.0; 119: Perf, 0.659; 119: 1min HRV, 83.610; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 20.0; 0: Triage SBP, 140.0; 0: Triage DBP, 119.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS,APPETITE DECREASED,EAR PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, first consider vital signs, lab results, and trends. The patient's heart rate, blood pressure, and respiratory rate are stable, with SpO2 consistently around 98-99%. The white blood cell count of 13 K/uL may suggest inflammation or infection but is not conclusive for sepsis. The patient does have an urgent triage acuity and presents general weakness. However, no severe abnormalities or trends indicate high sepsis risk within the next 12 hours.",
        "claims": [
            "To determine the sepsis risk, vital signs, lab results, and trends are considered.",
            "The patient's heart rate is stable.",
            "The patient's blood pressure is stable.",
            "The patient's respiratory rate is stable.",
            "The patient's SpO2 is consistently around 98-99%.",
            "A white blood cell count of 13 K/uL may suggest inflammation or infection.",
            "A white blood cell count of 13 K/uL is not conclusive for sepsis.",
            "The patient has an urgent triage acuity.",
            "The patient presents general weakness.",
            "No severe abnormalities indicate high sepsis risk within the next 12 hours.",
            "No trends indicate high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "A white blood cell count of 13 K/uL may suggest inflammation or infection.",
            "No trends indicate high sepsis risk within the next 12 hours."
        ],
        "alignment_scores": [
            1.0,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim explicitly mentions an elevated white blood cell count (13 K/uL), which exceeds the threshold of >12,000/\u00b5L as listed in the SIRS criteria. This directly aligns with the identification of systemic inflammation consistent with early sepsis, providing a strong match to the category.",
            "The claim suggests a lack of indicators for high sepsis risk, which indirectly relates to risk prediction models like NEWS. NEWS is a scoring system that reflects clinical deterioration compatible with sepsis. The statement does not provide specific scores or vitals, which weakens the alignment, but the lack of high-risk trends suggests some monitoring parameter (like NEWS) might not be met. The alignment is therefore indirect and weak."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 0
    },
    {
        "input": "3: HR, 74.0; 3: RR, 18.0; 3: SpO2, 94.0; 3: SBP, 113.0; 3: DBP, 71.0; 3: MAP, 85.0; 3: Pain, 4.0; 3: Temp, 99.7; 7: Pain, 3.0; 31: SpO2, 94.462; 31: SBP, 137.0; 31: DBP, 75.0; 31: MAP, 95.667; 32: SpO2, 93.0; 33: SpO2, 94.725; 33: Perf, 14.482; 34: SpO2, 94.914; 34: Perf, 18.411; 35: SpO2, 94.883; 35: Perf, 19.336; 36: SpO2, 94.982; 36: Perf, 16.918; 37: SpO2, 95.695; 37: Perf, 17.487; 38: SpO2, 95.690; 38: Perf, 17.235; 39: SpO2, 94.966; 39: Perf, 16.932; 40: SpO2, 94.559; 40: Perf, 16.699; 41: HR, 70.0; 41: RR, 18.0; 41: SpO2, 95.879; 41: Perf, 14.595; 41: SBP, 136.0; 41: DBP, 69.0; 41: MAP, 91.333; 41: Pain, 3.0; 42: SpO2, 95.7; 42: Perf, 17.597; 42: SBP, 136.0; 42: DBP, 69.0; 42: MAP, 91.333; 43: SpO2, 95.983; 43: Perf, 16.952; 44: SpO2, 96.0; 44: Perf, 18.613; 45: SpO2, 96.0; 45: Perf, 18.248; 46: SpO2, 94.881; 46: Perf, 17.846; 47: SpO2, 95.862; 47: Perf, 13.458; 48: SpO2, 96.254; 48: Perf, 14.139; 49: SpO2, 95.690; 49: Perf, 15.089; 50: SpO2, 96.153; 50: Perf, 14.664; 51: SpO2, 96.0; 51: Perf, 16.012; 52: SpO2, 96.034; 52: Perf, 16.036; 53: SpO2, 95.763; 53: Perf, 15.591; 56: SARS-COV-2 RNA, Not Detected; 56: INFLUENZA A, Not Detected; 56: RSV, Not Detected; 56: INFLUENZA B, Not Detected; 61: WAM DIFTYP, AUTO; 61: HEMATOCRIT (HCT), 41.4 %; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.72 K/uL; 61: MEAN CORPUSCULAR VOLUME (MCV), 90.0 fL; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: PLATELET COUNT (PLT), 222 K/uL; 61: BASOPHIL % (AUTO DIFF), 0.1 %; 61: NEUTROPHIL % (AUTO DIFF), 87.1 %; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 17.23 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 61: LYMPHOCYTE % (AUTO DIFF), 3.4 %; 61: RED BLOOD CELLS (RBC), 4.60 MIL/uL; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 61: WHITE BLOOD CELLS (WBC), 19.8 K/uL; 61: HEMOGLOBIN (HGB), 13.8 g/dL; 61: MONOCYTE % (AUTO DIFF), 8.7 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 71: SpO2, 95.972; 71: Perf, 19.384; 72: SpO2, 95.638; 72: Perf, 19.893; 73: SpO2, 95.593; 73: Perf, 18.497; 74: SpO2, 95.542; 74: Perf, 19.283; 75: SpO2, 95.259; 75: Perf, 19.124; 76: SpO2, 94.492; 76: Perf, 17.902; 77: POC PH (V) ISTAT, 7.44; 77: POC HCO3 (V) ISTAT, 28.5 mmol/L; 77: POC BASE EXCESS ISTAT, 4 mmol/L; 77: POC PO2 (V) ISTAT, 43 mmHg; 77: POC LACTATE ISTAT, 0.69 mmol/L; 77: POC TCO2 (V) ISTAT, 30 mmol/L; 77: POC PCO2 (V) ISTAT, 41.8 mmHg; 77: POC O2 SATURATION ISTAT VENOUS, 80 %; 77: SpO2, 94.0; 77: Perf, 15.710; 78: SpO2, 95.119; 78: Perf, 15.465; 79: SpO2, 95.136; 79: Perf, 15.434; 80: SpO2, 94.069; 80: Perf, 15.169; 81: SpO2, 94.831; 81: Perf, 14.358; 82: SpO2, 94.069; 82: Perf, 14.436; 83: SpO2, 94.0; 83: Perf, 16.667; 84: SpO2, 94.0; 84: Perf, 16.033; 85: HIGH SENSITIVITY TROPONIN, 14 ng/L; 85: SpO2, 94.0; 85: Perf, 14.911; 86: SpO2, 94.949; 86: Perf, 14.176; 87: SpO2, 95.052; 87: Perf, 15.782; 88: ALT (SGPT), 70 U/L; 88: BILIRUBIN TOTAL, 0.9 mg/dL; 88: CORRECTED CALCIUM, 9.1 mg/dL; 88: POTASSIUM, 3.2 mmol/L; 88: SODIUM, 139 mmol/L; 88: CREATININE, 1.40 mg/dL; 88: ALBUMIN, 4.1 g/dL; 88: GLOBULIN, 2.6 g/dL; 88: EGFR REFIT WITHOUT RACE (2021), 53 mL/min/1.73 m2; 88: ANION GAP, 13 mmol/L; 88: CO2, 27 mmol/L; 88: AST (SGOT), 72 U/L; 88: GLUCOSE, 156 mg/dL; 88: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 88: PROTEIN TOTAL, 6.7 g/dL; 88: ALKALINE PHOSPHATASE, 133 U/L; 88: CALCIUM, 9.2 mg/dL; 88: CHLORIDE, 99 mmol/L; 88: SpO2, 95.407; 88: Perf, 13.756; 89: SpO2, 94.305; 89: Perf, 15.369; 90: SpO2, 94.103; 90: Perf, 15.427; 91: SpO2, 93.983; 91: Perf, 12.664; 92: SpO2, 93.190; 92: Perf, 15.533; 93: SpO2, 93.237; 93: Perf, 16.274; 94: SpO2, 93.407; 94: Perf, 12.725; 95: SpO2, 92.569; 95: Perf, 10.715; 96: SpO2, 94.034; 96: Perf, 13.330; 97: SpO2, 92.845; 97: Perf, 14.170; 98: SpO2, 93.254; 98: Perf, 12.813; 99: SpO2, 91.695; 99: Perf, 8.233; 100: SpO2, 92.690; 100: Perf, 13.570; 101: SpO2, 92.729; 101: Perf, 12.566; 102: SpO2, 92.448; 102: Perf, 15.272; 103: GLUCOSE, URINE (UA): Negative; 103: PH, URINE (UA): 5.0; 103: SPECIFIC GRAVITY, URINE (UA): 1.026; 103: NITRITE, URINE (UA): Negative; 103: KETONE, URINE (UA): Negative; 103: SpO2, 93.576; 103: Perf, 12.770; 104: SpO2, 91.466; 104: Perf, 12.215; 105: SpO2, 94.458; 105: Perf, 14.273; 106: SpO2, 93.458; 106: Perf, 11.702; 107: SpO2, 92.690; 107: Perf, 12.907; 108: SpO2, 92.475; 108: Perf, 12.899; 109: SpO2, 91.345; 109: Perf, 8.859; 110: SpO2, 92.492; 110: Perf, 13.471; 111: SpO2, 90.932; 111: Perf, 9.334; 112: SpO2, 95.172; 112: Perf, 14.262; 113: SpO2, 94.102; 113: Perf, 13.637; 114: SpO2, 93.0; 114: Perf, 13.566; 115: SpO2, 93.0; 115: Perf, 14.340; 116: SpO2, 93.0; 116: Perf, 13.576; 117: SpO2, 93.569; 117: Perf, 12.735; 118: SpO2, 94.407; 118: Perf, 8.632; 119: SpO2, 93.310; 119: Perf, 11.099; 0: Age, 73; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 74.0; 0: Triage RR, 18.0; 0: Triage SBP, 113.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess the risk of sepsis, crucial factors include signs of infection, vital signs, and lab results indicative of infection. The patient, a 73-year-old male with a fever as a primary complaint, shows stable vitals (HR, RR, BP) and no significant decline in perfusion or organ function that might indicate severe sepsis. Blood tests, including WBC and lactate levels, do not raise a high suspicion for sepsis. Although the patient could be monitored for potential sepsis given age and initial complaint, the data do not suggest a high risk of developing sepsis within 12 hours based on current signs and lab results.",
        "claims": [
            "Signs of infection are crucial factors to assess the risk of sepsis.",
            "Vital signs are crucial factors to assess the risk of sepsis.",
            "Lab results indicative of infection are crucial factors to assess the risk of sepsis.",
            "The patient is a 73-year-old male.",
            "The patient has a fever as a primary complaint.",
            "The patient shows stable vital signs.",
            "The patient's heart rate (HR) is stable.",
            "The patient's respiratory rate (RR) is stable.",
            "The patient's blood pressure (BP) is stable.",
            "There is no significant decline in perfusion for the patient.",
            "There is no significant decline in organ function for the patient.",
            "The absence of significant decline in perfusion or organ function suggests the patient may not have severe sepsis.",
            "Blood tests, including WBC and lactate levels, do not raise a high suspicion for sepsis.",
            "The patient could be monitored for potential sepsis due to their age and initial complaint.",
            "The data do not suggest a high risk of developing sepsis within 12 hours based on current signs and lab results."
        ],
        "relevant_claims": [
            "There is no significant decline in perfusion for the patient.",
            "There is no significant decline in organ function for the patient.",
            "The absence of significant decline in perfusion or organ function suggests the patient may not have severe sepsis.",
            "Blood tests, including WBC and lactate levels, do not raise a high suspicion for sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.2,
            0.7,
            0.4
        ],
        "alignment_category": [
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "The claim mentions no significant decline in perfusion, which is indirectly relevant to elevated serum lactate levels. Elevated serum lactate is a marker of tissue hypoperfusion, meaning a lack of decline in perfusion might imply normal lactate levels. However, the claim does not specifically address serum lactate, so the alignment is weak.",
            "The claim directly mentions \"no significant decline in organ function,\" which aligns with the concept behind evaluating changes in the SOFA score, as this score tracks organ dysfunction. However, the claim is actually highlighting the absence of such changes, meaning the alignment is weak and indirect.",
            "The claim references the absence of a decline in perfusion or organ function, which are key considerations in the SOFA score that measures organ dysfunction. Although it does not mention a specific increase in SOFA score points, the focus on organ function aligns with the category's emphasis on identifying high sepsis risk through organ dysfunction. Hence, there is a meaningful, though not direct, alignment with the SOFA Score Increase category.",
            "The claim mentions blood tests, including lactate levels, which directly relates to the Elevated Serum Lactate category. However, since they do not raise a high suspicion for sepsis, it suggests that lactate levels are likely below the critical threshold of \u22652 mmol/L. Thus, the alignment is present but weak because it specifically indicates non-elevated lactate levels related to the category."
        ],
        "final_alignment_score": 0.4,
        "accuracy": 1
    },
    {
        "input": "5: HR, 79.0; 5: RR, 18.0; 5: SpO2, 94.0; 5: SBP, 118.0; 5: DBP, 46.0; 5: MAP, 70.0; 5: Temp, 99.1; 69: WAM DIFTYP, AUTO; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 69: WHITE BLOOD CELLS (WBC), 15.8 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.65 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 69: BASOPHIL % (AUTO DIFF), 0.3 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.42 K/uL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: HEMOGLOBIN (HGB), 9.4 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 69: LYMPHOCYTE % (AUTO DIFF), 2.7 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 92.7 %; 69: EOSINOPHIL % (AUTO DIFF), 0.0 %; 69: MONOCYTE % (AUTO DIFF), 3.9 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 94.9 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 69: HEMATOCRIT (HCT), 29.9 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 24.4 %; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 220 K/uL; 69: RED BLOOD CELLS (RBC), 3.15 MIL/uL; 80: HR, 79.0; 80: 1min HRV, 0.632; 80: SBP, 115.0; 80: DBP, 56.0; 80: MAP, 75.667; 81: HR, 77.627; 81: RR, 26.727; 81: SpO2, 95.828; 81: 1min HRV, 11.200; 82: HR, 74.552; 82: RR, 21.397; 82: SpO2, 90.466; 82: Perf, 1.034; 82: 1min HRV, 7.666; 83: HR, 72.559; 83: RR, 23.136; 83: SpO2, 92.373; 83: Perf, 1.478; 83: 1min HRV, 4.965; 84: HR, 71.259; 84: RR, 26.483; 84: SpO2, 92.741; 84: Perf, 1.973; 84: 1min HRV, 1.575; 84: 5min HRV, 26.452; 85: HR, 71.0; 85: RR, 24.576; 85: SpO2, 94.254; 85: Perf, 1.915; 85: 1min HRV, 4.954; 86: HR, 71.0; 86: RR, 21.237; 86: SpO2, 93.898; 86: Perf, 2.031; 86: 1min HRV, 0.982; 87: HR, 70.310; 87: RR, 21.121; 87: SpO2, 93.517; 87: Perf, 2.059; 87: 1min HRV, 4.349; 88: HR, 70.0; 88: RR, 20.712; 88: SpO2, 92.661; 88: Perf, 2.121; 88: 1min HRV, 0.977; 89: HR, 70.0; 89: RR, 20.259; 89: SpO2, 92.155; 89: Perf, 2.087; 89: 1min HRV, 7.373; 89: 5min HRV, 7.905; 90: HR, 69.949; 90: RR, 19.492; 90: SpO2, 92.610; 90: Perf, 2.144; 90: 1min HRV, 1.040; 91: HR, 70.0; 91: RR, 18.746; 91: SpO2, 92.271; 91: Perf, 2.171; 91: 1min HRV, 0.737; 92: HR, 70.0; 92: RR, 17.569; 92: SpO2, 92.379; 92: Perf, 2.239; 92: 1min HRV, 8.331; 93: HR, 70.0; 93: RR, 17.780; 93: SpO2, 91.576; 93: Perf, 2.413; 93: 1min HRV, 0.865; 94: HR, 70.0; 94: RR, 17.310; 94: SpO2, 91.724; 94: Perf, 2.581; 94: 1min HRV, 0.730; 94: 5min HRV, 3.782; 94: SBP, 102.0; 94: DBP, 57.0; 94: MAP, 72.0; 95: HR, 70.0; 95: RR, 17.797; 95: SpO2, 92.442; 95: Perf, 2.55; 95: 1min HRV, 1.324; 95: SBP, 102.0; 95: DBP, 57.0; 95: MAP, 72.0; 96: HR, 70.0; 96: RR, 23.610; 96: SpO2, 92.695; 96: Perf, 2.430; 96: 1min HRV, 1.110; 97: HR, 72.276; 97: RR, 25.0; 97: SpO2, 95.0; 97: Perf, 1.765; 97: 1min HRV, 101.809; 98: HR, 71.169; 98: RR, 26.373; 98: SpO2, 96.678; 98: Perf, 1.388; 98: 1min HRV, 20.553; 99: HR, 71.0; 99: RR, 24.466; 99: SpO2, 96.810; 99: Perf, 1.301; 99: 1min HRV, 5.030; 99: 5min HRV, 47.921; 99: NORMOSOL-R IV BOLUS -, 1000 ML; 100: HR:, 70.983; 100: RR, 26.254; 100: SpO2, 96.797; 100: Perf, 1.325; 100: 1min HRV, 31.615; 101: HR, 70.052; 101: RR, 22.190; 101: SpO2, 96.690; 101: Perf, 1.399; 101: 1min HRV, 0.887; 102: HR, 70.0; 102: RR, 24.831; 102: SpO2, 97.153; 102: Perf, 1.319; 102: 1min HRV, 0.702; 103: HR, 70.0; 103: RR, 24.237; 103: SpO2, 96.390; 103: Perf, 1.486; 103: 1min HRV, 0.833; 104: HR, 70.0; 104: RR, 21.776; 104: SpO2, 96.966; 104: Perf, 1.278; 104: 1min HRV, 0.877; 104: 5min HRV, 14.315; 105: HR, 70.0; 105: RR, 20.390; 105: SpO2, 96.508; 105: Perf, 1.329; 105: 1min HRV, 0.787; 106: HR, 70.0; 106: RR, 23.086; 106: SpO2, 96.103; 106: Perf, 1.450; 106: 1min HRV, 0.884; 107: HR, 70.0; 107: RR, 23.0; 107: SpO2, 96.305; 107: Perf, 1.023; 107: 1min HRV, 0.746; 108: HR, 70.0; 108: RR, 18.983; 108: SpO2, 96.288; 108: Perf, 1.068; 108: 1min HRV, 0.762; 109: HR, 70.0; 109: RR, 22.017; 109: SpO2, 96.517; 109: Perf, 0.975; 109: 1min HRV, 0.715; 109: 5min HRV, 0.781; 110: HR, 70.0; 110: RR, 17.712; 110: SpO2, 96.390; 110: Perf, 0.929; 110: 1min HRV, 0.772; 111: HR, 70.0; 111: RR, 21.914; 111: SpO2, 96.879; 111: Perf, 0.999; 111: 1min HRV, 0.665; 112: HR, 70.0; 112: RR, 21.915; 112: SpO2, 96.322; 112: Perf, 0.921; 112: 1min HRV, 0.640; 113: HR, 70.0; 113: RR, 22.638; 113: SpO2, 98.224; 113: Perf, 0.748; 113: 1min HRV, 0.715; 114: HR, 70.0; 114: RR, 19.017; 114: SpO2, 97.085; 114: Perf, 0.698; 114: 1min HRV, 0.565; 114: 5min HRV, 0.677; 115: HR, 70.0; 115: RR, 19.237; 115: SpO2, 97.475; 115: Perf, 0.734; 115: 1min HRV, 0.925; 116: HR, 70.0; 116: RR, 20.345; 116: SpO2, 98.155; 116: Perf, 0.717; 116: 1min HRV, 6.745; 117: HR, 70.0; 117: RR, 19.746; 117: SpO2, 95.98; 117: Perf, 0.707; 117: 1min HRV, 1.062; 118: HR, 70.0; 118: RR, 24.983; 118: SpO2, 96.436; 118: Perf, 0.771; 118: 1min HRV, 3.949; 119: HR, 70.0; 119: RR, 23.0; 119: SpO2, 97.328; 119: Perf, 0.813; 119: 1min HRV, 0.969; 119: 5min HRV, 3.700; 0: Age, 87; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 79.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 46.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To evaluate sepsis risk, examine vital signs, laboratory values, and clinical context. The patient's low diastolic blood pressure (DBP) at 46, high neutrophil percentage (92.7%), and elevated white blood cell count (15.8 K/uL) indicate potential infection but not sepsis risk alone. Heart rate (HR), respiratory rate (RR), and oxygen saturation (SpO2) are consistent with compensatory mechanisms for low blood pressure but don\u2019t suggest imminent sepsis. High variability in heart rate (HRV) occurs but stabilizes over time. Overall data show stable vital signs with elevated white cells and do not fulfill sepsis criteria immediately.",
        "claims": [
            "To evaluate sepsis risk, examine vital signs, laboratory values, and clinical context.",
            "The patient's low diastolic blood pressure (DBP) is 46.",
            "The patient's high neutrophil percentage is 92.7%.",
            "The patient's elevated white blood cell count is 15.8 K/uL.",
            "The low DBP, high neutrophil percentage, and elevated white blood cell count indicate potential infection.",
            "Potential infection does not indicate sepsis risk alone.",
            "The heart rate (HR) is consistent with compensatory mechanisms for low blood pressure.",
            "The respiratory rate (RR) is consistent with compensatory mechanisms for low blood pressure.",
            "The oxygen saturation (SpO2) is consistent with compensatory mechanisms for low blood pressure.",
            "Compensatory mechanisms do not suggest imminent sepsis.",
            "High variability in heart rate (HRV) occurs.",
            "High variability in heart rate (HRV) stabilizes over time.",
            "Overall data show stable vital signs.",
            "Elevated white blood cell count is noted in the overall data.",
            "The overall data do not fulfill sepsis criteria immediately."
        ],
        "relevant_claims": [
            "The patient's low diastolic blood pressure (DBP) is 46.",
            "The patient's high neutrophil percentage is 92.7%.",
            "The patient's elevated white blood cell count is 15.8 K/uL.",
            "The low DBP, high neutrophil percentage, and elevated white blood cell count indicate potential infection.",
            "The oxygen saturation (SpO2) is consistent with compensatory mechanisms for low blood pressure.",
            "Elevated white blood cell count is noted in the overall data.",
            "The overall data do not fulfill sepsis criteria immediately."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            1.0,
            0.7,
            0.7,
            1.0,
            0.5
        ],
        "alignment_category": [
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "While the claim specifically mentions low diastolic blood pressure (DBP), the Sepsis-Associated Hypotension category is concerned with systolic blood pressure (SBP), mean arterial pressure (MAP), or a significant drop in blood pressure. Low DBP contributes to decreased MAP, which may be <70 mmHg, fitting the broader indication of hypotension. However, since DBP alone does not directly meet the criteria, the alignment with this category is not perfect.",
            "While neutrophil percentage itself isn't explicitly mentioned in the SIRS criteria, an elevated neutrophil percentage often corresponds with an elevated WBC count, which is a part of the SIRS criteria. Neutrophilia typically indicates a systemic inflammatory response consistent with early sepsis. The alignment is moderately strong due to the conceptual correlation with systemic inflammation.",
            "An elevated white blood cell count is explicitly part of the SIRS criteria (WBC > 12,000/\u00b5L). The given WBC count of 15.8 K/uL meets this criterion, indicating systemic inflammation consistent with early sepsis detection according to the SIRS category. Therefore, the claim perfectly aligns with this category.",
            "The claim mentions an elevated white blood cell count and high neutrophil percentage, both of which suggest systemic inflammation and are components directly related to the SIRS criteria, which aim to identify early sepsis. While low diastolic blood pressure isn't part of the SIRS criteria itself, it can support the suspicion of infection or inflammation. Overall, the claim aligns with the SIRS criteria due to the specific mention of elevated WBC, but the inclusion of low DBP adds a slight reduction in perfect alignment.",
            "While the claim does not directly mention blood pressure measurements such as SBP or MAP, it references compensatory mechanisms for low blood pressure, which aligns with the concept of hypotension. This suggests an indirect link to sepsis-associated hypotension that indicates progression toward septic shock. The alignment is not direct (without explicit blood pressure values), but the claim situates itself conceptually within the realm of hemodynamic instability associated with this category.",
            "The claim explicitly mentions an elevated white blood cell count, which is one of the specified criteria for identifying systemic inflammation under the SIRS criteria. This direct reference aligns perfectly with the category, indicating a strong match with the criteria used for early sepsis identification.",
            "The claim indicates that sepsis criteria are not fulfilled immediately, which suggests the absence of key indicators such as those found in the SIRS criteria. This aligns somewhat with SIRS Positivity, as it implicitly references the lack of systemic inflammation markers but does not explicitly specify which criteria are unmet. Hence, the alignment is moderate."
        ],
        "final_alignment_score": 0.7571428571428571,
        "accuracy": 0
    },
    {
        "input": "2: HR, 110.0; 2: RR, 20.0; 2: SpO2, 99.0; 2: SBP, 170.0; 2: DBP, 125.0; 2: MAP, 140.0; 2: Temp, 98.3; 7: Pain, 8.0; 23: POC, HCG, ISTAT QUALITATIVE: Negative; 23: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 35: SpO2, 96.875; 35: SBP, 166.0; 35: DBP, 133.0; 35: MAP, 144.0; 36: SpO2, 96.729; 36: Perf, 2.419; 36: SBP, 181.0; 36: DBP, 117.0; 36: MAP, 138.333; 37: SpO2, 96.793; 37: Perf, 3.050; 38: SpO2, 98.407; 38: Perf, 3.127; 39: SpO2, 97.810; 39: Perf, 3.470; 40: SpO2, 96.864; 40: Perf, 2.914; 41: SpO2, 97.305; 41: Perf, 2.716; 42: SpO2, 98.690; 42: Perf, 4.093; 43: SpO2, 99.0; 43: Perf, 4.271; 44: SpO2, 98.879; 44: Perf, 4.363; 45: SpO2, 98.898; 45: Perf, 3.121; 46: SpO2, 98.034; 46: Perf, 3.241; 47: SpO2, 98.345; 47: Perf, 5.429; 48: SpO2, 98.339; 48: Perf, 4.260; 49: SpO2, 98.121; 49: Perf, 5.469; 50: SpO2, 98.085; 50: Perf, 4.044; 51: SpO2, 98.441; 51: Perf, 3.807; 52: SpO2, 98.121; 52: Perf, 4.583; 53: SpO2, 99.086; 53: Perf, 2.823; 54: SpO2, 98.898; 54: Perf, 2.241; 55: SpO2, 98.831; 55: Perf, 2.983; 56: SpO2, 98.695; 56: Perf, 3.286; 57: SpO2, 98.0; 57: Perf, 4.375; 58: SpO2, 98.220; 58: Perf, 4.053; 59: SpO2, 97.793; 59: Perf, 4.217; 60: SpO2, 98.0; 60: Perf, 2.665; 61: SpO2, 98.712; 61: Perf, 2.182; 62: SpO2, 98.466; 62: Perf, 3.111; 63: SpO2, 98.475; 63: Perf, 2.669; 64: SpO2, 98.741; 64: Perf, 2.308; 65: SpO2, 99.0; 65: Perf, 2.785; 66: SpO2, 98.186; 66: Perf, 3.892; 67: ALT (SGPT), 79 U/L; 67: CHLORIDE, 103 mmol/L; 67: BILIRUBIN TOTAL, 0.4 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 148 mL/min/1.73 m2; 67: ALBUMIN, 4.2 g/dL; 67: CO2, 23 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 128 mL/min/1.73 m2; 67: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 67: CREATININE, 0.65 mg/dL; 67: SODIUM, 138 mmol/L; 67: PROTEIN TOTAL, 8.0 g/dL; 67: GLUCOSE, 130 mg/dL; 67: GLOBULIN, 3.8 g/dL; 67: CALCIUM, 9.5 mg/dL; 67: ANION GAP, 12 mmol/L; 67: CORRECTED CALCIUM, 9.3 mg/dL; 67: POTASSIUM, 4.3 mmol/L; 67: ALKALINE PHOSPHATASE, 109 U/L; 67: AST (SGOT), 48 U/L; 67: SpO2, 98.552; 67: Perf, 2.511; 68: SpO2, 98.458; 68: Perf, 2.268; 69: SpO2, 98.138; 69: Perf, 3.142; 70: WAM DIFTYP, AUTO; 70: LYMPHOCYTE % (AUTO DIFF), 31.8 %; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: RED BLOOD CELLS (RBC), 5.35 MIL/uL; 70: NEUTROPHIL % (AUTO DIFF), 57.8 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 11.8 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.0 pg; 70: PLATELET COUNT (PLT), 258 K/uL; 70: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 2.3 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 86.2 fL; 70: HEMATOCRIT (HCT), 46.1 %; 70: BASOPHIL % (AUTO DIFF), 0.4 %; 70: HEMOGLOBIN (HGB), 15.5 g/dL; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.97 K/uL; 70: SpO2, 98.983; 70: Perf, 4.796; 71: SpO2, 98.638; 71: Perf, 4.103; 72: SpO2, 97.898; 72: Perf, 5.212; 73: SpO2, 97.949; 73: Perf, 6.655; 74: SpO2, 97.810; 74: Perf, 6.88; 75: SpO2, 97.712; 75: Perf, 7.503; 76: SpO2, 98.017; 76: Perf, 5.833; 77: SpO2, 98.068; 77: Perf, 5.273; 78: SpO2, 98.153; 78: Perf, 3.641; 79: SpO2, 97.534; 79: Perf, 4.4; 80: SpO2, 97.203; 80: Perf, 4.165; 81: SpO2, 97.569; 81: Perf, 4.237; 82: SpO2, 98.390; 82: Perf, 2.841; 83: SpO2, 98.407; 83: Perf, 1.946; 84: SpO2, 97.845; 84: Perf, 3.521; 85: SpO2, 98.017; 85: Perf, 3.399; 86: SpO2, 97.828; 86: Perf, 5.287; 87: SpO2, 97.542; 87: Perf, 5.983; 88: SpO2, 97.492; 88: Perf, 6.082; 89: SpO2, 97.534; 89: Perf, 6.151; 90: SpO2, 98.0; 90: Perf, 6.157; 91: SpO2, 98.103; 91: Perf, 4.832; 92: SpO2, 97.847; 92: Perf, 5.332; 92: ACETAMINOPHEN, 325 MG PO TABS; 92: IBUPROFEN, 400 MG PO TABS; 93: SpO2, 97.712; 93: Perf, 5.169; 93: LR IV BOLUS -, 1000 ML; 94: SpO, 2: 99.414; 94: Perf, 1.990; 94: Pain, 10.0; 94: HYDROMORPHONE, 1 MG/ML INJ SYRG; 95: SpO, 2: 99.0; 95: Perf, 3.394; 96: SpO2, 98.983; 96: Perf, 2.202; 97: SpO2, 98.305; 97: Perf, 3.937; 98: SARS-COV-2 RNA, Not Detected; 98: SpO2, 97.949; 98: Perf, 5.096; 99: SpO2, 97.810; 99: Perf, 4.267; 100: SpO2, 97.847; 100: Perf, 3.105; 101: SpO2, 97.776; 101: Perf, 2.793; 102: SpO2, 97.797; 102: Perf, 3.051; 103: SpO2, 98.328; 103: Perf, 2.511; 104: SpO2, 97.932; 104: Perf, 2.896; 105: SpO2, 97.5; 105: Perf, 2.787; 106: SpO2, 97.017; 106: Perf, 3.046; 107: SpO2, 96.797; 107: Perf, 3.829; 108: SpO2, 96.328; 108: Perf, 4.211; 109: SpO2, 96.508; 109: Perf, 4.35; 110: SpO2, 96.441; 110: Perf, 4.361; 111: SpO2, 96.914; 111: Perf, 4.117; 112: SpO2, 96.949; 112: Perf, 4.180; 113: SpO2, 97.672; 113: Perf, 3.597; 114: SpO2, 97.136; 114: Perf, 3.844; 115: SpO2, 97.793; 115: Perf, 3.008; 116: SpO2, 98.729; 116: Perf, 1.443; 117: SpO2, 99.448; 117: Perf, 1.378; 118: SpO2, 99.356; 118: Perf, 1.376; 119: SpO2, 98.627; 119: Perf, 1.548; 0: Age, 19; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 110.0; 0: Triage RR, 20.0; 0: Triage SBP, 170.0; 0: Triage DBP, 125.0; 0: Triage acuity, 3-Urgent; 0: CC, BLOOD IN URINE,ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, we need to assess vital signs, lab results, and symptoms from the initial data. The patient's high blood pressure (170/125 mmHg), tachycardia (HR 110 bpm), and tachypnea (RR 20 bpm) at arrival could be concerning, but overall, the patient has stable oxygen saturation (SpO2 consistently around 98% or higher), and their lab results (including normal white blood cell count and normal creatinine levels) are not suggestive of an acute infection or organ dysfunction. Also, there are no signs of a fever and the patient\u2019s perfusion index trends show no significant abnormalities. Based on these factors, the patient does not seem to be at a high risk of developing sepsis in the next 12 hours.",
        "claims": [
            "To determine sepsis risk, we need to assess vital signs, lab results, and symptoms from the initial data.",
            "The patient's blood pressure is 170/125 mmHg.",
            "The patient's blood pressure of 170/125 mmHg could be concerning.",
            "The patient has tachycardia with a heart rate of 110 bpm.",
            "The patient has tachypnea with a respiratory rate of 20 bpm.",
            "The patient has stable oxygen saturation consistently around 98% or higher.",
            "The patient's lab results include a normal white blood cell count.",
            "The patient's lab results include normal creatinine levels.",
            "The lab results are not suggestive of an acute infection.",
            "The lab results are not suggestive of organ dysfunction.",
            "There are no signs of a fever in the patient.",
            "The patient\u2019s perfusion index trends show no significant abnormalities.",
            "Based on these factors, the patient does not seem to be at high risk of developing sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's blood pressure is 170/125 mmHg.",
            "The patient's blood pressure of 170/125 mmHg could be concerning.",
            "The patient has tachycardia with a heart rate of 110 bpm.",
            "The lab results are not suggestive of an acute infection."
        ],
        "alignment_scores": [
            0.3,
            0.2,
            0.7,
            0.2
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim describes an elevated blood pressure, which doesn't directly correspond to low blood pressure indicators used for sepsis risk in other categories. However, the elevated shock index category involves heart rate and systolic blood pressure, and though the claim doesn't give heart rate, the focus on blood pressure hints at cardiovascular concern. The alignment is weak because the claim does not demonstrate the hypotension or specific shock index calculation used for direct alignment.",
            "The claim refers to high blood pressure (170/125 mmHg), which is not specifically tied to any of the expert sepsis categories directly. However, since the shock index involves heart rate and systolic blood pressure, and high blood pressure could relate to cardiovascular changes, there is a slight connection. Although the claim does not mention heart rate or systemic hypotension indicative of shock, the high blood pressure could suggest haemodynamic considerations, yet the alignment remains weak due to lack of direct criteria fulfillment.",
            "Tachycardia with a heart rate >90 bpm is one of the SIRS criteria, indicating possible systemic inflammation consistent with early sepsis. While the claim meets this specific criterion, the alignment is partial because the presence of only one SIRS criterion does not fully indicate SIRS positivity, which requires at least two criteria.",
            "The claim states that lab results are not suggestive of an acute infection, implying that there may be no immediate clinical suspicion of a serious infection that would typically lead to prompt actions like ordering antibiotics or drawing cultures. This tangentially touches on the concept of assessing infection risk, which could influence clinical decisions. However, it does not indicate any immediate action related to this category, resulting in a low alignment rating."
        ],
        "final_alignment_score": 0.35,
        "accuracy": 1
    },
    {
        "input": "6: Pain, 0.0; 16: HR, 110.0; 16: RR, 13.0; 16: SpO2, 97.0; 16: SBP, 126.0; 16: DBP, 108.0; 16: MAP, 114.0; 16: Temp, 97.7; 35: HR, 106.5; 35: RR, 24.346; 35: 1min HRV, 16.264; 36: HR, 108.483; 36: RR, 22.741; 36: SpO2, 86.5; 36: 1min HRV, 9.079; 37: HR, 106.458; 37: RR, 21.780; 37: 1min HRV, 19.289; 37: 5min HRV, 15.922; 38: HR, 104.793; 38: RR, 19.517; 38: SpO2, 97.4; 38: 1min HRV, 28.309; 39: HR, 106.237; 39: RR, 19.627; 39: SpO2, 98.0; 39: 1min HRV, 15.942; 40: HR, 101.254; 40: RR, 21.559; 40: SpO2, 99.714; 40: 1min HRV, 13.774; 41: HR, 102.086; 41: RR, 19.293; 41: SpO2, 99.459; 41: 1min HRV, 13.604; 42: HR, 102.898; 42: RR, 22.898; 42: SpO2, 99.0; 42: 1min HRV, 19.309; 42: 5min HRV, 20.796; 43: HR, 104.172; 43: RR, 20.310; 43: SpO2, 98.5; 43: Perf, 0.09; 43: 1min HRV, 13.262; 44: HR, 102.559; 44: RR, 23.898; 44: SpO2, 100.0; 44: Perf, 0.09; 44: 1min HRV, 12.124; 45: HR, 105.845; 45: RR, 22.483; 45: SpO2, 86.25; 45: Perf, 0.09; 45: 1min HRV, 8.539; 46: HR, 107.763; 46: RR, 23.237; 46: 1min HRV, 70.170; 47: HR, 101.407; 47: RR, 21.119; 47: SpO2, 96.409; 47: 1min HRV, 15.426; 47: 5min HRV, 36.245; 48: HR, 100.207; 48: RR, 20.517; 48: SpO2, 100.0; 48: 1min HRV, 27.094; 49: HR, 98.237; 49: RR, 20.119; 49: SpO2, 99.0; 49: 1min HRV, 12.805; 50: HR, 97.948; 50: RR, 24.276; 50: SpO2, 98.773; 50: Perf, 0.08; 50: 1min HRV, 16.305; 51: HR, 99.068; 51: RR, 25.390; 51: SpO2, 98.275; 51: Perf, 0.085; 51: 1min HRV, 35.372; 52: HR, 104.593; 52: RR, 19.102; 52: SpO2, 96.632; 52: Perf, 0.09; 52: 1min HRV, 10.054; 52: 5min HRV, 26.196; 53: HR, 103.931; 53: RR, 22.5; 53: SpO2, 99.390; 53: 1min HRV, 12.152; 54: HR, 103.203; 54: RR, 19.814; 54: SpO2, 100.0; 54: 1min HRV, 11.907; 55: HR, 104.259; 55: RR, 20.207; 55: SpO2, 99.933; 55: 1min HRV, 7.388; 56: HR, 105.661; 56: RR, 19.475; 56: SpO2, 99.939; 56: 1min HRV, 13.360; 57: HR, 104.724; 57: RR, 22.966; 57: SpO2, 100.0; 57: 1min HRV, 12.334; 57: 5min HRV, 12.666; 57: SBP, 99.0; 57: DBP, 65.0; 57: MAP, 76.333; 58: HR, 102.525; 58: RR, 20.220; 58: SpO2, 100.0; 58: 1min HRV, 20.083; 59: HR, 98.328; 59: RR, 16.862; 59: SpO2, 99.545; 59: Perf, 0.100; 59: 1min HRV, 34.211; 60: HR, 100.034; 60: RR, 19.203; 60: SpO2, 100.0; 60: Perf, 0.1; 60: 1min HRV, 10.732; 61: POC PH (V) ISTAT, 7.55; 61: POC HCO3 (V) ISTAT, 26.0 mmol/L; 61: POC LACTATE ISTAT, 1.13 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC PO2 (V) ISTAT, 33 mmHg; 61: POC PCO2 (V) ISTAT, 30.0 mmHg; 61: POC TCO2 (V) ISTAT, 27 mmol/L; 61: POC BASE EXCESS ISTAT, 4 mmol/L; 61: HR, 97.661; 61: RR, 19.508; 61: SpO2, 90.267; 61: 1min HRV, 10.219; 62: HR, 95.644; 62: RR, 20.322; 62: SpO2, 98.0; 62: 1min HRV, 17.941; 62: 5min HRV, 25.552; 63: HR, 94.483; 63: RR, 22.017; 63: SpO2, 95.0; 63: 1min HRV, 19.813; 63: SBP, 109.0; 63: DBP, 65.0; 63: MAP, 79.667; 64: HR, 95.288; 64: RR, 21.695; 64: 1min HRV, 9.077; 65: HR, 94.259; 65: RR, 21.897; 65: SpO2, 100.0; 65: 1min HRV, 35.389; 66: HR, 94.712; 66: RR, 22.814; 66: 1min HRV, 12.444; 67: HR, 95.576; 67: RR, 19.407; 67: SpO2, 99.0; 67: 1min HRV, 13.691; 67: 5min HRV, 20.499; 68: HR, 102.983; 68: RR, 21.190; 68: SpO2, 93.333; 68: 1min HRV, 29.881; 69: HR, 105.983; 69: RR, 19.759; 69: 1min HRV, 19.558; 70: HR, 105.898; 70: RR, 21.119; 70: 1min HRV, 20.311; 71: HR, 103.864; 71: RR, 19.390; 71: 1min HRV, 28.157; 72: HR, 94.831; 72: RR, 18.729; 72: SpO2, 98.946; 72: 1min HRV, 32.574; 72: 5min HRV, 38.943; 73: HR, 91.241; 73: RR, 23.483; 73: SpO2, 96.877; 73: 1min HRV, 26.875; 74: HR, 92.763; 74: RR, 23.254; 74: SpO2, 98.773; 74: 1min HRV, 27.392; 74: NORMOSOL-R IV BOLUS -, 1000 ML; 75: HR:, 87.534; 75: RR, 21.103; 75: SpO2, 95.188; 75: 1min HRV, 30.984; 76: HR, 87.237; 76: RR, 19.102; 76: SpO2, 99.25; 76: 1min HRV, 33.549; 77: HR, 88.534; 77: RR, 21.690; 77: SpO2, 99.077; 77: 1min HRV, 31.958; 77: 5min HRV, 34.560; 78: HR, 87.881; 78: RR, 22.814; 78: SpO2, 99.179; 78: 1min HRV, 14.725; 78: SBP, 103.0; 78: DBP, 61.0; 78: MAP, 75.0; 79: HR, 85.525; 79: RR, 17.0; 79: SpO2, 99.125; 79: Perf, 0.16; 79: 1min HRV, 24.524; 80: HR, 87.586; 80: RR, 21.828; 80: SpO2, 98.233; 80: Perf, 0.16; 80: 1min HRV, 23.789; 81: HR, 88.966; 81: RR, 17.322; 81: SpO2, 95.346; 81: 1min HRV, 20.920; 82: 5min HRV, 23.024; 94: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 94: PROTEIN TOTAL, 6.3 g/dL; 94: SODIUM, 131 mmol/L; 94: MAGNESIUM, 2.0 mg/dL; 94: AST (SGOT), 20 U/L; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: CREATININE, 0.46 mg/dL; 94: POTASSIUM, 3.8 mmol/L; 94: ANION GAP, 10 mmol/L; 94: BILIRUBIN TOTAL, 1.0 mg/dL; 94: ALBUMIN, 3.2 g/dL; 94: GLUCOSE, 124 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 94: ALKALINE PHOSPHATASE, 71 U/L; 94: ALT (SGPT), 14 U/L; 94: CO2, 25 mmol/L; 94: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 94: CHLORIDE, 96 mmol/L; 94: GLOBULIN, 3.1 g/dL; 94: CALCIUM, 8.6 mg/dL; 104: SARS-COV-2 RNA, Not Detected; 113: TROPONIN I, <.017 ng/mL; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 110.0; 0: Triage RR, 13.0; 0: Triage SBP, 126.0; 0: Triage DBP, 108.0; 0: Triage acuity, 2-Emergent; 0: CC, GENERAL WEAKNESS,COUGH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The first step is to determine if the available vital signs and lab results indicate signs of infection or physiological instability. The heart rate is slightly elevated, but the respiratory rate and blood pressure are reasonably stable, and there are no signs of fever or significant hypoxia. The lactate level is within normal limits, and other lab results do not indicate metabolic derangement or infection. A bolus of Normosol-R could suggest monitoring for potential instability, but trends in heart rate variability (HRV) and cardiovascular parameters do not point to a high risk of sepsis. Thus, the patient appears to be low risk for developing sepsis within the next 12 hours.",
        "claims": [
            "The first step is to determine if the available vital signs and lab results indicate signs of infection or physiological instability.",
            "The heart rate is slightly elevated.",
            "The respiratory rate is reasonably stable.",
            "The blood pressure is reasonably stable.",
            "There are no signs of fever.",
            "There are no signs of significant hypoxia.",
            "The lactate level is within normal limits.",
            "Other lab results do not indicate metabolic derangement.",
            "Other lab results do not indicate infection.",
            "A bolus of Normosol-R could suggest monitoring for potential instability.",
            "Trends in heart rate variability (HRV) do not point to a high risk of sepsis.",
            "Trends in cardiovascular parameters do not point to a high risk of sepsis.",
            "The patient appears to be low risk for developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "There are no signs of fever.",
            "There are no signs of significant hypoxia.",
            "The lactate level is within normal limits.",
            "Other lab results do not indicate infection."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.1,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The absence of fever could be relevant to the SIRS criteria since fever or hypothermia (temperature\u202f>\u202f38\u202f\u00b0C or\u202f<\u202f36\u202f\u00b0C) are part of the SIRS assessment. However, the claim indicates a lack of one of these criteria, which weakly informs the sepsis assessment as it alone doesn't confirm or negate the risk. The alignment is indirect and low because the absence of fever is just one component and doesn\u2019t confirm the presence of other SIRS criteria.",
            "The absence of significant hypoxia can influence the evaluation of a patient's respiratory status. While not directly related to the SOFA criteria, avoiding hypoxia could suggest stable oxygenation, thus indirectly affecting assessments involving PaO\u2082/FiO\u2082 ratios. Still, without specific reference to SOFA criteria or a quantitative measure of hypoxia, the alignment is weak.",
            "The claim references lactate levels, which is a specific component of the \"Elevated Serum Lactate\" category. However, stating that the lactate level is within normal limits directly opposes the elevated lactate criterion needed to assess sepsis risk. Thus, the alignment is minimal, as it mentions the category's focus but does not align with its sepsis risk indicator.",
            "The claim suggests that lab results do not indicate an infection, which might affect the likelihood of early antibiotic or culture orders being placed. However, the emphasis here is on the absence of evidence for infection, which indirectly connects to the clinician's decision-making regarding early tests or treatment. The connection to the category is indirect and weak, as it does not involve direct action relevant to the category's definition."
        ],
        "final_alignment_score": 0.25,
        "accuracy": 1
    },
    {
        "input": "5: HR, 95.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 131.0; 5: DBP, 71.0; 5: MAP, 91.0; 5: Pain, 10.0; 5: Temp, 100.0; 7: Pain, 10.0; 15: SpO2, 97.914; 15: Perf, 3.922; 15: SBP, 135.0; 15: DBP, 78.0; 15: MAP, 97.0; 16: SpO2, 97.621; 16: Perf, 4.766; 16: SBP, 128.0; 16: DBP, 76.0; 16: MAP, 93.333; 17: SpO2, 98.0; 17: Perf, 4.448; 18: SpO2, 97.431; 18: Perf, 4.878; 19: SpO2, 97.0; 19: Perf, 4.727; 20: SpO2, 97.508; 20: Perf, 4.079; 21: SpO2, 97.328; 21: Perf, 4.229; 22: SpO2, 97.831; 22: Perf, 3.967; 23: SpO2, 98.293; 23: Perf, 2.087; 24: SpO2, 97.729; 24: Perf, 3.178; 25: SpO2, 97.458; 25: Perf, 3.914; 26: SpO2, 97.759; 26: Perf, 3.689; 27: SpO2, 97.814; 27: Perf, 3.198; 28: SpO2, 97.345; 28: Perf, 3.3; 29: SpO2, 97.068; 29: Perf, 3.367; 30: SpO2, 97.0; 30: Perf, 3.384; 31: SpO2, 97.241; 31: Perf, 3.321; 32: SpO2, 97.932; 32: Perf, 3.390; 33: SpO2, 97.414; 33: Perf, 3.948; 34: SpO2, 97.119; 34: Perf, 4.267; 35: SpO2, 97.322; 35: Perf, 3.937; 36: SpO2, 97.569; 36: Perf, 3.674; 37: SpO2, 97.288; 37: Perf, 3.535; 38: SpO2, 97.845; 38: Perf, 3.626; 39: SpO2, 97.545; 39: Perf, 3.52; 40: SpO2, 97.805; 41: SpO2, 97.390; 41: Perf, 2.040; 42: SpO2, 97.542; 42: Perf, 3.324; 43: SpO2, 97.241; 43: Perf, 2.687; 44: SpO2, 97.051; 44: Perf, 2.293; 45: SpO2, 97.017; 45: Perf, 2.477; 46: SpO2, 97.0; 46: Perf, 2.558; 47: SpO2, 97.237; 47: Perf, 2.516; 48: SpO2, 97.0; 48: Perf, 2.645; 49: SpO2, 97.542; 49: Perf, 2.349; 50: SpO2, 97.328; 50: Perf, 2.295; 51: SpO2, 97.492; 51: Perf, 2.235; 52: SpO2, 97.814; 52: Perf, 2.463; 53: SpO2, 97.517; 53: Perf, 3.578; 54: SpO2, 97.153; 54: Perf, 3.237; 55: SpO2, 97.121; 55: Perf, 3.452; 56: SpO2, 97.017; 56: Perf, 4.274; 57: SpO2, 98.085; 57: Perf, 3.315; 58: SpO2, 97.379; 58: Perf, 3.838; 59: SpO2, 96.966; 59: Perf, 4.163; 60: SpO2, 96.759; 60: Perf, 3.612; 61: SpO2, 96.949; 61: Perf, 2.512; 62: SpO2, 97.0; 62: Perf, 2.677; 63: SpO2, 96.915; 63: Perf, 2.779; 64: SpO2, 97.305; 64: Perf, 2.938; 65: SpO2, 97.172; 65: Perf, 3.611; 66: SpO2, 98.932; 66: Perf, 2.547; 67: SpO2, 98.407; 67: Perf, 2.685; 68: SpO2, 97.914; 68: Perf, 2.764; 69: SpO2, 97.915; 69: Perf, 3.33; 70: SpO2, 97.862; 70: Perf, 2.763; 71: SpO2, 97.966; 71: Perf, 2.603; 72: SpO2, 97.759; 72: Perf, 3.783; 73: SpO2, 97.424; 73: Perf, 4.199; 74: SpO2, 96.746; 74: Perf, 3.387; 75: SpO2, 96.707; 75: Perf, 3.408; 76: SpO2, 96.780; 76: Perf, 3.828; 77: SpO2, 97.138; 77: Perf, 4.055; 78: SpO2, 97.271; 78: Perf, 4.364; 79: SpO2, 97.797; 79: Perf, 4.315; 80: SpO2, 98.0; 80: Perf, 4.72; 81: SpO2, 98.068; 81: Perf, 3.370; 82: SpO2, 97.914; 82: Perf, 4.015; 83: SpO2, 97.492; 83: Perf, 3.757; 84: SpO2, 97.763; 84: Perf, 3.819; 85: SpO2, 97.897; 85: Perf, 3.276; 86: SpO2, 97.864; 86: Perf, 3.438; 87: SpO2, 97.638; 87: Perf, 4.142; 88: SpO2, 97.339; 88: Perf, 3.754; 89: POC, HCG, ISTAT QUALITATIVE: Negative; 89: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 89: SpO2, 97.356; 89: Perf, 3.648; 90: SpO2, 97.759; 90: Perf, 2.604; 91: SpO2, 97.831; 91: Perf, 3.684; 91: LR IV BOLUS -, 1000 ML; 92: SpO, 2: 97.345; 92: Perf, 3.88; 93: SpO2, 97.288; 93: Perf, 3.398; 94: SpO2, 97.492; 94: Perf, 2.554; 95: SpO2, 97.259; 95: Perf, 3.043; 96: SpO2, 97.797; 96: Perf, 2.942; 97: SpO2, 97.793; 97: Perf, 2.923; 98: SpO2, 98.153; 98: Perf, 4.124; 99: SpO2, 98.190; 99: Perf, 4.331; 100: SpO2, 98.542; 100: Perf, 3.513; 101: SpO2, 98.203; 101: Perf, 3.262; 102: SpO2, 98.345; 102: Perf, 3.276; 103: SpO2, 98.305; 103: Perf, 3.638; 104: SpO2, 98.224; 104: Perf, 3.374; 105: SpO2, 98.0; 105: Perf, 3.113; 106: SpO2, 98.0; 106: Perf, 3.541; 107: SpO2, 98.0; 107: Perf, 3.784; 108: SpO2, 98.322; 108: Perf, 3.647; 109: SpO2, 98.293; 109: Perf, 2.863; 110: SpO2, 98.136; 110: Perf, 3.490; 111: WAM DIFTYP, AUTO; 111: PLATELET COUNT (PLT), 335 K/uL; 111: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 111: RED BLOOD CELLS (RBC), 4.56 MIL/uL; 111: HEMOGLOBIN (HGB), 12.0 g/dL; 111: EOSINOPHIL % (AUTO DIFF), 0.0 %; 111: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.62 K/uL; 111: MONOCYTE ABSOLUTE (AUTO DIFF), 1.12 K/uL; 111: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 111: NEUTROPHIL % (AUTO DIFF), 79.7 %; 111: BASOPHIL % (AUTO DIFF), 0.2 %; 111: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 111: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 111: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 111: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 111: RED CELL DISTRIBUTION WIDTH (RDW), 15.5 %; 111: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 111: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.3 pg; 111: MONOCYTE % (AUTO DIFF), 8.4 %; 111: HEMATOCRIT (HCT), 37.5 %; 111: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 111: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 111: MEAN CORPUSCULAR VOLUME (MCV), 82.2 fL; 111: NRBC PERCENT (HEMATOLOGY), 0.0 %; 111: SpO2, 98.034; 111: Perf, 3.432; 112: SpO2, 97.983; 112: Perf, 3.777; 113: SpO2, 98.0; 113: Perf, 4.029; 114: SpO2, 98.0; 114: Perf, 3.815; 115: SpO2, 98.034; 115: Perf, 3.668; 116: SpO2, 98.0; 116: Perf, 3.089; 117: SpO2, 98.121; 117: Perf, 3.028; 118: SpO2, 97.678; 118: Perf, 3.533; 119: SpO2, 97.086; 119: Perf, 3.043; 0: Age, 34; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 37.8; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 131.0; 0: Triage DBP, 71.0; 0: Triage acuity, 5-Non-Urgent; 0: CC, PAIN TOOTH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess the risk of sepsis, we first examine vital signs, including temperature, heart rate, and respiration rate, none of which show extreme abnormalities. The patient's body temperature initially records mild fever levels (100.0\u00b0F), and heart rate remains consistently within normal bounds. Blood pressure measurements are steady and not indicative of shock. Next, we look for further clinical signs like oxygen saturation, which consistently remains high, indicating good oxygenation. Finally, the lab values, particularly the white blood cell count, are elevated but not extreme enough to suggest an imminent septic state. Given the initial triage acuity and these assessments, the patient is not at a high risk of developing sepsis in the next 12 hours.",
        "claims": [
            "The risk of sepsis is assessed by examining vital signs.",
            "Vital signs include temperature, heart rate, and respiration rate.",
            "None of the vital signs show extreme abnormalities.",
            "The patient's body temperature initially records mild fever levels of 100.0\u00b0F.",
            "The heart rate remains consistently within normal bounds.",
            "Blood pressure measurements are steady and not indicative of shock.",
            "Oxygen saturation consistently remains high.",
            "High oxygen saturation indicates good oxygenation.",
            "The white blood cell count is elevated.",
            "The elevation of the white blood cell count is not extreme enough to suggest an imminent septic state.",
            "Given the initial triage acuity and these assessments, the patient is not at a high risk of developing sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "None of the vital signs show extreme abnormalities.",
            "The patient's body temperature initially records mild fever levels of 100.0\u00b0F.",
            "Blood pressure measurements are steady and not indicative of shock."
        ],
        "alignment_scores": [
            0.2,
            0.5,
            0.2
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
        ],
        "alignment_reasonings": [
            "The NEWS score is based on aggregates of vital signs, where extreme abnormalities in vitals are likely to increase the NEWS score, indicating imminent clinical deterioration. The claim's lack of extreme vital sign abnormalities suggests indirectly that the NEWS score might not be elevated, but since there's no direct measure or indication provided, the alignment is weak.",
            "The claim mentions a body temperature of 100.0\u00b0F, which is approximately 37.8\u00b0C. Although this does not meet the full SIRS criterion of >38\u00b0C for fever, it is close enough to suggest a potential febrile response related to systemic inflammation. Therefore, the claim is somewhat relevant to SIRS criteria, but it does not fully satisfy the condition, resulting in a moderate alignment score.",
            "The claim implies that the blood pressure is steady and not indicative of shock, which contrasts with the conditions described under the \"Sepsis-Associated Hypotension\" category. While the claim does relate to the concept of blood pressure and hypotension, it indicates stability rather than a problem, making the alignment weak."
        ],
        "final_alignment_score": 0.3,
        "accuracy": 1
    },
    {
        "input": "7: HR, 117.0; 7: RR, 21.0; 7: SpO2, 99.0; 7: SBP, 143.0; 7: DBP, 92.0; 7: MAP, 109.0; 7: Pain, 1.0; 7: Temp, 98.4; 25: POC, HCG, ISTAT QUALITATIVE: Positive; 25: POC, BHCG, ISTAT QUANTITATIVE: >2000.0 IU/L; 35: WAM DIFTYP, AUTO; 35: MEAN CORPUSCULAR VOLUME (MCV), 82.4 fL; 35: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 35: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 35: MONOCYTE ABSOLUTE (AUTO DIFF), 0.73 K/uL; 35: PLATELET COUNT (PLT), 229 K/uL; 35: RED BLOOD CELLS (RBC), 5.22 MIL/uL; 35: MONOCYTE % (AUTO DIFF), 9.4 %; 35: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.7 pg; 35: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 35: EOSINOPHIL % (AUTO DIFF), 0.4 %; 35: HEMATOCRIT (HCT), 43.0 %; 35: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 35: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 35: LYMPHOCYTE % (AUTO DIFF), 25.2 %; 35: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 35: HEMOGLOBIN (HGB), 15.0 g/dL; 35: WHITE BLOOD CELLS (WBC), 7.8 K/uL; 35: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.96 K/uL; 35: BASOPHIL % (AUTO DIFF), 0.3 %; 35: NRBC PERCENT (HEMATOLOGY), 0.0 %; 35: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.02 K/uL; 35: NEUTROPHIL % (AUTO DIFF), 64.3 %; 35: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.9 g/dL; 36: SpO2, 99.333; 37: SpO2, 99.458; 37: Perf, 1.035; 38: SpO2, 99.153; 38: Perf, 0.986; 39: SpO2, 99.0; 39: Perf, 1.041; 40: SpO2, 99.085; 40: Perf, 0.993; 41: SpO2, 99.517; 41: Perf, 0.938; 42: SpO2, 99.051; 42: Perf, 0.87; 43: SpO2, 99.0; 43: Perf, 1.305; 44: SpO2, 98.879; 44: Perf, 2.141; 45: SpO2, 98.746; 45: Perf, 1.711; 46: SpO2, 98.586; 46: Perf, 1.433; 47: SpO2, 98.932; 47: Perf, 1.495; 48: SpO2, 99.0; 48: Perf, 1.245; 49: SpO2, 99.0; 49: Perf, 1.705; 50: SpO2, 99.0; 50: Perf, 1.848; 51: SpO2, 99.310; 51: Perf, 1.121; 52: SpO2, 99.458; 52: Perf, 0.928; 53: SpO2, 99.864; 53: Perf, 0.844; 53: LR IV BOLUS -, 1000 ML; 54: SpO, 2: 99.5; 54: Perf, 0.705; 55: SpO2, 99.593; 55: Perf, 0.620; 56: SpO2, 100.0; 56: Perf, 0.649; 57: SpO2, 99.237; 57: Perf, 0.774; 58: SpO2, 99.203; 58: Perf, 0.742; 59: SpO2, 100.0; 59: Perf, 0.723; 60: SpO2, 99.458; 60: Perf, 0.647; 61: SpO2, 100.0; 61: Perf, 0.638; 62: GLUCOSE, URINE (UA): Negative; 62: SPECIFIC GRAVITY, URINE (UA): 1.028; 62: BLOOD, URINE (UA): Negative; 62: NITRITE, URINE (UA): Negative; 62: PH, URINE (UA): 6.0; 62: SpO2, 99.288; 62: Perf, 0.617; 63: SpO2, 99.931; 63: Perf, 0.602; 64: SpO2, 99.759; 64: Perf, 0.59; 65: INR, 1.3; 65: PART. THROMBOPLASTIN TIME, 29.9 seconds; 65: PROTHROMBIN TIME, 16.4 seconds; 65: SpO2, 99.229; 65: Perf, 0.584; 66: POTASSIUM, 3.2 mmol/L; 66: ALKALINE PHOSPHATASE, 165 U/L; 66: AST (SGOT), 103 U/L; 66: ALT (SGPT), 222 U/L; 66: CREATININE, 0.47 mg/dL; 66: GLOBULIN, 3.6 g/dL; 66: SODIUM, 135 mmol/L; 66: EGFR REFIT WITHOUT RACE (2021), 123 mL/min/1.73 m2; 66: CALCIUM, 9.8 mg/dL; 66: GLUCOSE, 104 mg/dL; 66: CORRECTED CALCIUM, 9.5 mg/dL; 66: ANION GAP, 15 mmol/L; 66: BILIRUBIN TOTAL, 1.0 mg/dL; 66: PROTEIN TOTAL, 8.0 g/dL; 66: LIPASE, 66 U/L; 66: CO2, 23 mmol/L; 66: ALBUMIN, 4.4 g/dL; 66: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 142 mL/min/1.73 m2; 66: CHLORIDE, 97 mmol/L; 66: SpO2, 100.0; 66: Perf, 0.583; 67: SpO2, 100.0; 67: Perf, 0.564; 68: SpO2, 100.0; 68: Perf, 0.563; 69: SpO2, 100.0; 69: Perf, 0.597; 70: SpO2, 99.881; 70: Perf, 0.587; 71: SpO2, 99.897; 71: Perf, 0.568; 72: SpO2, 100.0; 72: Perf, 0.541; 73: SpO2, 99.931; 73: Perf, 0.524; 74: SpO2, 100.0; 74: Perf, 0.507; 75: SpO2, 100.0; 75: Perf, 0.523; 76: SARS-COV-2 RNA, Not Detected; 76: SpO2, 100.0; 76: Perf, 0.531; 77: SpO2, 100.0; 77: Perf, 0.511; 78: SpO2, 100.0; 78: Perf, 0.512; 79: SpO2, 100.0; 79: Perf, 0.500; 80: SpO2, 100.0; 80: Perf, 0.504; 81: SpO2, 99.793; 81: Perf, 0.511; 82: SpO2, 99.271; 82: Perf, 0.52; 83: SpO2, 99.931; 83: Perf, 0.522; 84: SpO2, 100.0; 84: Perf, 0.553; 85: ANTIBODY SCREEN 3, NEG; 85: ABO/RH (AUTOMATION), O Positive; 85: BLOOD TYPE VERIFICATION-AUTOMATION, O Positive; 85: SpO2, 100.0; 85: Perf, 0.55; 86: SpO2, 99.914; 86: Perf, 0.55; 87: SpO2, 99.220; 87: Perf, 0.55; 88: SpO2, 100.0; 88: Perf, 0.524; 89: SpO2, 100.0; 89: Perf, 0.529; 90: SpO2, 100.0; 90: Perf, 0.527; 91: SpO2, 100.0; 91: Perf, 0.525; 92: SpO2, 100.0; 92: Perf, 0.54; 93: SpO2, 99.8; 93: Perf, 0.534; 94: SpO2, 100.0; 94: Perf, 0.528; 95: SpO2, 99.845; 95: Perf, 0.547; 96: SpO2, 100.0; 96: Perf, 0.53; 97: SpO2, 99.949; 97: Perf, 0.53; 98: SpO2, 99.842; 98: Perf, 0.53; 99: SpO2, 99.881; 99: Perf, 0.53; 100: SpO2, 99.931; 100: Perf, 0.53; 101: SpO2, 99.982; 101: Perf, 0.538; 102: SpO2, 100.0; 102: Perf, 0.539; 103: SpO2, 100.0; 103: Perf, 0.56; 104: SpO2, 100.0; 104: Perf, 0.575; 105: SpO2, 99.911; 105: Perf, 0.562; 106: SpO2, 98.538; 106: Perf, 0.56; 107: SpO2, 99.288; 107: Perf, 0.552; 108: SpO2, 99.707; 108: Perf, 0.559; 109: SpO2, 99.864; 109: Perf, 0.571; 110: SpO2, 99.931; 110: Perf, 0.58; 111: SpO2, 100.0; 111: Perf, 0.584; 112: SpO2, 100.0; 112: Perf, 0.586; 112: DOXYLAMINE-PYRIDOXINE (VIT B, 6) 10-10 MG PO TBEC; 112: ZZZ, IMS TEMPLATE; 113: SpO2, 100.0; 113: Perf, 0.649; 114: SpO2, 100.0; 114: Perf, 0.693; 115: SpO2, 100.0; 115: Perf, 0.658; 116: SpO2, 100.0; 116: Perf, 0.625; 0: Age, 41; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.9; 0: Triage HR, 117.0; 0: Triage RR, 21.0; 0: Triage SBP, 143.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To evaluate the risk of sepsis, I reviewed the EHR time series data for signs commonly associated with sepsis, such as elevated heart rate, respiratory rate, and temperature, along with low blood pressure, poor oxygen saturation, and abnormal lab values indicating infection or organ dysfunction. The heart rate is elevated, but the respiratory rate and temperature are within the normal range. Blood pressure readings (SBP and DBP) are also within or near the normal range, with no signs of hypotension. Laboratory results did not reveal critical abnormalities often seen with sepsis risk, and SpO2 levels remain consistently high. Overall, data do not indicate a high risk of sepsis within 12 hours.",
        "claims": [
            "The EHR time series data was reviewed to evaluate the risk of sepsis.",
            "Signs commonly associated with sepsis include elevated heart rate, respiratory rate, and temperature.",
            "Low blood pressure, poor oxygen saturation, and abnormal lab values indicate infection or organ dysfunction.",
            "The heart rate is elevated.",
            "The respiratory rate is within the normal range.",
            "The temperature is within the normal range.",
            "Blood pressure readings are within or near the normal range.",
            "There are no signs of hypotension.",
            "Laboratory results did not reveal critical abnormalities often seen with sepsis risk.",
            "SpO2 levels remain consistently high.",
            "Overall, the data do not indicate a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Low blood pressure, poor oxygen saturation, and abnormal lab values indicate infection or organ dysfunction.",
            "The heart rate is elevated.",
            "There are no signs of hypotension."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.2
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
        ],
        "alignment_reasonings": [
            "The claim mentions low blood pressure, poor oxygen saturation, and abnormal lab values. These are indicative of organ dysfunction, which aligns with the components of the SOFA score such as cardiovascular and respiratory function, and various blood parameters. While the claim does not specify exact values that would contribute to a SOFA score increase, it broadly captures the concept of new organ dysfunction in line with the SOFA criteria, thus justifying a strong, though not perfect, alignment.",
            "An elevated heart rate is specifically one of the criteria under SIRS, which identifies systemic inflammation consistent with early sepsis. However, since the exact heart rate is not provided to determine if it meets the threshold (heart rate > 90 bpm), the alignment is not perfect but is conceptually strong.",
            "The claim specifically mentions the absence of hypotension, which directly relates to the category of Sepsis-Associated Hypotension. However, the absence of hypotension does not directly indicate a positive sepsis risk factor. The information aligns with understanding what sepsis risk the patient does not have, which is relevant but minimally impactful for confirming a sepsis prediction by this specific category."
        ],
        "final_alignment_score": 0.5666666666666667,
        "accuracy": 1
    },
    {
        "input": "23: HR, 110.0; 23: RR, 18.0; 23: SpO2, 99.0; 23: SBP, 108.0; 23: DBP, 51.0; 23: MAP, 70.0; 23: Pain, 0.0; 23: Temp, 100.6; 51: HR, 102.542; 51: RR, 18.780; 51: 1min HRV, 30.357; 52: HR, 101.707; 52: RR, 20.155; 52: 1min HRV, 3.753; 53: HR, 104.932; 53: RR, 20.983; 53: SpO2, 98.0; 53: 1min HRV, 30.198; 53: 5min HRV, 25.872; 54: HR, 109.966; 54: RR, 22.707; 54: 1min HRV, 9.378; 55: HR, 108.271; 55: RR, 19.339; 55: SpO2, 98.278; 55: 1min HRV, 22.000; 56: HR, 107.345; 56: RR, 19.362; 56: SpO2, 98.15; 56: 1min HRV, 31.490; 57: HR, 105.881; 57: RR, 17.458; 57: SpO2, 98.0; 57: 1min HRV, 14.197; 58: HR, 102.847; 58: RR, 19.966; 58: 1min HRV, 8.543; 58: 5min HRV, 22.600; 59: HR, 107.431; 59: RR, 19.397; 59: SpO2, 81.0; 59: 1min HRV, 20.253; 60: HR, 106.288; 60: RR, 18.780; 60: 1min HRV, 10.695; 61: HR, 107.103; 61: RR, 19.241; 61: 1min HRV, 14.181; 62: HR, 107.458; 62: RR, 17.695; 62: SpO2, 95.207; 62: 1min HRV, 9.273; 63: HR, 110.203; 63: RR, 19.390; 63: SpO2, 83.444; 63: 1min HRV, 26.656; 63: 5min HRV, 18.861; 64: HR, 106.690; 64: RR, 16.328; 64: SpO2, 92.0; 64: 1min HRV, 10.083; 64: SBP, 119.0; 64: DBP, 58.0; 64: MAP, 78.333; 65: HR, 104.593; 65: RR, 17.508; 65: 1min HRV, 3.740; 66: HR, 102.121; 66: RR, 19.707; 66: SpO2, 99.0; 66: 1min HRV, 7.077; 67: HR, 99.220; 67: RR, 19.254; 67: 1min HRV, 34.203; 68: HR, 97.288; 68: RR, 19.0; 68: 1min HRV, 3.403; 68: 5min HRV, 25.038; 69: HR, 98.310; 69: RR, 18.966; 69: SpO2, 97.4; 69: Perf, 0.146; 69: 1min HRV, 34.288; 70: HR, 96.864; 70: RR, 19.797; 70: SpO2, 99.0; 70: Perf, 0.18; 70: 1min HRV, 5.437; 71: HR, 97.207; 71: RR, 19.414; 71: SpO2, 98.846; 71: Perf, 0.180; 71: 1min HRV, 7.924; 72: HR, 99.136; 72: RR, 19.864; 72: SpO2, 99.492; 72: Perf, 0.511; 72: 1min HRV, 9.633; 73: HR, 101.627; 73: RR, 19.186; 73: SpO2, 99.791; 73: Perf, 0.436; 73: 1min HRV, 49.909; 73: 5min HRV, 29.921; 74: HR, 100.759; 74: RR, 18.672; 74: SpO2, 100.0; 74: Perf, 0.183; 74: 1min HRV, 20.317; 75: HR, 99.136; 75: RR, 16.932; 75: 1min HRV, 28.707; 76: HR, 98.966; 76: RR, 18.862; 76: 1min HRV, 35.558; 77: HR, 96.966; 77: RR, 18.458; 77: SpO2, 100.0; 77: Perf, 0.1; 77: 1min HRV, 10.755; 78: HR, 96.458; 78: RR, 19.746; 78: 1min HRV, 4.215; 78: 5min HRV, 25.348; 79: HR, 96.172; 79: RR, 19.155; 79: SpO2, 100.0; 79: Perf, 0.21; 79: 1min HRV, 25.924; 80: HR, 95.610; 80: RR, 19.525; 80: SpO2, 100.0; 80: Perf, 0.191; 80: 1min HRV, 10.023; 81: HR, 95.828; 81: RR, 19.931; 81: SpO2, 100.0; 81: Perf, 0.198; 81: 1min HRV, 25.357; 82: HR, 96.017; 82: RR, 20.576; 82: SpO2, 100.0; 82: Perf, 0.298; 82: 1min HRV, 8.397; 83: HR, 97.186; 83: RR, 19.932; 83: SpO2, 99.508; 83: Perf, 0.428; 83: 1min HRV, 9.429; 83: 5min HRV, 18.159; 84: HR, 98.138; 84: RR, 20.948; 84: SpO2, 99.156; 84: Perf, 0.339; 84: 1min HRV, 37.668; 85: HR, 96.661; 85: RR, 18.644; 85: SpO2, 100.0; 85: Perf, 0.201; 85: 1min HRV, 25.358; 86: HR, 96.310; 86: RR, 18.603; 86: SpO2, 100.0; 86: Perf, 0.254; 86: 1min HRV, 34.768; 87: HR, 97.373; 87: RR, 19.288; 87: SpO2, 100.0; 87: Perf, 0.271; 87: 1min HRV, 25.799; 88: HR, 98.259; 88: RR, 21.103; 88: SpO2, 99.469; 88: Perf, 0.433; 88: 1min HRV, 28.125; 88: 5min HRV, 31.007; 89: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 90: NS IV BOLUS -, 30 ML/KG; 91: POC PH (V) ISTAT, 7.44; 91: POC PCO2 (V) ISTAT, 47.9 mmHg; 91: POC O2 SATURATION ISTAT VENOUS, 65 %; 91: POC HCO3 (V) ISTAT, 32.5 mmol/L; 91: POC TCO2 (V) ISTAT, 34 mmol/L; 91: POC PO2 (V) ISTAT, 33 mmHg; 91: POC BASE EXCESS ISTAT, 8 mmol/L; 91: POC LACTATE ISTAT, 0.72 mmol/L; 93: HR, 97.0; 93: RR, 19.0; 93: SpO2, 100.0; 93: SBP, 88.0; 93: DBP, 48.0; 93: MAP, 61.333; 95: WAM DIFTYP, AUTO; 95: HEMOGLOBIN (HGB), 11.5 g/dL; 95: WHITE BLOOD CELLS (WBC), 28.8 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.0 %; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.44 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 89.3 fL; 95: BASOPHIL % (AUTO DIFF), 0.3 %; 95: NRBC PERCENT (HEMATOLOGY), 0.0 %; 95: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 27.13 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.44 K/uL; 95: HEMATOCRIT (HCT), 35.7 %; 95: LYMPHOCYTE % (AUTO DIFF), 1.5 %; 95: RED BLOOD CELLS (RBC), 4.00 MIL/uL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 95: MONOCYTE % (AUTO DIFF), 2.6 %; 95: NEUTROPHIL % (AUTO DIFF), 94.1 %; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 95: PLATELET COUNT (PLT), 255 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.8 pg; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.2 g/dL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.75 K/uL; 104: HR, 92.0; 104: RR, 19.0; 104: SpO2, 99.0; 104: SBP, 90.0; 104: DBP, 41.0; 104: MAP, 57.333; 113: PART. THROMBOPLASTIN TIME, 37.1 seconds; 116: INR, 1.1; 116: PROTHROMBIN TIME, 14.2 seconds; 118: HR, 92.0; 118: RR, 13.0; 118: SpO2, 100.0; 118: SBP, 106.0; 118: DBP, 82.0; 118: MAP, 90.0; 0: Age, 69; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 108.0; 0: Triage DBP, 51.0; 0: Triage acuity, 3-Urgent; 0: CC, ACUTE NEUROLOGICAL PROBLEM",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The easiest subquestion to address is whether the patient demonstrates any physiological indications of sepsis, such as fever, elevated heart rate, tachypnea, or hypotension. Initially, the patient presents with a high heart rate (HR: 110) and high temperature (Temp: 38.1\u00b0C), suggesting the presence of an infection and inflammation. However, these values begin to normalize over time, and no other clear signs of organ dysfunction or a continually worsening condition are present, indicating that the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The easiest subquestion to address is whether the patient demonstrates any physiological indications of sepsis.",
            "Physiological indications of sepsis include fever, elevated heart rate, tachypnea, or hypotension.",
            "The patient presents with a high heart rate of 110.",
            "The patient presents with a high temperature of 38.1\u00b0C.",
            "A high heart rate and high temperature suggest the presence of an infection and inflammation.",
            "The patient's heart rate and temperature begin to normalize over time.",
            "No other clear signs of organ dysfunction are present.",
            "The patient's condition is not continually worsening.",
            "The patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient presents with a high heart rate of 110.",
            "A high heart rate and high temperature suggest the presence of an infection and inflammation."
        ],
        "alignment_scores": [
            0.7,
            1.0
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "A heart rate of >90 bpm is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The high heart rate of 110 directly satisfies one of the SIRS criteria, indicating strong but not exhaustive alignment since additional SIRS criteria would typically need to be fulfilled for full classification.",
            "The claim mentions a high heart rate and high temperature, both of which are explicitly stated criteria for SIRS. SIRS is used to identify systemic inflammation due to infection, which aligns perfectly with the claim provided."
        ],
        "final_alignment_score": 0.85,
        "accuracy": 0
    },
    {
        "input": "6: POC PH (V) ISTAT, 7.40; 6: POC LACTATE ISTAT, 0.71 mmol/L; 6: POC TCO2 (V) ISTAT, 19 mmol/L; 6: POC BASE EXCESS ISTAT, -7 mmol/L; 6: POC O2 SATURATION ISTAT VENOUS, 60 %; 6: POC PCO2 (V) ISTAT, 29.3 mmHg; 6: POC PO2 (V) ISTAT, 31 mmHg; 6: POC HCO3 (V) ISTAT, 18.0 mmol/L; 6: HR, 121.914; 6: RR, 17.690; 6: SpO2, 95.375; 6: 1min HRV, 1.823; 7: HR, 120.917; 7: RR, 20.717; 7: SpO2, 92.481; 7: 1min HRV, 6.958; 7: 5min HRV, 5.598; 8: HR, 119.483; 8: RR, 17.655; 8: SpO2, 96.975; 8: 1min HRV, 9.738; 9: HR, 122.0; 9: RR, 16.345; 9: SpO2, 96.294; 9: 1min HRV, 8.179; 10: HR, 120.525; 10: RR, 18.475; 10: SpO2, 88.769; 10: 1min HRV, 3.283; 10: LR IV BOLUS -, 1000 ML; 11: HR:, 119.448; 11: RR, 17.914; 11: SpO2, 89.429; 11: 1min HRV, 23.147; 11: ACETAMINOPHEN, 500 MG PO TABS; 12: HR:, 120.085; 12: RR, 14.051; 12: SpO2, 97.771; 12: 1min HRV, 7.207; 12: 5min HRV, 13.143; 12: SBP, 173.0; 12: DBP, 62.0; 12: MAP, 99.0; 13: HR, 120.966; 13: RR, 13.169; 13: SpO2, 96.971; 13: Perf, 0.165; 13: 1min HRV, 10.376; 13: Pain, 0.0; 13: Temp, 102.4; 14: HR, 120.879; 14: RR, 16.983; 14: SpO2, 98.2; 14: Perf, 0.16; 14: 1min HRV, 14.064; 15: HR, 122.356; 15: RR, 17.169; 15: SpO2, 95.0; 15: 1min HRV, 15.639; 16: HR, 122.847; 16: RR, 19.034; 16: SpO2, 98.741; 16: 1min HRV, 15.173; 17: HR, 123.085; 17: RR, 18.102; 17: 1min HRV, 11.870; 17: 5min HRV, 13.939; 18: HR, 122.052; 18: RR, 16.379; 18: SpO2, 92.308; 18: 1min HRV, 11.822; 18: SBP, 173.0; 18: DBP, 62.0; 18: MAP, 99.0; 19: HR, 121.915; 19: RR, 15.644; 19: 1min HRV, 9.792; 20: HR, 121.690; 20: RR, 15.793; 20: 1min HRV, 10.705; 21: HR, 120.695; 21: RR, 15.864; 21: SpO2, 85.457; 21: 1min HRV, 11.401; 22: HR, 121.845; 22: RR, 17.259; 22: SpO2, 94.048; 22: 1min HRV, 14.298; 22: 5min HRV, 11.833; 23: HR, 126.576; 23: RR, 18.373; 23: SpO2, 99.75; 23: 1min HRV, 11.039; 24: HR, 122.508; 24: RR, 15.559; 24: SpO2, 98.0; 24: 1min HRV, 6.847; 25: HR, 120.086; 25: RR, 19.069; 25: 1min HRV, 9.427; 26: HR, 117.763; 26: RR, 14.898; 26: 1min HRV, 11.920; 27: HR, 115.672; 27: RR, 12.552; 27: SpO2, 99.647; 27: 1min HRV, 17.602; 27: 5min HRV, 20.318; 27: SBP, 123.0; 27: DBP, 60.0; 27: MAP, 81.0; 28: HR, 113.797; 28: RR, 14.254; 28: SpO2, 99.695; 28: Perf, 0.213; 28: 1min HRV, 16.678; 29: HR, 113.186; 29: RR, 16.254; 29: SpO2, 99.711; 29: Perf, 0.238; 29: 1min HRV, 11.265; 30: HR, 111.914; 30: RR, 14.328; 30: SpO2, 98.877; 30: Perf, 0.267; 30: 1min HRV, 9.598; 30: SBP, 123.0; 30: DBP, 60.0; 30: MAP, 81.0; 31: HR, 113.254; 31: RR, 21.593; 31: SpO2, 97.136; 31: Perf, 0.297; 31: 1min HRV, 11.016; 32: HR, 113.707; 32: RR, 14.655; 32: SpO2, 96.483; 32: Perf, 0.34; 32: 1min HRV, 12.366; 32: 5min HRV, 12.877; 33: HR, 112.746; 33: RR, 14.356; 33: SpO2, 96.814; 33: Perf, 0.374; 33: 1min HRV, 14.593; 33: SBP, 139.0; 33: DBP, 65.0; 33: MAP, 89.667; 34: HR, 112.288; 34: RR, 15.492; 34: SpO2, 98.237; 34: Perf, 0.428; 34: 1min HRV, 14.612; 35: HR, 111.241; 35: RR, 16.810; 35: SpO2, 99.690; 35: Perf, 0.468; 35: 1min HRV, 17.067; 36: HR, 111.237; 36: RR, 15.220; 36: SpO2, 99.797; 36: Perf, 0.480; 36: 1min HRV, 13.064; 37: 5min HRV, 15.203; 42: HR, 109.0; 42: RR, 13.0; 42: SpO2, 99.0; 50: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 50: RED CELL DISTRIBUTION WIDTH (RDW), 14.3 %; 50: RED BLOOD CELLS (RBC), 2.92 MIL/uL; 50: WHITE BLOOD CELLS (WBC), 1.1 K/uL; 50: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 50: HEMOGLOBIN (HGB), 9.2 g/dL; 50: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 50: HEMATOCRIT (HCT), 27.1 %; 50: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.5 pg; 50: PLATELET COUNT (PLT), 299 K/uL; 50: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 0.66 K/uL; 50: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.15 K/uL; 50: MONOCYTES % (MANUAL DIFF), 17.9 %; 50: METAMYELOCYTES ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 50: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 51.7 %; 50: METAMYELOCYTES % (MANUAL DIFF), 5.4 %; 50: LYMPHOCYTES % (MANUAL DIFF), 14.3 %; 50: NEUTROPHILS BANDS % (MANUAL DIFF), 10.7 %; 50: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.19 K/uL; 51: NITRITE, URINE (UA): Negative; 51: GLUCOSE, URINE (UA): Negative; 51: SPECIFIC GRAVITY, URINE (UA): 1.011; 51: KETONE, URINE (UA): Negative; 51: PH, URINE (UA): 8.0; 52: HIGH SENSITIVITY TROPONIN, 13 ng/L; 58: RSV, Not Detected; 58: SARS-COV-2 RNA, Not Detected; 58: INFLUENZA B, Not Detected; 58: INFLUENZA A, Not Detected; 90: ANION GAP, 18 mmol/L; 90: CHLORIDE, 95 mmol/L; 90: LIPASE, 15 U/L; 90: ALT (SGPT), 102 U/L; 90: CALCIUM, 8.2 mg/dL; 90: CREATININE, 5.54 mg/dL; 90: ALKALINE PHOSPHATASE, 121 U/L; 90: CO2, 16 mmol/L; 90: AST (SGOT), 27 U/L; 90: CORRECTED CALCIUM, 9.2 mg/dL; 90: GLUCOSE, 127 mg/dL; 90: BILIRUBIN TOTAL, 0.5 mg/dL; 90: SODIUM, 129 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 88 mg/dL; 90: GLOBULIN, 3.0 g/dL; 90: EGFR REFIT WITHOUT RACE (2021), 10 mL/min/1.73 m2; 90: PROTEIN TOTAL, 5.8 g/dL; 90: ALBUMIN, 2.8 g/dL; 90: POTASSIUM, 4.9 mmol/L; 114: HR, 91.0; 114: RR, 12.0; 114: SpO2, 97.0; 114: SBP, 100.0; 114: DBP, 51.0; 114: MAP, 67.333; 117: CEFEPIME, 2 GRAM/20 ML IV PUSH; 0: Age:, 75; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 39.1; 0: Triage HR, 123.0; 0: Triage RR, 13.0; 0: Triage SBP, 173.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "The key subquestions involve identifying signs of high sepsis risk. First, assess whether vital signs indicate instability; the patient exhibits an early high heart rate and fever, indicating potential infection or sepsis. Next, evaluate lab results for markers like elevated lactate, low O2 saturation, and kidney function indicators (high creatinine), which signify tissue hypoperfusion and organ dysfunction. The patient's low white blood cell count and blood culture results further suggest an immune response. Given these indicators, the patient is at high risk of sepsis within the next 12 hours.",
        "claims": [
            "The key subquestions involve identifying signs of high sepsis risk.",
            "Vital signs should be assessed to determine instability.",
            "The patient exhibits an early high heart rate.",
            "The patient has a fever.",
            "A high heart rate and fever indicate potential infection or sepsis.",
            "Lab results should be evaluated for markers of sepsis risk.",
            "Elevated lactate levels are a marker of sepsis risk.",
            "Low O2 saturation levels are a marker of sepsis risk.",
            "High creatinine levels are indicators of kidney function issues.",
            "High creatinine levels signify tissue hypoperfusion.",
            "Indicators of organ dysfunction include high creatinine levels.",
            "The patient's low white blood cell count suggests an immune response.",
            "Blood culture results can provide insights into the patient's immune response.",
            "Given these indicators, the patient is at high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient exhibits an early high heart rate.",
            "The patient has a fever.",
            "A high heart rate and fever indicate potential infection or sepsis.",
            "Lab results should be evaluated for markers of sepsis risk.",
            "Elevated lactate levels are a marker of sepsis risk.",
            "Low O2 saturation levels are a marker of sepsis risk.",
            "High creatinine levels are indicators of kidney function issues.",
            "High creatinine levels signify tissue hypoperfusion.",
            "Indicators of organ dysfunction include high creatinine levels.",
            "The patient's low white blood cell count suggests an immune response.",
            "Given these indicators, the patient is at high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.6,
            1.0,
            0.3,
            1.0,
            0.7,
            0.7,
            0.7,
            1.0,
            0.8,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. While the claim does not specify the exact heart rate, the mention of a high heart rate aligns well with the SIRS criteria, indicating a significant probability of alignment. However, without additional information to confirm the heart rate and other SIRS criteria, the alignment is not perfect.",
            "The claim of having a fever aligns with the SIRS criteria, specifically \"temperature >38\u00b0C,\" which is used to identify systemic inflammation indicative of early sepsis. However, the claim does not specify the fever's exact temperature to confirm meeting the SIRS threshold (>38\u00b0C), so the alignment is partial rather than full.",
            "The claim mentions both a high heart rate and fever, which are explicitly listed as components of the SIRS criteria. Having at least two SIRS criteria is used to identify systemic inflammation consistent with early sepsis, representing a perfect alignment with this category.",
            "The claim suggests evaluating lab results for sepsis risk, which indirectly ties to the suspicion of infection. However, it does not indicate specific actions like ordering antibiotics or performing blood cultures, which would strongly align with this category. The connection is weak because it lacks direct evidence of immediate sepsis-related actions.",
            "The claim explicitly mentions elevated lactate levels as a marker of sepsis risk. This directly aligns with the category where serum lactate \u2265\u202f2\u202fmmol/L is noted as indicative of tissue hypoperfusion and increased sepsis mortality risk. The alignment is perfect because elevated lactate levels are specifically associated with this category.",
            "Low O2 saturation levels suggest impaired oxygenation, which conceptually aligns with a decreased PaO\u2082/FiO\u2082 ratio considered in the SOFA score. While not explicitly stated in the clinicians' criteria, hypoxia can indicate organ dysfunction featured in the SOFA score, thus posing a sepsis risk. The alignment is indirect but relevant, resulting in a moderate to high rating.",
            "High creatinine levels are directly related to kidney dysfunction, which is one of the components assessed in the SOFA score. An increase in creatinine levels is indicative of possible organ dysfunction, aligning with the SOFA score parameter for sepsis-related risk. The alignment is strong since creatinine is explicitly mentioned in the SOFA criteria, but the claim does not explicitly state a \u22652 point increase, so the rating is not at maximum.",
            "High creatinine levels are specifically mentioned as part of the SOFA score components, reflecting renal dysfunction. While \"tissue hypoperfusion\" is generally associated with sepsis, the presence of elevated creatinine more directly signifies organ dysfunction, which is a component of the SOFA score. Therefore, the alignment is strong but not perfect since tissue hypoperfusion itself is not explicitly stated in SOFA but relates to critical organ function assessment in sepsis prediction.",
            "The claim directly relates to the SOFA criteria, as an increase in creatinine levels is explicitly mentioned as a parameter indicating progression towards organ dysfunction. This is highly relevant to assessing sepsis risk, thus resulting in perfect alignment with the specified category.",
            "A low white blood cell count (<4,000/\u00b5L) is directly mentioned under the SIRS criteria as indicative of systemic inflammation, which aligns with an immune response relevant to sepsis. Although the claim doesn't specify the exact WBC count, the notion of a low count closely aligns with SIRS, making the alignment strong but slightly uncertain without precise values.",
            "The claim indicates the patient is at high risk of sepsis, which suggests clinical indicators of deterioration often captured through scores like the NEWS. However, without specific details on the patient's vital signs or any concrete criteria from the NEWS system, the alignment is speculative and weak. The NEWS category is partially relevant as it pertains to assessing overall clinical deterioration, which aligns with assessing sepsis risk."
        ],
        "final_alignment_score": 0.709090909090909,
        "accuracy": 0
    },
    {
        "input": "2: HR, 118.203; 2: RR, 29.864; 2: 1min HRV, 19.480; 3: HR, 119.772; 3: RR, 31.491; 3: SpO2, 93.0; 3: 1min HRV, 13.682; 3: 5min HRV, 17.005; 3: SBP, 128.0; 3: DBP, 58.0; 3: MAP, 81.333; 3: Pain, 0.0; 3: Temp, 97.7; 4: HR, 117.932; 4: RR, 30.593; 4: 1min HRV, 5.148; 5: HR, 115.305; 5: RR, 28.949; 5: 1min HRV, 10.322; 6: HR, 114.780; 6: RR, 28.525; 6: 1min HRV, 11.839; 7: HR, 115.610; 7: RR, 31.085; 7: SpO2, 93.714; 7: 1min HRV, 2.882; 8: HR, 114.862; 8: RR, 31.190; 8: 1min HRV, 5.909; 8: 5min HRV, 9.255; 9: HR, 114.932; 9: RR, 29.610; 9: 1min HRV, 8.274; 9: LPM O2, 40.0; 10: HR, 116.534; 10: RR, 28.483; 10: 1min HRV, 4.634; 11: HR, 116.390; 11: RR, 32.288; 11: 1min HRV, 5.701; 12: HR, 117.136; 12: RR, 32.508; 12: 1min HRV, 3.381; 13: HR, 115.966; 13: RR, 31.207; 13: SpO2, 94.0; 13: 1min HRV, 6.246; 13: 5min HRV, 6.479; 13: SBP, 119.0; 13: DBP, 61.0; 13: MAP, 80.333; 14: HR, 115.288; 14: RR, 34.322; 14: 1min HRV, 5.104; 14: SBP, 119.0; 14: DBP, 61.0; 14: MAP, 80.333; 15: HR, 116.172; 15: RR, 33.034; 15: SpO2, 95.0; 15: 1min HRV, 4.809; 16: HR, 114.672; 16: RR, 28.983; 16: SpO2, 95.167; 16: 1min HRV, 5.476; 17: HR, 113.033; 17: RR, 28.733; 17: SpO2, 63.0; 17: 1min HRV, 12.735; 18: HR, 117.293; 18: RR, 34.759; 18: SpO2, 74.25; 18: 1min HRV, 2.955; 18: 5min HRV, 9.442; 19: HR, 115.559; 19: RR, 31.475; 19: 1min HRV, 4.644; 20: HR, 114.983; 20: RR, 30.534; 20: SpO2, 84.571; 20: 1min HRV, 4.050; 21: HR, 117.288; 21: RR, 32.627; 21: 1min HRV, 14.262; 22: HR, 118.254; 22: RR, 34.847; 22: 1min HRV, 5.690; 23: HR, 117.672; 23: RR, 31.603; 23: 1min HRV, 4.177; 23: 5min HRV, 9.773; 24: HR, 117.864; 24: RR, 32.729; 24: SpO2, 69.905; 24: 1min HRV, 3.418; 25: HR, 119.293; 25: RR, 32.397; 25: SpO2, 68.0; 25: 1min HRV, 4.237; 26: HR, 117.576; 26: RR, 34.339; 26: SpO2, 92.333; 26: 1min HRV, 3.865; 27: HR, 117.203; 27: RR, 32.746; 27: SpO2, 82.857; 27: 1min HRV, 7.649; 28: HR, 117.259; 28: RR, 34.845; 28: SpO2, 93.964; 28: 1min HRV, 11.532; 28: 5min HRV, 7.533; 28: SBP, 129.0; 28: DBP, 68.0; 28: MAP, 88.333; 29: HR, 117.797; 29: RR, 33.203; 29: SpO2, 93.068; 29: Perf, 1.153; 29: 1min HRV, 5.902; 29: SBP, 129.0; 29: DBP, 68.0; 29: MAP, 88.333; 29: LPM O2, 50.0; 29: CEFEPIME, 2 GRAM/20 ML IV PUSH; 30: HR:, 115.690; 30: RR, 31.655; 30: SpO2, 91.276; 30: Perf, 0.995; 30: 1min HRV, 6.757; 31: HR, 120.203; 31: RR, 35.881; 31: SpO2, 89.983; 31: Perf, 1.044; 31: 1min HRV, 5.140; 32: HR, 118.644; 32: RR, 32.746; 32: SpO2, 93.542; 32: Perf, 1.100; 32: 1min HRV, 3.802; 33: HR, 115.155; 33: RR, 26.983; 33: SpO2, 96.138; 33: Perf, 0.922; 33: 1min HRV, 11.808; 33: 5min HRV, 11.632; 37: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 39: HR:, 122.0; 39: RR, 34.0; 39: SpO2, 93.0; 41: HR, 126.0; 41: RR, 36.0; 41: SpO2, 90.0; 41: LPM O2, 70.0; 43: HR, 122.0; 43: RR, 34.0; 43: SpO2, 95.0; 55: LPM O2, 50.0; 58: ALKALINE PHOSPHATASE, 72 U/L; 58: EGFR FOR AFRICAN AMERICAN, 69 mL/min/1.73 m2; 58: AST (SGOT), 127 U/L; 58: GLUCOSE, 136 mg/dL; 58: CREATININE, 1.11 mg/dL; 58: PROTEIN TOTAL, 6.9 g/dL; 58: EGFR REFIT WITHOUT RACE (2021), 60 mL/min/1.73 m2; 58: POTASSIUM, 4.1 mmol/L; 58: ALBUMIN, 3.3 g/dL; 58: ALT (SGPT), 84 U/L; 58: ANION GAP, 11 mmol/L; 58: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 58: CO2, 26 mmol/L; 58: CHLORIDE, 105 mmol/L; 58: CALCIUM, 9.1 mg/dL; 58: SODIUM, 142 mmol/L; 58: GLOBULIN, 3.6 g/dL; 58: BILIRUBIN TOTAL, 0.5 mg/dL; 58: CORRECTED CALCIUM, 9.7 mg/dL; 59: INR, 1.1; 59: PROTHROMBIN TIME, 14.2 seconds; 70: WAM DIFTYP, AUTO; 70: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 70: HEMOGLOBIN (HGB), 9.8 g/dL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.4 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 1.01 K/uL; 70: MEAN CORPUSCULAR VOLUME (MCV), 94.8 fL; 70: BASOPHIL % (AUTO DIFF), 0.3 %; 70: NRBC PERCENT (HEMATOLOGY), 1.9 %; 70: RED CELL DISTRIBUTION WIDTH (RDW), 21.2 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.8 pg; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 70: WHITE BLOOD CELLS (WBC), 22.7 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 4.0 %; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 19.79 K/uL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 70: HEMATOCRIT (HCT), 29.2 %; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 70: NEUTROPHIL % (AUTO DIFF), 87.2 %; 70: EOSINOPHIL % (AUTO DIFF), 0.0 %; 70: MONOCYTE % (AUTO DIFF), 4.1 %; 70: RED BLOOD CELLS (RBC), 3.08 MIL/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.42 K/uL; 70: PLATELET COUNT (PLT), 500 K/uL; 89: PART. THROMBOPLASTIN TIME, 20.3 seconds; 0: Age, 86; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 115.0; 0: Triage RR, 32.0; 0: Triage SBP, 128.0; 0: Triage DBP, 58.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess the patient's risk of developing sepsis, we should analyze their vital signs, laboratory results, and any clinical interventions. The patient exhibits tachycardia (HR consistently over 115), tachypnea (RR consistently over 28), and low Oxygen saturation (SpO2 fluctuating around low 90s, with some readings significantly lower). The use of antibiotics such as CEFEPIME and METRONIDAZOLE indicates a concern for infection. The lab results show elevated white blood cells (WBC: 22.7 K/uL), which suggests an acute inflammatory response, and anemia with low hemoglobin (HGB: 9.8 g/dL). The observed clinical picture, lab abnormalities, and interventions suggest the patient is at high risk for sepsis.",
        "claims": [
            "To assess the patient's risk of developing sepsis, we should analyze their vital signs, laboratory results, and any clinical interventions.",
            "The patient exhibits tachycardia with a heart rate consistently over 115.",
            "The patient exhibits tachypnea with a respiratory rate consistently over 28.",
            "The patient has low oxygen saturation, with SpO2 fluctuating around the low 90s.",
            "Some oxygen saturation readings are significantly lower than the low 90s.",
            "The use of antibiotics such as Cefepime indicates a concern for infection.",
            "The use of antibiotics such as Metronidazole indicates a concern for infection.",
            "The lab results show elevated white blood cells, specifically 22.7 K/uL.",
            "Elevated white blood cells suggest an acute inflammatory response.",
            "The lab results show anemia with a hemoglobin level of 9.8 g/dL.",
            "The observed clinical picture, lab abnormalities, and interventions suggest the patient is at high risk for sepsis."
        ],
        "relevant_claims": [
            "The patient exhibits tachycardia with a heart rate consistently over 115.",
            "The patient exhibits tachypnea with a respiratory rate consistently over 28.",
            "The patient has low oxygen saturation, with SpO2 fluctuating around the low 90s.",
            "Some oxygen saturation readings are significantly lower than the low 90s.",
            "The use of antibiotics such as Cefepime indicates a concern for infection.",
            "The use of antibiotics such as Metronidazole indicates a concern for infection.",
            "The lab results show elevated white blood cells, specifically 22.7 K/uL.",
            "Elevated white blood cells suggest an acute inflammatory response.",
            "The lab results show anemia with a hemoglobin level of 9.8 g/dL.",
            "The observed clinical picture, lab abnormalities, and interventions suggest the patient is at high risk for sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.6,
            0.7,
            0.8,
            0.7,
            1.0,
            1.0,
            0.3,
            0.5
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "Tachycardia, defined as a heart rate >90 bpm, is one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. The heart rate in this claim is well above the threshold, making it highly relevant, but it is only one component of the SIRS criteria, thereby not achieving full alignment.",
            "The claim indicates tachypnea, with a respiratory rate over 28, which is above the SIRS criterion threshold of respiratory rate > 20/min. This directly aligns with one of the criteria used to identify systemic inflammation consistent with early sepsis under the SIRS Positivity category. While only one SIRS criterion is noted, the match with one of them justifies a high alignment rating, but not a perfect one due to the requirement of meeting two criteria for full SIRS positivity.",
            "While SpO2 itself isn't a direct component of the SOFA score, low oxygen saturation suggests hypoxemia, which is conceptually related to impaired oxygenation\u2014a factor in the respiratory component of the SOFA score (PaO\u2082/FiO\u2082). The alignment is therefore indirect but relevant to assessing sepsis risk.",
            "The claim suggests low oxygen saturation, which can be associated with impaired oxygenation\u2014a component considered in the SOFA score (via PaO\u2082/FiO\u2082 ratio). While oxygen saturation isn't directly part of the SOFA score, it conceptually aligns with potential organ dysfunction due to inadequate oxygenation. The alignment is fairly strong but indirect.",
            "The administration of antibiotics like Cefepime suggests a suspicion of serious infection, which aligns with this category that uses early antibiotic or culture orders as indicators of sepsis risk. The claim doesn't specify the timing (e.g., within 2 hours), hence the rating isn't perfect, but it strongly indicates suspicion of infection.",
            "The claim mentions the use of antibiotics, which aligns with the administration of broad-spectrum antibiotics as part of the Early Antibiotic/Culture Orders category. However, the specific timing (i.e., administration within 2 hours) is not mentioned, reducing the alignment strength from a perfect score. Nonetheless, the action of using antibiotics does suggest a concern for serious infection, which is relevant to the category.",
            "The claim describes an elevated white blood cell count of 22.7 K/uL, which exceeds the SIRS criterion of WBC\u202f>\u202f12\u202f000/\u00b5L. This directly aligns with one of the criteria for identifying systemic inflammation indicative of early sepsis, hence a perfect alignment with the SIRS Positivity category.",
            "The claim directly references elevated white blood cell count, which is one of the specific criteria for identifying systemic inflammation typical in early sepsis as per the SIRS criteria. This indicates perfect alignment with the SIRS Positivity category.",
            "Anemia and low hemoglobin levels are not directly part of the SOFA score criteria, yet they can suggest possible organ dysfunction due to inadequate oxygen delivery, indirectly relating to the sepsis risk assessment. This creates a weak alignment with the SOFA criteria, which include measures of organ dysfunction.",
            "The claim mentions a combination of clinical factors including lab abnormalities and interventions, suggesting suspicion of serious infection. However, it stops short of specifically mentioning concrete actions such as administering antibiotics or drawing blood cultures, which would perfectly align with this category. Thus, while it reflects a general suspicion and preparedness for treating sepsis, it does not fully align with a specific action indicating heightened sepsis risk."
        ],
        "final_alignment_score": 0.72,
        "accuracy": 1
    },
    {
        "input": "5: HR, 88.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 95.0; 5: DBP, 67.0; 5: MAP, 76.333; 5: LPM O2, 2.0; 5: Temp, 98.2; 30: SpO2, 84.833; 31: SpO2, 88.586; 31: Perf, 0.691; 32: SpO2, 94.914; 32: Perf, 0.687; 33: SpO2, 95.567; 33: Perf, 0.734; 35: SpO2, 93.0; 36: SpO2, 90.449; 36: Perf, 0.51; 37: SpO2, 94.882; 37: SBP, 117.0; 37: DBP, 73.0; 37: MAP, 87.667; 38: HR, 88.9; 38: RR, 17.3; 38: SpO2, 92.897; 38: Perf, 0.577; 38: 1min HRV, 14.986; 39: HR, 89.780; 39: RR, 17.169; 39: SpO2, 93.712; 39: Perf, 0.677; 39: 1min HRV, 30.180; 40: HR, 88.407; 40: RR, 17.305; 40: SpO2, 92.434; 40: Perf, 0.698; 40: 1min HRV, 22.725; 40: 5min HRV, 24.935; 41: HR, 92.552; 41: RR, 19.276; 41: Perf, 0.7; 41: 1min HRV, 8.933; 42: HR, 88.102; 42: RR, 19.932; 42: SpO2, 96.0; 42: Perf, 0.702; 42: 1min HRV, 7.636; 43: HR, 86.175; 43: RR, 14.579; 43: SpO2, 96.807; 43: Perf, 0.838; 43: 1min HRV, 57.636; 44: HR, 86.881; 44: RR, 14.203; 44: SpO2, 95.898; 44: Perf, 0.925; 44: 1min HRV, 10.901; 45: HR, 86.288; 45: RR, 14.610; 45: SpO2, 96.373; 45: Perf, 0.903; 45: 1min HRV, 10.896; 45: 5min HRV, 31.860; 46: HR, 83.931; 46: RR, 9.255; 46: SpO2, 97.190; 46: Perf, 0.938; 46: 1min HRV, 10.150; 46: SBP, 105.0; 46: DBP, 72.0; 46: MAP, 83.0; 47: HR, 82.220; 47: RR, 7.271; 47: SpO2, 97.915; 47: Perf, 1.276; 47: 1min HRV, 9.098; 48: HR, 82.862; 48: RR, 11.793; 48: SpO2, 97.776; 48: Perf, 1.498; 48: 1min HRV, 7.660; 49: HR, 80.763; 49: RR, 13.102; 49: SpO2, 98.0; 49: Perf, 1.572; 49: 1min HRV, 8.148; 50: HR, 80.017; 50: RR, 10.203; 50: SpO2, 98.0; 50: Perf, 1.647; 50: 1min HRV, 7.351; 50: 5min HRV, 16.456; 51: HR, 80.586; 51: RR, 10.862; 51: SpO2, 98.0; 51: Perf, 1.438; 51: 1min HRV, 12.821; 52: HR, 82.186; 52: RR, 16.898; 52: SpO2, 97.780; 52: Perf, 1.173; 52: 1min HRV, 11.858; 53: HR, 83.534; 53: RR, 16.379; 53: SpO2, 97.776; 53: Perf, 1.011; 53: 1min HRV, 7.071; 54: HR, 84.121; 54: RR, 15.586; 54: SpO2, 97.586; 54: Perf, 1.138; 54: 1min HRV, 59.900; 55: HR, 83.305; 55: RR, 15.153; 55: SpO2, 97.576; 55: Perf, 1.345; 55: 1min HRV, 6.728; 55: 5min HRV, 30.099; 56: HR, 84.672; 56: RR, 17.534; 56: SpO2, 98.017; 56: Perf, 1.370; 56: 1min HRV, 8.407; 57: HR, 84.712; 57: RR, 16.559; 57: SpO2, 98.085; 57: Perf, 1.307; 57: 1min HRV, 10.786; 58: HR, 84.328; 58: RR, 14.776; 58: SpO2, 97.621; 58: Perf, 1.295; 58: 1min HRV, 8.478; 59: HR, 82.644; 59: RR, 14.407; 59: SpO2, 98.881; 59: Perf, 1.187; 59: 1min HRV, 10.463; 60: HR, 82.220; 60: RR, 14.458; 60: SpO2, 98.644; 60: Perf, 1.084; 60: 1min HRV, 8.076; 60: 5min HRV, 12.758; 60: SBP, 106.0; 60: DBP, 69.0; 60: MAP, 81.333; 60: LPM O2, 2.0; 61: POC PH (V) ISTAT, 7.44; 61: POC PO2 (V) ISTAT, 37 mmHg; 61: POC HCO3 (V) ISTAT, 29.5 mmol/L; 61: POC TCO2 (V) ISTAT, 31 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 73 %; 61: POC BASE EXCESS ISTAT, 5 mmol/L; 61: POC PCO2 (V) ISTAT, 43.5 mmHg; 61: POC LACTATE ISTAT, 1.26 mmol/L; 61: HR, 83.241; 61: RR, 15.448; 61: SpO2, 98.086; 61: Perf, 1.09; 61: 1min HRV, 9.775; 61: SBP, 106.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 82.898; 62: RR, 16.661; 62: SpO2, 98.068; 62: Perf, 1.344; 62: 1min HRV, 7.296; 63: HR, 83.569; 63: RR, 17.052; 63: SpO2, 97.897; 63: Perf, 1.436; 63: 1min HRV, 27.513; 64: HR, 81.627; 64: RR, 17.576; 64: SpO2, 98.102; 64: Perf, 1.201; 64: 1min HRV, 11.323; 65: HR, 82.053; 65: RR, 17.877; 65: SpO2, 98.754; 65: Perf, 1.020; 65: 1min HRV, 60.692; 65: 5min HRV, 31.430; 66: HR, 82.0; 66: RR, 13.407; 66: SpO2, 97.424; 66: Perf, 0.810; 66: 1min HRV, 10.620; 67: HR, 82.136; 67: RR, 11.407; 67: SpO2, 98.0; 67: Perf, 0.766; 67: 1min HRV, 8.232; 68: HR, 81.776; 68: RR, 10.862; 68: SpO2, 97.759; 68: Perf, 1.136; 68: 1min HRV, 9.964; 69: HR, 80.814; 69: RR, 10.542; 69: SpO2, 97.153; 69: Perf, 1.262; 69: 1min HRV, 12.166; 70: HR, 81.914; 70: RR, 10.534; 70: SpO2, 97.172; 70: Perf, 1.313; 70: 1min HRV, 11.149; 70: 5min HRV, 11.017; 84: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON, 4 MG PO TBDL; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: BASOPHIL % (AUTO DIFF), 0.4 %; 89: LYMPHOCYTE % (AUTO DIFF), 16.8 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.82 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 18.1 %; 89: HEMOGLOBIN (HGB), 9.7 g/dL; 89: HEMATOCRIT (HCT), 30.2 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.27 K/uL; 89: RED BLOOD CELLS (RBC), 3.17 MIL/uL; 89: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 95.3 fL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.05 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.60 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 4.5 %; 89: NEUTROPHIL % (AUTO DIFF), 65.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.69 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.6 pg; 89: PLATELET COUNT (PLT), 153 K/uL; 89: MONOCYTE % (AUTO DIFF), 12.5 %; 89: NRBC PERCENT (HEMATOLOGY), 0.4 %; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 89: EOSINOPHIL % (AUTO DIFF), 0.3 %; 111: TROPONIN I, <.017 ng/mL; 118: BNP NT-PRO, 204 pg/mL; 0: Age, 61; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 88.0; 0: Triage RR, 18.0; 0: Triage SBP, 95.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, BREAST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The patient's vital signs fluctuate but generally remain within normal ranges. Blood oxygen saturation (SpO2) temporarily drops but recovers quickly, suggesting a transient issue rather than persistent hypoxia. The blood test results, including white blood cell count and lactate levels, do not exhibit significant markers of sepsis. The presence of slightly elevated immature granulocytes might suggest an inflammatory response, but without consistent indicators of infection and organ dysfunction, the immediate risk of sepsis is low. Overall, the data doesn't strongly indicate a high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs fluctuate.",
            "The patient's vital signs generally remain within normal ranges.",
            "Blood oxygen saturation (SpO2) temporarily drops.",
            "The blood oxygen saturation (SpO2) recovers quickly.",
            "A temporary drop in blood oxygen saturation (SpO2) suggests a transient issue.",
            "A transient issue is indicated rather than persistent hypoxia.",
            "Blood test results include white blood cell count and lactate levels.",
            "Blood test results do not exhibit significant markers of sepsis.",
            "Slightly elevated immature granulocytes might suggest an inflammatory response.",
            "The presence of slightly elevated immature granulocytes is not consistent with infection and organ dysfunction.",
            "The immediate risk of sepsis is low.",
            "Overall, the data does not strongly indicate a high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Blood oxygen saturation (SpO2) temporarily drops.",
            "Slightly elevated immature granulocytes might suggest an inflammatory response."
        ],
        "alignment_scores": [
            0.5,
            0.5
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "Blood oxygen saturation (SpO2) is a measure of how well oxygen is being transported in the blood, which indirectly relates to the respiratory component of the SOFA score (PaO\u2082/FiO\u2082 ratio). While SpO2 is not directly part of the SOFA criteria, a drop in SpO2 may suggest respiratory compromise, reflecting a potential for organ dysfunction, which the SOFA score aims to capture. Thus, there is a meaningful but indirect alignment.",
            "Immature granulocytes can indicate an inflammatory response, which may be relevant to systemic inflammation and early sepsis. However, immature granulocytes are not explicitly listed in the SIRS criteria. Therefore, while there is a connection through the concept of inflammation, the alignment is only moderate."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "5: HR, 62.0; 5: RR, 30.0; 5: SpO2, 82.0; 5: SBP, 140.0; 5: DBP, 65.0; 5: MAP, 90.0; 5: LPM O2, 4.0; 5: Pain, 8.0; 5: Temp, 98.1; 6: RR, 30.0; 6: SpO2, 92.0; 6: LPM O2, 6.0; 18: Pain, 7.0; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA B, Not Detected; 77: RSV, Not Detected; 77: INFLUENZA A, Not Detected; 84: SpO2, 93.629; 85: HR, 50.1; 85: RR, 16.686; 85: SpO2, 93.286; 85: 1min HRV, 19.687; 86: HR, 50.326; 86: RR, 20.017; 86: SpO2, 91.745; 86: 1min HRV, 21.685; 87: HR, 54.966; 87: RR, 15.881; 87: SpO2, 88.678; 87: 1min HRV, 221.895; 88: HR, 52.723; 88: RR, 17.966; 88: SpO2, 90.534; 88: 1min HRV, 28.500; 88: 5min HRV, 125.288; 89: HR, 53.562; 89: RR, 15.322; 89: SpO2, 91.017; 89: Perf, 0.56; 89: 1min HRV, 22.452; 90: HR, 52.339; 90: RR, 16.881; 90: SpO2, 87.525; 90: Perf, 0.608; 90: 1min HRV, 169.545; 91: HR, 52.568; 91: RR, 23.552; 91: SpO2, 87.121; 91: Perf, 0.798; 91: 1min HRV, 46.723; 92: HR, 50.965; 92: RR, 19.052; 92: SpO2, 86.259; 92: Perf, 1.532; 92: 1min HRV, 32.224; 93: HR, 52.169; 93: RR, 14.305; 93: SpO2, 85.390; 93: Perf, 1.841; 93: 1min HRV, 202.136; 93: 5min HRV, 136.025; 93: LPM O2, 6.0; 94: HR, 53.276; 94: RR, 19.603; 94: SpO2, 86.707; 94: Perf, 1.810; 94: 1min HRV, 243.408; 95: HR, 51.288; 95: RR, 24.085; 95: SpO2, 88.559; 95: Perf, 1.322; 95: 1min HRV, 22.266; 96: HR, 49.678; 96: RR, 19.780; 96: SpO2, 96.712; 96: Perf, 1.31; 96: 1min HRV, 63.848; 97: HR, 50.017; 97: RR, 16.690; 97: SpO2, 97.603; 97: Perf, 1.289; 97: 1min HRV, 223.779; 98: HR, 49.254; 98: RR, 16.0; 98: SpO2, 98.746; 98: Perf, 1.253; 98: 1min HRV, 18.557; 98: 5min HRV, 161.749; 99: POC PH (V) ISTAT, 7.44; 99: POC BASE EXCESS ISTAT, 7 mmol/L; 99: POC HCO3 (V) ISTAT, 30.8 mmol/L; 99: POC TCO2 (V) ISTAT, 32 mmol/L; 99: POC PCO2 (V) ISTAT, 45.7 mmHg; 99: POC LACTATE ISTAT, 1.75 mmol/L; 99: POC O2 SATURATION ISTAT VENOUS, 47 %; 99: POC PO2 (V) ISTAT, 25 mmHg; 99: HR, 48.034; 99: RR, 16.879; 99: SpO2, 98.586; 99: Perf, 1.23; 99: 1min HRV, 20.593; 100: HR, 47.783; 100: RR, 16.35; 100: SpO2, 98.733; 100: Perf, 1.227; 100: 1min HRV, 19.668; 101: HR, 47.224; 101: RR, 18.362; 101: SpO2, 99.0; 101: Perf, 1.400; 101: 1min HRV, 11.765; 102: HR, 47.278; 102: RR, 22.390; 102: SpO2, 98.203; 102: Perf, 1.942; 102: 1min HRV, 24.580; 103: HR, 47.212; 103: RR, 21.138; 103: SpO2, 97.552; 103: Perf, 2.18; 103: 1min HRV, 29.295; 103: 5min HRV, 23.281; 104: HR, 46.424; 104: RR, 21.034; 104: SpO2, 97.220; 104: Perf, 2.167; 104: 1min HRV, 34.762; 105: HR, 47.810; 105: RR, 17.345; 105: SpO2, 97.172; 105: Perf, 1.823; 105: 1min HRV, 146.607; 106: HR, 46.407; 106: RR, 20.661; 106: SpO2, 98.525; 106: Perf, 1.007; 106: 1min HRV, 18.834; 107: HR, 45.431; 107: RR, 22.707; 107: SpO2, 97.172; 107: Perf, 1.056; 107: 1min HRV, 12.632; 108: WAM DIFTYP, AUTO; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.77 K/uL; 108: NEUTROPHIL % (AUTO DIFF), 81.2 %; 108: WHITE BLOOD CELLS (WBC), 9.8 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.97 K/uL; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.9 pg; 108: HEMOGLOBIN (HGB), 16.8 g/dL; 108: EOSINOPHIL % (AUTO DIFF), 3.2 %; 108: HEMATOCRIT (HCT), 54.0 %; 108: LYMPHOCYTE % (AUTO DIFF), 6.8 %; 108: MEAN CORPUSCULAR VOLUME (MCV), 96.1 fL; 108: MONOCYTE % (AUTO DIFF), 7.8 %; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.67 K/uL; 108: RED BLOOD CELLS (RBC), 5.62 MIL/uL; 108: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 108: BASOPHIL % (AUTO DIFF), 0.8 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: PLATELET COUNT (PLT), 209 K/uL; 108: HR, 45.847; 108: RR, 23.475; 108: SpO2, 96.407; 108: Perf, 0.972; 108: 1min HRV, 8.665; 108: 5min HRV, 74.502; 109: HR, 46.831; 109: RR, 24.576; 109: SpO2, 95.339; 109: Perf, 1.153; 109: 1min HRV, 34.172; 110: HR, 47.483; 110: RR, 17.207; 110: SpO2, 95.138; 110: Perf, 0.853; 110: 1min HRV, 23.770; 111: HR, 47.559; 111: RR, 14.915; 111: SpO2, 97.356; 111: Perf, 0.789; 111: 1min HRV, 20.254; 112: HR, 47.897; 112: RR, 16.241; 112: SpO2, 97.724; 112: Perf, 0.800; 112: 1min HRV, 27.911; 113: HR, 45.441; 113: RR, 18.441; 113: SpO2, 97.119; 113: Perf, 0.822; 113: 1min HRV, 18.948; 113: 5min HRV, 34.415; 114: HR, 46.780; 114: RR, 20.356; 114: SpO2, 96.441; 114: Perf, 1.242; 114: 1min HRV, 177.614; 115: HR, 46.0; 115: RR, 26.828; 115: SpO2, 95.034; 115: Perf, 1.25; 115: 1min HRV, 0.0; 115: Pain, 4.0; 116: HR, 46.780; 116: RR, 19.780; 116: SpO2, 96.636; 116: Perf, 1.298; 116: 1min HRV, 177.184; 117: HR, 45.634; 117: RR, 19.305; 117: SpO2, 97.610; 117: Perf, 1.520; 117: 1min HRV, 10.559; 118: HR, 46.111; 118: RR, 17.603; 118: SpO2, 97.448; 118: Perf, 1.65; 118: 1min HRV, 0.0; 118: 5min HRV, 171.327; 119: HR, 46.958; 119: RR, 24.831; 119: SpO2, 96.695; 119: Perf, 1.619; 119: 1min HRV, 25.599; 0: Age, 62; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 62.0; 0: Triage RR, 30.0; 0: Triage SBP, 140.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, we must assess vital signs, oxygen saturation, and overall stability. Initially, the patient had high respiratory rates and low oxygen saturation, suggesting respiratory distress, but oxygen treatment improved SpO2 levels. Throughout the time series, HR and RR decreased, HRV remained variable, and blood gas values were stable. Collectively, these trends suggest that the patient stabilizes over time, reducing the likelihood of sepsis development, hence the label \"No.\"",
        "claims": [
            "To determine sepsis risk, vital signs, oxygen saturation, and overall stability must be assessed.",
            "Initially, the patient had high respiratory rates.",
            "The patient\u2019s oxygen saturation was low.",
            "High respiratory rates and low oxygen saturation suggest respiratory distress.",
            "Oxygen treatment improved the patient's SpO2 levels.",
            "Throughout the time series, the heart rate (HR) decreased.",
            "The respiratory rate (RR) also decreased.",
            "Heart rate variability (HRV) remained variable.",
            "Blood gas values were stable.",
            "These trends suggest that the patient stabilizes over time.",
            "Stabilization reduces the likelihood of sepsis development.",
            "The patient is labeled \"No,\" indicating no high risk of sepsis."
        ],
        "relevant_claims": [
            "Initially, the patient had high respiratory rates.",
            "The patient\u2019s oxygen saturation was low.",
            "High respiratory rates and low oxygen saturation suggest respiratory distress."
        ],
        "alignment_scores": [
            0.7,
            0.6,
            0.7
        ],
        "alignment_category": [
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)"
        ],
        "alignment_reasonings": [
            "The claim about high respiratory rates most closely aligns with the High qSOFA Score (\u22652) category, where a respiratory rate of \u226522/min is a specific criterion. High respiratory rates directly relate to this criterion, indicating potential organ dysfunction and sepsis risk. However, since the claim only specifies high respiratory rates without additional qSOFA criteria, the alignment is strong but not complete, which justifies a rating of 0.7.",
            "Low oxygen saturation is not directly mentioned as a SOFA component but relates to potential respiratory dysfunction which aligns conceptually with impaired oxygenation (PaO\u2082/FiO\u2082) found in the SOFA score. The alignment is indirect yet meaningful in indicating possible organ dysfunction associated with a sepsis risk.",
            "The claim mentions high respiratory rates, which is a direct component of the qSOFA score (respiratory rate\u202f\u2265\u202f22/min), used to assess the risk of sepsis-related outcomes. Low oxygen saturation, while not explicitly a part of the qSOFA, indicates respiratory distress that might correlate with altered mentation or systemic issues related to sepsis complications. Hence, the qSOFA category is most aligned, albeit not perfectly, due to the partial relevance of low oxygen saturation to sepsis assessment."
        ],
        "final_alignment_score": 0.6666666666666666,
        "accuracy": 1
    },
    {
        "input": "6: HR, 86.0; 6: RR, 20.0; 6: SpO2, 98.0; 6: SBP, 115.0; 6: DBP, 62.0; 6: MAP, 79.667; 6: Temp, 97.3; 22: HR, 98.414; 22: RR, 31.643; 22: SpO2, 91.727; 22: 1min HRV, 110.846; 22: 5min HRV, 110.846; 23: HR, 98.136; 23: RR, 34.356; 23: SpO2, 92.0; 23: 1min HRV, 117.374; 23: SBP, 131.0; 23: DBP, 77.0; 23: MAP, 95.0; 24: HR, 95.534; 24: RR, 32.310; 24: 1min HRV, 113.171; 25: HR, 101.0; 25: RR, 29.898; 25: SpO2, 99.0; 25: 1min HRV, 162.398; 26: HR, 95.052; 26: RR, 29.517; 26: 1min HRV, 103.722; 27: HR, 100.220; 27: RR, 33.610; 27: 1min HRV, 138.512; 27: 5min HRV, 129.593; 28: HR, 95.407; 28: RR, 32.949; 28: 1min HRV, 125.817; 29: HR, 96.241; 29: RR, 34.931; 29: 1min HRV, 116.094; 30: HR, 88.407; 30: RR, 34.441; 30: 1min HRV, 109.284; 31: HR, 105.828; 31: RR, 30.397; 31: 1min HRV, 147.138; 32: HR, 98.322; 32: RR, 25.288; 32: 1min HRV, 138.014; 32: 5min HRV, 131.883; 33: HR, 90.017; 33: RR, 24.627; 33: 1min HRV, 92.595; 34: HR, 93.678; 34: RR, 29.627; 34: 1min HRV, 144.850; 35: HR, 93.828; 35: RR, 27.724; 35: 1min HRV, 120.825; 36: HR, 90.305; 36: RR, 27.576; 36: 1min HRV, 99.692; 37: HR, 92.759; 37: RR, 35.966; 37: 1min HRV, 125.839; 37: 5min HRV, 122.075; 38: HR, 92.949; 38: RR, 25.169; 38: 1min HRV, 131.881; 38: SBP, 115.0; 38: DBP, 69.0; 38: MAP, 84.333; 39: HR, 90.431; 39: RR, 28.448; 39: 1min HRV, 108.780; 40: HR, 90.356; 40: RR, 26.915; 40: 1min HRV, 135.773; 41: HR, 95.983; 41: RR, 26.407; 41: SpO2, 97.0; 41: 1min HRV, 145.704; 42: HR, 98.017; 42: RR, 33.052; 42: 1min HRV, 147.904; 42: 5min HRV, 135.808; 43: HR, 91.576; 43: RR, 32.75; 43: 1min HRV, 144.543; 44: HR, 100.644; 44: RR, 30.475; 44: 1min HRV, 99.454; 45: HR, 104.345; 45: RR, 27.672; 45: 1min HRV, 118.998; 46: HR, 102.034; 46: RR, 28.864; 46: 1min HRV, 137.662; 47: HR, 109.172; 47: RR, 29.086; 47: 1min HRV, 148.420; 47: 5min HRV, 137.077; 48: HR, 109.119; 48: RR, 23.196; 48: 1min HRV, 152.448; 49: HR, 102.559; 49: RR, 28.811; 49: 1min HRV, 167.416; 50: HR, 118.086; 50: RR, 32.224; 50: 1min HRV, 174.658; 51: HR, 96.949; 51: RR, 27.102; 51: 1min HRV, 141.684; 52: HR, 105.810; 52: RR, 23.483; 52: 1min HRV, 175.727; 52: 5min HRV, 167.496; 53: HR, 104.492; 53: RR, 22.644; 53: 1min HRV, 144.027; 53: SBP, 116.0; 53: DBP, 85.0; 53: MAP, 95.333; 54: HR, 102.931; 54: RR, 29.774; 54: 1min HRV, 146.443; 55: HR, 98.458; 55: RR, 33.310; 55: SpO2, 97.0; 55: 1min HRV, 140.776; 56: HR, 97.915; 56: RR, 35.864; 56: 1min HRV, 148.741; 57: HR, 111.828; 57: RR, 31.655; 57: 1min HRV, 154.844; 57: 5min HRV, 152.574; 58: HR, 109.508; 58: RR, 31.203; 58: 1min HRV, 160.695; 59: HR, 98.397; 59: RR, 36.534; 59: 1min HRV, 178.628; 60: HR, 91.593; 60: RR, 32.208; 60: 1min HRV, 133.466; 61: HR, 98.068; 61: RR, 40.339; 61: 1min HRV, 144.123; 62: HR, 96.810; 62: RR, 34.069; 62: 1min HRV, 146.344; 62: 5min HRV, 158.031; 63: HR, 98.593; 63: RR, 32.831; 63: 1min HRV, 156.849; 64: HR, 106.517; 64: RR, 37.741; 64: 1min HRV, 152.933; 65: HR, 97.203; 65: RR, 27.983; 65: 1min HRV, 169.895; 66: HR, 99.322; 66: RR, 29.797; 66: 1min HRV, 142.021; 67: HR, 96.966; 67: RR, 34.121; 67: 1min HRV, 128.693; 67: 5min HRV, 151.593; 68: HR, 93.492; 68: RR, 27.763; 68: 1min HRV, 119.736; 68: SBP, 103.0; 68: DBP, 67.0; 68: MAP, 79.0; 69: HR, 92.397; 69: RR, 26.690; 69: 1min HRV, 121.414; 70: HR, 88.780; 70: RR, 25.746; 70: 1min HRV, 151.117; 71: HR, 92.424; 71: RR, 29.356; 71: 1min HRV, 165.078; 72: HR, 105.810; 72: RR, 29.190; 72: 1min HRV, 177.500; 72: 5min HRV, 154.698; 73: HR, 97.508; 73: RR, 26.780; 73: 1min HRV, 174.835; 74: HR, 93.534; 74: RR, 26.534; 74: 1min HRV, 128.705; 75: HR, 97.424; 75: RR, 25.136; 75: SpO2, 98.818; 75: 1min HRV, 163.474; 76: HR, 96.661; 76: RR, 28.593; 76: SpO2, 93.4; 76: 1min HRV, 134.870; 77: ANION GAP, 12 mmol/L; 77: POTASSIUM, 4.1 mmol/L; 77: PROTEIN TOTAL, 7.2 g/dL; 77: CO2, 23 mmol/L; 77: GLUCOSE, 166 mg/dL; 77: ALBUMIN, 3.8 g/dL; 77: GLOBULIN, 3.4 g/dL; 77: ALKALINE PHOSPHATASE, 94 U/L; 77: CHLORIDE, 102 mmol/L; 77: EGFR FOR AFRICAN AMERICAN, 57 mL/min/1.73 m2; 77: AST (SGOT), 94 U/L; 77: ALT (SGPT), 76 U/L; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: CALCIUM, 9.1 mg/dL; 77: CORRECTED CALCIUM, 9.3 mg/dL; 77: EGFR REFIT WITHOUT RACE (2021), 49 mL/min/1.73 m2; 77: SODIUM, 137 mmol/L; 77: MAGNESIUM, 2.1 mg/dL; 77: CREATININE, 1.24 mg/dL; 77: BILIRUBIN TOTAL, 0.9 mg/dL; 77: BNP NT-PRO, 2309 pg/mL; 77: HR, 91.603; 77: RR, 28.534; 77: 1min HRV, 137.927; 77: 5min HRV, 149.995; 78: HR, 96.390; 78: RR, 27.424; 78: 1min HRV, 143.471; 79: HR, 94.138; 79: RR, 26.741; 79: 1min HRV, 122.539; 80: HR, 90.627; 80: RR, 30.136; 80: 1min HRV, 126.110; 81: HR, 102.305; 81: RR, 28.525; 81: 1min HRV, 138.593; 82: HR, 91.983; 82: RR, 30.379; 82: 1min HRV, 135.501; 82: 5min HRV, 135.292; 83: HR, 104.695; 83: RR, 26.305; 83: 1min HRV, 142.713; 83: SBP, 126.0; 83: DBP, 98.0; 83: MAP, 107.333; 84: TROPONIN I, <.017 ng/mL; 84: HR, 96.435; 84: RR, 41.448; 84: 1min HRV, 111.796; 85: RR, 40.085; 86: RR, 38.724; 87: HR, 124.944; 87: RR, 32.661; 87: 1min HRV, 15.413; 87: 5min HRV, 143.679; 88: HR, 113.475; 88: RR, 20.068; 88: 1min HRV, 102.226; 89: HR, 114.949; 89: RR, 36.155; 89: 1min HRV, 96.557; 90: HR, 115.356; 90: RR, 34.237; 90: 1min HRV, 130.746; 91: HR, 117.893; 91: RR, 35.038; 91: 1min HRV, 140.391; 92: 5min HRV, 126.029; 98: D-DIMER ELISA, >10000 ng/mL FEU; 100: SARS-COV-2 RNA, Not Detected; 112: SpO2, 93.0; 113: HR, 100.0; 113: RR, 33.35; 113: 1min HRV, 112.194; 114: HR, 114.0; 114: RR, 27.379; 114: 1min HRV, 134.805; 114: SBP, 128.0; 114: DBP, 81.0; 114: MAP, 96.667; 115: HR, 108.322; 115: RR, 37.034; 115: 1min HRV, 147.034; 116: HR, 98.828; 116: RR, 24.0; 116: 1min HRV, 124.792; 117: HR, 101.136; 117: RR, 23.322; 117: 1min HRV, 117.243; 117: 5min HRV, 134.779; 118: HR, 101.879; 118: RR, 33.328; 118: 1min HRV, 102.420; 119: HR, 100.644; 119: RR, 34.458; 119: 1min HRV, 105.178; 0: Age, 90; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 86.0; 0: Triage RR, 20.0; 0: Triage SBP, 115.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To determine the sepsis risk, the easiest subquestion is to check for elevated heart rate (HR) and respiratory rate (RR), as persistent tachycardia and tachypnea are indicators of sepsis. The patient's HR consistently exceeds 90 beats per minute, with peaks over 110, and the RR often exceeds 20 breaths per minute, consistently reaching or exceeding 30, and peaking at nearly 41. Additionally, the elevated D-Dimer and BNP levels, as well as occasional drops in SpO2, further suggest a risk of sepsis-related complications. Considering these persistent abnormalities and critical lab findings, the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To determine sepsis risk, checking for elevated heart rate (HR) and respiratory rate (RR) is important.",
            "Persistent tachycardia is an indicator of sepsis.",
            "Persistent tachypnea is an indicator of sepsis.",
            "The patient's heart rate consistently exceeds 90 beats per minute.",
            "The patient's heart rate peaks over 110 beats per minute.",
            "The patient's respiratory rate often exceeds 20 breaths per minute.",
            "The patient's respiratory rate consistently reaches or exceeds 30 breaths per minute.",
            "The patient's respiratory rate peaks at nearly 41 breaths per minute.",
            "Elevated D-Dimer levels suggest a risk of sepsis-related complications.",
            "Elevated BNP levels suggest a risk of sepsis-related complications.",
            "Occasional drops in SpO2 further suggest a risk of sepsis-related complications.",
            "The patient has persistent abnormalities in heart rate and respiratory rate.",
            "The patient has critical lab findings indicating a risk of sepsis.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "To determine sepsis risk, checking for elevated heart rate (HR) and respiratory rate (RR) is important.",
            "Persistent tachycardia is an indicator of sepsis.",
            "Persistent tachypnea is an indicator of sepsis.",
            "The patient's heart rate consistently exceeds 90 beats per minute.",
            "The patient's heart rate peaks over 110 beats per minute.",
            "The patient's respiratory rate often exceeds 20 breaths per minute.",
            "The patient's respiratory rate consistently reaches or exceeds 30 breaths per minute.",
            "The patient's respiratory rate peaks at nearly 41 breaths per minute.",
            "Elevated D-Dimer levels suggest a risk of sepsis-related complications.",
            "Elevated BNP levels suggest a risk of sepsis-related complications.",
            "The patient has persistent abnormalities in heart rate and respiratory rate.",
            "The patient has critical lab findings indicating a risk of sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.7,
            0.9,
            0.7,
            0.8,
            0.9,
            0.9,
            0.2,
            0.3,
            0.8,
            0.4
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "The claim mentions assessing elevated heart rate (HR) and respiratory rate (RR), both of which are part of the SIRS criteria. While the claim does not indicate the patient meets the specific SIRS thresholds, it identifies relevant indicators consistent with systemic inflammation potentially linked to early sepsis. Therefore, the alignment is significant but not complete, as the exact criteria are not specified.",
            "Tachycardia, defined as a heart rate >90 bpm, is one of the criteria used in the Systemic Inflammatory Response Syndrome (SIRS) to detect systemic inflammation associated with early sepsis. The claim specifically identifies persistent tachycardia as an indicator of sepsis, which aligns with the SIRS category. The alignment rating is 0.7 because, while tachycardia is a component of SIRS, the presence of just one SIRS criterion (tachycardia) is not sufficient on its own to predict sepsis, as SIRS requires \u22652 criteria. Thus, the alignment is significant but not complete.",
            "Tachypnea, or a high respiratory rate, is directly related to the components of the qSOFA score, with a criterion of respiratory rate \u226522/min. While the claim mentions \"persistent tachypnea\" as a sepsis indicator, it does not specify whether this meets the exact qSOFA threshold. Since the claim reflects a concept directly tied to one of the qSOFA factors, but does not provide enough specificity to fully confirm it aligns with meeting the exact criteria, I rate the alignment as 0.7.",
            "A heart rate exceeding 90 bpm is one of the specific criteria under the SIRS category for identifying systemic inflammation consistent with early sepsis. While the claim only addresses one of the necessary SIRS criteria, it aligns strongly with this category. However, since SIRS requires at least two criteria, the alignment isn't perfect, thus a 0.9 rating.",
            "A heart rate greater than 90 beats per minute is one of the criteria for SIRS. Though the claim specifies a heart rate of over 110, which surpasses the threshold, it only partially fulfills the SIRS positivity requirement (minimum of 2 criteria is needed). The alignment is strong due to the explicit mention of a heart rate above the SIRS threshold, but not absolute since it doesn't cover all criteria for a full SIRS diagnosis.",
            "The claim emphasizes an elevated respiratory rate, specifically a rate exceeding 20 breaths per minute, which is explicitly part of the SIRS criteria for systemic inflammation and early sepsis detection. The alignment is strong but not perfect, as SIRS requires meeting at least two criteria, and the claim only mentions one. Nonetheless, it strongly points towards this category.",
            "The claim specifies a respiratory rate of 30 breaths per minute, which exceeds the threshold for qSOFA (\u226522/min), indicating a high risk of sepsis-related organ dysfunction. This aligns very closely with the qSOFA criteria, but lacks other contributing qSOFA elements like systolic BP or altered mentation, resulting in a slightly less than perfect alignment.",
            "A respiratory rate of >20/min is one of the criteria for SIRS positivity. The claim indicates a respiratory rate significantly above this threshold, suggesting systemic inflammation consistent with early sepsis. While the claim strongly aligns with this category, without information on additional SIRS criteria, the rating is not a perfect alignment.",
            "The claim about elevated D-Dimer levels implies a risk of complications, but D-Dimer is not directly related to the expert sepsis categories provided. The closest category, in terms of indicating severity and systemic risk, is Elevated Serum Lactate, which signals tissue hypoperfusion and a risk of sepsis. However, D-Dimer specifically is more associated with clotting issues rather than lactate or directly with the markers used for sepsis prediction, resulting in low alignment.",
            "Elevated BNP levels are generally associated with heart failure and hemodynamic stress, which can relate indirectly to the hemodynamic instability considered in the Elevated Shock Index category. While BNP itself is not part of the sepsis criteria directly, its elevation could suggest cardiovascular strain relevant to severe sepsis. The alignment is weak due to the lack of direct connection to sepsis criteria but can imply potential complications.",
            "The claim notes abnormalities in heart rate and respiratory rate, both of which are components of the SIRS criteria (heart rate >90 bpm and respiratory rate >20/min). Although the claim does not specify the exact values needed to meet the individual criteria, it strongly hints at the type of physiological abnormalities relevant to SIRS, indicating a high relevance to this category.",
            "The claim of \"critical lab findings indicating a risk of sepsis\" is quite broad. However, elevated serum lactate is a specific lab finding directly associated with tissue hypoperfusion and elevated sepsis risk. Without explicit detail about the lab findings, the alignment is tentative and based on one of the more direct lab indicators of sepsis risk, hence the moderate alignment rating."
        ],
        "final_alignment_score": 0.6666666666666666,
        "accuracy": 1
    },
    {
        "input": "10: HR, 92.0; 10: RR, 16.0; 10: SpO2, 97.0; 10: SBP, 159.0; 10: DBP, 92.0; 10: MAP, 114.333; 10: Temp, 99.3; 67: POC, BHCG, ISTAT QUANTITATIVE: 6.9 IU/L; 71: POC PH (V) ISTAT, 7.32; 71: POC HCO3 (V) ISTAT, 20.7 mmol/L; 71: POC O2 SATURATION ISTAT VENOUS, 26 %; 71: POC PO2 (V) ISTAT, 19 mmHg; 71: POC BASE EXCESS ISTAT, -5 mmol/L; 71: POC TCO2 (V) ISTAT, 22 mmol/L; 71: POC LACTATE ISTAT, 0.69 mmol/L; 71: POC PCO2 (V) ISTAT, 40.5 mmHg; 76: POC POTASSIUM ISTAT, 6.6 mmol/L; 76: POC HGB (CALC) ISTAT, 12.9 g/dL; 76: POC SODIUM ISTAT, 134 mmol/L; 76: POC GLUCOSE ISTAT, 83 mg/dL; 76: POC HCT ISTAT, 38 %; 89: PART. THROMBOPLASTIN TIME, 35.2 seconds; 90: INR, 1.6; 90: PROTHROMBIN TIME, 18.5 seconds; 92: WAM DIFTYP, AUTO; 92: MONOCYTE ABSOLUTE (AUTO DIFF), 1.23 K/uL; 92: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 92: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.67 K/uL; 92: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 92: LYMPHOCYTE % (AUTO DIFF), 18.7 %; 92: MEAN CORPUSCULAR VOLUME (MCV), 91.2 fL; 92: EOSINOPHIL % (AUTO DIFF), 1.5 %; 92: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 92: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 92: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 92: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 92: NEUTROPHIL % (AUTO DIFF), 70.2 %; 92: MONOCYTE % (AUTO DIFF), 8.6 %; 92: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 92: HEMATOCRIT (HCT), 31.0 %; 92: PLATELET COUNT (PLT), 378 K/uL; 92: BASOPHIL % (AUTO DIFF), 0.4 %; 92: NRBC PERCENT (HEMATOLOGY), 0.0 %; 92: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 92: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 92: HEMOGLOBIN (HGB), 9.9 g/dL; 92: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.02 K/uL; 92: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 101: POC GLUCOSE BY METER, 98 mg/dL; 104: POC, BHCG, ISTAT QUANTITATIVE: 6.1 IU/L; 105: LIPASE, 11 U/L; 106: POC PH (V) ISTAT, 7.27; 106: POC PO2 (V) ISTAT, 22 mmHg; 106: POC BASE EXCESS ISTAT, -5 mmol/L; 106: POC LACTATE ISTAT, 1.44 mmol/L; 106: POC O2 SATURATION ISTAT VENOUS, 31 %; 106: POC PCO2 (V) ISTAT, 46.6 mmHg; 106: POC TCO2 (V) ISTAT, 23 mmol/L; 106: POC HCO3 (V) ISTAT, 21.6 mmol/L; 106: HR, 42.882; 106: RR, 17.5; 106: SpO2, 97.667; 106: Perf, 4.819; 106: 1min HRV, 16.461; 107: HR, 45.310; 107: RR, 16.966; 107: SpO2, 96.534; 107: Perf, 3.883; 107: 1min HRV, 27.125; 107: SBP, 139.0; 107: DBP, 84.0; 107: MAP, 102.333; 108: HR, 45.797; 108: RR, 13.712; 108: SpO2, 97.390; 108: Perf, 3.778; 108: 1min HRV, 27.967; 109: HR, 46.879; 109: RR, 15.5; 109: SpO2, 97.259; 109: Perf, 3.888; 109: 1min HRV, 41.979; 109: 5min HRV, 45.213; 110: HR, 44.864; 110: RR, 17.186; 110: SpO2, 97.780; 110: Perf, 4.039; 110: 1min HRV, 36.671; 111: HR, 44.729; 111: RR, 17.288; 111: SpO2, 97.475; 111: Perf, 6.292; 111: 1min HRV, 28.818; 112: HR, 44.172; 112: RR, 18.517; 112: SpO2, 96.914; 112: Perf, 6.863; 112: 1min HRV, 45.926; 113: HR, 44.356; 113: RR, 15.814; 113: SpO2, 96.322; 113: Perf, 5.662; 113: 1min HRV, 42.383; 114: SODIUM, 131 mmol/L; 114: SODIUM, 131 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: ALT (SGPT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: GLUCOSE, 88 mg/dL; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: BLOOD UREA NITROGEN (BUN), 46 mg/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: ALT (SGPT), 21 U/L; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: ANION GAP, 14 mmol/L; 114: ALKALINE PHOSPHATASE, 342 U/L; 114: GLUCOSE, 88 mg/dL; 114: CHLORIDE, 98 mmol/L; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CHLORIDE, 98 mmol/L; 114: GLOBULIN, 4.3 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: CO2, 19 mmol/L; 114: AST (SGOT), 21 U/L; 114: EGFR REFIT WITHOUT RACE (2021), 7 mL/min/1.73 m2; 114: PROTEIN TOTAL, 8.2 g/dL; 114: CO2, 19 mmol/L; 114: ALBUMIN, 3.9 g/dL; 114: CALCIUM, 8.1 mg/dL; 114: GLOBULIN, 4.3 g/dL; 114: EGFR FOR AFRICAN AMERICAN, 8 mL/min/1.73 m2; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ANION GAP, 14 mmol/L; 114: POTASSIUM, 6.6 mmol/L; 114: AST (SGOT), 21 U/L; 114: CREATININE, 7.03 mg/dL; 114: CORRECTED CALCIUM, 8.2 mg/dL; 114: BILIRUBIN TOTAL, 0.7 mg/dL; 114: ALBUMIN, 3.9 g/dL; 114: HR, 42.052; 114: RR, 16.552; 114: SpO2, 96.707; 114: Perf, 4.959; 114: 1min HRV, 39.438; 114: 5min HRV, 47.285; 115: HR, 42.102; 115: RR, 16.525; 115: SpO2, 96.0; 115: Perf, 4.387; 115: 1min HRV, 29.882; 115: SBP, 121.0; 115: DBP, 77.0; 115: MAP, 91.667; 116: HR, 43.305; 116: RR, 15.729; 116: SpO2, 96.254; 116: Perf, 4.035; 116: 1min HRV, 46.183; 117: HR, 41.845; 117: RR, 16.276; 117: SpO2, 96.276; 117: Perf, 4.256; 117: 1min HRV, 22.321; 118: HR, 41.373; 118: RR, 17.102; 118: SpO2, 96.458; 118: Perf, 4.405; 118: 1min HRV, 38.386; 119: HR, 44.534; 119: RR, 17.276; 119: SpO2, 96.5; 119: Perf, 4.310; 119: 1min HRV, 124.121; 119: 5min HRV, 73.300; 0: Age, 28; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 92.0; 0: Triage RR, 16.0; 0: Triage SBP, 159.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, LEG SWELLING,EMESIS,FEVER",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The patient shows no clear signs of sepsis within the monitored 2-hour timeframe. Vital signs such as heart rate, respiratory rate, blood pressure, and temperature are relatively stable. However, there is a metabolic disturbance indicative of renal impairment, as noted by the high creatinine and potassium levels, but these are not specific markers of imminent sepsis. The consistently normal lactate levels and absence of hypotension or escalating heart rate further reduce the immediate risk of sepsis, leading to the classification of 'No' for high sepsis risk within 12 hours.",
        "claims": [
            "The patient shows no clear signs of sepsis within the monitored 2-hour timeframe.",
            "Vital signs such as heart rate, respiratory rate, blood pressure, and temperature are relatively stable.",
            "There is a metabolic disturbance indicative of renal impairment.",
            "The high creatinine and potassium levels suggest renal impairment.",
            "High creatinine and potassium levels are not specific markers of imminent sepsis.",
            "The consistently normal lactate levels reduce the risk of sepsis.",
            "The absence of hypotension reduces the risk of sepsis.",
            "The absence of an escalating heart rate reduces the risk of sepsis.",
            "The patient is classified as 'No' for high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "There is a metabolic disturbance indicative of renal impairment.",
            "The high creatinine and potassium levels suggest renal impairment.",
            "High creatinine and potassium levels are not specific markers of imminent sepsis.",
            "The absence of hypotension reduces the risk of sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.8,
            0.3,
            0.8
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
        ],
        "alignment_reasonings": [
            "Renal impairment aligns with the SOFA scoring system, which includes creatinine levels >2 mg/dL as part of the scoring criteria to assess organ dysfunction. The mention of metabolic disturbance indicative of renal impairment suggests an increase in the SOFA score. However, since specific values are not provided in the claim, the alignment is not perfect but still strong.",
            "Increased creatinine is directly mentioned as a component of the SOFA score, signaling organ dysfunction and high sepsis risk. Although elevated potassium is not part of the SOFA criteria, the mention of renal impairment is consistent with potential increases in SOFA score related to renal function. Hence, the alignment is quite strong but not perfect since potassium is not a SOFA component.",
            "High creatinine levels are directly relevant to the SOFA score, which includes renal dysfunction as an increased risk of organ dysfunction in sepsis. However, potassium levels are not part of the SOFA criteria for sepsis risk assessment. Hence, the alignment with the SOFA Score Increase category is limited mainly to the creatinine aspect, resulting in a low alignment rating.",
            "The claim discusses the absence of hypotension, which directly relates to the Sepsis-Associated Hypotension category. This category specifically addresses how hypotension indicates sepsis progression toward shock. The reasoning aligns well because the claim implies that lacking hypotension lowers sepsis risk, addressing a key factor of interest in this category."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 0
    },
    {
        "input": "10: HR, 125.0; 10: RR, 20.0; 10: SpO2, 96.0; 10: SBP, 116.0; 10: DBP, 66.0; 10: MAP, 82.667; 10: Pain, 8.0; 10: Temp, 99.1; 55: SpO2, 96.364; 56: SpO2, 97.814; 56: Perf, 3.785; 57: POC PH (V) ISTAT, 7.47; 57: POC PCO2 (V) ISTAT, 38.9 mmHg; 57: POC BASE EXCESS ISTAT, 5 mmol/L; 57: POC LACTATE ISTAT, 1.53 mmol/L; 57: POC PO2 (V) ISTAT, 44 mmHg; 57: POC HCO3 (V) ISTAT, 28.4 mmol/L; 57: POC TCO2 (V) ISTAT, 30 mmol/L; 57: POC O2 SATURATION ISTAT VENOUS, 83 %; 57: SpO2, 97.75; 57: Perf, 4.13; 58: SpO2, 97.545; 60: SpO2, 97.5; 62: SpO2, 97.892; 62: Perf, 2.504; 63: HR, 120.688; 63: RR, 29.0; 63: SpO2, 97.482; 63: Perf, 2.431; 63: 1min HRV, 4.649; 63: SBP, 115.0; 63: DBP, 74.0; 63: MAP, 87.667; 64: HR, 121.288; 64: RR, 23.593; 64: SpO2, 96.966; 64: Perf, 2.527; 64: 1min HRV, 5.019; 65: HR, 120.914; 65: RR, 23.207; 65: SpO2, 96.724; 65: Perf, 2.408; 65: 1min HRV, 5.123; 65: LR IV BOLUS -, 1000 ML; 66: HR:, 120.983; 66: RR, 24.475; 66: SpO2, 96.898; 66: Perf, 2.540; 66: 1min HRV, 9.017; 66: 5min HRV, 6.528; 66: SBP, 115.0; 66: DBP, 74.0; 66: MAP, 87.667; 67: HR, 120.172; 67: RR, 19.828; 67: SpO2, 96.603; 67: Perf, 2.773; 67: 1min HRV, 4.176; 68: HR, 117.847; 68: RR, 26.475; 68: SpO2, 96.169; 68: Perf, 3.083; 68: 1min HRV, 3.796; 69: HR, 116.424; 69: RR, 27.881; 69: SpO2, 96.763; 69: Perf, 3.132; 69: 1min HRV, 3.793; 70: HR, 115.586; 70: RR, 30.172; 70: SpO2, 96.724; 70: Perf, 2.924; 70: 1min HRV, 3.025; 71: HR, 115.458; 71: RR, 31.322; 71: SpO2, 96.508; 71: Perf, 3.087; 71: 1min HRV, 4.311; 71: 5min HRV, 7.879; 72: HR, 116.759; 72: RR, 27.810; 72: SpO2, 96.603; 72: Perf, 2.989; 72: 1min HRV, 4.088; 73: HR, 116.203; 73: RR, 26.763; 73: SpO2, 97.203; 73: Perf, 2.665; 73: 1min HRV, 7.695; 74: HR, 115.644; 74: RR, 30.881; 74: SpO2, 97.373; 74: Perf, 2.693; 74: 1min HRV, 3.287; 75: HR, 114.672; 75: RR, 31.397; 75: SpO2, 97.172; 75: Perf, 2.736; 75: 1min HRV, 3.565; 76: HR, 115.237; 76: RR, 27.085; 76: SpO2, 96.966; 76: Perf, 2.905; 76: 1min HRV, 3.617; 76: 5min HRV, 5.477; 77: HR, 115.086; 77: RR, 28.845; 77: SpO2, 96.948; 77: Perf, 2.516; 77: 1min HRV, 3.056; 78: HR, 115.169; 78: RR, 29.356; 78: SpO2, 97.492; 78: Perf, 2.126; 78: 1min HRV, 5.350; 79: HR, 114.381; 79: RR, 35.0; 79: SpO2, 97.107; 79: Perf, 1.866; 79: 1min HRV, 2.431; 81: 5min HRV, 4.226; 90: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 94: INR:, 1.1; 94: PROTHROMBIN TIME, 15.1 seconds; 102: SpO2, 95.962; 103: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 103: RED BLOOD CELLS (RBC), 3.10 MIL/uL; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.8 pg; 103: MEAN CORPUSCULAR VOLUME (MCV), 84.8 fL; 103: HEMOGLOBIN (HGB), 8.3 g/dL; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 103: HEMATOCRIT (HCT), 26.3 %; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 103: PLATELET COUNT (PLT), 331 K/uL; 103: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.51 K/uL; 103: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.49 K/uL; 103: MONOCYTES % (MANUAL DIFF), 0.0 %; 103: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 103: NEUTROPHILS BANDS % (MANUAL DIFF), 7.8 %; 103: EOSINOPHILS % (MANUAL DIFF), 3.5 %; 103: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 82.6 %; 103: LYMPHOCYTES % (MANUAL DIFF), 6.1 %; 103: HR, 112.581; 103: RR, 18.032; 103: SpO2, 97.559; 103: 1min HRV, 7.885; 104: PART. THROMBOPLASTIN TIME, 32.3 seconds; 104: HR, 112.707; 104: RR, 28.879; 104: SpO2, 97.466; 104: Perf, 1.069; 104: 1min HRV, 5.442; 105: HR, 113.780; 105: RR, 24.034; 105: SpO2, 97.305; 105: Perf, 1.174; 105: 1min HRV, 2.973; 106: HR, 113.797; 106: RR, 22.712; 106: SpO2, 97.0; 106: Perf, 1.143; 106: 1min HRV, 4.693; 106: 5min HRV, 5.928; 107: HR, 112.448; 107: RR, 27.672; 107: SpO2, 97.707; 107: Perf, 1.229; 107: 1min HRV, 4.238; 108: HR, 113.186; 108: RR, 24.390; 108: SpO2, 97.678; 108: Perf, 1.205; 108: 1min HRV, 5.694; 109: HR, 112.638; 109: RR, 26.672; 109: SpO2, 97.534; 109: Perf, 1.260; 109: 1min HRV, 4.334; 110: HR, 112.661; 110: RR, 24.373; 110: SpO2, 98.0; 110: Perf, 1.144; 110: 1min HRV, 4.286; 111: HR, 115.448; 111: RR, 21.397; 111: SpO2, 98.0; 111: Perf, 1.383; 111: 1min HRV, 4.708; 111: 5min HRV, 7.053; 112: HR, 114.949; 112: RR, 20.220; 112: SpO2, 98.339; 112: Perf, 1.131; 112: 1min HRV, 9.737; 113: HR, 114.305; 113: RR, 25.542; 113: SpO2, 97.627; 113: Perf, 1.18; 113: 1min HRV, 9.114; 114: BLOOD, URINE (UA): Negative; 114: KETONE, URINE (UA): Negative; 114: SPECIFIC GRAVITY, URINE (UA): 1.003; 114: NITRITE, URINE (UA): Negative; 114: LEUKOCYTE ESTERASE, URINE (UA): Negative; 114: PROTEIN, URINE (UA): Negative; 114: GLUCOSE, URINE (UA): Negative; 114: PH, URINE (UA): 6.0; 114: HR, 114.259; 114: RR, 24.845; 114: SpO2, 97.155; 114: Perf, 1.245; 114: 1min HRV, 7.585; 115: HR, 114.068; 115: RR, 28.017; 115: SpO2, 97.102; 115: Perf, 1.962; 115: 1min HRV, 9.362; 116: HR, 113.914; 116: RR, 25.431; 116: SpO2, 96.948; 116: Perf, 1.619; 116: 1min HRV, 5.658; 116: 5min HRV, 8.827; 117: HR, 113.034; 117: RR, 22.119; 117: SpO2, 97.797; 117: Perf, 1.397; 117: 1min HRV, 6.426; 118: HR, 112.983; 118: RR, 25.729; 118: SpO2, 97.898; 118: Perf, 1.529; 118: 1min HRV, 4.914; 119: HR, 113.845; 119: RR, 24.638; 119: SpO2, 98.0; 119: Perf, 1.743; 119: 1min HRV, 9.732; 0: Age, 45; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 125.0; 0: Triage RR, 20.0; 0: Triage SBP, 116.0; 0: Triage DBP, 66.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess sepsis risk, key elements include temperature, heart rate, respiration rate, and lab values like lactate. This patient has a fever and elevated heart rate, but lactate levels are not concerning, and oxygen saturation (SpO2) is stable. HR and RR show some tachycardia/tachypnea but remain stable overall. Critical lab results like lactate are not high, and there is no significant hypotension. Therefore, the patient is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "Key elements to assess sepsis risk include temperature, heart rate, respiration rate, and lab values like lactate.",
            "The patient has a fever.",
            "The patient has an elevated heart rate.",
            "Lactate levels are not concerning for the patient.",
            "The patient's oxygen saturation (SpO2) is stable.",
            "Heart rate (HR) and respiration rate (RR) show some tachycardia/tachypnea.",
            "Heart rate (HR) and respiration rate (RR) remain stable overall.",
            "Critical lab results, such as lactate, are not high for the patient.",
            "There is no significant hypotension in the patient.",
            "The patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate.",
            "Heart rate (HR) and respiration rate (RR) show some tachycardia/tachypnea.",
            "Critical lab results, such as lactate, are not high for the patient.",
            "There is no significant hypotension in the patient."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.8,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is explicitly listed as one of the criteria under SIRS Positivity, which is used to identify systemic inflammation and potential early sepsis. The claim directly points to one aspect of the criteria, but since it doesn't specify the heart rate value or mention a second SIRS criterion, there is a slight drop from perfect alignment.",
            "The claim mentions tachycardia and tachypnea, which correspond to two SIRS criteria: heart rate > 90 bpm and respiratory rate > 20/min. Although the claim does not specify exact values to confirm these thresholds, the mention of \"some tachycardia/tachypnea\" suggests an alignment with the SIRS criteria, albeit without full certainty. Thus, the alignment with the SIRS Positivity category is strong but not definitive.",
            "The claim specifically addresses serum lactate levels, which directly relate to the \"Elevated Serum Lactate\" category in the expert sepsis categories. Although the claim indicates that lactate levels are not high, the reference to lactate as a critical lab result suggests it is under consideration for assessing sepsis risk. The alignment is strong due to the direct mention of lactate, but slightly less than perfect (0.8) as the result is explicitly stated to be \"not high.\"",
            "The claim directly addresses the absence of hypotension, which is a hallmark of the category \"Sepsis-Associated Hypotension.\" While the claim does not indicate the presence of sepsis-related hypotension, it is relevant because it specifically mentions the hemodynamic parameter that this category focuses on. The alignment is strong as it pertains to this specific category, but it notes the lack of a key risk factor rather than its presence, which prevents a perfect alignment rating."
        ],
        "final_alignment_score": 0.7750000000000001,
        "accuracy": 1
    },
    {
        "input": "3: HR, 87.0; 3: RR, 16.0; 3: SpO2, 90.0; 3: SBP, 134.0; 3: DBP, 80.0; 3: MAP, 98.0; 3: Temp, 99.5; 6: Pain, 0.0; 29: POC PH (V) ISTAT, 7.42; 29: POC HCO3 (V) ISTAT, 37.4 mmol/L; 29: POC PCO2 (V) ISTAT, 58.4 mmHg; 29: POC TCO2 (V) ISTAT, 39 mmol/L; 29: POC PO2 (V) ISTAT, 49 mmHg; 29: POC O2 SATURATION ISTAT VENOUS, 83 %; 29: POC BASE EXCESS ISTAT, 13 mmol/L; 29: POC LACTATE ISTAT, 1.38 mmol/L; 61: INR, 1.2; 61: WAM DIFTYP, AUTO; 61: PROTHROMBIN TIME, 15.4 seconds; 61: NEUTROPHIL ABSOLUTE (AUTO DIFF), 23.28 K/uL; 61: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 61: WHITE BLOOD CELLS (WBC), 26.0 K/uL; 61: NEUTROPHIL % (AUTO DIFF), 89.4 %; 61: BASOPHIL % (AUTO DIFF), 0.2 %; 61: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.8 pg; 61: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 61: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.9 %; 61: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 61: HEMOGLOBIN (HGB), 9.5 g/dL; 61: MEAN CORPUSCULAR VOLUME (MCV), 66.1 fL; 61: NRBC PERCENT (HEMATOLOGY), 0.0 %; 61: MONOCYTE % (AUTO DIFF), 4.2 %; 61: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 61: RED BLOOD CELLS (RBC), 5.05 MIL/uL; 61: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 61: LYMPHOCYTE % (AUTO DIFF), 5.3 %; 61: PLATELET COUNT (PLT), 365 K/uL; 61: HEMATOCRIT (HCT), 33.4 %; 61: EOSINOPHIL % (AUTO DIFF), 0.0 %; 61: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.4 g/dL; 61: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 61: MONOCYTE ABSOLUTE (AUTO DIFF), 1.10 K/uL; 62: CHLORIDE, 94 mmol/L; 62: GLUCOSE, 129 mg/dL; 62: CALCIUM, 9.1 mg/dL; 62: ANION GAP, 7 mmol/L; 62: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 62: ALBUMIN, 3.7 g/dL; 62: AST (SGOT), 15 U/L; 62: BILIRUBIN TOTAL, 0.3 mg/dL; 62: SODIUM, 136 mmol/L; 62: PROTEIN TOTAL, 7.5 g/dL; 62: CORRECTED CALCIUM, 9.3 mg/dL; 62: CREATININE, 0.33 mg/dL; 62: CO2, 35 mmol/L; 62: PART. THROMBOPLASTIN TIME, 36.4 seconds; 62: GLOBULIN, 3.8 g/dL; 62: ALKALINE PHOSPHATASE, 101 U/L; 62: EGFR FOR AFRICAN AMERICAN, 135 mL/min/1.73 m2; 62: ALT (SGPT), 12 U/L; 62: EGFR REFIT WITHOUT RACE (2021), 117 mL/min/1.73 m2; 62: POTASSIUM, 4.3 mmol/L; 85: HR, 161.0; 85: RR, 23.0; 85: SpO2, 97.0; 85: SBP, 127.0; 85: DBP, 90.0; 85: MAP, 102.333; 85: LPM O2, 2.0; 88: WAM DIFTYP, AUTO; 88: RED BLOOD CELLS (RBC), 4.88 MIL/uL; 88: HEMOGLOBIN (HGB), 9.2 g/dL; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 1.17 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 28.6 g/dL; 88: EOSINOPHIL % (AUTO DIFF), 0.0 %; 88: MONOCYTE % (AUTO DIFF), 4.6 %; 88: MEAN CORPUSCULAR VOLUME (MCV), 66.0 fL; 88: LYMPHOCYTE % (AUTO DIFF), 5.8 %; 88: WHITE BLOOD CELLS (WBC), 25.6 K/uL; 88: PLATELET COUNT (PLT), 346 K/uL; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: BASOPHIL % (AUTO DIFF), 0.2 %; 88: NEUTROPHIL % (AUTO DIFF), 88.7 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 88: HEMATOCRIT (HCT), 32.2 %; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 18.9 pg; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.49 K/uL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 22.66 K/uL; 96: PHOSPHORUS, 2.9 mg/dL; 96: MAGNESIUM, 2.2 mg/dL; 102: LR IV BOLUS -, 500 ML; 105: CEFEPIME, 2 GRAM/20 ML IV PUSH; 110: GLUCOSE, 118 mg/dL; 110: CO2, 33 mmol/L; 110: MAGNESIUM, 2.3 mg/dL; 110: CREATININE, 0.31 mg/dL; 110: ANION GAP, 8 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: ALKALINE PHOSPHATASE, 95 U/L; 110: CALCIUM, 9.0 mg/dL; 110: PHOSPHORUS, 2.9 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: PROTEIN TOTAL, 7.2 g/dL; 110: BILIRUBIN TOTAL, 0.3 mg/dL; 110: POTASSIUM, 4.1 mmol/L; 110: CORRECTED CALCIUM, 9.3 mg/dL; 110: CHLORIDE, 95 mmol/L; 110: AST (SGOT), 14 U/L; 110: SODIUM, 136 mmol/L; 110: ALBUMIN, 3.6 g/dL; 110: ALT (SGPT), 9 U/L; 110: GLOBULIN, 3.6 g/dL; 110: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 110: HR, 94.0; 110: RR, 21.0; 110: SpO2, 95.0; 110: SBP, 128.0; 110: DBP, 87.0; 110: MAP, 100.667; 110: LPM O2, 2.0; 111: TROPONIN I, <.017 ng/mL; 114: MAGNESIUM SULFATE IN WATER, 2 GRAM/50 ML (4 %) IV PGBK; 0: Age:, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 87.0; 0: Triage RR, 16.0; 0: Triage SBP, 134.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The key indicators for sepsis risk include elevated heart rate, respiratory rate, white blood cell count, and abnormal blood gas or electrolytes. The patient shows tachycardia with a heart rate spike to 161 bpm, a respiratory rate increase to 23 bpm, low venous oxygen saturation, very high white blood cell counts (26 K/uL, 25.6 K/uL), and a slightly elevated INR of 1.2. Combined with the administration of Cefepime, a broad-spectrum antibiotic, it suggests a concern for infection, pointing toward a high risk of sepsis.",
        "claims": [
            "Elevated heart rate is a key indicator for sepsis risk.",
            "A respiratory rate increase is a key indicator for sepsis risk.",
            "An elevated white blood cell count is a key indicator for sepsis risk.",
            "Abnormal blood gas or electrolyte levels are key indicators for sepsis risk.",
            "The patient shows tachycardia with a heart rate spike to 161 bpm.",
            "The patient's respiratory rate has increased to 23 bpm.",
            "The patient has low venous oxygen saturation.",
            "The patient's white blood cell counts are very high at 26 K/uL and 25.6 K/uL.",
            "The patient's INR is slightly elevated at 1.2.",
            "The administration of Cefepime suggests a concern for infection.",
            "The indicators combined suggest a high risk of sepsis."
        ],
        "relevant_claims": [
            "Elevated heart rate is a key indicator for sepsis risk.",
            "A respiratory rate increase is a key indicator for sepsis risk.",
            "An elevated white blood cell count is a key indicator for sepsis risk.",
            "Abnormal blood gas or electrolyte levels are key indicators for sepsis risk.",
            "The patient shows tachycardia with a heart rate spike to 161 bpm.",
            "The patient has low venous oxygen saturation.",
            "The patient's white blood cell counts are very high at 26 K/uL and 25.6 K/uL.",
            "The patient's INR is slightly elevated at 1.2.",
            "The administration of Cefepime suggests a concern for infection.",
            "The indicators combined suggest a high risk of sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            1.0,
            0.6,
            0.8,
            0.7,
            1.0,
            0.3,
            0.9,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is one of the explicitly mentioned criteria under SIRS, which is used to identify systemic inflammation consistent with early sepsis. However, since the claim doesn\u2019t mention the heart rate exceeding 90 bpm specifically or meeting multiple SIRS criteria, the alignment is strong but not perfect. Therefore, a rating of 0.8 is appropriate.",
            "The claim highlights an increase in respiratory rate as a key indicator of sepsis risk. An elevated respiratory rate (>20/min) is one of the criteria for SIRS, which is used to identify systemic inflammation and early sepsis. While the claim does not specify whether the respiratory rate increase meets the SIRS threshold, it is strongly related to identifying sepsis risk through increased respiratory rate, warranting a higher alignment rating.",
            "An elevated white blood cell count is one of the criteria explicitly listed under SIRS. The presence of \u22652 SIRS criteria indicates systemic inflammation indicative of early sepsis, making the alignment perfect with the claim.",
            "Abnormal blood gas or electrolyte levels can be indirectly linked to serum lactate levels, which indicate tissue hypoperfusion and a higher sepsis risk. While the claim doesn't specifically mention serum lactate, electrolyte imbalances or altered blood gases often accompany elevated lactate, making an indirect association relevant but not direct or definitive.",
            "Tachycardia with a heart rate >90 bpm is directly listed as one of the criteria for SIRS, which is used to identify systemic inflammation consistent with early sepsis. The heart rate of 161 bpm clearly exceeds this criterion, indicating strong alignment with SIRS Positivity. However, since more than one SIRS criterion is needed to be fully aligned and the claim only mentions one, the alignment is not perfect.",
            "Low venous oxygen saturation can indicate impaired oxygen delivery and utilization, which relates conceptually to SOFA criteria involving organ dysfunction, particularly oxygenation (PaO\u2082/FiO\u2082\u202f<\u202f300). Although venous oxygen saturation is not a direct SOFA measure, it implies potential organ dysfunction, suggesting a reasonable alignment.",
            "The claim describes a high white blood cell count, specifically greater than 12,000/\u00b5L, which is listed as a criterion under SIRS. This directly meets one of the SIRS criteria for systemic inflammation suggestive of early sepsis, indicating perfect alignment.",
            "The International Normalized Ratio (INR) is not directly associated with any given criteria but can relate to hepatic function, which is part of the SOFA scoring system (e.g., bilirubin levels indicate liver dysfunction). However, the claim of a slightly elevated INR (1.2) does not strongly correspond to critical hepatic dysfunction or the direct increase of SOFA score by \u22652 points; thus, the alignment is weak.",
            "The claim specifies the administration of Cefepime, a broad-spectrum antibiotic, which strongly indicates clinician suspicion of a serious infection. This directly relates to the expert category criterion of early antibiotic administration. The high alignment rating reflects the explicit action of starting antibiotics, which aligns closely but not perfectly since there\u2019s no timeframe mentioned; however, it's reasonable to infer timeliness from the context.",
            "The claim broadly states that various indicators suggest a high risk of sepsis but doesn\u2019t specify which indicators. The Elevated NEWS Score comprises multiple vital signs and changes, reflecting a combined risk assessment. The alignment is weak due to the nonspecific nature of the claim."
        ],
        "final_alignment_score": 0.7100000000000001,
        "accuracy": 1
    },
    {
        "input": "3: HR, 85.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 147.0; 3: DBP, 53.0; 3: MAP, 84.333; 3: Temp, 98.8; 11: Pain, 3.0; 13: POC PH (V) ISTAT, 7.44; 13: POC PCO2 (V) ISTAT, 32.8 mmHg; 13: POC BASE EXCESS ISTAT, -2 mmol/L; 13: POC PO2 (V) ISTAT, 29 mmHg; 13: POC O2 SATURATION ISTAT VENOUS, 60 %; 13: POC HCO3 (V) ISTAT, 22.3 mmol/L; 13: POC LACTATE ISTAT, 0.96 mmol/L; 13: POC TCO2 (V) ISTAT, 23 mmol/L; 31: WAM DIFTYP, AUTO; 31: NEUTROPHIL % (AUTO DIFF), 73.4 %; 31: MEAN CORPUSCULAR VOLUME (MCV), 91.9 fL; 31: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 31: PLATELET COUNT (PLT), 88 K/uL; 31: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 31: RED BLOOD CELLS (RBC), 3.47 MIL/uL; 31: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 31: MONOCYTE % (AUTO DIFF), 10.0 %; 31: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 31: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.25 K/uL; 31: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 31: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.69 K/uL; 31: NRBC PERCENT (HEMATOLOGY), 0.0 %; 31: BASOPHIL % (AUTO DIFF), 0.9 %; 31: EOSINOPHIL % (AUTO DIFF), 3.5 %; 31: HEMATOCRIT (HCT), 31.9 %; 31: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 31: RED CELL DISTRIBUTION WIDTH (RDW), 18.7 %; 31: LYMPHOCYTE % (AUTO DIFF), 10.9 %; 31: MONOCYTE ABSOLUTE (AUTO DIFF), 0.23 K/uL; 31: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 31: HEMOGLOBIN (HGB), 10.2 g/dL; 31: WHITE BLOOD CELLS (WBC), 2.3 K/uL; 44: INR, 0.9; 44: PROTHROMBIN TIME, 12.5 seconds; 45: PART. THROMBOPLASTIN TIME, 37.0 seconds; 61: EGFR FOR AFRICAN AMERICAN, 105 mL/min/1.73 m2; 61: CO2, 21 mmol/L; 61: CALCIUM, 10.0 mg/dL; 61: ANION GAP, 10 mmol/L; 61: SODIUM, 133 mmol/L; 61: CORRECTED CALCIUM, 10.2 mg/dL; 61: AST (SGOT), 16 U/L; 61: GLUCOSE, 91 mg/dL; 61: ALKALINE PHOSPHATASE, 135 U/L; 61: PROTEIN TOTAL, 6.2 g/dL; 61: ALT (SGPT), 25 U/L; 61: ALBUMIN, 3.8 g/dL; 61: CHLORIDE, 102 mmol/L; 61: GLOBULIN, 2.4 g/dL; 61: EGFR REFIT WITHOUT RACE (2021), 91 mL/min/1.73 m2; 61: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 61: CREATININE, 0.64 mg/dL; 61: POTASSIUM, 4.6 mmol/L; 61: BILIRUBIN TOTAL, 0.2 mg/dL; 70: SpO2, 89.632; 71: SpO2, 99.25; 73: SpO2, 98.556; 74: SpO2, 100.0; 75: SpO2, 98.6; 76: HR, 83.0; 76: SpO2, 98.679; 76: SBP, 147.0; 76: DBP, 66.0; 76: MAP, 93.0; 76: Pain, 0.0; 77: SpO2, 96.340; 78: SpO2, 96.558; 79: SpO2, 96.868; 79: Perf, 0.45; 80: SpO2, 97.736; 80: Perf, 0.469; 81: SpO2, 97.830; 81: Perf, 0.486; 82: SpO2, 97.509; 82: Perf, 0.452; 83: SpO2, 97.472; 83: Perf, 0.434; 84: SpO2, 97.057; 84: Perf, 0.474; 85: SpO2, 96.519; 85: Perf, 0.469; 86: SpO2, 96.623; 86: Perf, 0.450; 87: SpO2, 96.774; 87: Perf, 0.452; 88: SpO2, 97.808; 88: Perf, 0.466; 89: SpO2, 98.245; 89: Perf, 0.462; 90: SpO2, 97.769; 90: Perf, 0.443; 91: TROPONIN I, <.017 ng/mL; 91: SpO2, 97.792; 91: Perf, 0.426; 92: SpO2, 96.358; 92: Perf, 0.439; 93: SpO2, 96.462; 93: Perf, 0.419; 94: SpO2, 96.245; 94: Perf, 0.416; 95: SpO2, 96.377; 95: Perf, 0.434; 96: SpO2, 97.245; 96: Perf, 0.419; 97: SpO2, 96.654; 97: Perf, 0.424; 98: SpO2, 96.774; 98: Perf, 0.434; 99: SpO2, 96.744; 99: Perf, 0.42; 100: SpO2, 95.0; 100: Perf, 0.42; 101: SpO2, 97.0; 101: Perf, 0.42; 102: SpO2, 99.692; 102: Perf, 0.413; 103: SpO2, 99.707; 103: Perf, 0.427; 104: SpO2, 98.667; 104: Perf, 0.507; 105: SpO2, 98.731; 105: Perf, 0.503; 106: SpO2, 99.113; 106: Perf, 0.448; 107: SpO2, 99.226; 107: Perf, 0.454; 108: SpO2, 99.377; 108: Perf, 0.501; 109: SpO2, 98.642; 109: Perf, 0.570; 110: SpO2, 98.885; 110: Perf, 0.520; 111: SpO2, 99.453; 111: Perf, 0.479; 112: SpO2, 98.885; 112: Perf, 0.478; 113: SpO2, 99.114; 113: Perf, 0.481; 114: SpO2, 98.792; 114: Perf, 0.512; 115: SpO2, 98.923; 115: Perf, 0.51; 116: SpO2, 98.302; 116: Perf, 0.550; 117: SpO2, 98.096; 117: Perf, 0.555; 118: SpO2, 98.547; 118: Perf, 0.525; 119: SpO2, 98.528; 119: Perf, 0.515; 0: Age, 84; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 85.0; 0: Triage RR, 18.0; 0: Triage SBP, 147.0; 0: Triage DBP, 53.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,ANAL PAIN,GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To predict sepsis risk, we start by examining the patient's age and comorbidities; an 84-year old patient is indeed at a higher risk. Next, we check for vital signs and lab results indicative of possible sepsis, such as hypotension, tachycardia, fever, and abnormal lab markers. The patient's BP is somewhat low (DBP 53 mmHg), while other vitals are fairly stable, including normal lactate levels. The SpO2 shows some fluctuation but generally remains above 90%. Blood markers like WBC count are low which could indicate immunosuppression rather than infection. Given the lack of strong clinical indicators of sepsis in the time frame analyzed, the determination is low risk for sepsis within the next hours.",
        "claims": [
            "To predict sepsis risk, we examine the patient's age and comorbidities.",
            "An 84-year-old patient is at a higher risk of developing sepsis.",
            "We check for vital signs and lab results indicative of possible sepsis.",
            "Indicators of possible sepsis include hypotension, tachycardia, fever, and abnormal lab markers.",
            "The patient's blood pressure is somewhat low with a DBP of 53 mmHg.",
            "Other vital signs are fairly stable.",
            "The patient's lactate levels are normal.",
            "The SpO2 shows some fluctuation but generally remains above 90%.",
            "The patient's white blood cell (WBC) count is low.",
            "A low WBC count could indicate immunosuppression rather than infection.",
            "There is a lack of strong clinical indicators of sepsis in the analyzed time frame.",
            "The determination of sepsis risk for this patient is low for the next 12 hours."
        ],
        "relevant_claims": [
            "Indicators of possible sepsis include hypotension, tachycardia, fever, and abnormal lab markers.",
            "The patient's blood pressure is somewhat low with a DBP of 53 mmHg.",
            "The SpO2 shows some fluctuation but generally remains above 90%.",
            "There is a lack of strong clinical indicators of sepsis in the analyzed time frame."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.3,
            0.1
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SOFA Score Increase (\u22652 points)",
            "No strong alignment with a specific category"
        ],
        "alignment_reasonings": [
            "The claim mentions several indicators that overlap with SIRS criteria, such as fever and tachycardia, both of which are part of the systemic inflammatory response syndrome (SIRS) that can suggest early sepsis. Hypotension and abnormal lab markers (not specifically detailed) may also point to sepsis but are more indirectly linked to SIRS specificity. The alignment is strong because some direct SIRS criteria are clearly referenced, but not all indicators in the claim directly map to a single category without additional detail.",
            "The claim about the patient's low diastolic blood pressure (DBP) suggests the patient may be experiencing hypotension, which is relevant to sepsis-associated hypotension. While the claim does not provide a full picture of systolic blood pressure (SBP) or mean arterial pressure (MAP) to confirm the category\u2019s criteria definitively (SBP <90 mmHg, MAP <70 mmHg), it indicates potential alignment due to the concern for low blood pressure and its implications. The partial information on BP leads to a moderate alignment rating.",
            "The claim mentions SpO2 fluctuations with values generally remaining above 90%. While SpO2 is not a direct SOFA score component, it is related in the context of oxygenation. A persistently low SpO2 can relate to impaired oxygen exchange, which is a part of the SOFA criteria. However, since the SpO2 is above 90%, it doesn't strongly suggest sepsis-related organ dysfunction, leading to a low alignment rating.",
            "The claim reflects the absence of sepsis indicators rather than the presence of specific signs or risk factors. While it suggests a low risk based on the expert categories, it doesn't directly relate to any single category that indicates high or low sepsis risk. Therefore, the alignment is minimal and indirect."
        ],
        "final_alignment_score": 0.47500000000000003,
        "accuracy": 0
    },
    {
        "input": "10: HR, 77.0; 10: RR, 26.0; 10: SpO2, 94.0; 10: SBP, 124.0; 10: DBP, 62.0; 10: MAP, 82.667; 10: Temp, 96.5; 82: SpO2, 89.0; 83: SpO2, 90.429; 84: SpO2, 90.492; 84: Perf, 4.452; 84: SBP, 154.0; 84: DBP, 70.0; 84: MAP, 98.0; 85: SpO2, 96.466; 85: Perf, 4.148; 86: HR, 71.381; 86: RR, 16.0; 86: SpO2, 97.593; 86: Perf, 2.966; 86: 1min HRV, 16.155; 86: SBP, 154.0; 86: DBP, 70.0; 86: MAP, 98.0; 86: LPM O2, 4.0; 87: HR, 71.517; 87: RR, 16.621; 87: SpO2, 97.845; 87: Perf, 2.527; 87: 1min HRV, 66.844; 88: HR, 71.068; 88: RR, 18.305; 88: SpO2, 99.102; 88: Perf, 6.147; 88: 1min HRV, 88.071; 88: 5min HRV, 71.322; 89: HR, 69.712; 89: RR, 17.373; 89: SpO2, 99.0; 89: Perf, 6.267; 89: 1min HRV, 99.938; 89: SBP, 144.0; 89: DBP, 77.0; 89: MAP, 99.333; 90: HR, 68.655; 90: RR, 19.638; 90: SpO2, 98.931; 90: Perf, 5.382; 90: 1min HRV, 93.795; 91: HR, 68.068; 91: RR, 18.051; 91: SpO2, 99.0; 91: Perf, 3.774; 91: 1min HRV, 108.446; 92: HR, 67.914; 92: RR, 19.621; 92: SpO2, 99.207; 92: Perf, 2.366; 92: 1min HRV, 144.427; 93: HR, 66.576; 93: RR, 22.169; 93: SpO2, 99.339; 93: Perf, 2.173; 93: 1min HRV, 110.827; 93: 5min HRV, 113.988; 94: HR, 65.627; 94: RR, 18.288; 94: SpO2, 98.881; 94: Perf, 2.096; 94: 1min HRV, 110.571; 95: HR, 65.172; 95: RR, 19.759; 95: SpO2, 99.379; 95: Perf, 3.281; 95: 1min HRV, 77.063; 96: POC PH (V) ISTAT, 7.31; 96: POC TCO2 (V) ISTAT, 30 mmol/L; 96: POC BASE EXCESS ISTAT, 2 mmol/L; 96: POC O2 SATURATION ISTAT VENOUS, 64 %; 96: POC PCO2 (V) ISTAT, 57.5 mmHg; 96: POC LACTATE ISTAT, 0.93 mmol/L; 96: POC PO2 (V) ISTAT, 37 mmHg; 96: POC HCO3 (V) ISTAT, 28.7 mmol/L; 96: HR, 65.542; 96: RR, 19.153; 96: SpO2, 99.102; 96: Perf, 1.754; 96: 1min HRV, 27.516; 97: HR, 68.948; 97: RR, 24.897; 97: SpO2, 98.621; 97: Perf, 1.487; 97: 1min HRV, 45.742; 98: HR, 67.034; 98: RR, 21.712; 98: SpO2, 99.085; 98: Perf, 1.493; 98: 1min HRV, 104.683; 98: 5min HRV, 81.792; 99: HR, 67.932; 99: RR, 20.525; 99: SpO2, 99.0; 99: Perf, 1.597; 99: 1min HRV, 120.171; 100: HR, 66.862; 100: RR, 19.621; 100: SpO2, 99.052; 100: Perf, 1.658; 100: 1min HRV, 94.356; 101: HR, 66.831; 101: RR, 23.169; 101: SpO2, 99.136; 101: Perf, 1.661; 101: 1min HRV, 75.248; 102: HR, 65.862; 102: RR, 19.448; 102: SpO2, 99.138; 102: Perf, 1.378; 102: 1min HRV, 32.203; 103: HR, 65.492; 103: RR, 18.424; 103: SpO2, 99.237; 103: Perf, 1.368; 103: 1min HRV, 22.240; 103: 5min HRV, 79.378; 104: HR, 66.552; 104: RR, 26.276; 104: SpO2, 99.224; 104: Perf, 1.556; 104: 1min HRV, 102.855; 105: HR, 64.949; 105: RR, 19.288; 105: SpO2, 99.237; 105: Perf, 1.84; 105: 1min HRV, 23.225; 106: HR, 65.729; 106: RR, 21.475; 106: SpO2, 99.0; 106: Perf, 1.560; 106: 1min HRV, 19.443; 107: HR, 64.603; 107: RR, 24.466; 107: SpO2, 99.776; 107: Perf, 1.227; 107: 1min HRV, 85.820; 108: HR, 63.339; 108: RR, 23.695; 108: SpO2, 99.847; 108: Perf, 1.352; 108: 1min HRV, 26.607; 108: 5min HRV, 65.054; 109: HR, 63.138; 109: RR, 25.052; 109: SpO2, 100.0; 109: Perf, 1.304; 109: 1min HRV, 111.949; 110: HR, 62.695; 110: RR, 22.966; 110: SpO2, 100.0; 110: Perf, 1.205; 110: 1min HRV, 34.180; 111: HR, 65.424; 111: RR, 24.898; 111: SpO2, 99.831; 111: Perf, 1.268; 111: 1min HRV, 76.669; 112: HR, 66.448; 112: RR, 21.948; 112: SpO2, 99.897; 112: Perf, 1.413; 112: 1min HRV, 123.017; 112: Temp, 97.9; 113: HR, 64.915; 113: RR, 23.797; 113: SpO2, 100.0; 113: Perf, 1.788; 113: 1min HRV, 99.817; 113: 5min HRV, 98.123; 114: HR, 64.741; 114: RR, 21.103; 114: SpO2, 99.828; 114: Perf, 1.588; 114: 1min HRV, 154.840; 115: HR, 64.305; 115: RR, 24.051; 115: SpO2, 99.864; 115: Perf, 1.443; 115: 1min HRV, 156.988; 116: HR, 64.797; 116: RR, 22.0; 116: SpO2, 99.949; 116: Perf, 1.362; 116: 1min HRV, 112.948; 117: HR, 64.759; 117: RR, 24.741; 117: SpO2, 99.828; 117: Perf, 1.498; 117: 1min HRV, 138.767; 117: LPM O2, 2.0; 118: SARS-COV-2 RNA, Not Detected; 118: HR, 62.881; 118: RR, 23.424; 118: SpO2, 100.0; 118: Perf, 1.646; 118: 1min HRV, 122.625; 118: 5min HRV, 139.282; 119: WAM DIFTYP, AUTO; 119: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 119: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 119: NRBC PERCENT (HEMATOLOGY), 0.0 %; 119: HEMATOCRIT (HCT), 35.3 %; 119: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.30 K/uL; 119: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 119: NEUTROPHIL % (AUTO DIFF), 76.3 %; 119: RED CELL DISTRIBUTION WIDTH (RDW), 14.0 %; 119: MONOCYTE % (AUTO DIFF), 7.6 %; 119: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 119: RED BLOOD CELLS (RBC), 3.82 MIL/uL; 119: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 119: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.3 pg; 119: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 119: BASOPHIL % (AUTO DIFF), 0.5 %; 119: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 119: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 119: MEAN CORPUSCULAR VOLUME (MCV), 92.4 fL; 119: PLATELET COUNT (PLT), 147 K/uL; 119: EOSINOPHIL % (AUTO DIFF), 3.2 %; 119: HEMOGLOBIN (HGB), 11.2 g/dL; 119: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 119: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 119: HR, 62.966; 119: RR, 23.138; 119: SpO2, 99.603; 119: Perf, 1.539; 119: 1min HRV, 132.912; 0: Age, 72; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 35.8; 0: Triage HR, 77.0; 0: Triage RR, 26.0; 0: Triage SBP, 124.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, MULTIPLE COMPLAINTS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, examine vital sign stability over time for indicators like heart rate, blood pressure, respiratory rate, and temperature. The initial data shows a slightly low triage temperature and elevated respiratory rate but later stabilizes around normal ranges, with SPO2 levels improving and remaining high, reducing risk concerns. Next, consider laboratory values; the lactate is low, and other lab results do not indicate severe infection, as WBC count is normal and no bacterial infection markers are evident. Collectively, the data does not suggest a high risk for sepsis within the next 12 hours.",
        "claims": [
            "Vital sign stability over time should be examined for indicators such as heart rate, blood pressure, respiratory rate, and temperature.",
            "Initial data shows a slightly low triage temperature.",
            "The initial data shows an elevated respiratory rate.",
            "Vital signs later stabilize around normal ranges.",
            "SPO2 levels improve and remain high.",
            "Improving and high SPO2 levels reduce risk concerns.",
            "Laboratory values should be considered.",
            "The lactate level is low.",
            "Other lab results do not indicate severe infection.",
            "The WBC count is normal.",
            "No bacterial infection markers are evident.",
            "Collectively, the data does not suggest a high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Initial data shows a slightly low triage temperature.",
            "The initial data shows an elevated respiratory rate.",
            "Other lab results do not indicate severe infection.",
            "No bacterial infection markers are evident.",
            "Collectively, the data does not suggest a high risk for sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.2,
            0.3,
            0.0
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "None"
        ],
        "alignment_reasonings": [
            "A slightly low triage temperature suggests a temperature <36\u00b0C, which relates to one of the SIRS criteria. However, without specifics on how low the temperature is or any additional SIRS criteria, the alignment is weak. The mention of temperature aligns conceptually with the SIRS category but lacks sufficient detail for strong alignment.",
            "An elevated respiratory rate is one of the explicit SIRS criteria for identifying systemic inflammation consistent with early sepsis. While the claim does not provide the exact value of the respiratory rate to confirm whether it indeed meets the SIRS threshold of >20/min, its mention strongly suggests a potential for meeting this criterion. Thus, it aligns well with the SIRS Positivity category, but without the exact data, full certainty cannot be established, resulting in an alignment rating of 0.8.",
            "The claim mentions the absence of severe infection indicators in lab results, which loosely aligns with the notion of assessing infection severity. Though it suggests evaluation, it doesn't relate directly to initiating antibiotic treatment or culture orders. The alignment is weak because it lacks ties to unbiased suspicion or action indicative of this category.",
            "The claim suggests an absence of evidence for bacterial infection, which aligns indirectly with the category that would typically involve taking blood cultures or administering antibiotics in case of suspected infection. This lack of markers might mean there is no high suspicion of infection, resulting in lower alignment with this category focused on early intervention actions.",
            "The claim is a general statement indicating a lack of elevated sepsis risk, not specifying any particular physiological change or measurement. Consequently, no explicit expert sepsis category is aligned with this claim, resulting in no alignment."
        ],
        "final_alignment_score": 0.32,
        "accuracy": 1
    },
    {
        "input": "12: HR, 131.0; 12: RR, 26.0; 12: SpO2, 97.0; 12: SBP, 112.0; 12: DBP, 63.0; 12: MAP, 79.333; 12: Pain, 8.0; 12: Temp, 99.1; 16: HR, 130.224; 16: RR, 31.759; 16: SpO2, 96.810; 16: Perf, 2.298; 16: 1min HRV, 2.130; 17: HR, 130.271; 17: RR, 30.661; 17: SpO2, 96.169; 17: Perf, 2.430; 17: 1min HRV, 2.049; 18: HR, 129.879; 18: RR, 29.517; 18: SpO2, 96.328; 18: Perf, 2.537; 18: 1min HRV, 4.819; 19: HR, 129.661; 19: RR, 33.458; 19: SpO2, 97.0; 19: Perf, 2.426; 19: 1min HRV, 3.290; 20: HR, 128.695; 20: RR, 30.390; 20: SpO2, 96.373; 20: Perf, 2.076; 20: 1min HRV, 2.228; 20: 5min HRV, 3.789; 21: HR, 128.810; 21: RR, 30.638; 21: SpO2, 96.931; 21: Perf, 2.043; 21: 1min HRV, 2.866; 22: HR, 127.407; 22: RR, 31.864; 22: SpO2, 96.814; 22: Perf, 1.983; 22: 1min HRV, 2.082; 23: HR, 127.414; 23: RR, 31.052; 23: SpO2, 95.845; 23: Perf, 1.876; 23: 1min HRV, 2.009; 24: POC PH (V) ISTAT, 7.47; 24: POC PO2 (V) ISTAT, 47 mmHg; 24: POC LACTATE ISTAT, 1.31 mmol/L; 24: POC TCO2 (V) ISTAT, 15 mmol/L; 24: POC PCO2 (V) ISTAT, 19.9 mmHg; 24: POC O2 SATURATION ISTAT VENOUS, 87 %; 24: POC BASE EXCESS ISTAT, -9 mmol/L; 24: POC HCO3 (V) ISTAT, 14.4 mmol/L; 24: HR, 127.051; 24: RR, 32.576; 24: SpO2, 96.288; 24: Perf, 2.031; 24: 1min HRV, 2.624; 25: HR, 127.328; 25: RR, 31.345; 25: SpO2, 95.914; 25: Perf, 1.939; 25: 1min HRV, 2.888; 25: 5min HRV, 3.467; 26: HR, 127.407; 26: RR, 26.644; 26: SpO2, 95.593; 26: Perf, 1.900; 26: 1min HRV, 7.509; 27: HR, 127.932; 27: RR, 29.983; 27: SpO2, 95.780; 27: Perf, 1.887; 27: 1min HRV, 3.685; 28: HR, 127.983; 28: RR, 31.793; 28: SpO2, 94.569; 28: Perf, 2.606; 28: 1min HRV, 1.864; 29: HR, 127.542; 29: RR, 29.492; 29: SpO2, 94.0; 29: Perf, 2.147; 29: 1min HRV, 2.224; 30: 5min HRV, 4.540; 67: PROTEIN TOTAL, 7.2 g/dL; 67: ALKALINE PHOSPHATASE, 91 U/L; 67: ALT (SGPT), 13 U/L; 67: EGFR REFIT WITHOUT RACE (2021), 9 mL/min/1.73 m2; 67: CHLORIDE, 99 mmol/L; 67: GLOBULIN, 3.9 g/dL; 67: CO2, 12 mmol/L; 67: AST (SGOT), 14 U/L; 67: SODIUM, 133 mmol/L; 67: BILIRUBIN TOTAL, 0.8 mg/dL; 67: ANION GAP, 22 mmol/L; 67: ALBUMIN, 3.3 g/dL; 67: CALCIUM, 8.9 mg/dL; 67: EGFR FOR AFRICAN AMERICAN, 11 mL/min/1.73 m2; 67: GLUCOSE, 164 mg/dL; 67: CREATININE, 5.68 mg/dL; 67: CORRECTED CALCIUM, 9.5 mg/dL; 67: POTASSIUM, 4.7 mmol/L; 67: BLOOD UREA NITROGEN (BUN), 79 mg/dL; 72: INR, 1.3; 72: PROTHROMBIN TIME, 16.1 seconds; 73: PART. THROMBOPLASTIN TIME, 49.0 seconds; 73: CEFEPIME, 2 GRAM/20 ML IV PUSH; 82: HR:, 113.0; 82: RR, 27.0; 82: SpO2, 97.0; 82: Temp, 102.4; 85: VANCOMYCIN-WATER INJECT (PEG), 1.25 GRAM/250 ML IV PGBK; 86: WAM, DIFTYP: AUTO; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 29.65 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.3 %; 86: RED BLOOD CELLS (RBC), 3.66 MIL/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.0 %; 86: HEMATOCRIT (HCT), 32.2 %; 86: LYMPHOCYTE % (AUTO DIFF), 2.1 %; 86: HEMOGLOBIN (HGB), 10.4 g/dL; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: PLATELET COUNT (PLT), 420 K/uL; 86: MONOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.1 %; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.3 g/dL; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.34 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 94.9 %; 86: WHITE BLOOD CELLS (WBC), 31.2 K/uL; 86: MEAN CORPUSCULAR VOLUME (MCV), 88.0 fL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.8 %; 86: METAMYELOCYTE/MYELOCYTE/PROMYELOCYTE (SLIDE REVIEW), 54 %; 86: LR IV BOLUS -, 30 ML/KG (ED FOR BMI <= 30); 90: HR:, 116.0; 90: RR, 26.0; 90: SpO2, 97.0; 90: SBP, 95.0; 90: DBP, 56.0; 90: MAP, 69.0; 110: HR, 110.0; 110: RR, 29.0; 110: SpO2, 95.0; 110: SBP, 96.0; 110: DBP, 58.0; 110: MAP, 70.667; 0: Age, 73; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 131.0; 0: Triage RR, 26.0; 0: Triage SBP, 112.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,ABDOMINAL PAIN,NAUSEA",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, we assess the initial two hours after ED admission. The patient shows critical indicators: high heart rate (131 bpm), elevated respiration rate (26 breaths/min), and emergent triage acuity, suggesting potential sepsis risk factors. Further, lab results reveal severe acidosis (POC HCO3: 14.4 mmol/L, pH: 7.47), high anion gap (22 mmol/L), and acute kidney injury (BUN: 79 mg/dL, creatinine: 5.68 mg/dL). Additionally, there's leukocytosis (WBC: 31.2 K/uL) with neutrophil dominance (94.9%), signaling a potential infection or inflammatory response. These findings indicate a high risk of sepsis within the next 12 hours.",
        "claims": [
            "We assess the initial two hours after ED admission.",
            "The patient shows critical indicators suggesting potential sepsis risk factors.",
            "The patient's heart rate is 131 bpm.",
            "A heart rate of 131 bpm is considered high.",
            "The patient's respiration rate is 26 breaths/min.",
            "A respiration rate of 26 breaths/min is elevated.",
            "The patient has emergent triage acuity.",
            "Lab results reveal severe acidosis.",
            "The patient\u2019s POC HCO3 level is 14.4 mmol/L.",
            "The patient\u2019s pH level is 7.47.",
            "The lab results indicate a high anion gap of 22 mmol/L.",
            "The patient has acute kidney injury.",
            "The patient's BUN level is 79 mg/dL.",
            "The patient's creatinine level is 5.68 mg/dL.",
            "The patient shows leukocytosis with a WBC count of 31.2 K/uL.",
            "A WBC count of 31.2 K/uL indicates leukocytosis.",
            "There is neutrophil dominance at 94.9%.",
            "Neutrophil dominance suggests a potential infection or inflammatory response.",
            "These findings indicate a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient shows critical indicators suggesting potential sepsis risk factors.",
            "The patient's heart rate is 131 bpm.",
            "A heart rate of 131 bpm is considered high.",
            "The patient's respiration rate is 26 breaths/min.",
            "A respiration rate of 26 breaths/min is elevated.",
            "The patient has emergent triage acuity.",
            "Lab results reveal severe acidosis.",
            "The patient\u2019s POC HCO3 level is 14.4 mmol/L.",
            "The lab results indicate a high anion gap of 22 mmol/L.",
            "The patient has acute kidney injury.",
            "The patient's BUN level is 79 mg/dL.",
            "The patient's creatinine level is 5.68 mg/dL.",
            "The patient shows leukocytosis with a WBC count of 31.2 K/uL.",
            "A WBC count of 31.2 K/uL indicates leukocytosis.",
            "There is neutrophil dominance at 94.9%.",
            "Neutrophil dominance suggests a potential infection or inflammatory response.",
            "These findings indicate a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.8,
            0.8,
            0.9,
            0.3,
            0.7,
            0.3,
            0.3,
            0.8,
            0.5,
            1.0,
            1.0,
            1.0,
            0.7,
            0.7,
            0.4
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim is vague and does not specify any particular indicators or measurements that can be directly aligned with the expert categories. However, the mention of \"critical indicators\" suggesting potential sepsis risk factors could loosely relate to an elevated NEWS score, which considers a range of deranged vitals indicating clinical deterioration compatible with sepsis. The alignment is weak due to the lack of specific information.",
            "A heart rate >90 bpm is one of the SIRS criteria. The patient's heart rate of 131 bpm exceeds this threshold significantly, suggesting systemic inflammation consistent with early sepsis. The alignment is strong, though not exhaustive of the SIRS criteria.",
            "A heart rate greater than 90 bpm is explicitly listed as one of the SIRS criteria, which indicates systemic inflammation consistent with early sepsis. The claim specifies a heart rate of 131 bpm, which is significantly above the threshold. However, SIRS positivity requires the presence of at least two criteria, and the claim only provides information about the heart rate, not supplying enough for perfect alignment with the full SIRS criteria. Nonetheless, the heart rate itself strongly aligns with this category.",
            "The claim indicates that the patient's respiration rate is 26 breaths/min, which exceeds the qSOFA criterion for respiratory rate (\u226522/min). This suggests a high risk of sepsis-related organ dysfunction and mortality. The strong alignment is because one of the specific qSOFA criteria is directly addressed. However, to achieve a full qSOFA score of \u22652, more criteria would need to be met. Thus, the alignment is strong but not complete, leading to a rating of 0.8.",
            "A respiration rate of \u226522 breaths/min is a criterion for a qSOFA score, which identifies patients at increased risk for sepsis-related outcomes. The claim mentions a respiration rate of 26 breaths/min, which directly meets and exceeds the qSOFA threshold. This results in a strong alignment, justifying a high rating of 0.9, as it directly supports one of the parameters evaluated in the qSOFA score.",
            "Emergent triage acuity suggests that the patient's condition is serious and requires immediate attention, potentially including actions like early antibiotics or cultures, which are aspects of this category. However, the claim does not specifically mention the administration of antibiotics or taking cultures, making the alignment indirect and weaker.",
            "Severe acidosis often correlates with elevated serum lactate levels, a marker of tissue hypoperfusion and a high risk for sepsis. While the claim does not explicitly mention lactate levels, severe acidosis is frequently associated with increased lactate. The alignment is substantial, but not perfect, since serum lactate level is not directly stated.",
            "The claim refers to a low bicarbonate (HCO3) level rather than elevated lactate. Low HCO3 can indicate metabolic acidosis, which may be related to sepsis and tissue hypoperfusion, similar to elevated lactate. However, the claim does not directly match the elevated serum lactate category. The alignment is indirect and weak, hence a low rating.",
            "A high anion gap can be associated with conditions that elevate serum lactate, indicating tissue hypoperfusion and risk for sepsis. However, the claim does not directly mention serum lactate levels, which would be required for a direct alignment. Consequently, the alignment is conceptual but not explicit, leading to a low rating.",
            "Acute kidney injury can be reflected in the SOFA score through parameters like elevated creatinine levels or reduced urine output. If severe, this can contribute to an increase in the SOFA score by 2 points or more, indicating new organ dysfunction and increased sepsis risk. The alignment is quite strong, as acute kidney injury is directly relevant to this category.",
            "While blood urea nitrogen (BUN) is not explicitly mentioned in the SOFA criteria, it is often used clinically to assess kidney function alongside creatinine. Elevated BUN can indicate renal dysfunction, which is related to kidney-based components within the SOFA scoring system. Therefore, the claim indirectly aligns with the SOFA category, though the connection is not as direct as creatinine measurements.",
            "An elevated creatinine level, like 5.68 mg/dL, is explicitly stated in the SOFA components as indicative of new organ dysfunction (with a threshold of >2 mg/dL). This confirms a high risk of sepsis, showing perfect alignment with this category.",
            "The claim directly references an elevated white blood cell count, which is one of the criteria used to identify SIRS. A WBC count over 12,000/\u00b5L is a positive SIRS criterion used to identify systemic inflammation linked to early sepsis. Since a WBC count of 31.2 K/uL clearly meets this criterion, the alignment is direct and complete, thereby justifying a perfect alignment rating.",
            "An elevated white blood cell (WBC) count is explicitly one of the criteria under SIRS (Systemic Inflammatory Response Syndrome), which involves WBC > 12\u202f000/\u00b5L. The claim of leukocytosis directly aligns with the SIRS criteria used to detect systemic inflammation associated with early sepsis. This alignment is perfect as it meets one of the SIRS criteria.",
            "Neutrophil dominance is indicative of a significant inflammatory response, which is related to the systemic inflammation seen in sepsis and is a component often reflected in elevated white blood cell counts. Although neutrophil dominance itself is not explicitly stated within the SIRS criteria, it is a close marker of systemic inflammation related to infections. Therefore, it aligns with the concept of SIRS, albeit not as directly as specifically listed criteria like elevated WBCs or temperature changes.",
            "Neutrophil dominance indicates an active inflammatory response, which is conceptually aligned with systemic inflammation as captured by the SIRS criteria. While neutrophil dominance itself isn't explicitly listed as a SIRS criterion, it is closely related to elevated white blood cell count\u2014a direct SIRS criterion. Therefore, the alignment is strong but not absolute.",
            "The claim mentions a \"high risk of sepsis within the next 12 hours,\" which aligns loosely with what an elevated NEWS Score predicts\u2014imminent clinical deterioration compatible with sepsis. However, the claim is fairly vague and generic across multiple sepsis indicators without specifying elevated NEWS or any particular vital signs. Thus, the alignment is partial but indirect."
        ],
        "final_alignment_score": 0.6647058823529413,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 97.0; 2: SBP, 206.0; 2: DBP, 115.0; 2: MAP, 145.333; 3: SpO2, 97.185; 4: SpO2, 97.019; 4: Perf, 0.720; 5: SpO2, 97.491; 5: Perf, 0.742; 6: SpO2, 97.208; 6: Perf, 0.717; 7: SpO2, 98.0; 7: Perf, 0.701; 8: HR, 103.0; 8: RR, 18.0; 8: SpO2, 97.623; 8: Perf, 0.68; 8: SBP, 206.0; 8: DBP, 115.0; 8: MAP, 145.333; 8: Pain, 10.0; 9: SpO2, 97.615; 9: Perf, 0.680; 10: SpO2, 97.604; 10: Perf, 0.69; 11: SpO2, 98.0; 11: Perf, 0.772; 12: SpO2, 97.830; 12: Perf, 0.758; 13: SpO2, 97.566; 13: Perf, 0.740; 14: SpO2, 98.154; 14: Perf, 0.769; 15: SpO2, 98.189; 15: Perf, 0.763; 16: SpO2, 97.846; 16: Perf, 0.704; 17: SpO2, 97.283; 17: Perf, 0.726; 18: SpO2, 97.0; 18: Perf, 0.831; 19: SpO2, 97.242; 20: SpO2, 97.115; 20: Perf, 0.737; 21: SpO2, 96.923; 21: Perf, 0.927; 22: SpO2, 97.0; 23: SpO2, 97.586; 23: Perf, 1.114; 24: HR, 100.0; 24: RR, 18.0; 24: SpO2, 94.111; 24: SBP, 197.0; 24: DBP, 103.0; 24: MAP, 134.333; 25: SpO2, 97.0; 25: SBP, 197.0; 25: DBP, 103.0; 25: MAP, 134.333; 27: SpO2, 97.364; 28: SpO2, 97.623; 28: Perf, 1.001; 29: SpO2, 97.0; 29: Perf, 1.053; 31: SpO2, 88.0; 33: WAM DIFTYP, AUTO; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.39 K/uL; 33: LYMPHOCYTE % (AUTO DIFF), 14.0 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.18 K/uL; 33: MEAN CORPUSCULAR VOLUME (MCV), 99.5 fL; 33: BASOPHIL % (AUTO DIFF), 0.2 %; 33: PLATELET COUNT (PLT), 376 K/uL; 33: MONOCYTE % (AUTO DIFF), 7.3 %; 33: HEMOGLOBIN (HGB), 12.5 g/dL; 33: HEMATOCRIT (HCT), 39.4 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 33: NEUTROPHIL % (AUTO DIFF), 77.1 %; 33: RED CELL DISTRIBUTION WIDTH (RDW), 14.2 %; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.98 K/uL; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.89 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 0.1 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 33: WHITE BLOOD CELLS (WBC), 13.5 K/uL; 33: RED BLOOD CELLS (RBC), 3.96 MIL/uL; 33: SpO2, 94.0; 34: ACETAMINOPHEN, 325 MG PO TABS; 35: SpO, 2: 97.917; 36: SpO2, 97.308; 36: Perf, 0.873; 36: AMPICILLIN-SULBACTAM, 3 GRAM/100 ML MINIBAG PLUS; 37: SpO, 2: 97.170; 37: Perf, 0.920; 38: SpO2, 97.0; 38: Perf, 0.895; 39: SpO2, 97.0; 39: Perf, 0.892; 40: SpO2, 97.0; 40: Perf, 0.86; 41: SpO2, 97.0; 41: Perf, 0.827; 42: SpO2, 97.744; 43: SpO2, 98.0; 43: Perf, 0.891; 44: SpO2, 97.588; 44: Perf, 1.045; 45: SpO2, 97.0; 45: Perf, 0.975; 46: SpO2, 96.731; 46: Perf, 1.045; 47: SpO2, 96.302; 47: Perf, 1.191; 48: SpO2, 96.654; 48: Perf, 1.225; 49: SpO2, 97.0; 49: Perf, 1.303; 50: SpO2, 97.0; 50: Perf, 1.328; 51: SpO2, 97.0; 51: Perf, 1.327; 52: SpO2, 97.0; 52: Perf, 1.391; 53: SpO2, 97.0; 53: Perf, 1.318; 54: SpO2, 96.868; 54: Perf, 1.406; 55: SpO2, 96.0; 55: Perf, 1.390; 56: SpO2, 96.226; 56: Perf, 1.419; 57: SpO2, 96.327; 57: Perf, 1.422; 58: SpO2, 96.0; 58: Perf, 1.384; 59: SpO2, 95.774; 59: Perf, 1.254; 60: SpO2, 96.096; 60: Perf, 1.303; 61: SpO2, 96.264; 61: Perf, 1.389; 62: SpO2, 96.0; 62: Perf, 1.226; 63: SpO2, 95.340; 63: Perf, 1.125; 64: SpO2, 96.962; 64: Perf, 1.310; 65: SpO2, 97.0; 65: Perf, 1.818; 66: AST (SGOT), 33 U/L; 66: GLUCOSE, 102 mg/dL; 66: ALBUMIN, 4.3 g/dL; 66: PROTEIN TOTAL, 7.3 g/dL; 66: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 66: BILIRUBIN TOTAL, 1.5 mg/dL; 66: EGFR FOR AFRICAN AMERICAN, 78 mL/min/1.73 m2; 66: SODIUM, 138 mmol/L; 66: CREATININE, 0.76 mg/dL; 66: GLOBULIN, 3.0 g/dL; 66: EGFR REFIT WITHOUT RACE (2021), 67 mL/min/1.73 m2; 66: ALKALINE PHOSPHATASE, 150 U/L; 66: ANION GAP, 13 mmol/L; 66: CO2, 23 mmol/L; 66: CALCIUM, 9.4 mg/dL; 66: CHLORIDE, 102 mmol/L; 66: CORRECTED CALCIUM, 9.2 mg/dL; 66: POTASSIUM, 4.3 mmol/L; 66: ALT (SGPT), 28 U/L; 66: SpO2, 96.943; 66: Perf, 1.860; 67: SpO2, 96.827; 67: Perf, 1.841; 68: SpO2, 96.0; 68: Perf, 1.759; 69: SpO2, 96.113; 69: Perf, 1.695; 70: SpO2, 95.951; 70: Perf, 1.700; 71: SpO2, 96.0; 71: Perf, 1.540; 72: SpO2, 96.173; 72: Perf, 1.488; 73: SpO2, 96.0; 73: Perf, 1.600; 74: SpO2, 95.151; 74: Perf, 1.457; 75: SpO2, 95.904; 75: Perf, 1.517; 76: SpO2, 95.925; 76: Perf, 1.477; 77: SpO2, 95.058; 77: Perf, 1.363; 78: SpO2, 96.0; 78: Perf, 1.658; 79: SpO2, 95.642; 79: Perf, 1.595; 80: SpO2, 95.327; 80: Perf, 1.426; 81: SpO2, 95.226; 81: Perf, 1.360; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 95.0; 82: Perf, 1.314; 83: SpO2, 94.509; 83: Perf, 1.301; 84: SpO2, 94.538; 84: Perf, 1.324; 85: SpO2, 94.725; 85: Perf, 1.390; 104: SpO2, 96.365; 104: Perf, 1.140; 105: SpO2, 96.0; 105: Perf, 1.179; 106: SpO2, 96.0; 106: Perf, 1.165; 107: SpO2, 96.0; 108: SpO2, 96.721; 108: Perf, 1.267; 109: SpO2, 96.635; 109: Perf, 1.278; 110: SpO2, 96.245; 110: Perf, 1.290; 111: SpO2, 96.0; 111: Perf, 1.262; 112: SpO2, 96.282; 112: Perf, 1.303; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 113: SpO, 2: 97.0; 113: Perf, 1.497; 114: SpO2, 97.0; 114: Perf, 1.674; 115: SpO2, 97.189; 115: Perf, 1.635; 116: SpO2, 96.942; 116: Perf, 1.490; 117: SpO2, 97.377; 117: Perf, 1.634; 118: SpO2, 97.226; 118: Perf, 1.614; 119: SpO2, 96.635; 119: Perf, 1.432; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.4; 0: Triage HR, 103.0; 0: Triage RR, 18.0; 0: Triage SBP, 206.0; 0: Triage DBP, 115.0; 0: Triage acuity, 3-Urgent; 0: CC, JAW SWELLING",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, identify significant factors associated with sepsis risk: fever, tachycardia, high respiratory rate, hypotension, changes in mental status, and elevated white blood cell count. The patient is a 90-year-old female with elevated blood pressure (Triage SBP: 206) and heart rate (Triage HR: 103) suggesting hypertension and tachycardia. Although her SpO2 levels decrease slightly and fluctuate, they generally remain above 95%. Labs show elevated white blood cells (WBC: 13.5 K/uL) but not at critically high levels. There is no fever or hypotension. The administration of antibiotics could indicate concern, but overall, she seems stable without severe sepsis indicators: thus, the label remains No at this time.",
        "claims": [
            "Significant factors associated with sepsis risk include fever, tachycardia, high respiratory rate, hypotension, changes in mental status, and elevated white blood cell count.",
            "The patient is a 90-year-old female.",
            "The patient has elevated blood pressure with a triage systolic blood pressure of 206.",
            "The patient has an elevated heart rate with a triage heart rate of 103.",
            "The elevated blood pressure suggests hypertension.",
            "The elevated heart rate suggests tachycardia.",
            "The patient's SpO2 levels decrease slightly and fluctuate.",
            "The patient's SpO2 levels generally remain above 95%.",
            "Lab results show elevated white blood cells with a count of 13.5 K/uL.",
            "The elevated white blood cell count is not at critically high levels.",
            "The patient does not have a fever.",
            "The patient does not have hypotension.",
            "The administration of antibiotics could indicate concern for sepsis.",
            "Overall, the patient appears stable without severe sepsis indicators.",
            "The sepsis risk label for the patient remains No at this time."
        ],
        "relevant_claims": [
            "The patient has elevated blood pressure with a triage systolic blood pressure of 206.",
            "The elevated heart rate suggests tachycardia.",
            "Lab results show elevated white blood cells with a count of 13.5 K/uL.",
            "The patient does not have a fever.",
            "The patient does not have hypotension.",
            "The administration of antibiotics could indicate concern for sepsis."
        ],
        "alignment_scores": [
            0.2,
            0.8,
            1.0,
            0.3,
            0.3,
            0.8
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "Elevated blood pressure (specifically systolic blood pressure) does not align directly with any given categories as a risk factor for sepsis. High blood pressure may indirectly relate if the heart rate is elevated and contributes to the shock index, but the claim does not provide the heart rate needed to calculate the shock index. The alignment is minimal and indirect, hence the low rating.",
            "Tachycardia, or an elevated heart rate, is a specific criterion within the SIRS criteria (heart rate > 90 bpm). Although the claim doesn't specify whether the full SIRS criteria are met, the mention of tachycardia is directly relevant to SIRS Positivity, showing a strong but not complete alignment.",
            "The claim states that the patient has elevated white blood cells with a count greater than 12,000/\u00b5L, which directly aligns with one of the SIRS criteria for identifying systemic inflammation consistent with early sepsis. Therefore, the alignment is perfect.",
            "The absence of fever is relevant because fever is one of the SIRS criteria (>38\u00b0C) for systemic inflammation in early sepsis. While the claim about not having a fever does not indicate positivity for SIRS, it relates indirectly to assessing the presence or absence of SIRS criteria. The alignment is weak because it directly indicates the absence of one of the criteria rather than the presence of SIRS.",
            "The claim directly mentions the absence of hypotension, which is part of the criteria for sepsis-associated hypotension. While this does not align with identifying a risk of sepsis, hypotension is a referenced criterion. The alignment is based on the negation of a condition within the category, making the relevance weak.",
            "The administration of antibiotics indicates suspicion of a serious infection, which aligns closely with the category focusing on early antibiotic or culture orders within 2 hours as a marker for sepsis risk assessment. While the claim does not specify the timing or urgency in the context of 2 hours, the close association with clinical suspicion of infection justifies a high alignment score."
        ],
        "final_alignment_score": 0.5666666666666665,
        "accuracy": 1
    },
    {
        "input": "4: HR, 106.0; 4: RR, 18.0; 4: SpO2, 95.0; 4: SBP, 118.0; 4: DBP, 57.0; 4: MAP, 77.333; 4: Temp, 100.6; 11: Pain, 10.0; 78: INFLUENZA B, Not Detected; 78: RSV, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 86: WAM DIFTYP, AUTO; 86: MONOCYTE % (AUTO DIFF), 3.2 %; 86: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 86: NRBC PERCENT (HEMATOLOGY), 0.0 %; 86: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.37 K/uL; 86: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.89 K/uL; 86: BASOPHIL % (AUTO DIFF), 0.2 %; 86: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 86: NEUTROPHIL % (AUTO DIFF), 93.9 %; 86: HEMOGLOBIN (HGB), 12.1 g/dL; 86: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 86: RED CELL DISTRIBUTION WIDTH (RDW), 14.1 %; 86: PLATELET COUNT (PLT), 296 K/uL; 86: EOSINOPHIL % (AUTO DIFF), 0.1 %; 86: MEAN CORPUSCULAR VOLUME (MCV), 83.9 fL; 86: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 86: LYMPHOCYTE % (AUTO DIFF), 1.6 %; 86: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.23 K/uL; 86: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 86: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 86: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.9 pg; 86: HEMATOCRIT (HCT), 36.4 %; 86: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 86: RED BLOOD CELLS (RBC), 4.34 MIL/uL; 89: SpO2, 96.0; 89: Perf, 4.079; 90: AST (SGOT), 114 U/L; 90: PROTEIN TOTAL, 6.9 g/dL; 90: ALT (SGPT), 110 U/L; 90: CREATININE, 0.54 mg/dL; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.6 mg/dL; 90: ALBUMIN, 4.0 g/dL; 90: ALKALINE PHOSPHATASE, 96 U/L; 90: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 90: POTASSIUM, 3.9 mmol/L; 90: CHLORIDE, 101 mmol/L; 90: GLUCOSE, 133 mg/dL; 90: SODIUM, 137 mmol/L; 90: ANION GAP, 15 mmol/L; 90: CO2, 21 mmol/L; 90: CORRECTED CALCIUM, 9.4 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 101 mL/min/1.73 m2; 90: CALCIUM, 9.4 mg/dL; 90: HR, 84.517; 90: RR, 21.292; 90: SpO2, 95.458; 90: Perf, 4.041; 90: 1min HRV, 10.199; 91: HR, 83.949; 91: RR, 23.932; 91: SpO2, 95.590; 91: Perf, 3.659; 91: 1min HRV, 11.842; 91: 5min HRV, 11.409; 91: SBP, 116.0; 91: DBP, 50.0; 91: MAP, 72.0; 92: HR, 83.879; 92: RR, 27.276; 92: SpO2, 94.408; 92: Perf, 4.016; 92: 1min HRV, 9.479; 93: HR, 83.644; 93: RR, 26.017; 93: SpO2, 95.0; 93: Perf, 5.217; 93: 1min HRV, 10.131; 94: HR, 85.362; 94: RR, 23.397; 94: SpO2, 94.207; 94: Perf, 5.130; 94: 1min HRV, 10.629; 95: HR, 85.017; 95: RR, 22.847; 95: SpO2, 93.881; 95: Perf, 5.692; 95: 1min HRV, 11.154; 96: HR, 86.103; 96: RR, 22.017; 96: SpO2, 93.172; 96: Perf, 6.053; 96: 1min HRV, 6.565; 96: 5min HRV, 12.675; 97: HR, 88.797; 97: RR, 23.356; 97: SpO2, 91.763; 97: Perf, 5.578; 97: 1min HRV, 7.669; 98: HR, 88.475; 98: RR, 24.407; 98: SpO2, 92.407; 98: Perf, 5.426; 98: 1min HRV, 9.469; 99: HR, 89.207; 99: RR, 25.948; 99: SpO2, 92.172; 99: Perf, 5.348; 99: 1min HRV, 6.386; 100: HR, 86.966; 100: RR, 25.237; 100: SpO2, 92.068; 100: Perf, 5.777; 100: 1min HRV, 9.830; 101: HR, 86.914; 101: RR, 23.397; 101: SpO2, 94.155; 101: Perf, 6.101; 101: 1min HRV, 9.211; 101: 5min HRV, 11.822; 102: HR, 86.542; 102: RR, 24.0; 102: SpO2, 92.156; 102: Perf, 5.225; 102: 1min HRV, 5.188; 102: SBP, 110.0; 102: DBP, 58.0; 102: MAP, 75.333; 103: HR, 87.780; 103: RR, 23.678; 103: SpO2, 91.780; 103: Perf, 4.880; 103: 1min HRV, 7.196; 104: HR, 87.845; 104: RR, 25.397; 104: SpO2, 91.707; 104: Perf, 4.783; 104: 1min HRV, 8.222; 105: HR, 88.525; 105: RR, 26.814; 105: SpO2, 92.051; 105: Perf, 4.338; 105: 1min HRV, 7.789; 106: HIGH SENSITIVITY TROPONIN, 4 ng/L; 106: HR, 88.931; 106: RR, 25.759; 106: SpO2, 92.517; 106: Perf, 4.301; 106: 1min HRV, 8.454; 106: 5min HRV, 10.096; 107: HR, 88.847; 107: RR, 28.763; 107: SpO2, 92.712; 107: Perf, 4.237; 107: 1min HRV, 8.968; 108: HR, 88.322; 108: RR, 27.695; 108: SpO2, 94.831; 108: Perf, 4.0; 108: 1min HRV, 12.599; 109: HR, 88.897; 109: RR, 25.276; 109: SpO2, 96.0; 109: Perf, 4.164; 109: 1min HRV, 19.491; 110: HR, 86.797; 110: RR, 25.288; 110: SpO2, 96.0; 110: Perf, 4.062; 110: 1min HRV, 18.006; 111: HR, 85.241; 111: RR, 25.534; 111: SpO2, 95.534; 111: Perf, 4.561; 111: 1min HRV, 11.685; 111: 5min HRV, 18.796; 112: HR, 86.254; 112: RR, 25.847; 112: SpO2, 95.0; 112: Perf, 4.068; 112: 1min HRV, 14.892; 113: HR, 85.492; 113: RR, 26.373; 113: SpO2, 94.492; 113: Perf, 4.149; 113: 1min HRV, 12.022; 114: HR, 85.155; 114: RR, 23.362; 114: SpO2, 94.759; 114: Perf, 4.107; 114: 1min HRV, 17.338; 114: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 115: HR:, 85.966; 115: RR, 25.119; 115: SpO2, 94.932; 115: Perf, 3.909; 115: 1min HRV, 18.567; 115: SBP, 110.0; 115: DBP, 58.0; 115: MAP, 75.333; 115: Pain, 10.0; 116: HR, 94.586; 116: RR, 23.483; 116: SpO2, 95.224; 116: Perf, 2.791; 116: 1min HRV, 9.841; 116: 5min HRV, 32.305; 117: HR, 93.407; 117: RR, 20.458; 117: SpO2, 95.912; 117: Perf, 2.549; 117: 1min HRV, 28.365; 117: SBP, 132.0; 117: DBP, 60.0; 117: MAP, 84.0; 118: HR, 85.695; 118: RR, 26.695; 118: SpO2, 96.424; 118: Perf, 3.112; 118: 1min HRV, 16.910; 119: HR, 88.931; 119: RR, 22.603; 119: SpO2, 97.362; 119: Perf, 4.151; 119: 1min HRV, 14.827; 0: Age, 68; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 118.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess sepsis risk, consider the initial clinical presentation and vital signs. The patient shows tachycardia (high HR), slightly elevated temperature, and low diastolic blood pressure (DBP), which are potential signs of infection and sepsis risk. Additionally, the white blood cell (WBC) count is significantly elevated at 23.3 K/uL, which supports the likelihood of an ongoing infection. CEFTRIAXONE, an antibiotic, is administered, indicating suspicion of a bacterial infection. Despite some stable measures later in the records, the overall risk factors present early on indicate that the patient is at high risk for developing sepsis within 12 hours.",
        "claims": [
            "To assess sepsis risk, consider the initial clinical presentation and vital signs.",
            "The patient shows tachycardia (high HR).",
            "Tachycardia is a potential sign of infection and sepsis risk.",
            "The patient has a slightly elevated temperature.",
            "A slightly elevated temperature is a potential sign of infection and sepsis risk.",
            "The patient has low diastolic blood pressure (DBP).",
            "Low diastolic blood pressure is a potential sign of infection and sepsis risk.",
            "The white blood cell (WBC) count is significantly elevated at 23.3 K/uL.",
            "An elevated WBC count supports the likelihood of an ongoing infection.",
            "CEFTRIAXONE, an antibiotic, is administered.",
            "The administration of CEFTRIAXONE indicates suspicion of a bacterial infection.",
            "Some stable measures are present later in the records.",
            "The overall risk factors present early on indicate that the patient is at high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "To assess sepsis risk, consider the initial clinical presentation and vital signs.",
            "The patient shows tachycardia (high HR).",
            "Tachycardia is a potential sign of infection and sepsis risk.",
            "The patient has a slightly elevated temperature.",
            "A slightly elevated temperature is a potential sign of infection and sepsis risk.",
            "Low diastolic blood pressure is a potential sign of infection and sepsis risk.",
            "The white blood cell (WBC) count is significantly elevated at 23.3 K/uL.",
            "An elevated WBC count supports the likelihood of an ongoing infection.",
            "CEFTRIAXONE, an antibiotic, is administered.",
            "The administration of CEFTRIAXONE indicates suspicion of a bacterial infection.",
            "The overall risk factors present early on indicate that the patient is at high risk for developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.8,
            0.3,
            0.5,
            0.7,
            1.0,
            1.0,
            1.0,
            0.8,
            0.4
        ],
        "alignment_category": [
            "AElevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim mentions the importance of initial clinical presentation and vital signs in assessing sepsis risk. While it does not provide specific details that match exactly with the NEWS score criteria, the general focus on vital signs suggests some relevance to a system like NEWS that derives its score from deranged vitals. However, the connection is quite indirect as no specific vital sign threshold or derangement is mentioned, resulting in a low alignment rating.",
            "Tachycardia, or high heart rate (>90 bpm), is one of the specific criteria under the SIRS (Systemic Inflammatory Response Syndrome) category. The presence of tachycardia aligns with the SIRS criteria used to identify systemic inflammation potentially indicative of early sepsis. The alignment is strong but not complete, as the SIRS categorization requires at least two criteria; however, tachycardia is a concrete indicator within this framework.",
            "Tachycardia, defined as a heart rate >90 bpm, is directly included as one of the criteria for Systemic Inflammatory Response Syndrome (SIRS), which is used to identify systemic inflammation consistent with early sepsis. The claim specifically refers to tachycardia in the context of infection and sepsis risk, aligning it strongly with SIRS criteria. However, because the claim mentions only one criterion out of the \u22652 needed for full SIRS positivity, the alignment is not perfect, resulting in a slightly lower rating.",
            "The claim mentions a slightly elevated temperature, which is relevant to one of the SIRS criteria temperature thresholds (>38\u00b0C). However, \"slightly elevated\" suggests that it does not meet the explicit criteria for SIRS, indicating only a marginal link to systemic inflammation in early sepsis. Therefore, the alignment is weak.",
            "The mention of a slightly elevated temperature suggests an inflammatory or infectious process, which is a component of the SIRS criteria for identifying early sepsis. However, since the temperature is only slightly elevated, it might not meet the exact threshold of >38\u00b0C specified in the SIRS criteria. Thus, while the connection is relevant, it is not strong enough to warrant a full alignment, resulting in a moderate rating.",
            "The claim addresses low blood pressure as a potential sign of sepsis risk. While diastolic blood pressure specifically isn't explicitly mentioned, blood pressure is a primary component of assessing sepsis-associated hypotension, which includes measures like systolic blood pressure (SBP) and mean arterial pressure (MAP). The alignment is significant because hypotension (low blood pressure) is a known indicator of sepsis progression towards septic shock, even though the focus on diastolic pressure alone may not be fully comprehensive according to the given criteria.",
            "An elevated white blood cell (WBC) count is explicitly one of the criteria for SIRS. The WBC count of 23.3 K/uL is well above the threshold (>12,000/\u00b5L) for diagnosing systemic inflammation consistent with early sepsis. Therefore, the alignment with the SIRS category is direct and complete.",
            "An elevated white blood cell (WBC) count is explicitly part of the SIRS criteria, which helps identify systemic inflammation consistent with early sepsis. Thus, the claim perfectly aligns with this category, indicating a high risk of sepsis due to systemic inflammation.",
            "The administration of the antibiotic Ceftriaxone directly signifies a clinician's suspicion of a serious infection and aligns perfectly with the category of taking early action with antibiotics or blood cultures as part of sepsis risk assessment.",
            "The administration of Ceftriaxone, a broad-spectrum antibiotic, suggests a clinician's suspicion of a serious bacterial infection and aligns with the category of early administration of broad-spectrum antibiotics. This action is directly relevant to the category, although the timing within the first 2 hours is not explicitly mentioned in the claim, hence the slightly less than perfect alignment rating.",
            "The claim refers to \"overall risk factors\" suggesting a consolidated assessment, which is conceptually similar to how NEWS scores compile various vital signs to assess risk. However, without specific mention of NEWS criteria or scores, the alignment is indirect and limited. Thus, while it hints at a general assessment of deterioration risk, it lacks precise alignment, justifying a moderate rating."
        ],
        "final_alignment_score": 0.6909090909090909,
        "accuracy": 1
    },
    {
        "input": "5: HR, 89.0; 5: RR, 26.0; 5: SpO2, 99.422; 5: SBP, 134.0; 5: DBP, 89.0; 5: MAP, 104.0; 5: Temp, 98.0; 6: HR, 82.0; 6: RR, 25.0; 6: SpO2, 100.0; 6: Perf, 1.743; 6: 1min HRV, 8.815; 7: HR, 82.441; 7: RR, 24.983; 7: SpO2, 100.0; 7: Perf, 1.750; 7: 1min HRV, 13.853; 8: HR, 87.914; 8: RR, 19.672; 8: SpO2, 100.0; 8: Perf, 1.710; 8: 1min HRV, 19.853; 9: HR, 87.593; 9: RR, 24.797; 9: SpO2, 100.0; 9: Perf, 1.685; 9: 1min HRV, 11.920; 10: HR, 86.186; 10: RR, 20.915; 10: SpO2, 100.0; 10: Perf, 1.863; 10: 1min HRV, 15.067; 10: 5min HRV, 23.610; 11: HR, 82.586; 11: RR, 28.431; 11: SpO2, 100.0; 11: Perf, 2.261; 11: 1min HRV, 49.671; 12: HR, 84.254; 12: RR, 25.051; 12: SpO2, 100.0; 12: Perf, 2.640; 12: 1min HRV, 23.906; 13: HR, 82.707; 13: RR, 27.845; 13: SpO2, 100.0; 13: Perf, 2.562; 13: 1min HRV, 14.888; 14: HR, 83.051; 14: RR, 23.678; 14: SpO2, 100.0; 14: Perf, 2.033; 14: 1min HRV, 64.432; 15: HR, 81.288; 15: RR, 24.712; 15: SpO2, 100.0; 15: Perf, 1.790; 15: 1min HRV, 14.575; 15: 5min HRV, 40.136; 15: SBP, 127.0; 15: DBP, 77.0; 15: MAP, 93.667; 16: HR, 81.0; 16: RR, 24.5; 16: SpO2, 100.0; 16: Perf, 1.82; 16: 1min HRV, 0.0; 18: POC PH (V) ISTAT, 7.29; 18: POC PO2 (V) ISTAT, 19 mmHg; 18: POC PCO2 (V) ISTAT, 68.2 mmHg; 18: POC LACTATE ISTAT, 0.77 mmol/L; 18: POC HCO3 (V) ISTAT, 33.0 mmol/L; 18: POC TCO2 (V) ISTAT, 35 mmol/L; 18: POC BASE EXCESS ISTAT, 6 mmol/L; 18: POC O2 SATURATION ISTAT VENOUS, 22 %; 20: HR, 83.0; 20: RR, 27.0; 20: SpO2, 100.0; 20: 5min HRV, 0.0; 20: SBP, 132.0; 20: DBP, 77.0; 20: MAP, 95.333; 23: HR, 81.0; 23: RR, 22.0; 23: SpO2, 100.0; 23: SBP, 132.0; 23: DBP, 77.0; 23: MAP, 95.333; 23: LPM O2, 15.0; 24: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 25: HR:, 85.0; 25: RR, 27.0; 25: SpO2, 100.0; 59: ALBUTEROL SULFATE, 90 MCG/ACTUATION INH HFAA; 66: RR:, 25.0; 66: SpO2, 100.0; 66: LPM O2, 12.0; 80: HR, 81.0; 80: RR, 23.0; 80: SpO2, 100.0; 80: LPM O2, 3.0; 90: INR, 1.1; 90: PROTHROMBIN TIME, 13.6 seconds; 91: PART. THROMBOPLASTIN TIME, 29.2 seconds; 99: WAM DIFTYP, AUTO; 99: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 99: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.43 K/uL; 99: MEAN CORPUSCULAR VOLUME (MCV), 95.1 fL; 99: RED CELL DISTRIBUTION WIDTH (RDW), 13.6 %; 99: EOSINOPHIL % (AUTO DIFF), 2.0 %; 99: PLATELET COUNT (PLT), 136 K/uL; 99: MONOCYTE ABSOLUTE (AUTO DIFF), 0.87 K/uL; 99: MONOCYTE % (AUTO DIFF), 9.3 %; 99: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 99: HEMOGLOBIN (HGB), 14.2 g/dL; 99: BASOPHIL % (AUTO DIFF), 0.4 %; 99: NEUTROPHIL % (AUTO DIFF), 58.2 %; 99: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 99: LYMPHOCYTE % (AUTO DIFF), 29.8 %; 99: WHITE BLOOD CELLS (WBC), 9.3 K/uL; 99: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.78 K/uL; 99: NRBC PERCENT (HEMATOLOGY), 0.0 %; 99: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 99: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.19 K/uL; 99: HEMATOCRIT (HCT), 44.3 %; 99: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 99: RED BLOOD CELLS (RBC), 4.66 MIL/uL; 99: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 105: D-DIMER ELISA, 522 ng/mL FEU; 105: HR, 82.0; 105: RR, 20.0; 105: SpO2, 100.0; 105: SBP, 119.0; 105: DBP, 74.0; 105: MAP, 89.0; 105: LPM O2, 3.0; 107: POTASSIUM, 3.9 mmol/L; 107: ALT (SGPT), 23 U/L; 107: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 107: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 107: EGFR FOR AFRICAN AMERICAN, 106 mL/min/1.73 m2; 107: GLOBULIN, 2.6 g/dL; 107: ANION GAP, 9 mmol/L; 107: SODIUM, 144 mmol/L; 107: BILIRUBIN TOTAL, 0.6 mg/dL; 107: MAGNESIUM, 2.1 mg/dL; 107: AST (SGOT), 25 U/L; 107: CALCIUM, 9.0 mg/dL; 107: ALBUMIN, 4.4 g/dL; 107: CORRECTED CALCIUM, 8.7 mg/dL; 107: ALKALINE PHOSPHATASE, 65 U/L; 107: CREATININE, 0.88 mg/dL; 107: CHLORIDE, 103 mmol/L; 107: PROTEIN TOTAL, 7.0 g/dL; 107: GLUCOSE, 128 mg/dL; 107: CO2, 32 mmol/L; 107: HR, 70.55; 107: RR, 20.2; 107: SpO2, 98.0; 107: 1min HRV, 16.197; 108: HR, 69.717; 108: RR, 21.483; 108: SpO2, 98.45; 108: Perf, 10.850; 108: 1min HRV, 18.305; 108: SBP, 162.0; 108: DBP, 70.0; 108: MAP, 100.667; 109: HR, 70.741; 109: RR, 23.603; 109: SpO2, 98.0; 109: Perf, 10.095; 109: 1min HRV, 14.727; 110: HR, 70.525; 110: RR, 23.678; 110: SpO2, 97.729; 110: Perf, 10.250; 110: 1min HRV, 18.191; 110: 5min HRV, 17.916; 111: HR, 69.593; 111: RR, 21.678; 111: SpO2, 98.0; 111: Perf, 11.894; 111: 1min HRV, 17.194; 112: HR, 68.845; 112: RR, 22.069; 112: SpO2, 98.172; 112: Perf, 11.066; 112: 1min HRV, 18.784; 113: HR, 68.932; 113: RR, 23.898; 113: SpO2, 98.0; 113: Perf, 11.114; 113: 1min HRV, 17.758; 114: HR, 68.983; 114: RR, 19.983; 114: SpO2, 98.034; 114: Perf, 9.912; 114: 1min HRV, 17.644; 115: HR, 68.881; 115: RR, 21.441; 115: SpO2, 98.0; 115: Perf, 10.051; 115: 1min HRV, 14.015; 115: 5min HRV, 17.415; 116: HR, 67.797; 116: RR, 21.915; 116: SpO2, 97.881; 116: Perf, 10.571; 116: 1min HRV, 19.510; 117: HR, 68.259; 117: RR, 23.586; 117: SpO2, 98.0; 117: Perf, 10.108; 117: 1min HRV, 37.164; 118: HR, 68.525; 118: RR, 23.627; 118: SpO2, 98.0; 118: Perf, 9.978; 118: 1min HRV, 14.901; 119: HR, 68.138; 119: RR, 17.828; 119: SpO2, 98.362; 119: Perf, 9.379; 119: 1min HRV, 11.541; 0: Age, 64; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 89.0; 0: Triage RR, 26.0; 0: Triage SBP, 134.0; 0: Triage DBP, 89.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess the risk of sepsis, the first subquestion is whether vital signs and laboratory results show signs of potential infection or systemic inflammatory response. The patient's heart rate, respiratory rate, and blood pressure are stable, while temperature remains normal, suggesting no current fever. Blood tests, including lactate (0.77 mmol/L) and white blood cell count (9.3 K/uL), are within normal ranges, and there are no significant abnormalities in coagulation parameters or high D-dimer that would suggest possible sepsis. Despite the patient's initial complaint of shortness of breath, the consistent oxygen saturation and overall stable clinical picture suggest a low risk of developing sepsis within 12 hours.",
        "claims": [
            "To assess the risk of sepsis, it is important to examine vital signs and laboratory results for signs of potential infection or systemic inflammatory response.",
            "The patient's heart rate is stable.",
            "The patient's respiratory rate is stable.",
            "The patient's blood pressure is stable.",
            "The patient's temperature remains normal, suggesting no current fever.",
            "Blood tests show a lactate level of 0.77 mmol/L.",
            "A lactate level of 0.77 mmol/L is within normal ranges.",
            "The white blood cell count is 9.3 K/uL.",
            "A white blood cell count of 9.3 K/uL is within normal ranges.",
            "There are no significant abnormalities in coagulation parameters.",
            "There is no high D-dimer that would suggest possible sepsis.",
            "The patient initially complained of shortness of breath.",
            "The patient's oxygen saturation is consistent.",
            "The overall clinical picture is stable.",
            "These factors suggest a low risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's temperature remains normal, suggesting no current fever.",
            "A lactate level of 0.77 mmol/L is within normal ranges."
        ],
        "alignment_scores": [
            0.3,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "Normal temperature suggests the absence of one of the SIRS criteria (temperature >38\u00b0C or <36\u00b0C). While this is relevant to SIRS as it indicates a lack of systemic inflammation associated with early sepsis, it does not fulfill or suggest any positive criteria. Thus, the alignment is indirect and weak.",
            "The claim references lactate levels, which relates to the category discussing elevated serum lactate as a risk for sepsis. However, the specific value given (0.77 mmol/L) is not elevated and is within normal ranges, indicating no direct risk of sepsis from this measurement. Thus, the alignment is weak."
        ],
        "final_alignment_score": 0.25,
        "accuracy": 1
    },
    {
        "input": "5: HR, 116.0; 5: RR, 18.0; 5: SpO2, 99.0; 5: SBP, 100.0; 5: DBP, 53.0; 5: MAP, 68.667; 5: Temp, 98.8; 10: Pain, 0.0; 51: SpO2, 97.0; 51: Perf, 4.984; 52: SpO2, 97.089; 52: Perf, 4.915; 53: SpO2, 98.595; 54: SpO2, 96.5; 54: Perf, 4.248; 55: SpO2, 96.102; 55: Perf, 4.384; 55: SBP, 131.0; 55: DBP, 110.0; 55: MAP, 117.0; 56: HR, 131.0; 56: RR, 18.0; 56: SpO2, 94.517; 56: Perf, 4.223; 57: SpO2, 97.086; 57: Perf, 4.379; 58: SpO2, 96.390; 58: Perf, 5.404; 58: SBP, 136.0; 58: DBP, 73.0; 58: MAP, 94.0; 59: SpO2, 96.397; 59: Perf, 5.06; 60: SpO2, 95.729; 60: Perf, 5.474; 61: SpO2, 95.542; 61: Perf, 5.584; 62: SpO2, 94.190; 62: Perf, 6.141; 63: SpO2, 93.339; 63: Perf, 6.243; 64: SpO2, 92.707; 64: Perf, 6.196; 65: SpO2, 92.831; 65: Perf, 5.624; 66: SpO2, 93.655; 66: Perf, 5.275; 67: SpO2, 93.466; 67: Perf, 5.632; 68: SpO2, 92.0; 68: Perf, 5.250; 69: SpO2, 94.483; 69: Perf, 5.079; 70: SpO2, 95.644; 70: Perf, 4.544; 71: WAM DIFTYP, AUTO; 71: MONOCYTE % (AUTO DIFF), 12.4 %; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.17 K/uL; 71: HEMATOCRIT (HCT), 29.4 %; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.60 K/uL; 71: EOSINOPHIL % (AUTO DIFF), 0.7 %; 71: PLATELET COUNT (PLT), 194 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 90.2 fL; 71: BASOPHIL % (AUTO DIFF), 0.2 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 71: LYMPHOCYTE % (AUTO DIFF), 7.3 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 71: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.27 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: HEMOGLOBIN (HGB), 10.3 g/dL; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 71: WHITE BLOOD CELLS (WBC), 17.4 K/uL; 71: RED BLOOD CELLS (RBC), 3.26 MIL/uL; 71: NEUTROPHIL % (AUTO DIFF), 78.4 %; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: SpO2, 96.627; 71: Perf, 3.934; 72: HR, 128.0; 72: RR, 15.0; 72: SpO2, 96.948; 72: Perf, 3.796; 72: SBP, 111.0; 72: DBP, 58.0; 72: MAP, 75.667; 73: SpO2, 95.169; 73: Perf, 3.323; 74: SpO2, 95.862; 74: Perf, 3.46; 75: SpO2, 95.949; 75: Perf, 4.404; 76: SpO2, 96.424; 76: Perf, 4.125; 77: SpO2, 95.386; 77: Perf, 4.499; 78: SpO2, 95.847; 78: Perf, 4.029; 79: SpO2, 93.931; 79: Perf, 5.616; 80: SpO2, 93.712; 80: Perf, 5.950; 81: SpO2, 92.576; 81: Perf, 6.079; 82: SpO2, 91.5; 82: Perf, 6.108; 83: SpO2, 91.288; 83: Perf, 5.687; 84: SpO2, 92.759; 84: Perf, 4.941; 85: SpO2, 91.695; 85: Perf, 4.881; 86: SpO2, 94.155; 86: Perf, 4.166; 87: SpO2, 92.356; 87: Perf, 5.018; 88: SpO2, 92.017; 88: Perf, 4.251; 89: SARS-COV-2 RNA, Not Detected; 89: SpO2, 92.678; 89: Perf, 4.758; 90: SpO2, 93.431; 90: Perf, 4.360; 91: SpO2, 93.085; 91: Perf, 4.184; 92: SpO2, 92.138; 92: Perf, 4.353; 93: SpO2, 93.15; 93: Perf, 3.918; 94: SpO2, 92.982; 94: Perf, 4.616; 95: SpO2, 91.458; 95: Perf, 4.198; 96: SpO2, 92.508; 96: Perf, 3.947; 97: SpO2, 95.017; 97: Perf, 2.862; 98: SpO2, 95.172; 98: Perf, 3.838; 99: SpO2, 95.103; 99: Perf, 4.120; 100: SpO2, 95.155; 100: Perf, 3.586; 101: SpO2, 95.847; 101: Perf, 3.316; 102: SpO2, 96.483; 102: Perf, 3.631; 103: SpO2, 96.525; 103: Perf, 4.056; 104: SpO2, 95.339; 104: Perf, 4.778; 105: SpO2, 95.741; 105: Perf, 4.193; 106: SpO2, 95.305; 106: Perf, 4.879; 107: SpO2, 95.390; 107: Perf, 4.927; 108: HIGH SENSITIVITY TROPONIN, 12 ng/L; 108: SpO2, 94.627; 108: Perf, 5.704; 117: HR, 129.0; 117: RR, 17.0; 117: SpO2, 98.0; 117: SBP, 131.0; 117: DBP, 69.0; 117: MAP, 89.667; 119: ALKALINE PHOSPHATASE, 557 U/L; 119: ALBUMIN, 1.9 g/dL; 119: CALCIUM, 7.5 mg/dL; 119: EGFR REFIT WITHOUT RACE (2021), 92 mL/min/1.73 m2; 119: ANION GAP, 13 mmol/L; 119: ALT (SGPT), 63 U/L; 119: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 119: CHLORIDE, 92 mmol/L; 119: POTASSIUM, 4.0 mmol/L; 119: PROTEIN TOTAL, 4.6 g/dL; 119: GLUCOSE, 110 mg/dL; 119: CORRECTED CALCIUM, 9.2 mg/dL; 119: SODIUM, 128 mmol/L; 119: GLOBULIN, 2.7 g/dL; 119: AST (SGOT), 64 U/L; 119: CO2, 23 mmol/L; 119: BILIRUBIN TOTAL, 5.7 mg/dL; 119: CREATININE, 0.72 mg/dL; 119: LIPASE, 48 U/L; 0: Age, 66; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 116.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The assessment of sepsis risk requires evaluating multiple factors indicating infection and organ dysfunction. In this time series, several concerning indicators suggest a high sepsis risk: the patient presents with hypotension (DBP and SBP trends) and elevated heart rate (tachycardia), both common in sepsis. The lab results show elevated white blood cell count and bilirubin, indicating possible infection and liver dysfunction, and low albumin, which could suggest poor nutritional status or liver dysfunction. The blood pressure improvements might be due to medical intervention yet do not eliminate the indicators of sepsis, thus suggesting a high risk for developing sepsis within 12 hours.",
        "claims": [
            "The assessment of sepsis risk requires evaluating multiple factors indicating infection and organ dysfunction.",
            "Several concerning indicators suggest a high sepsis risk.",
            "The patient presents with hypotension.",
            "Hypotension is indicated by trends in diastolic blood pressure (DBP) and systolic blood pressure (SBP).",
            "The patient has an elevated heart rate.",
            "Tachycardia is common in sepsis.",
            "The lab results show an elevated white blood cell count.",
            "An elevated white blood cell count indicates possible infection.",
            "The lab results show elevated bilirubin.",
            "Elevated bilirubin indicates possible liver dysfunction.",
            "The lab results show low albumin.",
            "Low albumin could suggest poor nutritional status.",
            "Low albumin could suggest liver dysfunction.",
            "Blood pressure improvements might be due to medical intervention.",
            "Blood pressure improvements do not eliminate the indicators of sepsis.",
            "The indicators suggest a high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient presents with hypotension.",
            "Hypotension is indicated by trends in diastolic blood pressure (DBP) and systolic blood pressure (SBP).",
            "The patient has an elevated heart rate.",
            "Tachycardia is common in sepsis.",
            "The lab results show an elevated white blood cell count.",
            "An elevated white blood cell count indicates possible infection.",
            "The lab results show elevated bilirubin.",
            "Elevated bilirubin indicates possible liver dysfunction.",
            "The lab results show low albumin.",
            "Low albumin could suggest liver dysfunction.",
            "Blood pressure improvements do not eliminate the indicators of sepsis.",
            "The indicators suggest a high risk for developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.7,
            0.8,
            0.8,
            1.0,
            1.0,
            1.0,
            0.8,
            0.3,
            0.3,
            0.4,
            0.6
        ],
        "alignment_category": [
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "A Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim directly mentions hypotension, which is a key component of sepsis-associated hypotension as per the expert category. Although the specific details such as exact blood pressure values (SBP <90 mmHg or MAP <70 mmHg) or a significant drop (\u226540 mmHg from baseline) are not provided, the general presence of hypotension aligns strongly with this category used in sepsis prediction.",
            "The claim mentions hypotension, focusing on trends in diastolic and systolic blood pressure. This aligns with the Sepsis-Associated Hypotension category, as hypotension suggests progression toward septic shock. However, specificity regarding the exact measurements or changes in blood pressure is not provided (e.g., specific SBP values or MAP), so the alignment is strong but not perfect.",
            "An elevated heart rate (>90 bpm) is explicitly listed as one of the criteria under SIRS Positivity, which is used to identify systemic inflammation and potential early sepsis. The claim directly points to one aspect of the criteria, but since it doesn't specify the heart rate value or mention a second SIRS criterion, there is a slight drop from perfect alignment.",
            "Tachycardia (heart rate\u202f>\u202f90\u202fbpm) is explicitly listed as one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. While the claim mentions tachycardia as a common symptom of sepsis, it doesn't specify if the heart rate exceeds 90 bpm in this specific patient case. However, the relevance to the SIRS criteria is strong, hence a high alignment rating.",
            "An elevated white blood cell count is explicitly listed as one of the criteria under SIRS, which is utilized to identify systemic inflammation consistent with early sepsis. The claim directly corresponds to this criteria, indicating perfect alignment.",
            "An elevated white blood cell (WBC) count is explicitly mentioned as one of the SIRS criteria. SIRS (Systemic Inflammatory Response Syndrome) considers WBC count as a factor of systemic inflammation indicative of early sepsis, thus perfectly aligning with this category.",
            "Elevated bilirubin is explicitly mentioned as a component in the SOFA score criteria, which assesses organ dysfunction and is directly associated with increased sepsis risk. The claim about elevated bilirubin perfectly aligns with identifying new organ dysfunction as indicated by the SOFA score.",
            "Bilirubin is a component of the SOFA score, and an elevated level is directly related to liver dysfunction, which the category identifies as a marker of organ dysfunction. While the claim does not specify the exact level of bilirubin or the increase in SOFA points, the reference to liver dysfunction strongly aligns with this category's criteria for assessing sepsis risk.",
            "While low albumin is not directly part of the SOFA scoring criteria, it can be an indicator of liver dysfunction or malnutrition, related to the broader concept of organ dysfunction. Albumin is not directly measured in SOFA, so the alignment is indirect and weak, but there is a conceptual connection to overall organ health, which is central to SOFA scoring.",
            "Low albumin is suggestive of liver dysfunction, which could eventually relate to a higher bilirubin level\u2014a SOFA component. However, albumin itself isn't a direct measure in the SOFA score, indicating an indirect and weak alignment with the category.",
            "The claim mentions blood pressure but focuses on the presence of other indicators of sepsis beyond blood pressure. While improved blood pressure might suggest recovery from sepsis-associated hypotension, the claim emphasizes that other sepsis indicators still exist. This indirectly aligns with the category on a functional level but doesn't directly signify sepsis-related hypotension as the main concern. Therefore, the alignment is weak, as blood pressure is referenced without specific values or criteria for sepsis-associated hypotension.",
            "The claim broadly suggests a high risk for developing sepsis within 12 hours, which aligns generally with many categories. However, the National Early Warning Score (NEWS) is specifically designed to predict imminent clinical deterioration, including the risk of sepsis. Therefore, it is the most aligned category conceptually, though the claim does not mention specific details, like point scoring or vital sign derangements, that directly align with the NEWS criteria. Hence, the alignment is moderate but not explicit."
        ],
        "final_alignment_score": 0.7166666666666667,
        "accuracy": 1
    },
    {
        "input": "2: HR, 84.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 149.0; 2: DBP, 90.0; 2: MAP, 109.667; 2: Temp, 97.5; 9: Pain, 7.0; 29: SpO2, 99.615; 29: SBP, 133.0; 29: DBP, 66.0; 29: MAP, 88.333; 30: SpO2, 99.052; 30: Perf, 1.447; 31: SpO2, 99.136; 31: Perf, 1.132; 32: SpO2, 98.864; 32: Perf, 1.162; 33: SpO2, 98.678; 33: Perf, 1.168; 34: SpO2, 98.172; 34: Perf, 1.263; 35: SpO2, 97.729; 35: Perf, 1.112; 36: SpO2, 98.793; 36: Perf, 1.055; 37: SpO2, 99.932; 37: Perf, 2.007; 38: SpO2, 99.475; 38: Perf, 1.981; 39: SpO2, 100.0; 39: Perf, 1.991; 40: SpO2, 100.0; 40: Perf, 2.05; 40: SBP, 134.0; 40: DBP, 64.0; 40: MAP, 87.333; 41: SpO2, 100.0; 41: Perf, 1.834; 42: SpO2, 100.0; 42: Perf, 2.230; 43: SpO2, 100.0; 43: Perf, 2.98; 44: SpO2, 100.0; 44: Perf, 2.706; 45: SpO2, 100.0; 45: Perf, 2.465; 46: SpO2, 100.0; 46: Perf, 1.636; 47: SpO2, 100.0; 47: Perf, 1.171; 48: SpO2, 100.0; 48: Perf, 1.506; 49: SpO2, 100.0; 49: Perf, 1.302; 50: SpO2, 100.0; 50: Perf, 1.425; 51: SpO2, 100.0; 51: Perf, 1.422; 52: SpO2, 100.0; 52: Perf, 1.737; 53: SpO2, 99.949; 53: Perf, 1.718; 54: HR, 89.0; 54: SpO2, 99.776; 54: Perf, 2.102; 54: SBP, 149.0; 54: DBP, 87.0; 54: MAP, 107.667; 55: SpO2, 100.0; 55: Perf, 2.118; 55: SBP, 149.0; 55: DBP, 87.0; 55: MAP, 107.667; 56: SpO2, 99.948; 56: Perf, 1.947; 57: SpO2, 100.0; 57: Perf, 1.568; 58: SpO2, 100.0; 58: Perf, 1.255; 59: SpO2, 100.0; 59: Perf, 1.162; 60: SpO2, 100.0; 60: Perf, 1.636; 61: SpO2, 100.0; 61: Perf, 2.113; 62: SpO2, 100.0; 62: Perf, 2.164; 63: SpO2, 100.0; 63: Perf, 2.545; 64: SpO2, 100.0; 64: Perf, 1.976; 65: SpO2, 100.0; 65: Perf, 2.252; 66: SpO2, 100.0; 66: Perf, 2.494; 67: SpO2, 100.0; 67: Perf, 3.019; 68: SpO2, 100.0; 68: Perf, 2.882; 69: SpO2, 100.0; 69: Perf, 2.967; 70: SpO2, 100.0; 70: Perf, 2.846; 70: SBP, 161.0; 70: DBP, 59.0; 70: MAP, 93.0; 71: SpO2, 100.0; 71: Perf, 3.402; 72: SpO2, 100.0; 72: Perf, 3.417; 73: SpO2, 100.0; 73: Perf, 4.680; 74: SpO2, 100.0; 74: Perf, 4.734; 75: SpO2, 100.0; 75: Perf, 4.657; 76: SpO2, 100.0; 76: Perf, 4.039; 77: SpO2, 100.0; 77: Perf, 5.079; 78: SpO2, 100.0; 78: Perf, 6.706; 79: SpO2, 100.0; 79: Perf, 6.602; 80: SpO2, 100.0; 80: Perf, 2.713; 81: SpO2, 100.0; 81: Perf, 2.343; 82: SpO2, 100.0; 82: Perf, 4.020; 83: SARS-COV-2 RNA, Not Detected; 83: SpO2, 100.0; 83: Perf, 4.951; 84: SpO2, 100.0; 84: Perf, 4.196; 85: SpO2, 100.0; 85: Perf, 3.677; 85: SBP, 143.0; 85: DBP, 68.0; 85: MAP, 93.0; 85: HYDROMORPHONE, 1 MG/ML INJ SYRG; 85: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 86: SpO2, 100.0; 86: Perf, 4.171; 87: SpO2, 100.0; 87: Perf, 4.629; 88: SpO2, 100.0; 88: Perf, 6.049; 89: SpO2, 100.0; 89: Perf, 6.075; 90: HIGH SENSITIVITY TROPONIN, <4 ng/L; 90: SpO2, 100.0; 90: Perf, 5.209; 91: SpO2, 100.0; 91: Perf, 4.779; 92: SpO2, 100.0; 92: Perf, 4.859; 93: SpO2, 100.0; 93: Perf, 6.634; 94: SpO2, 100.0; 94: Perf, 5.851; 95: SpO2, 99.966; 95: Perf, 6.213; 96: SpO2, 99.797; 96: Perf, 5.211; 97: GLOBULIN, 4.5 g/dL; 97: CORRECTED CALCIUM, 9.1 mg/dL; 97: CALCIUM, 8.4 mg/dL; 97: EGFR REFIT WITHOUT RACE (2021), 79 mL/min/1.73 m2; 97: PROTEIN TOTAL, 7.6 g/dL; 97: CREATININE, 0.78 mg/dL; 97: ALT (SGPT), 92 U/L; 97: ALBUMIN, 3.1 g/dL; 97: GLUCOSE, 88 mg/dL; 97: CO2, 24 mmol/L; 97: AST (SGOT), 182 U/L; 97: SODIUM, 139 mmol/L; 97: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 97: ALKALINE PHOSPHATASE, 593 U/L; 97: BILIRUBIN TOTAL, 3.1 mg/dL; 97: POTASSIUM, 3.9 mmol/L; 97: CHLORIDE, 103 mmol/L; 97: ANION GAP, 12 mmol/L; 97: C-REACTIVE PROTEIN (CRP), 2.4 mg/dL; 97: SpO2, 100.0; 97: Perf, 3.267; 98: SpO2, 100.0; 98: Perf, 4.380; 99: HR, 89.0; 99: RR, 17.0; 99: SpO2, 100.0; 99: Perf, 3.140; 99: SBP, 148.0; 99: DBP, 75.0; 99: MAP, 99.333; 100: SpO2, 100.0; 100: Perf, 2.549; 100: SBP, 148.0; 100: DBP, 75.0; 100: MAP, 99.333; 101: SpO2, 100.0; 101: Perf, 2.340; 102: SpO2, 100.0; 102: Perf, 3.034; 103: SpO2, 99.897; 103: Perf, 3.312; 104: SpO2, 100.0; 104: Perf, 3.47; 115: Pain, 4.0; 118: WAM DIFTYP, AUTO; 118: LYMPHOCYTE % (AUTO DIFF), 31.0 %; 118: HEMATOCRIT (HCT), 34.7 %; 118: BASOPHIL % (AUTO DIFF), 1.0 %; 118: PLATELET COUNT (PLT), 65 K/uL; 118: NEUTROPHIL % (AUTO DIFF), 51.8 %; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.0 g/dL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.2 fL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 118: RED BLOOD CELLS (RBC), 3.57 MIL/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.50 K/uL; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: EOSINOPHIL % (AUTO DIFF), 3.8 %; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.35 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 118: MONOCYTE % (AUTO DIFF), 12.1 %; 0: Age, 78; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 84.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "To assess sepsis risk, key indicators include vital signs, blood work, and clinical presentation. Initially, the patient shows normal vital signs, except for elevated blood pressure and age being a risk factor. Over time, the patient\u2019s lab results show significant liver enzyme elevations and low platelet and white blood cell counts, which are concerning for systemic inflammation or infection. These laboratory abnormalities, alongside the patient's advanced age, suggest an increased risk for sepsis, leading to a high-risk prediction.",
        "claims": [
            "Key indicators for assessing sepsis risk include vital signs, blood work, and clinical presentation.",
            "The patient initially shows normal vital signs.",
            "The patient has elevated blood pressure.",
            "The patient's age is a risk factor for sepsis.",
            "The patient's lab results show significant elevations in liver enzymes.",
            "The patient's lab results show low platelet counts.",
            "The patient's lab results show low white blood cell counts.",
            "Low platelet and white blood cell counts are concerning for systemic inflammation or infection.",
            "The laboratory abnormalities suggest an increased risk for sepsis.",
            "The patient's advanced age suggests an increased risk for sepsis.",
            "These factors lead to a high-risk prediction for sepsis."
        ],
        "relevant_claims": [
            "The patient has elevated blood pressure.",
            "The patient's age is a risk factor for sepsis.",
            "The patient's lab results show low platelet counts.",
            "Low platelet and white blood cell counts are concerning for systemic inflammation or infection.",
            "The laboratory abnormalities suggest an increased risk for sepsis.",
            "The patient's advanced age suggests an increased risk for sepsis."
        ],
        "alignment_scores": [
            0.2,
            0.9,
            0.7,
            0.8,
            0.6,
            1.0
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Elderly Susceptibility (Age \u226565 years)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elderly Susceptibility (Age \u226565 years)"
        ],
        "alignment_reasonings": [
            "Elevated blood pressure is not directly indicative of sepsis risk factors, nor does it fall under any specific category criteria. However, blood pressure is a component of the shock index calculation (heart rate \u00f7 systolic BP), which is used to determine hemodynamic stability. Since elevated blood pressure could potentially correlate with a rise in systolic BP, which might reduce the shock index, the alignment here is weak and only minimally relevant.",
            "The claim references the patient's age as a risk factor for sepsis, which aligns with the category \"Elderly Susceptibility (Age \u226565 years).\" However, without specific age details, it's unclear if the patient is 65 or older, hence slightly lowering the rating.",
            "Low platelet counts are part of the criteria for SOFA score increase (platelets <100 x 10\u2079/L), which indicates organ dysfunction and increased sepsis risk. The alignment is strong given that low platelet counts can directly contribute to a SOFA score increase, a key indicator of sepsis risk. However, without specific values stated to fully assess the SOFA increase, a perfect alignment isn\u2019t certain, hence the 0.7 rating.",
            "The claim mentions low platelet and white blood cell counts. A low platelet count is directly related to the SOFA score criteria, specifically platelets\u202f<100\u202f\u00d7\u202f10\u2079/L, which confirms organ dysfunction and a high sepsis risk. Additionally, the mention of low white blood cell counts can align with SIRS criteria, but the primary emphasis is on low platelets here, which makes SOFA Score Increase the more fitting category. Because both conditions suggest serious systemic issues, the alignment is strong but not absolute, hence a 0.8 rating.",
            "The claim refers to laboratory abnormalities, which can be indicative of organ dysfunction (e.g., changes in PaO\u2082/FiO\u2082, platelets, bilirubin, creatinine, or GCS). These are parameters used in the SOFA score. However, the claim lacks specific details about the abnormalities that directly correspond to the specific components of the SOFA score. Thus, the alignment is indirect, but conceptually relevant in pointing toward organ dysfunction and sepsis risk.",
            "The claim explicitly references advanced age as a risk factor, aligning perfectly with the \"Elderly Susceptibility\" category, which identifies age \u226565 years as a significant risk factor for sepsis. Therefore, the alignment is clear and direct, warranting a perfect score."
        ],
        "final_alignment_score": 0.7000000000000001,
        "accuracy": 0
    },
    {
        "input": "8: HR, 112.0; 8: RR, 22.0; 8: SpO2, 92.0; 8: SBP, 120.0; 8: DBP, 73.0; 8: MAP, 88.667; 8: Pain, 10.0; 8: Temp, 102.4; 17: SpO2, 96.0; 17: LPM O2, 2.0; 66: SpO2, 98.478; 67: SpO2, 98.387; 67: SBP, 117.0; 67: DBP, 82.0; 67: MAP, 93.667; 68: SpO2, 98.891; 68: Perf, 0.407; 69: HR, 108.325; 69: RR, 44.0; 69: SpO2, 98.638; 69: Perf, 0.381; 69: 1min HRV, 41.156; 70: HR, 108.559; 70: RR, 45.661; 70: SpO2, 98.915; 70: Perf, 0.297; 70: 1min HRV, 5.363; 70: 5min HRV, 28.514; 71: HR, 108.068; 71: RR, 37.729; 71: SpO2, 98.780; 71: Perf, 0.294; 71: 1min HRV, 13.637; 72: POC PH (V) ISTAT, 7.36; 72: POC TCO2 (V) ISTAT, 23 mmol/L; 72: POC O2 SATURATION ISTAT VENOUS, 19 %; 72: POC PCO2 (V) ISTAT, 38.5 mmHg; 72: POC BASE EXCESS ISTAT, -4 mmol/L; 72: POC HCO3 (V) ISTAT, 21.5 mmol/L; 72: POC LACTATE ISTAT, 1.65 mmol/L; 72: POC PO2 (V) ISTAT, 15 mmHg; 72: HR, 109.293; 72: RR, 37.052; 72: SpO2, 98.310; 72: Perf, 0.303; 72: 1min HRV, 11.081; 73: HR, 108.983; 73: RR, 40.966; 73: SpO2, 98.593; 73: Perf, 0.307; 73: 1min HRV, 6.493; 74: HR, 109.741; 74: RR, 38.379; 74: SpO2, 98.603; 74: Perf, 0.296; 74: 1min HRV, 18.011; 75: HR, 110.949; 75: RR, 37.576; 75: SpO2, 98.475; 75: Perf, 0.286; 75: 1min HRV, 9.440; 75: 5min HRV, 13.032; 76: HR, 109.644; 76: RR, 36.441; 76: SpO2, 97.741; 76: Perf, 0.28; 76: 1min HRV, 7.183; 77: HR, 110.276; 77: RR, 35.690; 77: SpO2, 98.448; 77: Perf, 0.281; 77: 1min HRV, 7.025; 78: HR, 110.237; 78: RR, 43.407; 78: SpO2, 98.525; 78: Perf, 0.269; 78: 1min HRV, 7.783; 79: HR, 111.241; 79: RR, 38.638; 79: SpO2, 98.482; 79: Perf, 0.259; 79: 1min HRV, 10.516; 80: HR, 110.592; 80: RR, 37.695; 80: SpO2, 99.352; 80: Perf, 0.258; 80: 1min HRV, 10.900; 80: 5min HRV, 8.904; 81: HR, 109.362; 81: RR, 39.776; 81: SpO2, 99.583; 81: Perf, 0.230; 81: 1min HRV, 13.018; 81: Pain, 0.0; 82: HR, 110.339; 82: RR, 40.542; 82: SpO2, 99.814; 82: Perf, 0.247; 82: 1min HRV, 8.560; 83: HR, 109.763; 83: RR, 39.017; 83: SpO2, 100.0; 83: Perf, 0.238; 83: 1min HRV, 13.194; 84: HR, 111.088; 84: RR, 36.879; 84: SpO2, 99.878; 84: Perf, 0.246; 84: 1min HRV, 10.999; 85: HR, 113.475; 85: RR, 38.644; 85: SpO2, 99.508; 85: Perf, 0.278; 85: 1min HRV, 9.971; 85: 5min HRV, 12.858; 86: HR, 111.155; 86: RR, 33.845; 86: SpO2, 99.259; 86: Perf, 0.383; 86: 1min HRV, 14.009; 87: HR, 110.508; 87: RR, 41.932; 87: SpO2, 99.254; 87: Perf, 0.294; 87: 1min HRV, 5.862; 88: HR, 111.424; 88: RR, 40.847; 88: SpO2, 98.966; 88: Perf, 0.262; 88: 1min HRV, 4.613; 89: HR, 110.741; 89: RR, 41.483; 89: SpO2, 98.414; 89: Perf, 0.271; 89: 1min HRV, 2.881; 90: HR, 110.458; 90: RR, 40.831; 90: SpO2, 98.322; 90: Perf, 0.288; 90: 1min HRV, 4.093; 90: 5min HRV, 7.499; 91: HR, 111.466; 91: RR, 39.552; 91: SpO2, 98.155; 91: Perf, 0.272; 91: 1min HRV, 4.415; 92: HR, 111.220; 92: RR, 39.102; 92: SpO2, 98.356; 92: Perf, 0.274; 92: 1min HRV, 12.221; 93: HR, 111.627; 93: RR, 39.915; 93: SpO2, 98.966; 93: Perf, 0.280; 93: 1min HRV, 2.886; 94: HR, 111.414; 94: RR, 41.983; 94: SpO2, 99.448; 94: Perf, 0.296; 94: 1min HRV, 2.454; 95: HR, 110.814; 95: RR, 40.644; 95: SpO2, 98.966; 95: Perf, 0.308; 95: 1min HRV, 3.129; 95: 5min HRV, 6.370; 96: HR, 111.224; 96: RR, 39.759; 96: SpO2, 99.483; 96: Perf, 0.332; 96: 1min HRV, 2.579; 97: HR, 110.932; 97: RR, 39.932; 97: SpO2, 99.695; 97: Perf, 0.334; 97: 1min HRV, 49.577; 98: HR, 111.559; 98: RR, 39.983; 98: SpO2, 99.780; 98: Perf, 0.330; 98: 1min HRV, 3.696; 99: HR, 113.172; 99: RR, 42.103; 99: SpO2, 98.707; 99: Perf, 0.323; 99: 1min HRV, 5.145; 99: PIPERACILLIN-TAZOBACTAM-DEXTRS, 3.375 GRAM/50 ML IV PGBK; 100: HR:, 112.746; 100: RR, 43.661; 100: SpO2, 99.102; 100: Perf, 0.328; 100: 1min HRV, 6.513; 100: 5min HRV, 23.550; 101: HR, 114.190; 101: RR, 41.603; 101: SpO2, 99.190; 101: Perf, 0.33; 101: 1min HRV, 5.972; 102: HR, 114.695; 102: RR, 41.492; 102: SpO2, 98.552; 102: Perf, 0.33; 102: 1min HRV, 11.769; 103: HR, 114.373; 103: RR, 44.847; 103: SpO2, 99.843; 103: Perf, 0.338; 103: 1min HRV, 10.364; 104: HR, 114.310; 104: RR, 42.603; 104: SpO2, 99.862; 104: Perf, 0.327; 104: 1min HRV, 8.266; 105: INR, 1.3; 105: PROTHROMBIN TIME, 16.5 seconds; 105: HR, 114.186; 105: RR, 38.407; 105: SpO2, 99.169; 105: Perf, 0.3; 105: 1min HRV, 13.973; 105: 5min HRV, 10.070; 106: PART. THROMBOPLASTIN TIME, 34.9 seconds; 106: HR, 113.776; 106: RR, 42.138; 106: SpO2, 99.172; 106: Perf, 0.3; 106: 1min HRV, 7.621; 107: HR, 112.085; 107: RR, 39.305; 107: SpO2, 98.746; 107: Perf, 0.306; 107: 1min HRV, 54.041; 108: HR, 113.746; 108: RR, 41.508; 108: SpO2, 99.169; 108: Perf, 0.313; 108: 1min HRV, 54.108; 109: HR, 111.966; 109: RR, 40.017; 109: SpO2, 99.143; 109: Perf, 0.32; 109: 1min HRV, 9.468; 110: HR, 113.746; 110: RR, 39.746; 110: SpO2, 98.562; 110: Perf, 0.318; 110: 1min HRV, 4.468; 110: 5min HRV, 35.284; 111: HR, 113.897; 111: RR, 42.293; 111: SpO2, 99.103; 111: Perf, 0.327; 111: 1min HRV, 4.217; 112: HR, 112.932; 112: RR, 42.305; 112: SpO2, 98.831; 112: Perf, 0.343; 112: 1min HRV, 4.204; 113: HR, 112.207; 113: RR, 41.569; 113: SpO2, 99.466; 113: Perf, 0.396; 113: 1min HRV, 5.945; 114: HR, 112.831; 114: RR, 41.407; 114: SpO2, 99.305; 114: Perf, 0.383; 114: 1min HRV, 3.358; 115: HR, 113.017; 115: RR, 42.136; 115: SpO2, 99.475; 115: Perf, 0.405; 115: 1min HRV, 6.819; 115: 5min HRV, 5.540; 116: HR, 112.155; 116: RR, 41.862; 116: SpO2, 99.569; 116: Perf, 0.380; 116: 1min HRV, 3.962; 117: HR, 112.797; 117: RR, 42.576; 117: SpO2, 99.847; 117: Perf, 0.382; 117: 1min HRV, 2.799; 118: HR, 112.224; 118: RR, 41.310; 118: SpO2, 99.517; 118: Perf, 0.397; 118: 1min HRV, 4.919; 119: HR, 112.254; 119: RR, 44.492; 119: SpO2, 99.593; 119: Perf, 0.429; 119: 1min HRV, 2.948; 0: Age, 75; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 39.1; 0: Triage HR, 112.0; 0: Triage RR, 22.0; 0: Triage SBP, 120.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "Start by checking for key indicators of sepsis within the initial data, such as high fever (Temp: 39.1\u00b0C) and increased heart rate (HR: 112 bpm) upon admission, which could suggest infection-related stress. Observe persistent abnormalities, such as sustained high HRs and respiratory rates (RR) throughout the time series, particularly elevated during the initial hours, indicating potential systemic response. Additionally, low SpO2 levels (minimum recorded at 92.0) and increased respiratory effort (RR peaks at 45.661) suggest compromised ventilation and oxygenation. These factors, coupled with treatment with broad-spectrum antibiotics (e.g., Piperacillin-tazobactam), collectively point to a high risk of sepsis.",
        "claims": [
            "Check for key indicators of sepsis within the initial data.",
            "High fever is recorded at 39.1\u00b0C upon admission.",
            "An increased heart rate of 112 bpm upon admission could suggest infection-related stress.",
            "Persistent abnormalities, such as sustained high heart rates, should be observed throughout the time series.",
            "Elevated respiratory rates during the initial hours indicate a potential systemic response.",
            "Low SpO2 levels were recorded, with a minimum of 92.0.",
            "Increased respiratory effort, with peaks at 45.661, suggests compromised ventilation and oxygenation.",
            "Treatment with broad-spectrum antibiotics, such as Piperacillin-tazobactam, is ongoing.",
            "These factors collectively point to a high risk of sepsis."
        ],
        "relevant_claims": [
            "Check for key indicators of sepsis within the initial data.",
            "High fever is recorded at 39.1\u00b0C upon admission.",
            "An increased heart rate of 112 bpm upon admission could suggest infection-related stress.",
            "Persistent abnormalities, such as sustained high heart rates, should be observed throughout the time series.",
            "Elevated respiratory rates during the initial hours indicate a potential systemic response.",
            "Low SpO2 levels were recorded, with a minimum of 92.0.",
            "Increased respiratory effort, with peaks at 45.661, suggests compromised ventilation and oxygenation.",
            "Treatment with broad-spectrum antibiotics, such as Piperacillin-tazobactam, is ongoing.",
            "These factors collectively point to a high risk of sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.9,
            0.7,
            0.5,
            0.7,
            0.6,
            0.7,
            1.0,
            0.3
        ],
        "alignment_category": [
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim involves checking indicators of sepsis, which could lead to clinical actions such as early antibiotics or culture orders if sepsis is suspected. However, the claim itself speaks to assessment rather than specific interventions or indicators, resulting in weak alignment with the chosen category.",
            "The claim references a high fever (39.1\u00b0C), which meets one of the SIRS criteria (temperature >38\u00b0C). While the presence of only one SIRS criterion does not meet the requirement of \u22652 for full SIRS positivity, the fever is clearly indicative of systemic inflammation/early sepsis, aligning strongly with this category.",
            "An increased heart rate of >90 bpm is one of the criteria listed under SIRS for detecting systemic inflammation consistent with early sepsis. This falls directly within the SIRS criteria, making the alignment relatively strong but not perfect since other SIRS criteria are not mentioned in the claim.",
            "The claim emphasizes sustained high heart rates, which can contribute to an elevated shock index (heart rate \u00f7 systolic BP). While the claim does not mention blood pressure, a high heart rate alone can indicate hemodynamic instability. The alignment is indirect since it doesn't provide a complete shock index, but persistent high heart rates are a meaningful component of this category.",
            "An elevated respiratory rate is a key component of both the SIRS criteria and the qSOFA score. However, the claim emphasizes \"potential systemic response\" which is more indicative of sepsis risk and organ dysfunction, key aspects of the qSOFA score. This makes High qSOFA Score the most aligned category. The alignment is not perfect because the claim does not specify if the respiratory rate fulfills the qSOFA criteria (\u226522/min), thus the rating is 0.7.",
            "The claim refers to low SpO2 levels, which indicate potential issues with oxygenation. While SpO2 is not directly a component of the SOFA score, it conceptually relates to impaired oxygenation and respiratory function (a factor in SOFA scoring). The alignment is indirect but significant.",
            "The claim discusses increased respiratory effort, which can be associated with a respiratory rate of \u226522 per minute, a component of the qSOFA score. This aligns with compromised ventilation and oxygenation associated with a high risk of sepsis-related organ dysfunction and mortality. While the exact respiratory rate isn't specified, the description of \"peaks at 45.661\" suggests significant respiratory distress, which strongly leans towards the high qSOFA criteria of respiratory rate but does not directly define the qSOFA score threshold. Hence, the score is 0.7 for a strong but not perfectly aligned match.",
            "The claim specifies that treatment with broad-spectrum antibiotics is ongoing, aligning directly with the category that highlights the significance of administering antibiotics within the first two hours as a response to suspected sepsis. This demonstrates clinician suspicion of a serious infection, making the alignment perfect.",
            "The claim is non-specific, mentioning \"factors\" in a general manner without detailing any particular indicator that can be directly linked with the expert categories. It broadly suggests a high risk of sepsis, which resonates with the proactive clinical suspicion associated with early orders of antibiotics or cultures. However, due to the lack of specific clinical actions mentioned (such as antibiotics administration or culture draws), the alignment is weak."
        ],
        "final_alignment_score": 0.6333333333333333,
        "accuracy": 1
    },
    {
        "input": "6: HR, 118.0; 6: RR, 22.0; 6: SpO2, 100.0; 6: SBP, 132.0; 6: DBP, 94.0; 6: MAP, 106.667; 6: Pain, 5.0; 6: Temp, 98.1; 43: METOCLOPRAMIDE HCL, 5 MG/ML INJ SOLN; 52: SpO, 2: 95.903; 53: SpO2, 100.0; 53: SBP, 144.0; 53: DBP, 114.0; 53: MAP, 124.0; 54: SpO2, 100.0; 54: Perf, 0.382; 55: SpO2, 100.0; 55: Perf, 0.570; 56: SpO2, 100.0; 56: Perf, 1.475; 56: LR IV BOLUS -, 1000 ML; 57: SpO, 2: 99.898; 57: Perf, 1.808; 57: Pain, 0.0; 58: SpO2, 99.707; 58: Perf, 1.647; 59: SpO2, 100.0; 59: Perf, 1.412; 60: SpO2, 100.0; 60: Perf, 1.091; 61: SpO2, 100.0; 61: Perf, 0.924; 61: SBP, 125.0; 61: DBP, nan; 61: MAP, nan; 62: HR, 87.0; 62: RR, 18.0; 62: SpO2, 100.0; 62: Perf, 0.791; 62: SBP, 133.0; 62: DBP, 92.0; 62: MAP, 105.667; 62: Pain, 5.0; 63: SpO2, 100.0; 63: Perf, 0.720; 63: SBP, 133.0; 63: DBP, 92.0; 63: MAP, 105.667; 64: SARS-COV-2 RNA, Not Detected; 64: SpO2, 99.690; 64: Perf, 0.582; 65: SpO2, 99.897; 65: Perf, 0.660; 66: POC PH (V) ISTAT, 7.43; 66: POC LACTATE ISTAT, 2.70 mmol/L; 66: POC O2 SATURATION ISTAT VENOUS, 55 %; 66: POC PO2 (V) ISTAT, 28 mmHg; 66: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC TCO2 (V) ISTAT, 24 mmol/L; 66: POC PCO2 (V) ISTAT, 35.1 mmHg; 66: POC BASE EXCESS ISTAT, -1 mmol/L; 66: SpO2, 99.915; 66: Perf, 0.674; 67: SpO2, 100.0; 67: Perf, 0.690; 68: SpO2, 99.879; 68: Perf, 0.710; 69: SpO2, 100.0; 69: Perf, 0.765; 70: SpO2, 99.878; 70: Perf, 0.725; 71: SpO2, 99.830; 71: Perf, 0.598; 72: WAM DIFTYP, AUTO; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 72: NEUTROPHIL % (AUTO DIFF), 83.7 %; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.3 %; 72: MONOCYTE % (AUTO DIFF), 4.1 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 72: RED BLOOD CELLS (RBC), 4.89 MIL/uL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 72: HEMATOCRIT (HCT), 42.2 %; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.84 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.7 pg; 72: PLATELET COUNT (PLT), 323 K/uL; 72: EOSINOPHIL % (AUTO DIFF), 0.1 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.48 K/uL; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 72: BASOPHIL % (AUTO DIFF), 0.3 %; 72: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 11.4 %; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 72: HEMOGLOBIN (HGB), 14.5 g/dL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 72: SpO2, 100.0; 72: Perf, 0.590; 73: SpO2, 100.0; 73: Perf, 0.597; 74: SpO2, 100.0; 74: Perf, 0.607; 75: SpO2, 100.0; 75: Perf, 0.565; 76: SpO2, 100.0; 76: Perf, 0.524; 77: SpO2, 100.0; 77: Perf, 0.508; 78: SpO2, 100.0; 78: Perf, 0.520; 78: SBP, 114.0; 78: DBP, 75.0; 78: MAP, 88.0; 79: SpO2, 100.0; 79: Perf, 0.482; 80: SpO2, 100.0; 80: Perf, 0.443; 81: SpO2, 100.0; 81: Perf, 0.402; 82: HR, 100.0; 82: RR, 17.0; 82: SpO2, 100.0; 82: Perf, 0.384; 82: SBP, 114.0; 82: DBP, 75.0; 82: MAP, 88.0; 82: Pain, 5.0; 82: ACETAMINOPHEN, 500 MG PO TABS; 83: SpO, 2: 100.0; 83: Perf, 0.38; 84: SpO2, 100.0; 84: Perf, 0.38; 85: SpO2, 100.0; 85: Perf, 0.389; 86: Perf, 0.39; 87: SpO2, 100.0; 87: Perf, 0.39; 88: SpO2, 100.0; 88: Perf, 0.39; 89: Perf, 0.39; 90: Perf, 0.396; 91: Perf, 0.401; 92: SpO2, 100.0; 92: Perf, 0.375; 93: SpO2, 100.0; 93: Perf, 0.38; 93: SBP, 133.0; 93: DBP, 91.0; 93: MAP, 105.0; 94: SpO2, 100.0; 94: Perf, 0.384; 95: SpO2, 100.0; 95: Perf, 0.397; 96: SpO2, 100.0; 96: Perf, 0.4; 97: SpO2, 100.0; 97: Perf, 0.392; 98: SpO2, 100.0; 98: Perf, 0.361; 99: ALT (SGPT), 17 U/L; 99: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 99: SODIUM, 137 mmol/L; 99: CHLORIDE, 102 mmol/L; 99: AST (SGOT), 19 U/L; 99: BILIRUBIN TOTAL, 0.6 mg/dL; 99: GLUCOSE, 110 mg/dL; 99: CREATININE, 0.61 mg/dL; 99: CO2, 21 mmol/L; 99: ANION GAP, 14 mmol/L; 99: ALBUMIN, 4.3 g/dL; 99: POTASSIUM, 3.9 mmol/L; 99: GLOBULIN, 3.0 g/dL; 99: EGFR REFIT WITHOUT RACE (2021), 127 mL/min/1.73 m2; 99: CORRECTED CALCIUM, 9.0 mg/dL; 99: CALCIUM, 9.2 mg/dL; 99: EGFR FOR AFRICAN AMERICAN, 147 mL/min/1.73 m2; 99: PROTEIN TOTAL, 7.3 g/dL; 99: ALKALINE PHOSPHATASE, 57 U/L; 99: MAGNESIUM, 1.9 mg/dL; 99: SpO2, 100.0; 99: Perf, 0.359; 100: SpO2, 100.0; 100: Perf, 0.337; 101: SpO2, 100.0; 101: Perf, 0.28; 102: SpO2, 100.0; 102: Perf, 0.252; 103: SpO2, 100.0; 103: Perf, 0.26; 104: Perf, 0.26; 105: Perf, 0.26; 106: Perf, 0.26; 107: SpO2, 97.575; 107: Perf, 0.391; 108: SpO2, 100.0; 108: Perf, 0.39; 108: SBP, 115.0; 108: DBP, 70.0; 108: MAP, 85.0; 108: LR IV BOLUS -, 1000 ML; 109: SpO, 2: 100.0; 109: Perf, 0.398; 110: SpO2, 100.0; 110: Perf, 0.407; 111: SpO2, 100.0; 111: Perf, 0.396; 112: HR, 85.0; 112: RR, 16.0; 112: SpO2, 100.0; 112: Perf, 0.473; 112: SBP, 115.0; 112: DBP, 70.0; 112: MAP, 85.0; 112: Pain, 3.0; 113: SpO2, 100.0; 113: Perf, 0.453; 114: SpO2, 100.0; 114: Perf, 0.429; 115: SpO2, 100.0; 115: Perf, 0.413; 116: SpO2, 100.0; 116: Perf, 0.377; 117: SpO2, 100.0; 117: Perf, 0.364; 118: BETA HCG, 50897 mIU/mL; 118: SpO2, 100.0; 118: Perf, 0.364; 119: SpO2, 100.0; 119: Perf, 0.559; 0: Age, 26; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 132.0; 0: Triage DBP, 94.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS,HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the risk of sepsis, we evaluate vital signs, lab results, and interventions. The heart rate is consistently high initially but decreases over time, respiratory rate and blood pressure remain stable, and oxygen saturation is consistently high. Lab results, like lactate level, are slightly elevated but not critically so. Fluid boluses and medication for pain and nausea are administered, but there are no indications of severe infection or organ dysfunction. The patient's overall stability and normal lab values suggest a low risk for sepsis development in the next 12 hours.",
        "claims": [
            "Vital signs, lab results, and interventions are evaluated to determine the risk of sepsis.",
            "The heart rate is consistently high initially.",
            "The heart rate decreases over time.",
            "The respiratory rate remains stable.",
            "The blood pressure remains stable.",
            "Oxygen saturation is consistently high.",
            "Lab results show the lactate level is slightly elevated.",
            "The lactate level is not critically elevated.",
            "Fluid boluses are administered to the patient.",
            "Medication for pain is administered to the patient.",
            "Medication for nausea is administered to the patient.",
            "There are no indications of severe infection.",
            "There are no indications of organ dysfunction.",
            "The patient's overall stability suggests a low risk for sepsis development.",
            "Normal lab values suggest a low risk for sepsis development in the next 12 hours."
        ],
        "relevant_claims": [
            "The lactate level is not critically elevated.",
            "There are no indications of severe infection."
        ],
        "alignment_scores": [
            0.2,
            0.2
        ],
        "alignment_category": [
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The mention of lactate level directly pertains to the Elevated Serum Lactate category, which is concerned with levels \u22652 mmol/L indicating high sepsis risk. However, since the claim states that the lactate level is \"not critically elevated,\" it suggests that it may be below the significant threshold and thus does not strongly align with the risk marker concept. This indirect relevance results in a low alignment rating.",
            "The claim suggests a lack of suspicion for severe infection, which loosely relates to the absence of actions commonly taken when an infection is suspected, such as ordering antibiotics or cultures. The alignment is weak because the claim implies a lack of urgency or severe infection, contrasting with the proactive measures described in the category."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "5: HR, 104.0; 5: RR, 18.0; 5: SpO2, 98.0; 5: SBP, 126.0; 5: DBP, 78.0; 5: MAP, 94.0; 5: Pain, 7.0; 5: Temp, 99.9; 18: SBP, 126.0; 18: DBP, 86.0; 18: MAP, 99.333; 20: HR, 129.333; 20: 1min HRV, 10.333; 21: HR, 124.169; 21: RR, 20.098; 21: SpO2, 99.711; 21: 1min HRV, 33.530; 22: HR, 122.707; 22: RR, 11.466; 22: SpO2, 98.571; 22: 1min HRV, 17.122; 23: HR, 122.085; 23: RR, 14.085; 23: SpO2, 97.219; 23: 1min HRV, 24.052; 24: HR, 117.914; 24: RR, 17.724; 24: SpO2, 100.0; 24: 1min HRV, 21.285; 24: 5min HRV, 25.823; 25: HR, 122.220; 25: RR, 16.627; 25: SpO2, 99.808; 25: Perf, 0.192; 25: 1min HRV, 24.577; 25: SBP, 116.0; 25: DBP, 78.0; 25: MAP, 90.667; 26: HR, 117.746; 26: RR, 18.153; 26: SpO2, 99.679; 26: Perf, 0.206; 26: 1min HRV, 20.401; 27: HR, 124.672; 27: RR, 26.879; 27: SpO2, 99.552; 27: Perf, 0.2; 27: 1min HRV, 26.780; 28: HR, 123.627; 28: RR, 25.542; 28: SpO2, 96.894; 28: Perf, 0.2; 28: 1min HRV, 23.114; 29: HR, 123.052; 29: RR, 20.724; 29: SpO2, 99.707; 29: 1min HRV, 29.700; 29: 5min HRV, 26.483; 30: HR, 124.593; 30: RR, 16.186; 30: SpO2, 99.949; 30: 1min HRV, 22.922; 31: HR, 125.559; 31: RR, 19.305; 31: SpO2, 99.909; 31: 1min HRV, 28.814; 32: HR, 129.931; 32: RR, 28.155; 32: SpO2, 99.875; 32: Perf, 0.214; 32: 1min HRV, 28.843; 33: HR, 129.712; 33: RR, 26.254; 33: SpO2, 99.947; 33: Perf, 0.22; 33: 1min HRV, 25.706; 34: HR, 146.724; 34: RR, 30.155; 34: Perf, 0.22; 34: 1min HRV, 32.094; 34: 5min HRV, 35.024; 35: HR, 133.554; 35: RR, 27.847; 35: 1min HRV, 32.280; 36: HR, 123.441; 36: RR, 15.797; 36: 1min HRV, 35.801; 37: HR, 128.879; 37: RR, 24.828; 37: 1min HRV, 28.475; 38: HR, 132.051; 38: RR, 20.542; 38: 1min HRV, 16.376; 39: HR, 128.603; 39: RR, 20.069; 39: 1min HRV, 16.487; 39: 5min HRV, 30.643; 40: HR, 128.610; 40: RR, 16.712; 40: 1min HRV, 15.154; 40: SBP, 107.0; 40: DBP, 84.0; 40: MAP, 91.667; 41: HR, 121.483; 41: RR, 21.397; 41: 1min HRV, 19.597; 42: HR, 124.068; 42: RR, 20.373; 42: 1min HRV, 22.711; 43: HR, 116.780; 43: RR, 21.153; 43: 1min HRV, 16.104; 44: HR, 116.379; 44: RR, 19.914; 44: 1min HRV, 15.746; 44: 5min HRV, 25.775; 45: HR, 114.356; 45: RR, 20.746; 45: 1min HRV, 14.980; 46: HR, 113.724; 46: RR, 20.293; 46: 1min HRV, 22.211; 47: HR, 111.797; 47: RR, 21.017; 47: 1min HRV, 12.082; 48: HR, 111.288; 48: RR, 19.559; 48: 1min HRV, 19.268; 49: HR, 109.017; 49: RR, 18.345; 49: 1min HRV, 23.235; 49: 5min HRV, 20.667; 50: HR, 110.898; 50: RR, 18.576; 50: 1min HRV, 14.002; 51: HR, 115.966; 51: RR, 16.397; 51: 1min HRV, 18.354; 52: HR, 113.254; 52: RR, 19.898; 52: 1min HRV, 30.575; 53: HR, 111.898; 53: RR, 24.644; 53: 1min HRV, 22.842; 54: HR, 111.172; 54: RR, 23.534; 54: 1min HRV, 20.992; 54: 5min HRV, 24.145; 55: HR, 111.644; 55: RR, 17.237; 55: 1min HRV, 16.907; 56: HR, 115.121; 56: RR, 21.845; 56: 1min HRV, 29.425; 57: HR, 113.305; 57: RR, 19.746; 57: 1min HRV, 21.649; 58: HR, 116.712; 58: RR, 24.169; 58: 1min HRV, 28.961; 59: HR, 112.948; 59: RR, 21.069; 59: 1min HRV, 33.231; 59: 5min HRV, 27.756; 60: HR, 112.576; 60: RR, 22.441; 60: 1min HRV, 27.150; 61: HR, 114.328; 61: RR, 18.259; 61: 1min HRV, 29.118; 62: HR, 107.780; 62: RR, 18.492; 62: 1min HRV, 21.263; 63: HR, 105.661; 63: RR, 17.847; 63: 1min HRV, 15.294; 64: HR, 107.259; 64: RR, 17.793; 64: 1min HRV, 17.259; 64: 5min HRV, 29.527; 65: HR, 103.119; 65: RR, 20.339; 65: 1min HRV, 13.472; 66: HR, 104.931; 66: RR, 18.5; 66: 1min HRV, 11.080; 67: HR, 105.661; 67: RR, 19.186; 67: 1min HRV, 11.420; 68: HR, 104.678; 68: RR, 19.373; 68: 1min HRV, 12.364; 69: HR, 104.5; 69: RR, 17.828; 69: 1min HRV, 12.741; 69: 5min HRV, 13.261; 70: HR, 103.593; 70: RR, 16.898; 70: 1min HRV, 15.759; 71: HR, 103.172; 71: RR, 19.5; 71: 1min HRV, 18.602; 72: HR, 103.0; 72: RR, 18.203; 72: 1min HRV, 23.638; 73: HR, 102.190; 73: RR, 15.741; 73: 1min HRV, 18.132; 74: HR, 102.305; 74: RR, 20.254; 74: 1min HRV, 32.681; 74: 5min HRV, 23.049; 75: HR, 101.475; 75: RR, 16.881; 75: 1min HRV, 21.624; 76: HR, 100.534; 76: RR, 19.810; 76: 1min HRV, 16.212; 77: HR, 100.017; 77: RR, 17.949; 77: 1min HRV, 17.357; 78: HR, 102.121; 78: RR, 18.190; 78: 1min HRV, 13.711; 79: HR, 99.153; 79: RR, 17.661; 79: 1min HRV, 17.442; 79: 5min HRV, 18.412; 80: HR, 99.102; 80: RR, 18.763; 80: 1min HRV, 14.854; 81: HR, 97.5; 81: RR, 20.966; 81: 1min HRV, 12.589; 82: HR, 98.814; 82: RR, 18.475; 82: 1min HRV, 18.978; 83: HR, 96.672; 83: RR, 19.0; 83: 1min HRV, 13.628; 84: HR, 101.678; 84: RR, 21.288; 84: 1min HRV, 22.110; 84: 5min HRV, 20.979; 85: HR, 102.508; 85: RR, 20.085; 85: 1min HRV, 18.928; 85: LR IV BOLUS -, 1000 ML; 86: SARS-COV-, 2 RNA: Not Detected; 86: HR, 102.397; 86: RR, 17.707; 86: 1min HRV, 24.139; 87: HR, 101.610; 87: RR, 19.661; 87: 1min HRV, 30.701; 88: HR, 110.259; 88: RR, 19.207; 88: 1min HRV, 29.053; 89: HR, 115.8; 89: RR, 19.870; 89: 1min HRV, 31.107; 89: 5min HRV, 35.486; 0: Age, 25; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.7; 0: Triage HR, 104.0; 0: Triage RR, 18.0; 0: Triage SBP, 126.0; 0: Triage DBP, 78.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,FEMALE GENITAL PROBLEM",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, we first evaluate for any indications of sepsis, such as persistent high heart rate (HR), respiratory rate (RR), temperature, altered mental state, and markers like white blood cell count or lactic acid levels if available. The time series shows elevated HR and RR at various points, but these alone are insufficient without persistent trends or corroborating factors like a confirmed infection source, significant drop in blood pressure, or laboratory markers from the Electronic Health Record (EHR). In this case, without evidence of these additional sepsis indicators, the patient does not appear to be at high risk of developing sepsis within 12 hours based on the provided data.",
        "claims": [
            "To determine the sepsis risk, we first evaluate for indications of sepsis.",
            "Indications of sepsis include persistent high heart rate (HR).",
            "Indications of sepsis include persistent high respiratory rate (RR).",
            "Indications of sepsis include persistent high temperature.",
            "Indications of sepsis include altered mental state.",
            "Indicators of sepsis include markers like white blood cell count or lactic acid levels if available.",
            "The time series shows elevated heart rate (HR) at various points.",
            "The time series shows elevated respiratory rate (RR) at various points.",
            "Elevated HR and RR alone are insufficient for predicting sepsis risk.",
            "Persistent trends are necessary for assessing sepsis risk.",
            "Corroborating factors are needed to confirm sepsis risk.",
            "Corroborating factors include a confirmed infection source.",
            "Corroborating factors include a significant drop in blood pressure.",
            "Corroborating factors include laboratory markers from the Electronic Health Record (EHR).",
            "Without evidence of additional sepsis indicators, the patient does not appear to be at high risk of developing sepsis.",
            "The assessment is based on the provided data.",
            "The patient does not appear to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Indications of sepsis include persistent high heart rate (HR).",
            "Indications of sepsis include persistent high respiratory rate (RR).",
            "Indications of sepsis include persistent high temperature.",
            "Elevated HR and RR alone are insufficient for predicting sepsis risk."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.8,
            0.7
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "A persistent high heart rate (HR) can contribute to the shock index, specifically when coupled with systolic BP, which is a hallmark of haemodynamic instability associated with severe sepsis. However, the claim focuses solely on the HR and does not mention systolic BP, which is required to fully assess the shock index. Thus, while there is a partial alignment to the shock index concept, it is not complete, warranting a moderate alignment rating.",
            "A persistent high respiratory rate is one of the factors used in the qSOFA score, which flags the high risk of sepsis-related organ dysfunction. The alignment is strong but not complete, as a qSOFA score requires at least one additional criterion (such as altered mentation or low systolic blood pressure) to be fully applicable. The claim partially aligns with the category by referencing an element of the qSOFA criteria.",
            "Persistent high temperature is one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. Although the exact temperature is not specified, the mention of a high temperature strongly suggests the presence of a condition that could meet the SIRS criterion of temperature\u202f>\u202f38\u202f\u00b0C. Thus, there is a strong alignment with this category, but without an exact temperature value, it doesn't fully confirm it.",
            "The claim mentions elevated heart rate (HR) and respiratory rate (RR), which are criteria under the SIRS category, indicating systemic inflammation. However, since the claim states these alone are insufficient for predicting sepsis risk, the alignment is not direct or complete, but the relevance to SIRS is clear. Therefore, the rating reflects this partial but meaningful alignment."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    },
    {
        "input": "7: HR, 100.0; 7: RR, 16.0; 7: SpO2, 93.364; 7: Pain, 10.0; 7: Temp, 97.5; 8: SpO2, 96.0; 9: HR, 97.714; 9: 1min HRV, 46.887; 9: 5min HRV, 46.887; 9: SBP, 80.0; 9: DBP, 56.0; 9: MAP, 64.0; 10: HR, 99.339; 10: 1min HRV, 38.734; 11: HR, 98.414; 11: SpO2, 98.476; 11: 1min HRV, 37.015; 12: HR, 97.763; 12: 1min HRV, 37.484; 13: HR, 97.458; 13: SpO2, 100.0; 13: Perf, 0.11; 13: 1min HRV, 27.611; 14: HR, 97.018; 14: SpO2, 100.0; 14: Perf, 0.11; 14: 1min HRV, 22.578; 14: 5min HRV, 33.647; 15: HR, 97.034; 15: 1min HRV, 29.255; 16: HR, 95.672; 16: 1min HRV, 29.521; 17: HR, 94.644; 17: SpO2, 95.667; 17: 1min HRV, 20.008; 18: HR, 97.034; 18: SpO2, 97.474; 18: 1min HRV, 39.668; 19: HR, 95.75; 19: SpO2, 98.733; 19: 1min HRV, 26.890; 19: 5min HRV, 30.244; 19: SBP, 93.0; 19: DBP, 67.0; 19: MAP, 75.667; 20: HR, 96.153; 20: SpO2, 85.5; 20: 1min HRV, 29.099; 20: SBP, 93.0; 20: DBP, 67.0; 20: MAP, 75.667; 21: HR, 98.155; 21: SpO2, 100.0; 21: 1min HRV, 16.114; 22: HR, 95.508; 22: SpO2, 99.966; 22: 1min HRV, 19.910; 23: HR, 95.424; 23: SpO2, 100.0; 23: 1min HRV, 23.032; 24: HR, 94.810; 24: SpO2, 100.0; 24: 1min HRV, 13.884; 24: 5min HRV, 22.364; 25: HR, 92.966; 25: SpO2, 100.0; 25: 1min HRV, 9.650; 26: HR, 93.138; 26: SpO2, 100.0; 26: 1min HRV, 5.931; 27: HR, 94.695; 27: 1min HRV, 32.017; 28: HR, 93.5; 28: SpO2, 99.4; 28: 1min HRV, 36.406; 29: HR, 96.881; 29: SpO2, 99.0; 29: 1min HRV, 39.831; 29: 5min HRV, 30.991; 30: HR, 96.627; 30: SpO2, 100.0; 30: 1min HRV, 28.922; 31: HR, 95.796; 31: SpO2, 100.0; 31: 1min HRV, 28.161; 32: HR, 95.746; 32: SpO2, 96.556; 32: 1min HRV, 15.114; 33: HR, 95.293; 33: SpO2, 91.8; 33: 1min HRV, 18.812; 34: HR, 97.448; 34: SpO2, 93.95; 34: 1min HRV, 10.198; 34: 5min HRV, 22.786; 35: HR, 97.085; 35: SpO2, 94.5; 35: 1min HRV, 15.337; 35: ASPIRIN, 81 MG PO CHEW; 35: ACETAMINOPHEN, 500 MG PO TABS; 36: HR, 98.241; 36: SpO2, 95.518; 36: 1min HRV, 24.382; 37: HR, 97.492; 37: SpO2, 93.096; 37: 1min HRV, 45.606; 38: HR, 97.310; 38: SpO2, 93.85; 38: Perf, 0.24; 38: 1min HRV, 44.786; 39: HR, 97.305; 39: SpO2, 95.474; 39: Perf, 0.24; 39: 1min HRV, 40.561; 39: 5min HRV, 38.341; 40: HR, 97.0; 40: SpO2, 99.2; 40: Perf, 0.24; 40: 1min HRV, 39.062; 41: HR, 96.983; 41: SpO2, 100.0; 41: 1min HRV, 48.266; 42: HR, 97.356; 42: SpO2, 99.0; 42: 1min HRV, 40.408; 43: HR, 95.621; 43: SpO2, 100.0; 43: 1min HRV, 42.188; 44: HR, 96.5; 44: SpO2, 100.0; 44: 1min HRV, 37.516; 44: 5min HRV, 42.290; 45: HR, 92.847; 45: SpO2, 100.0; 45: 1min HRV, 23.501; 46: HR, 94.397; 46: SpO2, 100.0; 46: 1min HRV, 29.513; 47: HR, 93.034; 47: SpO2, 98.647; 47: 1min HRV, 32.125; 48: HR, 95.667; 48: SpO2, 99.143; 48: 1min HRV, 14.480; 49: HR, 93.831; 49: SpO2, 99.531; 49: 1min HRV, 16.465; 49: 5min HRV, 25.851; 50: HR, 93.661; 50: SpO2, 98.571; 50: 1min HRV, 13.106; 51: HR, 93.207; 51: 1min HRV, 11.248; 52: HR, 92.525; 52: 1min HRV, 12.237; 53: HR, 92.534; 53: SpO2, 100.0; 53: 1min HRV, 11.557; 54: HR, 92.508; 54: SpO2, 96.143; 54: 1min HRV, 6.789; 54: 5min HRV, 11.654; 54: Pain, 10.0; 55: HR, 92.559; 55: SpO2, 100.0; 55: 1min HRV, 9.271; 56: HR, 92.862; 56: SpO2, 99.853; 56: 1min HRV, 8.397; 57: HR, 92.237; 57: SpO2, 100.0; 57: 1min HRV, 9.517; 58: HR, 92.655; 58: SpO2, 99.955; 58: Perf, 0.15; 58: 1min HRV, 9.605; 59: HR, 93.0; 59: SpO2, 100.0; 59: Perf, 0.15; 59: 1min HRV, 6.399; 59: 5min HRV, 8.951; 60: HR, 92.897; 60: SpO2, 100.0; 60: Perf, 0.2; 60: 1min HRV, 7.052; 61: HR, 92.949; 61: SpO2, 100.0; 61: Perf, 0.21; 61: 1min HRV, 6.408; 62: HR, 92.492; 62: SpO2, 100.0; 62: Perf, 0.229; 62: 1min HRV, 7.471; 63: HR, 92.138; 63: 1min HRV, 8.428; 64: HR, 93.305; 64: SpO2, 100.0; 64: Perf, 0.216; 64: 1min HRV, 18.790; 64: 5min HRV, 10.843; 65: HR, 88.298; 65: SpO2, 100.0; 65: Perf, 0.23; 65: 1min HRV, 14.646; 66: HR, 91.559; 66: SpO2, 100.0; 66: 1min HRV, 13.013; 67: HR, 92.644; 67: SpO2, 100.0; 67: 1min HRV, 24.961; 68: HR, 91.724; 68: SpO2, 100.0; 68: 1min HRV, 43.105; 69: HR, 92.655; 69: SpO2, 96.95; 69: 1min HRV, 33.333; 69: 5min HRV, 28.986; 70: HR, 91.552; 70: SpO2, 93.75; 70: 1min HRV, 51.283; 71: HR, 90.492; 71: SpO2, 99.933; 71: Perf, 0.15; 71: 1min HRV, 22.465; 72: HR, 91.153; 72: SpO2, 99.867; 72: Perf, 0.155; 72: 1min HRV, 5.308; 73: HR, 91.741; 73: SpO2, 99.848; 73: Perf, 0.159; 73: 1min HRV, 22.532; 74: HR, 89.729; 74: SpO2, 99.595; 74: Perf, 0.160; 74: 1min HRV, 24.310; 74: 5min HRV, 26.494; 75: HR, 90.667; 75: SpO2, 100.0; 75: Perf, 0.165; 75: 1min HRV, 23.716; 76: HR, 91.729; 76: SpO2, 100.0; 76: Perf, 0.178; 76: 1min HRV, 22.482; 77: HR, 93.135; 77: SpO2, 97.852; 77: Perf, 0.18; 77: 1min HRV, 3.623; 78: HR, 97.52; 78: SpO2, 97.167; 78: 1min HRV, 37.103; 78: SBP, 72.0; 78: DBP, 54.0; 78: MAP, 60.0; 79: HR, 98.288; 79: SpO2, 98.667; 79: 1min HRV, 25.253; 79: 5min HRV, 35.545; 79: SBP, 72.0; 79: DBP, nan; 79: MAP, nan; 80: HR, 98.034; 80: SpO2, 100.0; 80: Perf, 0.22; 80: 1min HRV, 30.413; 80: SBP, 69.0; 80: DBP, 52.0; 80: MAP, 57.667; 81: HR, 97.949; 81: SpO2, 100.0; 81: Perf, 0.255; 81: 1min HRV, 28.517; 81: SBP, 69.0; 81: DBP, 52.0; 81: MAP, 57.667; 82: HR, 98.068; 82: SpO2, 100.0; 82: Perf, 0.279; 82: 1min HRV, 31.266; 83: HR, 97.621; 83: SpO2, 100.0; 83: Perf, 0.299; 83: 1min HRV, 23.406; 84: 5min HRV, 28.597; 86: NS IV BOLUS -, 250 ML; 94: HR:, 93.0; 94: SpO2, 100.0; 94: SBP, 86.0; 94: DBP, 68.0; 94: MAP, 74.0; 100: SARS-COV-2 RNA, Not Detected; 109: HR, 87.0; 109: SpO2, 100.0; 109: SBP, 76.0; 109: DBP, 48.0; 109: MAP, 57.333; 117: INR, 1.2; 117: PROTHROMBIN TIME, 15.1 seconds; 118: PART. THROMBOPLASTIN TIME, 47.1 seconds; 118: NS IV BOLUS -, 250 ML; 0: Age:, 65; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 16.0; 0: Triage SBP, 93.0; 0: Triage DBP, 67.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess the sepsis risk, we need to examine vital signs, particularly blood pressure, heart rate, respiratory rate, and oxygen saturation (SpO2), and look for evidence of organ dysfunction, which could manifest as altered parameters such as heart rate variability (HRV). The patient shows sustained low blood pressure with SBP dropping as low as 69 mmHg and DBP as low as 48 mmHg, despite receiving intravenous fluid boluses. There is also a consistently high heart rate and fluctuating oxygen saturation levels, with occasional drops below 95%, suggesting potential hypoxia or impaired oxygen delivery. The presence of such hemodynamic instability and potential signs of evolving organ dysfunction indicates the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To assess the sepsis risk, vital signs need to be examined.",
            "Key vital signs include blood pressure, heart rate, respiratory rate, and oxygen saturation (SpO2).",
            "Evidence of organ dysfunction should be looked for in sepsis risk assessment.",
            "Organ dysfunction may manifest as altered parameters like heart rate variability (HRV).",
            "The patient shows sustained low blood pressure.",
            "The systolic blood pressure (SBP) has dropped as low as 69 mmHg.",
            "The diastolic blood pressure (DBP) has dropped as low as 48 mmHg.",
            "The low blood pressure occurs despite the patient receiving intravenous fluid boluses.",
            "There is a consistently high heart rate in the patient.",
            "Oxygen saturation levels are fluctuating in the patient.",
            "Occasionally, the oxygen saturation levels drop below 95%.",
            "A drop in oxygen saturation below 95% suggests potential hypoxia or impaired oxygen delivery.",
            "The patient exhibits hemodynamic instability.",
            "The presence of hemodynamic instability and potential organ dysfunction indicates high sepsis risk.",
            "The patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Key vital signs include blood pressure, heart rate, respiratory rate, and oxygen saturation (SpO2).",
            "Evidence of organ dysfunction should be looked for in sepsis risk assessment.",
            "Organ dysfunction may manifest as altered parameters like heart rate variability (HRV).",
            "The patient shows sustained low blood pressure.",
            "The systolic blood pressure (SBP) has dropped as low as 69 mmHg.",
            "The diastolic blood pressure (DBP) has dropped as low as 48 mmHg.",
            "The low blood pressure occurs despite the patient receiving intravenous fluid boluses.",
            "There is a consistently high heart rate in the patient.",
            "Oxygen saturation levels are fluctuating in the patient.",
            "Occasionally, the oxygen saturation levels drop below 95%.",
            "A drop in oxygen saturation below 95% suggests potential hypoxia or impaired oxygen delivery.",
            "The patient exhibits hemodynamic instability.",
            "The presence of hemodynamic instability and potential organ dysfunction indicates high sepsis risk."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.3,
            0.8,
            1.0,
            0.3,
            0.9,
            0.8,
            0.5,
            0.4,
            0.7,
            0.8,
            0.7
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)"
        ],
        "alignment_reasonings": [
            "The claim mentions key vital signs such as blood pressure, heart rate, respiratory rate, and oxygen saturation (SpO2), which are components used to calculate the NEWS score. However, the claim does not provide specific values or indicate an elevated NEWS score. This makes the alignment relatively weak because it broadly highlights the importance of monitoring vital signs without directly linking them to a sepsis prediction criteria.",
            "The claim pertains to looking for evidence of organ dysfunction, which is directly assessed by the SOFA score. While the claim does not mention a specific SOFA score increase or criteria, it aligns in focus and purpose with the assessment for organ dysfunction. The alignment is relevant but would be stronger with explicit evidence of a SOFA score increase.",
            "The claim references \"organ dysfunction\" which relates vaguely to the purpose of the qSOFA score used to flag high risk of sepsis-related organ dysfunction. However, heart rate variability is not directly measured by qSOFA criteria, which include respiratory rate, systolic blood pressure, and altered mentation. The alignment is weak and indirect, as it suggests potential organ dysfunction but does not closely match the specific metrics of the qSOFA score.",
            "The claim of \"sustained low blood pressure\" aligns significantly with the category of Sepsis-Associated Hypotension, as it implies a persistent drop in blood pressure, which is a key characteristic of this category. However, without specific values such as SBP <90 mmHg, MAP <70 mmHg, or a clear drop of \u226540 mmHg from baseline, the alignment isn't fully definitive, hence not rated as a full 1.0.",
            "The claim directly states that the systolic blood pressure (SBP) has dropped to 69 mmHg, which falls below the SBP threshold of <90 mmHg used to define sepsis-associated hypotension. This condition is explicitly listed as an indicator of progression toward septic shock, making the alignment perfect.",
            "The claim references a drop in diastolic blood pressure to 48 mmHg, which is related to the concept of hypotension. However, the category specifically focuses on systolic blood pressure, mean arterial pressure, or significant drops from baseline, rather than solely diastolic measurements. Thus, while there is an indirect relationship to the hypotension category, the alignment is not strong.",
            "The claim describes a scenario where the patient is experiencing low blood pressure despite receiving intravenous fluid boluses, indicating refractory hypotension. This situation strongly suggests sepsis-associated hypotension, which is specifically characterized by hypotension resistant to fluid resuscitation. The alignment is very strong with the category but isn't mentioned explicitly to be a result of sepsis, thus slightly below perfect alignment.",
            "A high heart rate is explicitly one of the SIRS criteria (heart rate >90 bpm), which are used to identify systemic inflammation consistent with early sepsis. The claim's focus on a consistently high heart rate strongly aligns with SIRS criteria, though it does not specify a second SIRS criterion, making the alignment not fully perfect.",
            "Fluctuating oxygen saturation levels suggest potential respiratory distress, which can relate to impaired oxygenation, a component of the SOFA score (PaO\u2082/FiO\u2082). While it's not directly a SOFA measure, it indicates possible organ dysfunction. The alignment is indirect but relevant, reflecting moderate specificity to the category.",
            "The claim about oxygen saturation occasionally dropping below 95% does not directly correlate with a SOFA component, though it is indicative of possible impaired oxygenation. This can relate indirectly to PaO\u2082/FiO\u2082 ratios used in SOFA assessments. However, the alignment is weak because the claim does not specifically measure thresholds used in the SOFA score.",
            "Oxygen saturation isn't directly a SOFA measure, but hypoxia relates conceptually to impaired oxygenation reflected in PaO\u2082/FiO\u2082, a SOFA component. While not a direct match, the claim indicates possible oxygen delivery issues akin to what a SOFA score evaluates, hence a moderate alignment.",
            "Hemodynamic instability often aligns with an elevated shock index, as both involve irregularities in blood flow and pressure. While the claim doesn't provide specific values such as heart rate or blood pressure to definitively correlate with a shock index \u2265 1.0, it strongly implies a state of instability consistent with this category. Thus, the alignment is strong but not perfect because specific measurements are absent.",
            "The claim refers to hemodynamic instability and potential organ dysfunction. The Elevated Shock Index category specifically addresses hemodynamic instability, which aligns well with the claim. Although the claim also mentions potential organ dysfunction, which could relate to a few categories, the mention of hemodynamic instability is more directly aligned with the Shock Index category. The rating of 0.7 reflects a strong alignment due to the specificity of the hemodynamic aspect in the claim, even though the organ dysfunction is discussed more generally, not pointing to a specific category."
        ],
        "final_alignment_score": 0.6307692307692307,
        "accuracy": 1
    },
    {
        "input": "3: HR, 121.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 129.0; 3: DBP, 87.0; 3: MAP, 101.0; 3: Temp, 99.3; 16: SpO2, 96.45; 16: Perf, 0.6; 17: HR, 133.538; 17: RR, 22.158; 17: SpO2, 97.130; 17: Perf, 0.471; 17: 1min HRV, 16.532; 18: HR, 133.305; 18: RR, 21.966; 18: SpO2, 96.625; 18: Perf, 0.406; 18: 1min HRV, 19.165; 18: SBP, 114.0; 18: DBP, 76.0; 18: MAP, 88.667; 19: HR, 139.339; 19: RR, 18.746; 19: SpO2, 97.186; 19: Perf, 0.443; 19: 1min HRV, 20.527; 19: 5min HRV, 20.534; 20: HR, 131.103; 20: RR, 23.862; 20: SpO2, 96.793; 20: Perf, 0.505; 20: 1min HRV, 16.418; 21: HR, 130.086; 21: RR, 22.190; 21: SpO2, 97.138; 21: Perf, 0.542; 21: 1min HRV, 12.962; 22: HR, 129.103; 22: RR, 20.5; 22: SpO2, 96.931; 22: Perf, 0.499; 22: 1min HRV, 9.228; 23: HR, 131.356; 23: RR, 21.898; 23: SpO2, 97.356; 23: Perf, 0.426; 23: 1min HRV, 11.118; 24: HR, 131.390; 24: RR, 21.932; 24: SpO2, 97.441; 24: Perf, 0.427; 24: 1min HRV, 12.103; 24: 5min HRV, 13.005; 25: HR, 131.948; 25: RR, 21.914; 25: SpO2, 97.276; 25: Perf, 0.387; 25: 1min HRV, 10.485; 26: HR, 133.322; 26: RR, 22.390; 26: SpO2, 97.695; 26: Perf, 0.369; 26: 1min HRV, 13.968; 27: HR, 133.121; 27: RR, 22.517; 27: SpO2, 98.034; 27: Perf, 0.367; 27: 1min HRV, 16.834; 28: HR, 130.119; 28: RR, 22.068; 28: SpO2, 97.279; 28: Perf, 0.408; 28: 1min HRV, 10.430; 29: HR, 129.169; 29: RR, 20.814; 29: SpO2, 97.424; 29: Perf, 0.623; 29: 1min HRV, 5.235; 29: 5min HRV, 13.384; 29: SBP, 113.0; 29: DBP, 72.0; 29: MAP, 85.667; 30: HR, 129.017; 30: RR, 21.931; 30: SpO2, 98.023; 30: Perf, 0.61; 30: 1min HRV, 8.060; 30: SBP, 113.0; 30: DBP, 72.0; 30: MAP, 85.667; 31: HR, 130.0; 31: RR, 22.655; 31: SpO2, 98.0; 31: Perf, 0.628; 31: 1min HRV, 7.261; 32: HR, 130.810; 32: RR, 21.621; 32: SpO2, 98.0; 32: Perf, 0.555; 32: 1min HRV, 5.514; 33: HR, 130.661; 33: RR, 25.169; 33: SpO2, 98.0; 33: Perf, 0.507; 33: 1min HRV, 10.328; 34: 5min HRV, 8.431; 61: POC PH (V) ISTAT, 7.41; 61: POC LACTATE ISTAT, 1.49 mmol/L; 61: POC O2 SATURATION ISTAT VENOUS, 77 %; 61: POC PO2 (V) ISTAT, 41 mmHg; 61: POC TCO2 (V) ISTAT, 24 mmol/L; 61: POC BASE EXCESS ISTAT, -2 mmol/L; 61: POC PCO2 (V) ISTAT, 36.8 mmHg; 61: POC HCO3 (V) ISTAT, 23.1 mmol/L; 66: POC CREATININE ISTAT, 0.2 mg/dL; 66: POC EGFR REFIT WITHOUT RACE (2021), 169 mL/min/1.73 m2; 78: RSV, Not Detected; 78: INFLUENZA B, Not Detected; 78: SARS-COV-2 RNA, Not Detected; 78: INFLUENZA A, Not Detected; 84: WAM DIFTYP, AUTO; 84: NEUTROPHIL % (AUTO DIFF), 70.3 %; 84: PLATELET COUNT (PLT), 275 K/uL; 84: WHITE BLOOD CELLS (WBC), 7.6 K/uL; 84: EOSINOPHIL % (AUTO DIFF), 1.1 %; 84: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 84: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 84: BASOPHIL % (AUTO DIFF), 0.4 %; 84: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 84: NRBC PERCENT (HEMATOLOGY), 0.0 %; 84: MONOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 84: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 84: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 84: HEMATOCRIT (HCT), 47.6 %; 84: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.35 K/uL; 84: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 84: LYMPHOCYTE % (AUTO DIFF), 21.1 %; 84: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 84: RED BLOOD CELLS (RBC), 5.91 MIL/uL; 84: MONOCYTE % (AUTO DIFF), 6.8 %; 84: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.2 pg; 84: RED CELL DISTRIBUTION WIDTH (RDW), 17.4 %; 84: HEMOGLOBIN (HGB), 14.9 g/dL; 84: MEAN CORPUSCULAR VOLUME (MCV), 80.5 fL; 97: INR, 1.0; 97: PROTHROMBIN TIME, 13.8 seconds; 98: PART. THROMBOPLASTIN TIME, 32.9 seconds; 111: HIGH SENSITIVITY TROPONIN, <4 ng/L; 112: SODIUM, 137 mmol/L; 112: AST (SGOT), 57 U/L; 112: PROTEIN TOTAL, 8.1 g/dL; 112: BILIRUBIN TOTAL, 0.5 mg/dL; 112: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 112: ALKALINE PHOSPHATASE, 165 U/L; 112: GLUCOSE, 146 mg/dL; 112: CHLORIDE, 107 mmol/L; 112: GLOBULIN, 4.1 g/dL; 112: ANION GAP, 10 mmol/L; 112: POTASSIUM, 4.1 mmol/L; 112: EGFR REFIT WITHOUT RACE (2021), 181 mL/min/1.73 m2; 112: CREATININE, 0.16 mg/dL; 112: CALCIUM, 9.4 mg/dL; 112: CORRECTED CALCIUM, 9.4 mg/dL; 112: ALBUMIN, 4.0 g/dL; 112: ALT (SGPT), 122 U/L; 112: C-REACTIVE PROTEIN (CRP), 2.1 mg/dL; 112: CO2, 20 mmol/L; 119: HR, 120.0; 119: RR, 20.0; 119: SpO2, 96.0; 119: SBP, 120.0; 119: DBP, 90.0; 119: MAP, 100.0; 119: Pain, 0.0; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 121.0; 0: Triage RR, 22.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, VASCULAR ACCESS PROBLEM",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess sepsis risk, the first subquestion is whether there are vital signs indicating sepsis, such as high HR, RR, or low BP. The patient shows tachycardia (HR > 90 bpm) but stable BP and normal RR. Second, we assess lab markers and there's normal lactate levels (<2 mmol/L), which do not indicate sepsis. No inflammatory markers, like CRP, are notably elevated, and blood tests don\u2019t show abnormalities commonly associated with sepsis, such as increased WBC or a left shift. Finally, respiratory and oxygenation parameters are stable. Based on this, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To assess sepsis risk, the first subquestion is whether there are vital signs indicating sepsis. Vital signs indicative of sepsis include high heart rate (HR), high respiratory rate (RR), or low blood pressure (BP). The patient shows tachycardia with a heart rate greater than 90 beats per minute (bpm). The patient's blood pressure is stable. The patient's respiratory rate is normal. Lab markers are assessed for sepsis risk. The lactate levels are normal, at less than 2 mmol/L. Normal lactate levels do not indicate sepsis. No inflammatory markers, such as C-reactive protein (CRP), are notably elevated. Blood tests do not show abnormalities commonly associated with sepsis. Common abnormalities associated with sepsis include increased white blood cell (WBC) count or a left shift. Respiratory parameters are stable. Oxygenation parameters are stable. Based on the assessment, the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "To assess sepsis risk, the first subquestion is whether there are vital signs indicating sepsis. Vital signs indicative of sepsis include high heart rate (HR), high respiratory rate (RR), or low blood pressure (BP). The patient shows tachycardia with a heart rate greater than 90 beats per minute (bpm). The patient's blood pressure is stable. The patient's respiratory rate is normal. Lab markers are assessed for sepsis risk. The lactate levels are normal, at less than 2 mmol/L. Normal lactate levels do not indicate sepsis. No inflammatory markers, such as C-reactive protein (CRP), are notably elevated. Blood tests do not show abnormalities commonly associated with sepsis. Common abnormalities associated with sepsis include increased white blood cell (WBC) count or a left shift. Respiratory parameters are stable. Oxygenation parameters are stable. Based on the assessment, the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "The claim includes a mention of tachycardia (heart rate > 90 bpm), which aligns with one of the SIRS criteria. However, other potential indicators, such as abnormalities in respiratory rate or blood pressure that could further reinforce alignment with SIRS, are not met. Therefore, while the presence of tachycardia does relate to SIRS, the absence of other criteria reduces the strength of alignment somewhat. Nonetheless, the explicit mention of the heart rate exceeding 90 bpm is directly related to one SIRS criterion, resulting in a moderately strong alignment."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 0
    },
    {
        "input": "4: HR, 95.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 92.0; 4: DBP, 64.0; 4: MAP, 73.333; 4: Temp, 97.5; 5: SBP, 86.0; 5: DBP, 59.0; 5: MAP, 68.0; 8: Pain, 2.0; 38: POC PH (V) ISTAT, 7.36; 38: POC LACTATE ISTAT, 2.34 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 38: POC HCO3 (V) ISTAT, 29.3 mmol/L; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC PO2 (V) ISTAT, 24 mmHg; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 40 %; 44: WAM DIFTYP, AUTO; 44: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 44: NEUTROPHIL % (AUTO DIFF), 58.6 %; 44: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 44: RED CELL DISTRIBUTION WIDTH (RDW), 15.0 %; 44: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.38 K/uL; 44: HEMOGLOBIN (HGB), 11.4 g/dL; 44: EOSINOPHIL % (AUTO DIFF), 4.4 %; 44: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 44: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 44: NRBC PERCENT (HEMATOLOGY), 0.0 %; 44: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.66 K/uL; 44: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.03 K/uL; 44: MONOCYTE % (AUTO DIFF), 5.3 %; 44: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.7 pg; 44: BASOPHIL % (AUTO DIFF), 0.5 %; 44: HEMATOCRIT (HCT), 38.3 %; 44: MEAN CORPUSCULAR VOLUME (MCV), 86.5 fL; 44: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.8 g/dL; 44: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 44: LYMPHOCYTE % (AUTO DIFF), 30.9 %; 44: PLATELET COUNT (PLT), 425 K/uL; 44: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 44: RED BLOOD CELLS (RBC), 4.43 MIL/uL; 45: SpO2, 97.435; 46: SpO2, 95.0; 46: Perf, 0.797; 47: SpO2, 94.949; 47: Perf, 0.570; 48: SpO2, 97.222; 48: Perf, 0.413; 48: SBP, 106.0; 48: DBP, 63.0; 48: MAP, 77.333; 49: SpO2, 96.627; 49: Perf, 0.574; 50: SpO2, 95.379; 50: Perf, 0.486; 51: SpO2, 95.356; 51: Perf, 0.394; 52: SpO2, 95.759; 52: Perf, 0.377; 53: SpO2, 96.949; 53: Perf, 0.411; 54: SpO2, 97.0; 54: Perf, 0.439; 55: SpO2, 96.586; 55: Perf, 0.461; 56: SpO2, 97.0; 56: Perf, 0.387; 57: INR, 1.0; 57: PROTHROMBIN TIME, 13.5 seconds; 57: PART. THROMBOPLASTIN TIME, 27.1 seconds; 57: SpO2, 97.0; 57: Perf, 0.376; 58: HR, 79.0; 58: SpO2, 96.475; 58: Perf, 0.393; 59: HR, 79.0; 59: SpO2, 97.0; 59: Perf, 0.442; 59: SBP, 102.0; 59: DBP, 64.0; 59: MAP, 76.667; 60: SpO2, 97.333; 60: Perf, 0.45; 60: SBP, 102.0; 60: DBP, 64.0; 60: MAP, 76.667; 61: SpO2, 96.627; 61: Perf, 0.591; 62: SpO2, 96.207; 62: Perf, 0.531; 63: SpO2, 97.017; 63: Perf, 0.563; 64: SpO2, 96.678; 64: Perf, 0.502; 65: SpO2, 96.860; 65: Perf, 0.598; 66: SpO2, 96.483; 66: Perf, 0.573; 67: SpO2, 95.759; 67: Perf, 0.473; 68: SpO2, 94.576; 68: Perf, 0.374; 69: SpO2, 95.136; 69: Perf, 0.384; 70: SpO2, 95.397; 70: Perf, 0.361; 71: SpO2, 96.644; 71: Perf, 0.393; 72: SpO2, 96.879; 72: Perf, 0.448; 73: SpO2, 96.898; 73: Perf, 0.455; 74: SpO2, 97.0; 74: Perf, 0.478; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CALCIUM, 9.7 mg/dL; 75: GLUCOSE, 133 mg/dL; 75: CO2, 26 mmol/L; 75: AST (SGOT), 24 U/L; 75: ALBUMIN, 4.1 g/dL; 75: CORRECTED CALCIUM, 9.6 mg/dL; 75: PROTEIN TOTAL, 7.8 g/dL; 75: ANION GAP, 10 mmol/L; 75: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 75: CREATININE, 0.74 mg/dL; 75: GLOBULIN, 3.7 g/dL; 75: ALT (SGPT), 11 U/L; 75: BILIRUBIN TOTAL, 0.3 mg/dL; 75: SODIUM, 136 mmol/L; 75: ALKALINE PHOSPHATASE, 86 U/L; 75: CHLORIDE, 100 mmol/L; 75: POTASSIUM, 4.9 mmol/L; 75: SpO2, 97.190; 75: Perf, 0.538; 76: SpO2, 97.305; 76: Perf, 0.482; 77: SpO2, 96.897; 77: Perf, 0.432; 78: SpO2, 97.155; 78: Perf, 0.404; 79: SpO2, 97.661; 79: Perf, 0.421; 80: SARS-COV-2 RNA, Not Detected; 80: SpO2, 96.525; 80: Perf, 0.404; 81: SpO2, 96.695; 81: Perf, 0.383; 82: SpO2, 96.603; 82: Perf, 0.349; 82: LR IV BOLUS -, 1000 ML; 83: SpO, 2: 96.704; 83: Perf, 0.351; 84: SpO2, 96.604; 85: SpO2, 95.845; 86: SpO2, 96.576; 86: Perf, 0.305; 87: SpO2, 96.707; 87: Perf, 0.307; 88: SpO2, 96.522; 88: Perf, 0.3; 89: SpO2, 97.537; 89: Perf, 0.3; 90: SpO2, 97.0; 90: Perf, 0.382; 91: SpO2, 96.288; 91: Perf, 0.401; 92: SpO2, 94.915; 92: Perf, 0.369; 93: SpO2, 96.949; 93: Perf, 0.290; 94: SpO2, 95.310; 94: Perf, 0.277; 95: SpO2, 96.644; 95: Perf, 0.301; 96: SpO2, 95.537; 96: Perf, 0.269; 97: SpO2, 96.064; 97: Perf, 0.260; 98: SpO2, 97.091; 98: Perf, 0.255; 99: SpO2, 96.612; 99: Perf, 0.264; 100: SpO2, 96.409; 100: Perf, 0.242; 101: SpO2, 96.231; 101: Perf, 0.246; 102: SpO2, 96.735; 102: Perf, 0.238; 103: SpO2, 97.0; 103: Perf, 0.235; 104: SpO2, 97.217; 104: Perf, 0.236; 105: SpO2, 96.6; 105: Perf, 0.217; 106: SpO2, 96.675; 106: Perf, 0.224; 107: SpO2, 96.081; 107: Perf, 0.240; 108: SpO2, 96.806; 108: Perf, 0.232; 109: SpO2, 96.25; 109: Perf, 0.225; 110: SpO2, 96.759; 110: Perf, 0.220; 111: SpO2, 96.379; 111: Perf, 0.216; 112: SpO2, 96.455; 112: Perf, 0.222; 113: SpO2, 97.125; 113: Perf, 0.221; 114: SpO2, 96.318; 114: Perf, 0.227; 115: SpO2, 96.241; 115: Perf, 0.227; 116: SpO2, 96.714; 116: Perf, 0.216; 117: SpO2, 97.135; 117: Perf, 0.224; 118: SpO2, 97.318; 118: Perf, 0.227; 119: SpO2, 97.467; 119: Perf, 0.21; 0: Age, 90; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The subquestions to assess the risk of sepsis include evaluating vital sign trends, such as heart rate (HR), blood pressure (BP), and respiratory rate (RR), assessing laboratory test results like lactate levels, and considering clinical indicators like age and overall health status. This patient shows relatively stable vital signs, with no significant changes in HR or RR. The lactate level is slightly elevated, which could indicate stress but isn't critically high. The patient doesn't exhibit signs of systemic infection or significant organ dysfunction based on the provided data, which are typically required criteria for confirming sepsis risk.",
        "claims": [
            "The subquestions to assess the risk of sepsis include evaluating vital sign trends.",
            "Vital sign trends include heart rate (HR), blood pressure (BP), and respiratory rate (RR).",
            "Laboratory test results should also be assessed when evaluating sepsis risk.",
            "Lactate levels are an important laboratory test result for assessing sepsis risk.",
            "Clinical indicators, such as age and overall health status, should be considered in the assessment.",
            "This patient shows relatively stable vital signs.",
            "There are no significant changes in the patient's heart rate (HR).",
            "There are no significant changes in the patient's respiratory rate (RR).",
            "The patient's lactate level is slightly elevated.",
            "A slightly elevated lactate level could indicate stress.",
            "The lactate level is not critically high.",
            "The patient does not exhibit signs of systemic infection.",
            "The patient does not exhibit significant organ dysfunction based on the provided data.",
            "Signs of systemic infection and significant organ dysfunction are typically required criteria for confirming sepsis risk."
        ],
        "relevant_claims": [
            "The patient's lactate level is slightly elevated.",
            "A slightly elevated lactate level could indicate stress.",
            "The patient does not exhibit significant organ dysfunction based on the provided data."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.7
        ],
        "alignment_category": [
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The claim mentions a slightly elevated lactate level, which is related to the category of Elevated Serum Lactate (\u22652 mmol/L). Although the claim does not specify the exact lactate value, the mention of elevation suggests tissue hypoperfusion, pertinent to sepsis risk. The alignment is moderate, as the precise threshold (\u22652 mmol/L) isn't confirmed.",
            "The claim concerning a slightly elevated lactate level connects to the category of elevated serum lactate, signaling tissue hypoperfusion. However, the term \"slightly elevated\" lacks specificity and quantitative detail (\u22652 mmol/L), thus offering a weak alignment with the defined threshold for sepsis risk. The mention of \"stress\" rather than sepsis-related hypoperfusion further reduces the claim's relevance to this category.",
            "The mention of a lack of significant organ dysfunction directly relates to the SOFA score, which assesses organ dysfunction. The claim indicates an evaluation of organ function, aligning conceptually with SOFA's function, though it doesn't provide specific numerical data indicating an increase in SOFA points."
        ],
        "final_alignment_score": 0.5666666666666667,
        "accuracy": 1
    },
    {
        "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 99.0; 4: SBP, 141.0; 4: DBP, 92.0; 4: MAP, 108.333; 4: Pain, 6.0; 4: Temp, 97.9; 9: Pain, 7.0; 28: HR, 97.0; 28: RR, 15.0; 28: SpO2, 99.0; 28: SBP, 149.0; 28: DBP, 99.0; 28: MAP, 115.667; 28: Pain, 7.0; 29: SBP, 149.0; 29: DBP, 99.0; 29: MAP, 115.667; 30: SpO2, 98.833; 30: Perf, 2.51; 31: SpO2, 98.847; 31: Perf, 2.238; 32: SpO2, 98.103; 32: Perf, 1.899; 33: SpO2, 96.763; 33: Perf, 2.299; 34: SpO2, 97.034; 34: Perf, 2.379; 35: SpO2, 96.593; 35: Perf, 2.486; 36: SpO2, 98.322; 36: Perf, 2.368; 37: SpO2, 98.569; 37: Perf, 2.020; 38: SpO2, 97.0; 38: Perf, 2.242; 39: SpO2, 96.793; 39: Perf, 2.375; 40: SpO2, 97.814; 40: Perf, 2.22; 41: SpO2, 98.898; 41: Perf, 1.982; 42: SpO2, 98.983; 42: Perf, 1.713; 43: SpO2, 99.034; 43: Perf, 1.991; 44: SpO2, 97.5; 44: Perf, 2.662; 45: SpO2, 97.814; 45: Perf, 2.922; 46: SpO2, 98.322; 46: Perf, 2.619; 47: SpO2, 98.793; 47: Perf, 2.243; 48: SpO2, 97.407; 48: Perf, 1.931; 49: SpO2, 97.724; 49: Perf, 1.593; 50: SpO2, 97.898; 50: Perf, 1.594; 51: SpO2, 97.915; 51: Perf, 1.571; 52: SpO2, 98.776; 52: Perf, 1.957; 53: SpO2, 98.661; 53: Perf, 2.086; 54: SpO2, 98.328; 54: Perf, 1.897; 55: SpO2, 98.102; 55: Perf, 1.603; 56: SpO2, 98.322; 56: Perf, 1.592; 57: SpO2, 98.534; 57: Perf, 1.642; 58: SpO2, 99.237; 58: Perf, 1.675; 59: SpO2, 97.810; 59: Perf, 1.644; 60: SpO2, 97.729; 60: Perf, 1.421; 61: SpO2, 97.729; 61: Perf, 1.236; 62: SpO2, 98.103; 62: Perf, 1.116; 63: SpO2, 98.102; 63: Perf, 1.111; 64: SpO2, 98.862; 64: Perf, 1.314; 65: SpO2, 98.288; 65: Perf, 1.637; 66: SpO2, 98.810; 66: Perf, 1.958; 67: SpO2, 98.780; 67: Perf, 1.529; 68: SpO2, 97.831; 68: Perf, 1.272; 69: SpO2, 98.379; 69: Perf, 1.351; 70: SpO2, 98.254; 70: Perf, 1.663; 71: SpO2, 97.879; 71: Perf, 1.607; 72: SpO2, 98.746; 72: Perf, 1.151; 73: SpO2, 97.475; 73: Perf, 1.061; 74: SpO2, 97.466; 74: Perf, 1.162; 75: SpO2, 97.661; 75: Perf, 1.278; 76: SpO2, 98.155; 76: Perf, 1.366; 77: SpO2, 98.0; 77: Perf, 1.219; 78: SpO2, 99.034; 78: Perf, 0.794; 79: SpO2, 98.707; 79: Perf, 0.774; 80: SpO2, 97.254; 80: Perf, 1.277; 81: SpO2, 97.138; 81: Perf, 1.397; 82: SpO2, 96.949; 82: Perf, 1.276; 83: SpO2, 97.254; 83: Perf, 0.825; 84: SpO2, 97.483; 84: Perf, 1.056; 85: SpO2, 98.441; 85: Perf, 1.759; 86: SpO2, 98.086; 86: Perf, 1.750; 87: SpO2, 98.627; 87: Perf, 1.313; 88: SpO2, 98.051; 88: Perf, 1.599; 89: SpO2, 98.672; 89: Perf, 1.206; 89: SBP, 151.0; 89: DBP, 87.0; 89: MAP, 108.333; 90: SpO2, 98.864; 90: Perf, 1.203; 91: SpO2, 99.431; 91: Perf, 1.215; 92: SpO2, 98.881; 92: Perf, 1.043; 93: CHLORIDE, 105 mmol/L; 93: GLOBULIN, 2.6 g/dL; 93: ALKALINE PHOSPHATASE, 89 U/L; 93: CREATININE, 1.25 mg/dL; 93: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 93: ALT (SGPT), 29 U/L; 93: EGFR REFIT WITHOUT RACE (2021), 68 mL/min/1.73 m2; 93: AST (SGOT), 29 U/L; 93: CO2, 21 mmol/L; 93: POTASSIUM, 3.6 mmol/L; 93: GLUCOSE, 109 mg/dL; 93: ALBUMIN, 4.3 g/dL; 93: CORRECTED CALCIUM, 8.6 mg/dL; 93: PROTEIN TOTAL, 6.9 g/dL; 93: CALCIUM, 8.8 mg/dL; 93: ANION GAP, 13 mmol/L; 93: SODIUM, 139 mmol/L; 93: BILIRUBIN TOTAL, 0.6 mg/dL; 93: LIPASE, 23 U/L; 93: SpO2, 99.136; 93: Perf, 0.841; 94: SpO2, 98.931; 94: Perf, 0.738; 95: SpO2, 98.203; 95: Perf, 1.045; 96: SpO2, 98.293; 96: Perf, 1.207; 97: SARS-COV-2 RNA, Not Detected; 97: SpO2, 99.458; 97: Perf, 1.211; 98: SpO2, 99.259; 98: Perf, 1.108; 99: SpO2, 100.0; 99: Perf, 0.684; 100: SpO2, 99.932; 100: Perf, 0.549; 101: SpO2, 99.276; 101: Perf, 0.588; 102: SpO2, 98.780; 102: Perf, 0.494; 103: SpO2, 99.052; 103: Perf, 0.49; 104: SpO2, 98.424; 104: Perf, 0.535; 105: SpO2, 98.305; 105: Perf, 0.428; 106: SpO2, 98.897; 106: Perf, 0.391; 107: SpO2, 97.763; 107: Perf, 0.546; 108: SpO2, 98.483; 108: Perf, 0.491; 109: SpO2, 96.593; 109: Perf, 0.523; 110: SpO2, 97.627; 110: Perf, 0.64; 111: SpO2, 97.707; 111: Perf, 0.719; 112: SpO2, 98.525; 112: Perf, 0.737; 113: SpO2, 98.155; 113: Perf, 0.561; 114: SpO2, 97.525; 114: Perf, 0.627; 115: SpO2, 98.085; 115: Perf, 0.650; 116: PLATELET COUNT (PLT), 215 K/uL; 116: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.0 g/dL; 116: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 116: HEMATOCRIT (HCT), 37.6 %; 116: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 116: RED BLOOD CELLS (RBC), 4.01 MIL/uL; 116: MEAN CORPUSCULAR VOLUME (MCV), 93.8 fL; 116: HEMOGLOBIN (HGB), 12.8 g/dL; 116: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.9 pg; 116: NEUTROPHILS BANDS % (MANUAL DIFF), 10.4 %; 116: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.68 K/uL; 116: LYMPHOCYTES % (MANUAL DIFF), 8.7 %; 116: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.17 K/uL; 116: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.09 K/uL; 116: BASOPHILS % (MANUAL DIFF), 1.7 %; 116: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 71.4 %; 116: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.29 K/uL; 116: MONOCYTES % (MANUAL DIFF), 5.2 %; 116: EOSINOPHILS % (MANUAL DIFF), 2.6 %; 116: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 116: SpO2, 99.069; 116: Perf, 0.680; 117: SpO2, 98.864; 117: Perf, 0.548; 118: SpO2, 99.439; 118: Perf, 0.634; 119: SpO2, 98.75; 119: Perf, 0.77; 0: Age, 54; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 141.0; 0: Triage DBP, 92.0; 0: Triage acuity, 3-Urgent; 0: CC, FLANK PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the risk of sepsis, key indicators include vital signs (e.g., heart rate, respiratory rate, temperature, blood pressure), lab results, and clinical symptoms. Throughout the time series, vital signs remain relatively stable and within normal ranges, e.g., HR ~94-97, RR ~15-18, and BP values do not suggest significant hypotension. SpO2 levels are consistently high (above 96%), indicating good oxygenation. Laboratory values, such as normal white blood cell count and absence of significant acidosis or organ dysfunction, further support the conclusion that the patient is currently at low risk for developing sepsis within the next 12 hours.",
        "claims": [
            "Key indicators for determining the risk of sepsis include vital signs, lab results, and clinical symptoms.",
            "Vital signs are important for assessing sepsis risk.",
            "Vital signs include heart rate, respiratory rate, temperature, and blood pressure.",
            "Throughout the time series, vital signs remain relatively stable and within normal ranges.",
            "The heart rate ranges from approximately 94 to 97 beats per minute.",
            "The respiratory rate ranges from approximately 15 to 18 breaths per minute.",
            "Blood pressure values do not suggest significant hypotension.",
            "SpO2 levels are consistently above 96%.",
            "High SpO2 levels indicate good oxygenation.",
            "Laboratory values support the assessment of sepsis risk.",
            "The patient has a normal white blood cell count.",
            "There is an absence of significant acidosis or organ dysfunction.",
            "These findings suggest the patient is currently at low risk for developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Throughout the time series, vital signs remain relatively stable and within normal ranges.",
            "The heart rate ranges from approximately 94 to 97 beats per minute.",
            "Blood pressure values do not suggest significant hypotension.",
            "There is an absence of significant acidosis or organ dysfunction."
        ],
        "alignment_scores": [
            0.2,
            0.6,
            0.3,
            0.7
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The claim indicates that the vital signs are stable and within normal ranges, which suggests the patient would likely have a low NEWS score. While a stable NEWS score is not directly listed among criteria, the claim's mention of stable vitals contrasts with a high NEWS score, loosely associating it with this category. Therefore, there is minimal alignment.",
            "The heart rate of 94 to 97 bpm exceeds the threshold (>90 bpm) specified under SIRS criteria, which helps identify systemic inflammation indicative of early sepsis. The claim aligns with one of the SIRS criteria, but without additional criteria being met, the alignment is suggestive but not comprehensive.",
            "The claim indicates that blood pressure values do not suggest significant hypotension. This is marginally connected to the Sepsis-Associated Hypotension category, which focuses on low blood pressure as a key indicator of sepsis risk. The absence of hypotension suggests lower risk, but the connection to the specific category is indirect, leading to a low alignment rating.",
            "The claim mentions an absence of significant acidosis or organ dysfunction, which relates to the SOFA score that tracks organ dysfunction with specific metrics. The lack of organ dysfunction suggests a low SOFA score, which is relevant to sepsis risk assessment. However, it is more indicative of low risk rather than high risk. Thus, alignment is present but not directly pointing to high risk, resulting in a moderate alignment rating."
        ],
        "final_alignment_score": 0.45,
        "accuracy": 1
    },
    {
        "input": "7: Pain, 7.0; 32: HR, 117.0; 32: RR, 32.0; 32: SpO2, 86.0; 32: SBP, 109.0; 32: DBP, 68.0; 32: MAP, 81.667; 32: Pain, 10.0; 32: Temp, 100.9; 36: SpO2, 96.0; 36: LPM O2, 4.0; 68: WAM DIFTYP, AUTO; 68: RED BLOOD CELLS (RBC), 5.46 MIL/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 68: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 68: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: NEUTROPHIL % (AUTO DIFF), 80.3 %; 68: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.20 K/uL; 68: MONOCYTE ABSOLUTE (AUTO DIFF), 0.40 K/uL; 68: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 68: MONOCYTE % (AUTO DIFF), 5.2 %; 68: MEAN CORPUSCULAR VOLUME (MCV), 74.0 fL; 68: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.05 K/uL; 68: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 68: EOSINOPHIL % (AUTO DIFF), 0.4 %; 68: NRBC PERCENT (HEMATOLOGY), 0.0 %; 68: HEMOGLOBIN (HGB), 13.6 g/dL; 68: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 68: PLATELET COUNT (PLT), 312 K/uL; 68: HEMATOCRIT (HCT), 40.4 %; 68: LYMPHOCYTE % (AUTO DIFF), 13.6 %; 68: BASOPHIL % (AUTO DIFF), 0.4 %; 68: WHITE BLOOD CELLS (WBC), 7.7 K/uL; 68: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 68: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 85: SpO2, 98.0; 86: SpO2, 98.625; 86: Perf, 2.463; 86: SBP, 109.0; 86: DBP, 73.0; 86: MAP, 85.0; 87: HR, 113.469; 87: RR, 27.0; 87: SpO2, 99.155; 87: Perf, 2.662; 87: 1min HRV, 19.790; 87: 5min HRV, 19.790; 88: HR, 112.390; 88: RR, 21.492; 88: SpO2, 98.644; 88: Perf, 2.950; 88: 1min HRV, 20.380; 89: HR, 110.603; 89: RR, 27.207; 89: SpO2, 98.586; 89: Perf, 2.988; 89: 1min HRV, 18.547; 90: HR, 107.508; 90: RR, 27.237; 90: SpO2, 98.797; 90: Perf, 4.969; 90: 1min HRV, 11.911; 91: HR, 106.559; 91: RR, 22.780; 91: SpO2, 99.0; 91: Perf, 5.491; 91: 1min HRV, 7.818; 92: HR, 107.448; 92: RR, 21.603; 92: SpO2, 98.931; 92: Perf, 5.781; 92: 1min HRV, 17.544; 92: 5min HRV, 19.342; 92: SBP, 105.0; 92: DBP, 77.0; 92: MAP, 86.333; 92: LPM O2, 4.0; 93: HR, 106.458; 93: RR, 27.153; 93: SpO2, 99.152; 93: Perf, 5.267; 93: 1min HRV, 9.148; 93: SBP, 105.0; 93: DBP, 77.0; 93: MAP, 86.333; 94: HR, 105.397; 94: RR, 27.448; 94: SpO2, 98.931; 94: Perf, 4.354; 94: 1min HRV, 11.650; 95: HR, 105.983; 95: RR, 24.458; 95: SpO2, 98.475; 95: Perf, 5.262; 95: 1min HRV, 7.859; 96: HR, 104.966; 96: RR, 26.254; 96: SpO2, 98.0; 96: Perf, 5.722; 96: 1min HRV, 9.993; 97: HR, 104.759; 97: RR, 28.569; 97: SpO2, 98.345; 97: Perf, 5.849; 97: 1min HRV, 26.592; 97: 5min HRV, 15.220; 98: HR, 106.051; 98: RR, 28.017; 98: SpO2, 98.475; 98: Perf, 4.902; 98: 1min HRV, 13.398; 99: POC PH (V) ISTAT, 7.44; 99: POC LACTATE ISTAT, 0.97 mmol/L; 99: POC TCO2 (V) ISTAT, 36 mmol/L; 99: POC PCO2 (V) ISTAT, 51.2 mmHg; 99: POC O2 SATURATION ISTAT VENOUS, 86 %; 99: POC BASE EXCESS ISTAT, 10 mmol/L; 99: POC HCO3 (V) ISTAT, 34.4 mmol/L; 99: POC PO2 (V) ISTAT, 51 mmHg; 99: HR, 102.362; 99: RR, 23.259; 99: SpO2, 98.0; 99: Perf, 5.626; 99: 1min HRV, 9.641; 100: HR, 103.119; 100: RR, 26.407; 100: SpO2, 98.0; 100: Perf, 6.064; 100: 1min HRV, 9.006; 101: HR, 105.552; 101: RR, 21.793; 101: SpO2, 98.017; 101: Perf, 6.432; 101: 1min HRV, 26.363; 102: HR, 105.746; 102: RR, 21.576; 102: SpO2, 98.492; 102: Perf, 6.412; 102: 1min HRV, 15.509; 102: 5min HRV, 18.497; 103: LIPASE, 7 U/L; 103: HR, 103.559; 103: RR, 21.322; 103: SpO2, 97.966; 103: Perf, 7.953; 103: 1min HRV, 10.207; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 103.966; 104: RR, 22.931; 104: SpO2, 98.190; 104: Perf, 6.394; 104: 1min HRV, 12.384; 105: HR, 102.797; 105: RR, 22.898; 105: SpO2, 98.0; 105: Perf, 7.407; 105: 1min HRV, 9.324; 106: HR, 106.552; 106: RR, 26.207; 106: SpO2, 97.638; 106: Perf, 6.102; 106: 1min HRV, 22.177; 107: HR, 105.051; 107: RR, 20.458; 107: SpO2, 97.542; 107: Perf, 7.189; 107: 1min HRV, 15.540; 107: 5min HRV, 16.297; 108: HR, 102.203; 108: RR, 26.271; 108: SpO2, 98.0; 108: Perf, 8.579; 108: 1min HRV, 8.521; 108: SBP, 104.0; 108: DBP, 68.0; 108: MAP, 80.0; 109: HR, 102.862; 109: RR, 19.431; 109: SpO2, 98.0; 109: Perf, 7.502; 109: 1min HRV, 7.261; 110: HR, 102.322; 110: RR, 22.508; 110: SpO2, 98.0; 110: Perf, 8.154; 110: 1min HRV, 11.387; 111: HR, 100.224; 111: RR, 23.552; 111: SpO2, 98.0; 111: Perf, 7.929; 111: 1min HRV, 13.069; 112: HR, 100.729; 112: RR, 22.237; 112: SpO2, 98.0; 112: Perf, 7.754; 112: 1min HRV, 10.293; 112: 5min HRV, 11.824; 113: HR, 99.966; 113: RR, 24.864; 113: SpO2, 98.0; 113: Perf, 7.96; 113: 1min HRV, 13.281; 114: HR, 99.586; 114: RR, 24.603; 114: SpO2, 98.0; 114: Perf, 8.212; 114: 1min HRV, 12.548; 115: HR, 98.763; 115: RR, 22.390; 115: SpO2, 98.0; 115: Perf, 8.311; 115: 1min HRV, 10.531; 116: HR, 100.362; 116: RR, 22.362; 116: SpO2, 98.0; 116: Perf, 7.152; 116: 1min HRV, 24.455; 117: HR, 98.441; 117: RR, 21.373; 117: SpO2, 98.0; 117: Perf, 7.441; 117: 1min HRV, 13.903; 117: 5min HRV, 16.747; 118: HR, 97.034; 118: RR, 24.085; 118: SpO2, 98.0; 118: Perf, 7.582; 118: 1min HRV, 11.218; 119: HR, 96.879; 119: RR, 22.638; 119: SpO2, 98.0; 119: Perf, 8.531; 119: 1min HRV, 11.097; 0: Age, 23; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 32.0; 0: Triage SBP, 109.0; 0: Triage DBP, 68.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN,ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess the risk of sepsis, we first evaluate key physiological parameters. The patient has persistent tachycardia (high heart rate) and tachypnea (high respiratory rate), but blood pressure remains stable. The patient exhibits hypoxemia initially, with low SpO2 levels that respond to oxygen treatment. Despite the elevated temperature and pain, there is no indication from blood tests or lactate levels that suggest high sepsis risk within 12 hours. The patient's overall condition does not meet clinical criteria for a high risk of sepsis at this time.",
        "claims": [
            "Key physiological parameters are evaluated to assess the risk of sepsis.",
            "The patient has persistent tachycardia (high heart rate).",
            "The patient has tachypnea (high respiratory rate).",
            "The patient's blood pressure remains stable.",
            "The patient exhibits hypoxemia initially.",
            "The patient has low SpO2 levels.",
            "The low SpO2 levels respond to oxygen treatment.",
            "The patient has an elevated temperature.",
            "The patient is experiencing pain.",
            "There is no indication from blood tests that suggest high sepsis risk within 12 hours.",
            "There is no indication from lactate levels that suggest high sepsis risk within 12 hours.",
            "The patient's overall condition does not meet clinical criteria for a high risk of sepsis at this time."
        ],
        "relevant_claims": [
            "The patient has persistent tachycardia (high heart rate).",
            "The patient has tachypnea (high respiratory rate).",
            "The patient exhibits hypoxemia initially.",
            "The patient has low SpO2 levels.",
            "The patient has an elevated temperature.",
            "The patient's overall condition does not meet clinical criteria for a high risk of sepsis at this time."
        ],
        "alignment_scores": [
            0.6,
            0.8,
            0.7,
            0.7,
            0.8,
            0.0
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "No direct category alignment"
        ],
        "alignment_reasonings": [
            "Tachycardia, or a high heart rate (>90 bpm), is explicitly one of the SIRS criteria indicators of systemic inflammation and early sepsis. However, the claim does not specify other SIRS criteria necessary for full SIRS Positivity, so the alignment is present but only partial.",
            "Tachypnea, defined as a high respiratory rate, is explicitly listed as a criterion under the SIRS (Systemic Inflammatory Response Syndrome) criteria, where a respiratory rate >20/min indicates systemic inflammation. Although the claim does not specify the exact respiratory rate, the mention of tachypnea suggests alignment with the SIRS criteria, with moderate to strong relevance to early sepsis identification. Therefore, the alignment is substantial but not fully comprehensive without additional SIRS criteria.",
            "Hypoxemia generally indicates impaired oxygenation in the body, which is conceptually related to the PaO\u2082/FiO\u2082 ratio component of the SOFA score. Although the claim does not provide a specific PaO\u2082/FiO\u2082 ratio as indicated in the SOFA score criteria, the presence of hypoxemia suggests a potential decrease in this ratio, reflecting organ dysfunction. The alignment is indirect but fairly strong, as hypoxemia is a relevant factor in assessing respiratory dysfunction in sepsis.",
            "Low SpO2 levels indicate possible hypoxia, which relates to impaired oxygenation. In the context of the SOFA score, impaired oxygenation (specifically PaO\u2082/FiO\u2082\u202f<\u202f300) is a component that can indicate organ dysfunction. While SpO2 is not directly measured in the SOFA score, it is conceptually relevant to assessing respiratory function and potential sepsis risk through organ dysfunction. Given this connection, the alignment is indirect but significant.",
            "The claim about an elevated temperature aligns closely with the SIRS criteria, which include temperature >38\u00b0C (100.4\u00b0F). While the claim doesn\u2019t specify the exact temperature to confirm if it exceeds this threshold, the reference to an elevated temperature strongly suggests a potential systemic inflammatory response. Therefore, it aligns well with SIRS positivity, though not fully confirmed.",
            "The claim states that the patient's condition does not meet criteria for a high risk of sepsis, suggesting the absence of significant indicators from any of the categories. As none of the expert sepsis categories apply, there is no alignment."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 0
    },
    {
        "input": "12: SpO2, 98.026; 13: HR, 117.0; 13: RR, 18.0; 13: SpO2, 97.0; 13: SBP, 148.0; 13: DBP, 99.0; 13: MAP, 115.333; 13: Pain, 0.0; 13: Temp, 97.9; 14: SpO2, 96.877; 14: SBP, 148.0; 14: DBP, 99.0; 14: MAP, 115.333; 15: SpO2, 96.559; 15: Perf, 0.549; 16: SpO2, 96.121; 16: Perf, 0.543; 17: SpO2, 95.717; 17: Perf, 0.54; 18: SpO2, 96.339; 18: Perf, 0.569; 19: SpO2, 96.155; 19: Perf, 0.618; 20: SpO2, 94.929; 20: Perf, 0.62; 21: SpO2, 94.312; 21: Perf, 0.62; 22: SpO2, 94.214; 22: Perf, 0.631; 23: SpO2, 95.489; 23: Perf, 0.899; 24: SpO2, 94.466; 24: Perf, 0.986; 25: SpO2, 95.390; 25: Perf, 0.890; 26: SpO2, 95.707; 26: Perf, 0.893; 27: SpO2, 95.339; 27: Perf, 0.886; 28: SpO2, 95.932; 28: Perf, 0.794; 29: SpO2, 95.476; 29: Perf, 0.73; 30: SpO2, 95.695; 31: SpO2, 95.121; 31: Perf, 0.726; 32: SpO2, 95.881; 32: Perf, 0.751; 33: SpO2, 95.593; 33: Perf, 0.769; 34: SpO2, 95.828; 34: Perf, 0.635; 35: SpO2, 95.932; 35: Perf, 0.645; 36: SpO2, 96.517; 36: Perf, 0.65; 37: SpO2, 95.746; 37: Perf, 0.65; 37: Temp, 99.9; 38: SpO2, 95.1; 38: Perf, 0.65; 39: SpO2, 97.0; 39: Perf, 0.65; 40: Perf, 0.65; 41: SpO2, 95.769; 41: Perf, 0.654; 42: SpO2, 97.0; 42: Perf, 0.67; 43: SpO2, 95.35; 43: Perf, 0.704; 44: SpO2, 94.288; 44: Perf, 0.715; 45: SpO2, 93.421; 45: Perf, 0.72; 46: SpO2, 94.0; 46: Perf, 0.727; 47: SpO2, 94.458; 47: Perf, 0.74; 48: SpO2, 94.379; 48: Perf, 0.741; 49: SpO2, 94.153; 49: Perf, 0.844; 50: SpO2, 94.356; 50: Perf, 1.115; 51: SpO2, 94.524; 51: Perf, 1.12; 51: LR IV BOLUS -, 500 ML; 52: SpO, 2: 94.373; 52: Perf, 1.12; 53: SpO2, 94.569; 53: Perf, 1.139; 54: SpO2, 93.830; 54: Perf, 1.238; 55: SpO2, 93.714; 55: Perf, 1.176; 56: SpO2, 95.190; 56: Perf, 0.968; 57: SpO2, 94.169; 57: Perf, 0.96; 58: SpO2, 94.466; 58: Perf, 0.96; 59: SpO2, 93.712; 59: Perf, 0.946; 60: SpO2, 95.0; 60: Perf, 0.894; 61: SpO2, 95.017; 61: Perf, 0.882; 62: SpO2, 95.441; 62: Perf, 0.883; 63: SpO2, 94.707; 63: Perf, 0.87; 64: SpO2, 95.017; 64: Perf, 0.861; 65: SpO2, 94.644; 65: Perf, 0.857; 66: SpO2, 95.310; 66: Perf, 0.742; 67: SpO2, 94.824; 67: Perf, 0.69; 68: INR, 1.9; 68: PROTHROMBIN TIME, 21.2 seconds; 68: SpO2, 94.655; 69: PART. THROMBOPLASTIN TIME, 79.5 seconds; 69: SpO2, 96.525; 69: Perf, 0.725; 70: SpO2, 96.822; 70: Perf, 0.7; 71: SpO2, 95.085; 72: SpO2, 94.644; 72: Perf, 0.757; 73: WAM DIFTYP, AUTO; 73: POTASSIUM, 5.2 mmol/L; 73: CO2, 21 mmol/L; 73: GLUCOSE, 115 mg/dL; 73: BLOOD UREA NITROGEN (BUN), 51 mg/dL; 73: CALCIUM, 8.8 mg/dL; 73: CHLORIDE, 103 mmol/L; 73: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 73: ANION GAP, 14 mmol/L; 73: SODIUM, 138 mmol/L; 73: CREATININE, 1.15 mg/dL; 73: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: RED CELL DISTRIBUTION WIDTH (RDW), 15.8 %; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.15 K/uL; 73: EOSINOPHIL % (AUTO DIFF), 0.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 73: MONOCYTE % (AUTO DIFF), 0.3 %; 73: NEUTROPHIL % (AUTO DIFF), 87.1 %; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: PLATELET COUNT (PLT), 106 K/uL; 73: RED BLOOD CELLS (RBC), 3.70 MIL/uL; 73: LYMPHOCYTE % (AUTO DIFF), 11.8 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 73: HEMATOCRIT (HCT), 33.8 %; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.83 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 91.4 fL; 73: HEMOGLOBIN (HGB), 10.5 g/dL; 73: SpO2, 94.759; 73: Perf, 0.619; 74: SpO2, 95.083; 74: Perf, 0.627; 74: SBP, 127.0; 74: DBP, 67.0; 74: MAP, 87.0; 75: Perf, 0.63; 76: SpO2, 93.6; 76: Perf, 0.617; 77: SpO2, 94.621; 77: Perf, 0.6; 78: SpO2, 95.179; 78: Perf, 0.6; 79: SpO2, 95.542; 79: Perf, 0.6; 80: SpO2, 92.625; 80: Perf, 0.6; 81: SpO2, 91.722; 82: SpO2, 92.1; 83: SpO2, 95.957; 84: SpO2, 94.797; 85: SpO2, 95.552; 86: SpO2, 96.4; 87: SpO2, 99.4; 88: SpO2, 97.308; 90: SpO2, 95.739; 91: SpO2, 94.356; 92: SpO2, 94.293; 93: SpO2, 94.831; 94: SpO2, 95.220; 95: SpO2, 94.5; 95: Perf, 0.516; 96: SpO2, 94.780; 96: Perf, 0.531; 97: SpO2, 95.172; 97: Perf, 0.547; 98: SpO2, 95.390; 98: Perf, 0.573; 99: SpO2, 95.085; 99: Perf, 0.603; 100: SpO2, 94.845; 100: Perf, 0.638; 101: SpO2, 94.525; 101: Perf, 0.655; 102: SpO2, 93.333; 102: Perf, 0.66; 111: SpO2, 83.875; 112: SpO2, 94.931; 112: Perf, 0.38; 113: SpO2, 95.0; 113: Perf, 0.352; 114: SpO2, 95.746; 114: Perf, 0.358; 115: SpO2, 95.897; 115: Perf, 0.361; 116: SpO2, 94.830; 116: Perf, 0.274; 117: HR, 130.0; 117: SpO2, 94.0; 117: Temp, 103.1; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.6; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 99.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To determine the sepsis risk, I first identified abnormalities indicating potential sepsis risk factors such as high heart rate (HR) and changes in body temperature. The patient shows tachycardia with a consistently high HR, and there is a significant spike in temperature to 103.1\u00b0F, which could indicate a fever. The SpO2 levels varied but occasionally dropped to concerning levels (e.g., 83.875). Additionally, the administration of IV fluids suggests clinical suspicion of circulatory compromise. Therefore, considering these combined factors, the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "Abnormalities indicating potential sepsis risk factors were identified.",
            "High heart rate (HR) is a potential sepsis risk factor.",
            "The patient shows tachycardia with a consistently high HR.",
            "There is a significant spike in the patient's temperature to 103.1\u00b0F.",
            "A temperature of 103.1\u00b0F could indicate a fever.",
            "The SpO2 levels varied during the patient's assessment.",
            "The SpO2 levels occasionally dropped to concerning levels, such as 83.875.",
            "The administration of IV fluids suggests clinical suspicion of circulatory compromise.",
            "Considering these combined factors, the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "Abnormalities indicating potential sepsis risk factors were identified.",
            "High heart rate (HR) is a potential sepsis risk factor.",
            "The patient shows tachycardia with a consistently high HR.",
            "There is a significant spike in the patient's temperature to 103.1\u00b0F.",
            "A temperature of 103.1\u00b0F could indicate a fever.",
            "The SpO2 levels varied during the patient's assessment.",
            "The SpO2 levels occasionally dropped to concerning levels, such as 83.875.",
            "The administration of IV fluids suggests clinical suspicion of circulatory compromise.",
            "Considering these combined factors, the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.8,
            0.9,
            0.8,
            0.4,
            0.5,
            0.6,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Shock Index (\u22651.0)",
            "AElevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim is vague and non-specific but implies the presence of several potential sepsis risk factors or clinical abnormalities. The claim broadly aligns with categories that involve aggregate or multiple indicators pointing toward deterioration, such as a high NEWS score. However, without specific details or a direct mention of abnormal vitals, the alignment is weak and therefore rated 0.3.",
            "A high heart rate (>90 bpm) is explicitly one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The claim identifies high HR as a potential sepsis risk factor, which aligns significantly with the SIRS criterion, though it doesn't mention meeting a specific threshold.",
            "Tachycardia (high heart rate >90 bpm) is one of the specific criteria listed under SIRS (Systemic Inflammatory Response Syndrome). The claim directly references tachycardia, which aligns well with SIRS criteria, suggesting a significant risk of systemic inflammation and early sepsis. However, the claim does not mention any additional SIRS criteria, so the alignment isn\u2019t perfect.",
            "The patient's temperature of 103.1\u00b0F (approximately 39.5\u00b0C) exceeds the SIRS threshold of >38\u00b0C. This directly aligns with one of the SIRS criteria, indicating systemic inflammation consistent with early sepsis. The alignment is high since the temperature spike clearly meets one of the criteria, but since SIRS positivity requires \u22652 criteria, it isn't complete on its own.",
            "The claim mentions a temperature of 103.1\u00b0F, which is above the 38\u00b0C threshold (approximately 100.4\u00b0F) defined by one of the SIRS criteria. This strongly indicates the presence of systemic inflammation, suggesting the possibility of early sepsis. However, to fully satisfy the SIRS category, at least two criteria would need to be met. The temperature alone aligns strongly but not perfectly with the SIRS criteria requirement, hence the rating of 0.8.",
            "The SpO2 levels, or oxygen saturation, is not directly part of the SOFA scoring components. However, it indirectly relates to oxygenation, which can be associated with the PaO\u2082/FiO\u2082 ratio component in the SOFA score. This indicates a mild alignment with SOFA score increases reflecting impaired oxygenation, but it does not provide a complete picture for new organ dysfunction as defined by the SOFA score.",
            "While SpO2 levels do not directly correspond with the SOFA criteria, they are related to oxygenation status, which is a component of the SOFA score, specifically the PaO\u2082/FiO\u2082 ratio. The drop to 83.875% suggests significant hypoxia, which can imply oxygenation issues and potential organ dysfunction. Therefore, there is an indirect but significant alignment with the SOFA category criteria.",
            "The administration of IV fluids is often a response to recognized or anticipated circulatory compromise, which aligns with the concept of a shock index indicating haemodynamic instability. While IV fluid administration does not directly quantify shock index, it relates to managing potential sepsis-driven circulatory issues that the elevated shock index suggests, though this alignment is more inferential than direct.",
            "The claim is non-specific and mentions \"combined factors\" and \"high risk of developing sepsis,\" which generally aligns with the concept of clinical deterioration as captured by aggregated scores like the National Early Warning Score (NEWS). However, because the claim does not provide direct information on a particular scoring system or specific criteria from the NEWS scoring, the alignment is relatively weak. The claim reflects a general assessment rather than objective metrics specific to the given categories."
        ],
        "final_alignment_score": 0.6000000000000001,
        "accuracy": 1
    },
    {
        "input": "11: HR, 124.0; 11: RR, 24.0; 11: SpO2, 96.0; 11: SBP, 110.0; 11: DBP, 65.0; 11: MAP, 80.0; 11: Temp, 97.9; 32: HR, 123.588; 32: RR, 18.0; 32: SpO2, 96.067; 32: Perf, 0.2; 32: 1min HRV, 6.990; 32: SBP, 117.0; 32: DBP, 73.0; 32: MAP, 87.667; 33: HR, 120.208; 33: RR, 19.604; 33: 1min HRV, 2.968; 34: HR, 119.173; 34: RR, 17.942; 34: SpO2, 97.0; 34: Perf, 0.15; 34: 1min HRV, 4.574; 35: HR, 117.981; 35: RR, 16.547; 35: SpO2, 96.5; 35: Perf, 0.14; 35: 1min HRV, 2.616; 35: 5min HRV, 7.779; 35: SBP, 113.0; 35: DBP, 69.0; 35: MAP, 83.667; 36: HR, 118.132; 36: RR, 15.736; 36: 1min HRV, 5.070; 36: SBP, 113.0; 36: DBP, 69.0; 36: MAP, 83.667; 37: HR, 117.0; 37: RR, 16.0; 37: 1min HRV, 1.732; 38: HR, 117.113; 38: RR, 15.434; 38: SpO2, 95.0; 38: Perf, 0.207; 38: 1min HRV, 2.010; 39: HR, 116.019; 39: RR, 15.038; 39: SpO2, 95.0; 39: Perf, 0.21; 39: 1min HRV, 2.276; 40: HR, 116.075; 40: RR, 15.642; 40: 1min HRV, 2.121; 40: 5min HRV, 4.496; 41: HR, 115.623; 41: RR, 15.415; 41: SpO2, 95.0; 41: Perf, 0.233; 41: 1min HRV, 1.634; 42: HR, 115.717; 42: RR, 15.396; 42: SpO2, 95.333; 42: Perf, 0.22; 42: 1min HRV, 2.719; 43: HR, 115.755; 43: RR, 15.717; 43: SpO2, 95.963; 43: Perf, 0.226; 43: 1min HRV, 1.995; 44: HR, 115.462; 44: RR, 15.0; 44: SpO2, 94.288; 44: Perf, 0.281; 44: 1min HRV, 2.2; 45: HR, 115.340; 45: RR, 14.075; 45: SpO2, 94.472; 45: Perf, 0.278; 45: 1min HRV, 1.998; 45: 5min HRV, 2.160; 46: HR, 115.340; 46: RR, 13.660; 46: SpO2, 94.038; 46: Perf, 0.276; 46: 1min HRV, 2.547; 47: HR, 115.0; 47: RR, 13.923; 47: SpO2, 94.135; 47: Perf, 0.275; 47: 1min HRV, 3.042; 48: HR, 115.245; 48: RR, 14.019; 48: SpO2, 94.617; 48: Perf, 0.266; 48: 1min HRV, 2.396; 49: HR, 117.808; 49: RR, 17.981; 49: SpO2, 95.432; 49: Perf, 0.238; 49: 1min HRV, 5.660; 50: HR, 119.849; 50: RR, 18.453; 50: SpO2, 96.208; 50: Perf, 0.328; 50: 1min HRV, 2.571; 50: 5min HRV, 9.206; 51: HR, 119.170; 51: RR, 17.321; 51: SpO2, 95.264; 51: Perf, 0.421; 51: 1min HRV, 2.345; 52: HR, 118.288; 52: RR, 17.577; 52: SpO2, 95.08; 52: Perf, 0.331; 52: 1min HRV, 2.746; 53: HR, 118.519; 53: RR, 18.759; 53: SpO2, 95.630; 53: Perf, 0.334; 53: 1min HRV, 3.235; 54: HR, 118.519; 54: RR, 19.385; 54: SpO2, 94.212; 54: Perf, 0.363; 54: 1min HRV, 1.890; 55: HR, 117.547; 55: RR, 18.566; 55: SpO2, 95.0; 55: Perf, 0.332; 55: 1min HRV, 2.645; 55: 5min HRV, 3.315; 56: HR, 116.769; 56: RR, 18.385; 56: SpO2, 95.0; 56: Perf, 0.333; 56: 1min HRV, 4.047; 57: HR, 118.472; 57: RR, 21.830; 57: SpO2, 95.774; 57: Perf, 0.297; 57: 1min HRV, 8.639; 58: HR, 118.321; 58: RR, 20.208; 58: SpO2, 96.302; 58: Perf, 0.278; 58: 1min HRV, 4.660; 59: HR, 117.5; 59: RR, 16.981; 59: SpO2, 95.865; 59: Perf, 0.261; 59: 1min HRV, 4.249; 60: HR, 115.981; 60: RR, 15.962; 60: SpO2, 94.604; 60: Perf, 0.295; 60: 1min HRV, 1.728; 60: 5min HRV, 6.621; 61: HR, 115.558; 61: RR, 16.077; 61: SpO2, 94.404; 61: Perf, 0.293; 61: 1min HRV, 3.394; 62: HR, 115.509; 62: RR, 16.547; 62: SpO2, 95.0; 62: Perf, 0.267; 62: 1min HRV, 1.862; 63: HR, 115.981; 63: RR, 16.792; 63: SpO2, 95.115; 63: Perf, 0.258; 63: 1min HRV, 1.911; 64: HR, 116.654; 64: RR, 17.404; 64: SpO2, 95.654; 64: Perf, 0.279; 64: 1min HRV, 3.281; 65: HR, 118.889; 65: RR, 18.037; 65: SpO2, 95.0; 65: Perf, 0.319; 65: 1min HRV, 8.971; 65: 5min HRV, 7.523; 66: HR, 119.481; 66: RR, 19.615; 66: SpO2, 95.385; 66: Perf, 0.316; 66: 1min HRV, 3.115; 66: SBP, 108.0; 66: DBP, 76.0; 66: MAP, 86.667; 67: HR, 118.943; 67: RR, 18.264; 67: SpO2, 95.264; 67: Perf, 0.389; 67: 1min HRV, 2.462; 68: HR, 118.868; 68: RR, 18.019; 68: SpO2, 95.0; 68: Perf, 0.353; 68: 1min HRV, 3.067; 69: HR, 117.904; 69: RR, 18.192; 69: SpO2, 95.0; 69: Perf, 0.343; 69: 1min HRV, 2.331; 70: HR, 117.415; 70: RR, 17.057; 70: SpO2, 95.0; 70: Perf, 0.326; 70: 1min HRV, 2.257; 70: 5min HRV, 3.951; 71: HR, 118.788; 71: RR, 18.25; 71: SpO2, 95.0; 71: Perf, 0.294; 71: 1min HRV, 5.300; 72: HR, 120.094; 72: RR, 18.377; 72: SpO2, 95.340; 72: Perf, 0.285; 72: 1min HRV, 1.663; 73: HR, 119.283; 73: RR, 18.094; 73: SpO2, 95.528; 73: Perf, 0.277; 73: 1min HRV, 6.112; 74: HR, 118.692; 74: RR, 16.962; 74: SpO2, 95.385; 74: Perf, 0.294; 74: 1min HRV, 4.186; 75: HR, 118.075; 75: RR, 16.528; 75: SpO2, 95.811; 75: Perf, 0.311; 75: 1min HRV, 3.037; 75: 5min HRV, 5.208; 76: HR, 119.308; 76: RR, 17.538; 76: SpO2, 94.173; 76: Perf, 0.370; 76: 1min HRV, 5.686; 77: HR, 117.396; 77: RR, 15.623; 77: SpO2, 93.925; 77: Perf, 0.396; 77: 1min HRV, 2.105; 78: HR, 118.321; 78: RR, 16.755; 78: SpO2, 94.0; 78: Perf, 0.371; 78: 1min HRV, 3.661; 79: HR, 118.151; 79: RR, 16.623; 79: SpO2, 94.0; 79: Perf, 0.396; 79: 1min HRV, 2.929; 80: HR, 117.463; 80: RR, 15.056; 80: SpO2, 94.0; 80: Perf, 0.372; 80: 1min HRV, 1.731; 80: 5min HRV, 4.406; 81: HR, 117.5; 81: RR, 15.0; 81: SpO2, 93.923; 81: Perf, 0.317; 81: 1min HRV, 2.825; 82: HR, 119.370; 82: RR, 15.630; 82: SpO2, 93.833; 82: Perf, 0.315; 82: 1min HRV, 6.033; 83: HR, 117.679; 83: RR, 15.830; 83: SpO2, 94.0; 83: Perf, 0.320; 83: 1min HRV, 2.040; 84: HR, 116.788; 84: RR, 15.077; 84: SpO2, 93.423; 84: Perf, 0.391; 84: 1min HRV, 2.008; 85: 5min HRV, 5.663; 95: HR, 119.0; 95: RR, 17.0; 95: SpO2, 95.0; 95: SBP, 115.0; 95: DBP, 73.0; 95: MAP, 87.0; 116: POC PH (V) ISTAT, 7.43; 116: POC PCO2 (V) ISTAT, 46.2 mmHg; 116: POC LACTATE ISTAT, 2.90 mmol/L; 116: POC HCO3 (V) ISTAT, 30.7 mmol/L; 116: POC PO2 (V) ISTAT, 38 mmHg; 116: POC TCO2 (V) ISTAT, 32 mmol/L; 116: POC BASE EXCESS ISTAT, 6 mmol/L; 116: POC O2 SATURATION ISTAT VENOUS, 73 %; 118: POC, HCG, ISTAT QUALITATIVE: Negative; 118: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 0: Age, 52; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 124.0; 0: Triage RR, 24.0; 0: Triage SBP, 110.0; 0: Triage DBP, 65.0; 0: Triage acuity, 2-Emergent; 0: CC, EDEMA,JAUNDICE,ABNORMAL LAB",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To determine the sepsis risk prediction, the initial subquestion is to identify abnormal vital signs and lab results indicating sepsis risk. The patient has consistently high heart rate (>90 bpm), elevated respiratory rate (>22 breaths/min), low diastolic blood pressure, and fluctuating heart rate variability, suggesting autonomic instability. The lab result of elevated lactate (2.90 mmol/L) further supports increased sepsis risk. Additionally, symptoms such as edema and jaundice, combined with emergent triage acuity, indicate the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To determine the sepsis risk prediction, the initial subquestion is to identify abnormal vital signs and lab results indicating sepsis risk.",
            "The patient has a consistently high heart rate of over 90 bpm.",
            "A high heart rate of over 90 bpm indicates potential sepsis risk.",
            "The patient has an elevated respiratory rate of over 22 breaths per minute.",
            "An elevated respiratory rate of over 22 breaths per minute indicates potential sepsis risk.",
            "The patient has low diastolic blood pressure.",
            "Low diastolic blood pressure indicates potential sepsis risk.",
            "The patient has fluctuating heart rate variability.",
            "Fluctuating heart rate variability suggests autonomic instability.",
            "The lab result of elevated lactate is 2.90 mmol/L.",
            "An elevated lactate level of 2.90 mmol/L supports increased sepsis risk.",
            "The patient exhibits symptoms such as edema and jaundice.",
            "Symptoms such as edema and jaundice indicate potential sepsis risk.",
            "Emergent triage acuity suggests the patient is at high risk of developing sepsis.",
            "The combination of abnormal vital signs, lab results, and symptoms indicates the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "To determine the sepsis risk prediction, the initial subquestion is to identify abnormal vital signs and lab results indicating sepsis risk.",
            "The patient has a consistently high heart rate of over 90 bpm.",
            "A high heart rate of over 90 bpm indicates potential sepsis risk.",
            "The patient has an elevated respiratory rate of over 22 breaths per minute.",
            "An elevated respiratory rate of over 22 breaths per minute indicates potential sepsis risk.",
            "The patient has low diastolic blood pressure.",
            "Low diastolic blood pressure indicates potential sepsis risk.",
            "The patient has fluctuating heart rate variability.",
            "Fluctuating heart rate variability suggests autonomic instability.",
            "The lab result of elevated lactate is 2.90 mmol/L.",
            "An elevated lactate level of 2.90 mmol/L supports increased sepsis risk.",
            "The patient exhibits symptoms such as edema and jaundice.",
            "Symptoms such as edema and jaundice indicate potential sepsis risk.",
            "Emergent triage acuity suggests the patient is at high risk of developing sepsis.",
            "The combination of abnormal vital signs, lab results, and symptoms indicates the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.8,
            0.8,
            0.8,
            0.9,
            0.4,
            0.4,
            0.3,
            0.3,
            1.0,
            1.0,
            0.7,
            0.7,
            0.7,
            0.8
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim refers to identifying abnormal vital signs and lab results, which aligns with the purpose of calculating the National Early Warning Score (NEWS). NEWS uses deranged vitals to assess clinical deterioration, consistent with sepsis sorting. The alignment is moderate since the claim doesn't specifically mention the use or results of a NEWS score calculation, just the general process of identifying abnormalities.",
            "A heart rate of over 90 bpm is directly included in the criteria for SIRS (Systemic Inflammatory Response Syndrome), which is used to identify early stages of sepsis. While the claim mentions only one criterion (heart rate > 90 bpm), SIRS requires the presence of at least two criteria to be fully met. However, the heart rate criterion itself aligns well with the category, resulting in a high alignment rating.",
            "A heart rate >90 bpm is directly listed as one of the SIRS criteria for identifying systemic inflammation consistent with early sepsis. However, the claim addresses only one criterion rather than the required \u22652 SIRS criteria for full confirmation, resulting in a slightly lower than perfect alignment.",
            "An elevated respiratory rate of over 22 breaths per minute is explicitly a component of the qSOFA criteria, which is used to assess the risk of sepsis-related organ dysfunction and mortality. Although the claim mentions only one element of the qSOFA score, the elevated respiratory rate directly aligns with the criteria. Given that a complete qSOFA assessment requires meeting two out of three criteria, the alignment is strong but not perfect.",
            "The claim specifically mentions an elevated respiratory rate of over 22 breaths per minute, which is a criterion of the qSOFA score used to identify high risk of sepsis-related organ dysfunction and mortality. Since only one component of the qSOFA score is mentioned in the claim, it doesn\u2019t fully reach the threshold but strongly aligns with the criteria used in determining high qSOFA scores. Hence, the alignment rating is 0.9.",
            "The claim mentions low diastolic blood pressure, which is related to blood pressure measurement but focuses on the diastolic rather than systolic. Sepsis-associated hypotension concerns systolic blood pressure (SBP <90 mmHg) or mean arterial pressure (MAP <70 mmHg), which more directly aligns with severe sepsis criteria. While low diastolic pressure suggests hemodynamic changes, it doesn\u2019t directly fit the specified category indicators, resulting in a moderate alignment without full criterion relevance.",
            "Low diastolic blood pressure suggests potential hemodynamic instability, which is related to the concept of the shock index. However, the claim doesn't provide enough detail to calculate the shock index or directly align with its specific criteria (heart rate \u00f7 systolic BP). Therefore, while there is a conceptual link to hemodynamic instability and potential sepsis risk, the alignment is indirect and thus warrants a moderate rating.",
            "Fluctuating heart rate variability suggests some degree of hemodynamic instability, which conceptually relates to the Elevated Shock Index category that involves heart rate and blood pressure. However, without specific information on heart rate and systolic blood pressure, the alignment is indirect and speculative. Thus, the alignment is weak.",
            "Fluctuating heart rate variability implies potential autonomic instability, which can be associated with hemodynamic instability. While not directly a measure of shock index, autonomous instability can influence heart rate and blood pressure, indirectly affecting the shock index. The alignment is weak but somewhat present due to the shared theme of hemodynamic concerns.",
            "The claim specifically mentions an elevated lactate level of 2.90 mmol/L, which is above the threshold of 2 mmol/L associated with increased sepsis mortality risk. This corresponds perfectly with the category of Elevated Serum Lactate, as this measurement is a direct criterion under this category.",
            "The claim directly cites an elevated lactate level of 2.90 mmol/L, which exceeds the threshold of \u22652 mmol/L. This is a precise match with the Elevated Serum Lactate category, indicating tissue hypoperfusion and a high risk of sepsis. Thus, there is perfect alignment.",
            "Edema and jaundice relate to potential organ dysfunction, specifically renal and hepatic, which are components of the SOFA scoring system. Jaundice could indicate elevated bilirubin levels, while edema is often associated with renal impairment. Both symptoms suggest a possible increase in SOFA score, indicating new organ dysfunction and a high sepsis risk. The alignment is indirect but relevant to the SOFA components.",
            "The symptoms of edema and jaundice indicate potential issues related to organ function. Jaundice specifically can be associated with elevated bilirubin levels, which is a component of the SOFA score. Edema could suggest organ dysfunction that might align with sepsis indicators listed in the SOFA score. While the claim does not specify an increase in the score by 2 points, these symptoms align moderately with the category of SOFA Score Increase, hence the rating of 0.7.",
            "The term \"emergent triage acuity\" implies a clinical assessment that identifies the patient as high risk, which aligns with the principle of the National Early Warning Score (NEWS). NEWS is used to detect clinical deterioration and assess the risk for serious conditions like sepsis. Although the claim does not specify the details of the NEWS score or criteria met, the mention of high risk at triage suggests an evaluation of vital signs and clinical presentation consistent with how NEWS would be used, reflected in the strong but not perfect alignment.",
            "The claim references a combination of factors\u2014abnormal vital signs, lab results, and symptoms\u2014suggesting imminent clinical deterioration. The NEWS categorizes risk using deranged vitals similar to this description. However, the lack of specific NEWS score details prevents perfect alignment."
        ],
        "final_alignment_score": 0.6733333333333333,
        "accuracy": 1
    },
    {
        "input": "4: SBP, 87.0; 4: DBP, 67.0; 4: MAP, 73.667; 5: HR, 122.0; 5: RR, 20.0; 5: SpO2, 96.0; 5: 1min HRV, 35.0; 5: SBP, 87.0; 5: DBP, 67.0; 5: MAP, 73.667; 5: Pain, 0.0; 5: Temp, 97.6; 6: HR, 120.811; 6: 1min HRV, 27.447; 7: HR, 122.915; 7: SpO2, 100.0; 7: Perf, 0.11; 7: 1min HRV, 14.483; 7: 5min HRV, 22.525; 8: HR, 121.707; 8: SpO2, 100.0; 8: Perf, 0.087; 8: 1min HRV, 18.467; 9: HR, 121.949; 9: SpO2, 100.0; 9: Perf, 0.08; 9: 1min HRV, 20.872; 10: HR, 122.724; 10: SpO2, 100.0; 10: Perf, 0.08; 10: 1min HRV, 14.636; 11: POC GLUCOSE BY METER, 93 mg/dL; 11: HR, 124.707; 11: SpO2, 99.8; 11: Perf, 0.073; 11: 1min HRV, 16.397; 12: 5min HRV, 18.206; 18: POC, BHCG, ISTAT QUANTITATIVE: 7.1 IU/L; 20: POC PH (V) ISTAT, 7.47; 20: POC LACTATE ISTAT, 0.77 mmol/L; 20: POC PCO2 (V) ISTAT, 23.4 mmHg; 20: POC PO2 (V) ISTAT, 47 mmHg; 20: POC HCO3 (V) ISTAT, 16.9 mmol/L; 20: POC TCO2 (V) ISTAT, 18 mmol/L; 20: POC BASE EXCESS ISTAT, -7 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 86 %; 27: HR, 59.0; 27: RR, 16.0; 27: SpO2, 71.0; 27: SBP, 94.0; 27: DBP, 70.0; 27: MAP, 78.0; 27: Pain, 0.0; 30: LR IV BOLUS -, 1000 ML; 40: ABO/RH, (AUTOMATION): B Positive; 40: ANTIBODY SCREEN 3, NEG; 46: METRONIDAZOLE IN NACL (ISO-OS), 500 MG/100 ML IV PGBK; 47: PART. THROMBOPLASTIN TIME:, 37.6 seconds; 47: LEVOFLOXACIN IN D, 5W 750 MG/150 ML IV PGBK; 54: INR:, 1.7; 54: PROTHROMBIN TIME, 19.5 seconds; 64: LIPASE, 5 U/L; 83: DIPHENHYDRAMINE HCL, 50 MG/ML INJ SOLN; 86: TROPONIN I: <., 017 ng/mL; 92: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 86.9 %; 92: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 11.57 K/uL; 92: MONOCYTES % (MANUAL DIFF), 2.6 %; 92: LYMPHOCYTES % (MANUAL DIFF), 0.9 %; 92: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.31 K/uL; 92: NEUTROPHILS BANDS % (MANUAL DIFF), 9.6 %; 92: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 94: HEMOGLOBIN (HGB), 4.2 g/dL; 94: HEMATOCRIT (HCT), 12.2 %; 94: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 94: MEAN CORPUSCULAR VOLUME (MCV), 84.7 fL; 94: HEMOGLOBIN (HGB), 4.2 g/dL; 94: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 94: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 94: WHITE BLOOD CELLS (WBC), 12.0 K/uL; 94: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.2 pg; 94: MEAN CORPUSCULAR VOLUME (MCV), 84.7 fL; 94: PLATELET COUNT (PLT), 27 K/uL; 94: RED BLOOD CELLS (RBC), 1.44 MIL/uL; 94: WHITE BLOOD CELLS (WBC), 12.0 K/uL; 94: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 94: HEMATOCRIT (HCT), 12.2 %; 94: RED BLOOD CELLS (RBC), 1.44 MIL/uL; 94: PLATELET COUNT (PLT), 27 K/uL; 94: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.2 pg; 95: HR, 103.0; 95: RR, 24.0; 95: SpO2, 100.0; 95: SBP, 96.0; 95: DBP, 59.0; 95: MAP, 71.333; 95: Temp, 97.6; 102: HR, 123.0; 102: SpO2, 100.0; 102: SBP, 96.0; 102: DBP, 59.0; 102: MAP, 71.333; 111: HR, 114.0; 111: RR, 28.0; 111: SpO2, 100.0; 111: SBP, 94.0; 111: DBP, 55.0; 111: MAP, 68.0; 111: Temp, 97.7; 117: HR, 127.0; 117: SpO2, 100.0; 119: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 119: GLUCOSE, 89 mg/dL; 119: GLUCOSE, 89 mg/dL; 119: AST (SGOT), 15 U/L; 119: ALT (SGPT), 10 U/L; 119: ANION GAP, 15 mmol/L; 119: EGFR REFIT WITHOUT RACE (2021), 17 mL/min/1.73 m2; 119: PROTEIN TOTAL, 5.3 g/dL; 119: POTASSIUM, 3.1 mmol/L; 119: BILIRUBIN TOTAL, 0.3 mg/dL; 119: CORRECTED CALCIUM, 8.8 mg/dL; 119: ALBUMIN, 2.4 g/dL; 119: CHLORIDE, 88 mmol/L; 119: EGFR REFIT WITHOUT RACE (2021), 17 mL/min/1.73 m2; 119: CHLORIDE, 88 mmol/L; 119: PROTEIN TOTAL, 5.3 g/dL; 119: GLOBULIN, 2.9 g/dL; 119: AST (SGOT), 15 U/L; 119: CORRECTED CALCIUM, 8.8 mg/dL; 119: POTASSIUM, 3.1 mmol/L; 119: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 119: ALT (SGPT), 10 U/L; 119: SODIUM, 119 mmol/L; 119: ANION GAP, 15 mmol/L; 119: SODIUM, 119 mmol/L; 119: CALCIUM, 7.5 mg/dL; 119: CO2, 16 mmol/L; 119: ALKALINE PHOSPHATASE, 129 U/L; 119: CO2, 16 mmol/L; 119: GLOBULIN, 2.9 g/dL; 119: BILIRUBIN TOTAL, 0.3 mg/dL; 119: EGFR FOR AFRICAN AMERICAN, 20 mL/min/1.73 m2; 119: CREATININE, 3.12 mg/dL; 119: ALBUMIN, 2.4 g/dL; 119: EGFR FOR AFRICAN AMERICAN, 20 mL/min/1.73 m2; 119: ALKALINE PHOSPHATASE, 129 U/L; 119: CALCIUM, 7.5 mg/dL; 119: CREATININE, 3.12 mg/dL; 0: Age, 44; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.4; 0: Triage HR, 122.0; 0: Triage RR, 20.0; 0: Triage SBP, 87.0; 0: Triage DBP, 67.0; 0: Triage acuity, 1-Resuscitation; 0: CC, BLOOD IN URINE",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The assessment of sepsis risk involves evaluating several clinical indicators. First, the patient's initial vital signs indicate potential hemodynamic instability, with low blood pressure (SBP 87.0, MAP 73.667) and high heart rate (122.0). This scenario is often concerning in the context of sepsis. Additionally, the low SpO2 initially at 71% before it improved, low hemoglobin (4.2 g/dL), low platelet count (27 K/uL), and elevated white blood cells (12 K/uL), combined with significant kidney function impairment (eGFR 17 mL/min/1.73 m\u00b2, creatinine 3.12 mg/dL), further point towards a high risk of sepsis. The clinical acuity of \"1-Resuscitation\" indicates a need for immediate attention, which aligns with high-risk conditions like sepsis.",
        "claims": [
            "The assessment of sepsis risk involves evaluating several clinical indicators.",
            "The patient's initial vital signs indicate potential hemodynamic instability.",
            "The patient's blood pressure is low, with a systolic blood pressure (SBP) of 87.0.",
            "The patient's mean arterial pressure (MAP) is 73.667.",
            "The patient's heart rate is high, at 122.0.",
            "This scenario is often concerning in the context of sepsis.",
            "The patient's initial SpO2 is low at 71%.",
            "The patient's SpO2 improved after the initial reading.",
            "The patient's hemoglobin level is low at 4.2 g/dL.",
            "The patient's platelet count is low at 27 K/uL.",
            "The patient's white blood cell count is elevated at 12 K/uL.",
            "The patient has significant kidney function impairment, with an estimated glomerular filtration rate (eGFR) of 17 mL/min/1.73 m\u00b2.",
            "The patient's creatinine level is elevated at 3.12 mg/dL.",
            "These clinical indicators further point towards a high risk of sepsis.",
            "The clinical acuity of \"1-Resuscitation\" indicates a need for immediate attention.",
            "Immediate attention aligns with high-risk conditions like sepsis."
        ],
        "relevant_claims": [
            "The patient's initial vital signs indicate potential hemodynamic instability.",
            "The patient's blood pressure is low, with a systolic blood pressure (SBP) of 87.0.",
            "The patient's mean arterial pressure (MAP) is 73.667.",
            "The patient's heart rate is high, at 122.0.",
            "The patient's hemoglobin level is low at 4.2 g/dL.",
            "The patient's platelet count is low at 27 K/uL.",
            "The patient's white blood cell count is elevated at 12 K/uL.",
            "The patient has significant kidney function impairment, with an estimated glomerular filtration rate (eGFR) of 17 mL/min/1.73 m\u00b2.",
            "The patient's creatinine level is elevated at 3.12 mg/dL.",
            "These clinical indicators further point towards a high risk of sepsis.",
            "The clinical acuity of \"1-Resuscitation\" indicates a need for immediate attention.",
            "Immediate attention aligns with high-risk conditions like sepsis."
        ],
        "alignment_scores": [
            0.7,
            1.0,
            0.3,
            0.8,
            0.3,
            1.0,
            1.0,
            0.7,
            1.0,
            0.3,
            0.6,
            0.3
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)",
            "AElevated NEWS Score (\u22655 points)",
            "High qSOFA Score (\u22652)"
        ],
        "alignment_reasonings": [
            "The claim about \"hemodynamic instability\" aligns closely with the Elevated Shock Index category, which specifically addresses hemodynamic instability in the context of sepsis risk. The shock index, as a measure of hemodynamic stability (heart rate divided by systolic BP), directly reflects the concept of hemodynamic instability indicated in the claim. However, without specific numerical values, the alignment is good but not perfect.",
            "The claim directly references a systolic blood pressure (SBP) of 87.0, which is below the threshold of 90 mmHg defined by the Sepsis-Associated Hypotension category. This indicates clear alignment, as it specifically meets the criterion for this category associated with sepsis progression.",
            "The claim mentions a MAP of 73.667, which is above the threshold of <70 mmHg for sepsis-associated hypotension. While this does not directly meet the criterion, it is close enough to be considered relevant in assessing the risk of sepsis, but the alignment is weak since this MAP does not indicate hypotension by itself.",
            "A high heart rate (>90 bpm) is one of the specific criteria for SIRS (Systemic Inflammatory Response Syndrome) positivity, which indicates systemic inflammation consistent with early sepsis. The claim mentions a heart rate well above the threshold, providing strong alignment, although the claim does not mention other SIRS criteria that would confirm the presence of SIRS, hence the rating is not a full 1.0.",
            "A low hemoglobin level itself is not directly a SOFA component, but it indicates potential for anemia which could contribute to organ dysfunction. Though not a direct SOFA criterion like platelet count or creatinine level, it indirectly relates to the systemic issues assessed by SOFA, such as oxygen-carrying capacity impacting organ function. The alignment is weak as hemoglobin is not explicitly part of the SOFA score calculation.",
            "A platelet count of less than 100 \u00d7 10\u2079/L (or 100 K/uL) is a specific criterion for a SOFA score increase, indicating organ dysfunction. The patient's platelet count of 27 K/uL is well below this threshold, strongly aligning with the SOFA Score Increase category. Thus, there is a perfect alignment with this criterion.",
            "An elevated white blood cell count is explicitly one of the criteria listed for SIRS (\u2265\u202f12,000/\u00b5L). This claim directly aligns with the criteria used to identify systemic inflammation consistent with early sepsis, thus perfectly matching the category.",
            "Significant kidney function impairment, such as an eGFR of 17 mL/min/1.73 m\u00b2, is closely related to the SOFA criteria involving creatinine levels (>2 mg/dL) or acute renal conditions. Although eGFR is not explicitly listed in SOFA criteria, it implies a similar risk for organ dysfunction. The alignment is fairly strong due to the conceptual overlap in assessing organ function impairment.",
            "An elevated creatinine level above 2 mg/dL is explicitly part of the SOFA criteria, indicating renal dysfunction. The level of 3.12 mg/dL certainly supports a SOFA score increase, aligning perfectly with this expert category for assessing new organ dysfunction and high sepsis risk.",
            "The claim about \"clinical indicators\" suggesting a high risk of sepsis is quite broad and non-specific. While it doesn't directly reference elevated NEWS or any specific score, NEWS is tied to predicting clinical deterioration consistent with high sepsis risk. Thus, it somewhat aligns with the general notion of \"clinical indicators\" pointing towards sepsis, though the alignment is weak due to lack of specificity.",
            "The term \"1-Resuscitation\" implies the patient requires immediate medical attention, suggesting high clinical acuity and potential for rapid deterioration, similar to a high NEWS score indicating imminent clinical deterioration. While it does not explicitly use or mention NEWS scores, the implication of needing urgent care aligns conceptually with the purpose of elevated NEWS scores in predicting acute clinical deterioration, thus suggesting a moderate alignment.",
            "The claim mentions \"immediate attention\" for high-risk conditions like sepsis. This aligns somewhat with conditions identified by the High qSOFA Score category, which alerts to high risk of sepsis-related organ dysfunction that would require immediate medical attention. However, the claim is vague and does not specify qSOFA criteria directly, resulting in a low alignment score."
        ],
        "final_alignment_score": 0.6666666666666666,
        "accuracy": 1
    },
    {
        "input": "4: HR, 97.746; 4: RR, 22.186; 4: SpO2, 94.559; 4: Perf, 0.646; 4: 1min HRV, 11.968; 4: SBP, 92.0; 4: DBP, 66.0; 4: MAP, 74.667; 5: HR, 98.759; 5: RR, 23.724; 5: SpO2, 94.862; 5: Perf, 0.741; 5: 1min HRV, 8.708; 6: HR, 100.746; 6: RR, 26.729; 6: SpO2, 90.763; 6: Perf, 0.651; 6: 1min HRV, 5.674; 7: HR, 100.644; 7: RR, 28.102; 7: SpO2, 89.068; 7: Perf, 0.558; 7: 1min HRV, 12.144; 8: HR, 99.017; 8: RR, 27.690; 8: SpO2, 90.66; 8: Perf, 0.624; 8: 1min HRV, 8.066; 8: 5min HRV, 11.353; 9: HR, 97.288; 9: RR, 24.424; 9: SpO2, 91.576; 9: Perf, 0.602; 9: 1min HRV, 7.119; 9: SBP, 83.0; 9: DBP, 64.0; 9: MAP, 70.333; 10: HR, 96.627; 10: RR, 26.712; 10: SpO2, 92.0; 10: Perf, 0.704; 10: 1min HRV, 9.393; 10: SBP, 83.0; 10: DBP, 64.0; 10: MAP, 70.333; 10: Temp, 100.9; 11: HR, 96.776; 11: RR, 22.207; 11: SpO2, 92.621; 11: Perf, 0.637; 11: 1min HRV, 9.644; 12: HR, 97.034; 12: RR, 22.847; 12: SpO2, 92.017; 12: Perf, 0.600; 12: 1min HRV, 5.245; 13: HR, 96.879; 13: RR, 22.034; 13: SpO2, 92.088; 13: Perf, 0.632; 13: 1min HRV, 14.753; 13: 5min HRV, 9.971; 14: HR, 96.339; 14: RR, 21.119; 14: SpO2, 94.339; 14: Perf, 0.657; 14: 1min HRV, 10.121; 14: SBP, 90.0; 14: DBP, 60.0; 14: MAP, 70.0; 15: HR, 95.949; 15: RR, 22.492; 15: SpO2, 94.763; 15: Perf, 0.840; 15: 1min HRV, 4.013; 15: SBP, 90.0; 15: DBP, 60.0; 15: MAP, 70.0; 16: HR, 96.845; 16: RR, 22.259; 16: SpO2, 94.569; 16: Perf, 0.876; 16: 1min HRV, 3.703; 17: HR, 96.237; 17: RR, 22.627; 17: SpO2, 94.881; 17: Perf, 0.765; 17: 1min HRV, 6.290; 18: HR, 96.690; 18: RR, 21.793; 18: SpO2, 94.795; 18: Perf, 0.773; 18: 1min HRV, 4.852; 18: 5min HRV, 6.426; 19: HR, 97.254; 19: RR, 22.339; 19: SpO2, 94.526; 19: Perf, 0.814; 19: 1min HRV, 3.623; 19: SBP, 85.0; 19: DBP, 61.0; 19: MAP, 69.0; 20: HR, 96.186; 20: RR, 20.678; 20: SpO2, 94.0; 20: Perf, 0.843; 20: 1min HRV, 4.718; 21: HR, 96.052; 21: RR, 22.172; 21: SpO2, 94.0; 21: Perf, 0.719; 21: 1min HRV, 5.543; 22: HR, 96.593; 22: RR, 25.831; 22: SpO2, 94.0; 22: Perf, 0.723; 22: 1min HRV, 6.151; 23: HR, 97.552; 23: RR, 25.569; 23: SpO2, 95.672; 23: Perf, 0.807; 23: 1min HRV, 44.425; 23: 5min HRV, 20.809; 24: HR, 95.424; 24: RR, 24.492; 24: SpO2, 92.644; 24: Perf, 0.812; 24: 1min HRV, 4.431; 24: SBP, 94.0; 24: DBP, 84.0; 24: MAP, 87.333; 25: HR, 95.932; 25: RR, 23.441; 25: SpO2, 90.424; 25: Perf, 0.442; 25: 1min HRV, 7.390; 26: HR, 96.586; 26: RR, 23.5; 26: SpO2, 92.793; 26: Perf, 0.369; 26: 1min HRV, 7.642; 27: HR, 95.898; 27: RR, 22.407; 27: SpO2, 92.542; 27: Perf, 0.37; 27: 1min HRV, 10.837; 28: HR, 95.948; 28: RR, 23.241; 28: SpO2, 92.086; 28: Perf, 0.37; 28: 1min HRV, 2.685; 28: 5min HRV, 7.882; 29: SBP, 82.0; 29: DBP, 67.0; 29: MAP, 72.0; 44: POC PH (V) ISTAT, 7.45; 44: POC LACTATE ISTAT, 0.79 mmol/L; 44: POC PCO2 (V) ISTAT, 49.2 mmHg; 44: POC HCO3 (V) ISTAT, 34.0 mmol/L; 44: POC O2 SATURATION ISTAT VENOUS, 72 %; 44: POC BASE EXCESS ISTAT, 10 mmol/L; 44: POC TCO2 (V) ISTAT, 35 mmol/L; 44: POC PO2 (V) ISTAT, 37 mmHg; 47: SpO2, 94.0; 47: LPM O2, 15.0; 53: HR, 86.0; 53: RR, 34.0; 53: SpO2, 98.0; 53: SBP, 102.0; 53: DBP, 61.0; 53: MAP, 74.667; 57: LR IV BOLUS -, 500 ML; 58: HR:, 88.0; 58: RR, 20.0; 58: SpO2, 98.0; 58: SBP, 86.0; 58: DBP, 61.0; 58: MAP, 69.333; 58: Temp, 100.2; 68: HR, 87.0; 68: RR, 27.0; 68: SpO2, 93.0; 68: SBP, 92.0; 68: DBP, 66.0; 68: MAP, 74.667; 68: Temp, 100.2; 83: HR, 85.0; 83: RR, 20.0; 83: SpO2, 94.0; 83: Temp, 100.2; 88: HR, 85.0; 88: RR, 20.0; 88: SpO2, 96.0; 88: SBP, 84.0; 88: DBP, 59.0; 88: MAP, 67.333; 88: Temp, 100.2; 88: LR IV BOLUS -, 500 ML; 94: SODIUM:, 131 mmol/L; 94: GLOBULIN, 4.0 g/dL; 94: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 94: GLUCOSE, 128 mg/dL; 94: POTASSIUM, 4.3 mmol/L; 94: ALKALINE PHOSPHATASE, 159 U/L; 94: ALT (SGPT), 31 U/L; 94: CALCIUM, 8.5 mg/dL; 94: PROTEIN TOTAL, 7.1 g/dL; 94: ANION GAP, 10 mmol/L; 94: CREATININE, 0.55 mg/dL; 94: AST (SGOT), 51 U/L; 94: CHLORIDE, 94 mmol/L; 94: ALBUMIN, 3.1 g/dL; 94: CO2, 27 mmol/L; 94: BILIRUBIN TOTAL, 0.3 mg/dL; 94: BLOOD UREA NITROGEN (BUN), 5 mg/dL; 94: CORRECTED CALCIUM, 9.2 mg/dL; 94: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 98: HR:, 84.0; 98: RR, 22.0; 98: SpO2, 96.0; 98: SBP, 86.0; 98: DBP, 58.0; 98: MAP, 67.333; 98: Temp, 100.0; 113: HR, 80.0; 113: RR, 17.0; 113: SpO2, 96.0; 113: SBP, 84.0; 113: DBP, 57.0; 113: MAP, 66.0; 113: Temp, 99.7; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 38.3; 0: Triage HR, 97.0; 0: Triage RR, 21.0; 0: Triage SBP, 83.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The easiest subquestion tackles whether there are any indicators of sepsis risk, such as low blood pressure, high heart rate, increased respiratory rate, or fever within the provided time series data. Initially, the triage data shows hypotension (SBP 83.0) and an elevated temperature (38.3\u00b0C), factors that both indicate a potential infection risk. As time progresses (in hours 4\u201311), the patient shows persistent signs of tachycardia, elevated respiratory rates, decreased SpO2 levels, and variable blood pressure, consistent with potential sepsis symptoms. The final subquestion checks for the continuation or worsening of these parameters towards the end of the time series. Continued low blood pressure (SBP < 90 after 20.0 hours) and high respiratory rate further strengthen the case for sepsis risk. The consistent presence of these symptoms supports a \"Yes\" label for high sepsis risk within 12 hours.",
        "claims": [
            "There are indicators of sepsis risk in the provided time series data.",
            "Indicators of sepsis risk include low blood pressure, high heart rate, increased respiratory rate, and fever.",
            "The triage data shows hypotension with a systolic blood pressure (SBP) of 83.0.",
            "The triage data shows an elevated temperature of 38.3\u00b0C.",
            "Hypotension and elevated temperature indicate a potential infection risk.",
            "From hours 4 to 11, the patient shows persistent signs of tachycardia.",
            "The patient exhibits elevated respiratory rates from hours 4 to 11.",
            "The patient shows decreased SpO2 levels from hours 4 to 11.",
            "The patient has variable blood pressure from hours 4 to 11.",
            "These signs are consistent with potential sepsis symptoms.",
            "The final subquestion checks for the continuation or worsening of these parameters towards the end of the time series.",
            "Continued low blood pressure (SBP < 90) is observed after 20.0 hours.",
            "The patient exhibits a high respiratory rate towards the end of the time series.",
            "Continued low blood pressure and high respiratory rate strengthen the case for sepsis risk.",
            "The consistent presence of these symptoms supports a \"Yes\" label for high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "There are indicators of sepsis risk in the provided time series data.",
            "Indicators of sepsis risk include low blood pressure, high heart rate, increased respiratory rate, and fever.",
            "The triage data shows hypotension with a systolic blood pressure (SBP) of 83.0.",
            "The triage data shows an elevated temperature of 38.3\u00b0C.",
            "Hypotension and elevated temperature indicate a potential infection risk.",
            "From hours 4 to 11, the patient shows persistent signs of tachycardia.",
            "The patient exhibits elevated respiratory rates from hours 4 to 11.",
            "The patient shows decreased SpO2 levels from hours 4 to 11.",
            "The patient has variable blood pressure from hours 4 to 11.",
            "These signs are consistent with potential sepsis symptoms.",
            "The final subquestion checks for the continuation or worsening of these parameters towards the end of the time series.",
            "The patient exhibits a high respiratory rate towards the end of the time series.",
            "Continued low blood pressure and high respiratory rate strengthen the case for sepsis risk.",
            "The consistent presence of these symptoms supports a \"Yes\" label for high sepsis risk within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            1.0,
            0.7,
            0.7,
            0.7,
            0.7,
            0.6,
            0.3,
            0.3,
            0.5,
            0.7,
            0.8,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Shock Index (\u22651.0)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)"
        ],
        "alignment_reasonings": [
            "The claim mentions \"indicators of sepsis risk,\" which suggests encompassing observations from various physiological measures over time, similar to how a NEWS score might be assessed from trends in vital signs. However, no specific details or measures are provided directly linking the claim to an elevated NEWS score, making the alignment very general and loose. Therefore, the rating reflects a low but potential connection to the type of evaluative data collection implied by a monitoring tool like NEWS.",
            "The claim mentions indicators consistent with early sepsis and systemic inflammation: low blood pressure, high heart rate, increased respiratory rate, and fever. These overlap with the SIRS criteria (e.g., heart rate >90 bpm, respiratory rate >20/min, and temperature >38\u00b0C). The presence of these indicators supports alignment with the SIRS Positivity category, although low blood pressure itself is not a SIRS criterion but relates to a broader sepsis context. Thus, the alignment is strong but not perfect.",
            "The claim directly references hypotension with a specific systolic blood pressure (SBP) of 83.0, which is below the threshold of <90 mmHg outlined in the Sepsis-Associated Hypotension category. Therefore, there is perfect alignment with this category due to the explicit mention of low SBP, a key indicator of progression toward septic shock.",
            "The claim mentions a temperature of 38.3\u00b0C, which surpasses the threshold of >38\u00b0C for the SIRS criteria. An elevated temperature is one of the criteria indicating systemic inflammation, suggesting an early sepsis condition. However, SIRS requires the presence of two or more criteria. Since only one criterion is mentioned, the alignment is strong but not complete, warranting a rating of 0.7.",
            "The claim mentions hypotension, which directly aligns with the \"Sepsis-Associated Hypotension\" category that indicates progression toward septic shock. The elevated temperature suggests an infection risk and hints at systemic inflammation, which is related but not specific to the hypotension criteria. The alignment is substantial given the reference to hypotension, although it does not specify if it falls within the defined thresholds.",
            "Tachycardia is explicitly listed under SIRS criteria, where a heart rate >90\u202fbpm indicates systemic inflammation consistent with early sepsis. The claim's mention of \"persistent signs\" suggests repeated or continuous tachycardia, reinforcing the notion of systemic inflammation, albeit it doesn't provide a full picture of meeting \u22652 SIRS criteria. Hence, there's a solid but slightly indirect alignment.",
            "An elevated respiratory rate is one of the criteria for SIRS, specifically with a respiratory rate >20/min. The claim directly mentions elevated respiratory rates over a period of time, which aligns moderately well with the SIRS criteria. However, since it does not provide a specific rate to confirm the threshold, the alignment is not perfect, thus the rating of 0.7. It suggests a possibility of systemic inflammation consistent with early sepsis, but without additional information on the specific rates or other SIRS criteria, full alignment cannot be confirmed.",
            "Decreased SpO\u2082 levels indicate potential hypoxia, which can relate to impaired oxygenation. Although direct SpO\u2082 levels aren't a specific SOFA measure, they conceptually align with factors influencing the PaO\u2082/FiO\u2082 ratio. This relationship suggests a moderate alignment with the SOFA category, indicating possible organ dysfunction related to respiratory compromise.",
            "Although the claim refers to variable blood pressure, it does not specify a threshold drop or particular pattern pointing to hypotension or haemodynamic instability tied explicitly to an elevated shock index. Instead, it hints at potential hemodynamic issues, offering weak alignment with the Shock Index category, which assesses instability through HR and BP correlation.",
            "The claim suggests a general possibility of sepsis but lacks specific details. The high qSOFA score often encompasses symptoms suggestive of sepsis, such as altered mentation and hemodynamic instability. However, since no specific symptoms or scores are mentioned, the alignment is indirect and weak. The broad nature of the claim somewhat aligns with potential severe sepsis symptoms typically covered by qSOFA, but without specifics, the alignment is minimal.",
            "The claim discusses monitoring for the continuation or worsening of parameters, implying observation for changes in organ function or clinical status. SOFA score increases reflect deterioration through new organ dysfunction, which conceptually links to monitoring trends. However, the claim is vague and does not specify which parameters are worsening or if they align exactly with the SOFA criteria, so the alignment is moderate rather than strong.",
            "A high respiratory rate is one of the criteria for the qSOFA score, specifically respiratory rate \u226522/min. While the claim indicates an increased respiratory rate, it doesn't specify if the rate meets or exceeds the qSOFA threshold of 22/min. Thus, it suggests a potential alignment with high risk indicated by qSOFA but lacks specificity, resulting in a moderately strong alignment.",
            "The claim references low blood pressure and high respiratory rate. A high respiratory rate (\u226522/min) and low systolic blood pressure (\u2264100 mmHg) are both components of the qSOFA score, which is used to flag high risk of sepsis-related organ dysfunction and mortality. The mention of these two factors strongly suggests alignment with the qSOFA criteria. However, the claim does not specify exact values to confirm they meet the qSOFA thresholds, leading to a slightly conservative alignment rating.",
            "The claim is vague and does not specify which symptoms are present, making it difficult to strongly associate with a specific category. However, the qSOFA score uses a combination of symptoms related to respiration rate, blood pressure, and mentation to flag high sepsis risk, making it somewhat relevant to the claim of \"consistent presence of these symptoms\" leading to a high sepsis risk. This indirect and minimal alignment suggests a low rating of 0.3."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 1
    },
    {
        "input": "5: HR, 106.0; 5: RR, 32.0; 5: SpO2, 99.0; 5: SBP, 123.0; 5: DBP, 78.0; 5: MAP, 93.0; 5: Pain, 0.0; 5: Temp, 98.8; 27: SpO2, 95.804; 27: Perf, 0.518; 28: SpO2, 95.915; 28: Perf, 0.875; 29: SpO2, 93.810; 29: Perf, 0.93; 30: SpO2, 93.731; 30: Perf, 0.93; 31: HR, 105.0; 31: SpO2, 95.5; 31: Perf, 0.921; 31: SBP, 118.0; 31: DBP, 88.0; 31: MAP, 98.0; 32: SpO2, 94.926; 32: Perf, 0.769; 33: SpO2, 94.895; 33: Perf, 0.76; 34: SpO2, 95.0; 34: Perf, 0.76; 35: SpO2, 97.0; 35: Perf, 0.603; 36: HR, 101.952; 36: SpO2, 97.103; 36: Perf, 0.532; 36: 1min HRV, 35.120; 37: HR, 105.542; 37: SpO2, 96.441; 37: Perf, 0.586; 37: 1min HRV, 22.801; 38: HR, 104.845; 38: SpO2, 95.776; 38: Perf, 0.601; 38: 1min HRV, 17.379; 39: HR, 103.475; 39: SpO2, 95.881; 39: Perf, 0.698; 39: 1min HRV, 21.945; 39: 5min HRV, 25.526; 40: HR, 104.776; 40: SpO2, 95.259; 40: Perf, 0.889; 40: 1min HRV, 23.186; 41: HR, 107.186; 41: SpO2, 94.458; 41: Perf, 0.937; 41: 1min HRV, 27.290; 42: HR, 102.814; 42: SpO2, 94.712; 42: Perf, 1.16; 42: 1min HRV, 26.491; 43: HR, 104.983; 43: SpO2, 93.897; 43: Perf, 1.168; 43: 1min HRV, 19.577; 44: HR, 106.0; 44: SpO2, 95.085; 44: Perf, 0.625; 44: 1min HRV, 22.391; 44: 5min HRV, 24.972; 45: HR, 101.517; 45: SpO2, 94.690; 45: Perf, 0.590; 45: 1min HRV, 36.524; 46: HR, 106.186; 46: SpO2, 96.339; 46: Perf, 0.64; 46: 1min HRV, 41.338; 47: HR, 106.034; 47: SpO2, 95.576; 47: Perf, 0.64; 47: 1min HRV, 24.015; 48: HR, 101.431; 48: SpO2, 97.017; 48: Perf, 0.638; 48: 1min HRV, 27.987; 49: HR, 105.271; 49: SpO2, 96.026; 49: Perf, 0.623; 49: 1min HRV, 27.465; 49: 5min HRV, 36.044; 50: HR, 105.475; 50: SpO2, 95.458; 50: Perf, 0.709; 50: 1min HRV, 32.442; 51: HR, 104.569; 51: SpO2, 95.414; 51: Perf, 0.74; 51: 1min HRV, 29.709; 52: HR, 104.508; 52: SpO2, 94.0; 52: Perf, 0.74; 52: 1min HRV, 29.782; 53: HR, 109.086; 53: Perf, 0.74; 53: 1min HRV, 21.648; 54: HR, 108.237; 54: Perf, 0.74; 54: 1min HRV, 29.355; 54: 5min HRV, 30.426; 55: HR, 106.305; 55: SpO2, 91.417; 55: Perf, 0.74; 55: 1min HRV, 28.756; 56: HR, 100.034; 56: SpO2, 90.0; 56: 1min HRV, 30.972; 57: HR, 103.593; 57: 1min HRV, 26.173; 58: HR, 100.0; 58: 1min HRV, 36.792; 59: HR, 109.305; 59: 1min HRV, 33.558; 59: 5min HRV, 36.879; 60: HR, 102.017; 60: 1min HRV, 32.222; 61: HR, 107.780; 61: 1min HRV, 25.075; 62: HR, 109.136; 62: 1min HRV, 18.568; 63: HR, 107.483; 63: 1min HRV, 39.046; 64: HR, 109.356; 64: 1min HRV, 32.715; 64: 5min HRV, 33.510; 65: HR, 96.627; 65: SpO2, 91.484; 65: 1min HRV, 30.208; 66: HR, 102.293; 66: SpO2, 94.64; 66: 1min HRV, 31.751; 67: HR, 100.339; 67: SpO2, 96.913; 67: Perf, 0.65; 67: 1min HRV, 34.148; 68: HR, 106.034; 68: SpO2, 96.833; 68: Perf, 0.65; 68: 1min HRV, 31.407; 69: HR, 101.153; 69: SpO2, 97.0; 69: Perf, 0.402; 69: 1min HRV, 29.794; 69: 5min HRV, 36.688; 70: HR, 98.627; 70: SpO2, 96.949; 70: Perf, 0.405; 70: 1min HRV, 26.562; 71: HR, 111.034; 71: SpO2, 97.25; 71: Perf, 0.41; 71: 1min HRV, 20.913; 72: HR, 109.644; 72: SpO2, 94.857; 72: 1min HRV, 36.253; 73: POC, HCG, ISTAT QUALITATIVE: Negative; 73: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 73: HR, 101.759; 73: 1min HRV, 34.292; 74: HR, 105.780; 74: 1min HRV, 41.076; 74: 5min HRV, 41.376; 75: POC PH (V) ISTAT, 7.38; 75: POC LACTATE ISTAT, <.30 mmol/L; 75: POC HCO3 (V) ISTAT, 19.6 mmol/L; 75: POC O2 SATURATION ISTAT VENOUS, 86 %; 75: POC PCO2 (V) ISTAT, 33.3 mmHg; 75: POC TCO2 (V) ISTAT, 21 mmol/L; 75: POC PO2 (V) ISTAT, 53 mmHg; 75: POC BASE EXCESS ISTAT, -6 mmol/L; 75: HR, 107.724; 75: SpO2, 96.0; 75: 1min HRV, 29.352; 76: HR, 109.695; 76: SpO2, 96.0; 76: 1min HRV, 30.434; 77: HR, 106.627; 77: SpO2, 96.2; 77: 1min HRV, 24.569; 78: HR, 104.724; 78: SpO2, 96.0; 78: 1min HRV, 28.498; 79: HR, 110.661; 79: 1min HRV, 27.035; 79: 5min HRV, 30.151; 80: HR, 108.207; 80: 1min HRV, 18.073; 81: HR, 108.407; 81: SpO2, 99.0; 81: 1min HRV, 21.980; 82: HR, 106.983; 82: SpO2, 98.0; 82: 1min HRV, 26.322; 83: HR, 110.776; 83: 1min HRV, 24.902; 84: HR, 105.169; 84: 1min HRV, 25.793; 84: 5min HRV, 24.952; 85: HR, 107.724; 85: 1min HRV, 25.418; 86: HR, 107.661; 86: 1min HRV, 29.177; 87: HR, 107.220; 87: 1min HRV, 22.764; 88: SARS-COV-2 RNA, Not Detected; 88: HR, 108.845; 88: 1min HRV, 34.501; 89: HR, 105.915; 89: SpO2, 100.0; 89: 1min HRV, 23.263; 89: 5min HRV, 27.878; 90: HR, 105.138; 90: SpO2, 100.0; 90: 1min HRV, 21.307; 91: HR, 106.068; 91: SpO2, 99.0; 91: Perf, 1.246; 91: 1min HRV, 39.280; 92: HR, 107.915; 92: SpO2, 99.0; 92: Perf, 0.983; 92: 1min HRV, 27.151; 93: HR, 106.810; 93: SpO2, 99.0; 93: Perf, 0.870; 93: 1min HRV, 21.717; 94: HR, 107.0; 94: SpO2, 99.0; 94: Perf, 0.943; 94: 1min HRV, 17.297; 94: 5min HRV, 27.470; 118: WAM DIFTYP, AUTO; 118: BASOPHIL % (AUTO DIFF), 0.3 %; 118: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 118: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.26 K/uL; 118: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 118: MONOCYTE ABSOLUTE (AUTO DIFF), 0.70 K/uL; 118: PLATELET COUNT (PLT), 279 K/uL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 118: HEMOGLOBIN (HGB), 10.6 g/dL; 118: RED BLOOD CELLS (RBC), 3.40 MIL/uL; 118: MONOCYTE % (AUTO DIFF), 7.3 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.6 g/dL; 118: NEUTROPHIL % (AUTO DIFF), 76.0 %; 118: EOSINOPHIL % (AUTO DIFF), 2.7 %; 118: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 118: HEMATOCRIT (HCT), 33.5 %; 118: WHITE BLOOD CELLS (WBC), 9.6 K/uL; 118: LYMPHOCYTE % (AUTO DIFF), 13.3 %; 118: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 98.5 fL; 118: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.28 K/uL; 118: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 118: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.31 K/uL; 118: NRBC PERCENT (HEMATOLOGY), 0.0 %; 0: Age, 23; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 106.0; 0: Triage RR, 32.0; 0: Triage SBP, 123.0; 0: Triage DBP, 78.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, analyze vital sign abnormalities and lab values. The patient is tachycardic (HR consistently high) and has mild hypoxemia at some points, but other vitals like blood pressure, temperature, and MAP are normal or slightly elevated. Lab results do not show significant abnormalities indicative of sepsis, such as leukocytosis, elevated lactate, or disturbed pH. Thus, though there are signs of physiological stress, there is insufficient evidence indicating a high risk for sepsis within 12 hours.",
        "claims": [
            "To determine the sepsis risk, analyze vital sign abnormalities and lab values.",
            "The patient is tachycardic.",
            "The patient's heart rate is consistently high.",
            "The patient has mild hypoxemia at some points.",
            "Other vital signs like blood pressure are normal or slightly elevated.",
            "Other vital signs like temperature are normal or slightly elevated.",
            "Other vital signs like mean arterial pressure (MAP) are normal or slightly elevated.",
            "Lab results do not show significant abnormalities indicative of sepsis.",
            "Lab results do not show leukocytosis.",
            "Lab results do not show elevated lactate.",
            "Lab results do not show disturbed pH.",
            "There are signs of physiological stress.",
            "There is insufficient evidence indicating a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient is tachycardic.",
            "The patient's heart rate is consistently high.",
            "The patient has mild hypoxemia at some points.",
            "Lab results do not show significant abnormalities indicative of sepsis.",
            "Lab results do not show leukocytosis.",
            "Lab results do not show elevated lactate."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.5,
            0.2,
            0.3,
            0.1
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "Tachycardia (heart\u202frate\u202f>\u202f90\u202fbpm) is directly one of the SIRS criteria. The claim indicates the presence of tachycardia, thus aligning well with the SIRS category, though a complete SIRS positivity would require at least one more criterion to be present.",
            "A consistently high heart rate is related to SIRS criteria, which list a heart rate\u202f>\u202f90\u202fbpm as one of the indicators of systemic inflammation consistent with early sepsis. While the claim mentions a high heart rate, it lacks specific values, so the alignment rating is strong but not definitive.",
            "Mild hypoxemia is conceptually related to impaired oxygenation, which corresponds with the SOFA criteria involving PaO\u2082/FiO\u2082. Although the claim does not directly state an increase in the SOFA score, hypoxemia is related to the category's assessment of oxygenation issues, providing a moderate indirect alignment.",
            "The claim states that lab results do not show significant abnormalities indicative of sepsis. Elevated serum lactate is a specific lab marker used to assess sepsis risk and mortality. Since the claim suggests the absence of abnormalities, it indirectly relates to the lack of elevated serum lactate but does not directly align with any predictive categories. The alignment is weak, as the absence of abnormalities doesn't affirmatively fit within any specific category.",
            "A normal white blood cell count does not meet the SIRS criterion of leukocytosis (WBC\u202f>\u202f12\u202f000/\u00b5L) or leukopenia (WBC\u202f<\u202f4\u202f000/\u00b5L), which would indicate systemic inflammation. The claim partially relates to the SIRS category through the absence of meeting one of its criteria, leading to a low alignment rating.",
            "The claim makes a direct reference to elevated lactate levels, but specifically notes that lactate is not elevated. This is the inverse of what the category considers a risk factor, resulting in a very low alignment since the absence of elevated lactate does not contribute to sepsis risk assessment based on this criterion."
        ],
        "final_alignment_score": 0.43333333333333335,
        "accuracy": 0
    },
    {
        "input": "3: SpO2, 95.566; 3: Perf, 1.128; 4: SpO2, 94.811; 4: Perf, 0.859; 5: RR, 28.667; 5: SpO2, 88.321; 5: Perf, 0.710; 5: 1min HRV, 192.045; 6: HR, 87.510; 6: RR, 18.358; 6: SpO2, 86.736; 6: Perf, 0.617; 6: 1min HRV, 190.778; 7: HR, 84.615; 7: RR, 24.756; 7: SpO2, 94.173; 7: Perf, 0.719; 7: 1min HRV, 151.921; 7: 5min HRV, 200.315; 8: HR, 79.667; 8: RR, 17.333; 8: SpO2, 97.551; 8: Perf, 0.640; 8: SBP, 81.0; 8: DBP, 67.0; 8: MAP, 71.667; 8: LPM O2, 15.0; 8: Pain, 0.0; 8: Temp, 95.5; 9: HR, 80.896; 9: SpO2, 97.698; 9: Perf, 0.721; 9: 1min HRV, 123.937; 10: HR, 73.521; 10: SpO2, 95.0; 10: Perf, 0.766; 10: 1min HRV, 345.717; 10: SBP, 103.0; 10: DBP, 61.0; 10: MAP, 75.0; 11: HR, 54.913; 11: SpO2, 95.887; 11: Perf, 0.672; 11: 1min HRV, 55.263; 12: HR, 0.0; 12: SpO2, 96.472; 12: Perf, 0.808; 12: 5min HRV, 222.786; 13: POC PH (V) ISTAT, 7.34; 13: POC PO2 (V) ISTAT, 26 mmHg; 13: POC TCO2 (V) ISTAT, 39 mmol/L; 13: POC LACTATE ISTAT, 1.75 mmol/L; 13: POC HCO3 (V) ISTAT, 36.6 mmol/L; 13: POC PCO2 (V) ISTAT, 68.0 mmHg; 13: POC O2 SATURATION ISTAT VENOUS, 40 %; 13: POC BASE EXCESS ISTAT, 11 mmol/L; 13: HR, 0.0; 13: SpO2, 96.623; 13: Perf, 0.706; 13: 1min HRV, 178.75; 14: HR, 0.0; 14: SpO2, 97.852; 14: Perf, 0.518; 14: 1min HRV, 3.583; 15: HR, 0.0; 15: SpO2, 97.135; 15: Perf, 0.586; 15: 1min HRV, 8.225; 16: HR, 0.0; 16: SpO2, 97.585; 16: Perf, 0.585; 17: HR, 0.0; 17: SpO2, 97.774; 17: Perf, 0.55; 17: 1min HRV, 133.625; 17: 5min HRV, 125.316; 18: HR, 0.0; 18: SpO2, 96.925; 18: Perf, 0.553; 18: 1min HRV, 213.992; 19: HR, 6.276; 19: SpO2, 97.132; 19: Perf, 0.56; 19: 1min HRV, 93.679; 20: HR, 0.0; 20: SpO2, 97.596; 20: Perf, 0.56; 20: 1min HRV, 0.0; 21: HR, 0.0; 21: SpO2, 98.0; 21: Perf, 0.564; 21: 1min HRV, 0.0; 22: HR, 0.0; 22: SpO2, 97.269; 22: Perf, 0.574; 22: 5min HRV, 167.366; 23: HR, 0.0; 23: SpO2, 96.415; 23: Perf, 0.59; 23: SBP, 103.0; 23: DBP, 74.0; 23: MAP, 83.667; 24: HR, 0.0; 24: SpO2, 97.811; 24: Perf, 0.619; 25: HR, 0.0; 25: SpO2, 98.0; 25: Perf, 0.63; 26: HR, 0.0; 26: SpO2, 97.755; 26: Perf, 0.675; 27: HR, 0.0; 27: SpO2, 97.442; 27: Perf, 0.749; 28: HR, 14.6; 28: RR, 7.286; 28: SpO2, 98.113; 28: Perf, 0.786; 28: 1min HRV, 126.031; 29: HR, 0.0; 29: RR, 13.510; 29: SpO2, 98.019; 29: Perf, 0.809; 29: 1min HRV, 100.75; 30: HR, 0.0; 30: RR, 18.885; 30: SpO2, 97.885; 30: Perf, 0.8; 30: 1min HRV, 258.922; 31: HR, 33.793; 31: RR, 15.574; 31: SpO2, 97.704; 31: Perf, 0.790; 31: 1min HRV, 99.035; 32: HR, 15.778; 32: RR, 17.615; 32: SpO2, 96.942; 32: Perf, 0.688; 32: 1min HRV, 79.568; 32: 5min HRV, 173.597; 33: HR, 63.727; 33: RR, 32.547; 33: SpO2, 97.642; 33: Perf, 0.56; 33: 1min HRV, 59.396; 34: HR, 23.1; 34: RR, 23.788; 34: SpO2, 97.0; 34: Perf, 0.635; 34: 1min HRV, 20.603; 35: HR, 0.0; 35: RR, 24.767; 35: SpO2, 96.870; 35: Perf, 0.611; 36: HR, 16.818; 36: RR, 16.923; 36: SpO2, 96.717; 36: Perf, 0.6; 36: 1min HRV, 56.853; 37: HR, 31.882; 37: RR, 27.673; 37: SpO2, 95.308; 37: Perf, 0.601; 37: 1min HRV, 53.233; 37: 5min HRV, 56.500; 38: HR, 41.0; 38: RR, 28.075; 38: SpO2, 96.522; 38: Perf, 0.61; 38: 1min HRV, 65.923; 38: SBP, 100.0; 38: DBP, 63.0; 38: MAP, 75.333; 42: 5min HRV, 65.923; 46: WAM DIFTYP, AUTO; 46: NEUTROPHIL % (AUTO DIFF), 88.2 %; 46: HEMATOCRIT (HCT), 44.5 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: RED BLOOD CELLS (RBC), 4.53 MIL/uL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: HEMOGLOBIN (HGB), 14.3 g/dL; 46: MONOCYTE % (AUTO DIFF), 3.2 %; 46: EOSINOPHIL % (AUTO DIFF), 0.3 %; 46: WHITE BLOOD CELLS (WBC), 11.8 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.1 g/dL; 46: LYMPHOCYTE % (AUTO DIFF), 7.6 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 98.2 fL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.1 %; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: PLATELET COUNT (PLT), 113 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.43 K/uL; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 54: RR, 30.0; 54: SpO2, 97.0; 61: PROTEIN TOTAL, 7.9 g/dL; 61: CREATININE, 0.64 mg/dL; 61: ALT (SGPT), 17 U/L; 61: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 61: BILIRUBIN TOTAL, 0.3 mg/dL; 61: SODIUM, 138 mmol/L; 61: CORRECTED CALCIUM, 9.8 mg/dL; 61: ANION GAP, 8 mmol/L; 61: GLUCOSE, 78 mg/dL; 61: AST (SGOT), 40 U/L; 61: POTASSIUM, 5.2 mmol/L; 61: CO2, 27 mmol/L; 61: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 61: ALBUMIN, 2.6 g/dL; 61: GLOBULIN, 5.3 g/dL; 61: BNP NT-PRO, 2199 pg/mL; 61: CHLORIDE, 103 mmol/L; 61: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 61: CALCIUM, 8.7 mg/dL; 61: ALKALINE PHOSPHATASE, 115 U/L; 67: HR, 71.0; 67: RR, 28.0; 67: SpO2, 99.0; 67: SBP, 104.0; 67: DBP, 51.0; 67: MAP, 68.667; 72: TROPONIN I, <.017 ng/mL; 83: SARS-COV-2 RNA, Not Detected; 105: METHYLPREDNISOLONE SOD SUC(PF), 125 MG/2 ML INJ SOLR; 110: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age, 75; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 35.3; 0: Triage HR, 72.0; 0: Triage RR, 28.0; 0: Triage SBP, 103.0; 0: Triage DBP, 61.0; 0: Triage acuity, 2-Emergent; 0: CC, RESPIRATORY DISTRESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The patient's condition is concerning due to multiple factors. The respiratory distress noted at triage, high respiratory rate, low body temperature, and fluctuating heart rate variability suggest instability. The persistent low SpO2 levels (below 90% at times) and evident bradycardia with heart rates dropping to 0 indicate severe physiologic derangements. Additionally, elevated BNP suggests cardiac stress, and the extremely high neutrophil percentage combined with low platelets points towards a strong inflammatory response, commonly associated with sepsis. These indicators collectively suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient's condition is concerning due to multiple factors.",
            "The patient exhibits respiratory distress noted at triage.",
            "The patient has a high respiratory rate.",
            "The patient has a low body temperature.",
            "The patient has fluctuating heart rate variability.",
            "These factors suggest instability in the patient's condition.",
            "The patient has persistent low SpO2 levels, which are below 90% at times.",
            "The patient shows evident bradycardia.",
            "The patient's heart rates have dropped to 0.",
            "These signs indicate severe physiologic derangements.",
            "Elevated BNP levels suggest cardiac stress.",
            "The patient has an extremely high neutrophil percentage.",
            "The patient has low platelet counts.",
            "The combination of high neutrophil percentage and low platelets points towards a strong inflammatory response.",
            "A strong inflammatory response is commonly associated with sepsis.",
            "These indicators collectively suggest a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient exhibits respiratory distress noted at triage.",
            "The patient has a high respiratory rate.",
            "The patient has fluctuating heart rate variability.",
            "These factors suggest instability in the patient's condition.",
            "The patient has persistent low SpO2 levels, which are below 90% at times.",
            "These signs indicate severe physiologic derangements.",
            "Elevated BNP levels suggest cardiac stress.",
            "The patient has an extremely high neutrophil percentage.",
            "The patient has low platelet counts.",
            "The combination of high neutrophil percentage and low platelets points towards a strong inflammatory response.",
            "These indicators collectively suggest a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.7,
            0.3,
            0.3,
            0.7,
            0.4,
            0.3,
            0.6,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated NEWS Score (\u22655 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim refers to respiratory distress, which could indicate an elevated respiratory rate. An elevated respiratory rate is a component of the qSOFA score (respiratory rate\u202f\u2265\u202f22\u202f/min). However, the claim does not provide specific numerical data to confirm qSOFA criteria, so the alignment is indirect and incomplete but conceptually relevant.",
            "A high respiratory rate is directly mentioned in the SIRS criteria, which identifies systemic inflammation consistent with early sepsis. While the claim does not specify the exact respiratory rate, it suggests a potential alignment with the threshold of >20/min required for positive SIRS. Thus, the alignment is fairly strong, but not complete without further specifics.",
            "Fluctuating heart rate variability suggests some degree of hemodynamic instability, which conceptually relates to the Elevated Shock Index category that involves heart rate and blood pressure. However, without specific information on heart rate and systolic blood pressure, the alignment is indirect and speculative. Thus, the alignment is weak.",
            "The claim broadly mentions \"instability,\" which can imply clinical deterioration\u2014a concept relevant to the National Early Warning Score (NEWS) which assesses patient stability. However, the claim lacks specific details about vital signs or scoring that would directly tie it to the NEWS metric, resulting in a low alignment.",
            "Persistent low SpO2 levels suggest hypoxia, which can relate to impaired oxygenation. While SpO2 is not directly a SOFA score component, a low PaO\u2082/FiO\u2082 ratio is, making the connection relevant. The claim is indirectly related to the SOFA criteria but significantly suggests potential organ dysfunction risk.",
            "The claim refers to \"severe physiologic derangements,\" which can imply a significant alteration in vital signs potentially captured by the NEWS. However, the claim is vague and lacks direct reference to specific vital sign changes. Although NEWS encompasses multiple physiologic measures, the connection to the claim is indirect and generalized, warranting a moderate alignment rating. Other categories potentially reflect physiologic derangements, but NEWS explicitly combines vital readings into a single score.",
            "Elevated BNP levels are associated with cardiac stress, often linked to heart failure rather than directly to the shock index. However, cardiac stress can sometimes contribute to hemodynamic instability, which is relevant to the shock index category. The alignment is weak because BNP is not a direct component of the shock index metric, but there's a marginal connection through cardiac function and hemodynamic status.",
            "An extremely high neutrophil percentage suggests an ongoing inflammatory or infectious process, aligning conceptually with the SIRS criteria that identify systemic inflammation. However, while neutrophil percentage isn't explicitly listed as a SIRS criterion, it generally implies elevated white blood cell counts, which are part of SIRS. The alignment is indirect but somewhat significant.",
            "Low platelet counts are directly related to one of the SOFA score components (platelets <100\u202f\u00d7\u202f10\u2079/L). A decrease in platelet count is used to determine organ dysfunction in the SOFA scoring system, which is associated with a higher risk of sepsis. While the claim does not specify whether the platelet count is below the exact threshold mentioned in the SOFA criteria, it aligns strongly with the general concept of assessing for organ dysfunction in potential sepsis cases. Therefore, the alignment is substantial but not flawless without concrete values.",
            "The presence of low platelets is directly listed under the SOFA score criteria as it indicates impaired hemostasis and potential organ dysfunction, a significant factor in sepsis risk. High neutrophil percentage suggests an inflammatory response, which can be associated with sepsis but is not specifically a SOFA criterion. Therefore, while the platelet count strongly aligns with SOFA, the neutrophil percentage less directly so, leading to a moderate alignment rating.",
            "The claim broadly speaks to a high risk of sepsis within a short time frame, which involves a general prediction of clinical deterioration. While specific indicators aren't mentioned, the concept aligns best with elevated NEWS, which aggregates various warnings into a single score predicting deterioration. The lack of specific clinical signs or metrics makes the alignment weak, but the notion of predicting imminent risk provides some relevance."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "4: HR, 152.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 150.0; 4: DBP, 102.0; 4: MAP, 118.0; 4: Temp, 97.2; 24: Pain, 5.0; 57: SpO2, 100.0; 57: Perf, 0.247; 58: SpO2, 100.0; 58: Perf, 0.346; 59: SpO2, 100.0; 59: Perf, 0.383; 60: SpO2, 100.0; 60: Perf, 0.339; 61: SpO2, 100.0; 61: Perf, 0.721; 62: SpO2, 100.0; 62: Perf, 1.018; 63: SpO2, 100.0; 63: Perf, 0.941; 64: SpO2, 100.0; 64: Perf, 0.551; 65: SpO2, 100.0; 65: Perf, 0.336; 66: HR, 142.0; 66: RR, 11.0; 66: SpO2, 100.0; 66: Perf, 0.311; 67: SpO2, 100.0; 67: Perf, 0.243; 68: HR, 142.444; 68: RR, 30.6; 68: SpO2, 100.0; 68: Perf, 0.229; 68: 1min HRV, 12.486; 69: HR, 143.678; 69: RR, 14.271; 69: SpO2, 100.0; 69: Perf, 0.249; 69: 1min HRV, 7.575; 70: HR, 142.069; 70: RR, 20.431; 70: SpO2, 100.0; 70: Perf, 0.267; 70: 1min HRV, 5.002; 71: HR, 143.068; 71: RR, 16.136; 71: SpO2, 100.0; 71: Perf, 0.304; 71: 1min HRV, 6.348; 71: 5min HRV, 7.438; 72: HR, 141.569; 72: RR, 15.552; 72: SpO2, 100.0; 72: Perf, 0.481; 72: 1min HRV, 5.429; 73: HR, 141.559; 73: RR, 15.983; 73: SpO2, 100.0; 73: Perf, 0.340; 73: 1min HRV, 11.586; 74: HR, 146.741; 74: RR, 19.931; 74: SpO2, 100.0; 74: Perf, 0.334; 74: 1min HRV, 7.123; 75: HR, 142.169; 75: RR, 17.186; 75: SpO2, 100.0; 75: Perf, 0.285; 75: 1min HRV, 16.123; 76: HR, 148.475; 76: RR, 22.847; 76: SpO2, 100.0; 76: Perf, 0.271; 76: 1min HRV, 10.443; 76: 5min HRV, 12.894; 77: HR, 143.0; 77: RR, 18.241; 77: SpO2, 100.0; 77: Perf, 0.218; 77: 1min HRV, 8.013; 78: HR, 141.678; 78: RR, 13.186; 78: SpO2, 100.0; 78: Perf, 0.204; 78: 1min HRV, 7.869; 79: HR, 143.322; 79: RR, 17.186; 79: SpO2, 100.0; 79: Perf, 0.191; 79: 1min HRV, 5.016; 80: HR, 145.862; 80: RR, 21.483; 80: SpO2, 100.0; 80: Perf, 0.19; 80: 1min HRV, 14.273; 81: HR, 150.593; 81: RR, 24.136; 81: SpO2, 100.0; 81: Perf, 0.220; 81: 1min HRV, 4.908; 81: 5min HRV, 12.638; 82: HR, 147.724; 82: RR, 20.155; 82: SpO2, 100.0; 82: Perf, 0.193; 82: 1min HRV, 6.422; 83: HR, 145.864; 83: RR, 19.610; 83: SpO2, 100.0; 83: Perf, 0.198; 83: 1min HRV, 16.707; 84: HR, 146.103; 84: RR, 15.379; 84: SpO2, 100.0; 84: Perf, 0.203; 84: 1min HRV, 5.428; 85: HR, 146.881; 85: RR, 19.746; 85: SpO2, 100.0; 85: Perf, 0.2; 85: 1min HRV, 5.309; 86: HR, 147.690; 86: RR, 17.586; 86: SpO2, 100.0; 86: Perf, 0.2; 86: 1min HRV, 6.579; 86: 5min HRV, 9.290; 87: HR, 147.831; 87: RR, 16.932; 87: 1min HRV, 6.513; 88: HR, 146.373; 88: RR, 17.644; 88: 1min HRV, 5.914; 89: HR, 146.345; 89: RR, 18.966; 89: SpO2, 100.0; 89: Perf, 0.19; 89: 1min HRV, 4.308; 90: HR, 144.763; 90: RR, 19.559; 90: SpO2, 100.0; 90: Perf, 0.172; 90: 1min HRV, 6.645; 91: HR, 143.510; 91: RR, 16.830; 91: SpO2, 100.0; 91: Perf, 0.177; 91: 1min HRV, 6.265; 91: 5min HRV, 7.416; 92: HR, 143.94; 92: RR, 16.6; 92: SpO2, 100.0; 92: Perf, 0.177; 92: 1min HRV, 5.722; 93: HR, 145.458; 93: RR, 19.203; 93: SpO2, 100.0; 93: Perf, 0.179; 93: 1min HRV, 12.575; 94: HR, 145.466; 94: RR, 19.914; 94: SpO2, 100.0; 94: Perf, 0.276; 94: 1min HRV, 3.769; 95: HR, 140.983; 95: RR, 28.966; 95: SpO2, 100.0; 95: Perf, 0.435; 95: 1min HRV, 7.861; 96: HR, 141.915; 96: RR, 19.475; 96: SpO2, 100.0; 96: Perf, 0.645; 96: 1min HRV, 7.151; 96: 5min HRV, 9.919; 97: HR, 141.207; 97: RR, 15.810; 97: SpO2, 100.0; 97: Perf, 0.418; 97: 1min HRV, 8.263; 98: HR, 141.441; 98: RR, 15.542; 98: SpO2, 100.0; 98: Perf, 0.271; 98: 1min HRV, 5.571; 99: HR, 140.879; 99: RR, 16.121; 99: SpO2, 100.0; 99: Perf, 0.212; 99: 1min HRV, 6.727; 100: HR, 141.542; 100: RR, 17.492; 100: SpO2, 100.0; 100: Perf, 0.225; 100: 1min HRV, 6.407; 101: HR, 141.831; 101: RR, 17.068; 101: SpO2, 100.0; 101: Perf, 0.186; 101: 1min HRV, 8.050; 101: 5min HRV, 7.225; 102: HR, 135.224; 102: RR, 22.741; 102: SpO2, 100.0; 102: Perf, 0.207; 102: 1min HRV, 18.650; 103: HR, 137.288; 103: RR, 17.932; 103: SpO2, 100.0; 103: Perf, 0.205; 103: 1min HRV, 10.367; 104: HR, 139.483; 104: RR, 18.828; 104: SpO2, 100.0; 104: Perf, 0.205; 104: 1min HRV, 10.576; 105: HR, 139.983; 105: RR, 19.322; 105: SpO2, 100.0; 105: Perf, 0.185; 105: 1min HRV, 6.975; 106: SARS-COV-2 RNA, Not Detected; 106: HR, 139.864; 106: RR, 19.203; 106: SpO2, 100.0; 106: Perf, 0.192; 106: 1min HRV, 7.106; 106: 5min HRV, 12.724; 107: HR, 137.103; 107: RR, 15.759; 107: SpO2, 100.0; 107: Perf, 0.256; 107: 1min HRV, 6.563; 108: HR, 139.525; 108: RR, 18.593; 108: SpO2, 100.0; 108: Perf, 0.316; 108: 1min HRV, 5.620; 109: HR, 142.172; 109: RR, 19.672; 109: SpO2, 100.0; 109: Perf, 0.279; 109: 1min HRV, 7.703; 110: HR, 143.797; 110: RR, 15.898; 110: SpO2, 100.0; 110: Perf, 0.261; 110: 1min HRV, 5.670; 111: HR, 142.763; 111: RR, 17.085; 111: SpO2, 100.0; 111: Perf, 0.269; 111: 1min HRV, 6.064; 111: 5min HRV, 9.558; 112: HR, 143.172; 112: RR, 24.379; 112: SpO2, 100.0; 112: Perf, 0.222; 112: 1min HRV, 6.416; 113: HR, 146.136; 113: RR, 20.525; 113: SpO2, 100.0; 113: Perf, 0.214; 113: 1min HRV, 10.223; 114: HR, 142.983; 114: RR, 21.0; 114: SpO2, 100.0; 114: Perf, 0.235; 114: 1min HRV, 6.139; 115: HR, 146.153; 115: RR, 21.203; 115: SpO2, 100.0; 115: Perf, 0.246; 115: 1min HRV, 4.909; 116: HR, 148.845; 116: RR, 28.776; 116: SpO2, 100.0; 116: Perf, 0.22; 116: 1min HRV, 5.657; 116: 5min HRV, 9.084; 117: HR, 149.305; 117: RR, 22.729; 117: SpO2, 100.0; 117: Perf, 0.22; 117: 1min HRV, 4.460; 118: HR, 145.949; 118: RR, 20.814; 118: SpO2, 100.0; 118: Perf, 0.213; 118: 1min HRV, 5.542; 119: HR, 149.362; 119: RR, 19.431; 119: SpO2, 100.0; 119: Perf, 0.245; 119: 1min HRV, 6.651; 0: Age, 32; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 152.0; 0: Triage RR, 16.0; 0: Triage SBP, 150.0; 0: Triage DBP, 102.0; 0: Triage acuity, 2-Emergent; 0: CC, EMESIS,DIZZINESS,CHEST PRESSURE",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess the risk of sepsis, we need to evaluate factors such as heart rate (HR), blood pressure, respiratory rate (RR), temperature, and variability in these measurements, particularly HR variability (HRV) and perfusion (Perf) trends. The patient consistently shows a high heart rate and initially had elevated blood pressure, though these are not accompanied by other classic sepsis indicators like fever, hypothermia, or substantial fluctuations in blood pressure. The respiratory rate shows fluctuations but not consistently high, and SpO2 levels remain at 100%. The information provided suggests a high level of physiological stress or potential cardiovascular concerns rather than an imminent risk of sepsis.",
        "claims": [
            "To assess the risk of sepsis, we need to evaluate factors such as heart rate, blood pressure, respiratory rate, temperature, and variability in these measurements.",
            "Heart rate variability (HRV) and perfusion trends are particularly important in the evaluation.",
            "The patient consistently shows a high heart rate.",
            "The patient initially had elevated blood pressure.",
            "The elevated blood pressure is not accompanied by other classic sepsis indicators.",
            "Classic sepsis indicators include fever, hypothermia, and substantial fluctuations in blood pressure.",
            "The respiratory rate shows fluctuations but not consistently high levels.",
            "SpO2 levels remain at 100%.",
            "The information provided suggests a high level of physiological stress.",
            "The information provided suggests potential cardiovascular concerns.",
            "The information provided indicates that there is not an imminent risk of sepsis."
        ],
        "relevant_claims": [
            "The patient consistently shows a high heart rate.",
            "The patient initially had elevated blood pressure.",
            "The elevated blood pressure is not accompanied by other classic sepsis indicators."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.2
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "High qSOFA Score (\u22652)"
        ],
        "alignment_reasonings": [
            "A consistently high heart rate can contribute to a high shock index (heart rate \u00f7 systolic BP), which suggests hemodynamic instability and potential severe sepsis risk. While the claim does not provide information about blood pressure to directly calculate the shock index, a persistently high heart rate is closely related. This demonstrates a relevant but not complete alignment with the category.",
            "The claim involves blood pressure, which relates to this category as it involves sepsis-associated blood pressure changes. However, the statement only mentions elevated blood pressure, which does not directly correspond to hypotension or a significant drop in pressure indicative of sepsis. Therefore, the alignment is weak.",
            "The High qSOFA Score category involves systolic blood pressure of \u2264\u202f100\u202fmmHg as one of its indicators, which directly relates to blood pressure assessment. However, the claim mentions \"elevated blood pressure\" which is opposite to what is considered a risk in this category. The mention of \"other classic sepsis indicators\" is not detailed enough to strongly align with specific qSOFA criteria. The connection to sepsis risk is peripheral, as elevated blood pressure itself does not typically indicate sepsis in the framework given. Hence, the alignment rating is low."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 0
    },
    {
        "input": "3: HR, 106.0; 3: RR, 18.0; 3: SpO2, 99.0; 3: SBP, 133.0; 3: DBP, 83.0; 3: MAP, 99.667; 3: Temp, 97.9; 6: Pain, 8.0; 6: Pain, 5.0; 38: POC PH (V) ISTAT, 7.36; 38: POC PO2 (V) ISTAT, 34 mmHg; 38: POC PCO2 (V) ISTAT, 53.4 mmHg; 38: POC O2 SATURATION ISTAT VENOUS, 61 %; 38: POC BASE EXCESS ISTAT, 4 mmol/L; 38: POC LACTATE ISTAT, 0.90 mmol/L; 38: POC HCO3 (V) ISTAT, 29.9 mmol/L; 38: POC TCO2 (V) ISTAT, 31 mmol/L; 40: SpO2, 98.9; 40: Perf, 2.592; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 41: SpO, 2: 99.224; 41: Perf, 2.862; 42: SpO2, 98.948; 42: Perf, 2.541; 43: SpO2, 98.966; 43: Perf, 2.984; 44: SpO2, 98.436; 44: Perf, 2.976; 45: SpO2, 98.322; 45: Perf, 3.164; 46: SpO2, 98.310; 46: Perf, 3.478; 47: WAM DIFTYP, AUTO; 47: BASOPHIL ABSOLUTE (AUTO DIFF), 0.09 K/uL; 47: PLATELET COUNT (PLT), 370 K/uL; 47: NEUTROPHIL % (AUTO DIFF), 63.1 %; 47: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.43 K/uL; 47: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.80 K/uL; 47: MONOCYTE ABSOLUTE (AUTO DIFF), 0.62 K/uL; 47: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 47: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.3 pg; 47: BASOPHIL % (AUTO DIFF), 1.0 %; 47: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.23 K/uL; 47: MEAN CORPUSCULAR VOLUME (MCV), 89.0 fL; 47: EOSINOPHIL % (AUTO DIFF), 2.5 %; 47: HEMOGLOBIN (HGB), 13.9 g/dL; 47: RED BLOOD CELLS (RBC), 4.91 MIL/uL; 47: HEMATOCRIT (HCT), 43.7 %; 47: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.8 g/dL; 47: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 47: LYMPHOCYTE % (AUTO DIFF), 26.4 %; 47: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 47: NRBC PERCENT (HEMATOLOGY), 0.0 %; 47: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 47: MONOCYTE % (AUTO DIFF), 6.7 %; 47: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 47: SpO2, 98.797; 47: Perf, 3.236; 48: SpO2, 98.138; 48: Perf, 3.093; 49: SpO2, 97.780; 49: Perf, 3.111; 50: SpO2, 98.271; 50: Perf, 3.193; 51: SpO2, 97.914; 51: Perf, 3.141; 52: SpO2, 97.881; 52: Perf, 2.574; 53: SpO2, 98.655; 53: Perf, 1.647; 54: SpO2, 99.2; 54: Perf, 1.737; 55: SpO2, 98.875; 55: Perf, 1.658; 56: SpO2, 98.763; 56: Perf, 0.683; 57: SpO2, 98.831; 57: Perf, 0.945; 58: SpO2, 98.552; 58: Perf, 0.899; 59: SpO2, 98.705; 59: Perf, 1.609; 60: SpO2, 98.086; 60: Perf, 2.193; 61: SpO2, 98.475; 61: Perf, 1.659; 62: SpO2, 98.0; 62: Perf, 1.693; 63: SpO2, 97.345; 63: Perf, 1.119; 64: SpO2, 97.0; 64: Perf, 0.674; 65: SpO2, 96.466; 65: Perf, 0.71; 66: SpO2, 95.971; 66: Perf, 0.729; 67: SpO2, 98.138; 67: Perf, 1.856; 68: SpO2, 97.818; 68: Perf, 2.067; 69: SpO2, 98.780; 69: Perf, 2.496; 70: SpO2, 98.155; 70: Perf, 3.193; 71: SpO2, 98.186; 71: Perf, 2.602; 72: SpO2, 98.271; 72: Perf, 2.089; 73: SpO2, 98.517; 73: Perf, 1.809; 74: SpO2, 97.831; 74: Perf, 1.508; 75: SpO2, 97.897; 75: Perf, 1.814; 76: HR, 79.0; 76: SpO2, 98.322; 76: Perf, 1.851; 76: Pain, 2.0; 77: CREATININE, 0.97 mg/dL; 77: ALT (SGPT), 37 U/L; 77: CHLORIDE, 102 mmol/L; 77: ALKALINE PHOSPHATASE, 115 U/L; 77: GLOBULIN, 3.1 g/dL; 77: POTASSIUM, 4.1 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 93 mL/min/1.73 m2; 77: SODIUM, 142 mmol/L; 77: BILIRUBIN TOTAL, 0.3 mg/dL; 77: CALCIUM, 9.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 4.9 g/dL; 77: CO2, 29 mmol/L; 77: GLUCOSE, 121 mg/dL; 77: AST (SGOT), 30 U/L; 77: PROTEIN TOTAL, 8.0 g/dL; 77: CORRECTED CALCIUM, 9.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 107 mL/min/1.73 m2; 77: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 77: SpO2, 98.661; 77: Perf, 1.894; 78: SpO2, 98.155; 78: Perf, 1.599; 79: SpO2, 98.288; 79: Perf, 1.339; 80: SpO2, 98.649; 80: Perf, 1.626; 81: SpO2, 99.271; 81: Perf, 0.797; 82: SpO2, 99.576; 82: Perf, 0.516; 83: SpO2, 99.431; 83: Perf, 0.709; 84: SpO2, 99.814; 84: Perf, 0.594; 85: SpO2, 99.483; 85: Perf, 1.451; 86: SpO2, 98.847; 86: Perf, 1.900; 87: SpO2, 98.931; 87: Perf, 2.788; 88: SpO2, 98.847; 88: Perf, 3.167; 89: SpO2, 98.780; 89: Perf, 3.262; 90: SpO2, 98.776; 90: Perf, 3.402; 91: SpO2, 98.845; 91: Perf, 2.487; 92: SpO2, 98.729; 92: Perf, 2.223; 93: SpO2, 98.534; 93: Perf, 2.077; 94: SpO2, 98.783; 94: Perf, 1.206; 95: SpO2, 98.810; 95: Perf, 1.407; 96: SpO2, 98.864; 96: Perf, 1.919; 97: SpO2, 99.121; 97: Perf, 1.476; 98: SpO2, 98.797; 98: Perf, 1.537; 99: SpO2, 98.983; 99: Perf, 1.331; 100: SpO2, 98.0; 100: Perf, 1.937; 101: SpO2, 98.390; 101: Perf, 1.659; 102: SpO2, 98.466; 102: Perf, 1.656; 103: SpO2, 98.0; 103: Perf, 1.959; 104: SpO2, 98.567; 104: Perf, 1.748; 105: SpO2, 99.035; 105: Perf, 1.988; 106: SpO2, 99.0; 106: Perf, 2.469; 107: SpO2, 99.0; 107: Perf, 2.539; 108: SpO2, 99.0; 108: Perf, 1.821; 109: SpO2, 98.898; 109: Perf, 2.148; 110: SpO2, 99.0; 110: Perf, 1.34; 111: NITRITE, URINE (UA): Positive; 111: PH, URINE (UA): 6.0; 111: KETONE, URINE (UA): Negative; 111: SPECIFIC GRAVITY, URINE (UA): 1.028; 111: GLUCOSE, URINE (UA): Negative; 111: SpO2, 99.0; 111: Perf, 1.149; 112: SpO2, 99.0; 112: Perf, 1.797; 113: SpO2, 99.0; 113: Perf, 1.614; 114: SpO2, 99.0; 114: Perf, 1.840; 115: SpO2, 99.0; 115: Perf, 1.343; 116: SpO2, 99.0; 116: Perf, 1.33; 117: SpO2, 98.845; 117: Perf, 1.616; 118: SpO2, 98.932; 118: Perf, 1.644; 119: SpO2, 99.0; 119: Perf, 2.028; 0: Age, 49; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 106.0; 0: Triage RR, 18.0; 0: Triage SBP, 133.0; 0: Triage DBP, 83.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN,NEPHROSTOMY",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, consider vital signs like heart rate (HR), respiratory rate (RR), blood pressure (BP), temperature, and oxygen saturation (SpO2), alongside laboratory values such as lactate and white blood cell (WBC) count. The heart rate is initially elevated but is not accompanied by hypotension; vital signs remain relatively stable with no exacerbations or trends consistent with sepsis (e.g., hypothermia or hypotension). Lactate and WBC count are normal, further indicating low sepsis risk. The patient's condition does not align with SIRS criteria or qSOFA scores indicating potential sepsis development, leading to the conclusion that the patient is not at high risk for sepsis within the next 12 hours.",
        "claims": [
            "To determine sepsis risk, consider vital signs like heart rate, respiratory rate, blood pressure, temperature, and oxygen saturation.",
            "Laboratory values such as lactate and white blood cell count are also important for sepsis risk assessment.",
            "The heart rate is initially elevated.",
            "The elevated heart rate is not accompanied by hypotension.",
            "Vital signs remain relatively stable.",
            "There are no exacerbations consistent with sepsis.",
            "No trends indicating hypothermia are present.",
            "No trends indicating hypotension are present.",
            "Lactate levels are normal.",
            "White blood cell count is normal.",
            "Normal lactate and WBC count further indicate low sepsis risk.",
            "The patient's condition does not align with SIRS criteria.",
            "The patient's condition does not align with qSOFA scores.",
            "The lack of alignment with SIRS criteria and qSOFA scores indicates potential sepsis development is unlikely.",
            "The conclusion is that the patient is not at high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is initially elevated.",
            "The elevated heart rate is not accompanied by hypotension.",
            "No trends indicating hypotension are present.",
            "Normal lactate and WBC count further indicate low sepsis risk.",
            "The patient's condition does not align with SIRS criteria.",
            "The patient's condition does not align with qSOFA scores."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.8,
            0.6,
            0.9,
            0.2
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)"
        ],
        "alignment_reasonings": [
            "Elevated heart rate is a component of the shock index calculation, indicating potential haemodynamic instability. However, a heart rate alone is not sufficient to establish an elevated shock index without considering the systolic BP; hence, the alignment is partial and not fully conclusive.",
            "The claim refers to an elevated heart rate without hypotension, distinguishing it from the Elevated Shock Index category, which involves the ratio of heart rate to systolic blood pressure. While an elevated heart rate could contribute to an increased shock index if paired with low BP, the absence of hypotension makes the connection weaker, resulting in a low alignment rating.",
            "The claim directly addresses the absence of hypotensive trends, which relates directly to the category of sepsis-associated hypotension. As the criteria for this category involve monitoring blood pressure trends, the absence of such trends fits within the context of evaluating hypotension risk. However, the claim states what is absent, aligning less than fully but strongly with the category.",
            "Normal WBC count is part of the SIRS criteria assessment for systemic inflammation associated with early sepsis. Additionally, since lactate can be a marker for tissue hypoperfusion common in sepsis, its normal level further suggests low risk. While these normal values don't meet the criteria of interest directly, they contribute meaningfully to assessing the absence of signs indicating sepsis onset or progression. Thus, they align somewhat with ruling out sepsis probabilities.",
            "The claim explicitly references the SIRS criteria by indicating that the patient's condition does not meet them. This suggests a direct connection to the category, though the claim represents an absence rather than a presence of criteria, which slightly reduces the direct alignment from perfect.",
            "The claim specifically mentions the patient's condition not aligning with qSOFA scores, directly referencing this category. However, the claim describes a lack of alignment rather than confirming a matching condition, which results in a very weak alignment with the category."
        ],
        "final_alignment_score": 0.5166666666666667,
        "accuracy": 1
    },
    {
        "input": "5: HR, 109.0; 5: RR, 18.0; 5: SpO2, 100.0; 5: SBP, 127.0; 5: DBP, 69.0; 5: MAP, 88.333; 5: Pain, 6.0; 5: Temp, 98.2; 81: WAM DIFTYP, AUTO; 81: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 81: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.34 K/uL; 81: BASOPHIL % (AUTO DIFF), 0.9 %; 81: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 81: MONOCYTE ABSOLUTE (AUTO DIFF), 0.53 K/uL; 81: HEMATOCRIT (HCT), 43.5 %; 81: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 81: PLATELET COUNT (PLT), 241 K/uL; 81: NEUTROPHIL % (AUTO DIFF), 64.0 %; 81: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.78 K/uL; 81: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 81: MONOCYTE % (AUTO DIFF), 7.8 %; 81: MEAN CORPUSCULAR VOLUME (MCV), 104.6 fL; 81: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 81: NRBC PERCENT (HEMATOLOGY), 0.0 %; 81: EOSINOPHIL % (AUTO DIFF), 0.7 %; 81: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.3 pg; 81: RED BLOOD CELLS (RBC), 4.16 MIL/uL; 81: LYMPHOCYTE % (AUTO DIFF), 26.3 %; 81: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 81: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 81: HEMOGLOBIN (HGB), 13.0 g/dL; 81: WHITE BLOOD CELLS (WBC), 6.8 K/uL; 86: SpO2, 99.32; 87: SpO2, 99.552; 87: Perf, 2.687; 88: HR, 98.8; 88: RR, 19.467; 88: SpO2, 99.525; 88: Perf, 1.823; 88: 1min HRV, 17.223; 89: HR, 103.483; 89: RR, 18.948; 89: SpO2, 98.983; 89: Perf, 1.419; 89: 1min HRV, 28.598; 90: HR, 99.322; 90: RR, 22.068; 90: SpO2, 98.862; 90: Perf, 2.159; 90: 1min HRV, 16.204; 90: 5min HRV, 24.694; 91: HR, 96.356; 91: RR, 15.966; 91: SpO2, 98.983; 91: Perf, 2.292; 91: 1min HRV, 22.544; 91: SBP, 115.0; 91: DBP, 79.0; 91: MAP, 91.0; 92: HR, 95.0; 92: RR, 19.052; 92: SpO2, 98.879; 92: Perf, 3.058; 92: 1min HRV, 14.133; 93: HR, 95.932; 93: RR, 16.966; 93: SpO2, 98.746; 93: Perf, 4.128; 93: 1min HRV, 18.879; 94: HR, 96.397; 94: RR, 17.466; 94: SpO2, 98.052; 94: Perf, 4.146; 94: 1min HRV, 17.535; 95: HR, 96.424; 95: RR, 15.492; 95: SpO2, 98.627; 95: Perf, 3.096; 95: 1min HRV, 40.939; 95: 5min HRV, 25.220; 96: HR, 91.881; 96: RR, 11.475; 96: SpO2, 98.441; 96: Perf, 4.773; 96: 1min HRV, 19.820; 97: HR, 93.448; 97: RR, 13.672; 97: SpO2, 98.517; 97: Perf, 4.844; 97: 1min HRV, 17.150; 98: HR, 95.034; 98: RR, 9.695; 98: SpO2, 98.627; 98: Perf, 3.999; 98: 1min HRV, 20.632; 99: HR, 93.207; 99: RR, 12.017; 99: SpO2, 98.414; 99: Perf, 4.606; 99: 1min HRV, 19.888; 100: HR, 95.136; 100: RR, 11.525; 100: SpO2, 98.085; 100: Perf, 4.079; 100: 1min HRV, 21.264; 100: 5min HRV, 21.607; 101: HR, 94.678; 101: RR, 11.169; 101: SpO2, 98.729; 101: Perf, 2.924; 101: 1min HRV, 17.756; 102: HR, 94.517; 102: RR, 12.276; 102: SpO2, 98.741; 102: Perf, 3.257; 102: 1min HRV, 18.186; 103: HR, 94.288; 103: RR, 16.644; 103: SpO2, 98.797; 103: Perf, 2.705; 103: 1min HRV, 12.102; 104: HR, 95.414; 104: RR, 15.724; 104: SpO2, 98.207; 104: Perf, 1.763; 104: 1min HRV, 8.317; 105: HR, 94.797; 105: RR, 14.169; 105: SpO2, 99.068; 105: Perf, 1.365; 105: 1min HRV, 17.161; 105: 5min HRV, 15.655; 106: HR, 93.729; 106: RR, 13.593; 106: SpO2, 98.729; 106: Perf, 1.404; 106: 1min HRV, 12.790; 106: SBP, 126.0; 106: DBP, nan; 106: MAP, nan; 107: HR, 94.759; 107: RR, 13.276; 107: SpO2, 98.776; 107: Perf, 2.192; 107: 1min HRV, 34.534; 108: HR, 93.305; 108: RR, 16.305; 108: SpO2, 98.893; 108: Perf, 2.48; 108: 1min HRV, 38.104; 109: HR, 94.155; 109: RR, 11.897; 109: SpO2, 98.522; 109: Perf, 1.763; 109: 1min HRV, 21.272; 110: HR, 96.153; 110: RR, 11.661; 110: SpO2, 98.305; 110: Perf, 1.962; 110: 1min HRV, 20.947; 110: 5min HRV, 28.704; 111: HR, 98.356; 111: RR, 17.695; 111: SpO2, 98.627; 111: Perf, 1.963; 111: 1min HRV, 19.384; 112: HR, 98.379; 112: RR, 15.914; 112: SpO2, 98.534; 112: Perf, 1.66; 112: 1min HRV, 23.370; 113: HR, 96.068; 113: RR, 13.627; 113: SpO2, 98.661; 113: Perf, 1.335; 113: 1min HRV, 19.161; 114: CHLORIDE, 105 mmol/L; 114: GLOBULIN, 3.0 g/dL; 114: CO2, 23 mmol/L; 114: GLUCOSE, 126 mg/dL; 114: ALKALINE PHOSPHATASE, 91 U/L; 114: SODIUM, 140 mmol/L; 114: ALT (SGPT), 32 U/L; 114: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 114: PROTEIN TOTAL, 6.8 g/dL; 114: ANION GAP, 12 mmol/L; 114: CREATININE, 0.82 mg/dL; 114: EGFR REFIT WITHOUT RACE (2021), 89 mL/min/1.73 m2; 114: POTASSIUM, 4.6 mmol/L; 114: CORRECTED CALCIUM, 9.2 mg/dL; 114: CALCIUM, 9.0 mg/dL; 114: AST (SGOT), 40 U/L; 114: BILIRUBIN TOTAL, 0.3 mg/dL; 114: ALBUMIN, 3.8 g/dL; 114: HR, 94.655; 114: RR, 13.293; 114: SpO2, 99.241; 114: Perf, 1.235; 114: 1min HRV, 19.096; 115: HR, 94.017; 115: RR, 14.356; 115: SpO2, 99.322; 115: Perf, 1.177; 115: 1min HRV, 19.983; 115: 5min HRV, 23.273; 116: HR, 94.881; 116: RR, 19.356; 116: SpO2, 99.288; 116: Perf, 1.171; 116: 1min HRV, 23.524; 117: HR, 94.241; 117: RR, 14.534; 117: SpO2, 99.138; 117: Perf, 1.404; 117: 1min HRV, 19.643; 118: HR, 94.339; 118: RR, 19.746; 118: SpO2, 98.051; 118: Perf, 1.309; 118: 1min HRV, 33.339; 119: HR, 93.017; 119: RR, 15.897; 119: SpO2, 97.857; 119: Perf, 1.16; 119: 1min HRV, 24.704; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 109.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, DIZZINESS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine sepsis risk, key factors include vital signs (e.g., HR, RR, BP, and SpO2), laboratory values, and clinical indicators. The patient's vital signs are relatively stable, with HR fluctuating but generally below 110, RR within normal range, stable BP, and SpO2 consistently above 98%. Laboratory values such as WBC count, creatinine, and bilirubin are within normal ranges. Additionally, there are no significant indicators of infection or organ dysfunction. Thus, the data does not suggest a high risk of sepsis in the next 12 hours.",
        "claims": [
            "Key factors to determine sepsis risk include vital signs, laboratory values, and clinical indicators.",
            "The patient's vital signs are relatively stable.",
            "The heart rate (HR) fluctuates but is generally below 110.",
            "The respiratory rate (RR) is within normal range.",
            "The blood pressure (BP) is stable.",
            "The pulse oximetry (SpO2) is consistently above 98%.",
            "Laboratory values such as white blood cell (WBC) count, creatinine, and bilirubin are within normal ranges.",
            "There are no significant indicators of infection.",
            "There are no significant indicators of organ dysfunction.",
            "The data does not suggest a high risk of sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "There are no significant indicators of infection.",
            "There are no significant indicators of organ dysfunction."
        ],
        "alignment_scores": [
            0.2,
            0.2
        ],
        "alignment_category": [
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The claim indicates a lack of significant infection indicators, which indirectly suggests that measures like early antibiotics or culture orders may not be warranted. While the absence of these actions can imply low suspicion of sepsis, the connection to the category is weak because it primarily describes a negative finding rather than aligning with the proactive criteria of the category.",
            "The claim indicates the absence of organ dysfunction, which indirectly relates to the SOFA Score category (as SOFA Score measures organ dysfunction). However, the claim does not specifically mention increases in SOFA Score or new organ dysfunction, so the alignment is very low."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "4: HR, 91.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 168.0; 4: DBP, 100.0; 4: MAP, 122.667; 4: Pain, 6.0; 4: Temp, 97.9; 5: SBP, 159.0; 5: DBP, 100.0; 5: MAP, 119.667; 37: SpO2, 99.0; 38: SpO2, 98.932; 38: Perf, 3.107; 38: SBP, 158.0; 38: DBP, 127.0; 38: MAP, 137.333; 39: SpO2, 98.898; 39: Perf, 2.952; 40: SpO2, 98.638; 40: Perf, 2.714; 41: SpO2, 98.373; 41: Perf, 2.238; 42: SpO2, 98.552; 42: Perf, 2.528; 43: SpO2, 98.695; 43: Perf, 2.543; 44: SpO2, 98.322; 44: Perf, 2.768; 45: HR, 90.0; 45: SpO2, 98.741; 45: Perf, 2.907; 45: SBP, 163.0; 45: DBP, 113.0; 45: MAP, 129.667; 46: SpO2, 98.898; 46: Perf, 2.837; 46: SBP, 163.0; 46: DBP, 113.0; 46: MAP, 129.667; 47: SpO2, 98.621; 47: Perf, 2.756; 48: SpO2, 98.661; 48: Perf, 2.652; 49: SpO2, 98.085; 49: Perf, 2.790; 50: SpO2, 98.121; 50: Perf, 2.636; 51: SpO2, 98.356; 51: Perf, 2.65; 52: SpO2, 98.224; 52: Perf, 2.656; 53: SpO2, 98.119; 53: Perf, 2.71; 54: SpO2, 98.305; 54: Perf, 2.71; 55: SpO2, 98.621; 55: Perf, 2.71; 56: SpO2, 98.322; 56: Perf, 2.71; 57: SpO2, 98.328; 57: Perf, 2.71; 58: SpO2, 97.237; 58: Perf, 2.663; 59: SpO2, 98.373; 59: Perf, 2.71; 60: SpO2, 98.310; 60: Perf, 2.456; 60: KETOROLAC, 15 MG/ML INJ SOLN; 60: METOCLOPRAMIDE HCL, 5 MG/ML INJ SOLN; 60: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 61: SpO, 2: 98.780; 61: Perf, 1.355; 61: SBP, 177.0; 61: DBP, 119.0; 61: MAP, 138.333; 61: DIPHENHYDRAMINE HCL, 50 MG/ML INJ SOLN; 62: SpO, 2: 98.362; 62: Perf, 1.539; 63: SpO2, 98.525; 63: Perf, 2.468; 64: SpO2, 98.136; 64: Perf, 2.768; 65: SpO2, 98.190; 65: Perf, 3.867; 65: NS IV BOLUS -, 1000 ML; 66: SpO, 2: 98.085; 66: Perf, 2.609; 67: SpO2, 97.517; 67: Perf, 2.276; 68: SpO2, 97.897; 68: Perf, 3.014; 69: SpO2, 97.051; 69: Perf, 2.980; 70: SpO2, 97.407; 70: Perf, 3.188; 71: WAM DIFTYP, AUTO; 71: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.18 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.3 pg; 71: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 71: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 71: BASOPHIL % (AUTO DIFF), 1.1 %; 71: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.35 K/uL; 71: MEAN CORPUSCULAR VOLUME (MCV), 88.6 fL; 71: RED BLOOD CELLS (RBC), 4.58 MIL/uL; 71: EOSINOPHIL % (AUTO DIFF), 3.3 %; 71: HEMATOCRIT (HCT), 40.6 %; 71: LYMPHOCYTE % (AUTO DIFF), 37.4 %; 71: NEUTROPHIL % (AUTO DIFF), 50.7 %; 71: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 71: MONOCYTE ABSOLUTE (AUTO DIFF), 0.46 K/uL; 71: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.21 K/uL; 71: MONOCYTE % (AUTO DIFF), 7.3 %; 71: RED CELL DISTRIBUTION WIDTH (RDW), 12.6 %; 71: BASOPHIL ABSOLUTE (AUTO DIFF), 0.07 K/uL; 71: HEMOGLOBIN (HGB), 13.9 g/dL; 71: WHITE BLOOD CELLS (WBC), 6.3 K/uL; 71: NRBC PERCENT (HEMATOLOGY), 0.0 %; 71: PLATELET COUNT (PLT), 218 K/uL; 71: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 71: HR, 76.0; 71: SpO2, 96.672; 71: Perf, 4.325; 71: SBP, 177.0; 71: DBP, 119.0; 71: MAP, 138.333; 71: AMOXICILLIN-POT CLAVULANATE, 875-125 MG PO TABS; 71: LOSARTAN, 50 MG PO TABS; 72: SpO2, 96.847; 72: Perf, 4.581; 73: SpO2, 98.052; 73: Perf, 3.920; 74: SpO2, 97.390; 74: Perf, 3.688; 74: MAGNESIUM SULFATE IN D, 5W 1 GRAM/100 ML IV PGBK; 75: SpO, 2: 96.576; 75: Perf, 4.164; 76: SpO2, 97.119; 76: Perf, 4.159; 76: SBP, 138.0; 76: DBP, 85.0; 76: MAP, 102.667; 77: SpO2, 97.776; 77: Perf, 3.844; 78: HR, 78.0; 78: RR, 18.0; 78: SpO2, 96.948; 78: Perf, 4.500; 78: SBP, 138.0; 78: DBP, 85.0; 78: MAP, 102.667; 79: SpO2, 97.271; 79: Perf, 4.525; 80: SpO2, 97.914; 80: Perf, 4.377; 81: SpO2, 97.917; 81: Perf, 4.162; 82: SpO2, 97.828; 82: Perf, 4.318; 83: SpO2, 97.293; 83: Perf, 4.348; 84: SpO2, 97.0; 84: Perf, 4.549; 85: SpO2, 97.0; 85: Perf, 4.268; 86: SpO2, 97.153; 86: Perf, 3.840; 87: SpO2, 97.644; 87: Perf, 3.567; 88: SpO2, 97.655; 88: Perf, 3.958; 89: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 89: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 89: ALT (SGPT), 71 U/L; 89: CHLORIDE, 103 mmol/L; 89: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 89: SODIUM, 138 mmol/L; 89: ALBUMIN, 4.4 g/dL; 89: ANION GAP, 10 mmol/L; 89: CREATININE, 1.03 mg/dL; 89: POTASSIUM, 4.0 mmol/L; 89: ALKALINE PHOSPHATASE, 61 U/L; 89: GLUCOSE, 122 mg/dL; 89: AST (SGOT), 42 U/L; 89: CORRECTED CALCIUM, 9.2 mg/dL; 89: CO2, 25 mmol/L; 89: GLOBULIN, 2.4 g/dL; 89: MAGNESIUM, 2.1 mg/dL; 89: BILIRUBIN TOTAL, <.2 mg/dL; 89: CALCIUM, 9.5 mg/dL; 89: PROTEIN TOTAL, 6.8 g/dL; 89: SpO2, 97.864; 89: Perf, 4.193; 90: SpO2, 97.881; 90: Perf, 3.909; 91: SpO2, 98.390; 91: Perf, 4.445; 91: SBP, 130.0; 91: DBP, 81.0; 91: MAP, 97.333; 92: SpO2, 98.259; 92: Perf, 4.703; 93: SpO2, 98.0; 93: Perf, 3.96; 94: SpO2, 97.845; 94: Perf, 4.029; 95: SpO2, 97.593; 95: Perf, 3.823; 96: SpO2, 98.305; 96: Perf, 2.939; 97: SpO2, 98.224; 97: Perf, 3.344; 98: SpO2, 98.610; 98: Perf, 3.357; 99: SpO2, 97.879; 99: Perf, 4.154; 100: SpO2, 98.458; 100: Perf, 3.910; 101: SpO2, 98.5; 101: Perf, 3.063; 102: SpO2, 98.814; 102: Perf, 5.818; 103: SpO2, 98.128; 103: Perf, 7.793; 104: SpO2, 98.776; 105: SpO2, 98.881; 105: Perf, 3.678; 106: SpO2, 97.310; 106: Perf, 3.918; 106: SBP, 139.0; 106: DBP, 102.0; 106: MAP, 114.333; 107: SpO2, 97.746; 107: Perf, 3.92; 108: SpO2, 97.746; 108: Perf, 3.92; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 91.0; 0: Triage RR, 16.0; 0: Triage SBP, 168.0; 0: Triage DBP, 100.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, evaluate the vital signs and laboratory results, focusing on typical sepsis indicators like heart rate, respiratory rate, blood pressure, and oxygen saturation. All these values fall within normal ranges and show no significant abnormalities over time. Next, assess perfusion and biochemical results, which remain stable and do not suggest organ dysfunction. Lastly, consider medications administered, which focus on symptom relief rather than sepsis treatment. Together, these suggest the patient is not at high risk of developing sepsis.",
        "claims": [
            "Evaluate the vital signs and laboratory results.",
            "Focus on typical sepsis indicators like heart rate, respiratory rate, blood pressure, and oxygen saturation.",
            "All vital signs and laboratory results fall within normal ranges.",
            "There are no significant abnormalities in the vital signs and laboratory results over time.",
            "Assess perfusion and biochemical results.",
            "Perfusion and biochemical results remain stable.",
            "The stable perfusion and biochemical results do not suggest organ dysfunction.",
            "Consider medications administered to the patient.",
            "The medications administered focus on symptom relief.",
            "The medications administered do not focus on sepsis treatment.",
            "Together, these factors suggest the patient is not at high risk of developing sepsis."
        ],
        "relevant_claims": [
            "The stable perfusion and biochemical results do not suggest organ dysfunction.",
            "The medications administered do not focus on sepsis treatment."
        ],
        "alignment_scores": [
            0.7,
            0.3
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim addresses the absence of organ dysfunction. The SOFA score is a measure specifically used to track organ dysfunction and failure, particularly in sepsis. While the claim doesn't provide specific metrics related to the SOFA components, it conceptually aligns with monitoring for potential organ failure, which makes it a partial but meaningful fit for this category.",
            "The claim mentions that the medications administered do not focus on sepsis treatment, which implies a lack of early antibiotic administration, an important aspect of sepsis management highlighted in this category. However, the claim does not directly relate to the explicit early actions (antibiotic administration or culture draws) that define this category, therefore the alignment is weak."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "8: HR, 114.0; 8: RR, 18.0; 8: SpO2, 98.0; 8: SBP, 100.0; 8: DBP, 62.0; 8: MAP, 74.667; 8: Temp, 101.9; 54: POC PH (V) ISTAT, 7.45; 54: POC PCO2 (V) ISTAT, 41.3 mmHg; 54: POC TCO2 (V) ISTAT, 30 mmol/L; 54: POC PO2 (V) ISTAT, 28 mmHg; 54: POC BASE EXCESS ISTAT, 5 mmol/L; 54: POC O2 SATURATION ISTAT VENOUS, 55 %; 54: POC HCO3 (V) ISTAT, 28.8 mmol/L; 54: POC LACTATE ISTAT, 1.14 mmol/L; 61: SpO2, 96.667; 61: SBP, 106.0; 61: DBP, 75.0; 61: MAP, 85.333; 62: SpO2, 95.780; 63: SpO2, 96.729; 63: Perf, 1.77; 64: SpO2, 97.0; 64: Perf, 1.786; 64: NORMOSOL-R IV BOLUS -, 1000 ML; 65: HR:, 112.0; 65: SpO2, 97.271; 65: Perf, 1.638; 65: SBP, 115.0; 65: DBP, 84.0; 65: MAP, 94.333; 65: ACETAMINOPHEN, 500 MG PO TABS; 66: SpO, 2: 98.293; 66: Perf, 1.373; 66: SBP, 115.0; 66: DBP, 84.0; 66: MAP, 94.333; 67: SpO2, 96.085; 67: Perf, 1.177; 68: SpO2, 95.678; 68: Perf, 1.127; 69: SpO2, 96.5; 69: Perf, 0.956; 70: SpO2, 95.356; 70: Perf, 0.855; 71: SpO2, 95.828; 71: Perf, 0.802; 72: SpO2, 95.559; 72: Perf, 0.764; 73: SpO2, 96.254; 73: Perf, 0.803; 74: SpO2, 96.931; 74: Perf, 0.899; 74: AMOXICILLIN, 500 MG PO CAPS; 74: AZITHROMYCIN, 250 MG PO TABS; 75: SpO2, 96.339; 75: Perf, 0.968; 76: SpO2, 96.052; 76: Perf, 0.902; 77: HR, 110.528; 77: RR, 13.625; 77: SpO2, 95.780; 77: Perf, 0.899; 77: 1min HRV, 2.757; 78: HR, 109.741; 78: RR, 19.190; 78: SpO2, 95.638; 78: Perf, 0.769; 78: 1min HRV, 3.116; 79: HR, 109.322; 79: RR, 23.814; 79: SpO2, 96.0; 79: Perf, 0.738; 79: 1min HRV, 2.266; 80: HR, 111.475; 80: RR, 21.068; 80: SpO2, 96.153; 80: Perf, 0.685; 80: 1min HRV, 3.989; 80: 5min HRV, 5.418; 80: SBP, 102.0; 80: DBP, 90.0; 80: MAP, 94.0; 81: HR, 114.534; 81: RR, 21.552; 81: SpO2, 95.455; 81: Perf, 0.641; 81: 1min HRV, 5.618; 81: SBP, 102.0; 81: DBP, 90.0; 81: MAP, 94.0; 82: HR, 117.169; 82: RR, 25.864; 82: SpO2, 95.508; 82: Perf, 0.54; 82: 1min HRV, 9.593; 83: HR, 121.276; 83: RR, 26.914; 83: SpO2, 94.328; 83: Perf, 0.548; 83: 1min HRV, 5.129; 84: HR, 124.678; 84: RR, 30.169; 84: SpO2, 93.492; 84: Perf, 0.55; 84: 1min HRV, 7.047; 85: HR, 127.04; 85: RR, 26.220; 85: SpO2, 93.136; 85: Perf, 0.55; 85: 1min HRV, 7.672; 85: 5min HRV, 18.936; 86: HR, 132.0; 86: RR, 28.845; 86: SpO2, 94.103; 86: Perf, 0.55; 86: 1min HRV, 9.623; 87: RR, 31.966; 87: SpO2, 94.0; 87: Perf, 0.55; 88: HR, 136.0; 88: RR, 35.690; 88: SpO2, 94.897; 88: Perf, 0.55; 88: 1min HRV, 0.0; 89: HR, 133.906; 89: RR, 30.373; 89: SpO2, 94.085; 89: Perf, 0.55; 89: 1min HRV, 173.207; 90: HR, 125.0; 90: RR, 33.390; 90: SpO2, 95.05; 90: Perf, 0.55; 90: 5min HRV, 97.885; 91: HR, 149.054; 91: RR, 31.534; 91: SpO2, 97.679; 91: Perf, 0.55; 91: 1min HRV, 10.808; 92: HR, 156.712; 92: RR, 30.0; 92: SpO2, 98.271; 92: Perf, 0.55; 92: 1min HRV, 60.644; 93: HR, 161.025; 93: RR, 33.034; 93: SpO2, 98.6; 93: Perf, 0.55; 93: 1min HRV, 22.283; 94: HR, 156.370; 94: RR, 36.712; 94: SpO2, 98.2; 94: Perf, 0.55; 94: 1min HRV, 94.293; 95: HR, 157.196; 95: RR, 34.339; 95: SpO2, 96.737; 95: Perf, 0.55; 95: 1min HRV, 16.234; 95: 5min HRV, 49.010; 95: SBP, 111.0; 95: DBP, 53.0; 95: MAP, 72.333; 96: PROTEIN, URINE (UA): Negative; 96: SPECIFIC GRAVITY, URINE (UA): 1.001; 96: NITRITE, URINE (UA): Negative; 96: KETONE, URINE (UA): Negative; 96: LEUKOCYTE ESTERASE, URINE (UA): Negative; 96: PH, URINE (UA): 7.0; 96: HR, 164.089; 96: RR, 36.5; 96: SpO2, 97.32; 96: Perf, 0.55; 96: 1min HRV, 26.799; 97: INR, 1.2; 97: PART. THROMBOPLASTIN TIME, 38.8 seconds; 97: PROTHROMBIN TIME, 15.3 seconds; 97: HR, 163.871; 97: RR, 36.424; 97: SpO2, 96.475; 97: Perf, 0.55; 97: 1min HRV, 13.300; 98: HR, 153.0; 98: RR, 40.224; 98: SpO2, 96.771; 98: Perf, 0.55; 98: 1min HRV, 124.873; 99: HR, 144.982; 99: RR, 34.576; 99: SpO2, 95.875; 99: Perf, 0.55; 99: 1min HRV, 12.892; 100: HR, 162.524; 100: RR, 33.407; 100: SpO2, 96.271; 100: Perf, 0.55; 100: 1min HRV, 1.961; 100: 5min HRV, 75.241; 101: HR, 165.897; 101: RR, 36.362; 101: SpO2, 97.0; 101: Perf, 0.55; 101: 1min HRV, 13.371; 102: HR, 166.962; 102: RR, 41.898; 102: SpO2, 96.746; 102: Perf, 0.55; 102: 1min HRV, 15.235; 103: HR, 164.707; 103: RR, 34.897; 103: SpO2, 97.155; 103: Perf, 0.55; 103: 1min HRV, 13.524; 104: HR, 166.322; 104: RR, 36.576; 104: SpO2, 97.492; 104: Perf, 0.55; 104: 1min HRV, 16.295; 105: HR, 165.821; 105: RR, 37.136; 105: SpO2, 97.0; 105: Perf, 0.55; 105: 1min HRV, 16.144; 105: 5min HRV, 15.305; 106: CREATININE, 1.17 mg/dL; 106: ALT (SGPT), 56 U/L; 106: BILIRUBIN TOTAL, 0.7 mg/dL; 106: AST (SGOT), 53 U/L; 106: CALCIUM, 8.8 mg/dL; 106: SODIUM, 129 mmol/L; 106: EGFR FOR AFRICAN AMERICAN, 93 mL/min/1.73 m2; 106: ALBUMIN, 3.9 g/dL; 106: GLOBULIN, 3.0 g/dL; 106: GLUCOSE, 298 mg/dL; 106: POTASSIUM, 3.1 mmol/L; 106: ALKALINE PHOSPHATASE, 76 U/L; 106: CORRECTED CALCIUM, 8.9 mg/dL; 106: CHLORIDE, 96 mmol/L; 106: CO2, 24 mmol/L; 106: ANION GAP, 9 mmol/L; 106: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 106: BLOOD UREA NITROGEN (BUN), 7 mg/dL; 106: PROTEIN TOTAL, 6.9 g/dL; 106: HR, 166.759; 106: RR, 37.879; 106: SpO2, 97.741; 106: Perf, 0.55; 106: 1min HRV, 18.752; 107: HR, 166.305; 107: RR, 35.915; 107: SpO2, 97.339; 107: Perf, 0.55; 107: 1min HRV, 13.251; 108: HR, 161.741; 108: RR, 39.034; 108: SpO2, 97.190; 108: Perf, 0.55; 108: 1min HRV, 70.909; 109: HR, 159.644; 109: RR, 38.186; 109: SpO2, 97.254; 109: Perf, 0.55; 109: 1min HRV, 59.905; 110: HR, 165.724; 110: RR, 34.431; 110: SpO2, 97.310; 110: Perf, 0.55; 110: 1min HRV, 11.562; 110: 5min HRV, 46.894; 111: HR, 164.068; 111: RR, 31.051; 111: SpO2, 97.085; 111: Perf, 0.55; 111: 1min HRV, 8.139; 112: HR, 161.678; 112: RR, 32.475; 112: SpO2, 97.533; 112: Perf, 0.55; 112: 1min HRV, 10.966; 113: HR, 161.448; 113: RR, 36.655; 113: SpO2, 98.0; 113: 1min HRV, 34.426; 114: HR, 159.678; 114: RR, 29.136; 114: SpO2, 97.683; 114: 1min HRV, 11.619; 115: HR, 155.552; 115: RR, 22.431; 115: SpO2, 98.0; 115: 1min HRV, 13.881; 115: 5min HRV, 19.683; 116: HR, 153.390; 116: RR, 21.559; 116: SpO2, 98.0; 116: 1min HRV, 15.817; 117: HR, 151.356; 117: RR, 20.356; 117: SpO2, 98.0; 117: 1min HRV, 17.470; 117: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 118: HR:, 150.379; 118: RR, 20.672; 118: SpO2, 97.845; 118: 1min HRV, 17.041; 119: HR, 149.695; 119: RR, 23.661; 119: SpO2, 97.0; 119: 1min HRV, 18.899; 0: Age, 33; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To determine sepsis risk, check for symptoms like high heart rate, respiratory rate, confusion or altered mental state, and signs of infection. The patient shows persistent tachycardia with HR consistently above 110 bpm and increasingly erratic HRV, indicative of severe stress on the body. The elevated temperature suggests an infection, and fluctuating blood pressure, along with respiratory rate frequently above 20 breaths/min, supports potential sepsis. Lab markers and medications like antibiotics further indicate a high suspicion of sepsis, concluding a high risk of sepsis within 12 hours.",
        "claims": [
            "To determine sepsis risk, check for symptoms like high heart rate, respiratory rate, confusion or altered mental state, and signs of infection.",
            "The patient shows persistent tachycardia with a heart rate consistently above 110 bpm.",
            "The patient's heart rate variability (HRV) is increasingly erratic.",
            "Persistent tachycardia and erratic HRV are indicative of severe stress on the body.",
            "The patient has an elevated temperature.",
            "An elevated temperature suggests an infection.",
            "The patient has fluctuating blood pressure.",
            "The respiratory rate is frequently above 20 breaths per minute.",
            "Fluctuating blood pressure and a high respiratory rate support potential sepsis.",
            "Lab markers indicate a high suspicion of sepsis.",
            "Medications like antibiotics further indicate a high suspicion of sepsis.",
            "Based on the symptoms and findings, there is a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "To determine sepsis risk, check for symptoms like high heart rate, respiratory rate, confusion or altered mental state, and signs of infection.",
            "The patient shows persistent tachycardia with a heart rate consistently above 110 bpm.",
            "The patient's heart rate variability (HRV) is increasingly erratic.",
            "Persistent tachycardia and erratic HRV are indicative of severe stress on the body.",
            "The patient has an elevated temperature.",
            "An elevated temperature suggests an infection.",
            "The patient has fluctuating blood pressure.",
            "The respiratory rate is frequently above 20 breaths per minute.",
            "Fluctuating blood pressure and a high respiratory rate support potential sepsis.",
            "Lab markers indicate a high suspicion of sepsis.",
            "Medications like antibiotics further indicate a high suspicion of sepsis.",
            "Based on the symptoms and findings, there is a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.3,
            0.7,
            0.8,
            0.7,
            0.3,
            0.8,
            0.7,
            0.6,
            0.8,
            0.4
        ],
        "alignment_category": [
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim mentions checking for symptoms such as high heart rate, respiratory rate, and altered mental state, which correspond to the components of the qSOFA score (respiratory rate, systolic BP, and altered mentation). Although not all qSOFA criteria are explicitly mentioned, there is a strong alignment with the principle of assessing for organ dysfunction risk, which is central to qSOFA. The mention of signs of infection suggests a broader sepsis context, hence a very close fit with the qSOFA scoring system.",
            "Tachycardia, defined as a heart rate >90 bpm, is explicitly included in the SIRS criteria. A heart rate consistently above 110 bpm strongly suggests the presence of systemic inflammation consistent with early sepsis, thus fitting well within this category. The alignment is strong because tachycardia is a direct indicator under the SIRS framework, though the full SIRS criteria require the presence of at least two parameters.",
            "The claim regarding increasingly erratic heart rate variability (HRV) might suggest cardiovascular instability, which is conceptually related to the Elevated Shock Index (heart\u202frate\u202f\u00f7\u202fsystolic\u202fBP) category. However, HRV itself is not a direct component of the shock index. The connection is purely speculative and indirect, hence the low alignment rating.",
            "Persistent tachycardia indicates a high heart rate, which aligns with the concept of Elevated Shock Index, a measure defined by the ratio of heart rate to systolic blood pressure (HR/SBP) that can indicate hemodynamic instability. While the claim does not directly mention systolic BP, tachycardia is a crucial component of this category, and its presence suggests stress and potential instability consistent with a high shock index. Hence, there is a moderately strong alignment.",
            "The claim about an elevated temperature aligns closely with the SIRS criteria, which include temperature >38\u00b0C (100.4\u00b0F). While the claim doesn\u2019t specify the exact temperature to confirm if it exceeds this threshold, the reference to an elevated temperature strongly suggests a potential systemic inflammatory response. Therefore, it aligns well with SIRS positivity, though not fully confirmed.",
            "An elevated temperature is a specific criterion under the SIRS category (>38\u00b0C). The claim points to infection through elevated temperature, a central aspect of SIRS, although without a specific temperature value confirming it meets the SIRS threshold. Therefore, it reflects a relatively strong but not perfect alignment.",
            "Fluctuating blood pressure can suggest hemodynamic instability, which is relevant to the Elevated Shock Index category. However, the claim lacks the specific calculation of a shock index (heart rate \u00f7 systolic BP) or details about significant changes from baseline to strongly meet this category. Hence, the alignment is considered weak but somewhat relevant.",
            "A respiratory rate of >20 breaths per minute is specifically listed as a SIRS criterion. This claim directly aligns with one criterion needed for SIRS positivity, which is relevant to identifying systemic inflammation consistent with early sepsis. Given that SIRS requires \u22652 criteria and this claim mentions only one, the alignment is strong but not complete, warranting a slightly less than perfect rating.",
            "The claim mentions a high respiratory rate, which is one of the components of the qSOFA score (respiratory rate \u226522/min). Fluctuating blood pressure can relate to systolic BP \u2264100 mmHg, another qSOFA component. While fluctuating blood pressure isn't directly specified in the category, both factors suggest a risk for sepsis-related organ dysfunction. This provides a moderate to high level of alignment with the qSOFA criteria.",
            "The claim of \"lab markers indicate a high suspicion of sepsis\" suggests a clinical suspicion of a serious infection, which aligns with the rationale for ordering early antibiotics or cultures. However, the claim does not specify actual orders or actions taken in line with early sepsis intervention criteria, making the alignment moderate but not definitive.",
            "The claim references the use of antibiotics, which aligns closely with the category indicating a high suspicion of sepsis. While the claim does not specify the timing within the first 2 hours, it clearly identifies initiating antibiotics as a sign of suspected serious infection, meriting a strong alignment with this category.",
            "The claim is general and indicates a high risk of sepsis based on symptoms and findings. Though it doesn't specify, a NEWS score of \u22655 would cover compounded derangements in vitals that imply high sepsis risk, aligning somewhat with \"symptoms and findings.\" However, due to lack of specificity towards any particular clinical metric or scoring system that strongly predicts sepsis, the alignment is relatively weak."
        ],
        "final_alignment_score": 0.6416666666666667,
        "accuracy": 1
    },
    {
        "input": "4: HR, 77.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 111.0; 4: DBP, 62.0; 4: MAP, 78.333; 4: Temp, 98.1; 30: SpO2, 95.364; 31: SpO2, 98.15; 31: Perf, 1.224; 31: SBP, 141.0; 31: DBP, 64.0; 31: MAP, 89.667; 32: SpO2, 99.776; 32: Perf, 0.976; 33: SpO2, 99.847; 33: Perf, 0.968; 34: SpO2, 98.625; 34: SBP, 126.0; 34: DBP, 74.0; 34: MAP, 91.333; 35: SpO2, 99.086; 35: Perf, 0.972; 36: SpO2, 99.542; 36: Perf, 0.932; 37: SpO2, 99.086; 37: Perf, 0.882; 38: SpO2, 99.172; 38: Perf, 0.910; 39: SpO2, 99.917; 39: Perf, 0.988; 40: SpO2, 99.707; 40: Perf, 0.895; 41: SpO2, 99.271; 41: Perf, 0.855; 42: SpO2, 99.517; 42: Perf, 0.907; 43: POC, HCG, ISTAT QUALITATIVE: Negative; 43: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 43: SpO2, 100.0; 43: Perf, 0.995; 44: SpO2, 98.831; 44: Perf, 0.989; 45: SpO2, 98.034; 45: Perf, 0.958; 46: SpO2, 99.305; 46: Perf, 0.772; 47: SpO2, 98.897; 47: Perf, 0.843; 48: SpO2, 99.593; 48: Perf, 0.885; 49: SpO2, 99.0; 49: SBP, 122.0; 49: DBP, 85.0; 49: MAP, 97.333; 50: SpO2, 98.831; 50: Perf, 0.945; 51: SpO2, 99.310; 51: Perf, 0.891; 52: SpO2, 99.237; 52: Perf, 0.859; 53: SpO2, 99.644; 53: Perf, 0.846; 54: SpO2, 97.429; 54: Perf, 0.83; 55: SpO2, 99.322; 55: Perf, 0.887; 56: SpO2, 99.305; 56: Perf, 0.819; 57: SpO2, 99.379; 57: Perf, 0.925; 58: SpO2, 98.271; 58: Perf, 0.880; 59: SpO2, 97.727; 59: Perf, 0.86; 60: SpO2, 98.362; 60: Perf, 0.852; 61: SpO2, 99.085; 61: Perf, 0.805; 62: SpO2, 97.741; 62: Perf, 0.81; 63: SpO2, 97.636; 63: Perf, 0.811; 64: SpO2, 98.1; 64: SBP, 120.0; 64: DBP, 100.0; 64: MAP, 106.667; 65: SpO2, 96.872; 66: SpO2, 98.068; 66: Perf, 0.520; 67: SpO2, 98.707; 67: Perf, 0.486; 68: SpO2, 98.559; 68: Perf, 0.544; 69: WAM DIFTYP, AUTO; 69: RED BLOOD CELLS (RBC), 4.54 MIL/uL; 69: HEMATOCRIT (HCT), 43.4 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 69: HEMOGLOBIN (HGB), 14.1 g/dL; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 0.32 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 12.2 %; 69: MEAN CORPUSCULAR VOLUME (MCV), 95.6 fL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: PLATELET COUNT (PLT), 241 K/uL; 69: BASOPHIL % (AUTO DIFF), 0.9 %; 69: MONOCYTE % (AUTO DIFF), 9.2 %; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.1 pg; 69: LYMPHOCYTE % (AUTO DIFF), 38.6 %; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.5 g/dL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: EOSINOPHIL % (AUTO DIFF), 1.7 %; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.34 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 49.3 %; 69: WHITE BLOOD CELLS (WBC), 3.5 K/uL; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.71 K/uL; 69: SpO2, 98.724; 69: Perf, 0.638; 70: SARS-COV-2 RNA, Not Detected; 70: SpO2, 97.845; 70: Perf, 0.540; 71: SpO2, 98.0; 71: Perf, 0.48; 72: SpO2, 96.611; 72: Perf, 0.48; 73: SpO2, 94.722; 73: Perf, 0.48; 74: SpO2, 98.588; 74: Perf, 0.488; 75: SpO2, 95.053; 75: Perf, 0.52; 76: GLUCOSE, URINE (UA): Negative; 76: PROTEIN, URINE (UA): Negative; 76: NITRITE, URINE (UA): Negative; 76: PH, URINE (UA): 6.0; 76: KETONE, URINE (UA): Negative; 76: SPECIFIC GRAVITY, URINE (UA): 1.013; 76: SpO2, 97.562; 77: SpO2, 88.5; 78: SpO2, 95.889; 79: SpO2, 94.88; 79: SBP, 115.0; 79: DBP, 75.0; 79: MAP, 88.333; 80: SpO2, 97.727; 80: Perf, 0.173; 81: SpO2, 94.140; 83: SpO2, 91.75; 84: SpO2, 91.464; 86: SpO2, 90.294; 87: SpO2, 92.613; 88: SpO2, 97.147; 89: SpO2, 96.1; 90: SpO2, 91.103; 91: SpO2, 93.606; 92: SpO2, 92.714; 93: CREATININE, 0.85 mg/dL; 93: POTASSIUM, 4.1 mmol/L; 93: GLUCOSE, 100 mg/dL; 93: CORRECTED CALCIUM, 8.8 mg/dL; 93: ALBUMIN, 4.8 g/dL; 93: CALCIUM, 9.4 mg/dL; 93: ANION GAP, 9 mmol/L; 93: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 93: EGFR REFIT WITHOUT RACE (2021), 80 mL/min/1.73 m2; 93: BILIRUBIN TOTAL, 0.5 mg/dL; 93: LIPASE, 46 U/L; 93: ALKALINE PHOSPHATASE, 70 U/L; 93: AST (SGOT), 23 U/L; 93: CHLORIDE, 103 mmol/L; 93: SODIUM, 137 mmol/L; 93: EGFR FOR AFRICAN AMERICAN, 92 mL/min/1.73 m2; 93: CO2, 25 mmol/L; 93: PROTEIN TOTAL, 7.6 g/dL; 93: GLOBULIN, 2.8 g/dL; 93: ALT (SGPT), 18 U/L; 93: TSH, 2.77 uIU/mL; 93: SpO2, 88.762; 94: SpO2, 98.105; 94: SBP, 125.0; 94: DBP, 98.0; 94: MAP, 107.0; 95: SpO2, 95.966; 95: Perf, 0.92; 96: SpO2, 98.672; 96: Perf, 0.845; 97: SpO2, 98.169; 97: Perf, 0.894; 98: SpO2, 96.966; 98: Perf, 0.907; 99: SpO2, 96.175; 99: Perf, 0.898; 100: SpO2, 97.276; 100: Perf, 0.873; 101: SpO2, 98.288; 101: Perf, 0.865; 102: SpO2, 96.390; 102: Perf, 0.899; 103: SpO2, 98.508; 103: Perf, 1.044; 104: SpO2, 98.086; 104: Perf, 0.951; 105: SpO2, 96.68; 105: Perf, 0.95; 106: SpO2, 96.0; 106: Perf, 0.95; 107: SpO2, 97.746; 107: Perf, 0.898; 108: SpO2, 96.929; 108: Perf, 0.859; 109: SpO2, 96.611; 109: SBP, 114.0; 109: DBP, 72.0; 109: MAP, 86.0; 110: SpO2, 96.525; 110: Perf, 1.736; 111: SpO2, 98.786; 111: Perf, 1.821; 112: SpO2, 98.017; 112: Perf, 2.042; 113: SpO2, 98.153; 113: Perf, 1.672; 114: SpO2, 97.581; 114: Perf, 1.112; 0: Age, 48; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 111.0; 0: Triage DBP, 62.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The patient's vitals and lab results generally remain stable and within normal ranges throughout the time series. There are no significant abnormalities in blood pressure, heart rate, respiratory rate, or temperature, all of which are commonly monitored in sepsis risk assessment. Additionally, the perfusion index (Perf) and oxygen saturation (SpO2) mostly stay within acceptable ranges. While there are some fluctuations in SpO2 readings, these do not drop below the critical threshold that would indicate acute respiratory distress. Laboratory values such as white blood cell count and other metabolic markers do not show indications of infection or inflammation typically associated with sepsis. Therefore, based on the available data, the patient does not appear to be at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's vitals and lab results generally remain stable and within normal ranges throughout the time series.",
            "There are no significant abnormalities in blood pressure.",
            "There are no significant abnormalities in heart rate.",
            "There are no significant abnormalities in respiratory rate.",
            "There are no significant abnormalities in temperature.",
            "Blood pressure, heart rate, respiratory rate, and temperature are commonly monitored in sepsis risk assessment.",
            "The perfusion index (Perf) mostly stays within acceptable ranges.",
            "Oxygen saturation (SpO2) mostly stays within acceptable ranges.",
            "There are some fluctuations in SpO2 readings.",
            "The SpO2 readings do not drop below the critical threshold that would indicate acute respiratory distress.",
            "Laboratory values such as white blood cell count do not show indications of infection.",
            "Laboratory values do not show indications of inflammation typically associated with sepsis.",
            "Based on the available data, the patient does not appear to be at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's vitals and lab results generally remain stable and within normal ranges throughout the time series.",
            "There are no significant abnormalities in respiratory rate.",
            "There are no significant abnormalities in temperature.",
            "Laboratory values such as white blood cell count do not show indications of infection.",
            "Laboratory values do not show indications of inflammation typically associated with sepsis.",
            "Based on the available data, the patient does not appear to be at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.2,
            0.1,
            0.2,
            0.2,
            0.7,
            0.2
        ],
        "alignment_category": [
            "AElevated NEWS Score (\u22655 points)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions that the patient's vitals and lab results remain stable and within normal ranges. This indirectly implies a low NEWS score, which is based on deranged vitals. While this is relevant to the absence of an elevated NEWS score (\u22655 points), it does not explicitly confirm low sepsis risk per the scoring system. The alignment is weak because it talks about stable ranges rather than the metrics needed to calculate a NEWS score.",
            "The High qSOFA Score category involves assessing the respiratory rate, among other factors. The claim states there are no significant abnormalities in respiratory rate, which implies it is not high enough to contribute to a qSOFA score of \u22652. This is only marginally related and does not suggest a high risk of sepsis, hence the low alignment rating.",
            "The claim regarding the absence of significant temperature abnormalities suggests that one possible indicator of SIRS criteria (altered temperature) is not met. While this is relevant to the assessment of sepsis through SIRS, it is only a part of the criteria and indicates that this specific criterion is not fulfilled. Thus, the alignment is low.",
            "The claim mentions the absence of indications of infection in the white blood cell count, which is part of the SIRS criteria. However, since the claim is about the absence of abnormal findings, it only minimally aligns with SIRS Positivity, which focuses on the presence of specific criteria rather than their absence.",
            "The claim mentions the absence of laboratory indicators of inflammation, which typically relate to SIRS criteria. SIRS involves systemic inflammation markers such as WBC count. The claim's negation of these criteria implies that the SIRS criteria are not met, aligning well with this category's focus on inflammation markers, but not directly describing SIRS positivity. This indirect negation provides a strong yet not complete alignment.",
            "The claim indicates a low assessed risk of sepsis, suggesting there might not be an immediate clinical suspicion of serious infection that would necessitate urgent interventions such as antibiotics or cultures. Although not directly related to the category, the lack of perceived risk and consequent lack of urgent clinical actions indirectly aligns with the absence of criteria like early antibiotic or culture orders."
        ],
        "final_alignment_score": 0.26666666666666666,
        "accuracy": 1
    },
    {
        "input": "15: HR, 100.0; 15: RR, 22.0; 15: SpO2, 94.0; 15: SBP, 107.0; 15: DBP, 55.0; 15: MAP, 72.333; 15: Pain, 3.0; 15: Temp, 101.8; 28: SpO2, 87.0; 29: SpO2, 87.898; 30: HR, 101.765; 30: RR, 20.889; 30: SpO2, 90.632; 30: 1min HRV, 4.830; 30: SBP, 123.0; 30: DBP, 62.0; 30: MAP, 82.333; 31: HR, 101.333; 31: RR, 19.233; 31: SpO2, 92.1; 31: 1min HRV, 4.776; 32: HR, 100.138; 32: RR, 17.362; 32: SpO2, 91.483; 32: 1min HRV, 4.689; 32: 5min HRV, 6.331; 33: HR, 99.0; 33: RR, 17.983; 33: SpO2, 92.593; 33: 1min HRV, 3.153; 34: HR, 98.475; 34: RR, 23.085; 34: SpO2, 91.780; 34: 1min HRV, 7.334; 35: HR, 98.310; 35: RR, 19.121; 35: SpO2, 91.259; 35: 1min HRV, 6.017; 35: ACETAMINOPHEN, 325 MG PO TABS; 36: HR:, 97.169; 36: RR, 21.034; 36: SpO2, 91.119; 36: 1min HRV, 2.545; 37: HR, 96.707; 37: RR, 19.052; 37: SpO2, 90.759; 37: 1min HRV, 9.207; 37: 5min HRV, 7.719; 38: HR, 95.881; 38: RR, 21.695; 38: SpO2, 91.661; 38: 1min HRV, 13.105; 39: HR, 97.339; 39: RR, 26.017; 39: SpO2, 90.305; 39: 1min HRV, 6.039; 40: HR, 97.776; 40: RR, 20.672; 40: SpO2, 91.034; 40: 1min HRV, 4.908; 41: HR, 96.390; 41: RR, 18.407; 41: SpO2, 91.661; 41: 1min HRV, 9.422; 42: HR, 96.828; 42: RR, 20.569; 42: SpO2, 91.190; 42: 1min HRV, 8.440; 42: 5min HRV, 9.844; 43: HR, 96.466; 43: RR, 19.569; 43: SpO2, 90.586; 43: 1min HRV, 3.590; 44: HR, 96.339; 44: RR, 23.763; 44: SpO2, 91.542; 44: 1min HRV, 5.054; 45: HR, 95.831; 45: RR, 28.254; 45: SpO2, 90.932; 45: 1min HRV, 2.598; 46: HR, 95.525; 46: RR, 26.932; 46: SpO2, 90.136; 46: 1min HRV, 5.323; 47: HR, 95.483; 47: RR, 22.931; 47: SpO2, 90.621; 47: 1min HRV, 5.140; 47: 5min HRV, 5.528; 48: HR, 95.339; 48: RR, 27.0; 48: SpO2, 90.153; 48: 1min HRV, 4.641; 49: HR, 94.879; 49: RR, 24.948; 49: SpO2, 89.810; 49: 1min HRV, 4.375; 50: HR, 94.780; 50: RR, 22.0; 50: SpO2, 90.627; 50: 1min HRV, 2.481; 51: HR, 95.203; 51: RR, 27.576; 51: SpO2, 90.068; 51: 1min HRV, 2.493; 52: HR, 95.431; 52: RR, 23.103; 52: SpO2, 89.914; 52: 1min HRV, 4.808; 52: 5min HRV, 4.417; 53: HR, 94.864; 53: RR, 23.237; 53: SpO2, 90.610; 53: 1min HRV, 6.341; 54: HR, 95.655; 54: RR, 26.397; 54: SpO2, 91.241; 54: 1min HRV, 4.805; 55: HR, 96.431; 55: RR, 20.586; 55: SpO2, 91.345; 55: 1min HRV, 3.885; 56: POC PH (V) ISTAT, 7.40; 56: POC BASE EXCESS ISTAT, 9 mmol/L; 56: POC O2 SATURATION ISTAT VENOUS, 69 %; 56: POC PO2 (V) ISTAT, 37 mmHg; 56: POC HCO3 (V) ISTAT, 33.7 mmol/L; 56: POC LACTATE ISTAT, 1.52 mmol/L; 56: POC PCO2 (V) ISTAT, 53.9 mmHg; 56: POC TCO2 (V) ISTAT, 35 mmol/L; 56: HR, 95.881; 56: RR, 16.627; 56: SpO2, 91.695; 56: 1min HRV, 4.064; 57: HR, 95.966; 57: RR, 17.305; 57: SpO2, 92.153; 57: 1min HRV, 6.730; 57: 5min HRV, 6.051; 58: HR, 94.763; 58: RR, 16.831; 58: SpO2, 92.356; 58: 1min HRV, 16.739; 58: SBP, 134.0; 58: DBP, 72.0; 58: MAP, 92.667; 59: HR, 96.897; 59: RR, 19.690; 59: SpO2, 93.0; 59: 1min HRV, 4.855; 60: HR, 95.915; 60: RR, 19.458; 60: SpO2, 92.915; 60: 1min HRV, 8.370; 61: HR, 101.542; 61: RR, 22.881; 61: SpO2, 93.729; 61: 1min HRV, 16.173; 62: HR, 106.879; 62: RR, 23.190; 62: SpO2, 91.534; 62: Perf, 2.954; 62: 1min HRV, 17.762; 62: 5min HRV, 30.337; 72: WAM DIFTYP, AUTO; 72: EOSINOPHIL % (AUTO DIFF), 0.5 %; 72: MONOCYTE % (AUTO DIFF), 4.3 %; 72: HEMATOCRIT (HCT), 45.1 %; 72: NEUTROPHIL % (AUTO DIFF), 84.7 %; 72: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 72: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.7 pg; 72: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 72: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 72: PLATELET COUNT (PLT), 283 K/uL; 72: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 72: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.9 g/dL; 72: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 72: HEMOGLOBIN (HGB), 15.3 g/dL; 72: RED CELL DISTRIBUTION WIDTH (RDW), 12.8 %; 72: NRBC PERCENT (HEMATOLOGY), 0.0 %; 72: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 72: LYMPHOCYTE % (AUTO DIFF), 9.5 %; 72: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 72: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.99 K/uL; 72: WHITE BLOOD CELLS (WBC), 10.4 K/uL; 72: RED BLOOD CELLS (RBC), 4.82 MIL/uL; 72: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.84 K/uL; 72: BASOPHIL % (AUTO DIFF), 0.4 %; 86: DEXAMETHASONE SODIUM PHOSPHATE, 4 MG/ML INJ SOLN; 87: HR:, 93.0; 87: RR, 26.0; 87: SpO2, 92.0; 87: SBP, 114.0; 87: DBP, 49.0; 87: MAP, 70.667; 88: INR, 1.0; 88: PROTHROMBIN TIME, 12.5 seconds; 89: PART. THROMBOPLASTIN TIME, 27.9 seconds; 110: TROPONIN I, <.017 ng/mL; 113: CREATININE, 0.80 mg/dL; 113: SODIUM, 137 mmol/L; 113: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 113: EGFR FOR AFRICAN AMERICAN, 134 mL/min/1.73 m2; 113: BILIRUBIN TOTAL, 0.5 mg/dL; 113: EGFR REFIT WITHOUT RACE (2021), 116 mL/min/1.73 m2; 113: POTASSIUM, 5.0 mmol/L; 113: PROTEIN TOTAL, 7.5 g/dL; 113: CO2, 25 mmol/L; 113: GLUCOSE, 127 mg/dL; 113: CHLORIDE, 99 mmol/L; 113: ANION GAP, 13 mmol/L; 113: ALBUMIN, 4.2 g/dL; 113: CORRECTED CALCIUM, 9.3 mg/dL; 113: ALT (SGPT), 74 U/L; 113: CALCIUM, 9.5 mg/dL; 113: AST (SGOT), 47 U/L; 113: ALKALINE PHOSPHATASE, 66 U/L; 113: GLOBULIN, 3.3 g/dL; 0: Age, 34; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 100.0; 0: Triage RR, 22.0; 0: Triage SBP, 107.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, CHEST PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "To predict sepsis risk, it's critical to examine key indicators like vital signs, lab values, treatment interventions, and trends over time. This patient exhibits persistent hypotension (DBP: 55 mmHg), tachycardia (persistent HR around 100 bpm), fever (initial temp of 38.8\u00b0C), tachypnea (RR consistently elevated above 20), and hypoxemia (SpO2 below 92%). These are classic symptoms aligning with systemic inflammatory response syndrome (SIRS) criteria, which indicate a high risk for sepsis. Additionally, dexamethasone administration and decreased diastolic blood pressure later further suggest worsening condition. Hence, the time series suggests a high risk of sepsis within 12 hours, warranting a \"Yes\" label.",
        "claims": [
            "Key indicators to examine for predicting sepsis risk include vital signs, lab values, and treatment interventions.",
            "The patient exhibits persistent hypotension with a diastolic blood pressure of 55 mmHg.",
            "The patient exhibits tachycardia with a heart rate consistently around 100 bpm.",
            "The patient has a fever with an initial temperature of 38.8\u00b0C.",
            "The patient shows tachypnea with a respiratory rate consistently elevated above 20.",
            "The patient has hypoxemia with an SpO2 below 92%.",
            "These symptoms align with the criteria for systemic inflammatory response syndrome (SIRS).",
            "The presence of SIRS criteria indicates a high risk for sepsis.",
            "Dexamethasone administration suggests a worsening condition.",
            "Decreased diastolic blood pressure further indicates the patient's worsening condition.",
            "The time series of these indicators suggests a high risk of sepsis within the next 12 hours.",
            "A \"Yes\" label is warranted based on the predicted high risk of sepsis."
        ],
        "relevant_claims": [
            "The patient exhibits persistent hypotension with a diastolic blood pressure of 55 mmHg.",
            "The patient exhibits tachycardia with a heart rate consistently around 100 bpm.",
            "The patient has a fever with an initial temperature of 38.8\u00b0C.",
            "The patient shows tachypnea with a respiratory rate consistently elevated above 20.",
            "The patient has hypoxemia with an SpO2 below 92%.",
            "These symptoms align with the criteria for systemic inflammatory response syndrome (SIRS).",
            "The presence of SIRS criteria indicates a high risk for sepsis.",
            "Dexamethasone administration suggests a worsening condition.",
            "Decreased diastolic blood pressure further indicates the patient's worsening condition.",
            "The time series of these indicators suggests a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.5,
            0.9,
            0.8,
            0.7,
            1.0,
            1.0,
            0.3,
            0.3,
            0.3
        ],
        "alignment_category": [
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "While the claim focuses on diastolic blood pressure (DBP), sepsis-associated hypotension is more directly measured by systolic blood pressure (SBP) or mean arterial pressure (MAP) thresholds. However, a DBP of 55 mmHg likely corresponds to a low MAP, which aligns with the concept of sepsis-associated hypotension indicating progression toward septic shock. This gives a moderately strong alignment with the category.",
            "The claim mentions tachycardia with a heart rate consistently around 100 bpm. This directly relates to the SIRS criteria, which include heart rate >90 bpm. The claim aligns with one component of the SIRS criteria for systemic inflammation, suggesting potential sepsis risk but the alignment is partial as only one criterion is met.",
            "The patient's temperature exceeds the SIRS criterion of >38\u00b0C, indicating systemic inflammation consistent with early sepsis. The high alignment reflects that this is a direct and explicit criterion used to assess SIRS positivity. However, since SIRS requires \u22652 criteria and only temperature is mentioned here, the rating is below 1.0.",
            "Tachypnea with a respiratory rate consistently elevated above 20 is specifically mentioned as one of the criteria for SIRS positivity. While the claim focuses on only one SIRS criterion (tachypnea), the inclusion of an elevated respiratory rate indicates systemic inflammation consistent with early sepsis. The alignment is strong due to the direct reference to one of the SIRS criteria but only addresses one aspect rather than two.",
            "The claim of hypoxemia with an SpO2 below 92% relates to impaired oxygenation, which is conceptually connected to the PaO\u2082/FiO\u2082 ratio in the SOFA score. While SpO2 isn't directly measured by SOFA, it indicates a potential issue in oxygen delivery or utilization, reflecting new organ dysfunction, which is relevant to SOFA. The alignment is indirect but significant due to the implication of possible organ dysfunction linked to sepsis risk.",
            "The claim explicitly states that the symptoms align with SIRS criteria, which is directly related to this category. This indicates clear systemic inflammation, making the alignment perfect.",
            "The claim directly references the presence of SIRS criteria as an indicator of high sepsis risk. This aligns perfectly with the \"SIRS Positivity\" category, which is defined by the presence of at least two SIRS criteria to identify systemic inflammation consistent with early sepsis.",
            "The administration of dexamethasone implies a clinical concern potentially related to worsening inflammation or sepsis. However, dexamethasone is not specifically an antibiotic or culture order, making its alignment with sepsis risk assessment indirect and weak. The claim hints at a concern that warrants closer examination but doesn't concrete align with the criterion of early antibiotic or culture orders, hence the lower rating.",
            "The claim mentions decreased diastolic blood pressure, which doesn't directly pertain to any category but can be indirectly linked to haemodynamic instability, a component of the Elevated Shock Index category. However, the Shock Index is based on heart rate and systolic blood pressure rather than diastolic, causing a weak alignment. Thus, the alignment rating is set at 0.3 due to the indirect association with instability.",
            "The claim indicates a prediction of high sepsis risk based on a time series of indicators, which can relate to constantly monitored vitals suggesting imminent clinical deterioration. While it does not directly state a NEWS score, this score is derived from vital signs often used in time series predictions. The alignment is not strong due to the absence of specific criteria mentioned but is suggestive of NEWS or similar scores derived from continuous metrics."
        ],
        "final_alignment_score": 0.65,
        "accuracy": 0
    },
    {
        "input": "4: HR, 98.0; 4: RR, 20.0; 4: SpO2, 98.0; 4: SBP, 156.0; 4: DBP, 91.0; 4: MAP, 112.667; 4: Pain, 9.0; 4: Temp, 97.3; 17: Pain, 9.0; 47: SpO2, 99.815; 47: Perf, 5.65; 48: SpO2, 99.698; 48: Perf, 4.866; 49: SpO2, 99.654; 49: Perf, 6.326; 50: SpO2, 98.283; 50: Perf, 6.188; 51: SpO2, 98.692; 51: Perf, 4.329; 52: SpO2, 99.887; 52: Perf, 5.396; 53: SpO2, 98.698; 53: Perf, 6.652; 54: SpO2, 97.788; 54: Perf, 6.915; 55: SpO2, 98.321; 55: Perf, 5.774; 56: SpO2, 98.769; 56: Perf, 5.436; 57: SpO2, 99.796; 57: Perf, 3.147; 58: SpO2, 99.981; 58: Perf, 5.669; 59: SpO2, 98.852; 59: Perf, 6.074; 60: SpO2, 98.962; 60: Perf, 5.853; 61: SpO2, 98.327; 61: Perf, 6.366; 62: SpO2, 97.887; 62: Perf, 4.309; 63: WAM DIFTYP, AUTO; 63: WHITE BLOOD CELLS (WBC), 9.2 K/uL; 63: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 63: PLATELET COUNT (PLT), 111 K/uL; 63: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 63: RED BLOOD CELLS (RBC), 3.36 MIL/uL; 63: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.8 pg; 63: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 63: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 63: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 63: MONOCYTE % (AUTO DIFF), 6.5 %; 63: LYMPHOCYTE % (AUTO DIFF), 23.5 %; 63: NEUTROPHIL % (AUTO DIFF), 67.4 %; 63: MEAN CORPUSCULAR VOLUME (MCV), 90.8 fL; 63: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 63: HEMATOCRIT (HCT), 30.5 %; 63: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.21 K/uL; 63: BASOPHIL % (AUTO DIFF), 0.4 %; 63: EOSINOPHIL % (AUTO DIFF), 1.2 %; 63: HEMOGLOBIN (HGB), 10.0 g/dL; 63: NRBC PERCENT (HEMATOLOGY), 0.0 %; 63: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 63: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 63: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 63: SpO2, 98.472; 63: Perf, 5.038; 64: SpO2, 97.75; 64: Perf, 5.482; 65: SpO2, 98.811; 65: Perf, 4.566; 66: SpO2, 100.0; 66: Perf, 4.300; 67: SpO2, 99.679; 67: Perf, 4.146; 68: SpO2, 98.453; 68: Perf, 3.965; 69: SpO2, 97.692; 69: Perf, 3.954; 70: SpO2, 98.604; 70: Perf, 4.070; 71: SpO2, 98.963; 71: Perf, 3.789; 72: SpO2, 99.208; 72: Perf, 3.189; 73: SpO2, 99.226; 73: Perf, 3.142; 74: SpO2, 98.731; 74: Perf, 4.288; 75: SpO2, 99.830; 75: Perf, 4.364; 76: SpO2, 99.212; 76: Perf, 3.890; 77: SpO2, 99.358; 77: Perf, 2.905; 78: SpO2, 99.192; 78: Perf, 3.487; 79: SpO2, 100.0; 79: Perf, 2.814; 80: SpO2, 99.302; 80: Perf, 2.529; 81: SpO2, 99.827; 81: Perf, 2.478; 82: SpO2, 99.679; 82: Perf, 2.804; 83: SpO2, 99.358; 83: Perf, 3.397; 84: SpO2, 99.660; 84: Perf, 2.971; 85: SpO2, 99.722; 85: Perf, 3.593; 86: SpO2, 98.462; 86: Perf, 2.956; 87: SpO2, 99.094; 87: Perf, 2.975; 88: SpO2, 98.731; 88: Perf, 4.379; 89: SpO2, 99.226; 89: Perf, 7.745; 90: SpO2, 98.717; 90: Perf, 7.697; 91: SpO2, 98.885; 91: Perf, 5.139; 92: ANION GAP, 8 mmol/L; 92: PROTEIN TOTAL, 6.5 g/dL; 92: CREATININE, 1.69 mg/dL; 92: ALKALINE PHOSPHATASE, 204 U/L; 92: BLOOD UREA NITROGEN (BUN), 19 mg/dL; 92: GLUCOSE, 194 mg/dL; 92: AST (SGOT), 103 U/L; 92: BILIRUBIN TOTAL, 1.9 mg/dL; 92: POTASSIUM, 4.2 mmol/L; 92: CHLORIDE, 107 mmol/L; 92: GLOBULIN, 3.7 g/dL; 92: CALCIUM, 8.2 mg/dL; 92: EGFR REFIT WITHOUT RACE (2021), 41 mL/min/1.73 m2; 92: CORRECTED CALCIUM, 9.2 mg/dL; 92: SODIUM, 137 mmol/L; 92: ALT (SGPT), 35 U/L; 92: CO2, 22 mmol/L; 92: LIPASE, 7 U/L; 92: ALBUMIN, 2.8 g/dL; 92: SpO2, 99.585; 92: Perf, 5.095; 93: SpO2, 100.0; 93: Perf, 4.939; 93: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 94: SpO, 2: 100.0; 94: Perf, 6.090; 95: SpO2, 99.547; 95: Perf, 7.254; 96: SpO2, 99.698; 96: Perf, 3.639; 96: HYDROMORPHONE, 1 MG/ML INJ SYRG; 97: SpO, 2: 100.0; 97: Perf, 2.333; 98: SpO2, 100.0; 98: Perf, 1.970; 99: SpO2, 100.0; 99: Perf, 1.992; 100: SpO2, 100.0; 100: Perf, 2.358; 101: SpO2, 100.0; 101: Perf, 2.456; 102: SpO2, 100.0; 102: Perf, 2.726; 103: SpO2, 100.0; 103: Perf, 2.592; 104: SpO2, 100.0; 104: Perf, 2.425; 105: SpO2, 100.0; 105: Perf, 2.096; 106: SpO2, 100.0; 106: Perf, 2.291; 107: SpO2, 99.679; 107: Perf, 2.310; 108: POC PH (V) ISTAT, 7.54; 108: POC PCO2 (V) ISTAT, 23.5 mmHg; 108: POC O2 SATURATION ISTAT VENOUS, 77 %; 108: POC PO2 (V) ISTAT, 35 mmHg; 108: POC BASE EXCESS ISTAT, -2 mmol/L; 108: POC LACTATE ISTAT, 1.68 mmol/L; 108: POC TCO2 (V) ISTAT, 21 mmol/L; 108: POC HCO3 (V) ISTAT, 20.3 mmol/L; 108: SpO2, 99.792; 108: Perf, 2.784; 109: SpO2, 100.0; 109: Perf, 2.668; 110: POC, HCG, ISTAT QUALITATIVE: Negative; 110: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 110: SpO2, 99.788; 110: Perf, 2.271; 110: LR IV BOLUS -, 500 ML; 111: SpO, 2: 100.0; 111: Perf, 2.174; 112: SpO2, 100.0; 112: Perf, 2.461; 113: SpO2, 99.925; 113: Perf, 2.120; 114: SpO2, 98.736; 114: Perf, 2.366; 114: SBP, 125.0; 114: DBP, 72.0; 114: MAP, 89.667; 115: SpO2, 94.868; 115: Perf, 2.387; 116: SpO2, 99.302; 116: Perf, 2.58; 117: HR, 94.0; 117: RR, 18.0; 117: SpO2, 99.642; 117: Perf, 2.295; 117: SBP, 125.0; 117: DBP, 72.0; 117: MAP, 89.667; 117: Pain, 9.0; 118: SpO2, 97.231; 118: Perf, 2.053; 119: SpO2, 90.167; 119: Perf, 2.086; 0: Age, 31; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 98.0; 0: Triage RR, 20.0; 0: Triage SBP, 156.0; 0: Triage DBP, 91.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "Start by evaluating vital signs over time; BP and HR decrease, observing a drop in MAP and SpO2 at the end, indicating potential instability. Analyze lab values, noting low albumin and elevated bilirubin and AST, suggesting liver dysfunction, a risk for sepsis. Consider the patient\u2019s high pain score and recent medication administration (Ondansetron and Hydromorphone), which might mask symptoms; coupled with a high triage acuity, these factors amplify the risk of sepsis within 12 hours.",
        "claims": [
            "Vital signs should be evaluated over time.",
            "BP and HR have decreased.",
            "There is a drop in MAP at the end.",
            "There is a drop in SpO2 at the end.",
            "A drop in MAP and SpO2 indicates potential instability.",
            "Lab values should be analyzed.",
            "The albumin level is low.",
            "The bilirubin level is elevated.",
            "The AST level is elevated.",
            "Low albumin and elevated bilirubin and AST suggest liver dysfunction.",
            "Liver dysfunction is a risk factor for sepsis.",
            "The patient has a high pain score.",
            "Recent medication administration includes Ondansetron and Hydromorphone.",
            "Recent medication administration may mask symptoms.",
            "The patient has a high triage acuity.",
            "High triage acuity amplifies the risk of sepsis within 12 hours.",
            "Multiple factors contribute to the increased risk of sepsis."
        ],
        "relevant_claims": [
            "A drop in MAP and SpO2 indicates potential instability.",
            "The albumin level is low.",
            "The bilirubin level is elevated.",
            "The AST level is elevated.",
            "Low albumin and elevated bilirubin and AST suggest liver dysfunction.",
            "The patient has a high pain score.",
            "The patient has a high triage acuity.",
            "High triage acuity amplifies the risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.8,
            0.3,
            0.8,
            0.2,
            0.3,
            0.7
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim references a drop in mean arterial pressure (MAP) and SpO2 (oxygen saturation). While SpO2 is not directly part of the SOFA score, a decrease in oxygenation can relate to the PaO\u2082/FiO\u2082 ratio component of the SOFA score, indicative of respiratory dysfunction. A drop in MAP points toward possible cardiovascular concerns. Both elements are indicative of potential organ dysfunction, consistent with the intent of the SOFA score for identifying sepsis risk. Therefore, while not a perfect match, this claim aligns fairly well with the concept of organ dysfunction signals evaluated by the SOFA score.",
            "Although low albumin isn't directly a component of the SOFA score, low albumin levels can indicate poor nutritional status and could be associated with organ dysfunction. The SOFA score includes several elements that overlap with tissue and organ health. Therefore, while low albumin isn't a direct SOFA component, there is a loosely related conceptual alignment.",
            "Elevated bilirubin is a specific SOFA score component used to diagnose organ dysfunction related to sepsis. This direct relation indicates a strong alignment with the chosen category, though without specific values or additional context, it's slightly below perfect alignment.",
            "Elevated AST is not directly included in the SOFA score components. However, it relates to liver function, and the SOFA score includes bilirubin as a measure of liver dysfunction. The alignment is weak since AST itself doesn't contribute to the SOFA scoring, making it only marginally relevant.",
            "The claim mentions elevated bilirubin and liver dysfunction, both of which are directly related to the SOFA score, where bilirubin >2 mg/dL is a specific component indicating organ dysfunction. Although albumin and AST aren't direct SOFA measures, they pertain to liver function and potential organ dysfunction, emphasizing the claim's fit within the SOFA category. The alignment is strong but not perfect due to the inclusion of parameters not directly measured by SOFA.",
            "A high pain score does not directly match any of the listed sepsis prediction categories. However, it could indirectly relate to altered mentation or stress responses, which may influence SOFA components (e.g., altered consciousness). This connection is weak but somewhat related; hence a low alignment rating.",
            "A high triage acuity often reflects significant concern about the patient's immediate condition, which could align with elevated NEWS scores that predict clinical deterioration. However, without specific mention of NEWS criteria or values, the alignment is indirect and weak.",
            "High triage acuity often corresponds to an elevated NEWS score, which is designed to predict clinical deterioration such as sepsis. While the claim does not explicitly state a NEWS score, high acuity in triage settings frequently reflects deranged vital signs similar to what NEWS evaluates, implying a moderate alignment with the category."
        ],
        "final_alignment_score": 0.5125,
        "accuracy": 0
    },
    {
        "input": "8: HR, 120.0; 8: RR, 25.0; 8: SpO2, 86.0; 8: SBP, 105.0; 8: DBP, 77.0; 8: MAP, 86.333; 8: LPM O2, 2.0; 8: Pain, 0.0; 8: Temp, 98.8; 17: HR, 108.0; 17: SpO2, 91.538; 17: 1min HRV, 7.040; 18: HR, 112.138; 18: SpO2, 92.966; 18: Perf, 0.71; 18: 1min HRV, 6.005; 19: HR, 110.915; 19: RR, 24.2; 19: SpO2, 94.932; 19: Perf, 0.629; 19: 1min HRV, 24.315; 20: HR, 111.190; 20: RR, 17.7; 20: SpO2, 96.203; 20: Perf, 0.600; 20: 1min HRV, 4.859; 21: SpO2, 96.224; 21: Perf, 0.638; 21: 5min HRV, 16.412; 22: SpO2, 95.661; 22: Perf, 0.788; 23: HR, 110.6; 23: RR, 28.25; 23: SpO2, 96.310; 23: Perf, 0.871; 23: 1min HRV, 3.451; 24: HR, 110.644; 24: RR, 25.492; 24: SpO2, 95.441; 24: Perf, 0.802; 24: 1min HRV, 8.795; 25: POC PH (V) ISTAT, 7.33; 25: POC PCO2 (V) ISTAT, 34.3 mmHg; 25: POC HCO3 (V) ISTAT, 17.9 mmol/L; 25: POC O2 SATURATION ISTAT VENOUS, 63 %; 25: POC LACTATE ISTAT, 1.94 mmol/L; 25: POC PO2 (V) ISTAT, 35 mmHg; 25: POC TCO2 (V) ISTAT, 19 mmol/L; 25: POC BASE EXCESS ISTAT, -8 mmol/L; 25: HR, 110.576; 25: RR, 28.034; 25: SpO2, 92.746; 25: Perf, 0.727; 25: 1min HRV, 4.456; 26: HR, 109.914; 26: RR, 26.052; 26: SpO2, 92.931; 26: Perf, 0.758; 26: 1min HRV, 4.512; 26: 5min HRV, 6.624; 27: HR, 110.644; 27: RR, 27.237; 27: SpO2, 93.0; 27: Perf, 0.727; 27: 1min HRV, 6.069; 28: HR, 110.793; 28: RR, 24.707; 28: SpO2, 92.052; 28: Perf, 0.718; 28: 1min HRV, 5.125; 29: HR, 110.508; 29: RR, 24.441; 29: SpO2, 91.678; 29: Perf, 0.881; 29: 1min HRV, 24.560; 30: HR, 109.712; 30: RR, 27.068; 30: SpO2, 90.322; 30: Perf, 1.013; 30: 1min HRV, 7.817; 31: HR, 108.431; 31: RR, 26.759; 31: SpO2, 92.638; 31: Perf, 1.119; 31: 1min HRV, 6.071; 31: 5min HRV, 13.418; 31: LPM O2, 3.0; 32: HR, 106.271; 32: RR, 25.339; 32: SpO2, 94.542; 32: Perf, 1.045; 32: 1min HRV, 6.875; 32: SBP, 106.0; 32: DBP, 73.0; 32: MAP, 84.0; 33: HR, 107.586; 33: RR, 25.397; 33: SpO2, 95.0; 33: Perf, 1.158; 33: 1min HRV, 7.604; 35: POC, HCG, ISTAT QUALITATIVE: Negative; 35: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 36: 5min HRV, 7.778; 46: WAM DIFTYP, AUTO; 46: LYMPHOCYTE % (AUTO DIFF), 18.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 46: PLATELET COUNT (PLT), 209 K/uL; 46: MEAN CORPUSCULAR VOLUME (MCV), 78.8 fL; 46: RED BLOOD CELLS (RBC), 3.86 MIL/uL; 46: RED CELL DISTRIBUTION WIDTH (RDW), 18.5 %; 46: MONOCYTE % (AUTO DIFF), 11.2 %; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.77 K/uL; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.5 %; 46: HEMATOCRIT (HCT), 30.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.6 pg; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.63 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 1.60 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 46: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.3 %; 46: HEMOGLOBIN (HGB), 9.9 g/dL; 46: NEUTROPHIL % (AUTO DIFF), 68.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.1 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.1 %; 74: CEFEPIME, 2 GRAM/20 ML IV PUSH; 80: SARS-COV-, 2 RNA: Not Detected; 80: VANCOMYCIN-WATER INJECT (PEG), 1 GRAM/200 ML IV PGBK; 83: ALT (SGPT):, 33 U/L; 83: ALKALINE PHOSPHATASE, 300 U/L; 83: AST (SGOT), 27 U/L; 83: BLOOD UREA NITROGEN (BUN), 35 mg/dL; 83: PROTEIN TOTAL, 4.8 g/dL; 83: CALCIUM, 10.9 mg/dL; 83: CORRECTED CALCIUM, 12.3 mg/dL; 83: CREATININE, 1.40 mg/dL; 83: GLOBULIN, 2.5 g/dL; 83: ALBUMIN, 2.3 g/dL; 83: BILIRUBIN TOTAL, 1.2 mg/dL; 83: GLUCOSE, 117 mg/dL; 83: SODIUM, 125 mmol/L; 83: CHLORIDE, 98 mmol/L; 83: EGFR FOR AFRICAN AMERICAN, 56 mL/min/1.73 m2; 83: ANION GAP, 9 mmol/L; 83: POTASSIUM, 4.3 mmol/L; 83: EGFR REFIT WITHOUT RACE (2021), 48 mL/min/1.73 m2; 83: CO2, 18 mmol/L; 92: TROPONIN I, <.017 ng/mL; 99: GLUCOSE, URINE (UA): Negative; 99: NITRITE, URINE (UA): Negative; 99: SPECIFIC GRAVITY, URINE (UA): 1.009; 99: KETONE, URINE (UA): Negative; 99: PH, URINE (UA): 6.0; 117: BNP NT-PRO, 363 pg/mL; 0: Age, 35; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.1; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 105.0; 0: Triage DBP, 77.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To evaluate sepsis risk, I considered key indicators such as HR, RR, blood pressure, saturation, HRV, and laboratory results. The patient shows persistent tachycardia with HR > 100 bpm, tachypnea with RR often > 24, and oxygen saturation consistently below normal. Blood tests reflect leukocytosis (WBC count), anemia, and mild acidosis (low bicarbonate and base excess). These hints of systemic stress could indicate a high risk for sepsis. Moreover, the administration of broad-spectrum antibiotics (Cefepime and Vancomycin) further supports the suspicion of an infection, suggesting a high risk of evolving into sepsis.",
        "claims": [
            "To evaluate sepsis risk, key indicators were considered.",
            "Key indicators for evaluating sepsis risk include heart rate (HR), respiratory rate (RR), blood pressure, saturation, heart rate variability (HRV), and laboratory results.",
            "The patient shows persistent tachycardia with a heart rate greater than 100 bpm.",
            "The patient exhibits tachypnea with a respiratory rate often greater than 24.",
            "The patient's oxygen saturation is consistently below normal.",
            "Blood tests indicate leukocytosis, reflecting an elevated white blood cell count.",
            "Blood tests also show anemia.",
            "Blood tests reflect mild acidosis, indicated by low bicarbonate and base excess.",
            "These indicators suggest hints of systemic stress.",
            "Hints of systemic stress could indicate a high risk for sepsis.",
            "The administration of broad-spectrum antibiotics, specifically Cefepime and Vancomycin, supports the suspicion of an infection.",
            "The suspicion of an infection suggests a high risk of evolving into sepsis."
        ],
        "relevant_claims": [
            "Key indicators for evaluating sepsis risk include heart rate (HR), respiratory rate (RR), blood pressure, saturation, heart rate variability (HRV), and laboratory results.",
            "The patient shows persistent tachycardia with a heart rate greater than 100 bpm.",
            "The patient exhibits tachypnea with a respiratory rate often greater than 24.",
            "The patient's oxygen saturation is consistently below normal.",
            "Blood tests indicate leukocytosis, reflecting an elevated white blood cell count.",
            "Blood tests reflect mild acidosis, indicated by low bicarbonate and base excess.",
            "Hints of systemic stress could indicate a high risk for sepsis.",
            "The administration of broad-spectrum antibiotics, specifically Cefepime and Vancomycin, supports the suspicion of an infection.",
            "The suspicion of an infection suggests a high risk of evolving into sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.9,
            0.6,
            1.0,
            0.3,
            0.4,
            1.0,
            0.6
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions multiple vital signs (heart rate, respiratory rate, blood pressure) and laboratory results, which are elements integral to the NEWS score. Although heart rate variability (HRV) and saturation are not explicitly components of the NEWS score, the focus on evaluating multiple vitals aligns with the comprehensive nature of the NEWS score in assessing clinical deterioration. The alignment is robust, but not perfect, due to the inclusion of some elements not directly part of the NEWS calculation.",
            "Tachycardia, defined as a heart rate greater than 90 bpm, is one of the specific criteria for SIRS positivity. The claim mentions a heart rate greater than 100 bpm, which exceeds this threshold, indicating a notable alignment with the SIRS Positivity category, though it alone does not meet the requirement of having \u22652 SIRS criteria.",
            "The claim refers to tachypnea with a respiratory rate often greater than 24, which exceeds the threshold of \u226522/min, a critical component of the qSOFA score used to assess sepsis risk. Although the claim focuses on one aspect of the qSOFA criteria, it strongly aligns with the category because it meets the criterion for respiratory rate directly, indicating a high risk of sepsis. Hence, the alignment is very high.",
            "The claim about the patient's consistently low oxygen saturation hints at potential respiratory dysfunction, which conceptually relates to impaired oxygenation and could affect the PaO\u2082/FiO\u2082 ratio, a component of the SOFA score. Although the claim does not explicitly mention the specific metrics used in SOFA, the indication of hypoxia aligns meaningfully with the risk of organ dysfunction associated with sepsis.",
            "The claim mentions leukocytosis, which is an elevated white blood cell count. This is explicitly listed as one of the criteria under SIRS Positivity, aimed at identifying systemic inflammation and potential early sepsis. The claim aligns perfectly with the SIRS criteria.",
            "Acidosis, indicated by low bicarbonate and base excess, suggests metabolic derangement, often associated with tissue hypoperfusion. While this isn't a direct measure of serum lactate, which is the primary focus of this category, similar metabolic indicators can be related. Therefore, the alignment is weak but somewhat relevant.",
            "The mention of \"systemic stress\" suggests an underlying systemic inflammatory response, which aligns with the SIRS criteria designed to identify such states. However, the claim is vague and does not provide specific criteria such as temperature, heart rate, or white blood cell count that are explicitly listed under the SIRS criteria. Therefore, the alignment is partial and not definitive.",
            "The administration of broad-spectrum antibiotics such as Cefepime and Vancomycin indicates a strong clinical suspicion of a serious infection, which aligns directly with the category that focuses on early antibiotic or culture orders as a marker for assessing high sepsis risk. This is a perfect alignment with the provided category.",
            "The claim discusses suspicion of infection, which relates to clinician suspicion that may trigger early intervention actions like antibiotics or cultures. While the claim lacks explicit mention of such actions, the suspicion itself is a moderate precursor to these actions; hence the alignment rating isn't full but is moderately significant."
        ],
        "final_alignment_score": 0.6888888888888888,
        "accuracy": 1
    },
    {
        "input": "5: HR, 136.0; 5: RR, 16.0; 5: SpO2, 98.0; 5: SBP, 122.0; 5: DBP, 79.0; 5: MAP, 93.333; 5: Temp, 100.8; 14: SpO2, 96.089; 15: HR, 129.462; 15: RR, 20.722; 15: SpO2, 97.431; 15: 1min HRV, 7.348; 16: HR, 127.492; 16: RR, 21.695; 16: SpO2, 97.356; 16: 1min HRV, 3.740; 17: HR, 129.172; 17: RR, 20.086; 17: SpO2, 97.517; 17: 1min HRV, 4.378; 18: HR, 128.814; 18: RR, 21.169; 18: SpO2, 97.864; 18: 1min HRV, 3.746; 18: 5min HRV, 5.221; 19: HR, 126.881; 19: RR, 26.492; 19: SpO2, 97.576; 19: 1min HRV, 9.624; 20: POC PH (V) ISTAT, 7.44; 20: POC LACTATE ISTAT, 1.52 mmol/L; 20: POC TCO2 (V) ISTAT, 26 mmol/L; 20: POC BASE EXCESS ISTAT, 1 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 78 %; 20: POC HCO3 (V) ISTAT, 25.2 mmol/L; 20: POC PO2 (V) ISTAT, 41 mmHg; 20: POC PCO2 (V) ISTAT, 37.1 mmHg; 20: HR, 125.397; 20: RR, 25.517; 20: SpO2, 97.310; 20: 1min HRV, 6.978; 21: HR, 127.136; 21: RR, 26.424; 21: SpO2, 97.559; 21: 1min HRV, 4.623; 22: HR, 127.121; 22: RR, 24.828; 22: SpO2, 97.328; 22: 1min HRV, 16.265; 23: HR, 128.102; 23: RR, 21.220; 23: SpO2, 97.864; 23: 1min HRV, 17.616; 23: 5min HRV, 12.635; 24: HR, 126.051; 24: RR, 24.424; 24: SpO2, 97.729; 24: 1min HRV, 5.951; 25: HR, 126.776; 25: RR, 24.155; 25: SpO2, 97.362; 25: 1min HRV, 4.675; 26: HR, 127.0; 26: RR, 23.508; 26: SpO2, 97.966; 26: 1min HRV, 4.440; 26: SBP, 116.0; 26: DBP, 77.0; 26: MAP, 90.0; 27: HR, 125.879; 27: RR, 27.259; 27: SpO2, 97.466; 27: 1min HRV, 5.543; 28: HR, 126.508; 28: RR, 25.475; 28: SpO2, 97.712; 28: 1min HRV, 7.168; 28: 5min HRV, 6.036; 28: SBP, 124.0; 28: DBP, 74.0; 28: MAP, 90.667; 28: Temp, 101.1; 29: HR, 124.603; 29: RR, 24.052; 29: SpO2, 98.0; 29: 1min HRV, 8.227; 29: SBP, 124.0; 29: DBP, 74.0; 29: MAP, 90.667; 30: HR, 126.407; 30: RR, 21.610; 30: SpO2, 97.949; 30: 1min HRV, 5.456; 31: HR, 126.0; 31: RR, 27.0; 31: SpO2, 97.322; 31: 1min HRV, 4.318; 32: HR, 124.552; 32: RR, 27.586; 32: SpO2, 97.552; 32: 1min HRV, 18.025; 33: HR, 125.746; 33: RR, 27.695; 33: SpO2, 97.610; 33: 1min HRV, 4.128; 33: 5min HRV, 9.856; 34: HR, 125.310; 34: RR, 27.845; 34: SpO2, 97.621; 34: 1min HRV, 4.438; 35: HR, 124.068; 35: RR, 25.729; 35: SpO2, 97.576; 35: 1min HRV, 5.781; 36: HR, 124.966; 36: RR, 25.814; 36: SpO2, 97.864; 36: 1min HRV, 6.834; 37: HR, 124.621; 37: RR, 23.603; 37: SpO2, 97.983; 37: 1min HRV, 6.626; 38: HR, 128.559; 38: RR, 27.322; 38: SpO2, 97.542; 38: 1min HRV, 11.386; 38: 5min HRV, 10.032; 38: ACETAMINOPHEN, 500 MG PO TABS; 39: HR:, 125.466; 39: RR, 23.931; 39: SpO2, 98.586; 39: 1min HRV, 13.072; 40: HR, 125.305; 40: RR, 18.831; 40: SpO2, 98.068; 40: Perf, 1.216; 40: 1min HRV, 22.549; 41: HR, 123.034; 41: RR, 23.966; 41: SpO2, 97.966; 41: Perf, 1.656; 41: 1min HRV, 10.291; 42: HR, 127.224; 42: RR, 23.828; 42: SpO2, 97.862; 42: Perf, 1.72; 42: 1min HRV, 8.718; 43: HR, 124.763; 43: RR, 24.034; 43: SpO2, 97.475; 43: Perf, 1.72; 43: 1min HRV, 5.967; 43: 5min HRV, 13.759; 44: HR, 123.293; 44: RR, 24.672; 44: SpO2, 97.121; 44: Perf, 1.72; 44: 1min HRV, 6.401; 44: SBP, 130.0; 44: DBP, 76.0; 44: MAP, 94.0; 45: HR, 123.475; 45: RR, 26.712; 45: SpO2, 97.237; 45: Perf, 1.72; 45: 1min HRV, 4.158; 46: HR, 123.492; 46: RR, 27.729; 46: SpO2, 97.305; 46: Perf, 1.72; 46: 1min HRV, 4.571; 47: HR, 125.310; 47: RR, 25.017; 47: SpO2, 97.5; 47: Perf, 1.72; 47: 1min HRV, 8.107; 48: HR, 122.814; 48: RR, 24.271; 48: SpO2, 97.831; 48: Perf, 1.72; 48: 1min HRV, 4.364; 48: 5min HRV, 6.794; 49: HR, 123.655; 49: RR, 24.121; 49: SpO2, 97.862; 49: Perf, 1.72; 49: 1min HRV, 4.398; 53: 5min HRV, 4.398; 57: ANTIBODY SCREEN 3, NEG; 57: ABO/RH (AUTOMATION), A Positive; 61: LR IV BOLUS -, 1000 ML; 62: INR:, 1.0; 62: PROTHROMBIN TIME, 13.3 seconds; 63: PART. THROMBOPLASTIN TIME, 36.0 seconds; 71: GLOBULIN, 2.3 g/dL; 71: CALCIUM, 9.5 mg/dL; 71: EGFR FOR AFRICAN AMERICAN, 111 mL/min/1.73 m2; 71: ALT (SGPT), 58 U/L; 71: BILIRUBIN TOTAL, 1.3 mg/dL; 71: CO2, 24 mmol/L; 71: ALKALINE PHOSPHATASE, 89 U/L; 71: AST (SGOT), 35 U/L; 71: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 71: PROTEIN TOTAL, 6.5 g/dL; 71: ALBUMIN, 4.2 g/dL; 71: GLUCOSE, 120 mg/dL; 71: CHLORIDE, 102 mmol/L; 71: POTASSIUM, 4.0 mmol/L; 71: ANION GAP, 11 mmol/L; 71: CREATININE, 0.79 mg/dL; 71: EGFR REFIT WITHOUT RACE (2021), 96 mL/min/1.73 m2; 71: SODIUM, 137 mmol/L; 71: CORRECTED CALCIUM, 9.3 mg/dL; 95: SARS-COV-2 RNA, Not Detected; 116: CEFEPIME, 2 GRAM/20 ML IV PUSH; 118: HR:, 111.0; 118: RR, 20.0; 118: SpO2, 98.0; 118: SBP, 116.0; 118: DBP, 71.0; 118: MAP, 86.0; 118: Temp, 99.5; 0: Age, 62; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.2; 0: Triage HR, 136.0; 0: Triage RR, 16.0; 0: Triage SBP, 122.0; 0: Triage DBP, 79.0; 0: Triage acuity, 2-Emergent; 0: CC, CHILLS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, evaluate vital signs, noting the elevated heart rate, respiratory rate, and fever that suggest infection or sepsis risk, but noticeably stable blood pressure and oxygen saturation. Next, review laboratory results, which show a normal lactate level, minimizing concern for sepsis. An overall assessment indicates potential infection but not imminent sepsis risk, as trends don't show the substantial worsening typically seen in high-risk sepsis scenarios, leading to a \"No\" label for high sepsis risk within 12 hours.",
        "claims": [
            "Evaluate the vital signs of the patient.",
            "The patient has an elevated heart rate.",
            "The patient has an elevated respiratory rate.",
            "The patient has a fever that suggests infection or sepsis risk.",
            "The patient's blood pressure is stable.",
            "The patient's oxygen saturation is stable.",
            "Review the laboratory results of the patient.",
            "The laboratory results show a normal lactate level.",
            "A normal lactate level minimizes concern for sepsis.",
            "An overall assessment indicates potential infection.",
            "The overall assessment does not indicate imminent sepsis risk.",
            "Trends do not show the substantial worsening typically seen in high-risk sepsis scenarios.",
            "The assessment leads to a \"No\" label for high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate.",
            "The patient has a fever that suggests infection or sepsis risk."
        ],
        "alignment_scores": [
            0.8,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is explicitly listed as one of the criteria under SIRS Positivity, which is used to identify systemic inflammation and potential early sepsis. The claim directly points to one aspect of the criteria, but since it doesn't specify the heart rate value or mention a second SIRS criterion, there is a slight drop from perfect alignment.",
            "The claim mentions fever, which is part of the SIRS criteria (temperature\u202f>\u202f38\u202f\u00b0C). Fever is a direct indicator of systemic inflammation and aligns with the early detection of sepsis as per the SIRS criteria. However, without additional SIRS criteria being met, the alignment is strong but not complete."
        ],
        "final_alignment_score": 0.75,
        "accuracy": 0
    },
    {
        "input": "3: HR, 113.0; 3: RR, 16.0; 3: SpO2, 99.0; 3: SBP, 100.0; 3: DBP, 53.0; 3: MAP, 68.667; 3: Pain, 9.0; 3: Temp, 97.7; 63: HR, 108.259; 63: RR, 23.222; 63: 1min HRV, 2.271; 64: HR, 107.390; 64: RR, 18.0; 64: SpO2, 98.5; 64: 1min HRV, 20.909; 65: HR, 104.797; 65: RR, 18.288; 65: SpO2, 99.0; 65: Perf, 0.282; 65: 1min HRV, 3.347; 66: HR, 104.569; 66: RR, 20.379; 66: SpO2, 99.589; 66: Perf, 0.233; 66: 1min HRV, 3.413; 66: 5min HRV, 13.865; 66: SBP, 99.0; 66: DBP, 60.0; 66: MAP, 73.0; 67: HR, 105.220; 67: RR, 20.559; 67: SpO2, 99.305; 67: Perf, 0.468; 67: 1min HRV, 3.043; 68: HR, 104.862; 68: RR, 17.431; 68: SpO2, 99.138; 68: Perf, 0.607; 68: 1min HRV, 19.816; 69: HR, 103.508; 69: RR, 17.339; 69: SpO2, 98.746; 69: Perf, 0.731; 69: 1min HRV, 5.278; 70: HR, 103.397; 70: RR, 18.759; 70: SpO2, 98.276; 70: Perf, 0.855; 70: 1min HRV, 4.453; 71: HR, 105.220; 71: RR, 16.814; 71: SpO2, 97.672; 71: Perf, 0.354; 71: 1min HRV, 3.284; 71: 5min HRV, 10.753; 72: HR, 106.254; 72: RR, 19.525; 72: SpO2, 98.0; 72: Perf, 0.328; 72: 1min HRV, 3.043; 73: HR, 105.086; 73: RR, 17.379; 73: SpO2, 97.966; 73: Perf, 0.460; 73: 1min HRV, 4.894; 74: HR, 105.169; 74: RR, 19.407; 74: SpO2, 98.475; 74: Perf, 0.698; 74: 1min HRV, 5.951; 75: HR, 103.897; 75: RR, 20.086; 75: SpO2, 98.431; 75: Perf, 0.831; 75: 1min HRV, 2.929; 76: HR, 101.593; 76: RR, 22.356; 76: SpO2, 98.115; 76: Perf, 0.738; 76: 1min HRV, 5.040; 76: 5min HRV, 10.054; 76: SBP, 99.0; 76: DBP, 60.0; 76: MAP, 73.0; 77: HR, 101.475; 77: RR, 23.559; 77: SpO2, 98.891; 77: Perf, 0.798; 77: 1min HRV, 7.057; 78: HR, 102.517; 78: RR, 18.845; 78: SpO2, 99.25; 78: Perf, 0.83; 78: 1min HRV, 6.585; 79: HR, 102.220; 79: RR, 18.034; 79: 1min HRV, 15.981; 80: HR, 101.448; 80: RR, 17.914; 80: 1min HRV, 3.591; 81: HR, 101.763; 81: RR, 19.525; 81: 1min HRV, 4.064; 81: 5min HRV, 9.065; 82: HR, 102.237; 82: RR, 19.847; 82: 1min HRV, 4.790; 82: SBP, 93.0; 82: DBP, 60.0; 82: MAP, 71.0; 83: HR, 103.759; 83: RR, 21.017; 83: 1min HRV, 2.918; 84: HR, 103.458; 84: RR, 22.153; 84: 1min HRV, 25.080; 85: HR, 102.741; 85: RR, 17.431; 85: 1min HRV, 3.035; 86: HR, 102.763; 86: RR, 20.508; 86: SpO2, 97.707; 86: 1min HRV, 16.972; 86: 5min HRV, 14.220; 87: HR, 102.932; 87: RR, 16.169; 87: SpO2, 96.898; 87: Perf, 0.732; 87: 1min HRV, 2.928; 88: HR, 102.310; 88: RR, 15.914; 88: SpO2, 97.379; 88: Perf, 0.589; 88: 1min HRV, 2.836; 89: HR, 101.136; 89: RR, 20.339; 89: SpO2, 96.407; 89: Perf, 0.467; 89: 1min HRV, 28.272; 90: HR, 102.690; 90: RR, 18.552; 90: SpO2, 97.052; 90: Perf, 0.338; 90: 1min HRV, 2.962; 91: HR, 102.186; 91: RR, 20.288; 91: SpO2, 97.789; 91: Perf, 0.322; 91: 1min HRV, 2.993; 91: 5min HRV, 13.305; 92: HR, 101.017; 92: RR, 19.271; 92: SpO2, 97.741; 92: Perf, 0.298; 92: 1min HRV, 3.328; 93: HR, 100.914; 93: RR, 20.259; 93: SpO2, 98.328; 93: Perf, 0.307; 93: 1min HRV, 4.303; 94: HR, 100.254; 94: RR, 19.305; 94: SpO2, 98.542; 94: Perf, 0.392; 94: 1min HRV, 16.879; 95: BLOOD UREA NITROGEN (BUN), 44 mg/dL; 95: EGFR REFIT WITHOUT RACE (2021), 22 mL/min/1.73 m2; 95: AST (SGOT), 66 U/L; 95: SODIUM, 130 mmol/L; 95: ANION GAP, 18 mmol/L; 95: CO2, 24 mmol/L; 95: ALKALINE PHOSPHATASE, 67 U/L; 95: ALT (SGPT), 19 U/L; 95: CREATININE, 2.50 mg/dL; 95: CHLORIDE, 88 mmol/L; 95: GLOBULIN, 5.0 g/dL; 95: PROTEIN TOTAL, 8.7 g/dL; 95: POTASSIUM, 5.6 mmol/L; 95: CALCIUM, 9.9 mg/dL; 95: CORRECTED CALCIUM, 10.1 mg/dL; 95: BILIRUBIN TOTAL, 0.5 mg/dL; 95: ALBUMIN, 3.7 g/dL; 95: GLUCOSE, 158 mg/dL; 95: HR, 100.638; 95: RR, 20.466; 95: SpO2, 99.0; 95: Perf, 0.416; 95: 1min HRV, 8.345; 96: SARS-COV-2 RNA, Not Detected; 96: HR, 100.288; 96: RR, 17.864; 96: SpO2, 99.169; 96: Perf, 0.434; 96: 1min HRV, 7.287; 96: 5min HRV, 9.559; 96: Pain, 10.0; 97: HR, 97.322; 97: RR, 15.288; 97: SpO2, 99.339; 97: Perf, 0.489; 97: 1min HRV, 6.903; 98: HR, 95.603; 98: RR, 12.103; 98: SpO2, 98.121; 98: Perf, 0.430; 98: 1min HRV, 5.772; 99: HR, 97.0; 99: RR, 14.576; 99: SpO2, 97.356; 99: Perf, 0.417; 99: 1min HRV, 27.925; 100: HR, 95.448; 100: RR, 18.810; 100: SpO2, 98.241; 100: Perf, 0.445; 100: 1min HRV, 7.272; 101: HR, 96.712; 101: RR, 21.085; 101: SpO2, 98.0; 101: Perf, 0.409; 101: 1min HRV, 5.961; 101: 5min HRV, 14.265; 102: HR, 96.845; 102: RR, 18.397; 102: SpO2, 98.948; 102: Perf, 0.392; 102: 1min HRV, 5.895; 103: HR, 95.492; 103: RR, 19.153; 103: SpO2, 98.814; 103: Perf, 0.334; 103: 1min HRV, 5.351; 104: HR, 95.305; 104: RR, 19.644; 104: SpO2, 98.780; 104: Perf, 0.324; 104: 1min HRV, 8.790; 105: HR, 94.190; 105: RR, 18.190; 105: SpO2, 99.475; 105: Perf, 0.292; 105: 1min HRV, 3.851; 106: HR, 95.220; 106: RR, 18.983; 106: SpO2, 99.282; 106: Perf, 0.21; 106: 1min HRV, 7.364; 106: 5min HRV, 8.084; 107: HR, 92.397; 107: RR, 20.379; 107: SpO2, 99.394; 107: Perf, 0.216; 107: 1min HRV, 8.601; 108: HR, 92.254; 108: RR, 16.695; 108: SpO2, 98.947; 108: Perf, 0.201; 108: 1min HRV, 8.056; 108: MORPHINE, 4 MG/ML IV SYRG; 109: HR:, 92.678; 109: RR, 18.356; 109: SpO2, 98.814; 109: Perf, 0.276; 109: 1min HRV, 9.551; 110: HR, 93.259; 110: RR, 19.069; 110: SpO2, 97.509; 110: Perf, 0.314; 110: 1min HRV, 5.623; 111: HR, 93.763; 111: RR, 19.864; 111: SpO2, 98.807; 111: Perf, 0.306; 111: 1min HRV, 5.628; 111: 5min HRV, 8.911; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 95.345; 112: RR, 19.483; 112: SpO2, 98.879; 112: Perf, 0.294; 112: 1min HRV, 6.629; 112: SBP, 79.0; 112: DBP, 59.0; 112: MAP, 65.667; 113: HR, 95.373; 113: RR, 18.051; 113: SpO2, 99.356; 113: Perf, 0.352; 113: 1min HRV, 6.753; 114: HR, 93.881; 114: RR, 19.763; 114: SpO2, 99.407; 114: Perf, 0.336; 114: 1min HRV, 7.098; 115: HR, 93.741; 115: RR, 18.879; 115: SpO2, 98.912; 115: Perf, 0.289; 115: 1min HRV, 7.738; 116: HR, 94.119; 116: RR, 17.847; 116: SpO2, 99.0; 116: Perf, 0.26; 116: 1min HRV, 8.469; 116: 5min HRV, 9.063; 117: HR, 91.983; 117: RR, 20.207; 117: SpO2, 99.316; 117: Perf, 0.245; 117: 1min HRV, 6.011; 118: HR, 92.186; 118: RR, 18.119; 118: SpO2, 100.0; 118: Perf, 0.156; 118: 1min HRV, 7.891; 119: HR, 94.458; 119: RR, 18.220; 119: SpO2, 100.0; 119: Perf, 0.13; 119: 1min HRV, 23.407; 119: SBP, 84.0; 119: DBP, 53.0; 119: MAP, 63.333; 0: Age, 59; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 113.0; 0: Triage RR, 16.0; 0: Triage SBP, 100.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The patient shows signs of potential sepsis risk, such as persistently high heart rate (HR exceeds 100 bpm initially and barely falls below through the observations), elevated respiratory rate, low diastolic and systolic blood pressures (as low as 53 and 84, respectively), low mean arterial pressures (MAP around 63.333 at one point), and an initially high pain score. Additionally, the recorded creatinine and blood urea nitrogen (BUN) levels indicate potential kidney impairment, which can be linked to sepsis. These factors collectively suggest that the patient is at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The patient shows signs of potential sepsis risk.",
            "The patient's heart rate exceeds 100 bpm initially.",
            "The patient's heart rate barely falls below 100 bpm through the observations.",
            "The patient has an elevated respiratory rate.",
            "The patient's diastolic blood pressure is as low as 53.",
            "The patient's systolic blood pressure is as low as 84.",
            "The patient's mean arterial pressure (MAP) is around 63.333 at one point.",
            "The patient has an initially high pain score.",
            "The recorded creatinine levels indicate potential kidney impairment.",
            "The recorded blood urea nitrogen (BUN) levels indicate potential kidney impairment.",
            "Potential kidney impairment can be linked to sepsis.",
            "These factors suggest that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient shows signs of potential sepsis risk.",
            "The patient's heart rate exceeds 100 bpm initially.",
            "The patient's heart rate barely falls below 100 bpm through the observations.",
            "The patient has an elevated respiratory rate.",
            "The patient's diastolic blood pressure is as low as 53.",
            "The patient's systolic blood pressure is as low as 84.",
            "The patient's mean arterial pressure (MAP) is around 63.333 at one point.",
            "The patient has an initially high pain score.",
            "The recorded creatinine levels indicate potential kidney impairment.",
            "The recorded blood urea nitrogen (BUN) levels indicate potential kidney impairment.",
            "Potential kidney impairment can be linked to sepsis.",
            "These factors suggest that the patient is at high risk of developing sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.3,
            0.8,
            0.5,
            1.0,
            0.9,
            0.3,
            0.8,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated NEWS Score (\u22655 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim generally indicates suspicion of sepsis risk but lacks specific details related to vitals, clinical scores, or actions. The category of Early Antibiotic/Culture Orders might fit because it involves a proactive response to sepsis suspicion, but without further details about clinical actions or specific indicators, the alignment is weak.",
            "The heart rate exceeding 100 bpm satisfies one of the criteria for SIRS, which uses heart rate >90 bpm as a measure. This closely aligns with the conditions described in the SIRS category, though by itself, it does not fulfill the requirement of having \u22652 SIRS criteria. Therefore, the alignment is strong but not complete, leading to a 0.8 rating.",
            "The claim mentions the patient's heart rate being barely below 100 bpm, which can be relevant to the heart rate component in the Shock Index calculation (heart\u202frate\u202f\u00f7\u202fsystolic\u202fBP). While an elevated heart rate contributes to a higher Shock Index, the claim does not provide sufficient information about the systolic BP needed for full assessment. Consequently, this implies a weak alignment with the Elevated Shock Index category.",
            "An elevated respiratory rate is explicitly part of the SIRS criteria (respiratory rate\u202f>\u202f20\u202f/min), which identifies systemic inflammation consistent with early sepsis. As the claim clearly aligns with one of these criteria, the rating is high but not perfect because we don't know if other criteria are met for SIRS positivity.",
            "The claim references a low diastolic blood pressure, which may suggest hemodynamic instability and possible sepsis-associated hypotension. Although the claim does not provide the systolic blood pressure or mean arterial pressure (MAP) to directly meet the sepsis-associated hypotension criteria, the low diastolic value indicates potential hypotension. This partial alignment justifies a moderate rating.",
            "The claim explicitly states that the patient's systolic blood pressure (SBP) is 84 mmHg, which is directly below the identified threshold of 90 mmHg for sepsis-associated hypotension. This condition is a clear indicator of progression toward septic shock, making the alignment perfect.",
            "The claim mentions a MAP of 63.333, which is below the threshold of 70 mmHg for sepsis-associated hypotension according to the expert categories. This indicates a strong alignment, as a MAP less than 70 mmHg is a critical marker in the progression toward septic shock. The alignment is not perfect (1.0) due to the phrasing \"around 63.333,\" which implies some uncertainty or fluctuation but still strongly suggests hypotension.",
            "An elevated pain score by itself is not directly associated with the criteria listed in any expert categories. However, pain can contribute indirectly to the National Early Warning Score (NEWS) if it is part of a broader clinical deterioration. The alignment is weak because the pain score alone does not quantify into the NEWS score nor points explicitly to sepsis-related deterioration without additional context.",
            "Creatinine is a specific component of the SOFA score, where a level >2 mg/dL indicates organ dysfunction related to the kidneys, supporting sepsis risk. While the claim doesn't provide the exact level to confirm a \u22652-point increase, the mention of kidney impairment strongly suggests relevance to this category. Thus, the alignment is strong but not absolute due to missing specifics.",
            "Kidney impairment is related to the SOFA score through renal function, typically assessed via creatinine levels. While blood urea nitrogen (BUN) is not specifically listed in the SOFA criteria, it is indicative of kidney function issues, which aligns with SOFA's emphasis on organ dysfunction. The alignment is reasonably strong but not direct, as BUN is not a specific SOFA measure.",
            "Kidney impairment can lead to a rise in creatinine levels, which is a criterion under the SOFA score. This association with organ dysfunction is significant for sepsis risk prediction. Although the claim doesn't reference a specific creatinine level change, the link to potential kidney impairment suggests meaningful alignment with the SOFA category. The absence of quantitative details slightly reduces the alignment rating.",
            "The claim suggests an overall assessment of high risk for developing sepsis imminently, which is conceptually aligned with the use of clinical scoring systems like NEWS to predict clinical deterioration. However, the claim provides no specific information about vital signs or scores, making the direct connection weak. The alignment is predominantly indirect and assumes the use of a comprehensive clinical assessment."
        ],
        "final_alignment_score": 0.6166666666666667,
        "accuracy": 1
    },
    {
        "input": "14: HR, 142.0; 14: RR, 20.0; 14: SpO2, 94.0; 14: SBP, 105.0; 14: DBP, 72.0; 14: MAP, 83.0; 14: Pain, 0.0; 14: Temp, 97.9; 36: POC PH (V) ISTAT, 7.30; 36: POC LACTATE ISTAT, 1.08 mmol/L; 36: POC TCO2 (V) ISTAT, 27 mmol/L; 36: POC HCO3 (V) ISTAT, 25.2 mmol/L; 36: POC PCO2 (V) ISTAT, 51.6 mmHg; 36: POC PO2 (V) ISTAT, 29 mmHg; 36: POC BASE EXCESS ISTAT, -1 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 48 %; 37: HR, 126.719; 37: RR, 25.732; 37: 1min HRV, 13.425; 37: SBP, 121.0; 37: DBP, 73.0; 37: MAP, 89.0; 37: LR IV BOLUS -, 1000 ML; 38: HR:, 126.638; 38: RR, 22.397; 38: SpO2, 96.0; 38: 1min HRV, 14.436; 38: SBP, 121.0; 38: DBP, 73.0; 38: MAP, 89.0; 39: HR, 129.441; 39: RR, 16.407; 39: 1min HRV, 10.516; 40: HR, 126.203; 40: RR, 19.780; 40: 1min HRV, 21.605; 40: 5min HRV, 16.186; 41: HR, 124.534; 41: RR, 19.672; 41: 1min HRV, 15.972; 42: HR, 124.169; 42: RR, 23.763; 42: 1min HRV, 13.252; 42: Pain, 6.0; 43: HR, 121.569; 43: RR, 16.466; 43: 1min HRV, 23.672; 44: HR, 122.220; 44: RR, 19.169; 44: 1min HRV, 26.307; 45: HR, 120.678; 45: RR, 19.627; 45: SpO2, 96.0; 45: 1min HRV, 16.388; 45: 5min HRV, 20.748; 45: SBP, 114.0; 45: DBP, 88.0; 45: MAP, 96.667; 46: HR, 117.397; 46: RR, 17.362; 46: 1min HRV, 21.886; 46: SBP, 114.0; 46: DBP, nan; 46: MAP, nan; 47: HR, 115.661; 47: RR, 17.085; 47: 1min HRV, 45.698; 48: HR, 120.776; 48: RR, 20.293; 48: 1min HRV, 21.509; 49: HR, 119.339; 49: RR, 20.898; 49: 1min HRV, 19.138; 50: HR, 117.356; 50: RR, 19.220; 50: 1min HRV, 21.795; 50: 5min HRV, 28.716; 51: HR, 116.655; 51: RR, 17.638; 51: 1min HRV, 40.855; 52: HR, 116.390; 52: RR, 19.119; 52: 1min HRV, 20.976; 53: HR, 114.414; 53: RR, 21.828; 53: 1min HRV, 22.699; 54: HR, 111.559; 54: RR, 20.797; 54: 1min HRV, 23.915; 55: HR, 112.424; 55: RR, 20.881; 55: 1min HRV, 37.342; 55: 5min HRV, 31.574; 56: HR, 113.276; 56: RR, 17.328; 56: 1min HRV, 19.370; 57: HR, 110.576; 57: RR, 20.203; 57: 1min HRV, 38.104; 58: HR, 105.931; 58: RR, 22.845; 58: 1min HRV, 14.892; 59: HR, 107.576; 59: RR, 23.864; 59: 1min HRV, 16.178; 60: HR, 109.724; 60: RR, 23.914; 60: 1min HRV, 33.069; 60: 5min HRV, 29.141; 61: HR, 109.492; 61: RR, 21.271; 61: 1min HRV, 36.478; 62: HR, 107.949; 62: RR, 23.068; 62: 1min HRV, 28.136; 63: HR, 109.397; 63: RR, 25.552; 63: 1min HRV, 31.885; 64: HR, 105.881; 64: RR, 21.712; 64: 1min HRV, 45.909; 65: HR, 105.052; 65: RR, 20.966; 65: 1min HRV, 35.182; 65: 5min HRV, 37.445; 66: HR, 107.271; 66: RR, 23.085; 66: 1min HRV, 36.498; 67: HR, 103.695; 67: RR, 20.864; 67: 1min HRV, 40.807; 68: POC HGB (CALC) ISTAT, 17.7 g/dL; 68: POC HCT ISTAT, 52 %; 68: POC POTASSIUM ISTAT, 7.0 mmol/L; 68: POC SODIUM ISTAT, 128 mmol/L; 68: POC GLUCOSE ISTAT, 97 mg/dL; 68: HR, 102.897; 68: RR, 21.103; 68: 1min HRV, 42.232; 69: WAM DIFTYP, AUTO; 69: MEAN CORPUSCULAR VOLUME (MCV), 85.0 fL; 69: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 69: RED CELL DISTRIBUTION WIDTH (RDW), 14.6 %; 69: HEMATOCRIT (HCT), 54.4 %; 69: BASOPHIL % (AUTO DIFF), 0.6 %; 69: LYMPHOCYTE % (AUTO DIFF), 12.2 %; 69: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.58 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.1 pg; 69: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 69: RED BLOOD CELLS (RBC), 6.40 MIL/uL; 69: NRBC PERCENT (HEMATOLOGY), 0.0 %; 69: HEMOGLOBIN (HGB), 18.6 g/dL; 69: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 69: EOSINOPHIL % (AUTO DIFF), 1.6 %; 69: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.09 K/uL; 69: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.2 g/dL; 69: MONOCYTE ABSOLUTE (AUTO DIFF), 1.42 K/uL; 69: MONOCYTE % (AUTO DIFF), 8.0 %; 69: PLATELET COUNT (PLT), 520 K/uL; 69: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.16 K/uL; 69: NEUTROPHIL % (AUTO DIFF), 77.1 %; 69: BASOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 69: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.28 K/uL; 69: HR, 106.203; 69: RR, 22.695; 69: 1min HRV, 24.347; 70: 5min HRV, 38.258; 78: CALCIUM GLUC IN NACL ISO-OSM, 1 GRAM/50 ML IV SOLN; 82: HIGH SENSITIVITY TROPONIN: <, 4 ng/L; 94: INFLUENZA A, Not Detected; 94: RSV, Not Detected; 94: SARS-COV-2 RNA, Not Detected; 94: INFLUENZA B, Not Detected; 98: RR, 23.0; 98: SpO2, 97.0; 98: LPM O2, 15.0; 98: ALBUTEROL CONTINUOUS NEBULIZER SOLUTION, 15 MG/HR (RT MIXTURE); 116: POC GLUCOSE BY METER:, 88 mg/dL; 119: DEXTROSE, 20 % IN WATER (D20W) IVPB BOLUS; 0: Age:, 18; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 142.0; 0: Triage RR, 20.0; 0: Triage SBP, 105.0; 0: Triage DBP, 72.0; 0: Triage acuity, 2-Emergent; 0: CC, RAPID HEART RATE",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess the patient's sepsis risk, I first evaluated key vitals and lab results indicating potential sepsis. The initial heart rate (HR) was very high at 142 bpm along with low SpO2 at 94%, which persists with tachycardia and relative hypotension (even after fluid bolus). In labs, the abnormal values such as elevated WBC (17.6 K/uL), increased Neutrophil percentage (77.1%), low-sodium level (128 mmol/L), and elevated potassium (7.0 mmol/L), along with ongoing respiratory issues and significant IV fluid administration, suggest high sepsis risk. The persistence of tachycardia, relative hypotension, and those lab abnormalities indicate significant systemic stress suggestive of developing sepsis.",
        "claims": [
            "To assess the patient's sepsis risk, key vitals and lab results were evaluated.",
            "The initial heart rate (HR) was very high at 142 bpm.",
            "A heart rate of 142 bpm is considered very high.",
            "The SpO2 was low at 94%.",
            "A SpO2 level of 94% indicates a concern for oxygen saturation.",
            "Tachycardia is present in the patient.",
            "Relative hypotension is observed even after fluid bolus administration.",
            "Lab results showed an elevated white blood cell (WBC) count of 17.6 K/uL.",
            "An increased Neutrophil percentage of 77.1% was noted in the lab results.",
            "The sodium level was low at 128 mmol/L.",
            "Potassium levels were elevated at 7.0 mmol/L.",
            "Ongoing respiratory issues are occurring in the patient.",
            "The patient has received significant IV fluid administration.",
            "The collected data suggests a high risk of sepsis.",
            "The persistence of tachycardia and relative hypotension indicates significant systemic stress.",
            "The lab abnormalities suggest the patient may be developing sepsis."
        ],
        "relevant_claims": [
            "To assess the patient's sepsis risk, key vitals and lab results were evaluated.",
            "The initial heart rate (HR) was very high at 142 bpm.",
            "A heart rate of 142 bpm is considered very high.",
            "The SpO2 was low at 94%.",
            "A SpO2 level of 94% indicates a concern for oxygen saturation.",
            "Tachycardia is present in the patient.",
            "Relative hypotension is observed even after fluid bolus administration.",
            "Lab results showed an elevated white blood cell (WBC) count of 17.6 K/uL.",
            "An increased Neutrophil percentage of 77.1% was noted in the lab results.",
            "The sodium level was low at 128 mmol/L.",
            "Potassium levels were elevated at 7.0 mmol/L.",
            "Ongoing respiratory issues are occurring in the patient.",
            "The patient has received significant IV fluid administration.",
            "The persistence of tachycardia and relative hypotension indicates significant systemic stress.",
            "The lab abnormalities suggest the patient may be developing sepsis."
        ],
        "alignment_scores": [
            0.5,
            0.6,
            1.0,
            0.5,
            0.5,
            0.8,
            0.9,
            1.0,
            0.5,
            0.2,
            0.3,
            0.5,
            0.3,
            0.7,
            0.4
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Shock Index (\u22651.0)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "Evaluating key vitals and lab results is a general action relevant to both NEWS and other risk scores. While it does not specifically indicate a NEWS score, the NEWS system relies heavily on vital signs for assessment. Therefore, there is a moderate alignment with the concept of using observations to predict clinical deterioration, characteristic of the NEWS.",
            "A heart rate of 142 bpm is significantly high, which could denote haemodynamic instability, particularly when evaluated with blood pressure in the shock index. However, since the claim does not provide systolic blood pressure (necessary for shock index calculation), the alignment is indirect, but the high HR is suggestive of potential instability related to shock.",
            "A heart rate of 142 bpm exceeds the SIRS criterion of heart rate > 90 bpm, which is directly indicative of systemic inflammation and consistent with early sepsis. The claim explicitly addresses an aspect of SIRS criteria, resulting in perfect alignment.",
            "A low SpO2 of 94% suggests potential hypoxemia, related to impaired oxygenation. Although SpO2 is not directly a SOFA measure, the conceptual link to respiratory dysfunction aligns partially with the criteria for SOFA, which assesses respiratory function. Thus, the alignment is moderate but not precise.",
            "SpO2 level isn't a direct measure in the SOFA score, but it relates to oxygenation, which is monitored in the SOFA scoring (e.g., PaO\u2082/FiO\u2082 ratio). A SpO2 of 94% indicates mild hypoxia, suggesting possible respiratory dysfunction, hence its indirect but limited alignment with SOFA components.",
            "Tachycardia (heart rate > 90 bpm) is one of the criteria for SIRS positivity, which signals systemic inflammation consistent with early sepsis. The claim is directly aligned with one of the listed SIRS criteria, corresponding to sepsis prediction. It strongly correlates with the category, though it is just one of the necessary \u22652 criteria for full SIRS positivity.",
            "The claim describes \"relative hypotension\" even after fluid resuscitation, which is closely related to sepsis-associated hypotension. The persistence of hypotension after a fluid bolus suggests progressing septic shock, making the alignment with the category very strong. However, the claim doesn't specify exact blood pressure values or drops from baseline, preventing a perfect score.",
            "An elevated white blood cell count (WBC > 12,000/\u00b5L) is explicitly one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The WBC count of 17.6 K/uL directly meets this SIRS criterion, which aligns perfectly with the category.",
            "An increased neutrophil percentage often indicates an inflammatory or infectious process, which can be relevant for SIRS, as the SIRS criteria include elevated white blood cell count or abnormal differential count. While not explicitly listed, the claim has moderate relevance as increased neutrophils suggest systemic inflammation.",
            "A low sodium level (hyponatremia) is not directly aligned with any sepsis categories, especially SOFA criteria. However, electrolyte imbalances can indicate multi-organ dysfunction and metabolic disturbances related to severe illness, which marginally aligns with the concept of organ dysfunction in SOFA. Hence, the alignment is weak.",
            "Elevated potassium levels are not directly measured by the SOFA score but can indicate renal dysfunction, which influences SOFA assessment (e.g., increased creatinine levels). While it's not an exact match, it relates to organ dysfunction, suggesting a potential increase in the SOFA score. This results in a low but meaningful alignment.",
            "The claim refers to ongoing respiratory issues, which could relate to an elevated respiratory rate, a direct criterion of the qSOFA score. While the correlation is indirect and lacks specific details (e.g., precise respiratory rate), respiratory concerns are relevant to qSOFA, which assesses sepsis risk through criteria, including respiratory rate. The rating reflects this partial alignment and the need for more specific data to fully meet the criteria.",
            "Significant IV fluid administration is frequently used to treat or prevent hypotension, a known complication in sepsis. Although the claim doesn't specify hypotension directly, it suggests management of potential circulatory instability, which aligns with the Sepsis-Associated Hypotension category. The correlation is indirect, hence a moderate alignment rating.",
            "The claim refers to tachycardia and relative hypotension, elements that align well with the concept of an elevated shock index (heart rate \u00f7 systolic BP) \u2265 1.0, which denotes hemodynamic instability. While it doesn't provide specific values to calculate the shock index, the persistence of these symptoms suggests systemic stress compatible with an elevated shock index, making the alignment notable but not exact without numerical data.",
            "The claim mentions \"lab abnormalities,\" which could indicate changes in laboratory values used to assess organ dysfunction (e.g., PaO\u2082/FiO\u2082, platelets, bilirubin, creatinine) in the SOFA score context. However, without specific abnormal values mentioned, the alignment is circumstantial and not direct. Hence, a moderate alignment rating reflects this indirect connection."
        ],
        "final_alignment_score": 0.5800000000000001,
        "accuracy": 1
    },
    {
        "input": "8: HR, 70.0; 8: RR, 18.0; 8: SpO2, 100.0; 8: SBP, 159.0; 8: DBP, 83.0; 8: MAP, 108.333; 12: Pain, 9.0; 33: SpO2, 100.0; 34: HR, 82.0; 34: RR, 20.0; 34: SpO2, 100.0; 34: Perf, 1.700; 34: SBP, 138.0; 34: DBP, 81.0; 34: MAP, 100.0; 34: Temp, 97.9; 35: SpO2, 100.0; 35: Perf, 2.154; 36: SpO2, 100.0; 36: Perf, 2.221; 37: SpO2, 100.0; 37: Perf, 1.998; 38: SpO2, 100.0; 38: Perf, 1.810; 39: SpO2, 100.0; 39: Perf, 1.716; 40: SpO2, 99.915; 40: Perf, 1.645; 41: SpO2, 99.627; 41: Perf, 1.527; 42: SpO2, 99.897; 42: Perf, 1.582; 43: SpO2, 99.424; 43: Perf, 1.827; 44: HR, 80.0; 44: RR, 22.0; 44: SpO2, 99.328; 44: Perf, 1.891; 44: SBP, 159.0; 44: DBP, 92.0; 44: MAP, 114.333; 44: Pain, 9.0; 45: SpO2, 99.492; 45: Perf, 1.696; 45: SBP, 159.0; 45: DBP, 92.0; 45: MAP, 114.333; 46: SpO2, 99.898; 46: Perf, 1.302; 47: SpO2, 99.895; 47: Perf, 1.316; 48: SpO2, 100.0; 48: Perf, 1.239; 49: SpO2, 100.0; 49: Perf, 1.162; 50: SpO2, 99.932; 50: Perf, 1.170; 51: SpO2, 100.0; 51: Perf, 1.271; 52: SpO2, 100.0; 52: Perf, 1.272; 53: SpO2, 99.898; 53: Perf, 1.299; 54: POC, HCG, ISTAT QUALITATIVE: Negative; 54: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 54: SpO2, 99.914; 54: Perf, 1.518; 55: SpO2, 99.881; 55: Perf, 1.807; 56: SpO2, 99.776; 56: Perf, 1.771; 57: SpO2, 100.0; 57: Perf, 1.647; 58: SpO2, 100.0; 58: Perf, 1.594; 59: SpO2, 99.879; 59: Perf, 1.747; 60: SpO2, 99.814; 60: Perf, 1.711; 61: SpO2, 99.879; 61: Perf, 1.805; 62: SpO2, 99.831; 62: Perf, 2.869; 63: SpO2, 99.881; 63: Perf, 2.230; 64: SpO2, 100.0; 64: Perf, 1.868; 65: SpO2, 100.0; 65: Perf, 1.737; 66: SpO2, 100.0; 66: Perf, 1.750; 67: SpO2, 100.0; 67: Perf, 2.172; 68: SpO2, 99.475; 68: Perf, 3.406; 69: SpO2, 99.776; 69: Perf, 2.376; 70: SpO2, 99.593; 70: Perf, 1.955; 71: SpO2, 100.0; 71: Perf, 3.23; 72: SpO2, 99.288; 72: Perf, 7.179; 73: SpO2, 99.525; 73: Perf, 5.067; 74: SpO2, 98.741; 74: Perf, 1.804; 75: SpO2, 98.797; 75: Perf, 1.396; 76: SpO2, 99.0; 76: Perf, 1.391; 77: SpO2, 98.586; 77: Perf, 1.382; 78: SpO2, 98.458; 78: Perf, 1.414; 78: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 78: ACETAMINOPHEN 1,000 MG/100 ML (10 MG/ML) IV SOLN; 79: WAM DIFTYP, AUTO; 79: RED CELL DISTRIBUTION WIDTH (RDW), 18.6 %; 79: LYMPHOCYTE % (AUTO DIFF), 8.2 %; 79: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 79: PLATELET COUNT (PLT), 238 K/uL; 79: MONOCYTE ABSOLUTE (AUTO DIFF), 0.91 K/uL; 79: BASOPHIL % (AUTO DIFF), 0.8 %; 79: HEMOGLOBIN (HGB), 13.2 g/dL; 79: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 24.9 pg; 79: BASOPHIL ABSOLUTE (AUTO DIFF), 0.13 K/uL; 79: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 79: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 79: EOSINOPHIL % (AUTO DIFF), 0.1 %; 79: NRBC PERCENT (HEMATOLOGY), 0.0 %; 79: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 79: MEAN CORPUSCULAR VOLUME (MCV), 83.1 fL; 79: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 79: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 79: WHITE BLOOD CELLS (WBC), 16.9 K/uL; 79: MONOCYTE % (AUTO DIFF), 5.4 %; 79: HEMATOCRIT (HCT), 44.1 %; 79: RED BLOOD CELLS (RBC), 5.31 MIL/uL; 79: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.42 K/uL; 79: NEUTROPHIL % (AUTO DIFF), 85.0 %; 79: SpO2, 99.897; 79: Perf, 1.471; 79: KETOROLAC, 30 MG/ML (1 ML) INJ SOLN; 79: LR IV BOLUS -, 1000 ML; 80: SpO2, 99.864; 80: Perf, 1.835; 81: SpO2, 98.345; 81: Perf, 1.771; 82: SpO2, 98.356; 82: Perf, 1.736; 83: SpO2, 99.621; 83: Perf, 1.849; 84: SpO2, 99.475; 84: Perf, 1.761; 85: SpO2, 100.0; 85: Perf, 1.923; 86: SpO2, 99.707; 86: Perf, 1.697; 87: SpO2, 99.0; 87: Perf, 1.564; 88: SpO2, 99.0; 88: Perf, 1.585; 89: SpO2, 98.831; 89: Perf, 1.430; 90: INFLUENZA A, Not Detected; 90: SARS-COV-2 RNA, Not Detected; 90: RSV, Not Detected; 90: INFLUENZA B, Not Detected; 90: SpO2, 99.322; 90: Perf, 1.201; 91: SpO2, 99.845; 91: Perf, 1.121; 92: SpO2, 98.729; 92: Perf, 1.032; 93: SpO2, 98.276; 93: Perf, 1.166; 94: SpO2, 98.966; 94: Perf, 1.158; 95: SpO2, 98.712; 95: Perf, 1.161; 96: SpO2, 97.772; 96: Perf, 1.171; 97: SpO2, 99.068; 97: Perf, 1.172; 98: SpO2, 98.879; 98: Perf, 1.252; 99: SpO2, 98.695; 99: Perf, 1.220; 100: SpO2, 98.407; 100: Perf, 1.230; 101: SpO2, 99.0; 101: Perf, 1.339; 102: SpO2, 99.0; 102: Perf, 1.359; 103: SpO2, 99.0; 103: Perf, 1.370; 104: SpO2, 99.0; 104: Perf, 1.355; 105: SpO2, 99.0; 105: Perf, 1.396; 106: SpO2, 99.0; 106: Perf, 1.319; 107: SpO2, 99.0; 107: Perf, 1.301; 108: SpO2, 98.948; 108: Perf, 1.274; 109: SpO2, 99.0; 109: Perf, 1.318; 110: SpO2, 99.0; 110: Perf, 1.316; 111: SpO2, 99.0; 111: Perf, 1.387; 112: LIPASE, 22 U/L; 112: SpO2, 99.0; 112: Perf, 1.382; 113: SpO2, 99.0; 113: Perf, 1.321; 114: SpO2, 99.0; 114: Perf, 1.407; 115: SpO2, 99.0; 115: Perf, 1.360; 116: SpO2, 99.103; 116: Perf, 1.299; 117: SpO2, 99.576; 117: Perf, 1.475; 118: HR, 83.786; 118: SpO2, 99.517; 118: Perf, 1.436; 118: 1min HRV, 62.269; 119: HR, 83.746; 119: RR, 22.0; 119: SpO2, 99.610; 119: Perf, 1.606; 119: 1min HRV, 55.335; 119: 5min HRV, 60.184; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 70.0; 0: Triage RR, 18.0; 0: Triage SBP, 159.0; 0: Triage DBP, 83.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The primary indicators for sepsis risk include abnormal vital signs such as heart rate, respiratory rate, blood pressure, and temperature, along with altered mental status, high pain levels, and specific lab results indicating infection or organ dysfunction. In this case, the patient's vital signs remain relatively stable, with no indications of fever or hypothermia, no significant hypoxia (low SpO2), and stable perfusion. Additionally, while WBC count is elevated (16.9 K/uL), which can indicate infection, other laboratory markers or clinical symptoms suggesting sepsis are not evident. Importantly, the consistently high SpO2 and lack of declining vital signs support a classification of \"No\" for high sepsis risk in the next 12 hours.",
        "claims": [
            "The primary indicators for sepsis risk include abnormal vital signs.",
            "Abnormal vital signs consist of heart rate, respiratory rate, blood pressure, and temperature.",
            "Altered mental status is also an indicator for sepsis risk.",
            "High pain levels can indicate sepsis risk.",
            "Specific lab results indicating infection or organ dysfunction are relevant for sepsis risk assessment.",
            "The patient's vital signs remain relatively stable.",
            "The patient shows no indications of fever.",
            "The patient shows no indications of hypothermia.",
            "The patient shows no significant hypoxia, as indicated by SpO2 levels.",
            "The patient's perfusion is stable.",
            "The patient's WBC count is elevated at 16.9 K/uL.",
            "An elevated WBC count can indicate infection.",
            "Other laboratory markers suggesting sepsis are not evident in this case.",
            "Clinical symptoms suggesting sepsis are not evident in this case.",
            "The consistently high SpO2 supports a classification of \"No\" for high sepsis risk.",
            "There is a lack of declining vital signs in this patient.",
            "The patient is classified as \"No\" for high sepsis risk in the next 12 hours."
        ],
        "relevant_claims": [
            "The patient shows no indications of fever.",
            "The patient shows no significant hypoxia, as indicated by SpO2 levels.",
            "The patient's WBC count is elevated at 16.9 K/uL.",
            "An elevated WBC count can indicate infection.",
            "Other laboratory markers suggesting sepsis are not evident in this case.",
            "Clinical symptoms suggesting sepsis are not evident in this case."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            1.0,
            0.9,
            0.3,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The absence of fever relates to SIRS criteria, as fever (>38\u00b0C) or hypothermia (<36\u00b0C) are part of them. However, the claim only addresses the lack of one aspect of SIRS without any other criteria being mentioned. The alignment is weak because it negates a potential indicator of systemic inflammation rather than confirming a risk factor.",
            "The claim mentions SpO2 levels, which relate to oxygenation status. While SpO2 itself is not part of the SOFA score, oxygenation (PaO\u2082/FiO\u2082) is a relevant factor. The absence of hypoxia suggests stable oxygenation, indirectly touching upon the SOFA criteria for respiratory assessment, although not directly indicating a SOFA score increase. Therefore, the alignment is minimal.",
            "An elevated white blood cell (WBC) count is one of the explicit criteria listed under SIRS, which is used to identify systemic inflammation consistent with early sepsis. The claim directly aligns with the criteria outlined for SIRS positivity, thus indicating a strong alignment.",
            "An elevated WBC count is one of the criteria used in determining SIRS, which is intended to identify systemic inflammation consistent with early sepsis. The claim directly references an elevated WBC count as indicative of infection, which strongly aligns with the criteria for SIRS positivity. The wording (\"can indicate infection\") slightly lessens the certainty, thus the rating is not a full 1.0, but it is still highly relevant.",
            "The claim indicates that laboratory markers for sepsis are not evident. While the claim does not directly mention lactate levels, it implies the absence of such markers, of which elevated serum lactate is a critical one. The alignment is weak because the claim is about the absence of evidence, rather than providing direct data regarding lactate levels or other lab results.",
            "The claim that clinical symptoms suggesting sepsis are not evident implies a lack of suspicion of serious infection, which would typically lead to early antibiotics or culture orders if sepsis were suspected. While this is not a direct alignment with the category, it indirectly relates to the absence of actions that would be taken if sepsis were suspected. Hence, there is weak alignment with the category."
        ],
        "final_alignment_score": 0.5166666666666666,
        "accuracy": 1
    },
    {
        "input": "3: HR, 112.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 120.0; 3: DBP, 90.0; 3: MAP, 100.0; 3: Pain, 8.0; 3: Temp, 99.1; 8: Pain, 8.0; 38: POC PH (V) ISTAT, 7.38; 38: POC O2 SATURATION ISTAT VENOUS, 46 %; 38: POC PCO2 (V) ISTAT, 51.6 mmHg; 38: POC BASE EXCESS ISTAT, 5 mmol/L; 38: POC LACTATE ISTAT, 0.87 mmol/L; 38: POC TCO2 (V) ISTAT, 32 mmol/L; 38: POC HCO3 (V) ISTAT, 30.3 mmol/L; 38: POC PO2 (V) ISTAT, 26 mmHg; 53: WAM DIFTYP, AUTO; 53: RED BLOOD CELLS (RBC), 4.87 MIL/uL; 53: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 53: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 53: NRBC PERCENT (HEMATOLOGY), 0.0 %; 53: MEAN CORPUSCULAR VOLUME (MCV), 87.1 fL; 53: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 53: HEMOGLOBIN (HGB), 14.6 g/dL; 53: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 53: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 53: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.4 g/dL; 53: WHITE BLOOD CELLS (WBC), 8.6 K/uL; 53: MONOCYTE ABSOLUTE (AUTO DIFF), 0.94 K/uL; 53: NEUTROPHIL % (AUTO DIFF), 70.5 %; 53: PLATELET COUNT (PLT), 235 K/uL; 53: BASOPHIL % (AUTO DIFF), 0.2 %; 53: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 53: MONOCYTE % (AUTO DIFF), 10.9 %; 53: HEMATOCRIT (HCT), 42.4 %; 53: EOSINOPHIL % (AUTO DIFF), 0.5 %; 53: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.52 K/uL; 53: LYMPHOCYTE % (AUTO DIFF), 17.7 %; 53: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.0 pg; 53: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.06 K/uL; 81: ALKALINE PHOSPHATASE, 52 U/L; 81: CORRECTED CALCIUM, 9.3 mg/dL; 81: CALCIUM, 9.5 mg/dL; 81: CREATININE, 1.22 mg/dL; 81: POTASSIUM, 3.5 mmol/L; 81: GLUCOSE, 91 mg/dL; 81: ALT (SGPT), 15 U/L; 81: EGFR REFIT WITHOUT RACE (2021), 78 mL/min/1.73 m2; 81: GLOBULIN, 2.8 g/dL; 81: ANION GAP, 13 mmol/L; 81: BILIRUBIN TOTAL, 0.5 mg/dL; 81: BLOOD UREA NITROGEN (BUN), 12 mg/dL; 81: AST (SGOT), 17 U/L; 81: CO2, 28 mmol/L; 81: ALBUMIN, 4.3 g/dL; 81: CHLORIDE, 98 mmol/L; 81: SODIUM, 139 mmol/L; 81: PROTEIN TOTAL, 7.1 g/dL; 90: SpO2, 97.667; 91: SpO2, 97.766; 92: SpO2, 98.676; 93: HR, 117.189; 93: RR, 17.417; 93: SpO2, 98.339; 93: 1min HRV, 35.892; 94: HR, 118.897; 94: RR, 19.397; 94: SpO2, 99.052; 94: Perf, 0.651; 94: 1min HRV, 36.582; 94: SBP, 110.0; 94: DBP, 70.0; 94: MAP, 83.333; 95: HR, 112.356; 95: RR, 14.763; 95: SpO2, 98.949; 95: Perf, 0.622; 95: 1min HRV, 23.354; 95: SBP, 110.0; 95: DBP, 70.0; 95: MAP, 83.333; 95: Temp, 100.3; 96: HR, 117.103; 96: RR, 16.034; 96: SpO2, 97.828; 96: Perf, 0.617; 96: 1min HRV, 12.359; 96: 5min HRV, 30.311; 97: SARS-COV-2 RNA, Not Detected; 97: HR, 114.542; 97: RR, 19.729; 97: SpO2, 96.661; 97: Perf, 0.561; 97: 1min HRV, 10.839; 98: HR, 115.746; 98: RR, 16.831; 98: SpO2, 97.271; 98: Perf, 0.554; 98: 1min HRV, 70.725; 99: HR, 112.448; 99: RR, 14.552; 99: SpO2, 99.638; 99: Perf, 0.597; 99: 1min HRV, 15.210; 99: SBP, 111.0; 99: DBP, 73.0; 99: MAP, 85.667; 99: Pain, 9.0; 100: HR, 115.424; 100: RR, 14.949; 100: SpO2, 97.814; 100: Perf, 0.601; 100: 1min HRV, 7.647; 101: HR, 115.259; 101: RR, 17.172; 101: SpO2, 97.328; 101: Perf, 0.575; 101: 1min HRV, 18.362; 101: 5min HRV, 33.974; 102: HR, 113.593; 102: RR, 14.017; 102: SpO2, 97.797; 102: Perf, 0.537; 102: 1min HRV, 29.787; 102: SBP, 111.0; 102: DBP, 73.0; 102: MAP, 85.667; 103: HR, 116.407; 103: RR, 19.034; 103: SpO2, 99.0; 103: Perf, 0.519; 103: 1min HRV, 21.083; 103: HYDROMORPHONE, 1 MG/ML INJ SYRG; 104: HR:, 116.672; 104: RR, 18.190; 104: SpO2, 98.207; 104: Perf, 0.492; 104: 1min HRV, 17.796; 105: HR, 114.729; 105: RR, 15.881; 105: SpO2, 98.119; 105: Perf, 0.471; 105: 1min HRV, 30.473; 105: LR IV BOLUS -, 1000 ML; 106: HR:, 116.379; 106: RR, 17.379; 106: SpO2, 97.638; 106: Perf, 0.471; 106: 1min HRV, 16.924; 106: 5min HRV, 24.392; 106: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 107: HR:, 115.593; 107: RR, 21.797; 107: SpO2, 97.881; 107: Perf, 0.519; 107: 1min HRV, 13.793; 108: HR, 116.288; 108: RR, 20.780; 108: SpO2, 97.746; 108: Perf, 0.519; 108: 1min HRV, 14.276; 109: HR, 114.776; 109: RR, 11.345; 109: SpO2, 98.931; 109: Perf, 0.505; 109: 1min HRV, 13.103; 110: HR, 115.254; 110: RR, 16.0; 110: SpO2, 97.424; 110: Perf, 0.498; 110: 1min HRV, 21.313; 111: HR, 116.034; 111: RR, 17.034; 111: SpO2, 97.310; 111: Perf, 0.484; 111: 1min HRV, 19.157; 111: 5min HRV, 16.964; 112: HR, 112.034; 112: RR, 18.373; 112: SpO2, 96.559; 112: Perf, 0.524; 112: 1min HRV, 14.941; 113: HR, 113.983; 113: RR, 18.586; 113: SpO2, 97.466; 113: Perf, 0.536; 113: 1min HRV, 11.433; 114: HR, 112.271; 114: RR, 20.407; 114: SpO2, 96.780; 114: Perf, 0.540; 114: 1min HRV, 15.690; 115: HR, 112.051; 115: RR, 15.034; 115: SpO2, 95.356; 115: Perf, 0.529; 115: 1min HRV, 20.846; 116: HR, 111.948; 116: RR, 16.379; 116: SpO2, 95.914; 116: Perf, 0.514; 116: 1min HRV, 13.143; 116: 5min HRV, 15.961; 117: HR, 112.644; 117: RR, 14.203; 117: SpO2, 97.339; 117: Perf, 0.507; 117: 1min HRV, 16.865; 118: HR, 113.810; 118: RR, 16.741; 118: SpO2, 95.983; 118: Perf, 0.52; 118: 1min HRV, 11.521; 119: HR, 114.186; 119: RR, 17.254; 119: SpO2, 96.119; 119: Perf, 0.52; 119: 1min HRV, 13.682; 0: Age, 38; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 112.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, WOUND CHECK",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess the sepsis risk, first look for signs of systemic inflammation or organ dysfunction in the EHR data. The patient has elevated heart rate (around 110-117 bpm) and temperature (reaching 100.3\u00b0F), but other vital signs and laboratory tests do not show significant abnormalities indicative of sepsis risk, such as abnormal lactate levels or signs of organ dysfunction. The patient's blood pressure, oxygen saturation, respiratory rate, and blood test results, such as WBC count and lactate levels, are within normal ranges or do not suggest a high risk. Without more drastic signs of deterioration or multiple abnormal parameters, the risk for developing sepsis within 12 hours seems low.",
        "claims": [
            "To assess the sepsis risk, first look for signs of systemic inflammation or organ dysfunction in the EHR data.",
            "The patient has an elevated heart rate of around 110-117 bpm.",
            "The patient has a temperature reaching 100.3\u00b0F.",
            "Other vital signs and laboratory tests do not show significant abnormalities indicative of sepsis risk.",
            "Abnormal lactate levels are not present in the patient's tests.",
            "There are no signs of organ dysfunction in the patient's tests.",
            "The patient's blood pressure is within normal ranges.",
            "The patient's oxygen saturation is within normal ranges.",
            "The patient's respiratory rate is within normal ranges.",
            "The patient's blood test results, such as WBC count, are within normal ranges.",
            "Lactate levels in the patient are within normal ranges.",
            "The patient does not show more drastic signs of deterioration.",
            "The patient does not have multiple abnormal parameters.",
            "The risk for developing sepsis within 12 hours seems low."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate of around 110-117 bpm.",
            "Other vital signs and laboratory tests do not show significant abnormalities indicative of sepsis risk.",
            "The patient does not show more drastic signs of deterioration.",
            "The patient does not have multiple abnormal parameters."
        ],
        "alignment_scores": [
            0.6,
            0.2,
            0.3,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is directly listed as one of the criteria for SIRS. Although the claim mentions only one criterion (heart rate), it aligns moderately with SIRS Positivity since \u22652 SIRS criteria are required to identify early sepsis. The claim is partially aligned with this category, as the elevated heart rate is a component of SIRS.",
            "The claim indicates that other vital signs and lab tests do not show significant abnormalities, implying that a NEWS score based on deranged vitals is unlikely to be elevated. This indirectly aligns with the concept of tracking vital sign abnormalities for sepsis risk prediction but registers as minimally relevant because it specifically negates the presence of qualifying features.",
            "The claim suggests the absence of drastic deterioration, indicating that the patient's vitals may not be significantly deranged. Elevated NEWS scores indicate potential for imminent clinical deterioration, so the lack of severe symptoms implies a lower alignment with this category. The claim is indirectly related, as it rules out significant warning signs that would escalate risk levels according to NEWS scoring.",
            "The claim suggests that the patient does not exhibit multiple abnormal health indicators, implying a low likelihood of having a high National Early Warning Score (NEWS). However, since NEWS aims to predict clinical deterioration through aggregated parameter assessment, the absence of abnormal parameters weakly relates to this category, suggesting low sepsis risk. The alignment is indirect and minimal."
        ],
        "final_alignment_score": 0.35000000000000003,
        "accuracy": 1
    },
    {
        "input": "11: HR, 128.0; 11: RR, 22.0; 11: SpO2, 100.0; 11: SBP, 135.0; 11: DBP, 95.0; 11: MAP, 108.333; 11: LPM O2, 4.0; 11: Temp, 99.2; 20: Pain, 2.0; 46: HR, 122.0; 46: RR, 23.0; 46: SpO2, 100.0; 46: SBP, 150.0; 46: DBP, 110.0; 46: MAP, 123.333; 52: HR, 122.939; 52: RR, 23.25; 52: SpO2, 100.0; 52: 1min HRV, 5.704; 53: HR, 122.845; 53: RR, 21.517; 53: SpO2, 99.914; 53: Perf, 2.808; 53: 1min HRV, 5.565; 53: SBP, 150.0; 53: DBP, 110.0; 53: MAP, 123.333; 54: HR, 123.831; 54: RR, 24.644; 54: SpO2, 99.661; 54: Perf, 2.638; 54: 1min HRV, 10.795; 55: HR, 121.0; 55: RR, 25.508; 55: SpO2, 99.915; 55: Perf, 2.988; 55: 1min HRV, 10.056; 56: HR, 122.84; 56: RR, 26.149; 56: SpO2, 99.948; 56: Perf, 3.283; 56: 1min HRV, 8.571; 56: 5min HRV, 8.940; 57: HR, 122.576; 57: RR, 19.769; 57: SpO2, 99.864; 57: Perf, 3.919; 57: 1min HRV, 7.105; 58: HR, 122.879; 58: RR, 22.517; 58: SpO2, 99.879; 58: Perf, 4.124; 58: 1min HRV, 8.843; 59: HR, 123.034; 59: RR, 25.678; 59: SpO2, 100.0; 59: Perf, 3.976; 59: 1min HRV, 4.672; 60: HR, 122.508; 60: RR, 24.169; 60: SpO2, 100.0; 60: Perf, 3.974; 60: 1min HRV, 7.319; 61: HR, 120.776; 61: RR, 25.017; 61: SpO2, 100.0; 61: Perf, 3.710; 61: 1min HRV, 9.472; 61: 5min HRV, 8.257; 62: HR, 122.085; 62: RR, 21.136; 62: SpO2, 99.729; 62: Perf, 3.300; 62: 1min HRV, 5.797; 63: HR, 121.190; 63: RR, 22.569; 63: SpO2, 100.0; 63: Perf, 3.961; 63: 1min HRV, 6.137; 64: HR, 121.492; 64: RR, 23.712; 64: SpO2, 99.864; 64: Perf, 3.505; 64: 1min HRV, 7.056; 65: HR, 121.475; 65: RR, 21.966; 65: SpO2, 100.0; 65: Perf, 3.676; 65: 1min HRV, 5.555; 66: HR, 124.069; 66: RR, 25.638; 66: SpO2, 100.0; 66: Perf, 3.285; 66: 1min HRV, 6.096; 66: 5min HRV, 7.719; 67: HR, 122.441; 67: RR, 20.119; 67: SpO2, 99.932; 67: Perf, 3.020; 67: 1min HRV, 10.566; 68: POC PH (V) ISTAT, 7.27; 68: POC LACTATE ISTAT, <.30 mmol/L; 68: POC PO2 (V) ISTAT, 52 mmHg; 68: POC O2 SATURATION ISTAT VENOUS, 79 %; 68: POC BASE EXCESS ISTAT, 16 mmol/L; 68: POC TCO2 (V) ISTAT, 46 mmol/L; 68: POC PCO2 (V) ISTAT, 93.1 mmHg; 68: POC HCO3 (V) ISTAT, 43.1 mmol/L; 68: HR, 122.759; 68: RR, 22.862; 68: SpO2, 100.0; 68: Perf, 3.085; 68: 1min HRV, 6.594; 69: HR, 122.220; 69: RR, 24.593; 69: SpO2, 99.763; 69: Perf, 3.244; 69: 1min HRV, 11.331; 70: HR, 120.983; 70: RR, 23.356; 70: SpO2, 99.847; 70: Perf, 2.363; 70: 1min HRV, 7.587; 71: HR, 121.017; 71: RR, 22.431; 71: SpO2, 100.0; 71: Perf, 2.784; 71: 1min HRV, 9.820; 71: 5min HRV, 9.871; 72: HR, 120.864; 72: RR, 21.915; 72: SpO2, 99.915; 72: Perf, 3.830; 72: 1min HRV, 16.374; 73: HR, 120.103; 73: RR, 24.759; 73: SpO2, 100.0; 73: Perf, 3.610; 73: 1min HRV, 10.152; 74: HR, 118.492; 74: RR, 18.559; 74: SpO2, 99.492; 74: Perf, 3.811; 74: 1min HRV, 18.415; 75: HR, 101.776; 75: RR, 24.276; 75: SpO2, 98.810; 75: Perf, 3.638; 75: 1min HRV, 60.252; 76: HR, 112.729; 76: RR, 25.119; 76: SpO2, 97.441; 76: Perf, 4.093; 76: 1min HRV, 62.110; 76: 5min HRV, 53.036; 77: HR, 129.0; 77: RR, 21.203; 77: SpO2, 96.847; 77: Perf, 3.652; 77: 1min HRV, 4.517; 78: HR, 127.362; 78: RR, 21.466; 78: SpO2, 97.672; 78: Perf, 2.806; 78: 1min HRV, 9.283; 79: HR, 125.898; 79: RR, 30.441; 79: SpO2, 99.186; 79: Perf, 3.482; 79: 1min HRV, 7.209; 80: HR, 125.207; 80: RR, 27.448; 80: SpO2, 99.552; 80: Perf, 4.992; 80: 1min HRV, 7.198; 81: HR, 124.119; 81: RR, 25.729; 81: SpO2, 99.661; 81: Perf, 4.143; 81: 1min HRV, 4.572; 81: 5min HRV, 9.969; 82: HR, 122.712; 82: RR, 22.220; 82: SpO2, 99.814; 82: Perf, 4.987; 82: 1min HRV, 8.090; 83: HR, 121.931; 83: RR, 21.862; 83: SpO2, 99.621; 83: Perf, 2.813; 83: 1min HRV, 10.376; 86: 5min HRV, 9.461; 89: WAM DIFTYP, AUTO; 89: HEMATOCRIT (HCT), 40.8 %; 89: PLATELET COUNT (PLT), 327 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 89: HEMOGLOBIN (HGB), 12.1 g/dL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.7 g/dL; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.84 K/uL; 89: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 89: LYMPHOCYTE % (AUTO DIFF), 6.7 %; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.29 K/uL; 89: MONOCYTE % (AUTO DIFF), 8.5 %; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 12.4 %; 89: EOSINOPHIL % (AUTO DIFF), 2.3 %; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: NEUTROPHIL % (AUTO DIFF), 81.9 %; 89: WHITE BLOOD CELLS (WBC), 12.5 K/uL; 89: RED BLOOD CELLS (RBC), 4.48 MIL/uL; 89: BASOPHIL % (AUTO DIFF), 0.3 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.20 K/uL; 95: NS IV BOLUS -, 1000 ML; 97: INR:, 1.0; 97: PROTHROMBIN TIME, 13.2 seconds; 97: PART. THROMBOPLASTIN TIME, 29.0 seconds; 100: POC, BHCG, ISTAT QUANTITATIVE: 5.0 IU/L; 106: HR, 113.0; 106: RR, 17.0; 106: SpO2, 98.0; 106: SBP, 159.0; 106: DBP, 103.0; 106: MAP, 121.667; 106: LPM O2, 4.0; 110: CO2, 37 mmol/L; 110: CREATININE, 0.59 mg/dL; 110: BLOOD UREA NITROGEN (BUN), 25 mg/dL; 110: ANION GAP, 7 mmol/L; 110: EGFR FOR AFRICAN AMERICAN, 137 mL/min/1.73 m2; 110: GLUCOSE, 247 mg/dL; 110: CHLORIDE, 94 mmol/L; 110: CORRECTED CALCIUM, 9.9 mg/dL; 110: GLOBULIN, 3.4 g/dL; 110: AST (SGOT), 22 U/L; 110: ALKALINE PHOSPHATASE, 122 U/L; 110: SODIUM, 138 mmol/L; 110: PROTEIN TOTAL, 7.3 g/dL; 110: BILIRUBIN TOTAL, <.2 mg/dL; 110: EGFR REFIT WITHOUT RACE (2021), 119 mL/min/1.73 m2; 110: POTASSIUM, 4.4 mmol/L; 110: CALCIUM, 9.8 mg/dL; 110: ALBUMIN, 3.9 g/dL; 110: ALT (SGPT), 25 U/L; 111: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 0: Age:, 37; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 128.0; 0: Triage RR, 22.0; 0: Triage SBP, 135.0; 0: Triage DBP, 95.0; 0: Triage acuity, 2-Emergent; 0: CC, COUGH",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "First, identify the presence of vital signs and lab values indicating sepsis, such as elevated heart rate (HR), respiratory rate (RR), white blood cells (WBC) count, and lactate levels. The patient's HR and RR are indeed elevated, but the lactate levels are significantly low, and there is no fever or significant leukocytosis. Additionally, there's no mention of potential infection sources or organ dysfunction. Considering all available data, the evidence does not strongly suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "Vital signs and lab values indicating sepsis include elevated heart rate, respiratory rate, white blood cells count, and lactate levels.",
            "The patient's heart rate is elevated.",
            "The patient's respiratory rate is elevated.",
            "The patient's lactate levels are significantly low.",
            "There is no fever present in the patient.",
            "There is no significant leukocytosis present in the patient.",
            "There is no mention of potential infection sources.",
            "There is no mention of organ dysfunction.",
            "The available data does not strongly suggest a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is elevated.",
            "There is no fever present in the patient.",
            "There is no significant leukocytosis present in the patient.",
            "There is no mention of potential infection sources.",
            "There is no mention of organ dysfunction.",
            "The available data does not strongly suggest a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.3,
            0.3,
            0.2,
            0.7,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate is explicitly mentioned in the criteria for systemic inflammatory response syndrome (SIRS), which can be indicative of early sepsis. However, for definitive SIRS positivity, at least two criteria must be met, so the alignment is strong but not perfect without additional information.",
            "The absence of fever is relevant to the SIRS Criteria, which include temperature as one of the components. The lack of fever suggests the patient may not be meeting this SIRS criterion, which marginally impacts sepsis prediction. While it's related, the reference to a lack of fever isn\u2019t as strong as having fever or another explicit SIRS criterion.",
            "The claim mentions that there is no significant leukocytosis, which refers to white blood cell count. Leukocytosis is one of the criteria used in the SIRS framework to identify systemic inflammation and early sepsis. The claim suggests the absence of a key SIRS indicator, indirectly relating to SIRS criteria. However, as it points to what is not present (absence of leukocytosis), the alignment is weak.",
            "The claim highlights the absence of mention of infection sources. While this indirectly alludes to a lack of clinical suspicion prompting early interventions (like antibiotics or cultures), it doesn\u2019t provide evidence for or against the actions that fulfill the criteria under this category. This weak connection results in a low alignment rating.",
            "The absence of organ dysfunction implies stability and aligns closely with the SOFA score, which measures organ dysfunction. However, without mentioning a specific increase in SOFA points, the alignment remains indirect but relevant.",
            "The claim indicates there isn't strong evidence suggesting a high risk of sepsis. This points away from urgent clinical responses like early antibiotics/cultures, aligning weakly with this category. However, it hints at a situation where strong clinical actions presumably aren't necessary, as would be dictated by this category under suspicion of sepsis."
        ],
        "final_alignment_score": 0.4166666666666667,
        "accuracy": 0
    },
    {
        "input": "12: HR, 105.0; 12: RR, 28.0; 12: SpO2, 95.0; 12: SBP, 140.0; 12: DBP, 63.0; 12: MAP, 88.667; 12: Temp, 99.7; 74: HR, 95.688; 74: SpO2, 93.758; 74: 1min HRV, 8.974; 74: SBP, 144.0; 74: DBP, 63.0; 74: MAP, 90.0; 75: HR, 98.203; 75: SpO2, 94.966; 75: 1min HRV, 12.323; 75: 5min HRV, 14.276; 76: HR, 96.569; 76: SpO2, 94.776; 76: Perf, 6.578; 76: 1min HRV, 12.903; 77: SARS-COV-2 RNA, Not Detected; 77: HR, 99.102; 77: SpO2, 94.339; 77: Perf, 4.638; 77: 1min HRV, 15.613; 78: HR, 96.879; 78: SpO2, 94.431; 78: Perf, 4.077; 78: 1min HRV, 7.583; 79: HR, 97.881; 79: SpO2, 94.153; 79: Perf, 4.416; 79: 1min HRV, 18.735; 80: HR, 100.508; 80: SpO2, 94.322; 80: Perf, 4.084; 80: 1min HRV, 15.058; 80: 5min HRV, 16.596; 81: HR, 97.052; 81: SpO2, 94.138; 81: Perf, 3.874; 81: 1min HRV, 9.255; 82: HR, 98.153; 82: SpO2, 94.0; 82: Perf, 4.344; 82: 1min HRV, 8.571; 83: HR, 95.810; 83: SpO2, 93.724; 83: Perf, 4.399; 83: 1min HRV, 9.797; 84: HR, 95.508; 84: SpO2, 92.881; 84: Perf, 4.271; 84: 1min HRV, 15.169; 85: HR, 95.610; 85: SpO2, 93.0; 85: Perf, 4.012; 85: 1min HRV, 7.541; 85: 5min HRV, 12.341; 86: POC PH (V) ISTAT, 7.51; 86: POC LACTATE ISTAT, 1.04 mmol/L; 86: POC BASE EXCESS ISTAT, 7 mmol/L; 86: POC PO2 (V) ISTAT, 45 mmHg; 86: POC O2 SATURATION ISTAT VENOUS, 85 %; 86: POC HCO3 (V) ISTAT, 29.9 mmol/L; 86: POC PCO2 (V) ISTAT, 37.9 mmHg; 86: POC TCO2 (V) ISTAT, 31 mmol/L; 86: HR, 95.086; 86: SpO2, 93.397; 86: Perf, 4.21; 86: 1min HRV, 3.706; 87: HR, 95.525; 87: SpO2, 93.254; 87: Perf, 4.314; 87: 1min HRV, 10.295; 88: HR, 95.793; 88: SpO2, 94.0; 88: Perf, 4.491; 88: 1min HRV, 10.727; 89: HR, 94.186; 89: SpO2, 93.661; 89: Perf, 4.244; 89: 1min HRV, 6.677; 90: HR, 93.763; 90: SpO2, 93.542; 90: Perf, 4.679; 90: 1min HRV, 10.949; 90: 5min HRV, 9.909; 91: HR, 94.793; 91: SpO2, 93.207; 91: Perf, 4.523; 91: 1min HRV, 11.560; 92: HR, 92.186; 92: SpO2, 92.729; 92: Perf, 4.081; 92: 1min HRV, 10.722; 93: HR, 93.310; 93: SpO2, 93.259; 93: Perf, 4.575; 93: 1min HRV, 11.295; 93: LIDOCAINE, 5 % TP PTMD; 94: HR:, 94.041; 94: SpO2, 93.407; 94: Perf, 5.464; 94: 1min HRV, 18.225; 95: HR, 93.862; 95: SpO2, 94.276; 95: Perf, 4.087; 95: 1min HRV, 23.162; 95: 5min HRV, 16.508; 96: HR, 95.847; 96: SpO2, 93.898; 96: Perf, 3.660; 96: 1min HRV, 19.795; 97: HR, 95.288; 97: SpO2, 94.085; 97: Perf, 3.631; 97: 1min HRV, 26.480; 98: WAM DIFTYP, AUTO; 98: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.54 K/uL; 98: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 98: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 98: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 98: PLATELET COUNT (PLT), 363 K/uL; 98: MONOCYTE ABSOLUTE (AUTO DIFF), 1.35 K/uL; 98: RED CELL DISTRIBUTION WIDTH (RDW), 13.0 %; 98: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 98: BASOPHIL % (AUTO DIFF), 0.3 %; 98: WHITE BLOOD CELLS (WBC), 11.6 K/uL; 98: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 98: EOSINOPHIL % (AUTO DIFF), 0.3 %; 98: LYMPHOCYTE % (AUTO DIFF), 4.7 %; 98: HEMOGLOBIN (HGB), 13.1 g/dL; 98: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.3 pg; 98: MONOCYTE % (AUTO DIFF), 11.7 %; 98: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.7 g/dL; 98: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.52 K/uL; 98: NRBC PERCENT (HEMATOLOGY), 0.0 %; 98: MEAN CORPUSCULAR VOLUME (MCV), 96.0 fL; 98: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 98: NEUTROPHIL % (AUTO DIFF), 82.3 %; 98: HEMATOCRIT (HCT), 38.9 %; 98: HR, 93.810; 98: SpO2, 94.017; 98: Perf, 4.691; 98: 1min HRV, 23.968; 99: HR, 96.339; 99: SpO2, 94.203; 99: Perf, 5.558; 99: 1min HRV, 18.059; 100: HR, 94.052; 100: SpO2, 93.862; 100: Perf, 4.896; 100: 1min HRV, 20.223; 100: 5min HRV, 22.715; 101: HR, 92.797; 101: SpO2, 94.136; 101: Perf, 4.679; 101: 1min HRV, 18.505; 102: HR, 94.102; 102: SpO2, 93.356; 102: Perf, 4.308; 102: 1min HRV, 24.808; 103: HR, 90.397; 103: SpO2, 93.552; 103: Perf, 3.735; 103: 1min HRV, 21.601; 104: HR, 91.458; 104: SpO2, 94.0; 104: Perf, 3.391; 104: 1min HRV, 19.831; 105: HR, 90.362; 105: SpO2, 93.690; 105: Perf, 3.608; 105: 1min HRV, 19.193; 105: 5min HRV, 22.761; 106: HR, 88.695; 106: SpO2, 93.322; 106: Perf, 3.818; 106: 1min HRV, 30.647; 107: HR, 87.864; 107: SpO2, 93.102; 107: Perf, 6.080; 107: 1min HRV, 21.781; 108: HR, 91.793; 108: SpO2, 93.379; 108: Perf, 4.790; 108: 1min HRV, 20.482; 109: HR, 90.068; 109: SpO2, 93.627; 109: Perf, 5.224; 109: 1min HRV, 9.640; 110: HR, 90.690; 110: SpO2, 92.448; 110: Perf, 5.879; 110: 1min HRV, 10.436; 110: 5min HRV, 22.487; 111: HR, 91.017; 111: SpO2, 92.424; 111: Perf, 5.972; 111: 1min HRV, 13.902; 112: HR, 90.203; 112: SpO2, 93.0; 112: Perf, 6.482; 112: 1min HRV, 8.039; 113: HR, 90.483; 113: SpO2, 92.810; 113: Perf, 6.112; 113: 1min HRV, 9.718; 114: HR, 90.051; 114: SpO2, 92.864; 114: Perf, 5.358; 114: 1min HRV, 8.979; 115: HR, 90.879; 115: SpO2, 92.845; 115: Perf, 5.083; 115: 1min HRV, 16.757; 115: 5min HRV, 12.244; 116: HR, 88.525; 116: SpO2, 93.932; 116: Perf, 4.567; 116: 1min HRV, 22.357; 117: HR, 89.746; 117: SpO2, 93.814; 117: Perf, 4.894; 117: 1min HRV, 12.992; 118: HR, 91.879; 118: SpO2, 93.362; 118: Perf, 5.772; 118: 1min HRV, 13.784; 119: HR, 88.525; 119: SpO2, 93.661; 119: Perf, 4.697; 119: 1min HRV, 14.209; 0: Age, 81; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 105.0; 0: Triage RR, 28.0; 0: Triage SBP, 140.0; 0: Triage DBP, 63.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The first subquestion is to identify common indicators of high sepsis risk such as tachycardia, tachypnea, fever, low blood pressure, hypoxia, and altered heart rate variability. The second subquestion is to analyze these indicators in the provided time series. The data shows tachycardia and borderline low SpO2, but the patient's vital signs, including blood pressure and temperature, remain relatively stable and do not exhibit severe trends indicative of high sepsis risk. The patient's rapid heart rate variability (HRV) fluctuations are not uncommon, especially given the absence of other risk factors. Therefore, the data does not conclusively indicate a high risk of sepsis within the next 12 hours.",
        "claims": [
            "Common indicators of high sepsis risk include tachycardia, tachypnea, fever, low blood pressure, hypoxia, and altered heart rate variability.",
            "The second subquestion involves analyzing the indicators in the provided time series.",
            "The data shows tachycardia and borderline low SpO2.",
            "The patient's vital signs remain relatively stable.",
            "The patient's blood pressure does not exhibit severe trends indicative of high sepsis risk.",
            "The patient's temperature remains stable.",
            "Rapid heart rate variability (HRV) fluctuations are not uncommon.",
            "The absence of other risk factors is noted.",
            "The data does not conclusively indicate a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Common indicators of high sepsis risk include tachycardia, tachypnea, fever, low blood pressure, hypoxia, and altered heart rate variability.",
            "The data shows tachycardia and borderline low SpO2.",
            "The patient's blood pressure does not exhibit severe trends indicative of high sepsis risk."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
        ],
        "alignment_reasonings": [
            "The claim mentions tachycardia (increased heart rate), tachypnea (increased respiratory rate), and fever, which are elements of SIRS criteria. Although the claim covers a broad range of symptoms, most of them align with SIRS Positivity, which uses these indicators to identify systemic inflammation that could indicate early sepsis. However, the claim also includes symptoms beyond just SIRS criteria, leading to a moderately strong but not perfect alignment.",
            "Tachycardia is associated with an elevated heart rate, which can be a component of other scoring criteria like SIRS. However, the borderline low SpO2 suggests respiratory compromise, which is more closely related to the qSOFA criteria component of altered mentation (which could be affected by hypoxia). Although SpO2 is not directly mentioned in qSOFA, it indirectly aligns due to its relevance in assessing respiratory status and potential for sepsis-related organ dysfunction. The alignment is somewhat indirect, hence the 0.7 rating.",
            "The claim refers to the absence of severe blood pressure trends, which suggests considering sepsis-associated hypotension. However, it states there are no severe trends rather than confirming hypotension, lessening direct alignment. Thus, there's minimal, indirect relevance to the category."
        ],
        "final_alignment_score": 0.5333333333333333,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 95.604; 2: SBP, 73.0; 2: DBP, nan; 2: MAP, nan; 3: SpO2, 97.633; 3: Perf, 0.510; 4: SpO2, 98.0; 4: Perf, 0.485; 4: SBP, 71.0; 4: DBP, 48.0; 4: MAP, 55.667; 5: HR, 115.0; 5: RR, 19.0; 5: SpO2, 96.729; 5: Perf, 0.322; 5: SBP, 79.0; 5: DBP, 48.0; 5: MAP, 58.333; 5: Pain, 3.0; 5: Temp, 98.0; 6: SpO2, 95.264; 6: Perf, 0.711; 7: SpO2, 96.038; 7: Perf, 0.838; 8: SpO2, 97.849; 8: Perf, 0.911; 9: SpO2, 99.0; 9: Perf, 1.024; 10: SpO2, 98.212; 10: Perf, 0.978; 10: SBP, 73.0; 10: DBP, 43.0; 10: MAP, 53.0; 11: SpO2, 98.642; 11: Perf, 0.448; 12: SpO2, 98.712; 12: Perf, 0.979; 13: SpO2, 99.245; 13: Perf, 1.204; 14: SpO2, 99.212; 14: Perf, 1.499; 15: SpO2, 99.887; 15: Perf, 1.369; 16: SpO2, 99.478; 16: Perf, 1.329; 17: SpO2, 94.333; 17: Perf, 1.36; 19: SpO2, 93.769; 19: Perf, 0.170; 20: SpO2, 93.0; 20: Perf, 0.23; 20: SBP, 63.0; 20: DBP, 45.0; 20: MAP, 51.0; 21: SpO2, 94.0; 21: Perf, 0.286; 22: SpO2, 98.423; 22: Perf, 0.689; 23: SpO2, 98.0; 23: Perf, 0.410; 24: SpO2, 98.875; 24: Perf, 0.394; 24: LR IV BOLUS -, 500 ML; 25: SpO, 2: 96.395; 25: Perf, 0.432; 26: SpO2, 98.288; 26: Perf, 1.126; 27: SpO2, 95.981; 27: Perf, 1.025; 28: SpO2, 98.415; 28: Perf, 1.452; 28: SBP, 71.0; 28: DBP, 32.0; 28: MAP, 45.0; 29: SpO2, 99.192; 29: Perf, 0.813; 30: SpO2, 99.509; 30: Perf, 0.659; 31: POC PH (V) ISTAT, 7.63; 31: POC O2 SATURATION ISTAT VENOUS, 92 %; 31: POC TCO2 (V) ISTAT, 34 mmol/L; 31: POC BASE EXCESS ISTAT, 12 mmol/L; 31: POC PCO2 (V) ISTAT, 32.1 mmHg; 31: POC PO2 (V) ISTAT, 51 mmHg; 31: POC LACTATE ISTAT, 1.99 mmol/L; 31: POC HCO3 (V) ISTAT, 33.5 mmol/L; 31: SpO2, 99.385; 31: Perf, 0.763; 32: SpO2, 96.385; 32: Perf, 0.773; 33: SpO2, 96.094; 33: Perf, 0.739; 34: SpO2, 97.231; 34: Perf, 0.936; 35: SpO2, 99.094; 35: Perf, 1.320; 35: SBP, 76.0; 35: DBP, 54.0; 35: MAP, 61.333; 36: SpO2, 98.596; 36: Perf, 0.990; 37: SpO2, 98.094; 37: Perf, 0.757; 38: SpO2, 96.283; 38: Perf, 0.687; 39: SpO2, 95.712; 39: Perf, 0.747; 40: SpO2, 97.755; 40: Perf, 1.372; 41: SpO2, 97.923; 41: Perf, 1.720; 42: SpO2, 95.585; 42: Perf, 1.869; 43: SpO2, 94.72; 43: Perf, 1.339; 44: SpO2, 95.667; 44: Perf, 0.698; 45: SpO2, 96.019; 45: Perf, 0.370; 46: WAM DIFTYP, AUTO; 46: RED CELL DISTRIBUTION WIDTH (RDW), 16.2 %; 46: HEMATOCRIT (HCT), 30.5 %; 46: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 46: MONOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 46: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 46: PLATELET COUNT (PLT), 250 K/uL; 46: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.1 pg; 46: NEUTROPHIL % (AUTO DIFF), 75.4 %; 46: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.8 g/dL; 46: HEMOGLOBIN (HGB), 10.0 g/dL; 46: MEAN CORPUSCULAR VOLUME (MCV), 97.8 fL; 46: LYMPHOCYTE % (AUTO DIFF), 12.8 %; 46: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 46: NRBC PERCENT (HEMATOLOGY), 0.0 %; 46: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.82 K/uL; 46: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 46: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 46: BASOPHIL % (AUTO DIFF), 0.5 %; 46: EOSINOPHIL % (AUTO DIFF), 0.6 %; 46: MONOCYTE % (AUTO DIFF), 9.9 %; 46: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 46: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.82 K/uL; 46: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 46: SpO2, 98.75; 46: Perf, 1.011; 47: SpO2, 99.585; 47: Perf, 0.703; 48: SpO2, 98.830; 48: Perf, 0.596; 49: SpO2, 98.462; 49: Perf, 0.741; 50: SpO2, 97.868; 50: Perf, 0.314; 51: SpO2, 99.0; 51: Perf, 0.335; 52: SpO2, 99.82; 52: Perf, 0.290; 53: SpO2, 98.733; 53: Perf, 0.208; 54: SpO2, 99.442; 54: Perf, 0.407; 55: SpO2, 98.698; 55: Perf, 0.510; 56: SpO2, 97.885; 56: Perf, 0.373; 57: SpO2, 97.717; 57: Perf, 0.412; 58: SpO2, 99.5; 58: Perf, 0.699; 59: SpO2, 99.019; 59: Perf, 0.417; 60: SpO2, 99.226; 60: Perf, 0.292; 61: SpO2, 99.154; 61: Perf, 0.311; 62: SpO2, 99.434; 62: Perf, 0.488; 63: SpO2, 100.0; 63: Perf, 0.649; 63: SBP, 103.0; 63: DBP, 54.0; 63: MAP, 70.333; 67: ALT (SGPT), 20 U/L; 67: PROTEIN TOTAL, 7.8 g/dL; 67: BILIRUBIN TOTAL, 0.5 mg/dL; 67: ALKALINE PHOSPHATASE, 81 U/L; 67: SODIUM, 131 mmol/L; 67: CALCIUM, 8.9 mg/dL; 67: ANION GAP, 14 mmol/L; 67: ALBUMIN, 4.1 g/dL; 67: POTASSIUM, 4.5 mmol/L; 67: CO2, 28 mmol/L; 67: EGFR REFIT WITHOUT RACE (2021), 14 mL/min/1.73 m2; 67: AST (SGOT), 54 U/L; 67: BLOOD UREA NITROGEN (BUN), 18 mg/dL; 67: GLUCOSE, 118 mg/dL; 67: GLOBULIN, 3.7 g/dL; 67: CHLORIDE, 89 mmol/L; 67: CREATININE, 3.37 mg/dL; 67: CORRECTED CALCIUM, 8.8 mg/dL; 69: HR, 89.0; 69: SpO2, 99.0; 69: SBP, 87.0; 69: DBP, 58.0; 69: MAP, 67.667; 87: HR, 82.0; 87: RR, 18.0; 87: SpO2, 99.0; 87: SBP, 85.0; 87: DBP, 69.0; 87: MAP, 74.333; 95: INR, 1.1; 95: PROTHROMBIN TIME, 15.0 seconds; 96: PART. THROMBOPLASTIN TIME, 28.3 seconds; 114: SARS-COV-2 RNA, Not Detected; 114: INFLUENZA B, Not Detected; 114: RSV, Not Detected; 114: INFLUENZA A, Not Detected; 0: Age, 67; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 115.0; 0: Triage RR, 19.0; 0: Triage SBP, 101.0; 0: Triage DBP, 57.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To determine the sepsis risk, we first assess the patient's initial clinical presentation and subsequent vital signs. The patient is a 67-year-old female presenting with general weakness, hypotension (SBP dropping as low as 63.0 mmHg), and high heart rate (initial HR of 115 bpm), which suggest potential hemodynamic instability. Hypotension is persistent, and perfusion index values fluctuate, indicating compromised perfusion. Additionally, the patient has documented renal impairment (eGFR of 14 mL/min/1.73 m\u00b2), major risk factors for sepsis, alongside nonspecific signs of infection such as increased white blood cell count. Given these considerations, there is a high risk of sepsis within the next 12 hours.",
        "claims": [
            "To determine the sepsis risk, we first assess the patient's initial clinical presentation and subsequent vital signs.",
            "The patient is a 67-year-old female.",
            "The patient presents with general weakness.",
            "The patient exhibits hypotension, with an SBP dropping as low as 63.0 mmHg.",
            "A low SBP of 63.0 mmHg suggests potential hemodynamic instability.",
            "The patient has a high heart rate, with an initial HR of 115 bpm.",
            "Hypotension in this patient is persistent.",
            "Perfusion index values in this patient fluctuate.",
            "Fluctuating perfusion index values indicate compromised perfusion.",
            "The patient has documented renal impairment, with an eGFR of 14 mL/min/1.73 m\u00b2.",
            "Renal impairment is a major risk factor for sepsis.",
            "The patient has nonspecific signs of infection, including an increased white blood cell count.",
            "Given these considerations, there is a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "To determine the sepsis risk, we first assess the patient's initial clinical presentation and subsequent vital signs.",
            "The patient exhibits hypotension, with an SBP dropping as low as 63.0 mmHg.",
            "A low SBP of 63.0 mmHg suggests potential hemodynamic instability.",
            "The patient has a high heart rate, with an initial HR of 115 bpm.",
            "Hypotension in this patient is persistent.",
            "Perfusion index values in this patient fluctuate.",
            "Fluctuating perfusion index values indicate compromised perfusion.",
            "The patient has documented renal impairment, with an eGFR of 14 mL/min/1.73 m\u00b2.",
            "Renal impairment is a major risk factor for sepsis."
        ],
        "alignment_scores": [
            0.4,
            1.0,
            1.0,
            0.7,
            0.8,
            0.3,
            0.6,
            0.7,
            0.7
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The claim mentions assessing the patient's initial clinical presentation and subsequent vital signs, which is consistent with the process of calculating the National Early Warning Score (NEWS). However, the claim is vague and does not provide specific information about the NEWS calculation or any score threshold. The alignment is indirect because vital signs are a key component of the NEWS but the claim lacks specifics on how these assessments impact sepsis risk in terms of NEWS scoring.",
            "The claim directly mentions hypotension with a systolic blood pressure (SBP) dropping as low as 63.0 mmHg, which is explicitly described in the Sepsis-Associated Hypotension category as a strong indicator of progression toward septic shock. The alignment is perfect because it directly corresponds with the defined criteria for this category.",
            "The claim explicitly mentions a low systolic blood pressure (SBP) of 63.0 mmHg, which is well below the threshold of 90 mmHg defined in the Sepsis-Associated Hypotension category. This aligns perfectly with the criteria used to identify potential septic shock and hemodynamic instability, warranting a strong alignment rating.",
            "The claim mentions a high heart rate of 115 bpm, which exceeds the SIRS criterion of heart rate >90 bpm. This indicates systemic inflammation consistent with early sepsis. However, the SIRS category requires the presence of at least two criteria for a full match, so the alignment is not complete, but still strong due to the presence of one key criterion.",
            "The claim mentions \"hypotension,\" which directly aligns with the Sepsis-Associated Hypotension category. Although \"persistent\" hypotension suggests a worsening condition typical of sepsis progression, the claim lacks specific numeric thresholds or changes that would fully confirm sepsis-associated hypotension per the expert criteria. Thus, while the alignment is significant, it isn't complete without additional detail.",
            "While perfusion index fluctuations are not directly equivalent to elevated serum lactate levels, both relate to issues with tissue perfusion and, by extension, hypoperfusion. The connection is more conceptual as perfusion index reflects changes in peripheral perfusion, which might suggest concerns similar to those raised by elevated lactate. This makes the category somewhat relevant but not a direct match, thus the low alignment rating.",
            "The perfusion index is an indirect measure of peripheral blood flow and circulation, similar in concept to how elevated serum lactate indicates tissue hypoperfusion and elevated sepsis mortality risk. While compromised perfusion aligns with the broader idea of tissue hypoperfusion noted in the serum lactate category, it doesn't directly measure serum lactate levels, hence the moderate alignment rating.",
            "Renal impairment, indicated by a low eGFR, is related to a SOFA component (creatinine >2 mg/dL). Although eGFR is not directly mentioned under the SOFA criteria, it is a measure of kidney function, which can relate to organ dysfunction. The alignment is not perfect but is significantly relevant, reflecting an increased risk of sepsis linked to renal impairment.",
            "Renal impairment can be related to an increase in SOFA score, particularly through the creatinine measurement, which is one of the SOFA components. This association suggests potential organ dysfunction consistent with an increased sepsis risk. However, the claim does not specify the level of impairment or other components, so the alignment is not perfect but significant."
        ],
        "final_alignment_score": 0.6888888888888889,
        "accuracy": 1
    },
    {
        "input": "2: SpO2, 92.286; 3: HR, 108.0; 3: RR, 18.0; 3: SpO2, 94.712; 3: SBP, 104.0; 3: DBP, 58.0; 3: MAP, 73.333; 3: Pain, 10.0; 3: Temp, 98.4; 4: SpO2, 94.424; 4: 1min HRV, 3.128; 5: HR, 105.679; 5: RR, 22.017; 5: SpO2, 95.345; 5: 1min HRV, 12.321; 5: 5min HRV, 12.071; 5: SBP, 104.0; 5: DBP, 58.0; 5: MAP, 73.333; 6: HR, 100.898; 6: RR, 14.288; 6: SpO2, 94.881; 6: 1min HRV, 13.117; 7: HR, 99.603; 7: RR, 16.103; 7: SpO2, 94.172; 7: 1min HRV, 11.406; 8: HR, 98.797; 8: RR, 15.797; 8: SpO2, 93.305; 8: Perf, 3.430; 8: 1min HRV, 10.144; 9: HR, 97.695; 9: RR, 22.237; 9: SpO2, 93.932; 9: Perf, 3.684; 9: 1min HRV, 4.646; 10: HR, 97.810; 10: RR, 27.793; 10: SpO2, 94.672; 10: Perf, 4.924; 10: 1min HRV, 6.557; 10: 5min HRV, 11.750; 11: HR, 98.678; 11: RR, 18.847; 11: SpO2, 96.0; 11: Perf, 4.99; 11: 1min HRV, 6.099; 12: HR, 101.091; 12: RR, 18.091; 12: SpO2, 95.455; 12: Perf, 4.99; 12: 1min HRV, 1.898; 14: HR, 101.0; 14: RR, 27.0; 14: SpO2, 95.0; 14: Perf, 4.99; 15: HR, 103.562; 15: RR, 26.562; 15: SpO2, 93.55; 15: Perf, 4.75; 15: 1min HRV, 2.806; 15: 5min HRV, 11.961; 16: HR, 102.559; 16: RR, 21.864; 16: SpO2, 93.712; 16: Perf, 3.154; 16: 1min HRV, 9.604; 16: SBP, 92.0; 16: DBP, 53.0; 16: MAP, 66.0; 17: HR, 101.559; 17: RR, 21.627; 17: SpO2, 94.424; 17: Perf, 1.920; 17: 1min HRV, 14.599; 18: HR, 96.690; 18: RR, 29.897; 18: SpO2, 94.741; 18: Perf, 2.758; 18: 1min HRV, 11.359; 19: HR, 93.864; 19: RR, 25.746; 19: SpO2, 94.542; 19: Perf, 3.453; 19: 1min HRV, 14.594; 20: HR, 96.052; 20: RR, 28.724; 20: SpO2, 95.0; 20: Perf, 3.637; 20: 1min HRV, 4.509; 20: 5min HRV, 23.489; 21: HR, 97.441; 21: RR, 32.508; 21: SpO2, 94.271; 21: Perf, 3.552; 21: 1min HRV, 4.268; 22: HR, 97.814; 22: RR, 31.441; 22: SpO2, 93.136; 22: Perf, 3.410; 22: 1min HRV, 4.070; 23: HR, 96.862; 23: RR, 30.345; 23: SpO2, 92.362; 23: Perf, 3.15; 23: 1min HRV, 6.574; 24: HR, 97.898; 24: RR, 29.271; 24: SpO2, 94.362; 24: Perf, 3.041; 24: 1min HRV, 6.397; 25: HR, 96.931; 25: RR, 33.103; 25: SpO2, 94.034; 25: 1min HRV, 2.760; 25: 5min HRV, 5.875; 26: HR, 98.356; 26: RR, 32.441; 26: SpO2, 93.780; 26: 1min HRV, 3.452; 27: HR, 99.542; 27: RR, 33.661; 27: SpO2, 94.0; 27: 1min HRV, 2.319; 28: HR, 100.103; 28: RR, 33.569; 28: SpO2, 93.810; 28: 1min HRV, 1.990; 29: HR, 100.729; 29: RR, 33.407; 29: SpO2, 94.0; 29: 1min HRV, 2.201; 30: HR, 100.879; 30: RR, 32.776; 30: SpO2, 93.931; 30: 1min HRV, 4.129; 30: 5min HRV, 5.757; 31: HR, 100.186; 31: RR, 32.424; 31: SpO2, 92.273; 31: 1min HRV, 9.024; 31: SBP, 99.0; 31: DBP, 47.0; 31: MAP, 64.333; 32: HR, 101.525; 32: RR, 33.542; 32: SpO2, 93.932; 32: 1min HRV, 2.930; 33: HR, 102.655; 33: RR, 32.517; 33: SpO2, 93.914; 33: 1min HRV, 2.312; 34: HR, 101.373; 34: RR, 28.576; 34: SpO2, 93.390; 34: 1min HRV, 9.428; 35: HR, 101.241; 35: RR, 22.172; 35: SpO2, 93.621; 35: Perf, 3.324; 35: 1min HRV, 8.231; 35: 5min HRV, 8.377; 36: HR, 102.712; 36: RR, 20.797; 36: SpO2, 94.254; 36: Perf, 3.239; 36: 1min HRV, 6.205; 37: HR, 101.576; 37: RR, 32.373; 37: SpO2, 93.322; 37: Perf, 2.84; 37: 1min HRV, 4.236; 38: HR, 102.293; 38: RR, 26.017; 38: SpO2, 93.638; 38: Perf, 2.84; 38: 1min HRV, 3.312; 39: HR, 101.237; 39: RR, 20.508; 39: SpO2, 94.149; 39: Perf, 2.84; 39: 1min HRV, 9.369; 40: HR, 100.190; 40: RR, 20.034; 40: SpO2, 93.845; 40: 1min HRV, 9.251; 40: 5min HRV, 9.019; 41: HR, 98.085; 41: RR, 22.288; 41: SpO2, 95.475; 41: 1min HRV, 11.561; 42: HR, 98.559; 42: RR, 28.881; 42: SpO2, 95.034; 42: 1min HRV, 3.942; 43: HR, 98.621; 43: RR, 28.138; 43: SpO2, 94.966; 43: 1min HRV, 5.115; 44: HR, 98.322; 44: RR, 32.017; 44: SpO2, 94.136; 44: 1min HRV, 8.521; 45: HR, 98.879; 45: RR, 33.534; 45: SpO2, 92.586; 45: Perf, 2.88; 45: 1min HRV, 4.662; 45: 5min HRV, 7.515; 46: HR, 98.966; 46: RR, 31.475; 46: SpO2, 92.0; 46: Perf, 3.082; 46: 1min HRV, 8.390; 46: SBP, 89.0; 46: DBP, 44.0; 46: MAP, 59.0; 47: HR, 101.818; 47: RR, 21.762; 47: SpO2, 92.535; 47: Perf, 2.787; 47: 1min HRV, 4.126; 47: SBP, 94.0; 47: DBP, 56.0; 47: MAP, 68.667; 50: HR, 102.0; 50: RR, 19.0; 50: SpO2, 94.0; 50: 5min HRV, 10.895; 50: SBP, 94.0; 50: DBP, 56.0; 50: MAP, 68.667; 77: SpO2, 95.176; 78: SpO2, 95.932; 78: Perf, 3.047; 79: SpO2, 95.397; 79: Perf, 2.886; 80: SpO2, 95.576; 80: Perf, 2.753; 81: SpO2, 95.153; 81: Perf, 2.917; 82: SpO2, 94.759; 82: Perf, 3.042; 83: SpO2, 95.0; 83: Perf, 2.844; 84: SpO2, 95.0; 84: Perf, 2.474; 85: SpO2, 95.0; 85: Perf, 2.152; 86: SpO2, 95.138; 86: Perf, 2.112; 87: SpO2, 95.492; 87: Perf, 2.163; 88: SpO2, 95.763; 88: Perf, 2.362; 89: SpO2, 95.586; 89: Perf, 2.067; 90: SpO2, 95.763; 90: Perf, 1.954; 91: SpO2, 95.644; 91: Perf, 1.944; 92: SpO2, 95.603; 92: Perf, 1.77; 93: SpO2, 94.932; 93: Perf, 1.731; 94: SpO2, 95.207; 94: Perf, 1.576; 95: SpO2, 95.0; 95: Perf, 1.505; 96: SpO2, 95.390; 96: Perf, 1.500; 97: SpO2, 95.759; 97: Perf, 1.497; 98: SpO2, 95.379; 98: Perf, 1.476; 99: SpO2, 95.780; 99: Perf, 1.509; 100: SpO2, 95.492; 100: Perf, 1.502; 101: SpO2, 95.593; 101: Perf, 1.464; 102: SpO2, 94.931; 102: Perf, 1.498; 103: SpO2, 95.576; 103: Perf, 1.543; 104: SpO2, 95.845; 104: Perf, 1.474; 105: SpO2, 95.644; 105: Perf, 1.305; 106: SpO2, 96.151; 106: Perf, 0.808; 107: SpO2, 97.207; 107: Perf, 0.534; 108: SpO2, 97.271; 108: Perf, 0.505; 109: SpO2, 95.793; 109: Perf, 0.665; 110: SpO2, 93.414; 110: Perf, 0.695; 111: SpO2, 96.983; 111: Perf, 0.61; 112: SpO2, 97.169; 112: Perf, 0.61; 113: SpO2, 97.525; 113: Perf, 0.61; 114: SpO2, 97.345; 114: Perf, 0.61; 115: SpO2, 96.644; 115: Perf, 0.61; 116: SpO2, 96.034; 116: Perf, 0.61; 117: SpO2, 95.932; 117: Perf, 0.61; 118: SpO2, 95.576; 118: Perf, 0.61; 118: SBP, 93.0; 118: DBP, nan; 118: MAP, nan; 119: SpO2, 96.172; 119: Perf, 0.612; 0: Age, 46; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 36.9; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 104.0; 0: Triage DBP, 58.0; 0: Triage acuity, 3-Urgent; 0: CC, KNEE PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, we subanalyze indicators such as heart rate (HR), respiratory rate (RR), blood pressure (BP), temperature, oxygen saturation (SpO2), and heart rate variability (HRV) over the given timeframe. The patient presents with elevated HR, RR variations, and episodes of low SBP with SpO2 fluctuating but eventually stabilizing, however, these values alone do not reach thresholds indicating acute risk for sepsis within 12 hours. Further, there is normalization over time, and the lack of persistent, profound hypotension, severe temperature deviation, or sustained low SpO2 suggests the patient is currently not at high risk for developing sepsis.",
        "claims": [
            "Indicators such as heart rate (HR), respiratory rate (RR), blood pressure (BP), temperature, oxygen saturation (SpO2), and heart rate variability (HRV) are analyzed to determine sepsis risk.",
            "The patient presents with an elevated heart rate (HR).",
            "The patient presents with variations in respiratory rate (RR).",
            "The patient experiences episodes of low systolic blood pressure (SBP).",
            "The patient's oxygen saturation (SpO2) fluctuates but eventually stabilizes.",
            "These values alone do not reach thresholds indicating acute risk for sepsis within 12 hours.",
            "There is normalization of the indicators over time.",
            "The patient does not have persistent, profound hypotension.",
            "The patient does not have severe temperature deviation.",
            "The patient does not have sustained low oxygen saturation (SpO2).",
            "These factors suggest the patient is currently not at high risk for developing sepsis."
        ],
        "relevant_claims": [
            "The patient presents with an elevated heart rate (HR).",
            "These values alone do not reach thresholds indicating acute risk for sepsis within 12 hours.",
            "The patient does not have persistent, profound hypotension.",
            "The patient does not have severe temperature deviation.",
            "These factors suggest the patient is currently not at high risk for developing sepsis."
        ],
        "alignment_scores": [
            0.4,
            0.0,
            0.7,
            0.2,
            0.0
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "None",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "Not Explicitly Categorized"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (HR) alone does not fully align with any single sepsis prediction category, but it is one component of calculating the Shock Index, which is heart rate divided by systolic blood pressure. While the claim mentions only the heart rate, it suggests a potential contribution to hemodynamic instability assessed via the Shock Index. This relationship earns a moderate alignment rating, reflecting partial but incomplete criteria matching.",
            "The claim indicates that the values do not meet the thresholds for acute risk of sepsis, suggesting none of the specific expert categories are applicable. Without any specific data aligning with any given category, there is no alignment, resulting in a 0.0 rating.",
            "The claim directly mentions the absence of persistent, profound hypotension, which relates to the criteria for sepsis-associated hypotension as defined by the category. While the absence of this condition does not confirm the presence of sepsis, it is directly relevant to evaluating hypotension status with respect to sepsis risk. The alignment is strong because the claim specifically addresses whether a key hypotension criterion is met, although it indicates the opposite condition.",
            "This claim refers to the patient's temperature, which is one of the SIRS criteria. However, it states that the patient does not have a severe temperature deviation, implying the absence of a fever (>38\u00b0C) or hypothermia (<36\u00b0C). This indirectly relates to the absence of one of the SIRS criteria, but since there is no mention of other SIRS criteria, the alignment is weak.",
            "The claim does not specify any particular clinical marker or condition from the expert sepsis categories. It is a general statement about the patient's low risk of sepsis rather than an explicit alignment with any specific category, thus resulting in no direct connection to the listed categories."
        ],
        "final_alignment_score": 0.26,
        "accuracy": 0
    },
    {
        "input": "10: HR, 96.0; 10: RR, 26.0; 10: SpO2, 98.0; 10: SBP, 133.0; 10: DBP, 76.0; 10: MAP, 95.0; 10: Temp, 99.1; 27: SpO2, 97.156; 27: SBP, 131.0; 27: DBP, nan; 27: MAP, nan; 28: SpO2, 97.357; 29: SpO2, 98.341; 30: SpO2, 97.492; 31: SpO2, 95.793; 31: SBP, 119.0; 31: DBP, 58.0; 31: MAP, 78.333; 32: SpO2, 95.237; 33: SpO2, 97.308; 34: SpO2, 97.517; 35: SpO2, 97.932; 36: SpO2, 97.569; 37: SpO2, 97.655; 38: SpO2, 97.367; 39: SpO2, 97.263; 40: SpO2, 97.914; 41: SpO2, 97.644; 42: SpO2, 97.724; 43: SpO2, 96.5; 44: SpO2, 99.0; 44: Perf, 3.644; 45: SpO2, 97.983; 45: Perf, 3.672; 46: HR, 69.0; 46: RR, 30.0; 46: SpO2, 96.958; 46: Perf, 3.73; 46: SBP, 130.0; 46: DBP, 116.0; 46: MAP, 120.667; 46: Temp, 98.3; 47: HR, 62.0; 47: SpO2, 95.103; 47: SBP, 130.0; 47: DBP, 116.0; 47: MAP, 120.667; 48: SpO2, 99.375; 49: SpO2, 97.864; 50: SpO2, 95.862; 51: SpO2, 95.644; 52: SpO2, 95.949; 53: SpO2, 96.712; 54: SpO2, 97.052; 55: SpO2, 97.102; 56: SpO2, 96.810; 57: SpO2, 96.276; 57: Perf, 3.434; 58: SpO2, 96.780; 58: Perf, 3.367; 59: SpO2, 96.276; 59: Perf, 3.348; 60: SpO2, 96.831; 60: Perf, 3.294; 61: SpO2, 96.879; 61: Perf, 3.28; 62: HR, 106.809; 62: RR, 19.659; 62: SpO2, 97.203; 62: Perf, 3.316; 62: 1min HRV, 66.908; 63: HR, 107.776; 63: RR, 20.328; 63: SpO2, 97.034; 63: Perf, 3.291; 63: 1min HRV, 64.980; 64: HR, 107.103; 64: RR, 23.525; 64: SpO2, 97.729; 64: Perf, 3.29; 64: 1min HRV, 61.610; 65: HR, 108.610; 65: RR, 14.053; 65: SpO2, 97.847; 65: Perf, 3.232; 65: 1min HRV, 71.515; 65: 5min HRV, 66.948; 66: HR, 107.789; 66: SpO2, 97.333; 66: Perf, 3.108; 66: 1min HRV, 64.832; 67: HR, 109.559; 67: SpO2, 97.305; 67: Perf, 3.065; 67: 1min HRV, 66.942; 68: HR, 111.069; 68: SpO2, 96.810; 68: Perf, 3.06; 68: 1min HRV, 67.297; 69: HR, 105.695; 69: SpO2, 96.085; 69: Perf, 3.204; 69: 1min HRV, 65.368; 70: WAM DIFTYP, AUTO; 70: MEAN CORPUSCULAR VOLUME (MCV), 91.1 fL; 70: HEMOGLOBIN (HGB), 16.0 g/dL; 70: HEMATOCRIT (HCT), 48.3 %; 70: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 70: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 70: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 70: MONOCYTE % (AUTO DIFF), 7.3 %; 70: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 70: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 70: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.1 g/dL; 70: MONOCYTE ABSOLUTE (AUTO DIFF), 0.47 K/uL; 70: LYMPHOCYTE % (AUTO DIFF), 9.7 %; 70: NEUTROPHIL % (AUTO DIFF), 81.6 %; 70: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.63 K/uL; 70: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 70: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 70: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 70: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.29 K/uL; 70: NRBC PERCENT (HEMATOLOGY), 0.0 %; 70: BASOPHIL % (AUTO DIFF), 0.5 %; 70: PLATELET COUNT (PLT), 203 K/uL; 70: EOSINOPHIL % (AUTO DIFF), 0.3 %; 70: HR, 107.627; 70: SpO2, 96.424; 70: Perf, 3.251; 70: 1min HRV, 60.198; 70: 5min HRV, 65.907; 71: HR, 104.517; 71: SpO2, 97.621; 71: Perf, 3.208; 71: 1min HRV, 76.915; 72: HR, 107.390; 72: SpO2, 97.119; 72: Perf, 3.320; 72: 1min HRV, 64.587; 73: HR, 105.534; 73: SpO2, 96.966; 73: Perf, 3.356; 73: 1min HRV, 65.170; 74: GLUCOSE, URINE (UA): Negative; 74: KETONE, URINE (UA): Negative; 74: PH, URINE (UA): 5.0; 74: LEUKOCYTE ESTERASE, URINE (UA): Negative; 74: NITRITE, URINE (UA): Negative; 74: SPECIFIC GRAVITY, URINE (UA): 1.027; 74: HR, 106.881; 74: SpO2, 96.153; 74: Perf, 3.34; 74: 1min HRV, 67.444; 75: HR, 109.949; 75: SpO2, 96.542; 75: Perf, 3.34; 75: 1min HRV, 64.928; 75: 5min HRV, 68.501; 76: HR, 106.569; 76: SpO2, 97.0; 76: Perf, 3.365; 76: 1min HRV, 66.408; 77: HR, 108.746; 77: SpO2, 97.203; 77: Perf, 3.376; 77: 1min HRV, 59.347; 78: HR, 111.0; 78: SpO2, 97.466; 78: Perf, 3.38; 78: 1min HRV, 72.866; 79: HR, 108.351; 79: RR, 29.957; 79: SpO2, 97.458; 79: Perf, 3.38; 79: 1min HRV, 69.164; 80: HR, 113.881; 80: RR, 28.872; 80: SpO2, 95.746; 80: Perf, 3.38; 80: 1min HRV, 56.213; 80: 5min HRV, 66.186; 81: HR, 111.0; 81: RR, 21.552; 81: SpO2, 97.931; 81: Perf, 3.390; 81: 1min HRV, 54.996; 82: HR, 109.322; 82: RR, 19.471; 82: SpO2, 97.864; 82: Perf, 3.436; 82: 1min HRV, 58.811; 83: HR, 110.707; 83: RR, 22.382; 83: SpO2, 97.810; 83: Perf, 3.44; 83: 1min HRV, 50.588; 84: HR, 110.203; 84: RR, 31.25; 84: SpO2, 97.085; 84: Perf, 3.44; 84: 1min HRV, 57.078; 85: HR, 104.948; 85: RR, 21.397; 85: SpO2, 97.0; 85: Perf, 3.421; 85: 1min HRV, 63.378; 85: 5min HRV, 57.972; 86: HR, 105.455; 86: RR, 19.75; 86: SpO2, 97.103; 86: Perf, 3.377; 86: 1min HRV, 62.959; 87: HR, 104.224; 87: RR, 21.069; 87: SpO2, 97.0; 87: Perf, 3.37; 87: 1min HRV, 65.987; 88: HR, 107.471; 88: RR, 25.810; 88: SpO2, 97.845; 88: Perf, 3.351; 88: 1min HRV, 59.549; 89: HR, 107.932; 89: RR, 13.639; 89: SpO2, 97.593; 89: Perf, 3.289; 89: 1min HRV, 63.945; 90: HR, 109.508; 90: RR, 16.552; 90: SpO2, 96.831; 90: Perf, 3.182; 90: 1min HRV, 64.924; 90: 5min HRV, 64.664; 91: HR, 107.0; 91: SpO2, 96.0; 91: Perf, 2.889; 93: INR, 1.2; 93: PROTHROMBIN TIME, 15.0 seconds; 94: PART. THROMBOPLASTIN TIME, 36.6 seconds; 102: BNP NT-PRO, 2531 pg/mL; 102: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 109: TROPONIN I: ., 030 ng/mL; 0: Age, 48; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.3; 0: Triage HR, 96.0; 0: Triage RR, 26.0; 0: Triage SBP, 133.0; 0: Triage DBP, 76.0; 0: Triage acuity, 3-Urgent; 0: CC, URINARY PAIN,FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "The patient's elevated heart rate, respiratory rate, and recent administration of antibiotics suggest a high risk of developing sepsis. The patient's fever and urinary pain further support this assessment. Elevated heart and respiratory rates are notable markers, particularly in conjunction with the administration of antibiotics in a typically urgent scenario, leading to the conclusion of a high sepsis risk within the next 12 hours.",
        "claims": [
            "The patient's heart rate is elevated.",
            "The patient's respiratory rate is elevated.",
            "The recent administration of antibiotics suggests a high risk of developing sepsis.",
            "The patient has a fever.",
            "The patient has urinary pain.",
            "The fever and urinary pain support the assessment of high sepsis risk.",
            "Elevated heart and respiratory rates are notable markers for sepsis risk.",
            "The administration of antibiotics in an urgent scenario contributes to the assessment of high sepsis risk.",
            "There is a conclusion of high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is elevated.",
            "The patient's respiratory rate is elevated.",
            "The recent administration of antibiotics suggests a high risk of developing sepsis.",
            "The patient has a fever.",
            "The patient has urinary pain.",
            "The fever and urinary pain support the assessment of high sepsis risk.",
            "Elevated heart and respiratory rates are notable markers for sepsis risk.",
            "The administration of antibiotics in an urgent scenario contributes to the assessment of high sepsis risk."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.8,
            0.6,
            0.2,
            0.6,
            0.9,
            0.9
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate is explicitly mentioned in the criteria for systemic inflammatory response syndrome (SIRS), which can be indicative of early sepsis. However, for definitive SIRS positivity, at least two criteria must be met, so the alignment is strong but not perfect without additional information.",
            "The claim about an elevated respiratory rate aligns most closely with the High qSOFA Score. An elevated respiratory rate is a specific component (\u226522/min) of the qSOFA score used to assess the risk of sepsis-related organ dysfunction. Although the claim doesn't specify whether the respiratory rate is \u226522, the fact that it is elevated suggests potential relevance to qSOFA criteria. Thus, the alignment is significant but not complete without exact values.",
            "The administration of antibiotics is a significant clinical action indicating suspicion of serious infection, aligning directly with the early antibiotic/culture orders category. However, the claim lacks specific timing details (e.g., within the first 2 hours), which slightly reduces the alignment from a perfect score.",
            "The claim of having a fever aligns with the SIRS criteria, specifically \"temperature >38\u00b0C,\" which is used to identify systemic inflammation indicative of early sepsis. However, the claim does not specify the fever's exact temperature to confirm meeting the SIRS threshold (>38\u00b0C), so the alignment is partial rather than full.",
            "Urinary pain can indicate a urinary tract infection, which can lead to sepsis if untreated. However, the claim doesn't specify any direct action like ordering antibiotics or cultures that falls under this category. Thus, the claim indirectly suggests a suspicion of infection with weak alignment.",
            "The claim implies suspicion of infection based on symptoms (fever and urinary pain), which commonly prompts actions like antibiotic administration or ordering cultures to assess sepsis risk. While not explicitly stated, the claim closely aligns with the reasoning underpinning early diagnostic and treatment interventions for suspected serious infections, indicating a moderate alignment with the category.",
            "The claim highlights elevated heart and respiratory rates, both of which are explicitly part of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. While it does not specify the exact values needed to meet the criteria, the mention of these two markers strongly aligns with the SIRS Positivity category.",
            "The claim emphasizes the urgent administration of antibiotics, which aligns very closely with the expert category of \"Early Antibiotic/Culture Orders.\" This category involves the prompt administration of broad-spectrum antibiotics as a response to suspected severe infection, which contributes to high sepsis risk assessment. Although the exact timing of \"within 2 hours\" is not specified, the urgency implied strongly suggests a close match with this category. Hence, the alignment rating is high at 0.9."
        ],
        "final_alignment_score": 0.6875,
        "accuracy": 0
    },
    {
        "input": "12: HR, 71.0; 12: RR, 14.0; 12: SpO2, 95.0; 12: SBP, 101.0; 12: DBP, 53.0; 12: MAP, 69.0; 12: Temp, 95.5; 15: Pain, 0.0; 21: POC GLUCOSE BY METER, 110 mg/dL; 23: Temp, 98.4; 68: HR, 71.048; 68: RR, 21.216; 68: 1min HRV, 118.647; 68: 5min HRV, 118.647; 69: HR, 68.203; 69: RR, 22.881; 69: SpO2, 94.054; 69: Perf, 8.043; 69: 1min HRV, 25.429; 70: HR, 69.0; 70: RR, 20.069; 70: SpO2, 95.190; 70: Perf, 7.138; 70: 1min HRV, 23.513; 71: HR, 68.661; 71: RR, 21.051; 71: SpO2, 94.983; 71: Perf, 6.486; 71: 1min HRV, 22.759; 72: HR, 66.881; 72: RR, 20.169; 72: SpO2, 94.729; 72: Perf, 6.701; 72: 1min HRV, 13.082; 73: HR, 66.293; 73: RR, 20.914; 73: SpO2, 93.914; 73: Perf, 6.633; 73: 1min HRV, 10.359; 73: 5min HRV, 24.827; 74: HR, 67.627; 74: RR, 20.729; 74: SpO2, 94.017; 74: Perf, 6.500; 74: 1min HRV, 14.015; 75: HR, 68.741; 75: RR, 20.983; 75: SpO2, 94.776; 75: Perf, 6.494; 75: 1min HRV, 23.017; 76: HR, 68.051; 76: RR, 18.847; 76: SpO2, 93.915; 76: Perf, 6.348; 76: 1min HRV, 24.286; 77: HR, 66.864; 77: RR, 20.542; 77: SpO2, 94.458; 77: Perf, 6.000; 77: 1min HRV, 17.775; 78: HR, 67.270; 78: RR, 20.324; 78: SpO2, 93.625; 78: Perf, 5.996; 78: 1min HRV, 22.862; 78: 5min HRV, 21.776; 93: HR, 67.0; 93: RR, 21.0; 93: SpO2, 96.0; 93: Pain, 0.0; 94: HR, 66.0; 94: RR, 15.412; 94: SpO2, 95.077; 94: 1min HRV, 9.971; 95: HR, 66.724; 95: RR, 19.362; 95: SpO2, 95.534; 95: Perf, 5.150; 95: 1min HRV, 20.369; 96: HR, 67.949; 96: RR, 18.458; 96: SpO2, 95.305; 96: Perf, 5.37; 96: 1min HRV, 19.084; 97: INFLUENZA A, Not Detected; 97: INFLUENZA B, Not Detected; 97: SARS-COV-2 RNA, Not Detected; 97: RSV, Not Detected; 97: HR, 66.534; 97: RR, 18.845; 97: SpO2, 94.328; 97: Perf, 5.031; 97: 1min HRV, 18.682; 98: HR, 67.153; 98: RR, 19.746; 98: SpO2, 94.153; 98: Perf, 4.881; 98: 1min HRV, 13.253; 98: 5min HRV, 18.928; 99: HR, 66.932; 99: RR, 18.373; 99: SpO2, 94.627; 99: Perf, 4.283; 99: 1min HRV, 22.392; 100: HR, 65.966; 100: RR, 18.293; 100: SpO2, 94.328; 100: Perf, 4.909; 100: 1min HRV, 11.049; 101: HR, 66.356; 101: RR, 17.458; 101: SpO2, 94.661; 101: Perf, 4.382; 101: 1min HRV, 21.931; 102: HR, 68.517; 102: RR, 19.534; 102: SpO2, 96.828; 102: Perf, 4.202; 102: 1min HRV, 41.638; 103: HR, 66.881; 103: RR, 19.356; 103: SpO2, 94.627; 103: Perf, 3.830; 103: 1min HRV, 27.780; 103: 5min HRV, 28.206; 104: HR, 66.881; 104: RR, 18.220; 104: SpO2, 93.169; 104: Perf, 3.421; 104: 1min HRV, 24.512; 105: HR, 67.310; 105: RR, 19.190; 105: SpO2, 94.345; 105: Perf, 2.697; 105: 1min HRV, 26.227; 106: HR, 66.102; 106: RR, 19.136; 106: SpO2, 94.373; 106: Perf, 2.676; 106: 1min HRV, 26.542; 107: HR, 65.897; 107: RR, 19.172; 107: SpO2, 94.431; 107: Perf, 2.753; 107: 1min HRV, 27.196; 108: HR, 66.034; 108: RR, 18.949; 108: SpO2, 94.220; 108: Perf, 2.97; 108: 1min HRV, 28.092; 108: 5min HRV, 27.770; 109: POC HCT ISTAT, 30 %; 109: POC GLUCOSE ISTAT, 119 mg/dL; 109: POC HGB (CALC) ISTAT, 10.2 g/dL; 109: POC SODIUM ISTAT, 133 mmol/L; 109: POC POTASSIUM ISTAT, 3.3 mmol/L; 109: HR, 65.356; 109: RR, 17.559; 109: SpO2, 94.322; 109: Perf, 2.850; 109: 1min HRV, 27.110; 110: POC PH (V) ISTAT, 7.48; 110: POC BASE EXCESS ISTAT, 9 mmol/L; 110: POC PCO2 (V) ISTAT, 44.2 mmHg; 110: POC TCO2 (V) ISTAT, 34 mmol/L; 110: POC O2 SATURATION ISTAT VENOUS, 85 %; 110: POC PO2 (V) ISTAT, 47 mmHg; 110: POC LACTATE ISTAT, 0.50 mmol/L; 110: POC HCO3 (V) ISTAT, 33.0 mmol/L; 110: HR, 67.259; 110: RR, 20.552; 110: SpO2, 94.793; 110: Perf, 2.956; 110: 1min HRV, 30.449; 111: HR, 68.034; 111: RR, 19.203; 111: SpO2, 95.0; 111: Perf, 3.131; 111: 1min HRV, 23.808; 112: HR, 67.879; 112: RR, 19.293; 112: SpO2, 94.052; 112: Perf, 3.301; 112: 1min HRV, 28.090; 113: HR, 68.339; 113: RR, 20.508; 113: SpO2, 94.542; 113: Perf, 3.465; 113: 1min HRV, 20.705; 113: 5min HRV, 29.870; 114: HR, 68.542; 114: RR, 20.186; 114: SpO2, 94.458; 114: Perf, 3.305; 114: 1min HRV, 25.128; 115: HR, 66.586; 115: RR, 20.552; 115: SpO2, 93.776; 115: Perf, 4.752; 115: 1min HRV, 23.213; 116: HR, 66.525; 116: RR, 18.508; 116: SpO2, 95.983; 116: Perf, 3.87; 116: 1min HRV, 24.671; 117: HR, 67.793; 117: RR, 19.276; 117: SpO2, 94.345; 117: Perf, 4.154; 117: 1min HRV, 28.839; 118: HR, 67.475; 118: RR, 18.322; 118: SpO2, 94.203; 118: Perf, 4.330; 118: 1min HRV, 31.003; 118: 5min HRV, 28.383; 119: ABO/RH (AUTOMATION), O Positive; 119: HR, 67.932; 119: RR, 20.203; 119: SpO2, 93.966; 119: Perf, 4.078; 119: 1min HRV, 32.047; 0: Age, 69; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 35.3; 0: Triage HR, 71.0; 0: Triage RR, 14.0; 0: Triage SBP, 101.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, FALL",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The easiest subquestion is identifying if there are immediate signs or symptoms indicative of sepsis risk such as abnormal vitals or changes in mental status. The patient's initial vital signs show hypotension with a low diastolic blood pressure (DBP 53) and hypothermia (Temp 35.3). However, these do not persist throughout the time series, and there are no signs of steadily worsening multisystem dysfunction, organ failure, or markedly elevated lactate levels (0.5 mmol/L). The second subquestion checks for trending abnormalities or sustained instability in heart rate, respiratory rate, blood pressure, or perfusion; the patient's metrics remain largely stable without alarming trends. Thus, given the data and lack of critical warning signs, the patient is not considered at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The easiest subquestion is identifying if there are immediate signs or symptoms indicative of sepsis risk.",
            "Immediate signs of sepsis risk include abnormal vitals or changes in mental status.",
            "The patient's initial vital signs show hypotension.",
            "The patient's diastolic blood pressure (DBP) is 53.",
            "The patient shows hypothermia with a temperature of 35.3.",
            "The hypotension and hypothermia do not persist throughout the time series.",
            "There are no signs of steadily worsening multisystem dysfunction.",
            "There are no signs of organ failure.",
            "There are no markedly elevated lactate levels; the lactate level is 0.5 mmol/L.",
            "The second subquestion checks for trending abnormalities or sustained instability in vital signs.",
            "The patient's heart rate metrics remain largely stable.",
            "The patient's respiratory rate metrics remain largely stable.",
            "The patient's blood pressure metrics remain largely stable.",
            "The patient's perfusion metrics remain largely stable.",
            "There are no alarming trends in the patient's vital signs.",
            "Given the data, the patient is not considered at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's initial vital signs show hypotension.",
            "The hypotension and hypothermia do not persist throughout the time series.",
            "There are no signs of organ failure.",
            "There are no markedly elevated lactate levels; the lactate level is 0.5 mmol/L."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.7,
            0.2
        ],
        "alignment_category": [
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "The claim directly mentions hypotension, which is a key aspect of the \"Sepsis-Associated Hypotension\" category. This category identifies sepsis-associated hypotension through specific thresholds (SBP\u202f<\u202f90\u202fmmHg, MAP\u202f<\u202f70\u202fmmHg, or a\u202f\u2265\u202f40\u202fmmHg drop from baseline) that indicate progression toward septic shock. While the claim does not provide the exact measurements or detail the extent of the hypotension, the alignment with the category is strong, indicating a significant potential risk of sepsis.",
            "The claim mentions hypotension, which is directly relevant to the Sepsis-Associated Hypotension category. Although it doesn't specify the blood pressure values or a sustained drop, the mention of hypotension is significant. Hypothermia is related to SIRS criteria, but the lack of persistence aligns better with a transient hypotensive state rather than fulfilling the persistent criteria for sepsis or SIRS. Therefore, due to its direct reference, it has a strong alignment with the hypotension aspect of the category, although not a perfect one due to the lack of sustained or specified severity.",
            "The absence of organ failure suggests no increase in the SOFA score, which is used to assess organ dysfunction in sepsis. Although the claim does not explicitly discuss the SOFA score, it directly relates to the absence of factors that would increase the score, making this category pertinent. The alignment is strong due to the direct relation to organ function, but it's slightly less than perfect since the claim is about the absence of a condition rather than a specific measurement.",
            "The claim mentions lactate levels but indicates they are not elevated (0.5 mmol/L is well below the threshold of \u22652 mmol/L that signifies risk of sepsis mortality). While it is related to the elevated lactate category, the lack of elevation suggests a very weak alignment."
        ],
        "final_alignment_score": 0.6000000000000001,
        "accuracy": 0
    },
    {
        "input": "8: HR, 122.0; 8: 1min HRV, 6.485; 9: HR, 119.949; 9: 1min HRV, 5.774; 10: HR, 119.431; 10: RR, 25.0; 10: SpO2, 99.0; 10: 1min HRV, 7.438; 10: SBP, 157.0; 10: DBP, 111.0; 10: MAP, 126.333; 10: Pain, 10.0; 10: Temp, 97.7; 11: HR, 125.864; 11: 1min HRV, 5.985; 12: HR, 128.552; 12: 1min HRV, 12.354; 12: 5min HRV, 15.326; 13: HR, 132.763; 13: 1min HRV, 5.476; 14: HR, 128.237; 14: 1min HRV, 5.782; 15: HR, 127.052; 15: 1min HRV, 6.009; 16: HR, 129.576; 16: 1min HRV, 3.205; 17: HR, 131.397; 17: SpO2, 81.0; 17: 1min HRV, 3.718; 17: 5min HRV, 8.351; 18: HR, 134.780; 18: SpO2, 81.6; 18: 1min HRV, 3.966; 19: HR, 134.322; 19: 1min HRV, 3.130; 20: HR, 134.966; 20: 1min HRV, 2.578; 21: HR, 136.186; 21: 1min HRV, 3.903; 22: HR, 135.621; 22: 1min HRV, 2.507; 22: 5min HRV, 3.855; 23: HR, 135.915; 23: 1min HRV, 3.906; 24: HR, 138.593; 24: 1min HRV, 12.697; 25: HR, 137.172; 25: 1min HRV, 2.892; 26: HR, 137.729; 26: 1min HRV, 5.677; 27: HR, 141.534; 27: 1min HRV, 10.735; 27: 5min HRV, 9.730; 28: HR, 140.305; 28: 1min HRV, 3.041; 29: HR, 136.603; 29: 1min HRV, 7.352; 30: HR, 136.898; 30: SpO2, 72.030; 30: 1min HRV, 3.811; 31: HR, 141.288; 31: SpO2, 71.5; 31: 1min HRV, 10.722; 32: HR, 141.086; 32: 1min HRV, 6.121; 32: 5min HRV, 10.326; 33: HR, 140.068; 33: 1min HRV, 3.493; 34: HR, 140.362; 34: 1min HRV, 3.298; 35: HR, 145.552; 35: SpO2, 84.059; 35: 1min HRV, 11.218; 36: HR, 143.617; 36: 1min HRV, 12.918; 37: HR, 147.948; 37: 1min HRV, 17.235; 37: 5min HRV, 13.856; 38: HR, 145.186; 38: SpO2, 80.0; 38: 1min HRV, 11.901; 39: HR, 143.362; 39: SpO2, 80.611; 39: 1min HRV, 5.209; 40: HR, 141.119; 40: 1min HRV, 4.706; 41: HR, 143.576; 41: 1min HRV, 15.462; 42: HR, 143.431; 42: 1min HRV, 5.235; 42: 5min HRV, 10.431; 43: HR, 143.085; 43: 1min HRV, 16.664; 44: HR, 142.431; 44: 1min HRV, 3.801; 44: HYDROMORPHONE, 1 MG/ML INJ SYRG; 45: HR:, 141.322; 45: 1min HRV, 3.006; 46: HR, 140.729; 46: 1min HRV, 6.007; 47: HR, 144.759; 47: 1min HRV, 5.140; 47: 5min HRV, 9.141; 48: HR, 140.534; 48: 1min HRV, 12.333; 49: HR, 137.186; 49: 1min HRV, 2.207; 50: HR, 137.153; 50: 1min HRV, 3.967; 51: HR, 135.915; 51: 1min HRV, 3.492; 52: HR, 137.448; 52: 1min HRV, 5.259; 52: 5min HRV, 7.911; 53: HR, 140.576; 53: 1min HRV, 7.635; 54: HR, 140.586; 54: 1min HRV, 3.035; 55: HR, 139.763; 55: 1min HRV, 2.794; 56: HR, 136.746; 56: 1min HRV, 4.514; 57: HR, 136.224; 57: 1min HRV, 5.090; 57: 5min HRV, 7.816; 58: HR, 135.525; 58: 1min HRV, 2.689; 59: HR, 136.483; 59: 1min HRV, 3.506; 60: HR, 136.569; 60: 1min HRV, 2.851; 61: HR, 136.915; 61: 1min HRV, 15.564; 62: HR, 136.068; 62: 1min HRV, 2.720; 62: 5min HRV, 7.596; 63: HR, 135.356; 63: 1min HRV, 3.134; 64: HR, 136.552; 64: 1min HRV, 4.518; 65: HR, 139.661; 65: 1min HRV, 7.439; 66: HR, 133.0; 66: 1min HRV, 19.097; 67: HR, 132.492; 67: 1min HRV, 3.197; 67: 5min HRV, 12.820; 68: HR, 133.186; 68: 1min HRV, 4.656; 69: HR, 134.966; 69: 1min HRV, 3.943; 70: HR, 134.712; 70: 1min HRV, 2.937; 71: HR, 134.983; 71: 1min HRV, 3.785; 72: HR, 133.879; 72: 1min HRV, 2.891; 72: 5min HRV, 4.401; 73: HR, 133.85; 73: 1min HRV, 3.464; 74: HR, 135.828; 74: 1min HRV, 5.596; 75: HR, 139.271; 75: 1min HRV, 5.174; 76: HR, 142.5; 76: 1min HRV, 0.740; 77: SARS-COV-2 RNA, Not Detected; 77: 5min HRV, 9.243; 79: HR, 143.0; 79: 1min HRV, 1.797; 80: HR, 140.949; 80: 1min HRV, 16.120; 81: HR, 136.966; 81: 1min HRV, 3.455; 82: HR, 135.542; 82: 1min HRV, 2.452; 82: 5min HRV, 12.124; 83: HR, 134.797; 83: 1min HRV, 2.825; 84: HR, 135.483; 84: 1min HRV, 2.503; 84: LR IV BOLUS -, 1000 ML; 85: HR:, 135.068; 85: 1min HRV, 3.966; 86: HR, 135.310; 86: 1min HRV, 4.188; 87: HR, 135.288; 87: 1min HRV, 3.515; 87: 5min HRV, 3.577; 88: HR, 136.417; 88: 1min HRV, 2.231; 92: 5min HRV, 2.231; 93: SpO2, 94.778; 97: Pain, 8.0; 110: SpO2, 92.444; 0: Age, 40; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 120.0; 0: Triage RR, 25.0; 0: Triage SBP, 157.0; 0: Triage DBP, 111.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,FLANK PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The patient's data indicates a high risk of developing sepsis. The elevated heart rate (HR) and low heart rate variability (HRV) are concerning signs, as they may signify autonomic instability, often linked with sepsis. Additionally, the patient experiences episodes of low SpO2 (as low as 71.5%), indicative of possible hypoxemia\u2014a critical sign in evaluating sepsis risk. Such persistently abnormal vital signs, especially in conjunction with severe pain, indicate that this patient is likely at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's data indicates a high risk of developing sepsis.",
            "The elevated heart rate (HR) is a concerning sign.",
            "The low heart rate variability (HRV) is a concerning sign.",
            "Elevated HR and low HRV may signify autonomic instability.",
            "Autonomic instability is often linked with sepsis.",
            "The patient experiences episodes of low SpO2.",
            "The patient's SpO2 levels have been as low as 71.5%.",
            "A SpO2 level as low as 71.5% is indicative of possible hypoxemia.",
            "Possible hypoxemia is a critical sign in evaluating sepsis risk.",
            "Persistently abnormal vital signs indicate that the patient is likely at high risk of developing sepsis.",
            "Severe pain in conjunction with abnormal vital signs increases the risk of sepsis.",
            "This patient is likely at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's data indicates a high risk of developing sepsis.",
            "The elevated heart rate (HR) is a concerning sign.",
            "The low heart rate variability (HRV) is a concerning sign.",
            "Elevated HR and low HRV may signify autonomic instability.",
            "Autonomic instability is often linked with sepsis.",
            "The patient experiences episodes of low SpO2.",
            "The patient's SpO2 levels have been as low as 71.5%.",
            "A SpO2 level as low as 71.5% is indicative of possible hypoxemia.",
            "Possible hypoxemia is a critical sign in evaluating sepsis risk.",
            "Persistently abnormal vital signs indicate that the patient is likely at high risk of developing sepsis.",
            "Severe pain in conjunction with abnormal vital signs increases the risk of sepsis.",
            "This patient is likely at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.3,
            0.5,
            0.7,
            0.5,
            0.8,
            0.7,
            0.7,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim \"The patient's data indicates a high risk of developing sepsis\" suggests an overall assessment of risk, which is often captured by scoring systems like the NEWS. However, the claim does not specify which clinical parameters or scoring criteria were used. Without specific data points or scores given, the alignment is weak and indirect, hence the moderate but not strong rating.",
            "An elevated heart rate is directly referenced as part of the SIRS criteria, which requires a heart rate of >90 bpm. While the claim indicates concern about heart rate, it doesn't specify the exact heart rate or any additional SIRS criteria that might be present, leading to a less than perfect alignment, but it still strongly suggests potential systemic inflammation consistent with early sepsis.",
            "Low heart rate variability (HRV) is generally a marker of autonomic dysfunction, which can be associated with haemodynamic instability often seen in sepsis scenarios. While HRV isn't a direct component of the Shock Index, both are indicative of instability and stress responses within the cardiovascular system. Thus, there is a conceptual but indirect overlap\u2014hence a low alignment rating.",
            "The claim regarding elevated heart rate (HR) suggests hemodynamic instability which can be tied to the Elevated Shock Index category, where heart rate is a primary component. However, the claim does not directly mention the systolic blood pressure or provide a calculated Shock Index value, so while there is some alignment due to the concept of instability, it isn't fully comprehensive or directly measured against the category criterion. Additionally, low heart rate variability (HRV) could indicate autonomic instability, which indirectly relates to the physiological stress seen in sepsis, but it is not explicitly covered in any category.",
            "The claim refers to \"autonomic instability,\" which relates to haemodynamic instability\u2014a key element of the Elevated Shock Index category. While the claim itself doesn't provide quantitative data to confirm an elevated shock index, the concept of autonomic instability being linked with sepsis aligns with the idea of haemodynamic problems like those measured by the shock index. Thus, the alignment is indirect but significant.",
            "Episodes of low SpO2 suggest issues with oxygenation, conceptually related to impaired ventilation, which can be a concern in SOFA evaluations (e.g., low PaO\u2082/FiO\u2082 ratio). Although SpO2 is not directly mentioned in SOFA criteria, it indicates a potential risk of sepsis-related organ dysfunction through respiratory compromise. Thus, there is a moderate alignment.",
            "The claim regarding SpO2 levels as low as 71.5% strongly suggests significant hypoxia, which relates to impaired oxygenation\u2014a key component of the SOFA score (PaO\u2082/FiO\u2082). Although SpO2 isn\u2019t directly a measure in the SOFA categories, it is an indicator of severe oxygenation impairment, suggesting new organ dysfunction and a high sepsis risk. The alignment is strong but not exact, warranting a high rating.",
            "A SpO2 level of 71.5% indicates possible hypoxemia, which is conceptually related to impaired oxygenation associated with the respiratory component of the SOFA score (such as PaO\u2082/FiO\u2082 ratio). Although SpO2 is not directly measured in the SOFA criteria, the severity of hypoxemia suggests a potential for significant organ dysfunction, thus creating a moderate alignment.",
            "The concept of hypoxemia relates to impaired oxygenation, similar to how the SOFA score considers PaO\u2082/FiO\u2082 for organ dysfunction assessment. While not directly part of the SOFA score measures, hypoxemia signals potential organ impairment. This creates a strong but indirect alignment with the category.",
            "The claim about persistently abnormal vital signs aligns with the criteria for an elevated NEWS score, which assesses deranged vitals to predict clinical deterioration. The claim's reference to \"persistently abnormal vital signs\" suggests a systematic measurement like NEWS, though it doesn't specify a score. Consequently, while the alignment is substantial, it is not explicitly confirmed to the criteria for a perfect match.",
            "The claim mentions severe pain and abnormal vital signs, which can contribute to an elevated NEWS score. Although severe pain isn't a direct component of the NEWS score, the reference to abnormal vital signs suggests clinical instability, aligning with the criteria used in calculating NEWS. Thus, the category reflects a moderate to strong alignment with the claim, despite severe pain not being explicitly part of the NEWS criteria.",
            "The claim broadly states a high risk of developing sepsis within 12 hours without providing specific details or clinical data. The Elevated NEWS Score category is associated with predictions of imminent clinical deterioration, making it the closest fit conceptually. However, due to the lack of specific information or metrics in the claim, the alignment is weak, and the rating reflects this indirect and speculative connection."
        ],
        "final_alignment_score": 0.5750000000000001,
        "accuracy": 1
    },
    {
        "input": "9: HR, 95.0; 9: RR, 18.0; 9: SpO2, 77.0; 9: SBP, 112.0; 9: DBP, 84.0; 9: MAP, 93.333; 9: LPM O2, nan; 9: Temp, 98.1; 14: SpO2, 96.0; 14: LPM O2, 4.0; 45: HR, 82.0; 45: SpO2, 96.0; 45: SBP, 122.0; 45: DBP, 80.0; 45: MAP, 94.0; 45: LPM O2, 4.0; 49: SpO2, 96.0; 50: SpO2, 95.109; 50: Perf, 1.92; 51: SpO2, 94.774; 51: Perf, 1.96; 75: SpO2, 97.0; 76: SpO2, 96.566; 77: SpO2, 96.358; 78: SpO2, 96.808; 79: SpO2, 97.245; 80: SpO2, 97.135; 81: SpO2, 97.093; 82: SpO2, 97.321; 82: Perf, 0.838; 83: SpO2, 98.115; 83: Perf, 1.027; 84: SpO2, 98.811; 84: Perf, 1.008; 85: HR, 83.152; 85: RR, 23.25; 85: SpO2, 98.962; 85: Perf, 0.881; 85: 1min HRV, 92.396; 85: 5min HRV, 92.396; 86: HR, 83.981; 86: RR, 22.811; 86: SpO2, 99.415; 86: Perf, 0.951; 86: 1min HRV, 91.875; 87: HR, 83.189; 87: RR, 18.151; 87: SpO2, 98.906; 87: Perf, 0.996; 87: 1min HRV, 99.886; 88: HR, 84.346; 88: RR, 20.596; 88: SpO2, 98.904; 88: Perf, 0.978; 88: 1min HRV, 98.378; 89: HR, 87.698; 89: RR, 23.340; 89: SpO2, 98.684; 89: Perf, 0.97; 89: 1min HRV, 103.759; 90: HR, 86.269; 90: RR, 19.558; 90: SpO2, 98.0; 90: Perf, 0.974; 90: 1min HRV, 87.281; 90: 5min HRV, 97.058; 91: HR, 86.170; 91: RR, 24.434; 91: SpO2, 97.830; 91: Perf, 0.982; 91: 1min HRV, 114.745; 92: HR, 86.547; 92: RR, 20.755; 92: SpO2, 98.377; 92: Perf, 0.993; 92: 1min HRV, 96.649; 93: HR, 87.887; 93: RR, 25.377; 93: SpO2, 98.509; 93: Perf, 1.400; 93: 1min HRV, 128.835; 94: HR, 88.094; 94: RR, 23.755; 94: SpO2, 98.377; 94: Perf, 1.707; 94: 1min HRV, 115.796; 95: HR, 85.423; 95: RR, 20.481; 95: SpO2, 98.0; 95: Perf, 1.755; 95: 1min HRV, 87.944; 95: 5min HRV, 109.781; 96: HR, 84.811; 96: RR, 19.170; 96: SpO2, 98.308; 96: Perf, 1.494; 96: 1min HRV, 107.870; 97: HR, 83.887; 97: RR, 18.962; 97: SpO2, 98.0; 97: Perf, 1.488; 97: 1min HRV, 96.765; 98: HR, 83.654; 98: RR, 19.212; 98: SpO2, 98.269; 98: Perf, 1.531; 98: 1min HRV, 106.380; 99: HR, 83.415; 99: RR, 16.887; 99: SpO2, 98.576; 99: Perf, 1.367; 99: 1min HRV, 102.632; 100: HR, 83.846; 100: RR, 17.75; 100: SpO2, 97.923; 100: Perf, 1.313; 100: 1min HRV, 83.002; 100: 5min HRV, 99.817; 101: WAM DIFTYP, AUTO; 101: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 101: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.80 K/uL; 101: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.4 g/dL; 101: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 101: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 101: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 101: MONOCYTE % (AUTO DIFF), 9.9 %; 101: LYMPHOCYTE % (AUTO DIFF), 15.4 %; 101: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 101: NRBC PERCENT (HEMATOLOGY), 0.0 %; 101: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.35 K/uL; 101: EOSINOPHIL % (AUTO DIFF), 5.0 %; 101: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.07 K/uL; 101: MEAN CORPUSCULAR VOLUME (MCV), 114.1 fL; 101: NEUTROPHIL % (AUTO DIFF), 69.2 %; 101: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 35.9 pg; 101: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 101: HEMOGLOBIN (HGB), 10.4 g/dL; 101: HEMATOCRIT (HCT), 33.1 %; 101: PLATELET COUNT (PLT), 197 K/uL; 101: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.1 %; 101: RED CELL DISTRIBUTION WIDTH (RDW), 14.4 %; 101: BASOPHIL % (AUTO DIFF), 0.4 %; 101: HR, 84.057; 101: RR, 19.132; 101: SpO2, 98.453; 101: Perf, 1.311; 101: 1min HRV, 120.978; 102: HR, 83.396; 102: RR, 17.943; 102: SpO2, 97.566; 102: Perf, 1.299; 102: 1min HRV, 100.458; 103: HR, 84.192; 103: RR, 21.981; 103: SpO2, 98.0; 103: Perf, 1.255; 103: 1min HRV, 117.417; 104: HR, 83.981; 104: RR, 19.226; 104: SpO2, 97.906; 104: Perf, 1.149; 104: 1min HRV, 95.129; 105: HR, 82.942; 105: RR, 17.558; 105: SpO2, 98.327; 105: Perf, 1.450; 105: 1min HRV, 86.174; 105: 5min HRV, 103.831; 105: LPM O2, 4.0; 106: HR, 83.509; 106: RR, 19.019; 106: SpO2, 97.566; 106: Perf, 1.604; 106: 1min HRV, 98.076; 107: HR, 83.472; 107: RR, 20.075; 107: SpO2, 98.019; 107: Perf, 1.633; 107: 1min HRV, 81.495; 108: HR, 82.925; 108: RR, 20.679; 108: SpO2, 98.245; 108: Perf, 0.948; 108: 1min HRV, 121.444; 109: HR, 83.075; 109: RR, 21.132; 109: SpO2, 98.434; 109: Perf, 0.889; 109: 1min HRV, 102.718; 110: HR, 81.923; 110: RR, 22.231; 110: SpO2, 97.962; 110: Perf, 1.283; 110: 1min HRV, 85.795; 110: 5min HRV, 99.079; 111: HR, 82.642; 111: RR, 20.585; 111: SpO2, 98.830; 111: Perf, 1.488; 111: 1min HRV, 84.665; 112: HR, 84.712; 112: RR, 20.635; 112: SpO2, 98.769; 112: Perf, 1.543; 112: 1min HRV, 110.879; 113: HR, 82.283; 113: RR, 25.396; 113: SpO2, 98.434; 113: Perf, 1.144; 113: 1min HRV, 86.141; 114: HR, 83.222; 114: RR, 20.778; 114: SpO2, 98.611; 114: Perf, 0.899; 114: 1min HRV, 84.949; 115: HR, 82.423; 115: RR, 21.827; 115: SpO2, 98.365; 115: Perf, 0.94; 115: 1min HRV, 89.629; 115: 5min HRV, 91.965; 116: HR, 82.755; 116: RR, 20.811; 116: SpO2, 98.755; 116: Perf, 1.107; 116: 1min HRV, 102.620; 117: HR, 83.712; 117: RR, 18.865; 117: SpO2, 98.308; 117: Perf, 1.218; 117: 1min HRV, 88.153; 118: HR, 83.094; 118: RR, 20.962; 118: SpO2, 97.792; 118: Perf, 1.218; 118: 1min HRV, 102.102; 119: HR, 85.111; 119: RR, 22.0; 119: SpO2, 98.0; 119: Perf, 1.23; 119: 1min HRV, 109.427; 0: Age, 66; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 112.0; 0: Triage DBP, 84.0; 0: Triage acuity, 2-Emergent; 0: CC, BREATHING PROBLEM",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "First, consider whether the patient's initial presentation and subsequent vital signs indicate an elevated risk of sepsis. The presence of significant respiratory distress or compromised oxygenation could suggest higher risk. Initially, the SpO2 is critically low at 77%, but it improves to acceptable levels (above 95%) with supplemental oxygen, suggesting temporary respiratory compromise likely due to initial presentation rather than progressive sepsis. Second, examine the heart rate, blood pressure, and temperature for abnormal values indicating systemic infection. The HR and BP remain relatively stable, and there is no fever or hypothermia present. Additionally, white blood cell count and other laboratory values do not indicate an acute infectious process. Finally, consider the variability in measurements over time and the response to interventions. The patient maintains stable vitals with intervention, suggesting that while oxygen levels were initially concerning, the patient does not demonstrate other physiological markers of sepsis.",
        "claims": [
            "The patient's initial presentation and subsequent vital signs need to be considered to assess the risk of sepsis.",
            "Significant respiratory distress or compromised oxygenation could suggest a higher risk of sepsis.",
            "The initial SpO2 level is critically low at 77%.",
            "The SpO2 level improves to acceptable levels above 95% with supplemental oxygen.",
            "The improvement in SpO2 suggests temporary respiratory compromise likely due to initial presentation rather than progressive sepsis.",
            "The heart rate, blood pressure, and temperature should be examined for abnormal values indicating systemic infection.",
            "The heart rate and blood pressure remain relatively stable.",
            "There is no fever present in the patient.",
            "There is no hypothermia present in the patient.",
            "The white blood cell count and other laboratory values do not indicate an acute infectious process.",
            "The variability in measurements over time and the response to interventions should be considered.",
            "The patient maintains stable vitals with interventions.",
            "While oxygen levels were initially concerning, the patient does not demonstrate other physiological markers of sepsis."
        ],
        "relevant_claims": [
            "The patient's initial presentation and subsequent vital signs need to be considered to assess the risk of sepsis.",
            "Significant respiratory distress or compromised oxygenation could suggest a higher risk of sepsis.",
            "The initial SpO2 level is critically low at 77%.",
            "The SpO2 level improves to acceptable levels above 95% with supplemental oxygen.",
            "The heart rate, blood pressure, and temperature should be examined for abnormal values indicating systemic infection.",
            "There is no fever present in the patient.",
            "The white blood cell count and other laboratory values do not indicate an acute infectious process."
        ],
        "alignment_scores": [
            0.4,
            0.7,
            0.7,
            0.3,
            0.7,
            0.3,
            0.6
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "The claim mentions the necessity to evaluate the patient's initial presentation and vital signs, which aligns generally with assessing clinical deterioration through vital sign alterations indicated by the NEWS score. However, it lacks specifics on the actual scoring or threshold that would indicate sepsis risk, leading to a partial but not strong alignment with this category.",
            "The claim highlights respiratory distress or compromised oxygenation, which aligns with the SOFA component involving impaired oxygenation (PaO\u2082/FiO\u2082 < 300). While not directly measured by oxygenation metrics alone, respiratory distress suggests possible organ dysfunction relevant to SOFA. The connection to the SOFA increase justifies a strong but not perfect alignment.",
            "The claim of a critically low SpO\u2082 level (77%) suggests significant hypoxia, which conceptually aligns with the SOFA criteria related to respiratory function (e.g., PaO\u2082/FiO\u2082 ratio). Although SpO\u2082 is not a direct component of the SOFA score, it relates to impaired oxygenation, indicating potential organ dysfunction noted by a SOFA score increase. The alignment is moderate due to the indirect connection.",
            "The claim involves SpO2 and the effect of supplemental oxygen, which suggests concerns about hypoxia and potential respiratory support needs. While not a direct measure in the SOFA scoring system, it touches on respiratory function, which can relate to PaO\u2082/FiO\u2082, a component of the SOFA score. The alignment is indirect as it only hints at respiratory function issues without specifying organ dysfunction directly measured by SOFA criteria.",
            "The claim suggests examining heart rate, blood pressure, and temperature for abnormalities. SIRS criteria include temperature (>38 \u00b0C or <36 \u00b0C) and heart rate (>90 bpm), which aligns partially with the elements of assessment described in the claim. Blood pressure is not directly in SIRS, but these vitals are commonly assessed when considering sepsis. Therefore, there's a moderate alignment with the SIRS positivity criteria.",
            "The absence of fever is relevant to the SIRS Criteria, which include temperature as one of the components. The lack of fever suggests the patient may not be meeting this SIRS criterion, which marginally impacts sepsis prediction. While it's related, the reference to a lack of fever isn\u2019t as strong as having fever or another explicit SIRS criterion.",
            "The mention of white blood cell count and laboratory values not indicating an acute infection is related to SIRS criteria, which include elevated or decreased WBC counts as indicators of systemic inflammation. While the claim specifies the absence of an infectious process rather than meeting the criteria, it still directly references components relevant to SIRS assessment. Hence, the alignment is partial but significant."
        ],
        "final_alignment_score": 0.5285714285714286,
        "accuracy": 1
    },
    {
        "input": "10: HR, 124.0; 10: RR, 18.0; 10: SBP, 123.0; 10: DBP, 85.0; 10: MAP, 97.667; 10: Temp, 99.3; 34: SpO2, 98.474; 35: SpO2, 99.169; 35: Perf, 2.224; 36: SpO2, 98.948; 36: Perf, 2.137; 37: SpO2, 99.119; 37: Perf, 2.362; 38: SpO2, 98.603; 38: Perf, 1.824; 39: SpO2, 97.678; 39: Perf, 1.582; 40: SpO2, 98.458; 40: Perf, 1.283; 41: SpO2, 98.534; 41: Perf, 1.659; 42: SpO2, 98.746; 42: Perf, 1.824; 43: SpO2, 98.379; 43: Perf, 1.852; 44: SpO2, 98.441; 44: Perf, 1.785; 45: SpO2, 98.220; 45: Perf, 1.027; 46: SpO2, 98.690; 46: Perf, 1.103; 47: SpO2, 99.678; 47: Perf, 1.772; 48: SpO2, 99.810; 48: Perf, 2.277; 49: SpO2, 99.780; 49: Perf, 2.665; 50: SpO2, 98.661; 50: Perf, 2.874; 51: SpO2, 98.810; 51: Perf, 2.65; 52: SpO2, 99.0; 52: Perf, 1.746; 53: SpO2, 98.414; 53: Perf, 1.777; 54: SpO2, 98.237; 54: Perf, 1.994; 55: SpO2, 97.678; 55: Perf, 2.447; 56: SpO2, 99.017; 56: Perf, 2.373; 57: SpO2, 98.203; 57: Perf, 2.956; 58: SpO2, 98.914; 58: Perf, 3.224; 59: SpO2, 99.186; 59: Perf, 2.435; 60: SpO2, 98.271; 60: Perf, 1.618; 61: SpO2, 97.224; 61: Perf, 1.683; 62: SpO2, 96.339; 62: Perf, 0.938; 63: SpO2, 96.724; 63: Perf, 0.922; 64: SpO2, 97.153; 64: Perf, 0.700; 65: SpO2, 97.0; 65: Perf, 0.776; 66: SpO2, 97.186; 66: Perf, 1.047; 67: SpO2, 97.237; 67: Perf, 1.001; 68: SpO2, 96.845; 68: Perf, 0.894; 69: SpO2, 97.085; 69: Perf, 0.953; 70: POC, HCG, ISTAT QUALITATIVE: Negative; 70: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 70: SpO2, 99.138; 70: Perf, 1.017; 71: SpO2, 97.661; 71: Perf, 1.419; 72: POC PH (V) ISTAT, 7.40; 72: POC PCO2 (V) ISTAT, 40.6 mmHg; 72: POC PO2 (V) ISTAT, 36 mmHg; 72: POC O2 SATURATION ISTAT VENOUS, 69 %; 72: POC HCO3 (V) ISTAT, 25.0 mmol/L; 72: POC LACTATE ISTAT, 0.93 mmol/L; 72: POC BASE EXCESS ISTAT, 0 mmol/L; 72: POC TCO2 (V) ISTAT, 26 mmol/L; 72: SpO2, 98.0; 72: Perf, 1.794; 73: SpO2, 98.0; 73: Perf, 1.956; 74: SpO2, 98.0; 74: Perf, 2.021; 74: LR IV BOLUS -, 1000 ML; 75: SpO, 2: 97.293; 75: Perf, 1.599; 76: SpO2, 97.492; 76: Perf, 2.369; 77: SpO2, 97.424; 77: Perf, 2.6; 78: SpO2, 99.207; 78: Perf, 2.413; 79: SpO2, 98.678; 79: Perf, 2.122; 80: SpO2, 98.879; 80: Perf, 1.586; 81: SpO2, 98.898; 81: Perf, 1.792; 82: SpO2, 98.237; 82: Perf, 1.856; 83: SpO2, 98.897; 83: Perf, 1.813; 84: SpO2, 98.814; 84: Perf, 1.436; 85: SpO2, 99.138; 85: Perf, 1.005; 86: SpO2, 98.356; 86: Perf, 1.135; 87: SpO2, 98.034; 87: Perf, 1.147; 88: SpO2, 99.0; 88: Perf, 1.075; 89: SpO2, 98.712; 89: Perf, 1.979; 90: SpO2, 98.966; 90: Perf, 1.538; 91: SpO2, 97.746; 91: Perf, 0.917; 92: SpO2, 97.559; 92: Perf, 0.788; 93: SpO2, 98.293; 93: Perf, 0.755; 94: SpO2, 98.339; 94: Perf, 0.913; 95: SpO2, 98.121; 95: Perf, 1.300; 96: SpO2, 97.695; 96: Perf, 1.225; 97: SpO2, 97.569; 97: Perf, 1.103; 98: SpO2, 98.237; 98: Perf, 0.971; 99: SpO2, 98.254; 99: Perf, 1.076; 100: SpO2, 99.052; 100: Perf, 0.774; 101: SpO2, 99.610; 101: Perf, 0.882; 102: SpO2, 98.707; 102: Perf, 0.931; 103: SpO2, 99.542; 103: Perf, 0.719; 104: SpO2, 99.931; 104: Perf, 1.281; 105: SpO2, 100.0; 105: Perf, 1.238; 106: SpO2, 99.610; 106: Perf, 1.108; 107: SpO2, 99.086; 107: Perf, 0.759; 108: SpO2, 97.636; 108: Perf, 0.521; 109: SpO2, 98.611; 110: SpO2, 98.966; 110: Perf, 0.720; 111: SpO2, 99.593; 111: Perf, 0.645; 112: SpO2, 99.707; 112: Perf, 0.756; 113: SpO2, 98.966; 113: Perf, 0.805; 114: SpO2, 98.690; 114: Perf, 0.62; 115: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 115: PROTEIN TOTAL, 7.6 g/dL; 115: ANION GAP, 11 mmol/L; 115: ALT (SGPT), 12 U/L; 115: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 115: GLUCOSE, 132 mg/dL; 115: AST (SGOT), 16 U/L; 115: EGFR REFIT WITHOUT RACE (2021), 44 mL/min/1.73 m2; 115: GLOBULIN, 4.0 g/dL; 115: CHLORIDE, 105 mmol/L; 115: CORRECTED CALCIUM, 8.4 mg/dL; 115: SODIUM, 142 mmol/L; 115: ALKALINE PHOSPHATASE, 82 U/L; 115: POTASSIUM, 3.5 mmol/L; 115: CO2, 26 mmol/L; 115: CALCIUM, 8.1 mg/dL; 115: BILIRUBIN TOTAL, 0.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 51 mL/min/1.73 m2; 115: ALBUMIN, 3.6 g/dL; 115: CREATININE, 1.52 mg/dL; 115: RED CELL DISTRIBUTION WIDTH (RDW), 18.8 %; 115: HEMATOCRIT (HCT), 24.7 %; 115: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 115: WHITE BLOOD CELLS (WBC), 8.5 K/uL; 115: HEMOGLOBIN (HGB), 6.4 g/dL; 115: PLATELET COUNT (PLT), 369 K/uL; 115: MEAN CORPUSCULAR VOLUME (MCV), 69.0 fL; 115: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 25.9 g/dL; 115: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 115: NEUTROPHILS BANDS % (MANUAL DIFF), 0.0 %; 115: LYMPHOCYTES % (MANUAL DIFF), 10.4 %; 115: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.14 K/uL; 115: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.30 K/uL; 115: EOSINOPHILS % (MANUAL DIFF), 1.7 %; 115: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 7.19 K/uL; 115: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.89 K/uL; 115: MONOCYTES % (MANUAL DIFF), 3.5 %; 115: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 84.4 %; 115: SpO2, 98.576; 115: Perf, 0.578; 116: SpO2, 98.136; 116: Perf, 0.589; 117: SpO2, 98.414; 117: Perf, 0.684; 118: SpO2, 98.508; 118: Perf, 1.111; 119: SpO2, 98.593; 119: Perf, 1.259; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 37.4; 0: Triage HR, 124.0; 0: Triage RR, 18.0; 0: Triage SBP, 123.0; 0: Triage DBP, 85.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER,EMESIS,DIARRHEA",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The subquestions to determine sepsis risk involve evaluating vital signs, laboratory results, and clinical signs. The initial subquestion assesses vital signs: the patient's heart rate is elevated at 124 BPM, but other signs like blood pressure, temperature, and respiratory rate do not indicate sepsis. The SpO2 values are consistently within the normal range. Next, laboratory results show no significantly abnormal values for lactate or white blood cells that would suggest a high sepsis risk. Finally, the symptoms and triage acuity of \"urgent\" align with potential infection but do not indicate an immediate danger. Based on this analysis, the patient does not exhibit a high risk for sepsis within the next 12 hours.",
        "claims": [
            "The subquestions to determine sepsis risk involve evaluating vital signs, laboratory results, and clinical signs.",
            "The initial subquestion assesses vital signs.",
            "The patient's heart rate is elevated at 124 BPM.",
            "The patient's elevated heart rate of 124 BPM does not alone indicate sepsis.",
            "Other vital signs such as blood pressure, temperature, and respiratory rate do not indicate sepsis.",
            "The SpO2 values are consistently within the normal range.",
            "Laboratory results show no significantly abnormal values for lactate.",
            "Laboratory results show no significantly abnormal values for white blood cells.",
            "No abnormal laboratory results suggest a high sepsis risk.",
            "Symptoms and triage acuity of \"urgent\" align with potential infection.",
            "The symptoms do not indicate an immediate danger.",
            "Based on this analysis, the patient does not exhibit a high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate is elevated at 124 BPM.",
            "The patient's elevated heart rate of 124 BPM does not alone indicate sepsis.",
            "Laboratory results show no significantly abnormal values for lactate.",
            "Laboratory results show no significantly abnormal values for white blood cells.",
            "No abnormal laboratory results suggest a high sepsis risk."
        ],
        "alignment_scores": [
            1.0,
            0.5,
            0.2,
            0.2,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90\u202fbpm) is explicitly listed as a SIRS criterion, which is used to identify systemic inflammation consistent with early sepsis. The claim directly aligns with this criterion.",
            "An elevated heart rate (>90 BPM) is one of the criteria listed under SIRS, which is used to identify systemic inflammation consistent with early sepsis. However, the claim notes that this heart rate alone does not indicate sepsis, highlighting that other indicators are needed. Therefore, while the heart rate is relevant to SIRS, the alignment is not strong unless paired with other criteria.",
            "The claim references lactate levels, which are directly relevant to the Elevated Serum Lactate category that indicates sepsis risk when elevated. However, because the lactate levels are not abnormal, which means they do not elevate the sepsis risk, the alignment is weak.",
            "The claim's reference to white blood cells relates to SIRS criteria, as abnormal WBC levels are part of these criteria. However, the absence of significant abnormalities means that none of the SIRS criteria for WBC count are met, resulting in a low alignment with this category.",
            "The claim mentions the absence of abnormal laboratory results, which indirectly suggests a lack of SIRS criteria. While it doesn't directly reference the SIRS criteria, the notion of abnormal labs such as altered WBC levels is relevant to identifying systemic inflammation in early sepsis. The alignment is weak because it focuses on the absence of abnormalities rather than a direct reference to specific criteria or results."
        ],
        "final_alignment_score": 0.43999999999999995,
        "accuracy": 1
    },
    {
        "input": "13: HR, 128.0; 13: RR, 18.0; 13: SpO2, 99.0; 13: SBP, 120.0; 13: DBP, 51.0; 13: MAP, 74.0; 13: Temp, 99.5; 59: HR, 117.362; 59: RR, 23.914; 59: Perf, 0.43; 59: 1min HRV, 6.545; 60: HR, 117.915; 60: RR, 23.441; 60: SpO2, 100.0; 60: 1min HRV, 7.644; 61: HR, 119.576; 61: RR, 23.373; 61: SpO2, 99.610; 61: Perf, 0.551; 61: 1min HRV, 6.043; 61: 5min HRV, 7.955; 62: HR, 120.086; 62: RR, 23.328; 62: SpO2, 99.310; 62: Perf, 0.769; 62: 1min HRV, 4.305; 63: HR, 121.153; 63: RR, 25.085; 63: SpO2, 99.153; 63: Perf, 0.875; 63: 1min HRV, 4.458; 64: HR, 121.810; 64: RR, 24.466; 64: SpO2, 98.931; 64: Perf, 0.934; 64: 1min HRV, 3.305; 65: HR, 122.034; 65: RR, 22.525; 65: SpO2, 99.305; 65: Perf, 0.970; 65: 1min HRV, 7.228; 66: HR, 122.542; 66: RR, 25.068; 66: SpO2, 99.407; 66: Perf, 1.144; 66: 1min HRV, 9.828; 66: 5min HRV, 7.036; 67: HR, 121.397; 67: RR, 23.034; 67: SpO2, 99.621; 67: Perf, 1.108; 67: 1min HRV, 15.414; 68: HR, 121.966; 68: RR, 22.949; 68: SpO2, 99.780; 68: Perf, 0.948; 68: 1min HRV, 4.909; 69: HR, 121.517; 69: RR, 22.776; 69: SpO2, 99.017; 69: Perf, 1.183; 69: 1min HRV, 13.828; 70: HR, 122.475; 70: RR, 25.169; 70: SpO2, 99.203; 70: Perf, 1.144; 70: 1min HRV, 3.591; 71: HR, 123.259; 71: RR, 24.966; 71: SpO2, 99.810; 71: Perf, 1.064; 71: 1min HRV, 4.648; 71: 5min HRV, 10.297; 72: HR, 122.034; 72: RR, 23.254; 72: SpO2, 99.508; 72: Perf, 0.958; 72: 1min HRV, 10.127; 72: SBP, 102.0; 72: DBP, 58.0; 72: MAP, 72.667; 73: HR, 121.237; 73: RR, 24.169; 73: SpO2, 99.525; 73: Perf, 1.137; 73: 1min HRV, 4.810; 74: HR, 122.638; 74: RR, 24.983; 74: SpO2, 99.828; 74: Perf, 1.003; 74: 1min HRV, 3.128; 75: HR, 122.458; 75: RR, 24.254; 75: SpO2, 99.644; 75: Perf, 0.895; 75: 1min HRV, 8.975; 76: HR, 121.638; 76: RR, 25.379; 76: SpO2, 99.690; 76: Perf, 0.811; 76: 1min HRV, 12.485; 76: 5min HRV, 8.911; 77: HR, 122.915; 77: RR, 25.085; 77: SpO2, 99.729; 77: Perf, 0.893; 77: 1min HRV, 3.437; 78: HR, 123.034; 78: RR, 24.644; 78: SpO2, 99.915; 78: Perf, 0.860; 78: 1min HRV, 3.121; 79: HR, 122.190; 79: RR, 20.793; 79: SpO2, 99.759; 79: Perf, 0.882; 79: 1min HRV, 8.052; 80: HR, 119.610; 80: RR, 19.559; 80: SpO2, 99.322; 80: Perf, 0.682; 80: 1min HRV, 15.067; 81: HR, 119.586; 81: RR, 17.759; 81: SpO2, 98.586; 81: Perf, 0.478; 81: 1min HRV, 21.346; 81: 5min HRV, 14.003; 82: HR, 121.678; 82: RR, 23.390; 82: SpO2, 98.2; 82: Perf, 0.48; 82: 1min HRV, 7.006; 83: HR, 120.729; 83: RR, 22.237; 83: SpO2, 99.677; 83: Perf, 0.48; 83: 1min HRV, 10.215; 84: HR, 122.069; 84: RR, 25.603; 84: SpO2, 99.845; 84: Perf, 0.596; 84: 1min HRV, 2.628; 85: HR, 123.051; 85: RR, 24.407; 85: SpO2, 99.949; 85: Perf, 0.599; 85: 1min HRV, 4.199; 86: HR, 123.224; 86: RR, 24.138; 86: SpO2, 100.0; 86: Perf, 0.641; 86: 1min HRV, 6.186; 86: 5min HRV, 7.510; 87: HR, 120.254; 87: RR, 31.0; 87: SpO2, 99.939; 87: Perf, 0.620; 87: 1min HRV, 11.018; 87: SBP, 106.0; 87: DBP, 63.0; 87: MAP, 77.333; 88: HR, 118.186; 88: RR, 23.068; 88: SpO2, 99.949; 88: Perf, 0.555; 88: 1min HRV, 17.155; 89: HR, 119.828; 89: RR, 23.569; 89: SpO2, 99.789; 89: Perf, 0.579; 89: 1min HRV, 11.270; 90: HR, 118.927; 90: RR, 22.322; 90: SpO2, 99.641; 90: Perf, 0.542; 90: 1min HRV, 4.142; 91: HR, 122.190; 91: RR, 26.397; 91: Perf, 0.54; 91: 1min HRV, 5.678; 91: 5min HRV, 13.005; 92: HR, 122.339; 92: RR, 26.288; 92: 1min HRV, 12.070; 93: HR, 119.102; 93: RR, 23.966; 93: SpO2, 100.0; 93: Perf, 0.37; 93: 1min HRV, 17.897; 94: HR, 117.983; 94: RR, 25.293; 94: SpO2, 99.948; 94: Perf, 0.498; 94: 1min HRV, 11.574; 95: HR, 117.847; 95: RR, 23.915; 95: SpO2, 100.0; 95: Perf, 0.695; 95: 1min HRV, 13.356; 96: HR, 118.776; 96: RR, 22.707; 96: SpO2, 99.966; 96: Perf, 0.776; 96: 1min HRV, 3.920; 96: 5min HRV, 13.245; 97: HR, 118.102; 97: RR, 24.627; 97: SpO2, 99.102; 97: Perf, 0.695; 97: 1min HRV, 5.616; 98: HR, 120.102; 98: RR, 23.339; 98: SpO2, 98.661; 98: Perf, 0.927; 98: 1min HRV, 2.730; 99: HR, 121.190; 99: RR, 24.052; 99: SpO2, 99.759; 99: Perf, 0.931; 99: 1min HRV, 8.752; 100: HR, 121.864; 100: RR, 24.424; 100: SpO2, 100.0; 100: Perf, 1.029; 100: 1min HRV, 2.311; 101: HR, 122.828; 101: RR, 24.672; 101: SpO2, 99.655; 101: Perf, 1.052; 101: 1min HRV, 3.685; 101: 5min HRV, 8.392; 101: SBP, 105.0; 101: DBP, 61.0; 101: MAP, 75.667; 102: HR, 121.576; 102: RR, 24.915; 102: SpO2, 99.407; 102: Perf, 1.066; 102: 1min HRV, 3.417; 102: SBP, 105.0; 102: DBP, 61.0; 102: MAP, 75.667; 103: HR, 123.224; 103: RR, 24.828; 103: SpO2, 98.897; 103: Perf, 1.087; 103: 1min HRV, 2.370; 104: HR, 123.661; 104: RR, 26.085; 104: SpO2, 98.915; 104: Perf, 1.184; 104: 1min HRV, 3.678; 105: HR, 124.390; 105: RR, 25.390; 105: SpO2, 98.983; 105: Perf, 1.227; 105: 1min HRV, 2.959; 106: HR, 124.707; 106: RR, 23.983; 106: SpO2, 98.914; 106: Perf, 1.160; 106: 1min HRV, 6.864; 106: 5min HRV, 6.006; 107: SARS-COV-2 RNA, Not Detected; 107: HR, 124.390; 107: RR, 27.017; 107: SpO2, 99.034; 107: Perf, 1.212; 107: 1min HRV, 3.047; 108: HR, 124.897; 108: RR, 28.0; 108: SpO2, 99.103; 108: Perf, 1.169; 108: 1min HRV, 12.130; 109: HR, 124.339; 109: RR, 24.322; 109: SpO2, 99.288; 109: Perf, 0.893; 109: 1min HRV, 10.818; 110: HR, 124.271; 110: RR, 26.475; 110: SpO2, 98.949; 110: Perf, 0.796; 110: 1min HRV, 11.932; 111: HR, 123.069; 111: RR, 24.259; 111: SpO2, 99.845; 111: Perf, 0.678; 111: 1min HRV, 11.822; 111: 5min HRV, 10.934; 112: HR, 120.864; 112: RR, 28.068; 112: SpO2, 99.442; 112: Perf, 0.482; 112: 1min HRV, 24.982; 113: HR, 123.190; 113: RR, 27.034; 113: SpO2, 97.909; 113: Perf, 0.26; 113: 1min HRV, 8.670; 114: HR, 122.153; 114: RR, 26.780; 114: Perf, 0.26; 114: 1min HRV, 6.498; 115: HR, 123.627; 115: RR, 27.017; 115: SpO2, 98.0; 115: Perf, 0.224; 115: 1min HRV, 11.989; 116: HR, 123.948; 116: RR, 28.414; 116: 1min HRV, 4.802; 116: 5min HRV, 14.052; 117: HR, 122.932; 117: RR, 27.763; 117: 1min HRV, 4.905; 117: SBP, 110.0; 117: DBP, 58.0; 117: MAP, 75.333; 118: HR, 123.897; 118: RR, 25.638; 118: SpO2, 95.0; 118: 1min HRV, 3.633; 119: HR, 121.847; 119: RR, 32.153; 119: 1min HRV, 16.656; 0: Age, 44; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.5; 0: Triage HR, 128.0; 0: Triage RR, 18.0; 0: Triage SBP, 120.0; 0: Triage DBP, 51.0; 0: Triage acuity, 2-Emergent; 0: CC, WOUND CHECK",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The initial step to answer whether the patient is at high risk of sepsis involves evaluating the condition through their EHR parameters, such as heart rate (HR), respiratory rate (RR), and blood pressure (BP). Over time, the patient exhibits consistently elevated HR and RR, with HR persistently above 120 beats per minute and RR notably high, sometimes exceeding 24 breaths per minute. Furthermore, low diastolic blood pressure and fluctuating HRV indicate potential physiological instability. The combination of these elevated and fluctuating parameters and blood pressure inconsistencies suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "The initial step to determine if the patient is at high risk of sepsis involves evaluating their EHR parameters.",
            "Key EHR parameters include heart rate (HR), respiratory rate (RR), and blood pressure (BP).",
            "The patient exhibits consistently elevated heart rate (HR).",
            "The patient's heart rate (HR) is persistently above 120 beats per minute.",
            "The patient exhibits a notably high respiratory rate (RR).",
            "The patient's respiratory rate (RR) sometimes exceeds 24 breaths per minute.",
            "The patient has low diastolic blood pressure.",
            "Fluctuating heart rate variability (HRV) indicates potential physiological instability.",
            "The combination of elevated and fluctuating EHR parameters suggests a high risk of sepsis.",
            "Blood pressure inconsistencies further suggest a high risk of sepsis.",
            "There is a high risk of sepsis within 12 hours based on the evaluated parameters."
        ],
        "relevant_claims": [
            "The initial step to determine if the patient is at high risk of sepsis involves evaluating their EHR parameters.",
            "The patient exhibits consistently elevated heart rate (HR).",
            "The patient's heart rate (HR) is persistently above 120 beats per minute.",
            "The patient exhibits a notably high respiratory rate (RR).",
            "The patient's respiratory rate (RR) sometimes exceeds 24 breaths per minute.",
            "The patient has low diastolic blood pressure.",
            "Fluctuating heart rate variability (HRV) indicates potential physiological instability.",
            "The combination of elevated and fluctuating EHR parameters suggests a high risk of sepsis.",
            "Blood pressure inconsistencies further suggest a high risk of sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.5,
            0.8,
            0.7,
            0.8,
            0.4,
            0.5,
            0.7,
            0.7
        ],
        "alignment_category": [
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated NEWS Score (\u22655 points)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)"
        ],
        "alignment_reasonings": [
            "The claim mentions evaluating EHR parameters, which implies a general assessment of clinical data that could include various risk factors for sepsis, leading to actions like antibiotics and culture orders. However, the claim does not directly mention any specific criteria or actions such as early antibiotic administration or culture orders, which would strongly indicate this category. The alignment is weak and general.",
            "An elevated heart rate contributes to an increased Shock Index when compared with systolic blood pressure, indicating hemodynamic instability and potential severe sepsis risk. However, the claim only mentions an elevated heart rate without information on systolic blood pressure to calculate the Shock Index, resulting in a partial alignment with the category.",
            "The claim pertains to a significantly elevated heart rate (>90 bpm), which is specifically mentioned as one of the SIRS criteria. However, more than one SIRS criterion is required for full positivity. With only the heart rate mentioned, this aligns well but doesn't fully satisfy the SIRS positivity requirement.",
            "A high respiratory rate is directly involved in calculating the qSOFA score, which includes respiratory rate\u202f\u2265\u202f22\u202f/min as one of its criteria. While the claim does not specify the exact value or whether the patient meets the complete qSOFA threshold, the mention of a \"notably high respiratory rate\" strongly suggests a potential contribution to qSOFA criteria, making the alignment partial but significant.",
            "The claim highlights a respiratory rate exceeding 22/min, which is one of the criteria for a high qSOFA score (\u22652). While the claim addresses only one component of the qSOFA score, the respiratory rate criteria is fully met, making it a strong but not exclusive indicator of sepsis risk according to this category. Thus, the alignment is strong but not complete, as additional criteria for qSOFA were not mentioned.",
            "The claim mentions low diastolic blood pressure, which is related to blood pressure measurement but focuses on the diastolic rather than systolic. Sepsis-associated hypotension concerns systolic blood pressure (SBP <90 mmHg) or mean arterial pressure (MAP <70 mmHg), which more directly aligns with severe sepsis criteria. While low diastolic pressure suggests hemodynamic changes, it doesn\u2019t directly fit the specified category indicators, resulting in a moderate alignment without full criterion relevance.",
            "Heart rate variability (HRV) suggests potential physiological instability, which ties into the concept of hemodynamic instability covered by the Elevated Shock Index category. However, it doesn't directly mention heart rate or blood pressure measures required for calculating the Shock Index, making the alignment indirect but relevant.",
            "The claim about elevated and fluctuating EHR parameters aligns with the idea of a National Early Warning Score (NEWS), which incorporates various vital sign abnormalities to predict clinical deterioration and risk of sepsis. While the exact parameters aren't specified, the description of elevated and fluctuating parameters suggests instability that could correspond to a high NEWS score. However, without specific values, the alignment isn't perfect.",
            "The claim about \"blood pressure inconsistencies\" suggests a potential problem with blood pressure, which is relevant to the category of Sepsis-Associated Hypotension. This category involves blood pressure being low or a significant drop from baseline, serving as an indicator of septic shock. The mention of inconsistencies doesn't specify low blood pressure or a significant drop, so it aligns somewhat with the category but isn't a direct match, thus the partial alignment rating of 0.7."
        ],
        "final_alignment_score": 0.6000000000000001,
        "accuracy": 1
    },
    {
        "input": "3: HR, 83.0; 3: RR, 22.0; 3: SpO2, 97.0; 3: SBP, 132.0; 3: DBP, 70.0; 3: MAP, 90.667; 3: Temp, 101.8; 26: ACETAMINOPHEN, 500 MG PO TABS; 58: SpO, 2: 95.778; 58: SBP, 138.0; 58: DBP, 104.0; 58: MAP, 115.333; 59: SpO2, 96.0; 60: SpO2, 96.135; 61: HR, 78.4; 61: RR, 37.636; 61: SpO2, 96.966; 61: Perf, 2.613; 61: 1min HRV, 54.137; 61: 5min HRV, 54.137; 62: HR, 80.552; 62: RR, 22.569; 62: SpO2, 96.759; 62: Perf, 2.475; 62: 1min HRV, 31.869; 63: HR, 84.203; 63: RR, 22.576; 63: SpO2, 96.288; 63: Perf, 2.57; 63: 1min HRV, 24.486; 64: HR, 86.881; 64: RR, 16.373; 64: SpO2, 95.407; 64: Perf, 2.217; 64: 1min HRV, 12.052; 65: HR, 83.121; 65: RR, 15.793; 65: SpO2, 95.552; 65: Perf, 1.664; 65: 1min HRV, 63.931; 66: HR, 81.746; 66: RR, 19.051; 66: SpO2, 96.559; 66: Perf, 2.129; 66: 1min HRV, 99.476; 66: 5min HRV, 58.807; 67: HR, 81.707; 67: RR, 25.707; 67: SpO2, 96.638; 67: Perf, 2.599; 67: 1min HRV, 47.917; 68: HR, 84.153; 68: RR, 21.271; 68: Perf, 2.62; 68: 1min HRV, 47.688; 69: HR, 83.983; 69: RR, 21.390; 69: SpO2, 95.0; 69: 1min HRV, 44.754; 70: HR, 80.034; 70: RR, 20.845; 70: SpO2, 95.0; 70: Perf, 1.500; 70: 1min HRV, 105.585; 71: HR, 78.288; 71: RR, 18.814; 71: SpO2, 94.475; 71: Perf, 1.42; 71: 1min HRV, 14.070; 71: 5min HRV, 63.502; 72: HR, 82.414; 72: RR, 22.397; 72: SpO2, 95.345; 72: Perf, 1.442; 72: 1min HRV, 15.649; 73: HR, 80.0; 73: RR, 22.983; 73: SpO2, 95.397; 73: Perf, 1.507; 73: 1min HRV, 74.428; 74: HR, 80.237; 74: RR, 22.458; 74: SpO2, 96.898; 74: Perf, 1.717; 74: 1min HRV, 58.426; 75: HR, 80.322; 75: RR, 20.932; 75: SpO2, 97.085; 75: Perf, 1.729; 75: 1min HRV, 50.628; 76: HR, 81.763; 76: RR, 23.610; 76: SpO2, 96.213; 76: Perf, 1.724; 76: 1min HRV, 64.968; 76: 5min HRV, 58.062; 77: HR, 84.811; 77: RR, 20.515; 77: SpO2, 95.467; 77: 1min HRV, 16.010; 78: SpO2, 94.261; 78: 1min HRV, 1.0; 79: SpO2, 92.0; 79: 1min HRV, 187.650; 80: HR, 75.95; 80: SpO2, 94.136; 80: 1min HRV, 104.821; 81: HR, 75.271; 81: SpO2, 98.936; 81: Perf, 2.756; 81: 1min HRV, 26.686; 81: 5min HRV, 78.357; 82: HR, 74.276; 82: SpO2, 98.707; 82: Perf, 2.544; 82: 1min HRV, 16.525; 83: HR, 71.458; 83: SpO2, 98.847; 83: Perf, 2.519; 83: 1min HRV, 28.946; 84: HR, 69.414; 84: SpO2, 99.5; 84: Perf, 2.354; 84: 1min HRV, 23.730; 85: HR, 68.025; 85: SpO2, 98.322; 85: Perf, 2.74; 85: 1min HRV, 14.451; 86: SpO2, 98.678; 86: Perf, 2.871; 86: 1min HRV, 12.582; 86: 5min HRV, 34.479; 87: SpO2, 97.793; 87: Perf, 2.800; 88: SpO2, 97.75; 88: Perf, 2.76; 89: HR, 78.973; 89: SpO2, 97.0; 89: 1min HRV, 28.399; 90: HR, 74.571; 90: SpO2, 97.591; 90: 1min HRV, 59.356; 91: HR, 74.508; 91: SpO2, 93.556; 91: 1min HRV, 30.373; 91: 5min HRV, 46.173; 92: HR, 74.293; 92: 1min HRV, 33.253; 93: HR, 74.881; 93: SpO2, 97.2; 93: 1min HRV, 77.865; 94: HR, 79.25; 94: RR, 19.0; 94: SpO2, 97.237; 94: 1min HRV, 26.789; 95: HR, 82.949; 95: RR, 24.492; 95: 1min HRV, 51.157; 96: HR, 78.288; 96: RR, 18.915; 96: SpO2, 96.062; 96: 1min HRV, 72.650; 96: 5min HRV, 65.329; 97: HR, 76.759; 97: RR, 19.587; 97: SpO2, 98.155; 97: 1min HRV, 66.829; 98: HR, 75.814; 98: RR, 21.102; 98: SpO2, 98.305; 98: Perf, 1.928; 98: 1min HRV, 37.754; 99: HR, 82.397; 99: RR, 21.052; 99: SpO2, 99.0; 99: Perf, 2.0; 99: 1min HRV, 63.652; 99: SBP, 143.0; 99: DBP, 115.0; 99: MAP, 124.333; 99: NS IV BOLUS -, 1000 ML; 100: HR:, 86.508; 100: RR, 15.407; 100: 1min HRV, 139.471; 101: HR, 87.254; 101: RR, 17.712; 101: SpO2, 100.0; 101: Perf, 3.762; 101: 1min HRV, 96.572; 101: 5min HRV, 100.532; 102: HR, 81.672; 102: RR, 20.103; 102: SpO2, 100.0; 102: Perf, 4.789; 102: 1min HRV, 123.858; 103: HR, 81.186; 103: RR, 23.678; 103: SpO2, 99.542; 103: Perf, 3.881; 103: 1min HRV, 52.570; 104: HR, 79.5; 104: RR, 19.879; 104: SpO2, 97.5; 104: Perf, 1.252; 104: 1min HRV, 53.142; 105: HR, 78.542; 105: RR, 20.729; 105: SpO2, 97.525; 105: Perf, 1.479; 105: 1min HRV, 22.765; 106: SARS-COV-2 RNA, Detected; 106: INFLUENZA A, Not Detected; 106: RSV, Not Detected; 106: INFLUENZA A, Not Detected; 106: INFLUENZA B, Not Detected; 106: SARS-COV-2 RNA, Detected; 106: INFLUENZA B, Not Detected; 106: RSV, Not Detected; 106: HR, 79.830; 106: RR, 13.413; 106: SpO2, 98.328; 106: Perf, 2.225; 106: 1min HRV, 44.293; 106: 5min HRV, 71.117; 107: HR, 75.844; 107: RR, 21.462; 107: SpO2, 98.525; 107: Perf, 2.288; 107: 1min HRV, 83.852; 108: HR, 74.729; 108: RR, 19.932; 108: SpO2, 98.932; 108: Perf, 3.335; 108: 1min HRV, 28.074; 109: HR, 77.534; 109: RR, 25.509; 109: SpO2, 99.138; 109: Perf, 5.675; 109: 1min HRV, 62.654; 110: HR, 75.316; 110: SpO2, 98.438; 110: Perf, 5.76; 110: 1min HRV, 170.130; 111: HR, 72.448; 111: Perf, 5.76; 111: 1min HRV, 100.507; 111: 5min HRV, 94.140; 112: HR, 68.186; 112: SpO2, 96.0; 112: Perf, 5.714; 112: 1min HRV, 25.196; 113: HR, 71.562; 113: SpO2, 94.286; 113: Perf, 5.58; 113: 1min HRV, 132.946; 114: HR, 71.25; 114: Perf, 5.58; 114: 1min HRV, 148.337; 115: HR, 73.971; 115: 1min HRV, 142.429; 116: SpO2, 100.0; 116: 5min HRV, 102.586; 117: SpO2, 22.583; 118: SpO2, 100.0; 119: SpO2, 98.558; 0: Age, 66; 0: Gender, F; 0: Race, Black or African American; 0: Means of arrival, Self; 0: Triage Temp, 38.8; 0: Triage HR, 83.0; 0: Triage RR, 22.0; 0: Triage SBP, 132.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,COUGH,SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "To assess sepsis risk, key signs include temperature, heart rate, respiratory rate, blood pressure, and SpO2 levels. Initially, the patient's temperature is elevated, and the respiratory rate is high, which are worrying signs. The presence of SARS-CoV-2 RNA and fluctuations in HRV indicate potential stress on the body, contributing to the risk. The drop in blood oxygen saturation (SpO2) at time 117.0 is critical, suggesting severe respiratory distress. Combined, these factors suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "To assess sepsis risk, key signs include temperature, heart rate, respiratory rate, blood pressure, and SpO2 levels.",
            "The patient's temperature is elevated.",
            "An elevated temperature is a worrying sign.",
            "The patient's respiratory rate is high.",
            "A high respiratory rate is a worrying sign.",
            "The presence of SARS-CoV-2 RNA indicates potential stress on the body.",
            "Fluctuations in heart rate variability (HRV) indicate potential stress on the body.",
            "Potential stress on the body contributes to the risk of sepsis.",
            "The drop in blood oxygen saturation (SpO2) at time 117.0 is critical.",
            "A critical drop in SpO2 suggests severe respiratory distress.",
            "Combined factors suggest a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "To assess sepsis risk, key signs include temperature, heart rate, respiratory rate, blood pressure, and SpO2 levels.",
            "The patient's temperature is elevated.",
            "An elevated temperature is a worrying sign.",
            "The patient's respiratory rate is high.",
            "A high respiratory rate is a worrying sign.",
            "The presence of SARS-CoV-2 RNA indicates potential stress on the body.",
            "Fluctuations in heart rate variability (HRV) indicate potential stress on the body.",
            "The drop in blood oxygen saturation (SpO2) at time 117.0 is critical.",
            "A critical drop in SpO2 suggests severe respiratory distress."
        ],
        "alignment_scores": [
            0.7,
            0.6,
            0.7,
            0.7,
            0.8,
            0.3,
            0.3,
            0.7,
            0.6
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)"
        ],
        "alignment_reasonings": [
            "The claim lists key vital signs such as temperature, heart rate, respiratory rate, blood pressure, and SpO2 levels, which are components used in the calculation of the NEWS score. While it does not explicitly state that a NEWS score is calculated or elevated, the mention of these signs strongly implies monitoring for clinical deterioration, which aligns with this category. The alignment is moderate to strong based on the general reference to vital signs used in NEWS calculations.",
            "An elevated temperature is part of the SIRS criteria, which helps identify systemic inflammation consistent with early sepsis. However, without knowing the exact temperature to confirm it meets the SIRS threshold (>38\u00b0C), the alignment is partial rather than full. Thus, the alignment rating is 0.6.",
            "An elevated temperature is one of the criteria for SIRS, which suggests systemic inflammation and potential early sepsis. While the claim is not specific about meeting the SIRS threshold, it indicates a relevant concern and direction towards SIRS criteria. Therefore, the alignment is fairly strong but not absolute without specific temperature values.",
            "The claim mentions a high respiratory rate, which is directly related to the SIRS criteria, where a respiratory rate greater than 20/min is indicative of systemic inflammation and early sepsis. However, the claim does not specify the exact rate, nor does it indicate the presence of a second SIRS criterion, which slightly diminishes the strength of the alignment with the SIRS category. Nonetheless, the direct reference to high respiratory rate has a significant alignment with the SIRS criteria.",
            "The claim highlights an elevated respiratory rate, which is one of the criteria for a high qSOFA score (\u2265\u202f22\u202f/min). A high respiratory rate indicates deteriorating clinical status and increased sepsis risk, aligning well with this category. However, without specifying that the other criteria of qSOFA are met, it is not a perfect alignment.",
            "The presence of SARS-CoV-2 RNA suggests an infectious process that might lead to systemic inflammation, which could relate to SIRS criteria. However, the claim doesn\u2019t directly mention specific SIRS criteria like temperature changes, heart rate, respiratory rate, or WBC count, making the alignment indirect and weak.",
            "While heart rate variability (HRV) is not directly included in any of the listed categories, it can be seen as an indirect measure of physiological instability or stress, which is relevant to the NEWS score that assesses deranged vitals for imminent clinical deterioration. However, the claim lacks specificity regarding vital signs that directly contribute to the NEWS score, so the alignment is quite weak.",
            "While SpO2 is not directly measured in the SOFA scoring system, it is functionally indicative of impaired oxygenation, which relates to the PaO\u2082/FiO\u2082 measure used in SOFA for assessing respiratory function. A critical drop in blood oxygen saturation could potentially align with the criteria for respiratory dysfunction in SOFA. Thus, the alignment is not direct but conceptually significant, warranting a strong yet not perfect rating.",
            "The claim mentions \"a critical drop in SpO2,\" which implies severe respiratory distress and potential impaired oxygenation, closely related to respiratory rate\u2014an element of the qSOFA score. While SpO2 is not directly part of the qSOFA criteria, respiratory issues contribute to it, suggesting partial alignment. Given this indirect linkage, I\u2019ve rated the alignment as 0.6."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 0
    },
    {
        "input": "2: HR, 135.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 148.0; 2: DBP, 93.0; 2: MAP, 111.333; 2: Temp, 97.5; 12: Pain, 0.0; 51: HR, 128.0; 51: 1min HRV, 19.943; 52: HR, 128.946; 52: RR, 22.490; 52: SpO2, 99.0; 52: 1min HRV, 4.637; 52: 5min HRV, 5.984; 52: SBP, 168.0; 52: DBP, 90.0; 52: MAP, 116.0; 53: HR, 128.136; 53: RR, 22.153; 53: SpO2, 98.746; 53: Perf, 0.575; 53: 1min HRV, 7.372; 54: HR, 127.397; 54: RR, 21.259; 54: SpO2, 98.810; 54: Perf, 0.537; 54: 1min HRV, 7.201; 55: HR, 128.407; 55: RR, 26.441; 55: SpO2, 98.153; 55: Perf, 0.493; 55: 1min HRV, 7.224; 56: HR, 126.897; 56: RR, 22.017; 56: SpO2, 98.793; 56: Perf, 0.455; 56: 1min HRV, 3.731; 57: HR, 126.379; 57: RR, 19.310; 57: SpO2, 98.552; 57: Perf, 0.399; 57: 1min HRV, 4.321; 57: 5min HRV, 6.676; 58: HR, 127.407; 58: RR, 19.593; 58: SpO2, 98.712; 58: Perf, 0.374; 58: 1min HRV, 3.207; 59: HR, 127.5; 59: RR, 19.966; 59: SpO2, 99.0; 59: Perf, 0.362; 59: 1min HRV, 3.383; 59: SBP, 168.0; 59: DBP, 93.0; 59: MAP, 118.0; 60: HR, 128.0; 60: RR, 23.085; 60: SpO2, 98.966; 60: Perf, 0.370; 60: 1min HRV, 4.359; 61: HR, 126.190; 61: RR, 22.966; 61: SpO2, 98.966; 61: Perf, 0.390; 61: 1min HRV, 5.101; 62: HR, 126.475; 62: RR, 26.017; 62: SpO2, 99.0; 62: Perf, 0.407; 62: 1min HRV, 3.753; 62: 5min HRV, 4.820; 63: HR, 125.746; 63: RR, 24.881; 63: SpO2, 98.898; 63: Perf, 0.429; 63: 1min HRV, 6.197; 64: HR, 125.828; 64: RR, 19.931; 64: SpO2, 99.0; 64: Perf, 0.400; 64: 1min HRV, 5.279; 64: LR IV BOLUS -, 1000 ML; 65: HR:, 125.915; 65: RR, 20.831; 65: SpO2, 99.0; 65: Perf, 0.416; 65: 1min HRV, 4.462; 66: HR, 126.569; 66: RR, 21.259; 66: SpO2, 99.0; 66: Perf, 0.439; 66: 1min HRV, 4.439; 67: HR, 126.155; 67: RR, 17.017; 67: SpO2, 99.0; 67: Perf, 0.456; 67: 1min HRV, 7.104; 67: 5min HRV, 5.712; 68: HR, 125.102; 68: RR, 16.831; 68: SpO2, 99.0; 68: Perf, 0.495; 68: 1min HRV, 7.596; 69: HR, 127.259; 69: RR, 23.638; 69: SpO2, 99.0; 69: Perf, 0.476; 69: 1min HRV, 5.688; 69: FAMOTIDINE (PF), 20 MG/2 ML IV SOLN; 70: HR:, 125.949; 70: RR, 22.576; 70: SpO2, 99.0; 70: Perf, 0.472; 70: 1min HRV, 4.833; 70: SBP, 168.0; 70: DBP, 93.0; 70: MAP, 118.0; 71: HR, 124.931; 71: RR, 20.845; 71: SpO2, 99.0; 71: Perf, 0.459; 71: 1min HRV, 6.740; 72: HR, 125.729; 72: RR, 18.881; 72: SpO2, 99.0; 72: Perf, 0.45; 72: 1min HRV, 4.659; 72: 5min HRV, 6.808; 72: SBP, 160.0; 72: DBP, 93.0; 72: MAP, 115.333; 73: INFLUENZA A, Not Detected; 73: INFLUENZA B, Not Detected; 73: RSV, Not Detected; 73: SARS-COV-2 RNA, Not Detected; 73: HR, 125.322; 73: RR, 16.864; 73: SpO2, 99.0; 73: Perf, 0.458; 73: 1min HRV, 6.378; 73: SBP, 160.0; 73: DBP, 93.0; 73: MAP, 115.333; 74: HR, 124.397; 74: RR, 18.431; 74: SpO2, 99.172; 74: Perf, 0.450; 74: 1min HRV, 8.981; 75: HR, 124.203; 75: RR, 17.186; 75: SpO2, 99.305; 75: Perf, 0.461; 75: 1min HRV, 7.082; 76: HR, 126.224; 76: RR, 18.759; 76: SpO2, 98.879; 76: Perf, 0.458; 76: 1min HRV, 7.494; 77: HR, 123.228; 77: RR, 18.439; 77: SpO2, 99.386; 77: Perf, 0.438; 77: 1min HRV, 5.823; 77: 5min HRV, 7.821; 78: HR, 124.55; 78: RR, 18.867; 78: SpO2, 99.133; 78: Perf, 0.445; 78: 1min HRV, 7.017; 79: HR, 122.614; 79: RR, 17.561; 79: SpO2, 99.0; 79: Perf, 0.436; 79: 1min HRV, 8.683; 80: HR, 125.017; 80: RR, 19.133; 80: SpO2, 99.05; 80: Perf, 0.435; 80: 1min HRV, 15.972; 81: HR, 125.690; 81: RR, 19.207; 81: SpO2, 99.310; 81: Perf, 0.393; 81: 1min HRV, 11.273; 82: HR, 124.475; 82: RR, 18.017; 82: SpO2, 99.576; 82: Perf, 0.411; 82: 1min HRV, 9.940; 82: 5min HRV, 11.653; 83: HR, 124.458; 83: RR, 20.898; 83: SpO2, 99.390; 83: Perf, 0.430; 83: 1min HRV, 6.755; 84: HR, 124.053; 84: RR, 20.544; 84: SpO2, 99.0; 84: Perf, 0.41; 84: 1min HRV, 12.448; 85: HR, 123.85; 85: RR, 21.683; 85: SpO2, 99.317; 85: Perf, 0.401; 85: 1min HRV, 9.913; 86: HR, 126.456; 86: RR, 22.053; 86: SpO2, 99.123; 86: Perf, 0.385; 86: 1min HRV, 7.107; 87: HR, 117.224; 87: RR, 25.190; 87: SpO2, 98.397; 87: Perf, 0.39; 87: 1min HRV, 72.391; 87: 5min HRV, 33.854; 88: HR, 132.881; 88: RR, 22.322; 88: SpO2, 99.3; 88: Perf, 0.401; 88: 1min HRV, 64.352; 89: WAM DIFTYP, AUTO; 89: EOSINOPHIL % (AUTO DIFF), 0.1 %; 89: HEMATOCRIT (HCT), 49.6 %; 89: BASOPHIL % (AUTO DIFF), 0.7 %; 89: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.24 K/uL; 89: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 89: RED CELL DISTRIBUTION WIDTH (RDW), 13.2 %; 89: NEUTROPHIL % (AUTO DIFF), 81.2 %; 89: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.28 K/uL; 89: RED BLOOD CELLS (RBC), 4.73 MIL/uL; 89: NRBC PERCENT (HEMATOLOGY), 0.0 %; 89: HEMOGLOBIN (HGB), 15.6 g/dL; 89: BASOPHIL ABSOLUTE (AUTO DIFF), 0.12 K/uL; 89: MONOCYTE % (AUTO DIFF), 7.8 %; 89: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.55 K/uL; 89: MONOCYTE ABSOLUTE (AUTO DIFF), 1.38 K/uL; 89: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.4 %; 89: MEAN CORPUSCULAR VOLUME (MCV), 104.9 fL; 89: LYMPHOCYTE % (AUTO DIFF), 8.8 %; 89: WHITE BLOOD CELLS (WBC), 17.6 K/uL; 89: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 33.0 pg; 89: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 89: PLATELET COUNT (PLT), 291 K/uL; 89: HR, 137.879; 89: RR, 22.241; 89: SpO2, 99.224; 89: Perf, 0.513; 89: 1min HRV, 13.514; 90: HR, 133.712; 90: RR, 24.831; 90: SpO2, 99.0; 90: Perf, 0.515; 90: 1min HRV, 17.901; 91: HR, 129.291; 91: RR, 27.667; 91: SpO2, 99.0; 91: Perf, 0.474; 91: 1min HRV, 9.513; 92: 5min HRV, 36.740; 107: LORAZEPAM, 2 MG/ML INJ SOLN; 0: Age:, 58; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 135.0; 0: Triage RR, 18.0; 0: Triage SBP, 148.0; 0: Triage DBP, 93.0; 0: Triage acuity, 3-Urgent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, assess key indicators of sepsis risk from the data within the first 12 hours. The patient consistently displays high heart rates (e.g., 135 BPM at triage and continued elevated rates thereafter) and high respiratory rates (e.g., reaching 27.667 BPM), both markers for sepsis risk. Further, the white blood cell count is high (17.6 K/uL), indicating a potential infection response, and there\u2019s a pattern of decreasing heart rate variability, which might indicate physiological stress. These factors combined suggest a high risk for sepsis within 12 hours.",
        "claims": [
            "Assess key indicators of sepsis risk from data within the first 12 hours.",
            "The patient consistently displays high heart rates.",
            "The patient had a heart rate of 135 BPM at triage.",
            "The patient's heart rates have remained elevated thereafter.",
            "The patient has high respiratory rates.",
            "The patient's respiratory rate reached 27.667 BPM.",
            "High heart rates and high respiratory rates are markers for sepsis risk.",
            "The white blood cell count of the patient is high at 17.6 K/uL.",
            "A high white blood cell count indicates a potential infection response.",
            "There is a pattern of decreasing heart rate variability in the patient.",
            "Decreasing heart rate variability might indicate physiological stress.",
            "These factors combined suggest a high risk for sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient consistently displays high heart rates.",
            "The patient had a heart rate of 135 BPM at triage.",
            "The patient's heart rates have remained elevated thereafter.",
            "The patient has high respiratory rates.",
            "The patient's respiratory rate reached 27.667 BPM.",
            "High heart rates and high respiratory rates are markers for sepsis risk.",
            "The white blood cell count of the patient is high at 17.6 K/uL.",
            "A high white blood cell count indicates a potential infection response.",
            "There is a pattern of decreasing heart rate variability in the patient.",
            "Decreasing heart rate variability might indicate physiological stress.",
            "These factors combined suggest a high risk for sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.9,
            0.6,
            0.7,
            1.0,
            0.8,
            1.0,
            1.0,
            0.3,
            0.3,
            0.3
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim indicating consistently high heart rates suggests potential hemodynamic instability, which aligns with the concept of an elevated shock index (heart rate divided by systolic BP). However, the claim does not provide information about blood pressure to confirm an elevated shock index, nor does it specify an actual shock index value. Thus, while relevant to this category, the alignment is moderate due to the lack of complete information needed to assess the shock index fully.",
            "A heart rate >90 BPM is one of the criteria for SIRS, indicating systemic inflammation which can be consistent with early sepsis. The heart rate of 135 BPM well exceeds this threshold, strongly aligning with this category. However, SIRS requires the presence of \u22652 criteria, which is not confirmed in the claim, slightly reducing the alignment from perfect.",
            "Elevated heart rate can suggest increased hemodynamic demand and instability, related to the Shock Index, which is heart rate divided by systolic blood pressure. While the claim mentions only elevated heart rate without specific blood pressure information, it implies a component of the shock index. Thus, there's a moderate alignment with the category, as elevated heart rates can be a sign in determining the shock index, although it is incomplete without blood pressure data.",
            "A high respiratory rate is directly related to the qSOFA criteria, which includes respiratory rate\u202f\u2265\u202f22/min as one of its components. However, without specifying the exact rate or additional components, it's not fully clear if the qSOFA threshold is met, which moderately aligns the claim with this category.",
            "The claim states a respiratory rate of 27.667 BPM, which meets the threshold of \u226522 BPM for the qSOFA criteria. A respiratory rate above this level is a direct component of the qSOFA scoring system, indicating a high risk of sepsis-related complications. Thus, the alignment with the High qSOFA Score is perfect.",
            "Both an elevated heart rate (>90 bpm) and an elevated respiratory rate (>20/min) are directly included as criteria for SIRS, which is a marker of systemic inflammation and can indicate early sepsis. The claim mentions both heart rate and respiratory rate as markers for sepsis risk, which strongly aligns with the SIRS criteria, but since the claim does not specify exact values or thresholds, the alignment is strong but not perfect.",
            "The claim directly identifies an elevated white blood cell count (17.6 K/uL), which is explicitly listed as one of the SIRS criteria (WBC >12,000/\u00b5L or <4,000/\u00b5L). This meets one of the conditions for systemic inflammation consistent with early sepsis. Therefore, the alignment is perfect.",
            "A high white blood cell (WBC) count is explicitly one of the criteria listed under the SIRS (Systemic Inflammatory Response Syndrome) criteria. SIRS is used to identify systemic inflammation that is consistent with early signs of sepsis. The claim directly mentions a component that is used for SIRS Positivity, providing a perfect alignment with the category.",
            "A decrease in heart rate variability can point to autonomic nervous system impairment, which may relate to haemodynamic instability leading to severe sepsis. While not a direct measure, it can conceptually align with haemodynamic concerns, though the connection to the shock index is indirect and less precise. Other categories, like SOFA score, are not explicitly associated with heart rate variability, making this the closest fit, albeit weakly.",
            "While the claim is about heart rate variability, it does not directly correspond to any specific criteria in the expert categories. However, elevated shock index, which relates to heart rate and blood pressure, is somewhat conceptually related since they both concern heart function and hemodynamic stability. The alignment is indirect and weak, hence a low rating.",
            "The claim mentions \"factors combined\" suggesting a high risk for sepsis, which generally implies the aggregation of deranged physiological measurements. This is conceptually similar to the NEWS score, which combines multiple vital signs to predict deterioration. However, the claim lacks specifics about which factors are involved, resulting in a weak alignment."
        ],
        "final_alignment_score": 0.6727272727272727,
        "accuracy": 1
    },
    {
        "input": "6: HR, 107.0; 6: RR, 22.0; 6: SpO2, 98.0; 6: SBP, 150.0; 6: DBP, 92.0; 6: MAP, 111.333; 6: Temp, 98.1; 8: Pain, 6.0; 35: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 39: NS IV BOLUS -, 1000 ML; 40: SBP, 146.0; 40: DBP, 103.0; 40: MAP, 117.333; 43: SBP, 145.0; 43: DBP, 100.0; 43: MAP, 115.0; 44: SpO2, 99.0; 45: SpO2, 98.471; 46: SpO2, 98.593; 46: Perf, 5.352; 47: SpO2, 98.780; 47: Perf, 5.709; 48: SpO2, 98.632; 48: Perf, 5.135; 49: WAM DIFTYP, AUTO; 49: WHITE BLOOD CELLS (WBC), 13.3 K/uL; 49: NRBC PERCENT (HEMATOLOGY), 0.0 %; 49: PLATELET COUNT (PLT), 394 K/uL; 49: HEMOGLOBIN (HGB), 14.0 g/dL; 49: BASOPHIL % (AUTO DIFF), 0.2 %; 49: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 49: HEMATOCRIT (HCT), 44.5 %; 49: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.22 K/uL; 49: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 49: LYMPHOCYTE % (AUTO DIFF), 14.6 %; 49: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 49: RED CELL DISTRIBUTION WIDTH (RDW), 17.6 %; 49: MONOCYTE % (AUTO DIFF), 9.4 %; 49: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 49: MONOCYTE ABSOLUTE (AUTO DIFF), 1.25 K/uL; 49: NEUTROPHIL % (AUTO DIFF), 73.6 %; 49: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 20.9 pg; 49: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 49: MEAN CORPUSCULAR VOLUME (MCV), 66.4 fL; 49: RED BLOOD CELLS (RBC), 6.70 MIL/uL; 49: NEUTROPHIL ABSOLUTE (AUTO DIFF), 9.80 K/uL; 49: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.94 K/uL; 49: EOSINOPHIL % (AUTO DIFF), 1.7 %; 49: SpO2, 98.814; 49: Perf, 5.578; 50: SpO2, 98.621; 50: Perf, 2.859; 51: SpO2, 98.0; 51: Perf, 3.014; 52: SpO2, 98.864; 52: Perf, 2.384; 53: SpO2, 98.259; 53: Perf, 4.219; 54: SpO2, 98.407; 54: Perf, 4.476; 55: SpO2, 99.017; 55: Perf, 3.234; 56: SpO2, 99.153; 56: Perf, 3.459; 57: SpO2, 99.169; 57: Perf, 4.327; 58: SpO2, 98.554; 58: Perf, 3.131; 58: SBP, 146.0; 58: DBP, 90.0; 58: MAP, 108.667; 59: SpO2, 98.948; 59: Perf, 3.605; 60: SpO2, 98.544; 60: Perf, 4.458; 61: SpO2, 98.508; 61: Perf, 4.895; 62: SpO2, 98.483; 62: Perf, 4.893; 63: SpO2, 98.810; 63: Perf, 3.064; 64: SpO2, 98.831; 64: Perf, 4.203; 65: SpO2, 98.759; 65: Perf, 5.463; 66: SpO2, 99.0; 66: Perf, 6.117; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.2 seconds; 67: PART. THROMBOPLASTIN TIME, 29.8 seconds; 67: SpO2, 98.458; 67: Perf, 7.107; 68: SARS-COV-2 RNA, Not Detected; 68: INFLUENZA B, Not Detected; 68: INFLUENZA A, Not Detected; 68: SpO2, 98.655; 68: Perf, 4.515; 69: SpO2, 99.102; 69: Perf, 5.877; 70: SpO2, 99.088; 70: Perf, 5.058; 71: SpO2, 98.661; 71: Perf, 5.588; 72: SpO2, 98.897; 72: Perf, 5.861; 73: SpO2, 99.324; 73: Perf, 6.02; 74: SpO2, 98.672; 74: Perf, 5.988; 75: SpO2, 98.322; 75: Perf, 5.623; 76: SpO2, 98.305; 76: Perf, 4.111; 77: SpO2, 98.155; 77: Perf, 2.146; 78: SpO2, 97.983; 78: Perf, 2.190; 79: SpO2, 98.203; 79: Perf, 2.648; 80: EGFR FOR AFRICAN AMERICAN, 156 mL/min/1.73 m2; 80: ALBUMIN, 4.7 g/dL; 80: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 80: CALCIUM, 9.8 mg/dL; 80: EGFR REFIT WITHOUT RACE (2021), 135 mL/min/1.73 m2; 80: AST (SGOT), 37 U/L; 80: ALKALINE PHOSPHATASE, 50 U/L; 80: ANION GAP, 13 mmol/L; 80: SODIUM, 138 mmol/L; 80: LIPASE, 33 U/L; 80: ALT (SGPT), 76 U/L; 80: GLOBULIN, 3.2 g/dL; 80: GLUCOSE, 140 mg/dL; 80: CREATININE, 0.61 mg/dL; 80: CHLORIDE, 101 mmol/L; 80: CORRECTED CALCIUM, 9.2 mg/dL; 80: POTASSIUM, 3.8 mmol/L; 80: CO2, 24 mmol/L; 80: BILIRUBIN TOTAL, 0.6 mg/dL; 80: PROTEIN TOTAL, 7.9 g/dL; 80: SpO2, 98.397; 80: Perf, 1.753; 81: SpO2, 98.5; 81: Perf, 1.938; 82: SpO2, 97.862; 82: Perf, 4.743; 83: SpO2, 98.356; 83: Perf, 3.823; 84: SpO2, 99.0; 84: Perf, 4.239; 85: SpO2, 98.879; 85: Perf, 3.032; 86: SpO2, 99.086; 86: Perf, 2.513; 87: SpO2, 99.458; 87: Perf, 2.665; 88: SpO2, 99.746; 88: Perf, 1.855; 89: SpO2, 99.525; 89: Perf, 2.494; 90: SpO2, 98.966; 90: Perf, 3.134; 91: SpO2, 98.763; 91: Perf, 2.510; 92: SpO2, 99.246; 92: Perf, 1.828; 93: SpO2, 99.534; 93: Perf, 1.934; 94: SpO2, 99.1; 94: Perf, 1.72; 95: SpO2, 97.860; 95: Perf, 1.700; 96: SpO2, 99.322; 96: Perf, 1.862; 97: POC GLUCOSE BY METER, 143 mg/dL; 97: SpO2, 99.379; 97: Perf, 2.176; 98: SpO2, 98.948; 98: Perf, 1.813; 99: SpO2, 99.695; 99: Perf, 2.000; 100: POC PH (V) ISTAT, 7.41; 100: POC HCO3 (V) ISTAT, 26.2 mmol/L; 100: POC BASE EXCESS ISTAT, 2 mmol/L; 100: POC PO2 (V) ISTAT, 28 mmHg; 100: POC LACTATE ISTAT, 1.44 mmol/L; 100: POC O2 SATURATION ISTAT VENOUS, 53 %; 100: POC PCO2 (V) ISTAT, 41.5 mmHg; 100: POC TCO2 (V) ISTAT, 27 mmol/L; 100: SpO2, 99.407; 100: Perf, 2.821; 101: SpO2, 99.186; 101: Perf, 2.667; 102: SpO2, 98.860; 102: Perf, 2.243; 103: SpO2, 98.729; 103: Perf, 3.206; 104: SpO2, 98.345; 104: Perf, 3.29; 105: SpO2, 98.695; 105: Perf, 3.340; 106: SpO2, 98.203; 106: Perf, 3.875; 107: SpO2, 98.368; 107: Perf, 4.513; 108: SpO2, 98.678; 108: Perf, 4.579; 109: SpO2, 98.103; 109: Perf, 4.212; 110: SpO2, 98.707; 110: Perf, 2.987; 111: SpO2, 99.153; 111: Perf, 2.532; 112: SpO2, 98.5; 112: Perf, 2.301; 113: SpO2, 98.0; 113: Perf, 1.517; 114: SpO2, 98.0; 114: Perf, 1.459; 115: SpO2, 98.475; 115: Perf, 1.668; 116: SpO2, 98.729; 116: Perf, 2.262; 117: SpO2, 98.431; 117: Perf, 2.479; 118: SpO2, 98.797; 118: Perf, 2.42; 119: SpO2, 98.621; 119: Perf, 2.42; 0: Age, 31; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 107.0; 0: Triage RR, 22.0; 0: Triage SBP, 150.0; 0: Triage DBP, 92.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess sepsis risk, we first identify key indicators such as elevated heart rate, respiratory rate, and white blood cell count, along with signs of organ dysfunction like altered mental state or low blood pressure. The patient presents some elevated vitals, such as heart rate and respiratory rate, which are indicative of systemic stress, but these are not severe and are stable over time. The white blood cell count is slightly elevated at 13.3 K/uL, but the patient's perfusion and oxygen saturation remain stable, suggesting no hypoperfusion or hypoxemia. Blood pressure and other lab values are largely normal, and the administration of ondansetron and IV fluids do not suggest acute deterioration. Given these observations, the patient does not exhibit high risk indicators for sepsis within the next 12 hours.",
        "claims": [
            "Key indicators for assessing sepsis risk include elevated heart rate, respiratory rate, and white blood cell count.",
            "Signs of organ dysfunction include altered mental state or low blood pressure.",
            "The patient presents some elevated vitals, including heart rate and respiratory rate.",
            "Elevated heart rate and respiratory rate are indicative of systemic stress.",
            "The elevated heart rate and respiratory rate are not severe.",
            "The elevated heart rate and respiratory rate are stable over time.",
            "The white blood cell count is slightly elevated at 13.3 K/uL.",
            "The patient's perfusion remains stable.",
            "The patient's oxygen saturation remains stable.",
            "Stable perfusion and oxygen saturation suggest no hypoperfusion.",
            "Stable perfusion and oxygen saturation suggest no hypoxemia.",
            "Blood pressure and other lab values are largely normal.",
            "The administration of ondansetron does not suggest acute deterioration.",
            "The administration of IV fluids does not suggest acute deterioration.",
            "Given these observations, the patient does not exhibit high risk indicators for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "Key indicators for assessing sepsis risk include elevated heart rate, respiratory rate, and white blood cell count.",
            "The patient presents some elevated vitals, including heart rate and respiratory rate.",
            "Elevated heart rate and respiratory rate are indicative of systemic stress.",
            "The white blood cell count is slightly elevated at 13.3 K/uL.",
            "The administration of ondansetron does not suggest acute deterioration."
        ],
        "alignment_scores": [
            0.9,
            0.8,
            0.8,
            0.9,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions elevated heart rate, respiratory rate, and white blood cell count, which are three of the criteria used to determine SIRS positivity (\u22652 criteria). All three are explicitly part of the SIRS criteria, indicating a strong alignment with systemic inflammation consistent with early sepsis. However, the alignment isn't perfect since the claim doesn't explicitly state meeting or exceeding the specific threshold values for each criterion, hence a 0.9 rather than a 1.0 rating.",
            "The claim mentions elevated heart rate and respiratory rate, both of which are part of the SIRS criteria. Since the presence of two or more SIRS criteria indicates systemic inflammation consistent with early sepsis, this aligns well with the category. However, the claim does not specify exact values, which slightly reduces the certainty of meeting the full criteria, hence the alignment rating is 0.8 instead of 1.0.",
            "The claim references an elevated heart rate and respiratory rate, both of which are specific criteria within the SIRS (Systemic Inflammatory Response Syndrome) category. While it does not directly mention all SIRS criteria, the presence of these two symptoms strongly aligns with the identification of systemic inflammation consistent with early sepsis. Hence, the alignment is strong but not perfect, as it doesn't explicitly state all conditions for SIRS positivity.",
            "The claim references an elevated white blood cell count, which is explicitly included in the SIRS criteria (WBC > 12,000/\u00b5L). Although the WBC count is only slightly elevated beyond the threshold, it still strongly aligns with one of the SIRS criteria for identifying systemic inflammation characteristic of early sepsis, thus warranting a high alignment rating.",
            "The mention of ondansetron, an antiemetic, implies management of nausea rather than sepsis-specific intervention like antibiotics or cultures. While it might be used in supportive care for a patient with sepsis, it does not directly correlate with predicting sepsis or suggesting deterioration due to infection. The link to any sepsis-related category is very weak, hence the low alignment rating."
        ],
        "final_alignment_score": 0.72,
        "accuracy": 1
    },
    {
        "input": "3: HR, 95.0; 3: RR, 18.0; 3: SpO2, 98.0; 3: SBP, 144.0; 3: DBP, 71.0; 3: MAP, 95.333; 3: Temp, 99.7; 5: Pain, 0.0; 28: SpO2, 98.576; 28: SBP, 123.0; 28: DBP, 80.0; 28: MAP, 94.333; 29: SpO2, 98.763; 29: Perf, 8.052; 30: SpO2, 98.534; 30: Perf, 7.895; 31: SpO2, 99.0; 31: Perf, 6.956; 32: SpO2, 99.0; 32: Perf, 6.084; 33: SpO2, 98.897; 33: Perf, 6.188; 33: SBP, 123.0; 33: DBP, 78.0; 33: MAP, 93.0; 34: SpO2, 99.0; 34: Perf, 5.995; 35: SpO2, 99.103; 35: Perf, 4.756; 36: SpO2, 99.017; 36: Perf, 4.286; 37: SpO2, 99.034; 37: Perf, 4.279; 38: SpO2, 98.864; 38: Perf, 4.909; 39: SpO2, 99.136; 39: Perf, 3.534; 40: SpO2, 98.776; 40: Perf, 3.986; 41: SpO2, 98.712; 41: Perf, 7.136; 42: SpO2, 99.0; 42: Perf, 8.326; 43: SpO2, 98.741; 43: Perf, 7.809; 44: SpO2, 98.695; 44: Perf, 8.455; 45: SpO2, 98.983; 45: Perf, 7.046; 46: SpO2, 98.593; 46: Perf, 7.803; 47: SpO2, 98.586; 47: Perf, 7.997; 48: SpO2, 98.729; 48: Perf, 8.226; 49: SpO2, 99.220; 49: Perf, 6.527; 50: SpO2, 98.966; 50: Perf, 5.83; 51: SpO2, 99.0; 51: Perf, 6.004; 52: SpO2, 99.0; 52: Perf, 4.165; 53: SpO2, 99.0; 53: Perf, 2.851; 54: SpO2, 98.966; 54: Perf, 3.823; 55: POC PH (V) ISTAT, 7.41; 55: POC BASE EXCESS ISTAT, 0 mmol/L; 55: POC TCO2 (V) ISTAT, 26 mmol/L; 55: POC PCO2 (V) ISTAT, 39.4 mmHg; 55: POC O2 SATURATION ISTAT VENOUS, 96 %; 55: POC PO2 (V) ISTAT, 79 mmHg; 55: POC LACTATE ISTAT, 0.68 mmol/L; 55: POC HCO3 (V) ISTAT, 24.9 mmol/L; 55: SpO2, 98.828; 55: Perf, 5.279; 56: SpO2, 99.034; 56: Perf, 6.270; 57: SpO2, 99.288; 57: Perf, 5.352; 58: SpO2, 99.0; 58: Perf, 6.585; 59: SpO2, 98.915; 59: Perf, 6.762; 60: INFLUENZA B, Not Detected; 60: RSV, Not Detected; 60: INFLUENZA A, Not Detected; 60: SARS-COV-2 RNA, Not Detected; 60: SpO2, 99.0; 60: Perf, 7.976; 61: SpO2, 98.898; 61: Perf, 7.899; 62: HR, 88.0; 62: SpO2, 98.898; 62: Perf, 6.503; 62: SBP, 118.0; 62: DBP, 76.0; 62: MAP, 90.0; 63: SpO2, 99.193; 63: Perf, 4.902; 63: SBP, 118.0; 63: DBP, 76.0; 63: MAP, 90.0; 64: SpO2, 99.0; 64: Perf, 5.622; 65: WAM DIFTYP, AUTO; 65: MONOCYTE ABSOLUTE (AUTO DIFF), 0.80 K/uL; 65: MEAN CORPUSCULAR VOLUME (MCV), 101.6 fL; 65: PLATELET COUNT (PLT), 264 K/uL; 65: MONOCYTE % (AUTO DIFF), 8.8 %; 65: WHITE BLOOD CELLS (WBC), 9.1 K/uL; 65: RED BLOOD CELLS (RBC), 3.12 MIL/uL; 65: NRBC ABSOLUTE (HEMATOLOGY), 0.02 K/uL; 65: BASOPHIL % (AUTO DIFF), 0.3 %; 65: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.48 K/uL; 65: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.12 K/uL; 65: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 65: LYMPHOCYTE % (AUTO DIFF), 16.4 %; 65: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.54 K/uL; 65: RED CELL DISTRIBUTION WIDTH (RDW), 11.9 %; 65: HEMATOCRIT (HCT), 31.7 %; 65: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.0 pg; 65: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 65: EOSINOPHIL % (AUTO DIFF), 0.9 %; 65: HEMOGLOBIN (HGB), 10.6 g/dL; 65: NRBC PERCENT (HEMATOLOGY), 0.2 %; 65: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.3 %; 65: NEUTROPHIL % (AUTO DIFF), 72.3 %; 65: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 65: SpO2, 99.0; 65: Perf, 6.659; 66: SpO2, 99.0; 66: Perf, 6.964; 67: SpO2, 98.695; 67: Perf, 6.546; 68: SpO2, 99.052; 68: Perf, 5.081; 69: SpO2, 99.034; 69: Perf, 5.156; 70: SpO2, 98.690; 70: Perf, 3.570; 71: SpO2, 98.034; 71: Perf, 1.72; 72: SpO2, 97.638; 72: Perf, 1.801; 73: SpO2, 98.424; 73: Perf, 2.185; 74: SpO2, 98.966; 74: Perf, 3.629; 75: SpO2, 98.810; 75: Perf, 3.656; 76: SpO2, 98.186; 76: Perf, 3.903; 77: SpO2, 99.052; 77: Perf, 6.108; 78: SpO2, 99.068; 78: Perf, 6.196; 79: SpO2, 98.424; 79: Perf, 6.029; 80: SpO2, 98.190; 80: Perf, 5.042; 81: SpO2, 98.35; 81: Perf, 5.184; 82: SpO2, 98.845; 82: Perf, 6.514; 83: SpO2, 98.797; 83: Perf, 6.342; 84: SpO2, 96.0; 84: Perf, 6.15; 89: ANION GAP, 12 mmol/L; 89: CORRECTED CALCIUM, 9.0 mg/dL; 89: GLUCOSE, 105 mg/dL; 89: POTASSIUM, 4.0 mmol/L; 89: BLOOD UREA NITROGEN (BUN), 13 mg/dL; 89: GLOBULIN, 2.9 g/dL; 89: ALKALINE PHOSPHATASE, 145 U/L; 89: ALBUMIN, 4.0 g/dL; 89: PROTEIN TOTAL, 6.9 g/dL; 89: SODIUM, 139 mmol/L; 89: AST (SGOT), 30 U/L; 89: ALT (SGPT), 55 U/L; 89: CALCIUM, 9.0 mg/dL; 89: CREATININE, 0.60 mg/dL; 89: BILIRUBIN TOTAL, 0.2 mg/dL; 89: EGFR REFIT WITHOUT RACE (2021), 123 mL/min/1.73 m2; 89: CHLORIDE, 105 mmol/L; 89: CO2, 22 mmol/L; 100: SpO2, 98.448; 100: SBP, 113.0; 100: DBP, 78.0; 100: MAP, 89.667; 101: SpO2, 98.254; 101: Perf, 5.693; 102: SpO2, 98.690; 102: Perf, 5.617; 103: SpO2, 98.780; 103: Perf, 4.489; 104: SpO2, 98.776; 104: Perf, 4.781; 105: SpO2, 98.915; 105: Perf, 5.713; 106: SpO2, 98.898; 106: Perf, 6.084; 107: SpO2, 98.931; 107: Perf, 6.246; 108: SpO2, 98.621; 108: Perf, 5.710; 109: SpO2, 99.0; 109: Perf, 5.128; 110: SpO2, 98.797; 110: Perf, 4.415; 111: SpO2, 98.254; 111: Perf, 5.385; 112: SpO2, 98.345; 112: Perf, 5.914; 113: SpO2, 98.356; 113: Perf, 6.226; 114: SpO2, 98.0; 114: Perf, 6.491; 115: SpO2, 98.0; 115: Perf, 7.201; 116: SpO2, 98.0; 116: Perf, 7.171; 117: SpO2, 98.241; 117: Perf, 7.102; 118: SpO2, 99.169; 118: Perf, 6.303; 119: SpO2, 98.828; 119: Perf, 6.511; 0: Age, 30; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 95.0; 0: Triage RR, 18.0; 0: Triage SBP, 144.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine sepsis risk, key indicators like heart rate, respiratory rate, temperature, blood pressure, and blood lactate levels need evaluation. The patient's vitals, such as HR, RR, and temperature, are within normal limits. Additionally, the lactate level is low (0.68 mmol/L). The patient shows no evidence of decreased perfusion or significant organ dysfunction, and other laboratory findings are unremarkable. Thus, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "Key indicators for determining sepsis risk include heart rate, respiratory rate, temperature, blood pressure, and blood lactate levels.",
            "The patient's heart rate (HR) is within normal limits.",
            "The patient's respiratory rate (RR) is within normal limits.",
            "The patient's temperature is within normal limits.",
            "The patient's blood lactate level is low at 0.68 mmol/L.",
            "The patient shows no evidence of decreased perfusion.",
            "The patient shows no significant organ dysfunction.",
            "Other laboratory findings for the patient are unremarkable.",
            "Therefore, the patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's blood lactate level is low at 0.68 mmol/L.",
            "The patient shows no evidence of decreased perfusion."
        ],
        "alignment_scores": [
            0.2,
            0.2
        ],
        "alignment_category": [
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "The claim specifically mentions blood lactate levels, which directly relates to the Elevated Serum Lactate category. However, the reported lactate level is low (0.68 mmol/L), far below the threshold of \u22652 mmol/L, indicating no risk from elevated lactate. The connection to the category is present but very weak, as it highlights the absence rather than the presence of risk.",
            "The claim mentions there is no evidence of decreased perfusion. Elevated serum lactate is associated with tissue hypoperfusion, a condition that is not present according to the claim. Thus, the category related to serum lactate indirectly aligns as it speaks to the absence of an indicator you'd expect in heightened sepsis risk. However, since the claim negates this aspect, alignment is weak."
        ],
        "final_alignment_score": 0.2,
        "accuracy": 1
    },
    {
        "input": "1: SpO2, 98.630; 1: Perf, 3.019; 1: SBP, 152.0; 1: DBP, 96.0; 1: MAP, 114.667; 2: HR, 143.083; 2: RR, 16.192; 2: SpO2, 98.810; 2: Perf, 3.446; 2: 1min HRV, 2.178; 3: HR, 141.678; 3: RR, 24.271; 3: SpO2, 98.322; 3: Perf, 3.714; 3: 1min HRV, 2.554; 3: 5min HRV, 3.429; 4: HR, 140.724; 4: RR, 27.379; 4: SpO2, 96.655; 4: Perf, 3.744; 4: 1min HRV, 2.447; 5: HR, 138.881; 5: RR, 36.847; 5: SpO2, 94.780; 5: Perf, 3.694; 5: 1min HRV, 5.014; 6: HR, 136.017; 6: RR, 37.0; 6: SpO2, 94.576; 6: Perf, 4.768; 6: 1min HRV, 2.594; 7: HR, 136.638; 7: RR, 27.707; 7: SpO2, 94.828; 7: Perf, 4.575; 7: 1min HRV, 3.223; 8: HR, 136.288; 8: RR, 35.712; 8: SpO2, 94.831; 8: Perf, 5.021; 8: 1min HRV, 2.220; 8: 5min HRV, 6.473; 9: HR, 137.220; 9: RR, 35.932; 9: SpO2, 93.847; 9: Perf, 4.974; 9: 1min HRV, 3.275; 10: HR, 135.517; 10: RR, 37.828; 10: SpO2, 94.224; 10: Perf, 4.255; 10: 1min HRV, 2.338; 10: SBP, 148.0; 10: DBP, 88.0; 10: MAP, 108.0; 10: Pain, 2.0; 10: Temp, 98.2; 11: HR, 136.237; 11: RR, 35.797; 11: SpO2, 93.644; 11: Perf, 4.098; 11: 1min HRV, 1.728; 11: SBP, 148.0; 11: DBP, 88.0; 11: MAP, 108.0; 12: HR, 136.362; 12: RR, 34.328; 12: SpO2, 93.138; 12: Perf, 3.829; 12: 1min HRV, 1.689; 13: HR, 136.814; 13: RR, 33.814; 13: SpO2, 93.068; 13: Perf, 3.642; 13: 1min HRV, 2.513; 13: 5min HRV, 3.005; 14: HR, 133.508; 14: RR, 35.390; 14: SpO2, 94.0; 14: Perf, 3.389; 14: 1min HRV, 5.601; 14: SBP, 145.0; 14: DBP, 85.0; 14: MAP, 105.0; 15: HR, 135.707; 15: RR, 29.966; 15: SpO2, 93.259; 15: Perf, 3.463; 15: 1min HRV, 1.602; 16: HR, 135.831; 16: RR, 35.068; 16: SpO2, 92.644; 16: Perf, 3.218; 16: 1min HRV, 2.306; 17: HR, 137.483; 17: RR, 28.017; 17: SpO2, 92.483; 17: Perf, 2.914; 17: 1min HRV, 2.149; 18: HR, 139.525; 18: RR, 33.695; 18: SpO2, 93.831; 18: Perf, 3.005; 18: 1min HRV, 4.277; 18: 5min HRV, 7.611; 19: HR, 140.5; 19: RR, 30.155; 19: SpO2, 94.276; 19: Perf, 3.315; 19: 1min HRV, 2.195; 20: HR, 142.136; 20: RR, 26.153; 20: SpO2, 93.983; 20: Perf, 3.305; 20: 1min HRV, 4.383; 21: HR, 138.356; 21: RR, 39.475; 21: SpO2, 93.780; 21: Perf, 3.03; 21: 1min HRV, 3.559; 22: HR, 137.534; 22: RR, 24.172; 22: SpO2, 94.103; 22: Perf, 3.151; 22: 1min HRV, 4.053; 23: HR, 138.203; 23: RR, 26.0; 23: SpO2, 94.407; 23: Perf, 3.031; 23: 1min HRV, 3.148; 23: 5min HRV, 6.289; 23: SBP, 160.0; 23: DBP, 84.0; 23: MAP, 109.333; 24: HR, 138.379; 24: RR, 27.431; 24: SpO2, 95.414; 24: Perf, 2.772; 24: 1min HRV, 2.778; 24: SBP, 160.0; 24: DBP, 84.0; 24: MAP, 109.333; 25: HR, 138.424; 25: RR, 30.458; 25: SpO2, 94.610; 25: Perf, 2.843; 25: 1min HRV, 4.149; 26: HR, 137.729; 26: RR, 30.288; 26: SpO2, 94.593; 26: Perf, 2.971; 26: 1min HRV, 3.643; 27: HR, 136.034; 27: RR, 34.276; 27: SpO2, 94.431; 27: Perf, 3.723; 27: 1min HRV, 4.158; 28: HR, 135.525; 28: RR, 36.847; 28: SpO2, 94.322; 28: Perf, 3.027; 28: 1min HRV, 3.855; 28: 5min HRV, 5.509; 29: HR, 133.897; 29: RR, 37.845; 29: SpO2, 94.862; 29: Perf, 2.952; 29: 1min HRV, 2.374; 30: HR, 134.424; 30: RR, 36.119; 30: SpO2, 94.492; 30: Perf, 2.938; 30: 1min HRV, 2.384; 31: HR, 133.915; 31: RR, 35.661; 31: SpO2, 94.119; 31: Perf, 2.657; 31: 1min HRV, 3.336; 32: HR, 132.431; 32: RR, 29.241; 32: SpO2, 94.845; 32: Perf, 2.761; 32: 1min HRV, 29.569; 33: HR, 140.0; 33: RR, 40.0; 33: SpO2, 94.0; 33: 5min HRV, 14.178; 33: SBP, 140.0; 33: DBP, 93.0; 33: MAP, 108.667; 42: NORMOSOL-R IV BOLUS -, 500 ML; 43: POC CREATININE,ISTAT: .6 mg/dL; 43: POC EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 43: POC EGFR FOR AFRICAN AMERICAN, 118 mL/min/1.73 m2; 43: HR, 130.0; 43: RR, 34.0; 43: SpO2, 95.0; 43: SBP, 139.0; 43: DBP, 81.0; 43: MAP, 100.333; 53: HR, 131.0; 53: RR, 37.0; 53: SpO2, 96.0; 53: SBP, 154.0; 53: DBP, 85.0; 53: MAP, 108.0; 56: AZITHROMYCIN, 500 MG IN D5W 250 ML IVPB; 61: CEFEPIME, 2 GRAM/20 ML IV PUSH; 63: HR, 130.0; 63: RR, 38.0; 63: SpO2, 96.0; 63: SBP, 122.0; 63: DBP, 109.0; 63: MAP, 113.333; 73: HR, 134.0; 73: RR, 25.0; 73: SpO2, 95.0; 83: HR, 132.0; 83: RR, 23.0; 83: SpO2, 96.0; 83: SBP, 145.0; 83: DBP, 76.0; 83: MAP, 99.0; 93: HR, 129.0; 93: RR, 35.0; 93: SpO2, 96.0; 93: SBP, 138.0; 93: DBP, 82.0; 93: MAP, 100.667; 103: HR, 127.0; 103: RR, 36.0; 103: SpO2, 95.0; 103: SBP, 118.0; 103: DBP, 92.0; 103: MAP, 100.667; 112: ALBUMIN, 3.7 g/dL; 112: GLUCOSE, 197 mg/dL; 112: ALKALINE PHOSPHATASE, 450 U/L; 112: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 112: POTASSIUM, 3.7 mmol/L; 112: GLOBULIN, 3.1 g/dL; 112: EGFR REFIT WITHOUT RACE (2021), 100 mL/min/1.73 m2; 112: CREATININE, 0.65 mg/dL; 112: CHLORIDE, 101 mmol/L; 112: LIPASE, 24 U/L; 112: AST (SGOT), 83 U/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: ANION GAP, 12 mmol/L; 112: SODIUM, 135 mmol/L; 112: MAGNESIUM, 1.9 mg/dL; 112: CALCIUM, 8.7 mg/dL; 112: BILIRUBIN TOTAL, 0.6 mg/dL; 112: CORRECTED CALCIUM, 8.9 mg/dL; 112: CO2, 22 mmol/L; 112: ALT (SGPT), 29 U/L; 112: EGFR FOR AFRICAN AMERICAN, 115 mL/min/1.73 m2; 112: TSH, 1.65 uIU/mL; 113: HR, 123.0; 113: RR, 29.0; 113: SpO2, 95.0; 113: SBP, 121.0; 113: DBP, 67.0; 113: MAP, 85.0; 114: TROPONIN I, <.017 ng/mL; 0: Age, 56; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 136.0; 0: Triage RR, 36.0; 0: Triage SBP, 148.0; 0: Triage DBP, 88.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The subquestions revolve around identifying sepsis risk indicators, which include high heart rate, abnormal respiratory rate, low SpO2, and changes in vital signs over time. Initially, the patient presents with likely abnormalities: elevated heart rate and respiratory rate at triage. Throughout the observation period, these vitals remain elevated, and the patient receives broad-spectrum antibiotics (Azithromycin and Cefepime), suggesting the clinical team suspects infection. Given these details and the medical interventions, the patient is at high risk of developing sepsis.",
        "claims": [
            "The subquestions revolve around identifying sepsis risk indicators.",
            "Sepsis risk indicators include high heart rate.",
            "Sepsis risk indicators include abnormal respiratory rate.",
            "Sepsis risk indicators include low SpO2.",
            "Sepsis risk indicators include changes in vital signs over time.",
            "Initially, the patient presents with elevated heart rate at triage.",
            "Initially, the patient presents with elevated respiratory rate at triage.",
            "Throughout the observation period, the patient's vital signs remain elevated.",
            "The patient receives broad-spectrum antibiotics.",
            "The patient receives Azithromycin as part of the treatment.",
            "The patient receives Cefepime as part of the treatment.",
            "The administration of antibiotics suggests the clinical team suspects infection.",
            "Given the details and medical interventions, the patient is at high risk of developing sepsis."
        ],
        "relevant_claims": [
            "Sepsis risk indicators include high heart rate.",
            "Sepsis risk indicators include abnormal respiratory rate.",
            "Sepsis risk indicators include low SpO2.",
            "Sepsis risk indicators include changes in vital signs over time.",
            "Initially, the patient presents with elevated heart rate at triage.",
            "Initially, the patient presents with elevated respiratory rate at triage.",
            "Throughout the observation period, the patient's vital signs remain elevated.",
            "The patient receives broad-spectrum antibiotics.",
            "The patient receives Azithromycin as part of the treatment.",
            "The patient receives Cefepime as part of the treatment.",
            "The administration of antibiotics suggests the clinical team suspects infection.",
            "Given the details and medical interventions, the patient is at high risk of developing sepsis."
        ],
        "alignment_scores": [
            0.8,
            0.7,
            0.6,
            0.7,
            0.5,
            0.7,
            0.7,
            1.0,
            0.7,
            0.9,
            0.8,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions a high heart rate, which is directly relevant to the SIRS criteria as heart\u202frate\u202f>\u202f90\u202fbpm is one of the specific indicators. However, the claim does not provide additional SIRS criteria needed for full confirmation (\u22652 criteria), thus the alignment is strong but not complete.",
            "An abnormal respiratory rate is part of the SIRS criteria (specifically, respiratory rate\u202f>\u202f20\u202f/min). The claim directly identifies an abnormal respiratory rate as a sepsis risk indicator, which aligns with SIRS Positivity, though the claim doesn't provide a specific value. This makes the alignment strong but not complete.",
            "The claim mentions low SpO2, which is indicative of potential respiratory compromise and relates conceptually to the SOFA score metric of impaired oxygenation (PaO\u2082/FiO\u2082). While SpO2 itself is not a direct component of the SOFA score, it is relevant to the assessment of organ dysfunction and the risk of sepsis, which enhances the alignment. However, since it does not directly map onto SOFA criteria, the alignment is not full.",
            "The claim refers to changes in vital signs over time, which aligns with the National Early Warning Score (NEWS) as it assesses and calculates risk based on various deranged vital signs predicting clinical deterioration compatible with sepsis. While the claim does not specify a NEWS score, the implication of monitoring and interpreting vital sign changes aligns fairly strongly with the NEWS category, which uses such changes to predict deterioration.",
            "An elevated heart rate (>90 bpm) is one of the criteria for SIRS, indicating systemic inflammation that may lead to sepsis. However, since the claim does not mention other SIRS criteria being met, the alignment is only partial. The elevated heart rate aligns with one aspect of the SIRS criteria, but not fully with the requirement of having at least two criteria.",
            "An elevated respiratory rate is one of the SIRS criteria (respiratory rate > 20/min or PaCO\u2082 < 32 mm Hg). The claim specifies an elevated respiratory rate, so it aligns well with the SIRS criteria, indicating earlier systemic inflammation consistent with potential sepsis. However, without more information on other criteria being met, the alignment is not complete, so a strong but not perfect rating is given.",
            "Elevated vital signs suggest clinical instability, which aligns with the rationale behind the National Early Warning Score (NEWS) that aggregates deranged vitals to predict deterioration, including sepsis. However, without specific details about the NEWS components or the exact score, the alignment isn't perfect but is significantly relevant.",
            "The claim explicitly mentions that the patient receives broad-spectrum antibiotics. This directly matches the expert sepsis category concerning the administration of antibiotics, signifying a clinician's suspicion of a serious infection, which is associated with sepsis risk assessment. Therefore, the alignment is perfect.",
            "The administration of Azithromycin, an antibiotic, implies suspicion of serious infection, corresponding to the category of early antibiotic orders. However, without a specific timeframe of administration relative to the evaluation or a mention of other actions like blood culture draws, the alignment is moderate rather than perfect. This claim moderately supports the idea of infection management, but additional details would strengthen the alignment.",
            "The claim directly refers to the administration of Cefepime, which is a broad-spectrum antibiotic. While the claim does not specify the timing within the first 2 hours, the use of a broad-spectrum antibiotic strongly aligns with the category that reflects suspicion of a serious infection, which warrants early treatment. The alignment is very high due to the direct match in clinical action, though not complete because the timing detail is not specified.",
            "The claim directly refers to the administration of antibiotics, which indicates the clinical suspicion of a serious infection. This aligns well with the expert category that flags early antibiotic orders as indicative of potential sepsis risk. However, because the timing of the antibiotic administration (within 2 hours) is not specified, the alignment is rated slightly less than perfect.",
            "The claim is quite general and does not specify which details or interventions are involved, making it challenging to assign a specific category. However, the notion of high risk and medical interventions suggests a potential suspicion of serious infection. Among the options, the initiation of antibiotics or cultures (indicative of suspicion of serious infection) could loosely relate. The alignment is weak due to the lack of specificity in the claim."
        ],
        "final_alignment_score": 0.7000000000000001,
        "accuracy": 1
    },
    {
        "input": "7: HR, 91.596; 7: RR, 24.462; 7: SpO2, 96.562; 7: Perf, 0.259; 7: 1min HRV, 72.990; 8: POC PH (V) ISTAT, 7.25; 8: POC GLUCOSE ISTAT, 100 mg/dL; 8: POC SODIUM ISTAT, 141 mmol/L; 8: POC HGB (CALC) ISTAT, 11.6 g/dL; 8: POC POTASSIUM ISTAT, 4.1 mmol/L; 8: POC HCT ISTAT, 34 %; 8: POC HCO3 (V) ISTAT, 30.1 mmol/L; 8: POC BASE EXCESS ISTAT, 3 mmol/L; 8: POC TCO2 (V) ISTAT, 32 mmol/L; 8: POC LACTATE ISTAT, 0.83 mmol/L; 8: POC O2 SATURATION ISTAT VENOUS, 21 %; 8: POC PO2 (V) ISTAT, 19 mmHg; 8: POC PCO2 (V) ISTAT, 68.9 mmHg; 8: HR, 92.434; 8: RR, 24.623; 8: SpO2, 96.519; 8: Perf, 0.241; 8: 1min HRV, 51.204; 8: 5min HRV, 63.099; 9: HR, 93.135; 9: RR, 19.731; 9: SpO2, 95.95; 9: Perf, 0.217; 9: 1min HRV, 56.604; 10: HR, 91.208; 10: RR, 21.585; 10: SpO2, 96.679; 10: Perf, 0.21; 10: 1min HRV, 41.598; 11: HR, 92.302; 11: RR, 21.321; 11: Perf, 0.21; 11: 1min HRV, 56.135; 12: HR, 92.481; 12: RR, 20.827; 12: SpO2, 97.778; 12: Perf, 0.21; 12: 1min HRV, 33.525; 13: HR, 97.585; 13: RR, 25.849; 13: SpO2, 96.811; 13: Perf, 0.21; 13: 1min HRV, 41.248; 13: 5min HRV, 50.267; 14: HR, 105.887; 14: RR, 21.642; 14: SpO2, 95.947; 14: 1min HRV, 52.404; 15: HR, 104.755; 15: RR, 16.019; 15: SpO2, 97.0; 15: 1min HRV, 15.021; 16: HR, 99.509; 16: RR, 22.623; 16: SpO2, 97.868; 16: Perf, 0.806; 16: 1min HRV, 6.890; 17: HR, 99.327; 17: RR, 19.538; 17: SpO2, 98.462; 17: Perf, 1.002; 17: 1min HRV, 45.299; 18: HR, 98.204; 18: RR, 25.833; 18: SpO2, 98.5; 18: Perf, 0.96; 18: 1min HRV, 7.606; 18: 5min HRV, 37.717; 19: HR, 98.538; 19: RR, 26.731; 19: SpO2, 98.0; 19: Perf, 0.96; 19: 1min HRV, 21.760; 19: SBP, 171.0; 19: DBP, 137.0; 19: MAP, 148.333; 20: HR, 97.667; 20: RR, 20.407; 20: SpO2, 97.824; 20: Perf, 0.96; 20: 1min HRV, 38.205; 21: HR, 97.887; 21: RR, 21.245; 21: SpO2, 98.302; 21: Perf, 0.96; 21: 1min HRV, 38.711; 22: HR, 96.212; 22: RR, 21.673; 22: SpO2, 99.0; 22: Perf, 0.96; 22: 1min HRV, 15.498; 23: HR, 95.679; 23: RR, 23.340; 23: SpO2, 98.041; 23: Perf, 0.959; 23: 1min HRV, 12.652; 23: 5min HRV, 29.080; 23: SBP, 171.0; 23: DBP, 137.0; 23: MAP, 148.333; 23: LPM O2, 2.0; 23: Pain, 1.0; 23: Temp, 101.3; 24: HR, 95.058; 24: RR, 23.654; 24: SpO2, 97.385; 24: Perf, 0.820; 24: 1min HRV, 17.024; 25: HR, 94.755; 25: RR, 22.038; 25: SpO2, 96.925; 25: Perf, 0.358; 25: 1min HRV, 13.002; 26: HR, 93.923; 26: RR, 20.442; 26: SpO2, 96.981; 26: Perf, 0.331; 26: 1min HRV, 17.608; 27: HR, 93.5; 27: RR, 22.519; 27: SpO2, 96.704; 27: Perf, 0.344; 27: 1min HRV, 10.366; 27: SBP, 125.0; 27: DBP, 33.0; 27: MAP, 63.667; 27: LPM O2, 2.0; 28: HR, 93.887; 28: RR, 23.151; 28: SpO2, 96.302; 28: Perf, 0.353; 28: 1min HRV, 4.850; 28: 5min HRV, 13.955; 29: HR, 94.5; 29: RR, 25.077; 29: SpO2, 96.077; 29: Perf, 0.371; 29: 1min HRV, 42.092; 30: HR, 92.208; 30: RR, 29.113; 30: SpO2, 95.660; 30: Perf, 0.388; 30: 1min HRV, 19.633; 31: HR, 93.0; 31: RR, 22.519; 31: SpO2, 94.808; 31: Perf, 0.391; 31: 1min HRV, 28.109; 32: HR, 92.593; 32: RR, 20.204; 32: SpO2, 95.185; 32: Perf, 0.455; 32: 1min HRV, 18.466; 33: 5min HRV, 29.373; 38: ABO/RH, B Positive; 39: ANTIBODY SCREEN 3, NEG; 44: PH.SER/PLAS, 7.22; 44: CALCIUM IONIZED, 1.14 mmol/L; 45: WAM DIFTYP, AUTO; 45: RED CELL DISTRIBUTION WIDTH (RDW), 15.3 %; 45: WHITE BLOOD CELLS (WBC), 11.9 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.3 g/dL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.07 K/uL; 45: HEMOGLOBIN (HGB), 10.0 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: MEAN CORPUSCULAR VOLUME (MCV), 110.3 fL; 45: HEMATOCRIT (HCT), 32.0 %; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: PLATELET COUNT (PLT), 185 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 34.5 pg; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 45: NEUTROPHIL % (AUTO DIFF), 84.7 %; 45: MONOCYTE % (AUTO DIFF), 6.0 %; 45: RED BLOOD CELLS (RBC), 2.90 MIL/uL; 45: BASOPHIL % (AUTO DIFF), 0.1 %; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.71 K/uL; 46: ACETAMINOPHEN, 1 000 MG/100 ML (10 MG/ML) IV SOLN; 58: CEFTRIAXONE, 1 GRAM/10 ML IV PUSH (VIAL ONLY); 63: HR, 91.0; 63: SpO2, 100.0; 63: SBP, 109.0; 63: DBP, 44.0; 63: MAP, 65.667; 63: LPM O2, 2.0; 63: VANCOMYCIN-WATER INJECT (PEG), 2 GRAM/400 ML IV PGBK; 69: INR:, 1.1; 69: THROMBIN TIME, 20.9 seconds; 69: PART. THROMBOPLASTIN TIME, 40.8 seconds; 69: FIBRINOGEN, 654 mg/dL; 69: D-DIMER, 1.40 ug/mL FEU; 69: PROTHROMBIN TIME, 13.4 seconds; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 70: SARS-COV-2 RNA, Detected; 70: INFLUENZA B, Not Detected; 70: INFLUENZA A, Not Detected; 71: BLOOD TYPE VERIFICATION-MANUAL, B Positive; 75: MAGNESIUM, 2.1 mg/dL; 75: PHOSPHORUS, 2.6 mg/dL; 75: BNP NT-PRO, 2986 pg/mL; 88: TROPONIN I, 0.020 ng/mL; 116: KETONE, URINE (UA): Negative; 116: NITRITE, URINE (UA): Negative; 116: SPECIFIC GRAVITY, URINE (UA): 1.020; 116: PH, URINE (UA): 5.0; 116: GLUCOSE, URINE (UA): Negative; 116: LEUKOCYTE ESTERASE, URINE (UA): Negative; 0: Age, 81; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, EMS; 0: Triage Temp, 38.5; 0: Triage HR, 94.0; 0: Triage RR, 23.0; 0: Triage SBP, 171.0; 0: Triage DBP, 137.0; 0: Triage acuity, 2-Emergent; 0: CC, ALTERED MENTAL STATUS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess the risk of sepsis, we first examine key indicators such as the patient's vital signs, blood markers, and medical interventions. The patient shows signs of potential sepsis: elevated temperature, rapid respiratory rate, altered mental status, and significant white blood cell count. Additionally, antibiotics like Ceftriaxone and Vancomycin were administered, which is often a response to suspected infection. Blood gas analysis indicating acidosis, alongside a detected SARS-CoV-2 RNA and elevated BNP, further support the likelihood of sepsis. These factors collectively point towards a high risk of sepsis, warranting the label \"Yes\".",
        "claims": [
            "To assess the risk of sepsis, key indicators are examined.",
            "Key indicators include the patient's vital signs.",
            "Key indicators also include blood markers.",
            "Key indicators include medical interventions.",
            "The patient shows signs of potential sepsis.",
            "The patient has an elevated temperature.",
            "The patient has a rapid respiratory rate.",
            "The patient has an altered mental status.",
            "The patient has a significant white blood cell count.",
            "Antibiotics like Ceftriaxone and Vancomycin were administered.",
            "Administering antibiotics is often a response to suspected infection.",
            "Blood gas analysis indicates acidosis.",
            "SARS-CoV-2 RNA was detected in the patient.",
            "The patient has an elevated BNP.",
            "The detected SARS-CoV-2 RNA supports the likelihood of sepsis.",
            "The elevated BNP supports the likelihood of sepsis.",
            "These factors collectively point towards a high risk of sepsis.",
            "The risk assessment warrants the label \"Yes\"."
        ],
        "relevant_claims": [
            "Key indicators include the patient's vital signs.",
            "Key indicators also include blood markers.",
            "The patient shows signs of potential sepsis.",
            "The patient has an elevated temperature.",
            "The patient has a rapid respiratory rate.",
            "The patient has an altered mental status.",
            "The patient has a significant white blood cell count.",
            "Antibiotics like Ceftriaxone and Vancomycin were administered.",
            "Administering antibiotics is often a response to suspected infection.",
            "Blood gas analysis indicates acidosis.",
            "SARS-CoV-2 RNA was detected in the patient.",
            "The patient has an elevated BNP.",
            "The detected SARS-CoV-2 RNA supports the likelihood of sepsis.",
            "The elevated BNP supports the likelihood of sepsis.",
            "These factors collectively point towards a high risk of sepsis."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.3,
            0.8,
            0.9,
            0.8,
            0.8,
            1.0,
            0.7,
            0.7,
            0.3,
            0.3,
            0.3,
            0.3,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Shock Index (\u22651.0)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim references \"vital signs\" without specifying which ones or giving any indication of derangement. The NEWS score is directly related to assessing risk through a combination of vitals; however, because the claim lacks detail about the vitals or their derangement, the alignment is weak and only suggests a potential relationship to the NEWS score.",
            "The claim vaguely mentions \"blood markers,\" which could suggest a variety of measurements. Elevated Serum Lactate is a specific blood marker associated with sepsis, so it has some relevance. However, the claim lacks specificity and does not explicitly mention lactate or any other specific marker. Therefore, the alignment is weak but potentially relevant.",
            "The claim broadly suggests signs of potential sepsis without specifying any particular clinical details or measurements. While this could broadly relate to several categories, the Elevated NEWS Score category accounts for a composite of vital signs that might generally indicate potential sepsis. Due to the lack of specific metrics (e.g., exact vital signs or scores), the alignment is weak, warranting a low rating.",
            "The claim about an elevated temperature aligns closely with the SIRS criteria, which include temperature >38\u00b0C (100.4\u00b0F). While the claim doesn\u2019t specify the exact temperature to confirm if it exceeds this threshold, the reference to an elevated temperature strongly suggests a potential systemic inflammatory response. Therefore, it aligns well with SIRS positivity, though not fully confirmed.",
            "A rapid respiratory rate is directly mentioned in the SIRS criteria (respiratory rate\u202f>\u202f20\u202f/min), which is used to identify systemic inflammation and potential early sepsis. This claim aligns strongly with the SIRS Positivity category, though the exact respiratory rate is not specified, slightly reducing certainty in meeting the criterion fully.",
            "An altered mental status is one of the criteria in the qSOFA score, which is used to flag a high risk of sepsis-related organ dysfunction and mortality. While altered mentation strongly aligns with the High qSOFA Score category, the alignment rating is slightly less than perfect because qSOFA also includes other criteria that are not mentioned in the claim.",
            "The claim regarding a significant white blood cell count aligns with the SIRS criteria, which includes WBC\u202f>\u202f12,000/\u00b5L or\u202f<\u202f4,000/\u00b5L as one of its components. However, the claim doesn't specify the exact level or if other SIRS criteria are met, so the alignment, while strong, is not absolute.",
            "The claim specifies that antibiotics have been administered, which directly aligns with this category's focus on early antibiotic or culture orders as an indicator of sepsis risk. The strong association between the administration of broad-spectrum antibiotics and the clinician's suspicion of a serious infection ensures a perfect alignment with the category.",
            "Administering antibiotics aligns with this category as it suggests clinician suspicion of infection, a fundamental part of the category's criteria. However, the claim does not specify if the antibiotics were administered within 2 hours, which is a critical aspect for full alignment, leading to a somewhat lower alignment rating.",
            "Acidosis in blood gas analysis can suggest lactic acidosis, which is linked to elevated serum lactate levels. Elevated lactate levels are directly related to tissue hypoperfusion, a key concern in assessing for sepsis risk. While the claim does not specify lactate levels, the relationship between acidosis and lactate suggests a substantial alignment with this category. However, without explicit lactate measurements, the alignment is not perfect.",
            "The detection of SARS-CoV-2 RNA indicates a viral infection that requires careful clinical monitoring and potential for further action like ordering cultures or antivirals, which could align with Early Antibiotic/Culture Orders category. However, it does not specify immediate clinical actions such as administering antibiotics or drawing cultures within the time frame mentioned. Thus, the alignment is indirect and not very strong.",
            "BNP (B-type Natriuretic Peptide) elevation indicates heart stress or heart failure but does not directly assess the metrics associated with sepsis prediction, such as vitals or inflammatory markers. It could suggest possible haemodynamic instability, similar to what elevated shock index identifies. However, BNP is not a direct measure of sepsis risk based on the categories given, so the alignment is weak and mostly conceptual.",
            "The detection of SARS-CoV-2 RNA suggests a viral infection, which can increase the risk of sepsis due to superimposed bacterial infections. However, the claim does not mention any immediate clinical actions, such as antibiotic administration or blood culture draws within 2 hours. That category is conceptually relevant, as detecting an infection often correlates with actions included in early sepsis recognition. The alignment is indirect and somewhat weak due to the lack of specific actions.",
            "Elevated BNP is not directly mentioned or measured within any of the sepsis criteria categories provided. However, BNP levels can sometimes correlate with cardiac stress and inflammation, slightly aligning with the concept of detecting abnormal physiological responses (such as tissue hypoperfusion, which is indicated by elevated lactate). The alignment is quite indirect, hence a low alignment rating of 0.3.",
            "The claim is a general statement about a high sepsis risk without specifying concrete clinical actions or measurements. The Elevated NEWS Score category involves a collective assessment of vital signs and clinical status to predict clinical deterioration, similar to assessing various factors together as in the claim. However, the alignment is low due to the lack of specificity in the claim regarding what those factors are."
        ],
        "final_alignment_score": 0.5399999999999999,
        "accuracy": 1
    },
    {
        "input": "3: HR, 114.0; 3: RR, 18.0; 3: SpO2, 100.0; 3: SBP, 150.0; 3: DBP, 95.0; 3: MAP, 113.333; 3: Temp, 98.4; 74: RR, 42.2; 74: SpO2, 99.878; 74: Perf, 0.56; 74: SBP, 149.0; 74: DBP, 103.0; 74: MAP, 118.333; 75: HR, 100.725; 75: RR, 21.948; 75: SpO2, 100.0; 75: Perf, 0.532; 75: 1min HRV, 10.091; 76: HR, 99.814; 76: RR, 18.746; 76: SpO2, 100.0; 76: Perf, 0.793; 76: 1min HRV, 14.214; 77: HR, 99.552; 77: RR, 20.517; 77: SpO2, 100.0; 77: Perf, 0.815; 77: 1min HRV, 11.457; 78: HR, 100.847; 78: RR, 18.288; 78: SpO2, 100.0; 78: Perf, 0.925; 78: 1min HRV, 4.612; 79: HR, 98.254; 79: RR, 17.763; 79: SpO2, 100.0; 79: Perf, 1.615; 79: 1min HRV, 3.239; 79: 5min HRV, 11.448; 80: HR, 96.466; 80: RR, 17.534; 80: SpO2, 100.0; 80: Perf, 1.863; 80: 1min HRV, 4.446; 80: SBP, 146.0; 80: DBP, 104.0; 80: MAP, 118.0; 81: HR, 95.373; 81: RR, 18.085; 81: SpO2, 100.0; 81: Perf, 1.857; 81: 1min HRV, 5.160; 82: HR, 95.897; 82: RR, 17.828; 82: SpO2, 100.0; 82: Perf, 2.077; 82: 1min HRV, 2.885; 83: HR, 95.237; 83: RR, 17.305; 83: SpO2, 100.0; 83: Perf, 2.075; 83: 1min HRV, 2.467; 84: HR, 95.407; 84: RR, 16.441; 84: SpO2, 100.0; 84: Perf, 2.015; 84: 1min HRV, 14.413; 84: 5min HRV, 7.621; 85: HR, 95.966; 85: RR, 18.534; 85: SpO2, 100.0; 85: Perf, 1.242; 85: 1min HRV, 6.758; 86: HR, 94.441; 86: RR, 17.661; 86: SpO2, 100.0; 86: Perf, 1.800; 86: 1min HRV, 7.076; 87: HR, 94.638; 87: RR, 18.810; 87: SpO2, 100.0; 87: Perf, 1.988; 87: 1min HRV, 6.194; 88: HR, 94.864; 88: RR, 18.305; 88: SpO2, 100.0; 88: Perf, 1.841; 88: 1min HRV, 6.704; 89: HR, 95.729; 89: RR, 18.712; 89: SpO2, 100.0; 89: Perf, 1.769; 89: 1min HRV, 11.545; 89: 5min HRV, 8.848; 90: HR, 97.345; 90: RR, 20.569; 90: SpO2, 100.0; 90: Perf, 1.424; 90: 1min HRV, 14.899; 91: HR, 97.220; 91: RR, 18.932; 91: SpO2, 100.0; 91: Perf, 1.581; 91: 1min HRV, 23.578; 92: HR, 95.431; 92: RR, 17.138; 92: SpO2, 100.0; 92: Perf, 1.650; 92: 1min HRV, 5.315; 93: HR, 94.322; 93: RR, 17.017; 93: SpO2, 100.0; 93: Perf, 1.803; 93: 1min HRV, 21.750; 94: HR, 94.864; 94: RR, 15.186; 94: SpO2, 100.0; 94: Perf, 1.650; 94: 1min HRV, 4.707; 94: 5min HRV, 17.740; 95: HR, 94.948; 95: RR, 15.845; 95: SpO2, 99.932; 95: Perf, 1.643; 95: 1min HRV, 7.039; 95: SBP, 153.0; 95: DBP, 101.0; 95: MAP, 118.333; 96: HR, 96.915; 96: RR, 19.593; 96: SpO2, 100.0; 96: Perf, 1.13; 96: 1min HRV, 6.773; 97: HR, 97.172; 97: RR, 20.759; 97: SpO2, 100.0; 97: Perf, 1.264; 97: 1min HRV, 5.834; 98: HR, 97.559; 98: RR, 17.458; 98: SpO2, 100.0; 98: Perf, 1.547; 98: 1min HRV, 3.804; 99: HR, 97.119; 99: RR, 19.627; 99: SpO2, 100.0; 99: Perf, 1.605; 99: 1min HRV, 4.123; 99: 5min HRV, 7.908; 100: HR, 96.310; 100: RR, 19.621; 100: SpO2, 100.0; 100: Perf, 1.606; 100: 1min HRV, 6.912; 101: HR, 96.492; 101: RR, 18.508; 101: SpO2, 100.0; 101: Perf, 1.390; 101: 1min HRV, 18.678; 102: HR, 95.1; 102: RR, 17.190; 102: SpO2, 100.0; 102: Perf, 1.610; 102: 1min HRV, 14.997; 103: HR, 96.356; 103: RR, 18.424; 103: SpO2, 100.0; 103: Perf, 1.005; 103: 1min HRV, 30.601; 104: HR, 100.322; 104: RR, 17.831; 104: SpO2, 99.186; 104: Perf, 0.591; 104: 1min HRV, 48.953; 104: 5min HRV, 32.817; 105: HR, 99.5; 105: RR, 21.069; 105: SpO2, 99.121; 105: Perf, 0.519; 105: 1min HRV, 17.292; 106: HR, 97.661; 106: RR, 18.966; 106: SpO2, 99.542; 106: Perf, 0.567; 106: 1min HRV, 11.182; 107: HR, 99.810; 107: RR, 19.362; 107: SpO2, 99.310; 107: Perf, 0.503; 107: 1min HRV, 8.945; 108: HR, 97.017; 108: RR, 23.593; 108: SpO2, 99.186; 108: Perf, 0.460; 108: 1min HRV, 11.619; 109: HR, 97.483; 109: RR, 20.138; 109: SpO2, 100.0; 109: Perf, 0.639; 109: 1min HRV, 13.210; 109: 5min HRV, 13.786; 110: HR, 95.559; 110: RR, 17.644; 110: SpO2, 100.0; 110: Perf, 0.806; 110: 1min HRV, 5.844; 111: HR, 93.966; 111: RR, 16.576; 111: SpO2, 100.0; 111: Perf, 0.747; 111: 1min HRV, 9.589; 112: HR, 96.672; 112: RR, 21.828; 112: SpO2, 100.0; 112: Perf, 0.716; 112: 1min HRV, 6.406; 113: HR, 96.712; 113: RR, 18.034; 113: SpO2, 100.0; 113: Perf, 0.719; 113: 1min HRV, 31.059; 114: HR, 94.207; 114: RR, 18.534; 114: SpO2, 100.0; 114: Perf, 0.779; 114: 1min HRV, 7.562; 114: 5min HRV, 17.005; 115: POC PH (V) ISTAT, 7.42; 115: POC HCO3 (V) ISTAT, 30.2 mmol/L; 115: POC PO2 (V) ISTAT, 48 mmHg; 115: POC O2 SATURATION ISTAT VENOUS, 83 %; 115: POC TCO2 (V) ISTAT, 32 mmol/L; 115: POC PCO2 (V) ISTAT, 46.3 mmHg; 115: POC LACTATE ISTAT, 2.32 mmol/L; 115: POC BASE EXCESS ISTAT, 6 mmol/L; 115: HR, 97.220; 115: RR, 18.339; 115: SpO2, 100.0; 115: Perf, 0.886; 115: 1min HRV, 8.098; 116: HR, 96.237; 116: RR, 18.847; 116: SpO2, 100.0; 116: Perf, 0.819; 116: 1min HRV, 6.137; 117: HR, 95.034; 117: RR, 17.190; 117: SpO2, 100.0; 117: Perf, 1.051; 117: 1min HRV, 16.127; 118: HR, 95.475; 118: RR, 15.831; 118: SpO2, 100.0; 118: Perf, 1.116; 118: 1min HRV, 8.013; 119: HR, 92.862; 119: RR, 18.155; 119: SpO2, 100.0; 119: Perf, 0.879; 119: 1min HRV, 9.869; 119: 5min HRV, 14.104; 0: Age, 71; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.9; 0: Triage HR, 114.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, DEHYDRATION,CHEST PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The first step in assessing sepsis risk is to identify any abnormal vital signs or lab results that indicate potential sepsis. In this time series, while the patient has a slightly elevated heart rate (HR: 114 at triage) and respiratory rate (RR: 42.2 at time 74), other critical parameters, such as blood pressure, SpO2, and temperature, remain within normal ranges. The lactate level is at 2.32 mmol/L, which is slightly elevated but not critically high. Overall, there are no strong or consistent indicators of sepsis within the 12-hour window, so the patient is not at high risk of developing sepsis imminently.",
        "claims": [
            "The first step in assessing sepsis risk is to identify abnormal vital signs or lab results.",
            "The patient has a slightly elevated heart rate of 114 at triage.",
            "The patient's respiratory rate is 42.2 at time 74.",
            "Other critical parameters, such as blood pressure, SpO2, and temperature, remain within normal ranges.",
            "The lactate level is at 2.32 mmol/L.",
            "The lactate level of 2.32 mmol/L is slightly elevated but not critically high.",
            "There are no strong or consistent indicators of sepsis within the 12-hour window.",
            "The patient is not at high risk of developing sepsis imminently."
        ],
        "relevant_claims": [
            "The patient's respiratory rate is 42.2 at time 74.",
            "The lactate level is at 2.32 mmol/L.",
            "The lactate level of 2.32 mmol/L is slightly elevated but not critically high.",
            "There are no strong or consistent indicators of sepsis within the 12-hour window."
        ],
        "alignment_scores": [
            1.0,
            1.0,
            0.8,
            0.3
        ],
        "alignment_category": [
            "High qSOFA Score (\u22652)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "A respiratory rate of 42.2 is well above the threshold of \u226522/min, which is one of the criteria in the qSOFA score used to assess high risk of sepsis-related organ dysfunction and mortality. This direct alignment with one of the qSOFA criteria ensures a perfect fit for the category.",
            "The claim directly references the lactate level, which is above the threshold of 2 mmol/L. This is a specific indicator noted in the \"Elevated Serum Lactate\" category, marking tissue hypoperfusion and elevating sepsis risk. The alignment is perfect, as the claim precisely meets the category's criteria.",
            "The claim mentions a lactate level of 2.32 mmol/L, which surpasses the threshold of 2 mmol/L specified in the Elevated Serum Lactate category. Although it is not described as critically high, it still falls within the range that signals increased risk of sepsis mortality, hence the strong alignment.",
            "The claim suggests an absence of significant indicators for sepsis, which indirectly suggests the absence of systemic inflammation\u2014characterized by SIRS criteria. While not a perfect fit, it aligns to a modest extent with not meeting SIRS conditions, as these would be indications of early sepsis if present."
        ],
        "final_alignment_score": 0.7749999999999999,
        "accuracy": 1
    },
    {
        "input": "3: SpO2, 97.5; 4: HR, 101.16; 4: RR, 25.739; 4: SpO2, 94.5; 4: 1min HRV, 6.414; 5: HR, 100.797; 5: RR, 24.475; 5: SpO2, 94.441; 5: Perf, 0.655; 5: 1min HRV, 35.949; 5: SBP, 158.0; 5: DBP, 97.0; 5: MAP, 117.333; 6: HR, 100.593; 6: RR, 23.966; 6: SpO2, 94.0; 6: Perf, 0.625; 6: 1min HRV, 17.024; 6: SBP, 158.0; 6: DBP, 97.0; 6: MAP, 117.333; 6: Temp, 98.8; 7: HR, 101.293; 7: RR, 22.828; 7: SpO2, 94.103; 7: Perf, 0.608; 7: 1min HRV, 37.928; 7: 5min HRV, 29.475; 8: HR, 100.593; 8: RR, 23.407; 8: SpO2, 94.186; 8: Perf, 0.596; 8: 1min HRV, 24.883; 9: HR, 99.707; 9: RR, 23.276; 9: SpO2, 93.172; 9: Perf, 0.576; 9: 1min HRV, 32.870; 10: HR, 99.847; 10: RR, 22.966; 10: SpO2, 93.644; 10: Perf, 0.543; 10: 1min HRV, 44.265; 11: HR, 100.051; 11: RR, 22.881; 11: SpO2, 93.271; 11: Perf, 0.491; 11: 1min HRV, 49.237; 12: HR, 99.776; 12: RR, 22.983; 12: SpO2, 93.845; 12: Perf, 0.489; 12: 1min HRV, 44.707; 12: 5min HRV, 40.246; 13: HR, 102.051; 13: RR, 21.831; 13: SpO2, 92.610; 13: Perf, 0.493; 13: 1min HRV, 37.201; 14: HR, 101.362; 14: RR, 23.224; 14: SpO2, 93.534; 14: Perf, 0.498; 14: 1min HRV, 58.304; 15: HR, 99.831; 15: RR, 23.186; 15: SpO2, 93.169; 15: Perf, 0.568; 15: 1min HRV, 33.361; 16: HR, 101.475; 16: RR, 19.525; 16: SpO2, 93.729; 16: Perf, 0.573; 16: 1min HRV, 54.280; 17: HR, 100.276; 17: RR, 22.017; 17: SpO2, 93.397; 17: Perf, 0.525; 17: 1min HRV, 41.692; 17: 5min HRV, 45.910; 18: HR, 100.271; 18: RR, 23.475; 18: SpO2, 92.932; 18: Perf, 0.523; 18: 1min HRV, 45.637; 19: HR, 99.724; 19: RR, 23.017; 19: SpO2, 93.552; 19: Perf, 0.519; 19: 1min HRV, 42.902; 20: HR, 100.203; 20: RR, 22.051; 20: SpO2, 93.492; 20: Perf, 0.52; 20: 1min HRV, 41.013; 21: HR, 100.186; 21: RR, 22.542; 21: SpO2, 93.271; 21: Perf, 0.513; 21: 1min HRV, 48.040; 22: HR, 101.069; 22: RR, 23.276; 22: SpO2, 93.483; 22: Perf, 0.511; 22: 1min HRV, 43.514; 22: 5min HRV, 44.399; 23: HR, 99.559; 23: RR, 24.441; 23: SpO2, 94.644; 23: Perf, 0.644; 23: 1min HRV, 36.599; 24: HR, 97.759; 24: RR, 21.293; 24: SpO2, 95.828; 24: Perf, 0.823; 24: 1min HRV, 42.457; 25: HR, 98.746; 25: RR, 20.220; 25: SpO2, 95.814; 25: Perf, 0.754; 25: 1min HRV, 75.012; 26: HR, 97.119; 26: RR, 20.695; 26: SpO2, 96.271; 26: Perf, 0.757; 26: 1min HRV, 44.336; 26: LPM O2, 2.0; 27: HR, 97.034; 27: RR, 19.276; 27: SpO2, 97.0; 27: Perf, 0.730; 27: 1min HRV, 55.894; 27: 5min HRV, 52.824; 28: HR, 98.305; 28: RR, 21.271; 28: SpO2, 97.627; 28: Perf, 0.694; 28: 1min HRV, 39.777; 29: HR, 96.069; 29: RR, 20.448; 29: SpO2, 97.914; 29: Perf, 0.660; 29: 1min HRV, 50.570; 30: HR, 94.949; 30: RR, 19.746; 30: SpO2, 97.576; 30: Perf, 0.699; 30: 1min HRV, 70.984; 31: HR, 94.707; 31: RR, 19.845; 31: SpO2, 97.655; 31: Perf, 0.726; 31: 1min HRV, 65.348; 32: HR, 94.780; 32: RR, 20.0; 32: SpO2, 98.0; 32: Perf, 0.718; 32: 1min HRV, 59.486; 32: 5min HRV, 58.790; 33: HR, 94.712; 33: RR, 19.712; 33: SpO2, 98.0; 33: Perf, 0.696; 33: 1min HRV, 44.407; 34: HR, 96.828; 34: RR, 21.931; 34: SpO2, 97.724; 34: Perf, 0.615; 34: 1min HRV, 56.587; 35: HR, 99.254; 35: RR, 20.797; 35: SpO2, 98.119; 35: Perf, 0.565; 35: 1min HRV, 41.004; 36: WAM DIFTYP, AUTO; 36: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 36: MONOCYTE % (AUTO DIFF), 5.1 %; 36: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 36: WHITE BLOOD CELLS (WBC), 9.4 K/uL; 36: NRBC PERCENT (HEMATOLOGY), 0.0 %; 36: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.9 g/dL; 36: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 36: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 36: MEAN CORPUSCULAR VOLUME (MCV), 92.2 fL; 36: HEMOGLOBIN (HGB), 11.6 g/dL; 36: RED BLOOD CELLS (RBC), 3.95 MIL/uL; 36: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 36: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 36: MONOCYTE ABSOLUTE (AUTO DIFF), 0.48 K/uL; 36: RED CELL DISTRIBUTION WIDTH (RDW), 15.2 %; 36: PLATELET COUNT (PLT), 320 K/uL; 36: LYMPHOCYTE % (AUTO DIFF), 6.4 %; 36: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.24 K/uL; 36: HEMATOCRIT (HCT), 36.4 %; 36: BASOPHIL % (AUTO DIFF), 0.2 %; 36: NEUTROPHIL % (AUTO DIFF), 88.0 %; 36: EOSINOPHIL % (AUTO DIFF), 0.0 %; 36: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 36: HR, 96.517; 36: RR, 21.103; 36: SpO2, 98.948; 36: Perf, 0.573; 36: 1min HRV, 47.855; 37: HR, 96.814; 37: RR, 21.475; 37: SpO2, 98.797; 37: Perf, 0.501; 37: 1min HRV, 33.828; 37: 5min HRV, 45.940; 38: HR, 96.847; 38: RR, 21.085; 38: SpO2, 98.797; 38: Perf, 0.480; 38: 1min HRV, 51.357; 39: HR, 97.931; 39: RR, 22.310; 39: SpO2, 99.0; 39: Perf, 0.461; 39: 1min HRV, 18.436; 40: HR, 96.627; 40: RR, 21.424; 40: SpO2, 98.475; 40: Perf, 0.442; 40: 1min HRV, 59.154; 41: HR, 97.724; 41: RR, 22.190; 41: SpO2, 98.483; 41: Perf, 0.406; 41: 1min HRV, 20.682; 42: HR, 97.169; 42: RR, 23.458; 42: SpO2, 98.085; 42: Perf, 0.421; 42: 1min HRV, 42.586; 42: 5min HRV, 41.790; 43: HR, 98.814; 43: RR, 24.136; 43: SpO2, 98.254; 43: Perf, 0.396; 43: 1min HRV, 40.306; 44: HR, 96.845; 44: RR, 22.017; 44: SpO2, 98.603; 44: Perf, 0.434; 44: 1min HRV, 71.813; 45: HR, 95.847; 45: RR, 20.678; 45: SpO2, 97.831; 45: Perf, 0.465; 45: 1min HRV, 33.861; 47: 5min HRV, 52.008; 67: INR, 1.0; 67: PROTHROMBIN TIME, 13.0 seconds; 68: PART. THROMBOPLASTIN TIME, 30.7 seconds; 73: ABO/RH (AUTOMATION), A Positive; 73: ANTIBODY SCREEN 3, NEG; 77: SARS-COV-2 RNA, Not Detected; 77: INFLUENZA A, Not Detected; 77: INFLUENZA B, Not Detected; 100: TROPONIN I, <.017 ng/mL; 118: EGFR FOR AFRICAN AMERICAN, 119 mL/min/1.73 m2; 118: CO2, 18 mmol/L; 118: ANION GAP, 18 mmol/L; 118: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 118: CORRECTED CALCIUM, 9.5 mg/dL; 118: GLUCOSE, 97 mg/dL; 118: ALBUMIN, 3.5 g/dL; 118: BILIRUBIN TOTAL, 0.4 mg/dL; 118: MAGNESIUM, 1.8 mg/dL; 118: CREATININE, 0.38 mg/dL; 118: SODIUM, 141 mmol/L; 118: PROTEIN TOTAL, 6.5 g/dL; 118: LIPASE, 20 U/L; 118: POTASSIUM, 5.3 mmol/L; 118: AST (SGOT), 63 U/L; 118: ALT (SGPT), 9 U/L; 118: CALCIUM, 9.1 mg/dL; 118: ALKALINE PHOSPHATASE, 63 U/L; 118: GLOBULIN, 3.0 g/dL; 118: EGFR REFIT WITHOUT RACE (2021), 103 mL/min/1.73 m2; 118: CHLORIDE, 105 mmol/L; 0: Age, 78; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 37.1; 0: Triage HR, 100.0; 0: Triage RR, 24.0; 0: Triage SBP, 158.0; 0: Triage DBP, 97.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The key factors to assess for sepsis prediction include the patient's vital signs, heart rate variability (HRV), respiratory rate, and arterial oxygen saturation (SpO2), as well as the presence of abnormal lab values or clinical parameters. This patient exhibits slight tachycardia and tachypnea, but their blood pressure, SpO2, and other lab values such as white blood cells remain within normal or non-critical ranges. Over time, HRV is variable without clear deterioration, suggesting preserved autonomic function. The patient's respiratory rate and heart rate are slightly elevated, but stable, and there is no sudden deterioration or clear signs of systemic infection, hypoperfusion, or organ dysfunction that would indicate a high risk for sepsis within the next 12 hours.",
        "claims": [
            "The key factors to assess for sepsis prediction include the patient's vital signs, heart rate variability (HRV), respiratory rate, and arterial oxygen saturation (SpO2).",
            "The presence of abnormal lab values or clinical parameters is also important for assessing sepsis risk.",
            "This patient exhibits slight tachycardia.",
            "This patient exhibits tachypnea.",
            "The patient's blood pressure remains within normal ranges.",
            "The patient's SpO2 is within normal ranges.",
            "Other lab values, such as white blood cells, remain within normal or non-critical ranges.",
            "Over time, HRV is variable without clear deterioration.",
            "The patient's HRV suggests preserved autonomic function.",
            "The patient's respiratory rate is slightly elevated but stable.",
            "The patient's heart rate is slightly elevated but stable.",
            "There is no sudden deterioration in the patient's condition.",
            "There are no clear signs of systemic infection in this patient.",
            "There are no signs of hypoperfusion in this patient.",
            "There are no signs of organ dysfunction in this patient.",
            "The current assessment does not indicate a high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "This patient exhibits slight tachycardia.",
            "This patient exhibits tachypnea.",
            "There are no clear signs of systemic infection in this patient.",
            "The current assessment does not indicate a high risk for sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.8,
            0.3,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "Tachycardia, which is an increased heart rate, aligns with one of the specific criteria under SIRS (heart rate\u202f>\u202f90\u202fbpm). While \"slight tachycardia\" suggests that the heart rate is elevated but may not exceed the threshold, the relationship to SIRS criteria is still meaningful, albeit less direct or conclusive without specific heart rate details.",
            "Tachypnea, defined as a respiratory rate greater than 20/min, is explicitly listed as one of the criteria for SIRS positivity. However, the claim does not specify the respiratory rate, making it unclear if it definitively meets the SIRS threshold. This creates a strong but slightly incomplete alignment since an exact value isn't provided.",
            "The claim indicates there are no clear signs of systemic infection, suggesting an absence of systemic inflammatory response indicators like those in the SIRS criteria. The alignment is low because the claim references the lack of features typically associated with SIRS positivity. It indirectly relates by indicating the patient's condition does not meet sepsis indicators associated with systemic inflammation.",
            "The claim lacks specific medical indicators or actions aligned with high sepsis risk. While it implies no immediate suspicion of sepsis (and hence no immediate need for culture or antibiotics), this isn't directly tied to any single category. \"Early Antibiotic/Culture Orders\" is the closest implicit category, suggesting absence of action. The alignment is weak due to indirect and broad alignment with the indication of no immediate intervention required."
        ],
        "final_alignment_score": 0.475,
        "accuracy": 0
    },
    {
        "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 99.0; 2: SBP, 92.0; 2: DBP, 49.0; 2: MAP, 63.333; 2: Pain, 10.0; 2: Temp, 97.5; 21: SpO2, 96.0; 22: HR, 109.821; 22: RR, 16.308; 22: SpO2, 95.831; 22: Perf, 0.709; 22: 1min HRV, 55.738; 22: SBP, 113.0; 22: DBP, 64.0; 22: MAP, 80.333; 23: HR, 109.412; 23: RR, 21.983; 23: SpO2, 95.897; 23: Perf, 1.001; 23: 1min HRV, 2.469; 24: HR, 109.655; 24: RR, 15.407; 24: SpO2, 97.678; 24: Perf, 0.791; 24: 1min HRV, 47.215; 25: HR, 105.810; 25: RR, 12.259; 25: SpO2, 98.0; 25: Perf, 0.890; 25: 1min HRV, 62.161; 25: 5min HRV, 51.744; 26: HR, 105.322; 26: RR, 14.644; 26: SpO2, 96.034; 26: Perf, 1.468; 26: 1min HRV, 66.515; 26: SBP, 111.0; 26: DBP, 64.0; 26: MAP, 79.667; 27: HR, 103.915; 27: RR, 13.644; 27: SpO2, 96.254; 27: Perf, 1.285; 27: 1min HRV, 50.293; 28: HR, 103.603; 28: RR, 18.483; 28: SpO2, 96.414; 28: Perf, 1.205; 28: 1min HRV, 56.883; 29: HR, 104.356; 29: RR, 16.508; 29: SpO2, 96.712; 29: Perf, 0.952; 29: 1min HRV, 74.698; 30: HR, 105.678; 30: RR, 17.475; 30: SpO2, 96.831; 30: Perf, 0.944; 30: 1min HRV, 41.682; 30: 5min HRV, 59.934; 31: HR, 105.345; 31: RR, 18.379; 31: SpO2, 97.276; 31: Perf, 0.855; 31: 1min HRV, 71.599; 32: HR, 104.492; 32: RR, 16.729; 32: SpO2, 96.898; 32: Perf, 1.194; 32: 1min HRV, 62.066; 33: HR, 105.069; 33: RR, 16.621; 33: SpO2, 96.397; 33: Perf, 1.545; 33: 1min HRV, 80.449; 34: HR, 104.746; 34: RR, 18.983; 34: SpO2, 95.983; 34: Perf, 1.803; 34: 1min HRV, 73.898; 35: HR, 105.576; 35: RR, 16.322; 35: SpO2, 95.729; 35: Perf, 1.834; 35: 1min HRV, 61.796; 35: 5min HRV, 70.356; 36: HR, 104.983; 36: RR, 15.448; 36: SpO2, 96.069; 36: Perf, 1.99; 36: 1min HRV, 83.070; 37: HR, 104.034; 37: RR, 16.475; 37: SpO2, 95.610; 37: Perf, 2.194; 37: 1min HRV, 102.005; 38: HR, 104.966; 38: RR, 15.845; 38: SpO2, 95.759; 38: Perf, 2.007; 38: 1min HRV, 69.008; 39: HR, 103.780; 39: RR, 14.119; 39: SpO2, 95.254; 39: Perf, 2.145; 39: 1min HRV, 83.238; 40: HR, 103.881; 40: RR, 19.559; 40: SpO2, 94.847; 40: Perf, 2.348; 40: 1min HRV, 76.667; 40: 5min HRV, 83.563; 40: SBP, 111.0; 40: DBP, 64.0; 40: MAP, 79.667; 41: HR, 102.759; 41: RR, 14.621; 41: SpO2, 95.552; 41: Perf, 2.174; 41: 1min HRV, 86.573; 41: SBP, 111.0; 41: DBP, 64.0; 41: MAP, 79.667; 42: HR, 102.576; 42: RR, 17.508; 42: SpO2, 95.102; 42: Perf, 2.320; 42: 1min HRV, 82.545; 43: HR, 102.966; 43: RR, 14.897; 43: SpO2, 94.948; 43: Perf, 2.434; 43: 1min HRV, 91.755; 44: HR, 103.017; 44: RR, 16.254; 44: SpO2, 94.712; 44: Perf, 2.529; 44: 1min HRV, 70.841; 45: HR, 103.898; 45: RR, 15.186; 45: SpO2, 95.305; 45: Perf, 2.507; 45: 1min HRV, 75.420; 45: 5min HRV, 82.383; 46: HR, 103.431; 46: RR, 17.828; 46: SpO2, 96.103; 46: Perf, 2.182; 46: 1min HRV, 83.408; 47: HR, 102.203; 47: RR, 19.492; 47: SpO2, 94.017; 47: Perf, 1.954; 47: 1min HRV, 77.013; 48: HR, 104.759; 48: RR, 18.517; 48: SpO2, 95.448; 48: Perf, 1.667; 48: 1min HRV, 72.746; 49: HR, 104.153; 49: RR, 17.983; 49: SpO2, 95.0; 49: Perf, 1.693; 49: 1min HRV, 76.780; 50: HR, 103.017; 50: RR, 17.397; 50: SpO2, 94.759; 50: Perf, 2.124; 50: 1min HRV, 79.480; 50: 5min HRV, 78.245; 51: HR, 104.136; 51: RR, 19.288; 51: SpO2, 95.254; 51: Perf, 2.163; 51: 1min HRV, 92.776; 52: HR, 103.847; 52: RR, 18.390; 52: SpO2, 97.542; 52: Perf, 1.824; 52: 1min HRV, 83.089; 53: HR, 103.034; 53: RR, 18.431; 53: SpO2, 97.328; 53: Perf, 1.928; 53: 1min HRV, 76.756; 54: HR, 102.508; 54: RR, 14.390; 54: SpO2, 96.424; 54: Perf, 2.107; 54: 1min HRV, 85.108; 55: HR, 104.121; 55: RR, 12.517; 55: SpO2, 95.310; 55: Perf, 2.358; 55: 1min HRV, 81.613; 55: 5min HRV, 83.963; 56: HR, 103.407; 56: RR, 18.271; 56: SpO2, 96.0; 56: Perf, 1.747; 56: 1min HRV, 82.473; 56: SBP, 117.0; 56: DBP, 67.0; 56: MAP, 83.667; 57: HR, 103.085; 57: RR, 16.525; 57: SpO2, 95.0; 57: Perf, 1.738; 57: 1min HRV, 90.579; 58: HR, 103.983; 58: RR, 15.431; 58: SpO2, 95.017; 58: Perf, 1.492; 58: 1min HRV, 82.048; 59: HR, 103.169; 59: RR, 14.203; 59: SpO2, 96.0; 59: Perf, 1.310; 59: 1min HRV, 69.464; 60: HR, 103.052; 60: RR, 19.690; 60: SpO2, 95.879; 60: Perf, 1.244; 60: 1min HRV, 78.540; 60: 5min HRV, 81.043; 61: HR, 104.271; 61: RR, 15.153; 61: SpO2, 97.153; 61: Perf, 1.157; 61: 1min HRV, 82.632; 65: 5min HRV, 82.632; 86: SARS-COV-2 RNA, Not Detected; 95: WAM DIFTYP, AUTO; 95: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.40 K/uL; 95: NRBC ABSOLUTE (HEMATOLOGY), 0.04 K/uL; 95: RED CELL DISTRIBUTION WIDTH (RDW), 19.4 %; 95: NEUTROPHIL % (AUTO DIFF), 91.0 %; 95: HEMATOCRIT (HCT), 30.8 %; 95: NEUTROPHIL ABSOLUTE (AUTO DIFF), 21.21 K/uL; 95: EOSINOPHIL % (AUTO DIFF), 0.1 %; 95: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 95: NRBC PERCENT (HEMATOLOGY), 0.2 %; 95: LYMPHOCYTE % (AUTO DIFF), 3.3 %; 95: PLATELET COUNT (PLT), 666 K/uL; 95: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 95: MEAN CORPUSCULAR VOLUME (MCV), 60.0 fL; 95: RED BLOOD CELLS (RBC), 5.13 MIL/uL; 95: BASOPHIL % (AUTO DIFF), 0.1 %; 95: HEMOGLOBIN (HGB), 9.2 g/dL; 95: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.7 %; 95: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 29.9 g/dL; 95: MONOCYTE % (AUTO DIFF), 3.8 %; 95: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 95: MONOCYTE ABSOLUTE (AUTO DIFF), 0.88 K/uL; 95: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.78 K/uL; 95: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 17.9 pg; 97: INR, 1.5; 97: PROTHROMBIN TIME, 17.6 seconds; 97: PART. THROMBOPLASTIN TIME, 34.5 seconds; 100: HR, 98.0; 100: RR, 17.0; 100: SpO2, 98.0; 100: SBP, 115.0; 100: DBP, 76.0; 100: MAP, 89.0; 0: Age, 74; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 92.0; 0: Triage DBP, 49.0; 0: Triage acuity, 2-Emergent; 0: CC, FALL,ALTERED MENTAL STATUS,BACK PAIN",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess the risk of sepsis, I first evaluated the patient's vital signs, especially focusing on low blood pressure (SBP and DBP), elevated heart rate, and abnormal temperature during the initial 2-hour window, which showed hypotension and high heart rate. I then examined HRV, which consistently showed high variability, potentially indicating stress on the cardiovascular system. Finally, the laboratory results, such as elevated white blood cell count and high neutrophil percentage, suggest a possible infection or inflammatory response. Collectively, these findings indicate a high risk of developing sepsis within 12 hours.",
        "claims": [
            "The patient's vital signs were evaluated to assess the risk of sepsis.",
            "Low blood pressure (SBP and DBP) was a focus during the evaluation.",
            "An elevated heart rate was a focus during the evaluation.",
            "Abnormal temperature was a focus during the evaluation.",
            "The initial 2-hour window showed hypotension.",
            "The initial 2-hour window showed a high heart rate.",
            "Heart rate variability (HRV) was examined.",
            "HRV consistently showed high variability.",
            "High variability in HRV potentially indicates stress on the cardiovascular system.",
            "Laboratory results included an elevated white blood cell count.",
            "Laboratory results included a high neutrophil percentage.",
            "An elevated white blood cell count suggests a possible infection or inflammatory response.",
            "A high neutrophil percentage suggests a possible infection or inflammatory response.",
            "Collectively, these findings indicate a high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs were evaluated to assess the risk of sepsis.",
            "Low blood pressure (SBP and DBP) was a focus during the evaluation.",
            "An elevated heart rate was a focus during the evaluation.",
            "Abnormal temperature was a focus during the evaluation.",
            "The initial 2-hour window showed hypotension.",
            "The initial 2-hour window showed a high heart rate.",
            "High variability in HRV potentially indicates stress on the cardiovascular system.",
            "Laboratory results included an elevated white blood cell count.",
            "Laboratory results included a high neutrophil percentage.",
            "An elevated white blood cell count suggests a possible infection or inflammatory response.",
            "A high neutrophil percentage suggests a possible infection or inflammatory response.",
            "Collectively, these findings indicate a high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.8,
            0.5,
            0.7,
            1.0,
            0.7,
            0.3,
            1.0,
            0.7,
            1.0,
            0.7,
            0.4
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "Evaluating vital signs is a broad assessment often associated with the NEWS score, which uses deranged vital signs to predict clinical deterioration related to sepsis. However, the claim is vague as it does not specify any details such as a NEWS score or abnormal vitals, resulting in a low alignment rating.",
            "The claim highlights low blood pressure, which is directly related to the category of Sepsis-Associated Hypotension. This category specifically considers low systolic blood pressure (SBP) as a sign of sepsis progression towards septic shock. While the exact measurements are not provided in the claim, the focus on low blood pressure suggests a strong alignment with this sepsis risk factor. However, without specific values, it slightly lowers the certainty.",
            "An elevated heart rate (>90 bpm) is explicitly one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The claim directly references an elevated heart rate, which is relevant to this category. However, since only a single criterion is mentioned and the complete SIRS positivity requires the presence of \u22652 criteria, the alignment is partial rather than full.",
            "The focus on abnormal temperature directly relates to one of the SIRS criteria, which includes temperature >38\u00b0C or <36\u00b0C. Although the claim does not specify if the temperature meets those thresholds, the emphasis on temperature in the evaluation strongly suggests consideration within the SIRS framework. The lack of specific values prevents a perfect alignment; therefore, a rating of 0.7 reflects that it is highly relevant but not explicitly meeting the criteria.",
            "The claim directly mentions hypotension within the initial 2-hour window, which is a key indicator within this category. It aligns perfectly with the category definition, as hypotension is used to assess the risk of progression toward septic shock in sepsis patients.",
            "A high heart rate could contribute to an elevated shock index, which is calculated as heart rate divided by systolic blood pressure. While the claim does not directly provide information about the patient's blood pressure, an elevated heart rate is a key component of the shock index. Therefore, the claim aligns reasonably well with the Elevated Shock Index category, although the absence of blood pressure details prevents a perfect alignment.",
            "High variability in heart rate variability (HRV) can indicate stress on the cardiovascular system, which somewhat relates to the concept of hemodynamic instability seen in an elevated shock index. However, HRV and shock index are distinct measurements, with HRV focusing more on autonomic nervous system function and shock index concentrating on the ratio of heart rate to blood pressure. The alignment is indirect and not a direct match, thus a low alignment rating.",
            "The claim explicitly mentions an elevated white blood cell count, which is one of the SIRS criteria for detecting systemic inflammation related to early sepsis. This aspect is directly aligned with the SIRS Positivity category, indicating a perfect alignment.",
            "A high neutrophil percentage suggests an inflammatory or infectious process, which is indirectly related to the SIRS criteria of high WBC count. While it's not explicitly one of the SIRS criteria, it is closely related to systemic inflammation and the presence of infection that could point to early sepsis, marking a strong conceptual alignment.",
            "An elevated white blood cell count is directly listed as one of the criteria for SIRS, which indicates systemic inflammation and is consistent with early signs of sepsis. The claim explicitly references this indicator, showing perfect alignment with the SIRS Positivity category.",
            "A high neutrophil percentage is indicative of an inflammatory or infectious response, which is conceptually aligned with the systemic inflammation indicated by the SIRS criteria. Although it isn't directly one of the SIRS criteria, it closely relates to the intent of identifying systemic inflammation, making the alignment fairly strong.",
            "The claim is broad and does not provide specific clinical details. However, it mentions a high risk of developing sepsis within 12 hours, which is conceptually aligned with the predictive nature of the Elevated NEWS Score, which highlights imminent clinical deterioration. The alignment is weak due to the lack of specific vital derangements or scores, hence a rating of 0.4."
        ],
        "final_alignment_score": 0.6749999999999999,
        "accuracy": 1
    },
    {
        "input": "6: Pain, 5.0; 11: HR, 102.0; 11: RR, 18.0; 11: SpO2, 99.0; 11: SBP, 100.0; 11: DBP, 65.0; 11: MAP, 76.667; 11: Pain, 5.0; 11: Temp, 98.2; 30: HR, 111.25; 30: RR, 14.657; 30: SpO2, 100.0; 30: 1min HRV, 81.817; 31: HR, 102.414; 31: RR, 16.914; 31: SpO2, 100.0; 31: Perf, 0.753; 31: 1min HRV, 98.629; 31: SBP, 110.0; 31: DBP, 75.0; 31: MAP, 86.667; 32: HR, 103.237; 32: RR, 17.898; 32: SpO2, 100.0; 32: Perf, 1.658; 32: 1min HRV, 78.261; 33: HR, 97.517; 33: RR, 15.517; 33: SpO2, 100.0; 33: Perf, 1.683; 33: 1min HRV, 150.061; 33: 5min HRV, 109.610; 34: HR, 80.729; 34: RR, 18.966; 34: SpO2, 99.926; 34: Perf, 2.32; 34: 1min HRV, 122.922; 34: SBP, 91.0; 34: DBP, 52.0; 34: MAP, 65.0; 35: HR, 89.085; 35: RR, 16.661; 35: SpO2, 100.0; 35: Perf, 2.199; 35: 1min HRV, 78.485; 36: HR, 92.931; 36: RR, 17.672; 36: SpO2, 100.0; 36: Perf, 2.005; 36: 1min HRV, 93.865; 37: HR, 85.085; 37: RR, 19.864; 37: SpO2, 100.0; 37: Perf, 2.101; 37: 1min HRV, 84.424; 38: HR, 91.086; 38: RR, 20.397; 38: SpO2, 100.0; 38: Perf, 1.374; 38: 1min HRV, 77.182; 38: 5min HRV, 98.481; 39: HR, 89.237; 39: RR, 17.610; 39: SpO2, 100.0; 39: Perf, 2.134; 39: 1min HRV, 48.857; 40: HR, 96.373; 40: RR, 19.288; 40: SpO2, 100.0; 40: Perf, 2.359; 40: 1min HRV, 75.919; 41: HR, 99.724; 41: RR, 14.759; 41: SpO2, 100.0; 41: Perf, 1.386; 41: 1min HRV, 88.768; 42: HR, 95.814; 42: RR, 16.593; 42: SpO2, 100.0; 42: Perf, 1.323; 42: 1min HRV, 64.111; 43: HR, 103.603; 43: RR, 14.776; 43: SpO2, 100.0; 43: Perf, 1.383; 43: 1min HRV, 67.070; 43: 5min HRV, 76.235; 44: HR, 102.017; 44: RR, 13.475; 44: SpO2, 100.0; 44: Perf, 1.581; 44: 1min HRV, 90.454; 45: HR, 90.586; 45: RR, 18.483; 45: SpO2, 100.0; 45: Perf, 2.140; 45: 1min HRV, 117.585; 46: HR, 86.678; 46: RR, 14.729; 46: SpO2, 100.0; 46: Perf, 1.606; 46: 1min HRV, 109.479; 47: HR, 88.390; 47: RR, 15.915; 47: SpO2, 99.898; 47: Perf, 1.572; 47: 1min HRV, 82.073; 48: HR, 92.207; 48: RR, 19.259; 48: SpO2, 100.0; 48: Perf, 1.086; 48: 1min HRV, 70.404; 48: 5min HRV, 102.281; 49: HR, 89.458; 49: RR, 14.542; 49: SpO2, 100.0; 49: Perf, 0.949; 49: 1min HRV, 91.342; 49: SBP, 120.0; 49: DBP, 91.0; 49: MAP, 100.667; 50: HR, 89.345; 50: RR, 21.069; 50: SpO2, 100.0; 50: Perf, 1.104; 50: 1min HRV, 58.674; 51: HR, 93.746; 51: RR, 17.288; 51: SpO2, 100.0; 51: Perf, 1.145; 51: 1min HRV, 52.221; 52: HR, 94.814; 52: RR, 13.254; 52: SpO2, 100.0; 52: Perf, 0.876; 52: 1min HRV, 103.907; 53: HR, 90.397; 53: RR, 16.0; 53: SpO2, 100.0; 53: Perf, 0.88; 53: 1min HRV, 81.909; 53: 5min HRV, 81.277; 54: HR, 86.441; 54: RR, 16.119; 54: SpO2, 100.0; 54: Perf, 0.841; 54: 1min HRV, 85.111; 55: HR, 92.845; 55: RR, 16.897; 55: SpO2, 100.0; 55: Perf, 1.127; 55: 1min HRV, 66.007; 56: HR, 96.271; 56: RR, 17.542; 56: SpO2, 100.0; 56: Perf, 1.338; 56: 1min HRV, 73.784; 57: HR, 100.729; 57: RR, 18.814; 57: SpO2, 100.0; 57: Perf, 1.393; 57: 1min HRV, 88.383; 58: HR, 88.517; 58: RR, 17.069; 58: SpO2, 100.0; 58: Perf, 1.814; 58: 1min HRV, 76.327; 58: 5min HRV, 85.133; 59: HR, 81.674; 59: RR, 17.568; 59: SpO2, 100.0; 59: Perf, 1.497; 59: 1min HRV, 79.274; 63: 5min HRV, 79.274; 72: NS IV BOLUS -, 1000 ML; 73: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 88: WAM DIFTYP, AUTO; 88: MONOCYTE ABSOLUTE (AUTO DIFF), 0.45 K/uL; 88: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 88: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.71 K/uL; 88: RED BLOOD CELLS (RBC), 4.81 MIL/uL; 88: BASOPHIL % (AUTO DIFF), 0.7 %; 88: LYMPHOCYTE % (AUTO DIFF), 24.8 %; 88: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 88: NEUTROPHIL % (AUTO DIFF), 67.0 %; 88: EOSINOPHIL % (AUTO DIFF), 0.3 %; 88: RED CELL DISTRIBUTION WIDTH (RDW), 16.5 %; 88: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.1 g/dL; 88: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.61 K/uL; 88: HEMATOCRIT (HCT), 36.7 %; 88: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 88: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 23.7 pg; 88: PLATELET COUNT (PLT), 346 K/uL; 88: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 88: HEMOGLOBIN (HGB), 11.4 g/dL; 88: MEAN CORPUSCULAR VOLUME (MCV), 76.3 fL; 88: MONOCYTE % (AUTO DIFF), 6.5 %; 88: NRBC PERCENT (HEMATOLOGY), 0.0 %; 88: WHITE BLOOD CELLS (WBC), 6.9 K/uL; 88: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.7 %; 107: SARS-COV-2 RNA, Not Detected; 107: RSV, Not Detected; 107: INFLUENZA A, Not Detected; 107: INFLUENZA B, Not Detected; 118: GLUCOSE, URINE (UA): Negative; 118: SPECIFIC GRAVITY, URINE (UA): 1.024; 118: PH, URINE (UA): 5.0; 118: NITRITE, URINE (UA): Negative; 118: PROTEIN, URINE (UA): Negative; 118: PROTEIN TOTAL, 8.2 g/dL; 118: SODIUM, 133 mmol/L; 118: ALT (SGPT), 13 U/L; 118: CO2, 13 mmol/L; 118: CHLORIDE, 98 mmol/L; 118: GLUCOSE, 64 mg/dL; 118: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 118: BILIRUBIN TOTAL, 0.7 mg/dL; 118: ALBUMIN, 5.5 g/dL; 118: CREATININE, 0.61 mg/dL; 118: ALKALINE PHOSPHATASE, 58 U/L; 118: GLOBULIN, 2.7 g/dL; 118: CALCIUM, 9.9 mg/dL; 118: EGFR FOR AFRICAN AMERICAN, 152 mL/min/1.73 m2; 118: BLOOD UREA NITROGEN (BUN), 8 mg/dL; 118: CORRECTED CALCIUM, 8.7 mg/dL; 118: ANION GAP, 22 mmol/L; 118: POTASSIUM, 3.7 mmol/L; 118: AST (SGOT), 22 U/L; 0: Age, 20; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.8; 0: Triage HR, 102.0; 0: Triage RR, 18.0; 0: Triage SBP, 100.0; 0: Triage DBP, 65.0; 0: Triage acuity, 3-Urgent; 0: CC, EMESIS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess sepsis risk, key factors include vital signs, lab results, and clinical context. Initial vital signs such as high heart rate (Triage HR: 102) and slightly low blood pressure (Triage SBP: 100) could indicate potential risk; however, these stabilize over time. Both HR and BP show improvement, and respiratory rate remains normal. Labs do not indicate significant infection signs\u2014WBC count is normal and neutrophil percentage is within standard range. Despite initial symptoms, stabilized vitals and lack of lab abnormalities suggest a low risk of sepsis within 12 hours.",
        "claims": [
            "Key factors to assess sepsis risk include vital signs, lab results, and clinical context.",
            "The initial vital signs include a high heart rate of 102.",
            "A high heart rate of 102 could indicate potential risk for sepsis.",
            "The initial vital signs also include slightly low blood pressure, measured at 100.",
            "Slightly low blood pressure of 100 could indicate potential risk for sepsis.",
            "The vital signs stabilize over time.",
            "Both heart rate and blood pressure show improvement over time.",
            "The respiratory rate remains normal.",
            "Lab results do not indicate significant signs of infection.",
            "The white blood cell (WBC) count is normal.",
            "The neutrophil percentage is within the standard range.",
            "Despite initial symptoms, stabilized vital signs suggest a low risk of sepsis.",
            "The lack of lab abnormalities also suggests a low risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "A high heart rate of 102 could indicate potential risk for sepsis.",
            "The initial vital signs also include slightly low blood pressure, measured at 100.",
            "Slightly low blood pressure of 100 could indicate potential risk for sepsis.",
            "Lab results do not indicate significant signs of infection."
        ],
        "alignment_scores": [
            0.6,
            0.7,
            0.6,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim identifies a heart rate of 102 bpm, which surpasses the SIRS criterion threshold of >90 bpm, indicating systemic inflammation consistent with early sepsis. While a high heart rate is one criterion, SIRS positivity requires \u22652 criteria. Therefore, the alignment is not full, but it is directly relevant.",
            "The claim mentions slightly low blood pressure at 100 mmHg. While not meeting the Sepsis-Associated Hypotension category (<90 mmHg), a systolic blood pressure of 100 mmHg is relevant to the qSOFA criteria, which flags a high risk of sepsis-related organ dysfunction at a rate of \u2264100 mmHg. The alignment is not perfect because the blood pressure is on the threshold, but it aligns more closely with the qSOFA indicator than other categories.",
            "The claim mentions low blood pressure, specifically a systolic BP of 100, which is a criterion for a qSOFA score. While a systolic BP \u2264100 mmHg meets the threshold, the claim describes it as only slightly low, indicating potential risk rather than definite high risk. This makes it relevant, but it does not confirm a high qSOFA score on its own, resulting in a moderate alignment.",
            "The claim suggests an absence of significant infection, which indirectly relates to a decreased suspicion of serious infection. This most closely aligns with the consideration around whether or not to order early antibiotics or cultures, as such orders would typically follow significant signs of infection. The alignment is weak because the claim states the opposite (no significant signs of infection), indicating that this category is unlikely being considered."
        ],
        "final_alignment_score": 0.5499999999999999,
        "accuracy": 1
    },
    {
        "input": "14: HR, 156.0; 14: RR, 22.0; 14: SpO2, 93.0; 14: SBP, 184.0; 14: DBP, 168.0; 14: MAP, 173.333; 14: Temp, 97.3; 35: HR, 73.452; 35: RR, 33.366; 35: 1min HRV, 88.112; 36: HR, 70.379; 36: RR, 41.362; 36: 1min HRV, 83.043; 37: HR, 70.136; 37: RR, 39.831; 37: 1min HRV, 83.907; 38: HR, 71.271; 38: RR, 37.661; 38: 1min HRV, 104.463; 39: HR, 69.610; 39: RR, 38.0; 39: 1min HRV, 87.117; 39: 5min HRV, 90.988; 40: HR, 70.379; 40: RR, 38.190; 40: 1min HRV, 113.496; 41: HR, 70.678; 41: RR, 40.169; 41: 1min HRV, 117.322; 42: HR, 69.776; 42: RR, 37.0; 42: 1min HRV, 115.847; 43: HR, 68.390; 43: RR, 40.169; 43: 1min HRV, 110.946; 44: HR, 70.373; 44: RR, 41.017; 44: 1min HRV, 121.203; 44: 5min HRV, 116.373; 45: HR, 64.345; 45: RR, 38.948; 45: 1min HRV, 6.663; 46: HR, 62.780; 46: RR, 39.864; 46: 1min HRV, 92.436; 47: HR, 73.276; 47: RR, 24.948; 47: 1min HRV, 154.990; 48: HR, 69.915; 48: RR, 25.254; 48: 1min HRV, 110.643; 49: HR, 75.483; 49: RR, 23.448; 49: 1min HRV, 131.734; 49: 5min HRV, 125.448; 50: HR, 77.559; 50: RR, 23.831; 50: 1min HRV, 147.393; 51: HR, 76.407; 51: RR, 30.068; 51: 1min HRV, 107.678; 51: Temp, 100.6; 52: HR, 74.534; 52: RR, 38.569; 52: 1min HRV, 124.051; 53: HR, 71.661; 53: RR, 33.695; 53: 1min HRV, 122.241; 54: HR, 71.759; 54: RR, 36.5; 54: 1min HRV, 130.296; 54: 5min HRV, 130.490; 55: HR, 71.729; 55: RR, 36.305; 55: 1min HRV, 135.077; 56: HR, 68.153; 56: RR, 37.983; 56: 1min HRV, 125.658; 57: HR, 63.828; 57: RR, 36.776; 57: 1min HRV, 103.130; 58: HR, 65.407; 58: RR, 37.729; 58: 1min HRV, 103.953; 59: HR, 66.466; 59: RR, 38.414; 59: 1min HRV, 135.229; 59: 5min HRV, 127.500; 60: HR, 70.102; 60: RR, 31.085; 60: 1min HRV, 142.860; 61: HR, 68.017; 61: RR, 31.305; 61: 1min HRV, 147.320; 62: HR, 69.914; 62: RR, 31.121; 62: 1min HRV, 141.935; 63: HR, 67.271; 63: RR, 36.932; 63: 1min HRV, 139.864; 64: HR, 68.155; 64: RR, 38.310; 64: 1min HRV, 163.649; 64: 5min HRV, 147.753; 65: HR, 69.441; 65: RR, 34.898; 65: 1min HRV, 157.793; 66: HR, 69.780; 66: RR, 37.508; 66: SpO2, 97.0; 66: 1min HRV, 148.174; 67: HR, 66.0; 67: RR, 38.224; 67: 1min HRV, 146.767; 68: HR, 66.203; 68: RR, 36.678; 68: 1min HRV, 137.768; 69: HR, 64.672; 69: RR, 40.121; 69: 1min HRV, 136.136; 69: 5min HRV, 149.031; 70: HR, 63.220; 70: RR, 38.797; 70: 1min HRV, 133.571; 71: HR, 70.814; 71: RR, 38.542; 71: 1min HRV, 157.983; 72: HR, 65.414; 72: RR, 38.466; 72: 1min HRV, 144.074; 73: HR, 64.254; 73: RR, 34.102; 73: 1min HRV, 140.864; 74: HR, 68.517; 74: RR, 29.448; 74: 1min HRV, 137.646; 74: 5min HRV, 148.502; 75: HR, 68.627; 75: RR, 29.271; 75: 1min HRV, 140.437; 76: HR, 69.322; 76: RR, 30.797; 76: 1min HRV, 153.600; 77: HR, 69.052; 77: RR, 34.431; 77: 1min HRV, 154.615; 78: HR, 67.407; 78: RR, 35.729; 78: 1min HRV, 139.424; 79: HR, 69.086; 79: RR, 26.397; 79: 1min HRV, 140.216; 79: 5min HRV, 146.596; 80: HR, 64.390; 80: RR, 38.661; 80: 1min HRV, 146.641; 81: SARS-COV-2 RNA, Not Detected; 81: HR, 66.190; 81: RR, 35.707; 81: 1min HRV, 129.707; 82: HR, 65.186; 82: RR, 38.034; 82: 1min HRV, 128.806; 83: HR, 68.983; 83: RR, 34.644; 83: 1min HRV, 144.160; 84: HR, 70.931; 84: RR, 37.103; 84: 1min HRV, 154.379; 84: 5min HRV, 144.235; 85: HR, 68.661; 85: RR, 35.610; 85: 1min HRV, 154.297; 86: HR, 69.931; 86: RR, 37.397; 86: 1min HRV, 151.109; 87: HR, 70.390; 87: RR, 39.305; 87: 1min HRV, 156.446; 88: HR, 69.475; 88: RR, 36.949; 88: 1min HRV, 151.355; 89: HR, 67.793; 89: RR, 34.845; 89: 1min HRV, 149.483; 89: 5min HRV, 153.149; 90: HR, 65.017; 90: RR, 33.831; 90: SpO2, 96.0; 90: 1min HRV, 131.283; 91: HR, 67.5; 91: RR, 30.017; 91: 1min HRV, 139.116; 92: HR, 70.949; 92: RR, 38.763; 92: SpO2, 97.0; 92: 1min HRV, 174.120; 93: HR, 76.407; 93: RR, 32.576; 93: SpO2, 97.0; 93: 1min HRV, 141.376; 94: HR, 73.017; 94: RR, 34.138; 94: 1min HRV, 135.197; 94: 5min HRV, 152.108; 95: HR, 71.915; 95: RR, 36.458; 95: 1min HRV, 138.877; 96: HR, 71.190; 96: RR, 39.517; 96: 1min HRV, 156.430; 97: HR, 66.492; 97: RR, 34.322; 97: 1min HRV, 132.356; 98: HR, 69.119; 98: RR, 30.983; 98: 1min HRV, 147.886; 99: HR, 69.190; 99: RR, 34.5; 99: 1min HRV, 144.492; 99: 5min HRV, 145.686; 100: HR, 71.492; 100: RR, 38.237; 100: 1min HRV, 150.561; 101: HR, 71.293; 101: RR, 37.793; 101: 1min HRV, 138.640; 102: HR, 68.424; 102: RR, 38.237; 102: 1min HRV, 133.726; 103: HR, 67.881; 103: RR, 38.288; 103: 1min HRV, 135.745; 104: HR, 69.310; 104: RR, 39.690; 104: 1min HRV, 134.999; 104: 5min HRV, 139.607; 105: HR, 69.356; 105: RR, 40.051; 105: SpO2, 96.0; 105: 1min HRV, 160.859; 106: HR, 74.793; 106: RR, 39.690; 106: 1min HRV, 165.740; 107: HR, 66.797; 107: RR, 34.356; 107: SpO2, 94.5; 107: 1min HRV, 141.305; 108: HR, 65.424; 108: RR, 35.186; 108: SpO2, 94.0; 108: 1min HRV, 133.033; 109: HR, 67.914; 109: RR, 38.517; 109: SpO2, 94.889; 109: 1min HRV, 148.623; 109: 5min HRV, 153.681; 110: HR, 69.254; 110: RR, 36.085; 110: 1min HRV, 146.020; 111: HR, 69.397; 111: RR, 35.603; 111: SpO2, 100.0; 111: 1min HRV, 152.806; 111: SBP, 102.0; 111: DBP, 52.0; 111: MAP, 68.667; 112: HR, 68.237; 112: RR, 27.881; 112: 1min HRV, 181.621; 113: HR, 71.5; 113: RR, 30.466; 113: 1min HRV, 139.520; 114: HR, 66.407; 114: RR, 38.373; 114: SpO2, 93.2; 114: 1min HRV, 139.131; 114: 5min HRV, 152.803; 115: HR, 69.661; 115: RR, 34.288; 115: 1min HRV, 139.376; 115: SBP, 106.0; 115: DBP, 63.0; 115: MAP, 77.333; 116: HR, 69.448; 116: RR, 35.690; 116: 1min HRV, 141.771; 117: HR, 66.407; 117: RR, 37.017; 117: 1min HRV, 123.354; 118: HR, 67.810; 118: RR, 34.707; 118: 1min HRV, 144.249; 119: HR, 66.746; 119: RR, 34.610; 119: 1min HRV, 138.079; 119: 5min HRV, 138.635; 0: Age, 88; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.3; 0: Triage HR, 156.0; 0: Triage RR, 22.0; 0: Triage SBP, 184.0; 0: Triage DBP, 168.0; 0: Triage acuity, 3-Urgent; 0: CC, REFERRAL",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The primary indicators for sepsis risk include elevated heart rate, respiratory rate, and temperature, alongside indicators of potential organ dysfunction, like low blood pressure and SpO2. Initially, the patient's vital signs at Time 0.0 suggest hypertension and tachycardia, which are not uncommon in emergency settings and do not conclusively indicate high sepsis risk. Subsequent data show that the heart rate and respiratory rate stabilize within normal ranges. Additionally, SpO2 remains relatively stable and without significant hypoxia, and there is no significant indication of organ dysfunction or infection (e.g., elevated temperature, consciousness changes). Thus, this suggests no immediate high risk for sepsis within the next 12 hours.",
        "claims": [
            "The primary indicators for sepsis risk include elevated heart rate, respiratory rate, and temperature.",
            "Indicators of potential organ dysfunction for sepsis risk include low blood pressure and SpO2.",
            "The patient's vital signs at Time 0.0 suggest hypertension.",
            "The patient's vital signs at Time 0.0 suggest tachycardia.",
            "Hypertension and tachycardia are not uncommon in emergency settings.",
            "Hypertension and tachycardia do not conclusively indicate high sepsis risk.",
            "Subsequent data show that the heart rate stabilizes within normal ranges.",
            "Subsequent data show that the respiratory rate stabilizes within normal ranges.",
            "SpO2 remains relatively stable.",
            "SpO2 does not show significant hypoxia.",
            "There is no significant indication of organ dysfunction.",
            "There is no significant indication of infection.",
            "There is no elevated temperature.",
            "There are no changes in consciousness.",
            "These observations suggest no immediate high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The primary indicators for sepsis risk include elevated heart rate, respiratory rate, and temperature.",
            "The patient's vital signs at Time 0.0 suggest hypertension.",
            "The patient's vital signs at Time 0.0 suggest tachycardia.",
            "There is no significant indication of infection."
        ],
        "alignment_scores": [
            0.9,
            0.3,
            0.7,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions elevated heart rate, respiratory rate, and temperature, which are directly associated with the SIRS criteria for systemic inflammation in early sepsis identification. The alignment is very strong as these indicators reflect \u22652 SIRS criteria, though without explicit numerical thresholds mentioned, a slight deduction is considered.",
            "The claim mentions hypertension, which alone doesn't directly indicate a sepsis risk under the provided categories. However, elevated blood pressure can affect scoring on the NEWS system, which assesses a range of vital signs. Although hypertension isn't directly a part of the NEWS criteria that indicate sepsis, vital sign assessment is conceptually linked, hence a low alignment rating.",
            "Tachycardia (heart rate > 90 bpm) directly corresponds to one of the SIRS criteria, which are used to identify systemic inflammation consistent with early sepsis. However, SIRS positivity requires the presence of \u22652 criteria, so the alignment isn't perfect but is strongly indicative of early sepsis risk.",
            "The claim implies a low risk of sepsis due to the absence of indications of infection, which contrasts with the active suspicion reflected by early antibiotic or culture orders. While it is an inverse scenario, the category is relevant in assessing suspicion levels of sepsis. The alignment is minimal since no clinical actions were taken that involve diagnostics or treatment intended for possible infection."
        ],
        "final_alignment_score": 0.525,
        "accuracy": 0
    },
    {
        "input": "3: HR, 94.929; 3: RR, 16.486; 3: SpO2, 91.0; 3: 1min HRV, 17.711; 3: SBP, 127.0; 3: DBP, 80.0; 3: MAP, 95.667; 4: HR, 91.220; 4: RR, 13.746; 4: SpO2, 94.0; 4: Perf, 4.33; 4: 1min HRV, 26.173; 5: HR, 91.034; 5: RR, 18.759; 5: SpO2, 94.034; 5: Perf, 4.506; 5: 1min HRV, 21.867; 6: HR, 88.085; 6: RR, 14.915; 6: SpO2, 92.595; 6: Perf, 5.485; 6: 1min HRV, 38.426; 7: HR, 88.508; 7: RR, 14.797; 7: 1min HRV, 22.214; 7: 5min HRV, 30.947; 8: HR, 89.069; 8: RR, 11.793; 8: SpO2, 95.04; 8: Perf, 4.972; 8: 1min HRV, 31.508; 8: SBP, 127.0; 8: DBP, 80.0; 8: MAP, 95.667; 8: Temp, 98.0; 9: HR, 86.559; 9: RR, 12.068; 9: SpO2, 97.034; 9: Perf, 4.628; 9: 1min HRV, 31.643; 10: HR, 90.517; 10: RR, 14.103; 10: SpO2, 96.569; 10: Perf, 5.033; 10: 1min HRV, 24.404; 11: HR, 92.695; 11: RR, 15.254; 11: SpO2, 95.071; 11: Perf, 5.347; 11: 1min HRV, 36.291; 12: HR, 91.864; 12: RR, 19.831; 12: 1min HRV, 17.732; 12: 5min HRV, 32.707; 13: HR, 94.052; 13: RR, 18.914; 13: SpO2, 96.467; 13: 1min HRV, 18.839; 14: HR, 91.898; 14: RR, 18.466; 14: SpO2, 97.702; 14: Perf, 5.816; 14: 1min HRV, 23.276; 17: 5min HRV, 22.371; 18: HR, 94.154; 18: RR, 16.143; 18: 1min HRV, 14.662; 19: HR, 88.831; 19: RR, 17.034; 19: SpO2, 93.017; 19: 1min HRV, 51.436; 20: HR, 87.069; 20: RR, 16.707; 20: SpO2, 96.517; 20: Perf, 3.891; 20: 1min HRV, 57.287; 21: HR, 79.034; 21: RR, 9.797; 21: SpO2, 91.068; 21: Perf, 2.904; 21: 1min HRV, 32.628; 22: HR, 79.695; 22: RR, 10.220; 22: SpO2, 89.102; 22: Perf, 2.107; 22: 1min HRV, 26.250; 22: 5min HRV, 58.567; 23: HR, 89.776; 23: RR, 17.552; 23: SpO2, 90.448; 23: Perf, 1.569; 23: 1min HRV, 48.867; 24: HR, 79.339; 24: RR, 13.254; 24: SpO2, 94.305; 24: Perf, 1.277; 24: 1min HRV, 37.752; 25: HR, 75.086; 25: RR, 13.276; 25: SpO2, 92.983; 25: Perf, 2.273; 25: 1min HRV, 35.708; 26: HR, 76.898; 26: RR, 12.559; 26: SpO2, 94.508; 26: Perf, 1.732; 26: 1min HRV, 24.237; 27: HR, 86.466; 27: RR, 15.586; 27: SpO2, 93.023; 27: Perf, 1.560; 27: 1min HRV, 60.706; 27: 5min HRV, 70.179; 28: HR, 78.559; 28: RR, 14.712; 28: SpO2, 95.731; 28: 1min HRV, 65.069; 29: HR, 74.864; 29: RR, 12.017; 29: SpO2, 96.694; 29: 1min HRV, 63.373; 30: HR, 85.155; 30: RR, 19.828; 30: SpO2, 95.583; 30: Perf, 3.318; 30: 1min HRV, 77.497; 31: HR, 81.644; 31: RR, 16.542; 31: 1min HRV, 53.816; 32: HR, 74.017; 32: RR, 11.052; 32: 1min HRV, 61.141; 32: 5min HRV, 82.942; 33: HR, 70.915; 33: RR, 10.898; 33: 1min HRV, 53.525; 34: HR, 77.203; 34: RR, 15.169; 34: 1min HRV, 48.164; 35: HR, 80.948; 35: RR, 14.741; 35: 1min HRV, 84.492; 36: HR, 91.356; 36: RR, 20.424; 36: 1min HRV, 40.012; 37: HR, 81.414; 37: RR, 18.052; 37: 1min HRV, 66.938; 37: 5min HRV, 83.929; 38: HR, 73.746; 38: RR, 15.017; 38: 1min HRV, 101.429; 39: HR, 79.847; 39: RR, 21.763; 39: 1min HRV, 101.943; 40: HR, 67.293; 40: RR, 13.345; 40: 1min HRV, 18.546; 41: HR, 81.881; 41: RR, 18.898; 41: 1min HRV, 82.296; 42: HR, 73.534; 42: RR, 14.086; 42: 1min HRV, 50.919; 42: 5min HRV, 96.880; 43: HR, 80.373; 43: RR, 15.712; 43: 1min HRV, 70.035; 44: HR, 74.305; 44: RR, 18.237; 44: 1min HRV, 67.631; 45: HR, 74.086; 45: RR, 16.052; 45: 1min HRV, 63.685; 46: HR, 68.661; 46: RR, 12.220; 46: 1min HRV, 32.208; 47: HR, 86.845; 47: RR, 20.483; 47: 1min HRV, 23.165; 47: 5min HRV, 90.445; 48: HR, 79.220; 48: RR, 18.458; 48: 1min HRV, 65.133; 49: HR, 83.983; 49: RR, 14.576; 49: 1min HRV, 96.461; 50: HR, 78.138; 50: RR, 15.862; 50: 1min HRV, 79.422; 51: HR, 78.339; 51: RR, 14.186; 51: 1min HRV, 89.940; 52: HR, 82.379; 52: RR, 18.690; 52: 1min HRV, 78.629; 52: 5min HRV, 89.913; 53: HR, 69.576; 53: RR, 14.576; 53: 1min HRV, 55.195; 54: HR, 66.966; 54: RR, 10.475; 54: 1min HRV, 20.401; 55: HR, 67.672; 55: RR, 10.103; 55: 1min HRV, 24.726; 56: HR, 72.085; 56: RR, 12.0; 56: 1min HRV, 65.450; 57: HR, 73.828; 57: RR, 16.621; 57: 1min HRV, 47.900; 57: 5min HRV, 57.603; 58: HR, 71.949; 58: RR, 17.576; 58: 1min HRV, 34.180; 59: HR, 85.586; 59: RR, 20.810; 59: 1min HRV, 51.570; 60: HR, 76.424; 60: RR, 17.525; 60: 1min HRV, 47.778; 61: HR, 69.085; 61: RR, 18.220; 61: 1min HRV, 67.097; 62: HR, 69.897; 62: RR, 10.724; 62: 1min HRV, 53.313; 62: 5min HRV, 80.218; 63: HR, 76.271; 63: RR, 13.119; 63: 1min HRV, 28.041; 64: HR, 70.690; 64: RR, 10.5; 64: 1min HRV, 66.011; 65: HR, 92.085; 65: RR, 15.932; 65: 1min HRV, 55.711; 66: HR, 88.881; 66: RR, 22.271; 66: 1min HRV, 22.920; 67: HR, 92.552; 67: RR, 23.207; 67: 1min HRV, 64.729; 67: 5min HRV, 92.926; 68: HR, 88.881; 68: RR, 14.610; 68: 1min HRV, 79.447; 69: HR, 101.0; 69: RR, 27.0; 72: 5min HRV, 79.447; 0: Age, 33; 0: Gender, M; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 83.0; 0: Triage RR, 16.0; 0: Triage SBP, 127.0; 0: Triage DBP, 80.0; 0: Triage acuity, 2-Emergent; 0: CC, ACUTE NEUROLOGICAL PROBLEM",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To determine the sepsis risk, it's important to assess factors such as heart rate, respiratory rate, blood pressure, oxygen saturation, and temperature. Initially, none of these parameters are critically alarming, but there is a notable trend between times 0.0 and 69.0 where HR, SpO2, and RR fluctuate significantly, with periods of tachycardia (high HR), low SpO2, and increased RR at multiple points (e.g., time 69.0 shows HR: 101.0 and RR: 27.0). These signs indicate potential hemodynamic instability and respiratory distress, suggesting a heightened risk for sepsis.",
        "claims": [
            "To determine the sepsis risk, it's important to assess factors such as heart rate, respiratory rate, blood pressure, oxygen saturation, and temperature.",
            "Initially, none of these parameters are critically alarming.",
            "There is a notable trend between times 0.0 and 69.0.",
            "Heart rate (HR), oxygen saturation (SpO2), and respiratory rate (RR) fluctuate significantly between times 0.0 and 69.0.",
            "There are periods of tachycardia (high HR) observed.",
            "There are periods of low SpO2 observed.",
            "There are periods of increased RR observed at multiple points.",
            "At time 69.0, the heart rate is 101.0.",
            "At time 69.0, the respiratory rate is 27.0.",
            "These signs indicate potential hemodynamic instability.",
            "These signs indicate potential respiratory distress.",
            "The observed signs suggest a heightened risk for sepsis."
        ],
        "relevant_claims": [
            "To determine the sepsis risk, it's important to assess factors such as heart rate, respiratory rate, blood pressure, oxygen saturation, and temperature.",
            "Heart rate (HR), oxygen saturation (SpO2), and respiratory rate (RR) fluctuate significantly between times 0.0 and 69.0.",
            "There are periods of tachycardia (high HR) observed.",
            "There are periods of low SpO2 observed.",
            "There are periods of increased RR observed at multiple points.",
            "At time 69.0, the heart rate is 101.0.",
            "At time 69.0, the respiratory rate is 27.0.",
            "These signs indicate potential hemodynamic instability.",
            "These signs indicate potential respiratory distress.",
            "The observed signs suggest a heightened risk for sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.7,
            0.6,
            0.7,
            0.8,
            0.9,
            0.7,
            0.5,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "Elevated Shock Index (\u22651.0)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions assessing heart rate, respiratory rate, blood pressure, oxygen saturation, and temperature, which are vital signs assessed in the National Early Warning Score (NEWS). However, the claim doesn't explicitly connect these assessments to a specific NEWS score threshold (\u22655), so the alignment is not perfect but meaningful due to the overlap in vital sign monitoring.",
            "The claim describes fluctuations in heart rate, oxygen saturation, and respiratory rate, all of which are vital parameters considered in calculating the National Early Warning Score (NEWS). While not explicitly tied to a NEWS score of \u22655, the significant fluctuations in these vital signs suggest potential deterioration consistent with elevated NEWS, though without specific values reported, it is not a full match. Therefore, it aligns with the category to a moderate degree.",
            "Tachycardia, or a high heart rate (>90 bpm), is one of the explicit criteria for SIRS (Systemic Inflammatory Response Syndrome). This aligns well with the \"SIRS Positivity\" category, indicating systemic inflammation consistent with early sepsis. However, to fully meet the SIRS criteria, at least one more criterion is needed, so the alignment is not perfect, but it is strong.",
            "Periods of low SpO\u2082 indicate potential issues with oxygenation, which conceptually aligns with the PaO\u2082/FiO\u2082 measure in the SOFA score. Although SpO\u2082 is not a direct SOFA component, it suggests impaired respiratory function relevant to SOFA's assessment of organ dysfunction in sepsis risk, resulting in an indirect yet notable alignment.",
            "The claim mentions increased respiratory rate (RR), which aligns with one of the criteria for a high qSOFA score (specifically, RR \u226522/min). The qSOFA score uses this as an indicator of potential organ dysfunction and sepsis risk. Although the exact RR value is not provided, the mention of increased RR suggests a potential risk, hence the strong but not perfect alignment.",
            "The claim mentions a heart rate of 101.0 bpm, which exceeds the SIRS criterion of >90 bpm, highlighting the presence of systemic inflammation indicative of early sepsis. The alignment is strong, as it directly fulfills one of the SIRS criteria, despite not addressing the other criteria required for full SIRS positivity.",
            "The claim specifically mentions a respiratory rate of 27.0, which exceeds the threshold for the qSOFA score criterion of respiratory rate \u226522\u202f/min. This places the patient at high risk for sepsis-related organ dysfunction and mortality. The alignment is strong because the claim directly matches one of the explicit qSOFA score criteria, indicating potential for a high risk of sepsis.",
            "Hemodynamic instability is closely related to the concept of shock, and the Shock Index directly measures this instability. However, the claim lacks specific details such as heart rate or blood pressure measurements that definitively align with the Shock Index criterion, so the alignment is moderate rather than strong.",
            "The claim mentions \"potential respiratory distress,\" which can relate to respiratory rate\u2014one of the components of the qSOFA score. A respiratory rate \u226522/min contributes to a high qSOFA score, indicating a risk for sepsis-related organ dysfunction. However, without specific details on respiratory rate, the alignment is indirect and not definitive; hence, a moderate alignment rating is given.",
            "The claim indicates a general concern for sepsis risk but lacks specificity regarding particular symptoms or clinical criteria. The expression of \"heightened risk for sepsis\" aligns loosely with clinician suspicion of infection, akin to deciding on early interventions like antibiotics or cultures. However, without specifying actions like ordering antibiotics or cultures, the alignment is weak, leading to a lower rating."
        ],
        "final_alignment_score": 0.6599999999999999,
        "accuracy": 1
    },
    {
        "input": "5: HR, 148.0; 6: HR, 147.308; 6: RR, 33.12; 6: SpO2, 99.0; 6: 1min HRV, 1.682; 6: SBP, 129.0; 6: DBP, 87.0; 6: MAP, 101.0; 6: LPM O2, 6.0; 6: Pain, 0.0; 6: Temp, 98.2; 7: HR, 147.224; 7: RR, 33.569; 7: 1min HRV, 1.191; 8: HR, 146.763; 8: RR, 30.068; 8: 1min HRV, 2.764; 8: 5min HRV, 2.393; 9: HR, 145.961; 9: RR, 29.65; 9: 1min HRV, 1.375; 9: SBP, 127.0; 9: DBP, 80.0; 9: MAP, 95.667; 10: HR, 146.276; 10: RR, 31.103; 10: 1min HRV, 0.989; 11: HR, 145.441; 11: RR, 28.847; 11: 1min HRV, 2.797; 12: HR, 145.466; 12: RR, 27.776; 12: 1min HRV, 1.743; 13: HR, 145.424; 13: RR, 29.831; 13: 1min HRV, 1.490; 13: 5min HRV, 2.104; 14: HR, 145.610; 14: RR, 29.831; 14: SpO2, 100.0; 14: Perf, 0.57; 14: 1min HRV, 1.934; 15: HR, 147.259; 15: RR, 34.121; 15: SpO2, 100.0; 15: 1min HRV, 3.816; 16: HR, 147.864; 16: RR, 26.898; 16: 1min HRV, 3.060; 17: HR, 147.052; 17: RR, 31.310; 17: SpO2, 99.636; 17: 1min HRV, 4.018; 18: HR, 150.305; 18: RR, 24.373; 18: SpO2, 98.0; 18: 1min HRV, 2.201; 18: 5min HRV, 5.055; 19: HR, 151.169; 19: RR, 33.508; 19: SpO2, 99.062; 19: 1min HRV, 3.213; 20: HR, 147.517; 20: RR, 30.552; 20: SpO2, 99.176; 20: Perf, 0.37; 20: 1min HRV, 2.140; 21: HR, 148.102; 21: RR, 31.305; 21: SpO2, 99.133; 21: Perf, 0.389; 21: 1min HRV, 4.108; 22: HR, 148.052; 22: RR, 33.414; 22: SpO2, 99.0; 22: 1min HRV, 2.972; 23: HR, 146.593; 23: RR, 30.915; 23: SpO2, 99.0; 23: 1min HRV, 1.722; 23: 5min HRV, 5.107; 23: SBP, 128.0; 23: DBP, 83.0; 23: MAP, 98.0; 23: LPM O2, 6.0; 24: HR, 145.881; 24: RR, 31.136; 24: SpO2, 99.592; 24: 1min HRV, 1.097; 24: SBP, 128.0; 24: DBP, 83.0; 24: MAP, 98.0; 25: HR, 146.241; 25: RR, 28.759; 25: SpO2, 98.438; 25: Perf, 0.793; 25: 1min HRV, 1.190; 26: HR, 145.881; 26: RR, 28.119; 26: SpO2, 99.932; 26: Perf, 0.795; 26: 1min HRV, 0.960; 27: HR, 145.138; 27: RR, 28.672; 27: SpO2, 99.017; 27: Perf, 0.723; 27: 1min HRV, 1.042; 28: HR, 145.153; 28: RR, 28.593; 28: SpO2, 99.173; 28: Perf, 0.73; 28: 1min HRV, 1.207; 28: 5min HRV, 1.542; 29: HR, 145.525; 29: RR, 27.407; 29: Perf, 0.73; 29: 1min HRV, 1.633; 30: HR, 145.517; 30: RR, 27.552; 30: 1min HRV, 1.037; 31: HR, 145.915; 31: RR, 29.610; 31: SpO2, 97.195; 31: 1min HRV, 1.695; 32: HR, 147.879; 32: RR, 39.362; 32: SpO2, 97.889; 32: Perf, 0.77; 32: 1min HRV, 3.703; 33: HR, 146.678; 33: RR, 33.051; 33: 1min HRV, 2.117; 33: 5min HRV, 3.198; 66: WAM DIFTYP, AUTO; 66: HEMATOCRIT (HCT), 27.6 %; 66: EOSINOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.60 K/uL; 66: RED BLOOD CELLS (RBC), 2.95 MIL/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 93.6 fL; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.03 K/uL; 66: PLATELET COUNT (PLT), 172 K/uL; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.83 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 10.6 %; 66: WHITE BLOOD CELLS (WBC), 6.2 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 19.5 %; 66: HEMOGLOBIN (HGB), 8.3 g/dL; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 78.4 %; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.65 K/uL; 66: BASOPHIL % (AUTO DIFF), 0.3 %; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: MONOCYTE % (AUTO DIFF), 9.7 %; 99: CHLORIDE, 93 mmol/L; 99: ALKALINE PHOSPHATASE, 232 U/L; 99: EGFR REFIT WITHOUT RACE (2021), 155 mL/min/1.73 m2; 99: BLOOD UREA NITROGEN (BUN), 3 mg/dL; 99: POTASSIUM, 4.1 mmol/L; 99: CO2, 37 mmol/L; 99: SODIUM, 135 mmol/L; 99: AST (SGOT), 60 U/L; 99: EGFR FOR AFRICAN AMERICAN, 178 mL/min/1.73 m2; 99: GLOBULIN, 3.4 g/dL; 99: PROTEIN TOTAL, 5.9 g/dL; 99: CORRECTED CALCIUM, 9.9 mg/dL; 99: ANION GAP, 5 mmol/L; 99: BILIRUBIN TOTAL, 0.2 mg/dL; 99: ALBUMIN, 2.5 g/dL; 99: CREATININE, 0.25 mg/dL; 99: ALT (SGPT), 16 U/L; 99: CALCIUM, 8.7 mg/dL; 99: GLUCOSE, 104 mg/dL; 99: BNP NT-PRO, 415 pg/mL; 100: LR IV BOLUS -, 500 ML; 0: Age:, 38; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.8; 0: Triage HR, 147.0; 0: Triage RR, 29.0; 0: Triage SBP, 129.0; 0: Triage DBP, 87.0; 0: Triage acuity, 2-Emergent; 0: CC, SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The first subquestion is to evaluate the initial vital signs and symptoms for signs of sepsis, particularly focusing on elevated heart rate (HR: 147 at triage) and respiratory rate (RR: 29 at triage), which are both high and could be indicative of sepsis. The second subquestion involves analyzing lab results for signals of infection or organ dysfunction, such as low hemoglobin (8.3 g/dL) and low albumin (2.5 g/dL), which can be related to sepsis. Lastly, these signs are contextualized with the patient's reported shortness of breath and emergent acuity, indicating a high risk of sepsis within 12 hours.",
        "claims": [
            "The first subquestion is to evaluate the initial vital signs and symptoms for signs of sepsis.",
            "The initial vital signs include an elevated heart rate of 147 at triage.",
            "An elevated heart rate of 147 at triage is high and could be indicative of sepsis.",
            "The initial vital signs also include a respiratory rate of 29 at triage.",
            "A respiratory rate of 29 at triage is high and could be indicative of sepsis.",
            "The second subquestion involves analyzing lab results for signals of infection or organ dysfunction.",
            "Low hemoglobin is noted at 8.3 g/dL.",
            "A hemoglobin level of 8.3 g/dL can be related to sepsis.",
            "Low albumin is noted at 2.5 g/dL.",
            "A serum albumin level of 2.5 g/dL can be related to sepsis.",
            "The patient's reported shortness of breath is a relevant symptom.",
            "The patient's emergent acuity indicates a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The initial vital signs include an elevated heart rate of 147 at triage.",
            "An elevated heart rate of 147 at triage is high and could be indicative of sepsis.",
            "The initial vital signs also include a respiratory rate of 29 at triage.",
            "A respiratory rate of 29 at triage is high and could be indicative of sepsis.",
            "The second subquestion involves analyzing lab results for signals of infection or organ dysfunction.",
            "Low hemoglobin is noted at 8.3 g/dL.",
            "A hemoglobin level of 8.3 g/dL can be related to sepsis.",
            "Low albumin is noted at 2.5 g/dL.",
            "A serum albumin level of 2.5 g/dL can be related to sepsis.",
            "The patient's reported shortness of breath is a relevant symptom.",
            "The patient's emergent acuity indicates a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.9,
            0.8,
            0.4,
            0.3,
            0.3,
            0.3,
            0.3,
            0.4,
            0.7
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "High qSOFA Score (\u22652)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate is a direct component in calculating the Shock Index, which is the heart rate divided by the systolic blood pressure. While the claim does not specify the blood pressure needed to complete the Shock Index, a heart rate of 147 is significantly elevated and suggests possible hemodynamic instability. Therefore, this aligns moderately well with the Elevated Shock Index category without the full calculation.",
            "The claim mentions an elevated heart rate, which is a component of the Shock Index calculation (heart rate \u00f7 systolic BP). While the claim does not provide information about blood pressure to directly calculate the Shock Index, a very high heart rate, like 147, suggests potential hemodynamic instability. Though not definitive without BP data, the elevated heart rate strongly aligns with the concept of assessing hemodynamic status, hence, a rating of 0.7.",
            "The claim states that the respiratory rate is 29, which exceeds the qSOFA criterion of a respiratory rate \u226522/min. This indicates a possible high risk of sepsis-related organ dysfunction and mortality, aligning strongly with the qSOFA category. The alignment is nearly perfect since the claim is directly relevant to the qSOFA scoring system, but the full qSOFA score isn't detailed in the claim.",
            "The claim mentions a high respiratory rate (29 breaths per minute) as potentially indicative of sepsis, which specifically aligns with one of the qSOFA criteria (respiratory rate \u2265 22/min) used to assess the risk of sepsis-related organ dysfunction and mortality. While the elevated respiratory rate is a clear match to qSOFA, without additional qSOFA criteria being met, there is not perfect alignment.",
            "The claim references analyzing lab results for signals of infection or organ dysfunction, which aligns with monitoring for changes in SOFA score components. However, it does not explicitly mention any specific changes in lab results that directly map to the SOFA criteria, which limits the strength of the alignment. Thus, the alignment is weak and indirect.",
            "Low hemoglobin is not directly part of the SOFA scoring system, which includes parameters like PaO\u2082/FiO\u2082, platelets, bilirubin, creatinine, and GCS. However, low hemoglobin could indicate anemia, which might indirectly suggest decreased organ perfusion or oxygen carrying capacity, somewhat relating to overall organ dysfunction. The alignment is weak due to its indirect connection and not directly affecting the SOFA criteria.",
            "The claim refers to a low hemoglobin level, which is not directly related to any of the listed categories. However, anemia could indirectly point towards organ dysfunction, which aligns somewhat with the concepts of SOFA score components like platelet count or overall organ dysfunction assessment. The alignment with the SOFA Score Increase category is indirect and weak, hence the low rating.",
            "Low albumin levels can be indicative of liver dysfunction or malnutrition, but they do not directly correspond to any of the sepsis categories listed. However, albumin is part of the broader context of liver function markers and could be conceptually linked to the organ dysfunction captured by SOFA. The alignment is quite indirect and weak since it's not a direct criterion of the SOFA score.",
            "A serum albumin level of 2.5 g/dL suggests hypoalbuminemia, which is not explicitly part of the SOFA scoring criteria. However, low albumin levels can indicate poor nutritional status, chronic illness, or liver dysfunction, all of which can contribute to the physiological disturbances seen in sepsis. Although this does not directly affect the SOFA score, it provides indirect evidence of physiological compromise that may be associated with the risk of sepsis. The alignment is therefore indirect and weak.",
            "Shortness of breath could suggest an increased respiratory rate, which is a component of the qSOFA score (respiratory rate \u2265 22/min). However, the claim doesn\u2019t provide specific quantitative information to determine a high qSOFA score; thus, the alignment is weak but relevant to the qSOFA category.",
            "The claim speaks to the patient's \"emergent acuity,\" which suggests clinical deterioration\u2014something closely monitored by the National Early Warning Score (NEWS). Although the claim does not specify an actual NEWS score, the context of \"emergent acuity\" aligns well with the use of NEWS to predict imminent clinical issues, like sepsis. The alignment is strong due to the conceptual overlap but not perfect due to the lack of specific scoring details."
        ],
        "final_alignment_score": 0.5272727272727273,
        "accuracy": 1
    },
    {
        "input": "3: HR, 99.0; 3: RR, 22.0; 3: SpO2, 100.0; 3: SBP, 105.0; 3: DBP, 69.0; 3: MAP, 81.0; 3: Temp, 97.9; 22: SpO2, 93.583; 22: SBP, 117.0; 22: DBP, 84.0; 22: MAP, 95.0; 23: HR, 97.0; 23: SpO2, 99.780; 23: Perf, 2.001; 23: SBP, 117.0; 23: DBP, 84.0; 23: MAP, 95.0; 24: SpO2, 99.932; 24: Perf, 2.445; 25: SpO2, 99.661; 25: Perf, 2.122; 26: SpO2, 99.38; 26: Perf, 1.821; 27: SpO2, 97.827; 27: Perf, 1.817; 28: SpO2, 98.931; 28: Perf, 1.873; 29: SpO2, 99.366; 29: Perf, 1.780; 30: SpO2, 98.368; 30: Perf, 1.356; 31: SpO2, 98.845; 31: Perf, 0.549; 32: SpO2, 98.492; 32: Perf, 0.372; 33: SpO2, 99.379; 33: Perf, 0.356; 34: SpO2, 100.0; 34: Perf, 0.402; 35: SpO2, 99.069; 35: Perf, 0.376; 36: SpO2, 99.661; 36: Perf, 0.32; 37: SpO2, 99.828; 37: Perf, 0.361; 38: SpO2, 99.822; 38: Perf, 0.566; 39: SpO2, 99.897; 39: Perf, 0.906; 40: SpO2, 100.0; 40: Perf, 0.948; 41: SpO2, 99.6; 41: Perf, 0.961; 42: SpO2, 99.931; 42: Perf, 0.961; 43: SpO2, 99.881; 43: Perf, 1.230; 44: SpO2, 99.897; 44: Perf, 1.309; 45: SpO2, 99.627; 45: Perf, 1.438; 46: SpO2, 99.610; 46: Perf, 1.369; 47: SpO2, 99.879; 47: Perf, 1.217; 48: SpO2, 100.0; 48: Perf, 1.026; 49: SpO2, 99.289; 49: Perf, 1.059; 50: SpO2, 99.431; 50: Perf, 1.124; 51: SpO2, 99.051; 51: Perf, 1.196; 52: SpO2, 99.508; 52: Perf, 1.242; 53: SpO2, 99.741; 53: Perf, 1.119; 54: POC GLUCOSE BY METER, 362 mg/dL; 54: SpO2, 99.898; 54: Perf, 0.730; 54: Pain, 10.0; 55: SpO2, 99.897; 55: Perf, 0.728; 56: SpO2, 100.0; 56: Perf, 0.930; 57: SpO2, 99.909; 57: Perf, 1.122; 58: SpO2, 99.926; 58: Perf, 1.155; 59: SpO2, 99.017; 59: Perf, 1.204; 60: SpO2, 98.397; 60: Perf, 1.234; 61: SpO2, 99.254; 61: Perf, 1.24; 62: SpO2, 99.746; 62: Perf, 1.293; 63: SpO2, 100.0; 63: Perf, 1.296; 63: ACETAMINOPHEN, 325 MG PO TABS; 64: SpO, 2: 98.974; 64: Perf, 1.24; 65: SpO2, 100.0; 65: Perf, 0.973; 66: SpO2, 98.385; 66: Perf, 0.579; 67: SpO2, 99.3; 67: Perf, 0.605; 68: SpO2, 100.0; 68: Perf, 0.708; 69: SpO2, 100.0; 69: Perf, 0.72; 70: SpO2, 99.345; 70: Perf, 0.714; 71: SpO2, 97.136; 71: Perf, 0.901; 72: SpO2, 99.610; 72: Perf, 1.007; 73: WAM DIFTYP, AUTO; 73: NEUTROPHIL % (AUTO DIFF), 74.7 %; 73: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 73: PLATELET COUNT (PLT), 330 K/uL; 73: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 73: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 73: MONOCYTE ABSOLUTE (AUTO DIFF), 0.69 K/uL; 73: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 73: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.64 K/uL; 73: MEAN CORPUSCULAR VOLUME (MCV), 82.8 fL; 73: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 73: WHITE BLOOD CELLS (WBC), 9.7 K/uL; 73: LYMPHOCYTE % (AUTO DIFF), 17.0 %; 73: BASOPHIL % (AUTO DIFF), 0.3 %; 73: NRBC PERCENT (HEMATOLOGY), 0.0 %; 73: HEMOGLOBIN (HGB), 11.3 g/dL; 73: HEMATOCRIT (HCT), 33.8 %; 73: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 73: NEUTROPHIL ABSOLUTE (AUTO DIFF), 7.21 K/uL; 73: RED CELL DISTRIBUTION WIDTH (RDW), 13.1 %; 73: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 73: MONOCYTE % (AUTO DIFF), 7.2 %; 73: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.7 pg; 73: EOSINOPHIL % (AUTO DIFF), 0.4 %; 73: SpO2, 96.224; 73: Perf, 0.768; 74: SpO2, 95.458; 74: Perf, 0.792; 75: SpO2, 98.293; 75: Perf, 0.817; 76: SpO2, 98.136; 76: Perf, 0.884; 77: SpO2, 99.517; 77: Perf, 0.841; 78: SpO2, 98.644; 78: Perf, 0.785; 79: SpO2, 97.102; 79: Perf, 0.917; 80: RSV, Not Detected; 80: INFLUENZA A, Not Detected; 80: RSV, Not Detected; 80: INFLUENZA B, Not Detected; 80: INFLUENZA B, Not Detected; 80: SARS-COV-2 RNA, Detected; 80: SARS-COV-2 RNA, Detected; 80: INFLUENZA A, Not Detected; 80: SpO2, 99.483; 80: Perf, 0.866; 81: SpO2, 96.712; 81: Perf, 0.947; 82: SpO2, 98.776; 82: Perf, 0.976; 83: SpO2, 99.017; 83: Perf, 0.907; 84: SpO2, 97.814; 84: Perf, 0.839; 85: SpO2, 99.155; 85: Perf, 1.053; 86: SpO2, 99.627; 86: Perf, 1.14; 87: SpO2, 99.517; 87: Perf, 1.522; 88: SpO2, 99.966; 88: Perf, 1.546; 89: SpO2, 99.627; 89: Perf, 1.1; 90: SpO2, 99.603; 90: Perf, 1.061; 91: C-REACTIVE PROTEIN (CRP), 0.2 mg/dL; 91: SpO2, 98.695; 91: Perf, 0.867; 92: SpO2, 98.672; 92: Perf, 0.728; 93: SpO2, 98.610; 93: Perf, 0.464; 94: SpO2, 98.390; 94: Perf, 0.468; 95: SpO2, 98.638; 95: Perf, 0.427; 96: SpO2, 98.508; 96: Perf, 0.42; 97: SpO2, 98.121; 97: Perf, 0.421; 98: SpO2, 98.305; 98: Perf, 0.429; 99: SpO2, 98.237; 99: Perf, 0.415; 100: SpO2, 99.241; 100: Perf, 0.502; 101: SpO2, 99.949; 101: Perf, 1.445; 102: SpO2, 99.566; 102: Perf, 1.361; 103: SpO2, 100.0; 103: Perf, 1.270; 104: SpO2, 100.0; 104: Perf, 1.095; 113: TSH, 1.50 uIU/mL; 113: DROPERIDOL, 2.5 MG/ML INJ SOLN; 116: SpO, 2: 97.286; 117: SpO2, 96.672; 117: Perf, 1.520; 118: SpO2, 99.041; 118: Perf, 1.304; 119: SpO2, 95.509; 119: Perf, 1.17; 0: Age, 29; 0: Gender, F; 0: Race, Native Hawaiian or Other Pacific Islander; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 99.0; 0: Triage RR, 22.0; 0: Triage SBP, 105.0; 0: Triage DBP, 69.0; 0: Triage acuity, 3-Urgent; 0: CC, ELBOW PAIN,KNEE PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess the sepsis risk, subquestions include determining whether vital signs indicate instability, lab results suggest infection or inflammation, and any other clinical indicators of sepsis are present. The patient's vital signs, such as heart rate, respiratory rate, blood pressure, and temperature, are relatively stable and not indicative of sepsis. The SpO2 levels and perfusion index remain within normal ranges throughout. The glucose reading is high, but there are no signs of significant systemic inflammation, such as elevated CRP. The detected SARS-CoV-2 RNA could indicate a respiratory infection, but overall, the data does not show a high risk of sepsis within 12 hours.",
        "claims": [
            "To assess the sepsis risk, subquestions must be considered.",
            "Determining whether vital signs indicate instability is necessary.",
            "Lab results suggesting infection or inflammation are relevant to sepsis risk.",
            "Other clinical indicators of sepsis should be evaluated.",
            "The patient's vital signs are relatively stable.",
            "The patient's vital signs are not indicative of sepsis.",
            "The heart rate is stable.",
            "The respiratory rate is stable.",
            "The blood pressure is stable.",
            "The temperature is stable.",
            "The SpO2 levels remain within normal ranges.",
            "The perfusion index remains within normal ranges.",
            "The glucose reading is high.",
            "There are no signs of significant systemic inflammation.",
            "The CRP levels are not elevated.",
            "The detected SARS-CoV-2 RNA could indicate a respiratory infection.",
            "Overall, the data does not show a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's vital signs are not indicative of sepsis.",
            "The glucose reading is high.",
            "The CRP levels are not elevated.",
            "The detected SARS-CoV-2 RNA could indicate a respiratory infection."
        ],
        "alignment_scores": [
            0.3,
            0.3,
            0.2,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim suggests the vital signs do not indicate sepsis, implying stability or normalcy. Elevated NEWS includes deranged vitals, which would indicate sepsis risk. The absence of indicative vital signs can weakly connect to not meeting the NEWS threshold. However, because the claim does not specify a NEWS score or any vital sign detail, the alignment is indirect and weak.",
            "While glucose levels are not a direct component of the SOFA score, they can be related to metabolic disturbances often seen in critically ill patients, which may indirectly relate to sepsis risk. However, the SOFA score does not specifically account for hyperglycemia, making the alignment weak and indirect.",
            "Although CRP levels can indicate inflammation and potential infection, which may prompt early antibiotic orders, the absence of elevated CRP directly impacts none of the listed expert categories. The low alignment suggests that while CRP might influence suspicion of infection, it does not directly relate to any specific criteria or immediate clinical actions within the sepsis categories provided.",
            "The detection of SARS-CoV-2 RNA suggests the presence of a respiratory infection and potential sepsis risk due to viral infection. However, the claim does not mention concrete actions such as ordering antibiotics or blood cultures, which would more closely align with the category. The alignment is therefore indirect and based on potential clinical suspicion and monitoring rather than the specific actions outlined in the category."
        ],
        "final_alignment_score": 0.275,
        "accuracy": 0
    },
    {
        "input": "3: SpO2, 98.0; 5: SpO2, 98.333; 6: HR, 93.0; 6: RR, 28.0; 6: SpO2, 95.75; 6: 1min HRV, 31.387; 6: SBP, 134.0; 6: DBP, 95.0; 6: MAP, 108.0; 6: Pain, 0.0; 6: Temp, 99.0; 7: HR, 84.458; 7: RR, 21.627; 7: SpO2, 98.0; 7: 1min HRV, 104.688; 8: HR, 94.293; 8: RR, 23.052; 8: SpO2, 96.0; 8: 1min HRV, 94.542; 9: HR, 93.038; 9: RR, 24.254; 9: SpO2, 98.083; 9: 1min HRV, 92.495; 10: HR, 90.259; 10: RR, 23.293; 10: SpO2, 97.0; 10: 1min HRV, 112.587; 10: 5min HRV, 101.228; 11: HR, 81.390; 11: RR, 22.051; 11: SpO2, 99.0; 11: 1min HRV, 72.280; 12: HR, 82.881; 12: RR, 22.407; 12: 1min HRV, 129.498; 13: HR, 88.017; 13: RR, 20.914; 13: SpO2, 97.0; 13: 1min HRV, 95.278; 14: HR, 78.102; 14: RR, 19.322; 14: SpO2, 96.667; 14: 1min HRV, 109.998; 15: HR, 82.964; 15: RR, 31.448; 15: SpO2, 96.0; 15: 1min HRV, 31.449; 15: 5min HRV, 113.038; 16: HR, 94.931; 16: RR, 24.847; 16: SpO2, 99.489; 16: 1min HRV, 69.945; 17: HR, 94.678; 17: RR, 25.644; 17: SpO2, 96.759; 17: 1min HRV, 40.994; 18: HR, 85.517; 18: RR, 24.517; 18: SpO2, 96.24; 18: 1min HRV, 93.672; 19: HR, 90.220; 19: RR, 21.763; 19: SpO2, 97.030; 19: 1min HRV, 79.258; 20: HR, 92.0; 20: RR, 19.586; 20: SpO2, 98.0; 20: 1min HRV, 87.822; 20: 5min HRV, 92.999; 21: HR, 82.475; 21: RR, 25.186; 21: SpO2, 95.4; 21: 1min HRV, 109.828; 21: SBP, 123.0; 21: DBP, 94.0; 21: MAP, 103.667; 22: HR, 85.414; 22: RR, 22.0; 22: SpO2, 94.0; 22: 1min HRV, 83.980; 23: HR, 81.847; 23: 1min HRV, 124.486; 24: HR, 94.831; 24: SpO2, 92.737; 24: 1min HRV, 63.324; 25: HR, 87.224; 25: 1min HRV, 86.715; 25: 5min HRV, 103.995; 26: HR, 79.339; 26: SpO2, 94.0; 26: 1min HRV, 94.155; 27: HR, 92.207; 27: 1min HRV, 83.240; 28: HR, 79.220; 28: 1min HRV, 81.363; 29: HR, 86.525; 29: SpO2, 96.0; 29: 1min HRV, 86.182; 30: HR, 92.190; 30: RR, 24.4; 30: SpO2, 84.0; 30: 1min HRV, 80.311; 30: 5min HRV, 98.806; 31: HR, 101.153; 31: RR, 24.610; 31: 1min HRV, 55.800; 32: WAM DIFTYP, AUTO; 32: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 32: RED CELL DISTRIBUTION WIDTH (RDW), 18.7 %; 32: BASOPHIL % (AUTO DIFF), 0.9 %; 32: RED BLOOD CELLS (RBC), 3.85 MIL/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 32: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 32: NRBC PERCENT (HEMATOLOGY), 0.0 %; 32: NEUTROPHIL ABSOLUTE (AUTO DIFF), 2.49 K/uL; 32: WHITE BLOOD CELLS (WBC), 4.4 K/uL; 32: EOSINOPHIL % (AUTO DIFF), 1.8 %; 32: LYMPHOCYTE % (AUTO DIFF), 32.9 %; 32: NEUTROPHIL % (AUTO DIFF), 56.8 %; 32: MEAN CORPUSCULAR VOLUME (MCV), 86.8 fL; 32: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 32: HEMATOCRIT (HCT), 33.4 %; 32: PLATELET COUNT (PLT), 481 K/uL; 32: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.2 g/dL; 32: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 32: MONOCYTE ABSOLUTE (AUTO DIFF), 0.31 K/uL; 32: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 32: MONOCYTE % (AUTO DIFF), 7.1 %; 32: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.44 K/uL; 32: HEMOGLOBIN (HGB), 10.1 g/dL; 32: HR, 101.455; 32: RR, 25.707; 32: SpO2, 76.0; 32: 1min HRV, 41.524; 33: HR, 94.418; 33: RR, 21.186; 33: SpO2, 85.639; 33: 1min HRV, 75.895; 34: HR, 79.864; 34: RR, 22.492; 34: SpO2, 83.6; 34: 1min HRV, 131.719; 35: HR, 81.966; 35: RR, 27.207; 35: 1min HRV, 94.631; 35: 5min HRV, 112.726; 35: SBP, 126.0; 35: DBP, 99.0; 35: MAP, 108.0; 36: HR, 77.385; 36: RR, 24.644; 36: 1min HRV, 64.092; 36: SBP, 126.0; 36: DBP, 99.0; 36: MAP, 108.0; 37: HR, 81.414; 37: RR, 18.862; 37: 1min HRV, 106.216; 38: HR, 84.932; 38: RR, 19.390; 38: 1min HRV, 120.461; 39: HR, 94.833; 39: RR, 22.524; 39: SpO2, 71.714; 39: 1min HRV, 104.928; 40: HR, 102.116; 40: RR, 28.2; 40: SpO2, 81.0; 40: 1min HRV, 76.230; 40: 5min HRV, 116.478; 41: HR, 100.567; 41: RR, 30.424; 41: SpO2, 84.0; 41: 1min HRV, 146.366; 42: HR, 96.966; 42: RR, 24.475; 42: SpO2, 92.895; 42: 1min HRV, 198.539; 43: HR, 95.579; 43: RR, 29.667; 43: 1min HRV, 31.594; 44: HR, 99.754; 44: RR, 25.74; 44: 1min HRV, 57.814; 45: HR, 96.348; 45: RR, 28.833; 45: 1min HRV, 11.723; 45: 5min HRV, 84.891; 46: HR, 91.780; 46: 1min HRV, 56.944; 47: HR, 88.333; 47: 1min HRV, 38.182; 48: HR, 88.205; 48: 1min HRV, 140.676; 49: HR, 89.158; 49: 1min HRV, 118.585; 50: HR, 98.868; 50: 1min HRV, 41.762; 50: 5min HRV, 81.611; 60: SpO2, 71.0; 61: Pain, 0.0; 62: HIGH SENSITIVITY TROPONIN, 24 ng/L; 63: BLOOD UREA NITROGEN (BUN), 22 mg/dL; 63: CHLORIDE, 106 mmol/L; 63: ALBUMIN, 3.1 g/dL; 63: GLOBULIN, 4.1 g/dL; 63: CREATININE, 0.80 mg/dL; 63: ANION GAP, 9 mmol/L; 63: CORRECTED CALCIUM, 9.2 mg/dL; 63: POTASSIUM, 3.6 mmol/L; 63: GLUCOSE, 103 mg/dL; 63: ALKALINE PHOSPHATASE, 168 U/L; 63: PROTEIN TOTAL, 7.2 g/dL; 63: ALT (SGPT), 100 U/L; 63: AST (SGOT), 40 U/L; 63: SODIUM, 139 mmol/L; 63: EGFR REFIT WITHOUT RACE (2021), 110 mL/min/1.73 m2; 63: CALCIUM, 8.5 mg/dL; 63: BILIRUBIN TOTAL, 0.8 mg/dL; 63: CO2, 24 mmol/L; 63: BNP NT-PRO, 17298 pg/mL; 73: SpO2, 86.714; 82: HR, 88.833; 82: 1min HRV, 108.601; 83: HR, 79.333; 83: 1min HRV, 112.306; 84: HR, 74.733; 84: 1min HRV, 114.475; 85: 5min HRV, 121.752; 0: Age, 47; 0: Gender, M; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 37.2; 0: Triage HR, 105.0; 0: Triage RR, 19.0; 0: Triage SBP, 134.0; 0: Triage DBP, 95.0; 0: Triage acuity, 3-Urgent; 0: CC, CHEST PAIN",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "The subquestions to determine sepsis risk, given the data, include evaluating the patient's vital sign trends, identifying critical abnormalities, and assessing laboratory results. The patient exhibits elevated heart rates and respiratory rates, and fluctuating SpO2 levels with a noteworthy drop to the 70s range, indicative of possible hypoxemia. Additionally, the blood test results show anemia and elevated BNP, suggesting a risk of heart failure or other severe cardiac stress, which can correlate with sepsis risk. Based on irregular vital signs and concerning lab results, the patient is at high risk of developing sepsis within 12 hours.",
        "claims": [
            "The subquestions to determine sepsis risk include evaluating the patient's vital sign trends.",
            "The subquestions to determine sepsis risk include identifying critical abnormalities.",
            "The subquestions to determine sepsis risk include assessing laboratory results.",
            "The patient exhibits elevated heart rates.",
            "The patient exhibits elevated respiratory rates.",
            "The patient exhibits fluctuating SpO2 levels.",
            "The patient had a noteworthy drop in SpO2 levels to the 70s range.",
            "A drop in SpO2 levels to the 70s range is indicative of possible hypoxemia.",
            "The blood test results show anemia.",
            "The blood test results show elevated BNP.",
            "Elevated BNP may suggest a risk of heart failure.",
            "Elevated BNP may suggest other severe cardiac stress.",
            "Severe cardiac stress can correlate with sepsis risk.",
            "Based on irregular vital signs, the patient is at high risk of developing sepsis within 12 hours.",
            "Based on concerning lab results, the patient is at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The subquestions to determine sepsis risk include evaluating the patient's vital sign trends.",
            "The patient exhibits elevated heart rates.",
            "The patient exhibits elevated respiratory rates.",
            "The patient exhibits fluctuating SpO2 levels.",
            "The patient had a noteworthy drop in SpO2 levels to the 70s range.",
            "A drop in SpO2 levels to the 70s range is indicative of possible hypoxemia.",
            "The blood test results show elevated BNP.",
            "Elevated BNP may suggest a risk of heart failure.",
            "Elevated BNP may suggest other severe cardiac stress.",
            "Severe cardiac stress can correlate with sepsis risk.",
            "Based on irregular vital signs, the patient is at high risk of developing sepsis within 12 hours.",
            "Based on concerning lab results, the patient is at high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.9,
            0.5,
            0.7,
            0.7,
            0.2,
            0.3,
            0.3,
            0.6,
            0.7,
            0.6
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated Shock Index (\u22651.0)",
            "Elevated NEWS Score (\u22655 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim mentions evaluating vital sign trends, which aligns closely with the National Early Warning Score (NEWS) system. The NEWS system uses deranged vital signs to predict clinical deterioration, which is pertinent to assessing sepsis risk. While the statement does not explicitly mention NEWS or specify the scoring, the focus on vital sign trends indicates a moderate alignment with this category.",
            "Elevated heart rate is explicitly part of the SIRS criteria (heart rate > 90 bpm), which is used to assess systemic inflammation consistent with early sepsis. However, without further context about meeting other SIRS criteria, the alignment is significant but not complete.",
            "An elevated respiratory rate (>20/min) is one of the specific criteria listed under SIRS for identifying systemic inflammation consistent with early sepsis. Since the claim directly mentions elevated respiratory rates, it strongly aligns with the SIRS Positivity category, warranting a high alignment rating. However, the exact rate is not specified, so the full context of meeting the SIRS criteria is uncertain, preventing a perfect score.",
            "Fluctuating SpO2 levels suggest potential issues with oxygenation, which is conceptually related to the SOFA component measuring impaired respiratory function (PaO\u2082/FiO\u2082 < 300). While SpO2 is not a direct SOFA measurement, its fluctuation can imply respiratory instability linked to sepsis risk, giving a moderate level of alignment.",
            "A significant drop in SpO2 levels indicates possible hypoxia, which can affect PaO2/FiO2 ratios used in the SOFA score calculation. Although SpO2 is not a direct SOFA parameter, it indicates potential oxygenation issues and relates conceptually. The alignment is indirect but fairly strong given the severity implied by \"70s\" SpO2 levels, suggesting new or worsening organ dysfunction associated with high sepsis risk.",
            "The claim refers to SpO2 levels dropping to the 70s, indicating severe hypoxemia. While SpO2 isn't directly measured by the SOFA score, significant hypoxemia relates to impaired oxygenation, which is conceptually linked to the PaO\u2082/FiO\u2082 ratio used in the SOFA score. The alignment is strong due to this conceptual connection, but not direct, leading to a high but not perfect alignment rating.",
            "While elevated BNP (B-type Natriuretic Peptide) is typically associated more with heart failure than directly with sepsis, it indirectly suggests potential hemodynamic changes or stress, which could be related to septic shock or tissue hypoperfusion. However, BNP is not a direct marker of sepsis in the categories provided. Elevated lactate more directly signals tissue hypoperfusion, hence there is very weak alignment with the concept of circulatory issues related to sepsis.",
            "While BNP is not a direct measure within the expert sepsis categories, elevated BNP is associated with cardiac stress, which can relate to haemodynamic instability\u2014a concept central to the Elevated Shock Index category. However, BNP is more specific to heart failure rather than sepsis risk, making the alignment indirect and relatively weak.",
            "BNP (B-type Natriuretic Peptide) is not directly mentioned in the expert categories, but it is relevant to cardiac stress and heart functioning, which can relate indirectly to hemodynamic instability associated with an elevated shock index. However, because the claim does not refer to shock index parameters directly (heart rate and systolic blood pressure), the alignment is weak.",
            "The claim connects severe cardiac stress, which could be interpreted as haemodynamic instability, to sepsis risk. The category of Elevated Shock Index (\u22651.0) is concerned with cardiac and circulatory stress, identifying haemodynamic instability as indicative of severe sepsis. Although the claim does not specifically mention Shock Index parameters, the conceptual link to cardiac stress implies a moderate alignment.",
            "The mention of \"irregular vital signs\" suggests the use of a scoring system like the National Early Warning Score (NEWS), which tracks deranged vitals to predict clinical deterioration compatible with sepsis. Although the specific NEWS score is not given, irregular vital signs are likely to contribute to a high NEWS score. Hence, there is a fairly strong alignment with this category, though it is not explicit.",
            "The claim refers to \"concerning lab results\" that hint at clinical suspicion of an infectious process, which is indirectly related to the assessment that would lead to early antibiotic or culture order within the early hours of detecting potential sepsis. Since the claim does not mention actions like administering antibiotics or ordering cultures, the alignment isn't perfect but suggests clinician concern aligning partially with this category."
        ],
        "final_alignment_score": 0.5749999999999998,
        "accuracy": 0
    },
    {
        "input": "5: HR, 113.0; 5: RR, 18.0; 5: SpO2, 96.0; 5: SBP, 125.0; 5: DBP, 73.0; 5: MAP, 90.333; 5: Temp, 97.9; 37: HR, 110.0; 37: RR, 21.0; 37: SpO2, 97.0; 37: SBP, 127.0; 37: DBP, 72.0; 37: MAP, 90.333; 38: SpO2, 96.5; 39: SpO2, 96.9; 39: 1min HRV, 0.0; 40: HR, 110.833; 40: RR, 21.52; 40: SpO2, 97.695; 40: Perf, 1.694; 40: 1min HRV, 12.659; 41: HR, 110.759; 41: RR, 16.879; 41: SpO2, 97.810; 41: Perf, 2.023; 41: 1min HRV, 6.433; 42: HR, 109.864; 42: RR, 19.441; 42: SpO2, 98.305; 42: Perf, 1.888; 42: 1min HRV, 6.731; 43: HR, 111.224; 43: RR, 22.052; 43: SpO2, 98.466; 43: Perf, 1.622; 43: 1min HRV, 11.941; 43: 5min HRV, 10.269; 44: HR, 110.695; 44: RR, 21.695; 44: SpO2, 99.644; 44: Perf, 0.866; 44: 1min HRV, 5.987; 45: HR, 109.847; 45: RR, 22.831; 45: SpO2, 99.017; 45: Perf, 0.763; 45: 1min HRV, 3.764; 46: HR, 109.810; 46: RR, 22.034; 46: SpO2, 99.0; 46: Perf, 0.810; 46: 1min HRV, 6.749; 46: SBP, 121.0; 46: DBP, 79.0; 46: MAP, 93.0; 47: HR, 110.220; 47: RR, 20.356; 47: SpO2, 99.169; 47: Perf, 0.666; 47: 1min HRV, 6.619; 48: HR, 108.931; 48: RR, 22.259; 48: SpO2, 99.793; 48: Perf, 0.478; 48: 1min HRV, 6.830; 48: 5min HRV, 6.697; 49: HR, 109.254; 49: RR, 20.305; 49: SpO2, 100.0; 49: Perf, 0.428; 49: 1min HRV, 2.846; 50: HR, 109.793; 50: RR, 19.017; 50: SpO2, 100.0; 50: Perf, 0.474; 50: 1min HRV, 2.873; 51: HR, 109.780; 51: RR, 19.390; 51: SpO2, 100.0; 51: Perf, 0.514; 51: 1min HRV, 12.912; 52: HR, 109.559; 52: RR, 20.712; 52: SpO2, 100.0; 52: Perf, 0.488; 52: 1min HRV, 3.660; 53: HR, 110.793; 53: RR, 18.552; 53: SpO2, 99.552; 53: Perf, 0.612; 53: 1min HRV, 36.775; 53: 5min HRV, 17.866; 54: HR, 109.525; 54: RR, 18.915; 54: SpO2, 99.4; 54: Perf, 0.701; 54: 1min HRV, 6.136; 55: HR, 109.707; 55: RR, 20.276; 55: SpO2, 99.483; 55: Perf, 0.681; 55: 1min HRV, 8.137; 56: HR, 110.407; 56: RR, 19.593; 56: SpO2, 99.0; 56: Perf, 0.909; 56: 1min HRV, 3.681; 57: HR, 110.881; 57: RR, 21.932; 57: SpO2, 99.0; 57: Perf, 0.878; 57: 1min HRV, 4.624; 58: HR, 111.069; 58: RR, 21.224; 58: SpO2, 99.0; 58: Perf, 0.896; 58: 1min HRV, 3.577; 58: 5min HRV, 6.241; 59: HR, 111.220; 59: RR, 19.932; 59: SpO2, 99.288; 59: Perf, 0.800; 59: 1min HRV, 3.403; 60: HR, 111.190; 60: RR, 19.862; 60: SpO2, 99.241; 60: Perf, 0.764; 60: 1min HRV, 4.661; 61: HR, 110.983; 61: RR, 20.542; 61: SpO2, 99.271; 61: Perf, 0.727; 61: 1min HRV, 2.780; 61: SBP, 116.0; 61: DBP, 74.0; 61: MAP, 88.0; 62: HR, 110.695; 62: RR, 18.847; 62: SpO2, 99.305; 62: Perf, 0.716; 62: 1min HRV, 4.893; 63: HR, 109.862; 63: RR, 19.569; 63: SpO2, 99.534; 63: Perf, 0.562; 63: 1min HRV, 4.713; 63: 5min HRV, 4.639; 64: HR, 111.356; 64: RR, 19.847; 64: SpO2, 99.763; 64: Perf, 0.669; 64: 1min HRV, 4.143; 65: POC, BHCG, ISTAT QUANTITATIVE: 14.7 IU/L; 65: HR, 110.741; 65: RR, 18.259; 65: SpO2, 99.655; 65: Perf, 0.701; 65: 1min HRV, 4.586; 66: HR, 109.949; 66: RR, 19.051; 66: SpO2, 99.305; 66: Perf, 0.851; 66: 1min HRV, 4.560; 67: POC PH (V) ISTAT, 7.41; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC LACTATE ISTAT, 0.59 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 69 %; 67: POC HCO3 (V) ISTAT, 31.9 mmol/L; 67: POC TCO2 (V) ISTAT, 33 mmol/L; 67: POC PCO2 (V) ISTAT, 50.1 mmHg; 67: POC PO2 (V) ISTAT, 36 mmHg; 67: HR, 109.508; 67: RR, 18.390; 67: SpO2, 99.305; 67: Perf, 0.799; 67: 1min HRV, 5.604; 68: HR, 110.586; 68: RR, 18.241; 68: SpO2, 99.966; 68: Perf, 0.647; 68: 1min HRV, 5.464; 68: 5min HRV, 5.615; 69: HR, 110.576; 69: RR, 18.847; 69: SpO2, 99.822; 69: Perf, 0.63; 69: 1min HRV, 3.598; 69: SBP, 116.0; 69: DBP, 74.0; 69: MAP, 88.0; 70: HR, 110.207; 70: RR, 19.724; 70: SpO2, 99.879; 70: Perf, 0.533; 70: 1min HRV, 8.213; 71: HR, 112.5; 71: RR, 22.538; 71: SpO2, 99.0; 71: Perf, 0.54; 71: 1min HRV, 8.868; 73: 5min HRV, 7.325; 76: HR, 108.0; 76: RR, 20.0; 76: SpO2, 100.0; 99: ABO/RH (AUTOMATION), AB Positive; 99: ANTIBODY SCREEN 3, NEG; 109: WAM DIFTYP, AUTO; 109: WHITE BLOOD CELLS (WBC), 23.3 K/uL; 109: LYMPHOCYTE % (AUTO DIFF), 3.9 %; 109: RED CELL DISTRIBUTION WIDTH (RDW), 24.1 %; 109: HEMOGLOBIN (HGB), 8.4 g/dL; 109: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.90 K/uL; 109: EOSINOPHIL % (AUTO DIFF), 1.4 %; 109: PLATELET COUNT (PLT), 415 K/uL; 109: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 109: NRBC PERCENT (HEMATOLOGY), 0.0 %; 109: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 109: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.8 pg; 109: MEAN CORPUSCULAR VOLUME (MCV), 82.8 fL; 109: HEMATOCRIT (HCT), 26.9 %; 109: BASOPHIL % (AUTO DIFF), 0.3 %; 109: NEUTROPHIL % (AUTO DIFF), 79.9 %; 109: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.62 K/uL; 109: MONOCYTE % (AUTO DIFF), 11.8 %; 109: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.33 K/uL; 109: MONOCYTE ABSOLUTE (AUTO DIFF), 2.75 K/uL; 109: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.2 g/dL; 109: RED BLOOD CELLS (RBC), 3.25 MIL/uL; 109: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.61 K/uL; 109: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 2.7 %; 0: Age, 33; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.6; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 125.0; 0: Triage DBP, 73.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "To assess sepsis risk, we first consider vital signs such as high heart rate and respiratory rate, both of which are consistently elevated in this time series. Next, we look for signs of infection or organ dysfunction, which are suggested by the patient's chief complaint of blood in vomit, high white blood cell count, low hemoglobin and hematocrit levels, and high neutrophil percentage. These factors collectively indicate an increased risk of sepsis, leading to a final assessment of high risk for developing sepsis within 12 hours.",
        "claims": [
            "Vital signs are important for assessing sepsis risk.",
            "High heart rate is considered when assessing sepsis risk.",
            "The respiratory rate is consistently elevated in this time series.",
            "Signs of infection or organ dysfunction are important for assessing sepsis risk.",
            "The patient's chief complaint is blood in vomit.",
            "A high white blood cell count suggests infection.",
            "Low hemoglobin and hematocrit levels suggest possible organ dysfunction.",
            "A high neutrophil percentage indicates an immune response to infection.",
            "These factors collectively indicate an increased risk of sepsis.",
            "The final assessment based on these factors is a high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "High heart rate is considered when assessing sepsis risk.",
            "The respiratory rate is consistently elevated in this time series.",
            "Signs of infection or organ dysfunction are important for assessing sepsis risk.",
            "The patient's chief complaint is blood in vomit.",
            "A high white blood cell count suggests infection.",
            "Low hemoglobin and hematocrit levels suggest possible organ dysfunction.",
            "A high neutrophil percentage indicates an immune response to infection.",
            "These factors collectively indicate an increased risk of sepsis.",
            "The final assessment based on these factors is a high risk for developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.7,
            0.3,
            1.0,
            0.5,
            0.7,
            0.3,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "A high heart rate (>90 bpm) is explicitly listed as one of the SIRS criteria, which are used to identify systemic inflammation in early sepsis. The claim strongly relates to this category, though it does not explicitly state the heart rate value, which slightly reduces the direct alignment.",
            "The claim mentions an elevated respiratory rate, which is one of the criteria for a high qSOFA score (\u226522/min). The qSOFA score is used to assess the risk of sepsis-related complications, including organ dysfunction. While the claim does not specify if the respiratory rate meets the exact qSOFA threshold, it strongly suggests a potential criterion for high qSOFA. Therefore, this category is most aligned with the claim, although the specifics of the respiratory rate are not detailed, slightly reducing the alignment from perfect.",
            "The claim mentions signs of infection or organ dysfunction, both of which are integral to the SOFA score, which assesses new organ dysfunction as a high sepsis risk. While the claim doesn't specify a \u22652-point increase in SOFA score or list exact criteria, the mention of organ dysfunction aligns significantly with this category, indicating a meaningful but not precise alignment.",
            "The claim mentions \"blood in vomit,\" which could suggest gastrointestinal bleeding and potential organ dysfunction. While this is not directly a SOFA component, it conceptually aligns with the SOFA framework of assessing organ dysfunction. However, the alignment is weak since it doesn't specify metrics directly linked to the SOFA scoring system.",
            "A high white blood cell count is explicitly one of the criteria in the SIRS criteria used to identify systemic inflammation that is consistent with early sepsis. The claim directly aligns with this category as it highlights one of its defining factors.",
            "Low hemoglobin and hematocrit levels aren't directly specified in the SOFA score criteria, but they can be associated with organ dysfunction due to compromised oxygen delivery to tissues. The claim hints at potential organ dysfunction, making SOFA Score Increase the most relevant category despite the indirect link, resulting in a moderate alignment rating.",
            "A high neutrophil percentage suggests an inflammatory response, often seen in infections that might trigger systemic inflammation, aligning with the concept of SIRS. However, SIRS criteria specifically mention WBC count as a measure, not neutrophil percentage directly. Thus, while there is a conceptual link related to immune response, the direct alignment with SIRS criteria is partial, leading to a moderate alignment rating.",
            "The claim is very general and does not specify any particular clinical indicator or action that aligns clearly with a single category. However, the wording \"collectively indicate an increased risk of sepsis\" suggests an elevated NEWS score, which summarizes multiple deranged vitals to predict sepsis risk. Despite this connection, the claim lacks specific details about vitals or scores, leading to a low alignment rating.",
            "The claim is a general statement of high sepsis risk without specific details. The most applicable category in predicting an imminent risk of clinical deterioration is the Elevated NEWS Score, which is designed for early warning of potential sepsis. However, due to the lack of specific evidence or parameters in the claim, the alignment is weak."
        ],
        "final_alignment_score": 0.6,
        "accuracy": 0
    },
    {
        "input": "4: HR, 65.0; 4: RR, 16.0; 4: SpO2, 99.0; 4: SBP, 108.0; 4: DBP, 54.0; 4: MAP, 72.0; 4: Pain, 0.0; 4: Temp, 101.1; 15: SpO2, 97.0; 16: SpO2, 96.797; 16: Perf, 3.364; 17: SpO2, 96.5; 17: Perf, 4.262; 18: SpO2, 97.424; 18: Perf, 4.689; 18: SBP, 107.0; 18: DBP, 60.0; 18: MAP, 75.667; 19: SpO2, 96.169; 19: Perf, 6.684; 20: SpO2, 95.845; 20: Perf, 6.728; 21: SpO2, 95.847; 21: Perf, 5.936; 22: SpO2, 95.897; 22: Perf, 6.207; 23: SpO2, 96.0; 23: Perf, 5.800; 24: SpO2, 95.763; 24: Perf, 5.422; 25: SpO2, 95.879; 25: Perf, 4.448; 26: SpO2, 96.881; 26: Perf, 3.318; 27: SpO2, 96.897; 27: Perf, 3.804; 28: SpO2, 96.373; 28: Perf, 4.445; 29: SpO2, 96.153; 29: Perf, 4.615; 30: SpO2, 96.362; 30: Perf, 4.2; 31: SpO2, 96.119; 31: Perf, 4.233; 32: SpO2, 96.155; 32: Perf, 2.824; 33: SpO2, 96.797; 33: Perf, 2.251; 34: SpO2, 96.864; 34: Perf, 2.579; 35: SpO2, 96.879; 35: Perf, 2.442; 36: SpO2, 96.661; 36: Perf, 3.264; 37: SpO2, 96.207; 37: Perf, 3.824; 38: SpO2, 95.831; 38: Perf, 4.185; 39: SpO2, 97.068; 39: Perf, 4.148; 40: SpO2, 96.707; 40: Perf, 4.992; 41: HR, 66.0; 41: SpO2, 96.322; 41: Perf, 2.957; 41: SBP, 105.0; 41: DBP, 60.0; 41: MAP, 75.0; 42: SpO2, 96.793; 42: Perf, 2.268; 42: SBP, 105.0; 42: DBP, 60.0; 42: MAP, 75.0; 43: SpO2, 95.983; 43: Perf, 2.158; 44: SpO2, 96.276; 44: Perf, 1.960; 45: SpO2, 95.864; 45: Perf, 2.225; 46: SpO2, 96.085; 46: Perf, 2.727; 47: SpO2, 96.052; 47: Perf, 2.607; 48: SpO2, 95.712; 48: Perf, 2.585; 49: SpO2, 96.552; 49: Perf, 2.895; 50: SpO2, 97.0; 50: Perf, 3.872; 51: POC PH (V) ISTAT, 7.43; 51: POC LACTATE ISTAT, 1.50 mmol/L; 51: POC TCO2 (V) ISTAT, 28 mmol/L; 51: POC BASE EXCESS ISTAT, 2 mmol/L; 51: POC PO2 (V) ISTAT, 33 mmHg; 51: POC HCO3 (V) ISTAT, 26.7 mmol/L; 51: POC PCO2 (V) ISTAT, 40.1 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 65 %; 51: SpO2, 96.119; 51: Perf, 4.245; 52: SpO2, 95.379; 52: Perf, 4.339; 53: SpO2, 95.203; 53: Perf, 4.983; 54: SpO2, 95.414; 54: Perf, 4.544; 55: SpO2, 95.339; 55: Perf, 3.686; 56: SpO2, 95.492; 56: Perf, 2.525; 57: SpO2, 95.690; 57: Perf, 2.330; 58: SpO2, 96.322; 58: Perf, 2.288; 59: SpO2, 96.879; 59: Perf, 2.320; 60: SpO2, 96.576; 60: Perf, 2.423; 61: SpO2, 96.271; 61: Perf, 2.796; 62: SpO2, 96.603; 62: Perf, 2.776; 63: SpO2, 96.322; 63: Perf, 2.685; 64: SpO2, 96.569; 64: Perf, 2.665; 65: HR, 68.0; 65: RR, 18.0; 65: SpO2, 97.034; 65: Perf, 2.549; 65: Pain, 0.0; 65: Temp, 98.8; 66: SpO2, 96.153; 66: Perf, 3.064; 67: SpO2, 96.0; 67: Perf, 3.010; 68: SpO2, 96.0; 68: Perf, 3.140; 69: SpO2, 95.862; 69: Perf, 2.665; 70: SpO2, 96.017; 70: Perf, 2.534; 71: SpO2, 96.373; 71: Perf, 2.460; 72: SpO2, 95.724; 72: Perf, 2.733; 73: SpO2, 96.5; 73: Perf, 2.844; 74: SpO2, 97.475; 74: Perf, 2.574; 75: SpO2, 97.339; 75: Perf, 3.392; 76: SpO2, 96.776; 76: Perf, 3.584; 77: SpO2, 96.017; 77: Perf, 3.487; 78: SpO2, 96.102; 78: Perf, 3.156; 79: SpO2, 96.897; 79: Perf, 2.657; 80: SpO2, 97.356; 80: Perf, 1.940; 81: SpO2, 96.931; 81: Perf, 2.155; 82: SpO2, 97.254; 82: Perf, 3.481; 83: SpO2, 97.0; 83: Perf, 3.891; 84: SpO2, 96.948; 84: Perf, 4.301; 85: SpO2, 96.746; 85: Perf, 4.189; 86: SpO2, 96.879; 86: Perf, 4.32; 87: SpO2, 97.0; 87: Perf, 3.467; 88: SpO2, 97.0; 88: Perf, 3.842; 89: SpO2, 96.586; 89: Perf, 4.186; 90: SpO2, 97.288; 90: Perf, 2.210; 91: SpO2, 97.414; 91: Perf, 2.020; 92: SpO2, 97.627; 92: Perf, 2.045; 93: SpO2, 97.586; 93: Perf, 2.665; 94: SpO2, 97.102; 94: Perf, 2.485; 95: SpO2, 97.169; 95: Perf, 2.391; 96: SpO2, 97.741; 96: Perf, 1.804; 97: SpO2, 98.458; 97: Perf, 1.764; 98: INR, 1.3; 98: PROTHROMBIN TIME, 16.2 seconds; 98: SpO2, 97.724; 98: Perf, 1.940; 99: PART. THROMBOPLASTIN TIME, 40.6 seconds; 99: SpO2, 97.475; 99: Perf, 2.127; 100: SpO2, 97.220; 100: Perf, 2.529; 101: SpO2, 97.466; 101: Perf, 2.502; 102: SpO2, 98.0; 102: Perf, 2.511; 102: SBP, 102.0; 102: DBP, 60.0; 102: MAP, 74.0; 103: SpO2, 98.259; 103: Perf, 2.868; 104: SpO2, 97.237; 104: Perf, 3.350; 105: SpO2, 97.339; 105: Perf, 2.797; 106: SpO2, 97.138; 106: Perf, 2.413; 107: SpO2, 97.339; 107: Perf, 1.779; 108: SpO2, 97.172; 108: Perf, 2.104; 109: SpO2, 96.949; 109: Perf, 2.225; 110: SpO2, 97.169; 110: Perf, 1.982; 111: SpO2, 96.845; 111: Perf, 2.225; 112: ALKALINE PHOSPHATASE, 83 U/L; 112: GLUCOSE, 98 mg/dL; 112: POTASSIUM, 3.9 mmol/L; 112: BLOOD UREA NITROGEN (BUN), 14 mg/dL; 112: CHLORIDE, 103 mmol/L; 112: CALCIUM, 9.1 mg/dL; 112: EGFR FOR AFRICAN AMERICAN, 102 mL/min/1.73 m2; 112: ALBUMIN, 3.9 g/dL; 112: ALT (SGPT), 30 U/L; 112: EGFR REFIT WITHOUT RACE (2021), 88 mL/min/1.73 m2; 112: CORRECTED CALCIUM, 9.2 mg/dL; 112: GLOBULIN, 2.9 g/dL; 112: BILIRUBIN TOTAL, 0.8 mg/dL; 112: CO2, 25 mmol/L; 112: ANION GAP, 10 mmol/L; 112: PROTEIN TOTAL, 6.8 g/dL; 112: SODIUM, 138 mmol/L; 112: CREATININE, 0.97 mg/dL; 112: AST (SGOT), 37 U/L; 112: SpO2, 97.271; 112: Perf, 2.201; 113: SpO2, 97.069; 113: Perf, 2.263; 114: SpO2, 97.441; 114: Perf, 2.106; 115: SpO2, 97.153; 115: Perf, 2.087; 116: SpO2, 97.638; 116: Perf, 1.803; 117: SpO2, 97.712; 117: Perf, 2.006; 118: SpO2, 97.621; 118: Perf, 3.632; 119: SpO2, 96.831; 119: Perf, 2.841; 0: Age, 52; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.4; 0: Triage HR, 65.0; 0: Triage RR, 16.0; 0: Triage SBP, 108.0; 0: Triage DBP, 54.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The initial step is to evaluate the vital signs and lab results for any anomalies that could elevate sepsis risk, such as fever, high heart rate, low blood pressure, or increased lactate levels. In this case, the patient's triage vital signs indicated a fever, but no sustained tachycardia, hypotension, or hypoxia. The POC lactate level was normal, indicating no significant tissue hypoperfusion. Despite some fluctuations, SpO2 and perfusion values remained stable. Additionally, the basic metabolic panel and other lab results were within normal ranges. Consequently, the data does not reveal any significant predictors of high sepsis risk within the next 12 hours.",
        "claims": [
            "The initial step is to evaluate the vital signs and lab results for any anomalies that could elevate sepsis risk.",
            "Fever is one anomaly that could elevate sepsis risk.",
            "High heart rate is one anomaly that could elevate sepsis risk.",
            "Low blood pressure is one anomaly that could elevate sepsis risk.",
            "Increased lactate levels are one anomaly that could elevate sepsis risk.",
            "The patient's triage vital signs indicated a fever.",
            "The patient did not have sustained tachycardia.",
            "The patient did not have hypotension.",
            "The patient did not have hypoxia.",
            "The POC lactate level was normal.",
            "A normal POC lactate level indicates no significant tissue hypoperfusion.",
            "SpO2 and perfusion values remained stable despite some fluctuations.",
            "The basic metabolic panel results were within normal ranges.",
            "Other lab results were within normal ranges.",
            "The data does not reveal any significant predictors of high sepsis risk within the next 12 hours."
        ],
        "relevant_claims": [
            "Fever is one anomaly that could elevate sepsis risk.",
            "Increased lactate levels are one anomaly that could elevate sepsis risk.",
            "The patient did not have sustained tachycardia.",
            "The patient did not have hypotension.",
            "A normal POC lactate level indicates no significant tissue hypoperfusion.",
            "The data does not reveal any significant predictors of high sepsis risk within the next 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.9,
            0.3,
            0.2,
            0.8,
            0.0
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated Shock Index (\u22651.0)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "No Specific Category"
        ],
        "alignment_reasonings": [
            "Fever is a direct component of the SIRS criteria (temperature >38\u00b0C). Though the claim does not provide specific temperature data to confirm meeting this criterion, it correctly identifies fever as a potential indicator of systemic inflammation and early sepsis risk, aligning well with SIRS Positivity.",
            "The claim directly references increased lactate levels, which aligns with the category that identifies elevated serum lactate as a key predictor of sepsis risk. Although the claim does not specify the exact level, it strongly implies a relationship to sepsis risk, meriting a high alignment rating.",
            "Sustained tachycardia is typically associated with conditions such as hemodynamic instability or shock, which align most closely with the Elevated Shock Index category. However, the claim indicates the absence of sustained tachycardia, which means the specific criterion (heart rate element) of a high shock index is not met. This suggests a less direct connection, leading to a lower alignment rating.",
            "The claim indicates the absence of hypotension, which indirectly refers to the category of sepsis-associated hypotension by negating it. The alignment is weak because the claim addresses what isn't happening rather than confirming a positive presence of a risk factor.",
            "The claim specifically discusses lactate levels, which directly relates to the category focused on elevated serum lactate as a marker for tissue hypoperfusion and sepsis risk. However, the claim mentions \"normal\" lactate levels, indicating no significant risk, as opposed to elevated levels indicating high risk. The alignment is very strong due to the direct reference to lactate, despite the contrasting implications about risk.",
            "The claim states that there are no significant predictors of high sepsis risk. This claim explicitly indicates the absence of any of the specific predictors outlined in the expert categories. Therefore, it does not align with any category that describes a predictor of sepsis risk."
        ],
        "final_alignment_score": 0.4833333333333334,
        "accuracy": 1
    },
    {
        "input": "2: HR, 84.0; 2: RR, 24.0; 2: SpO2, 100.0; 2: SBP, 143.0; 2: DBP, 55.0; 2: MAP, 84.333; 2: Temp, 97.2; 80: HR, 94.548; 80: RR, 31.238; 80: 1min HRV, 56.958; 80: SBP, 148.0; 80: DBP, 61.0; 80: MAP, 90.0; 81: HR, 90.729; 81: RR, 33.898; 81: SpO2, 97.882; 81: 1min HRV, 103.265; 82: HR, 90.517; 82: RR, 30.293; 82: SpO2, 97.259; 82: Perf, 0.19; 82: 1min HRV, 62.996; 82: 5min HRV, 79.552; 82: SBP, 145.0; 82: DBP, 74.0; 82: MAP, 97.667; 83: HR, 89.898; 83: RR, 24.949; 83: SpO2, 98.316; 83: Perf, 0.153; 83: 1min HRV, 117.529; 83: SBP, 145.0; 83: DBP, 74.0; 83: MAP, 97.667; 84: HR, 90.914; 84: RR, 27.017; 84: SpO2, 98.941; 84: Perf, 0.186; 84: 1min HRV, 40.962; 85: HR, 90.729; 85: RR, 24.831; 85: SpO2, 98.957; 85: Perf, 0.170; 85: 1min HRV, 93.212; 86: HR, 92.017; 86: RR, 35.576; 86: SpO2, 99.842; 86: Perf, 0.17; 86: 1min HRV, 106.341; 87: HR, 90.569; 87: RR, 31.672; 87: SpO2, 98.661; 87: Perf, 0.17; 87: 1min HRV, 77.268; 87: 5min HRV, 90.692; 88: HR, 90.712; 88: RR, 29.339; 88: SpO2, 97.970; 88: Perf, 0.166; 88: 1min HRV, 39.251; 89: HR, 88.483; 89: RR, 30.345; 89: SpO2, 98.3; 89: Perf, 0.160; 89: 1min HRV, 59.194; 90: HR, 87.559; 90: RR, 32.051; 90: SpO2, 98.788; 90: Perf, 0.152; 90: 1min HRV, 83.922; 91: HR, 87.052; 91: RR, 28.690; 91: SpO2, 98.783; 91: Perf, 0.181; 91: 1min HRV, 16.064; 92: HR, 87.356; 92: RR, 25.373; 92: SpO2, 98.952; 92: Perf, 0.177; 92: 1min HRV, 32.678; 92: 5min HRV, 52.812; 93: HR, 88.407; 93: RR, 26.610; 93: SpO2, 98.837; 93: Perf, 0.163; 93: 1min HRV, 63.430; 94: HR, 87.483; 94: RR, 30.086; 94: SpO2, 99.463; 94: Perf, 0.168; 94: 1min HRV, 49.410; 95: HR, 87.153; 95: RR, 30.525; 95: SpO2, 98.5; 95: Perf, 0.163; 95: 1min HRV, 68.312; 96: HR, 88.203; 96: RR, 28.644; 96: SpO2, 98.310; 96: Perf, 0.16; 96: 1min HRV, 62.534; 97: HR, 89.052; 97: RR, 31.224; 97: SpO2, 99.0; 97: Perf, 0.16; 97: 1min HRV, 45.705; 97: 5min HRV, 58.445; 98: HR, 92.508; 98: RR, 31.339; 98: SpO2, 98.955; 98: Perf, 0.154; 98: 1min HRV, 58.106; 99: HR, 90.155; 99: RR, 30.672; 99: SpO2, 99.111; 99: Perf, 0.181; 99: 1min HRV, 72.588; 100: HR, 89.034; 100: RR, 29.610; 100: SpO2, 99.0; 100: Perf, 0.181; 100: 1min HRV, 74.885; 101: HR, 88.649; 101: RR, 27.345; 101: Perf, 0.18; 101: 1min HRV, 82.167; 102: HR, 86.345; 102: RR, 27.931; 102: 1min HRV, 85.908; 102: 5min HRV, 76.514; 103: HR, 84.678; 103: RR, 27.695; 103: SpO2, 98.889; 103: 1min HRV, 99.837; 104: HR, 86.576; 104: RR, 28.983; 104: SpO2, 95.444; 104: 1min HRV, 63.969; 105: HR, 84.949; 105: RR, 28.441; 105: SpO2, 98.944; 105: Perf, 0.18; 105: 1min HRV, 91.749; 106: HR, 84.508; 106: RR, 28.051; 106: SpO2, 98.429; 106: Perf, 0.18; 106: 1min HRV, 95.686; 107: HR, 84.759; 107: RR, 27.293; 107: SpO2, 97.095; 107: Perf, 0.171; 107: 1min HRV, 90.017; 107: 5min HRV, 89.852; 108: HR, 86.627; 108: RR, 28.305; 108: SpO2, 99.1; 108: Perf, 0.17; 108: 1min HRV, 9.485; 109: HR, 87.224; 109: RR, 27.241; 109: SpO2, 98.0; 109: Perf, 0.17; 109: 1min HRV, 47.279; 110: HR, 88.847; 110: RR, 26.644; 110: SpO2, 96.938; 110: Perf, 0.177; 110: 1min HRV, 95.307; 111: HR, 85.593; 111: RR, 28.102; 111: SpO2, 97.339; 111: Perf, 0.196; 111: 1min HRV, 28.518; 112: HR, 85.931; 112: RR, 27.5; 112: SpO2, 98.245; 112: Perf, 0.21; 112: 1min HRV, 34.042; 112: 5min HRV, 52.342; 113: HR, 84.814; 113: RR, 27.508; 113: SpO2, 98.389; 113: Perf, 0.208; 113: 1min HRV, 53.801; 114: HR, 87.328; 114: RR, 25.897; 114: SpO2, 99.2; 114: Perf, 0.17; 114: 1min HRV, 13.145; 115: HR, 86.102; 115: RR, 26.559; 115: SpO2, 98.188; 115: Perf, 0.18; 115: 1min HRV, 11.984; 116: HR, 86.569; 116: RR, 29.0; 116: SpO2, 97.333; 116: Perf, 0.19; 116: 1min HRV, 7.712; 117: HR, 86.085; 117: RR, 27.458; 117: SpO2, 98.857; 117: Perf, 0.174; 117: 1min HRV, 48.261; 117: 5min HRV, 33.786; 118: HR, 85.559; 118: RR, 27.322; 118: SpO2, 98.462; 118: Perf, 0.17; 118: 1min HRV, 13.360; 119: HR, 86.897; 119: RR, 28.741; 119: SpO2, 99.0; 119: Perf, 0.17; 119: 1min HRV, 48.790; 0: Age, 85; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, Self; 0: Triage Temp, 36.2; 0: Triage HR, 84.0; 0: Triage RR, 24.0; 0: Triage SBP, 143.0; 0: Triage DBP, 55.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess sepsis risk, we examine crucial indicators like heart rate (HR), respiratory rate (RR), systolic blood pressure (SBP), mean arterial pressure (MAP), and other vital signs over time. Notably elevated RR and fluctuating HRV are seen, but the patient's SpO2 remains stable and high, indicating effective oxygenation. MAP values are within normal range, and there is no evidence of persistent hypotension or marked organ dysfunction. While the elevated RR could suggest respiratory issues, the overall data does not firmly indicate a high risk of sepsis within the coming hours.",
        "claims": [
            "To assess sepsis risk, crucial indicators are examined.",
            "The indicators include heart rate (HR), respiratory rate (RR), systolic blood pressure (SBP), and mean arterial pressure (MAP).",
            "Notably elevated respiratory rate (RR) is observed.",
            "Fluctuating heart rate variability (HRV) is observed.",
            "The patient's SpO2 remains stable and high.",
            "A stable and high SpO2 indicates effective oxygenation.",
            "MAP values are within the normal range.",
            "There is no evidence of persistent hypotension.",
            "There is no evidence of marked organ dysfunction.",
            "The elevated respiratory rate (RR) could suggest respiratory issues.",
            "The overall data does not firmly indicate a high risk of sepsis within the coming hours."
        ],
        "relevant_claims": [
            "Notably elevated respiratory rate (RR) is observed.",
            "There is no evidence of persistent hypotension.",
            "There is no evidence of marked organ dysfunction.",
            "The elevated respiratory rate (RR) could suggest respiratory issues.",
            "The overall data does not firmly indicate a high risk of sepsis within the coming hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.2,
            0.3,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SOFA Score Increase (\u22652 points)",
            "High qSOFA Score (\u22652)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "An elevated respiratory rate is a specific criterion within the SIRS criteria (respiratory\u202frate\u202f>\u202f20\u202f/min), which are used to identify systemic inflammation consistent with early sepsis. However, since the claim does not specify the exact rate or whether other SIRS criteria are also met, it does not fully meet the threshold but has a strong alignment.",
            "The claim directly references hypotension, specifically indicating the absence of persistent hypotension. This ties directly to the category focused on sepsis-associated hypotension, which denotes progression toward septic shock. While the claim indicates a negative finding, the relationship with the category is clear and directly relevant, warranting a strong but not complete alignment rating due to the absence of the condition rather than its presence.",
            "The claim \"There is no evidence of marked organ dysfunction\" suggests that there is no change in the SOFA score, which assesses organ dysfunction. While it indirectly relates to the reversal of the SOFA Score Increase category, it's not directly reflective of sepsis risk. Thus, the alignment is very weak.",
            "An elevated respiratory rate is one component of the qSOFA score, which flags high risk of sepsis-related organ dysfunction and mortality. However, the claim does not provide enough information to confirm a high qSOFA score (\u22652), and it does not specify the exact respiratory rate threshold (\u226522/min) necessary for qSOFA consideration. Therefore, the alignment is weak and indirect.",
            "The claim suggests a lack of strong indication for sepsis risk, which somewhat aligns with the absence of urgent actions like early antibiotic administration or culture orders\u2014key indicators of clinical suspicion for sepsis. The alignment is weak as the claim is vague and does not strongly correspond to specific clinical criteria or actions."
        ],
        "final_alignment_score": 0.48,
        "accuracy": 0
    },
    {
        "input": "2: HR, 100.0; 2: RR, 18.0; 2: SpO2, 100.0; 2: SBP, 129.0; 2: DBP, 90.0; 2: MAP, 103.0; 2: Temp, 97.5; 32: POC, HCG, ISTAT QUALITATIVE: Negative; 32: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 42: SpO2, 100.0; 42: SBP, 121.0; 42: DBP, 84.0; 42: MAP, 96.333; 43: SpO2, 100.0; 43: Perf, 1.407; 44: SpO2, 100.0; 44: Perf, 1.549; 45: SpO2, 99.949; 45: Perf, 1.471; 45: SBP, 139.0; 45: DBP, 90.0; 45: MAP, 106.333; 46: SpO2, 100.0; 46: Perf, 1.485; 47: SpO2, 100.0; 47: Perf, 1.395; 48: SpO2, 100.0; 48: Perf, 1.493; 49: SpO2, 100.0; 49: Perf, 1.580; 50: SpO2, 100.0; 50: Perf, 1.320; 51: SpO2, 100.0; 51: Perf, 1.367; 52: SpO2, 100.0; 52: Perf, 1.446; 53: SpO2, 100.0; 53: Perf, 1.679; 54: SpO2, 100.0; 54: Perf, 1.779; 55: SpO2, 100.0; 55: Perf, 1.764; 56: SpO2, 99.845; 56: Perf, 1.48; 57: SpO2, 100.0; 57: Perf, 1.282; 58: SpO2, 100.0; 58: Perf, 1.390; 59: SpO2, 100.0; 59: Perf, 1.111; 60: SpO2, 100.0; 60: Perf, 1.357; 60: SBP, 148.0; 60: DBP, 91.0; 60: MAP, 110.0; 61: SpO2, 99.759; 61: Perf, 1.514; 62: SpO2, 99.915; 62: Perf, 1.576; 63: SpO2, 99.898; 63: Perf, 1.522; 64: SpO2, 99.914; 64: Perf, 1.142; 65: SpO2, 99.763; 65: Perf, 1.102; 66: WAM DIFTYP, AUTO; 66: BASOPHIL % (AUTO DIFF), 0.5 %; 66: MONOCYTE ABSOLUTE (AUTO DIFF), 0.38 K/uL; 66: HEMATOCRIT (HCT), 32.5 %; 66: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.05 K/uL; 66: RED CELL DISTRIBUTION WIDTH (RDW), 14.7 %; 66: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.5 pg; 66: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.37 K/uL; 66: NEUTROPHIL ABSOLUTE (AUTO DIFF), 6.03 K/uL; 66: MONOCYTE % (AUTO DIFF), 4.6 %; 66: RED BLOOD CELLS (RBC), 3.38 MIL/uL; 66: EOSINOPHIL % (AUTO DIFF), 4.7 %; 66: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 66: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.39 K/uL; 66: MEAN CORPUSCULAR VOLUME (MCV), 96.2 fL; 66: WHITE BLOOD CELLS (WBC), 8.3 K/uL; 66: LYMPHOCYTE % (AUTO DIFF), 16.6 %; 66: PLATELET COUNT (PLT), 349 K/uL; 66: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 66: NRBC PERCENT (HEMATOLOGY), 0.0 %; 66: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.6 %; 66: HEMOGLOBIN (HGB), 10.3 g/dL; 66: NEUTROPHIL % (AUTO DIFF), 73.0 %; 66: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.7 g/dL; 66: SpO2, 100.0; 66: Perf, 1.377; 67: SpO2, 99.898; 67: Perf, 1.314; 68: SpO2, 99.864; 68: Perf, 1.382; 69: SpO2, 99.293; 69: Perf, 1.647; 70: SpO2, 99.864; 70: Perf, 1.749; 71: SpO2, 99.897; 71: Perf, 1.719; 72: SpO2, 100.0; 72: Perf, 1.875; 73: SpO2, 100.0; 73: Perf, 2.066; 74: SpO2, 99.828; 74: Perf, 1.824; 75: SpO2, 100.0; 75: Perf, 1.525; 75: SBP, 145.0; 75: DBP, 94.0; 75: MAP, 111.0; 76: SpO2, 100.0; 76: Perf, 1.591; 77: SpO2, 98.949; 77: Perf, 1.554; 78: SpO2, 99.793; 78: Perf, 1.474; 79: SpO2, 100.0; 79: Perf, 1.346; 80: SpO2, 100.0; 80: Perf, 1.755; 81: SpO2, 99.914; 81: Perf, 1.211; 82: SARS-COV-2 RNA, Not Detected; 82: SpO2, 100.0; 82: Perf, 1.267; 83: SpO2, 99.879; 83: Perf, 1.263; 84: SpO2, 99.983; 84: Perf, 1.283; 85: SpO2, 100.0; 85: Perf, 1.625; 86: SpO2, 99.914; 86: Perf, 1.966; 87: SpO2, 100.0; 87: Perf, 1.905; 88: SpO2, 100.0; 88: Perf, 1.642; 89: SpO2, 100.0; 89: Perf, 1.408; 90: SpO2, 100.0; 90: Perf, 1.682; 90: SBP, 156.0; 90: DBP, 109.0; 90: MAP, 124.667; 91: SpO2, 100.0; 91: Perf, 1.419; 92: SpO2, 99.932; 92: Perf, 1.327; 93: SpO2, 99.828; 93: Perf, 1.536; 94: SpO2, 100.0; 94: Perf, 1.546; 95: SpO2, 99.525; 95: Perf, 1.69; 96: SpO2, 99.293; 96: Perf, 1.753; 97: SpO2, 100.0; 97: Perf, 1.554; 98: SpO2, 100.0; 98: Perf, 1.802; 99: SpO2, 100.0; 99: Perf, 1.849; 100: SpO2, 99.390; 100: Perf, 1.844; 101: SpO2, 99.897; 101: Perf, 1.603; 102: SpO2, 100.0; 102: Perf, 1.579; 103: SpO2, 99.897; 103: Perf, 1.589; 104: SpO2, 100.0; 104: Perf, 1.547; 105: SpO2, 100.0; 105: Perf, 1.587; 105: SBP, 168.0; 105: DBP, 155.0; 105: MAP, 159.333; 106: SpO2, 100.0; 106: Perf, 1.513; 107: SpO2, 100.0; 107: Perf, 1.597; 107: SBP, 149.0; 107: DBP, 98.0; 107: MAP, 115.0; 108: SpO2, 100.0; 108: Perf, 1.563; 109: SpO2, 100.0; 109: Perf, 1.600; 110: SpO2, 99.845; 110: Perf, 1.718; 111: SpO2, 100.0; 111: Perf, 1.665; 112: SpO2, 100.0; 112: Perf, 1.813; 113: SpO2, 99.931; 113: Perf, 1.657; 114: SpO2, 100.0; 114: Perf, 1.736; 115: SpO2, 99.793; 115: Perf, 1.530; 116: ALKALINE PHOSPHATASE, 72 U/L; 116: CORRECTED CALCIUM, 8.5 mg/dL; 116: BILIRUBIN TOTAL, 0.2 mg/dL; 116: EGFR REFIT WITHOUT RACE (2021), 63 mL/min/1.73 m2; 116: ALT (SGPT), 6 U/L; 116: PROTEIN TOTAL, 7.0 g/dL; 116: CO2, 18 mmol/L; 116: CHLORIDE, 102 mmol/L; 116: SODIUM, 136 mmol/L; 116: GLOBULIN, 3.1 g/dL; 116: AST (SGOT), 12 U/L; 116: GLUCOSE, 237 mg/dL; 116: ALBUMIN, 3.9 g/dL; 116: POTASSIUM, 4.3 mmol/L; 116: CALCIUM, 8.4 mg/dL; 116: BLOOD UREA NITROGEN (BUN), 15 mg/dL; 116: LIPASE, 16 U/L; 116: ANION GAP, 16 mmol/L; 116: EGFR FOR AFRICAN AMERICAN, 73 mL/min/1.73 m2; 116: CREATININE, 1.05 mg/dL; 116: SpO2, 100.0; 116: Perf, 2.034; 117: SpO2, 100.0; 117: Perf, 1.921; 118: SpO2, 99.897; 118: Perf, 1.865; 119: SpO2, 99.932; 119: Perf, 1.826; 0: Age, 47; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 100.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 90.0; 0: Triage acuity, 3-Urgent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To assess the risk of sepsis within 12 hours, key elements include vital signs, laboratory results, and the patient's overall condition during the early hours after ED admission. The patient\u2019s initial vital signs, such as temperature, heart rate, respiratory rate, and blood pressure, are stable and within normal ranges. Laboratory results later show no significant abnormalities, except a slightly elevated glucose level. Importantly, there is no new onset of fever, hypotension, tachypnea, or significantly abnormal lab markers like high WBC count or lactic acid that would increase suspicion for sepsis. Therefore, the overall risk of developing sepsis within 12 hours is low.",
        "claims": [
            "To assess the risk of sepsis within 12 hours, key elements include vital signs, laboratory results, and the patient's overall condition during the early hours after ED admission.",
            "The patient\u2019s initial vital signs are stable and within normal ranges.",
            "The patient's initial vital signs include temperature, heart rate, respiratory rate, and blood pressure.",
            "Laboratory results show no significant abnormalities.",
            "The laboratory results indicate a slightly elevated glucose level.",
            "There is no new onset of fever.",
            "There is no new onset of hypotension.",
            "There is no new onset of tachypnea.",
            "There are no significantly abnormal lab markers.",
            "Significantly abnormal lab markers would include a high WBC count or elevated lactic acid.",
            "The absence of new symptoms or significantly abnormal lab markers lowers suspicion for sepsis.",
            "Therefore, the overall risk of developing sepsis within the next 12 hours is low."
        ],
        "relevant_claims": [
            "The laboratory results indicate a slightly elevated glucose level.",
            "There is no new onset of fever.",
            "There is no new onset of hypotension.",
            "There is no new onset of tachypnea.",
            "There are no significantly abnormal lab markers."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.7,
            0.3,
            0.1
        ],
        "alignment_category": [
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "Elevated glucose levels aren't explicitly listed under any sepsis prediction categories. However, glucose level can sometimes indirectly relate to metabolic changes seen in sepsis, like altered lactic acid metabolism. Despite this potential indirect relationship, glucose levels are not a key sepsis predictor per the given expert categories, resulting in a low alignment rating.",
            "The absence of new fever is least aligned with SIRS positivity, as fever is one of the SIRS criteria. However, the claim mentions fever, which is tangentially related to the SIRS category but does not indicate positivity. As such, the alignment is very weak.",
            "The claim explicitly addresses hypotension, which is a primary indicator in the \"Sepsis-Associated Hypotension\" category. The absence of new onset hypotension suggests that this particular risk factor for sepsis is not present, which is directly related to the category. Therefore, the alignment is quite strong, although not a perfect match since it indicates what is not present rather than confirming criteria that are met.",
            "The absence of new tachypnea (elevated respiratory rate) is conceptually relevant to potential qSOFA criteria, as a qSOFA includes a respiratory rate\u202f\u2265\u202f22\u202f/min as one of its factors. However, since the claim only states that there is no new tachypnea, it does not explicitly indicate any qSOFA score components are met, thus having a low alignment with the category.",
            "The claim of no significantly abnormal lab markers suggests an absence of new organ dysfunction, in contrast to what would increase a SOFA score. While it indirectly relates to SOFA scoring, as normal labs imply stable organ function, the alignment is minimal because it is more about the absence of evidence than matching criteria."
        ],
        "final_alignment_score": 0.32,
        "accuracy": 1
    },
    {
        "input": "5: HR, 108.0; 5: RR, 18.0; 5: SpO2, 95.0; 5: SBP, 150.0; 5: DBP, 70.0; 5: MAP, 96.667; 5: Temp, 100.6; 47: POC PH (V) ISTAT, 7.41; 47: POC PO2 (V) ISTAT, 14 mmHg; 47: POC HCO3 (V) ISTAT, 28.3 mmol/L; 47: POC O2 SATURATION ISTAT VENOUS, 18 %; 47: POC LACTATE ISTAT, 0.82 mmol/L; 47: POC TCO2 (V) ISTAT, 30 mmol/L; 47: POC PCO2 (V) ISTAT, 44.7 mmHg; 47: POC BASE EXCESS ISTAT, 4 mmol/L; 69: SpO2, 95.082; 69: Perf, 6.772; 70: SpO2, 95.159; 70: Perf, 7.448; 70: SBP, 126.0; 70: DBP, 55.0; 70: MAP, 78.667; 72: HR, 92.64; 72: RR, 27.7; 72: 1min HRV, 57.204; 73: HR, 92.593; 73: RR, 24.898; 73: 1min HRV, 53.127; 74: HR, 93.281; 74: RR, 22.719; 74: SpO2, 96.0; 74: 1min HRV, 43.048; 74: 5min HRV, 50.360; 74: SBP, 126.0; 74: DBP, 55.0; 74: MAP, 78.667; 74: Pain, 0.0; 74: Temp, 100.0; 75: WAM DIFTYP, AUTO; 75: LYMPHOCYTE % (AUTO DIFF), 8.1 %; 75: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.2 pg; 75: RED BLOOD CELLS (RBC), 4.61 MIL/uL; 75: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.32 K/uL; 75: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.08 K/uL; 75: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 75: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 75: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 75: MONOCYTE % (AUTO DIFF), 6.6 %; 75: HEMOGLOBIN (HGB), 12.1 g/dL; 75: BASOPHIL % (AUTO DIFF), 0.3 %; 75: RED CELL DISTRIBUTION WIDTH (RDW), 14.9 %; 75: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.8 g/dL; 75: NEUTROPHIL ABSOLUTE (AUTO DIFF), 13.50 K/uL; 75: HEMATOCRIT (HCT), 39.3 %; 75: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.24 K/uL; 75: MONOCYTE ABSOLUTE (AUTO DIFF), 1.08 K/uL; 75: NRBC PERCENT (HEMATOLOGY), 0.0 %; 75: WHITE BLOOD CELLS (WBC), 16.3 K/uL; 75: PLATELET COUNT (PLT), 277 K/uL; 75: EOSINOPHIL % (AUTO DIFF), 1.5 %; 75: BASOPHIL ABSOLUTE (AUTO DIFF), 0.05 K/uL; 75: NEUTROPHIL % (AUTO DIFF), 83.0 %; 75: HR, 93.356; 75: RR, 27.746; 75: 1min HRV, 40.677; 76: HR, 91.914; 76: RR, 27.259; 76: 1min HRV, 8.585; 77: HR, 92.525; 77: RR, 27.780; 77: 1min HRV, 6.611; 78: HR, 92.661; 78: RR, 29.102; 78: 1min HRV, 7.071; 79: HR, 92.579; 79: RR, 27.789; 79: 1min HRV, 9.463; 79: 5min HRV, 19.702; 80: HR, 91.949; 80: RR, 27.085; 80: 1min HRV, 5.027; 81: HR, 91.138; 81: RR, 26.931; 81: 1min HRV, 4.219; 82: HR, 91.373; 82: RR, 27.576; 82: 1min HRV, 6.705; 83: HR, 92.158; 83: RR, 25.351; 83: 1min HRV, 9.338; 84: HR, 90.492; 84: RR, 25.271; 84: SpO2, 97.0; 84: 1min HRV, 9.232; 84: 5min HRV, 8.128; 84: SBP, 118.0; 84: DBP, 55.0; 84: MAP, 76.0; 85: HR, 90.085; 85: RR, 26.864; 85: 1min HRV, 59.939; 85: SBP, 118.0; 85: DBP, 55.0; 85: MAP, 76.0; 86: HR, 91.509; 86: RR, 27.386; 86: 1min HRV, 5.108; 87: HR, 90.017; 87: RR, 27.034; 87: 1min HRV, 10.785; 88: HR, 91.276; 88: RR, 27.017; 88: 1min HRV, 6.485; 89: HR, 90.034; 89: RR, 27.254; 89: 1min HRV, 41.373; 89: 5min HRV, 33.336; 90: HR, 90.949; 90: RR, 27.254; 90: 1min HRV, 7.295; 91: HR, 91.684; 91: RR, 28.228; 91: 1min HRV, 38.357; 92: HR, 90.593; 92: RR, 27.661; 92: 1min HRV, 14.779; 92: CEFEPIME, 2 GRAM/20 ML IV PUSH; 93: HR:, 91.034; 93: RR, 28.259; 93: 1min HRV, 5.225; 94: HR, 91.203; 94: RR, 27.831; 94: 1min HRV, 33.017; 94: 5min HRV, 24.101; 95: HR, 90.175; 95: RR, 28.053; 95: 1min HRV, 4.054; 96: HR, 90.085; 96: RR, 28.119; 96: 1min HRV, 9.153; 97: HR, 89.254; 97: RR, 28.356; 97: 1min HRV, 40.998; 98: HR, 91.983; 98: RR, 19.879; 98: 1min HRV, 13.356; 99: HR, 92.328; 99: RR, 25.224; 99: 1min HRV, 19.558; 99: 5min HRV, 23.573; 100: HR, 95.119; 100: RR, 19.356; 100: 1min HRV, 38.958; 100: SBP, 118.0; 100: DBP, 55.0; 100: MAP, 76.0; 100: LR IV BOLUS -, 1000 ML; 101: HR:, 92.828; 101: RR, 24.724; 101: 1min HRV, 7.677; 102: CO2, 27 mmol/L; 102: AST (SGOT), 20 U/L; 102: ALT (SGPT), 21 U/L; 102: CORRECTED CALCIUM, 9.8 mg/dL; 102: EGFR REFIT WITHOUT RACE (2021), 57 mL/min/1.73 m2; 102: CREATININE, 1.37 mg/dL; 102: SODIUM, 138 mmol/L; 102: BLOOD UREA NITROGEN (BUN), 20 mg/dL; 102: ANION GAP, 9 mmol/L; 102: GLUCOSE, 143 mg/dL; 102: GLOBULIN, 3.3 g/dL; 102: BILIRUBIN TOTAL, 0.2 mg/dL; 102: CALCIUM, 9.8 mg/dL; 102: ALBUMIN, 4.0 g/dL; 102: PROTEIN TOTAL, 7.3 g/dL; 102: ALKALINE PHOSPHATASE, 96 U/L; 102: POTASSIUM, 4.0 mmol/L; 102: CHLORIDE, 102 mmol/L; 102: HR, 92.780; 102: RR, 22.237; 102: 1min HRV, 7.634; 103: HR, 93.121; 103: RR, 23.086; 103: 1min HRV, 57.319; 104: HR, 91.729; 104: RR, 24.271; 104: 1min HRV, 9.637; 104: 5min HRV, 32.482; 105: HR, 92.414; 105: RR, 22.241; 105: 1min HRV, 3.310; 106: HR, 92.847; 106: RR, 23.424; 106: 1min HRV, 15.807; 107: HR, 92.845; 107: RR, 25.362; 107: 1min HRV, 9.563; 108: HR, 91.259; 108: RR, 25.034; 108: 1min HRV, 7.513; 109: INR, 1.2; 109: PART. THROMBOPLASTIN TIME, 30.9 seconds; 109: PROTHROMBIN TIME, 15.8 seconds; 109: HR, 90.627; 109: RR, 25.949; 109: 1min HRV, 7.505; 109: 5min HRV, 11.746; 110: HR, 94.879; 110: RR, 24.690; 110: 1min HRV, 19.871; 111: HR, 93.345; 111: RR, 28.793; 111: 1min HRV, 45.103; 112: HR, 91.661; 112: RR, 25.695; 112: 1min HRV, 6.633; 113: HR, 90.293; 113: RR, 25.155; 113: 1min HRV, 45.384; 114: HR, 89.881; 114: RR, 26.780; 114: 1min HRV, 42.987; 114: 5min HRV, 38.858; 115: HR, 89.789; 115: RR, 26.123; 115: 1min HRV, 8.617; 116: HR, 88.0; 116: RR, 28.0; 119: SARS-COV-2 RNA, Not Detected; 119: 5min HRV, 8.617; 0: Age, 65; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 38.1; 0: Triage HR, 108.0; 0: Triage RR, 18.0; 0: Triage SBP, 150.0; 0: Triage DBP, 70.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "The patient's elevated heart rate, respiratory rate, fever, and high white blood cell count are indicative of systemic inflammation, which is a hallmark of sepsis. Additionally, the low diastolic blood pressure and administration of cefepime, an antibiotic, suggest the clinical team is concerned about a potential infection, supporting a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient has an elevated heart rate.",
            "The patient has an elevated respiratory rate.",
            "The patient has a fever.",
            "The patient has a high white blood cell count.",
            "Elevated heart rate, respiratory rate, fever, and high white blood cell count are indicative of systemic inflammation.",
            "Systemic inflammation is a hallmark of sepsis.",
            "The patient has low diastolic blood pressure.",
            "Administration of cefepime suggests the clinical team is concerned about a potential infection.",
            "Concern about a potential infection supports a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient has an elevated heart rate.",
            "The patient has an elevated respiratory rate.",
            "The patient has a fever.",
            "The patient has a high white blood cell count.",
            "Elevated heart rate, respiratory rate, fever, and high white blood cell count are indicative of systemic inflammation.",
            "Administration of cefepime suggests the clinical team is concerned about a potential infection.",
            "Concern about a potential infection supports a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.8,
            0.6,
            1.0,
            1.0,
            0.9,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate (>90 bpm) is explicitly listed as one of the criteria under SIRS Positivity, which is used to identify systemic inflammation and potential early sepsis. The claim directly points to one aspect of the criteria, but since it doesn't specify the heart rate value or mention a second SIRS criterion, there is a slight drop from perfect alignment.",
            "An elevated respiratory rate is explicitly part of the SIRS criteria (respiratory rate\u202f>\u202f20\u202f/min), which identifies systemic inflammation consistent with early sepsis. As the claim clearly aligns with one of these criteria, the rating is high but not perfect because we don't know if other criteria are met for SIRS positivity.",
            "The claim of having a fever aligns with the SIRS criteria, specifically \"temperature >38\u00b0C,\" which is used to identify systemic inflammation indicative of early sepsis. However, the claim does not specify the fever's exact temperature to confirm meeting the SIRS threshold (>38\u00b0C), so the alignment is partial rather than full.",
            "A high white blood cell (WBC) count is explicitly mentioned as one of the SIRS criteria. The presence of one or more SIRS criteria, like elevated WBCs, is utilized to identify systemic inflammation and potential early sepsis. The alignment here is perfect, as a high WBC count directly relates to the SIRS category.",
            "The claim lists elevated heart rate, respiratory rate, fever, and high white blood cell count, all of which are specific criteria for SIRS. The presence of these criteria indicates systemic inflammation consistent with early sepsis. Thus, the alignment is perfect with the SIRS category.",
            "The administration of cefepime, a broad-spectrum antibiotic, strongly suggests that the clinical team is concerned about a serious infection, aligning well with the category Early Antibiotic/Culture Orders. However, without specific timing details (i.e., \"within 2 hours\"), the alignment is slightly less than perfect, hence the rating of 0.9.",
            "The claim expresses concern about a potential infection, which indicates suspicion of sepsis. However, it does not mention any concrete actions like administering antibiotics or ordering cultures, which are specific actions in this category. Thus, the alignment is weak and more implied than directly stated."
        ],
        "final_alignment_score": 0.7714285714285715,
        "accuracy": 0
    },
    {
        "input": "8: HR, 119.0; 8: RR, 18.0; 8: SpO2, 95.0; 8: SBP, 169.0; 8: DBP, 103.0; 8: MAP, 125.0; 8: Pain, 6.0; 8: Temp, 95.0; 33: POC PH (V) ISTAT, 7.45; 33: POC O2 SATURATION ISTAT VENOUS, 55 %; 33: POC LACTATE ISTAT, 1.54 mmol/L; 33: POC HCO3 (V) ISTAT, 29.1 mmol/L; 33: POC PO2 (V) ISTAT, 28 mmHg; 33: POC BASE EXCESS ISTAT, 5 mmol/L; 33: POC TCO2 (V) ISTAT, 30 mmol/L; 33: POC PCO2 (V) ISTAT, 42.3 mmHg; 44: HR, 88.590; 44: RR, 18.406; 44: SpO2, 99.0; 44: 1min HRV, 20.500; 44: 5min HRV, 20.500; 45: HR, 92.305; 45: RR, 15.068; 45: SpO2, 98.797; 45: Perf, 0.735; 45: 1min HRV, 15.914; 46: HR, 94.085; 46: RR, 17.729; 46: SpO2, 98.542; 46: Perf, 0.682; 46: 1min HRV, 20.121; 47: HR, 94.931; 47: RR, 12.603; 47: SpO2, 97.980; 47: Perf, 0.69; 47: 1min HRV, 17.878; 48: HR, 88.931; 48: RR, 11.190; 48: SpO2, 98.604; 48: Perf, 0.69; 48: 1min HRV, 25.098; 49: HR, 90.576; 49: RR, 14.102; 49: SpO2, 98.881; 49: Perf, 0.691; 49: 1min HRV, 22.655; 49: 5min HRV, 26.130; 50: HR, 88.254; 50: RR, 13.356; 50: SpO2, 99.797; 50: Perf, 0.768; 50: 1min HRV, 20.065; 51: HR, 85.797; 51: RR, 12.881; 51: SpO2, 99.847; 51: Perf, 0.780; 51: 1min HRV, 25.433; 51: NORMOSOL-R IV BOLUS -, 1000 ML; 52: HR:, 87.828; 52: RR, 14.483; 52: SpO2, 99.0; 52: Perf, 0.801; 52: 1min HRV, 17.872; 53: HR, 87.492; 53: RR, 13.441; 53: SpO2, 98.424; 53: Perf, 0.752; 53: 1min HRV, 14.349; 54: HR, 87.259; 54: RR, 12.741; 54: SpO2, 98.552; 54: Perf, 0.726; 54: 1min HRV, 21.211; 54: 5min HRV, 21.158; 54: SBP, 194.0; 54: DBP, 112.0; 54: MAP, 139.333; 55: HR, 87.797; 55: RR, 16.271; 55: SpO2, 98.909; 55: Perf, 0.696; 55: 1min HRV, 20.357; 55: SBP, 194.0; 55: DBP, 112.0; 55: MAP, 139.333; 56: HR, 88.542; 56: RR, 11.136; 56: SpO2, 99.164; 56: Perf, 0.578; 56: 1min HRV, 21.854; 56: SBP, 191.0; 56: DBP, 107.0; 56: MAP, 135.0; 56: Temp, 99.0; 57: HR, 85.724; 57: RR, 12.897; 57: SpO2, 98.638; 57: Perf, 0.604; 57: 1min HRV, 23.184; 57: SBP, 191.0; 57: DBP, 107.0; 57: MAP, 135.0; 58: HR, 86.508; 58: RR, 14.508; 58: SpO2, 99.409; 58: Perf, 0.57; 58: 1min HRV, 24.025; 59: HR, 85.845; 59: RR, 17.259; 59: SpO2, 99.310; 59: Perf, 0.546; 59: 1min HRV, 35.505; 59: 5min HRV, 27.028; 60: HR, 93.741; 60: RR, 23.621; 60: SpO2, 98.707; 60: Perf, 0.559; 60: 1min HRV, 31.804; 61: HR, 96.627; 61: RR, 13.831; 61: SpO2, 98.458; 61: Perf, 0.563; 61: 1min HRV, 16.269; 62: HR, 97.305; 62: RR, 14.695; 62: SpO2, 97.0; 62: Perf, 0.586; 62: 1min HRV, 13.340; 63: INR, 1.0; 63: PROTHROMBIN TIME, 12.6 seconds; 63: PART. THROMBOPLASTIN TIME, 27.5 seconds; 63: HR, 97.220; 63: RR, 14.390; 63: SpO2, 97.305; 63: Perf, 0.606; 63: 1min HRV, 40.075; 64: HR, 93.259; 64: RR, 13.259; 64: SpO2, 98.586; 64: Perf, 0.716; 64: 1min HRV, 16.946; 64: 5min HRV, 29.308; 64: SBP, 178.0; 64: DBP, 99.0; 64: MAP, 125.333; 65: HR, 89.305; 65: RR, 12.458; 65: SpO2, 99.153; 65: Perf, 0.709; 65: 1min HRV, 14.345; 65: SBP, 178.0; 65: DBP, 99.0; 65: MAP, 125.333; 66: HR, 89.914; 66: RR, 15.5; 66: SpO2, 99.069; 66: Perf, 0.746; 66: 1min HRV, 11.732; 67: HR, 89.983; 67: RR, 15.492; 67: SpO2, 98.881; 67: Perf, 0.7; 67: 1min HRV, 12.711; 68: HR, 90.356; 68: RR, 18.373; 68: SpO2, 98.610; 68: Perf, 0.700; 68: 1min HRV, 21.647; 69: HR, 88.190; 69: RR, 14.379; 69: SpO2, 98.828; 69: Perf, 0.804; 69: 1min HRV, 16.146; 69: 5min HRV, 16.123; 70: HR, 88.695; 70: RR, 13.322; 70: SpO2, 98.576; 70: Perf, 0.778; 70: 1min HRV, 12.567; 71: HR, 89.517; 71: RR, 14.190; 71: SpO2, 97.586; 71: Perf, 0.757; 71: 1min HRV, 18.283; 72: HR, 90.831; 72: RR, 13.034; 72: SpO2, 97.712; 72: Perf, 0.781; 72: 1min HRV, 30.201; 73: HR, 89.441; 73: RR, 13.441; 73: SpO2, 97.763; 73: Perf, 0.792; 73: 1min HRV, 17.698; 74: HR, 90.052; 74: RR, 15.517; 74: SpO2, 97.552; 74: Perf, 0.767; 74: 1min HRV, 18.816; 74: 5min HRV, 21.222; 75: AST (SGOT), 38 U/L; 75: EGFR FOR AFRICAN AMERICAN, 88 mL/min/1.73 m2; 75: CHLORIDE, 101 mmol/L; 75: EGFR REFIT WITHOUT RACE (2021), 76 mL/min/1.73 m2; 75: CORRECTED CALCIUM, 9.4 mg/dL; 75: ALBUMIN, 4.4 g/dL; 75: CO2, 27 mmol/L; 75: ANION GAP, 13 mmol/L; 75: GLOBULIN, 2.5 g/dL; 75: CALCIUM, 9.7 mg/dL; 75: POTASSIUM, 3.7 mmol/L; 75: BILIRUBIN TOTAL, 0.6 mg/dL; 75: CREATININE, 0.85 mg/dL; 75: ALT (SGPT), 75 U/L; 75: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 75: ALKALINE PHOSPHATASE, 136 U/L; 75: PROTEIN TOTAL, 6.9 g/dL; 75: GLUCOSE, 134 mg/dL; 75: SODIUM, 141 mmol/L; 75: MAGNESIUM, 2.2 mg/dL; 75: C-REACTIVE PROTEIN (CRP), 12.9 mg/dL; 75: HR, 92.576; 75: RR, 15.492; 75: SpO2, 97.458; 75: Perf, 0.738; 75: 1min HRV, 15.039; 75: LABETALOL, 5 MG/ML IV SOLN; 76: HR:, 91.172; 76: RR, 14.914; 76: SpO2, 98.086; 76: Perf, 0.761; 76: 1min HRV, 22.991; 77: HR, 92.593; 77: RR, 12.966; 77: SpO2, 97.847; 77: Perf, 0.732; 77: 1min HRV, 12.759; 78: HR, 90.322; 78: RR, 11.407; 78: SpO2, 97.763; 78: Perf, 0.629; 78: 1min HRV, 29.457; 79: HR, 81.672; 79: RR, 11.603; 79: SpO2, 96.724; 79: Perf, 0.630; 79: 1min HRV, 12.557; 79: 5min HRV, 39.153; 80: SBP, 160.0; 80: DBP, 140.0; 80: MAP, 146.667; 98: PROCALCITONIN, 3.91 ng/mL; 100: ESR (AUTOMATED), 112 mm/hr; 110: TROPONIN I, 0.028 ng/mL; 0: Age, 57; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 119.0; 0: Triage RR, 18.0; 0: Triage SBP, 169.0; 0: Triage DBP, 103.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "To determine if the patient is at high risk of developing sepsis, I first look at vital signs and lab results. The patient has a high heart rate (initially 119 bpm), high blood pressure (SBP 169, DBP 103), elevated C-reactive protein (12.9 mg/dL), elevated lactate (1.54 mmol/L), significantly elevated procalcitonin (3.91 ng/mL), and an extremely high erythrocyte sedimentation rate (ESR) at 112 mm/hr. Procalcitonin levels and ESR are particularly indicative of infection and inflammation. The combination of these indicators suggests a high risk for sepsis, classifying the patient as Yes, at high risk for developing sepsis within 12 hours.",
        "claims": [
            "To determine if the patient is at high risk of developing sepsis, vital signs and lab results are examined.",
            "The patient has a high heart rate of 119 bpm.",
            "The patient's blood pressure is high, with a systolic blood pressure of 169 and a diastolic blood pressure of 103.",
            "The patient's C-reactive protein level is elevated at 12.9 mg/dL.",
            "The patient's lactate level is elevated at 1.54 mmol/L.",
            "The patient's procalcitonin level is significantly elevated at 3.91 ng/mL.",
            "The patient's erythrocyte sedimentation rate (ESR) is extremely high at 112 mm/hr.",
            "Procalcitonin levels are indicative of infection and inflammation.",
            "ESR is indicative of infection and inflammation.",
            "The combination of these indicators suggests a high risk for sepsis.",
            "The patient is classified as at high risk for developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "To determine if the patient is at high risk of developing sepsis, vital signs and lab results are examined.",
            "The patient has a high heart rate of 119 bpm.",
            "The patient's blood pressure is high, with a systolic blood pressure of 169 and a diastolic blood pressure of 103.",
            "The patient's C-reactive protein level is elevated at 12.9 mg/dL.",
            "The patient's lactate level is elevated at 1.54 mmol/L.",
            "The patient's procalcitonin level is significantly elevated at 3.91 ng/mL.",
            "The patient's erythrocyte sedimentation rate (ESR) is extremely high at 112 mm/hr.",
            "Procalcitonin levels are indicative of infection and inflammation.",
            "ESR is indicative of infection and inflammation.",
            "The combination of these indicators suggests a high risk for sepsis.",
            "The patient is classified as at high risk for developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.6,
            0.8,
            0.2,
            0.5,
            0.3,
            0.5,
            0.3,
            0.6,
            0.3,
            0.2,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim refers to the examination of vital signs and lab results, which are key components of calculating the National Early Warning Score (NEWS). NEWS incorporates derangements in vital signs to predict clinical deterioration that might align with sepsis. While the claim does not specify an actual NEWS score or detail the derangements, the use of vital signs and lab results implies a focus on identifying risk through these parameters. The alignment is indirect but present, warranting a moderate rating.",
            "A heart rate >90 bpm is a specific criterion within the SIRS framework, indicating systemic inflammation that may be consistent with early sepsis. The patient's high heart rate of 119 bpm exceeds this threshold, aligning well with the category. However, since SIRS positivity requires presence of two or more criteria, and only one is mentioned, the alignment is not perfect.",
            "The claim refers to high blood pressure, which does not directly correlate with a high shock index\u2014a ratio of heart rate to systolic blood pressure that signals haemodynamic instability. The elevated blood pressure does not suggest hypotension or shock, and therefore aligns poorly with the category's criteria, justifying a low alignment rating.",
            "While C-reactive protein (CRP) is not explicitly listed under the SIRS criteria, an elevated CRP is a marker of systemic inflammation, which can correlate with sepsis. This indication relates to SIRS criteria that involve systemic inflammation, although it is not a direct match. The alignment is moderate due to this conceptual overlap.",
            "The claim references an elevated lactate level, closely related to the category \"Elevated Serum Lactate (\u22652 mmol/L).\" However, the lactate level mentioned (1.54 mmol/L) does not meet the threshold (\u22652 mmol/L) required to significantly elevate sepsis mortality risk, resulting in a weak alignment with the category.",
            "An elevated procalcitonin level suggests a heightened inflammatory or infectious response, akin to indications captured by the SIRS criteria. However, procalcitonin is not explicitly a SIRS criterion; thus, alignment is moderate as it implies possible systemic inflammation seen in early sepsis.",
            "An elevated erythrocyte sedimentation rate (ESR) is indicative of inflammation, similar to the SIRS criteria that identify systemic inflammation. However, ESR is not a part of the specific SIRS criteria mentioned, like temperature or WBC count. Therefore, while it suggests inflammation, the direct alignment with SIRS criteria is moderate and indirect.",
            "Procalcitonin is a biomarker that indicates infection and inflammation, which can trigger suspicion of sepsis. While it does not directly fall under the listed categories, it is a diagnostic marker often used to decide on initiating antibiotics or further investigation, suggesting clinical suspicion of serious infection. Therefore, it aligns somewhat with the Early Antibiotic/Culture Orders category, though the alignment is indirect.",
            "Elevated ESR (Erythrocyte Sedimentation Rate) indicates inflammation and infection, which broadly relates to the concept of systemic inflammation in SIRS. However, ESR itself is not directly part of the SIRS criteria; thus, the alignment is indirect and relatively weak.",
            "The claim is vague and lacks specificity about which particular indicators are being referred to. The language suggests a general assessment of risk, which loosely aligns with the concept of a cumulative score such as the NEWS score, which aggregates various vital sign derangements. However, without specific details, the alignment is minimal.",
            "The claim lacks specific details about which clinical indicators were used to classify the patient as at high risk for sepsis. Despite this, the idea of being classified as \"high risk for developing sepsis\" within a short timeframe aligns most with the Elevated NEWS Score, which predicts imminent clinical deterioration. However, due to the absence of specific data points such as vital signs or a NEWS score calculation, the alignment is weak and therefore rated at 0.3."
        ],
        "final_alignment_score": 0.41818181818181815,
        "accuracy": 0
    },
    {
        "input": "2: SpO2, 98.912; 3: HR, 127.55; 3: RR, 25.833; 3: SpO2, 99.0; 3: 1min HRV, 9.900; 3: 5min HRV, 9.900; 3: SBP, 112.0; 3: DBP, 60.0; 3: MAP, 77.333; 4: HR, 123.810; 4: RR, 14.64; 4: SpO2, 93.6; 4: 1min HRV, 8.630; 5: HR, 123.759; 5: RR, 20.083; 5: SpO2, 100.0; 5: Perf, 0.17; 5: 1min HRV, 9.799; 6: HR, 121.237; 6: RR, 20.864; 6: SpO2, 100.0; 6: Perf, 0.173; 6: 1min HRV, 8.424; 7: HR, 122.534; 7: RR, 18.897; 7: SpO2, 99.806; 7: Perf, 0.180; 7: 1min HRV, 10.581; 8: HR, 122.237; 8: RR, 21.153; 8: SpO2, 100.0; 8: Perf, 0.165; 8: 1min HRV, 11.457; 8: 5min HRV, 10.763; 8: SBP, 112.0; 8: DBP, 60.0; 8: MAP, 77.333; 8: Pain, 0.0; 8: Temp, 99.1; 9: HR, 121.466; 9: RR, 22.138; 9: SpO2, 99.711; 9: Perf, 0.17; 9: 1min HRV, 12.729; 10: HR, 120.085; 10: RR, 18.373; 10: SpO2, 99.826; 10: Perf, 0.17; 10: 1min HRV, 8.977; 11: HR, 121.356; 11: RR, 20.847; 11: SpO2, 99.96; 11: Perf, 0.159; 11: 1min HRV, 6.412; 13: 5min HRV, 10.151; 20: POC PH (V) ISTAT, 7.35; 20: POC TCO2 (V) ISTAT, 32 mmol/L; 20: POC O2 SATURATION ISTAT VENOUS, 28 %; 20: POC PCO2 (V) ISTAT, 54.3 mmHg; 20: POC HCO3 (V) ISTAT, 30.1 mmol/L; 20: POC LACTATE ISTAT, 0.86 mmol/L; 20: POC BASE EXCESS ISTAT, 5 mmol/L; 20: POC PO2 (V) ISTAT, 20 mmHg; 27: ABO/RH (AUTOMATION), AB Positive; 27: ANTIBODY SCREEN 3, NEG; 29: HR, 117.0; 29: RR, 20.0; 29: SpO2, 100.0; 29: SBP, 104.0; 29: DBP, 67.0; 29: MAP, 79.333; 40: WAM DIFTYP, AUTO; 40: PLATELET COUNT (PLT), 300 K/uL; 40: HEMATOCRIT (HCT), 29.4 %; 40: HEMOGLOBIN (HGB), 9.7 g/dL; 40: MONOCYTE ABSOLUTE (AUTO DIFF), 1.06 K/uL; 40: MEAN CORPUSCULAR VOLUME (MCV), 85.2 fL; 40: NEUTROPHIL ABSOLUTE (AUTO DIFF), 12.92 K/uL; 40: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.06 K/uL; 40: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 40: RED BLOOD CELLS (RBC), 3.45 MIL/uL; 40: EOSINOPHIL % (AUTO DIFF), 0.0 %; 40: BASOPHIL % (AUTO DIFF), 0.1 %; 40: NEUTROPHIL % (AUTO DIFF), 87.3 %; 40: MONOCYTE % (AUTO DIFF), 7.2 %; 40: NRBC PERCENT (HEMATOLOGY), 0.0 %; 40: WHITE BLOOD CELLS (WBC), 14.8 K/uL; 40: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 40: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 40: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 40: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.0 g/dL; 40: RED CELL DISTRIBUTION WIDTH (RDW), 17.3 %; 40: LYMPHOCYTE % (AUTO DIFF), 5.0 %; 40: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.1 pg; 40: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.00 K/uL; 43: HR, 114.0; 43: RR, 27.0; 43: SpO2, 100.0; 43: SBP, 107.0; 43: DBP, 62.0; 43: MAP, 77.0; 50: INR, 1.1; 50: PROTHROMBIN TIME, 14.4 seconds; 51: PART. THROMBOPLASTIN TIME, 33.5 seconds; 56: ETOMIDATE, 2 MG/ML IV SOLN; 58: SUCCINYLCHOLINE CHLORIDE, 20 MG/ML INJ SOLN; 60: ALT (SGPT), 47 U/L; 60: ANION GAP, 8 mmol/L; 60: ALBUMIN, 3.4 g/dL; 60: EGFR FOR AFRICAN AMERICAN, 150 mL/min/1.73 m2; 60: CALCIUM, 8.6 mg/dL; 60: CREATININE, 0.42 mg/dL; 60: GLUCOSE, 120 mg/dL; 60: CORRECTED CALCIUM, 9.1 mg/dL; 60: GLOBULIN, 3.2 g/dL; 60: BILIRUBIN TOTAL, 0.3 mg/dL; 60: EGFR REFIT WITHOUT RACE (2021), 130 mL/min/1.73 m2; 60: SODIUM, 130 mmol/L; 60: PROTEIN TOTAL, 6.6 g/dL; 60: ALKALINE PHOSPHATASE, 95 U/L; 60: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 60: AST (SGOT), 33 U/L; 60: CHLORIDE, 95 mmol/L; 60: CO2, 27 mmol/L; 60: POTASSIUM, 4.6 mmol/L; 63: HR, 59.0; 63: RR, 18.0; 63: SBP, 117.0; 63: DBP, 100.0; 63: MAP, 105.667; 68: HR, 59.0; 68: RR, 20.0; 68: SBP, 100.0; 68: DBP, 49.0; 68: MAP, 66.0; 69: HR, 59.0; 69: RR, 23.0; 69: SBP, 72.0; 69: DBP, 45.0; 69: MAP, 54.0; 69: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 70: RR:, 24.0; 70: SBP, 87.0; 70: DBP, 54.0; 70: MAP, 65.0; 71: PHENYLEPHRINE HCL IN, 0.9% NACL 0.5 MG/5 ML (100 MCG/ML) IV SYRG; 72: TRANEXAMIC ACID, 100 MG/ML NEBULIZED INHALATION; 73: RR, 18.0; 73: SBP, 89.0; 73: DBP, 63.0; 73: MAP, 71.667; 74: HR, 140.0; 74: RR, 21.0; 74: SBP, 139.0; 74: DBP, 86.0; 74: MAP, 103.667; 74: NOREPINEPHRINE BITARTRATE-NACL, 4 MG/250 ML (16 MCG/ML) IV SOLN; 76: CALCIUM GLUCONATE IN, 0.9% NACL 1 GRAM/50 ML IV SOLN; 78: HR, 138.0; 78: RR, 16.0; 78: SpO2, 100.0; 78: SBP, 167.0; 78: DBP, 91.0; 78: MAP, 116.333; 82: HR, 138.0; 82: RR, 24.0; 82: SpO2, 100.0; 82: SBP, 118.0; 82: DBP, 89.0; 82: MAP, 98.667; 83: HR, 133.0; 83: RR, 14.0; 83: SpO2, 100.0; 83: SBP, 140.0; 83: DBP, 76.0; 83: MAP, 97.333; 85: PROPOFOL, 10 MG/ML IV INFUSION; 87: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 88: HR, 125.0; 88: RR, 13.0; 88: SpO2, 100.0; 88: SBP, 105.0; 88: DBP, 47.0; 88: MAP, 66.333; 93: HR, 119.0; 93: RR, 20.0; 93: SpO2, 99.0; 93: SBP, 133.0; 93: DBP, 50.0; 93: MAP, 77.667; 98: HR, 109.0; 98: RR, 21.0; 98: SpO2, 99.0; 98: FENTANYL CITRATE (PF), 50 MCG/ML INJ SOLN (WRAPPER RECORD); 102: POC PH (A), ISTAT: 7.21; 102: POC BASE EXCESS ISTAT, -11 mmol/L; 102: POC LACTATE ISTAT, 7.13 mmol/L; 102: POC HCO3 (A) ISTAT, 16.6 mmol/L; 102: POC O2 SATURATION ISTAT, 98 %; 102: POC PO2 (A) ISTAT, 122 mmHg; 102: POC TCO2 (A) ISTAT, 18 mmol/L; 102: POC PCO2 (A) ISTAT, 41.2 mmHg; 108: HR, 105.0; 108: RR, 20.0; 108: SpO2, 98.0; 113: HR, 89.0; 113: RR, 21.0; 113: SpO2, 100.0; 118: HR, 103.0; 118: RR, 20.0; 118: SpO2, 100.0; 118: Pain, 0.0; 118: Pain, 1.0; 0: Age, 37; 0: Gender, F; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 118.0; 0: Triage RR, 22.0; 0: Triage SBP, 112.0; 0: Triage DBP, 60.0; 0: Triage acuity, 2-Emergent; 0: CC, BLOOD IN VOMIT",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "The patient presents with multiple concerning indicators within the first few hours of admission: high heart rates throughout the time series data, episodes of low blood pressure at later timestamps, notably after the 12-hour window, and significantly elevated lactate levels observed at time 102.0. Early tachycardia, combined with a presentation complaint of \"BLOOD IN VOMIT,\" suggests possible sepsis. Additional clues such as high immature granulocyte percentage, low arterial pH, and dyspnea bolster this assessment, increasing the likelihood of sepsis risk within 12 hours.",
        "claims": [
            "The patient presents with multiple concerning indicators within the first few hours of admission.",
            "High heart rates are observed throughout the time series data.",
            "Episodes of low blood pressure occur at later timestamps.",
            "Low blood pressure episodes are noted notably after the 12-hour window.",
            "Significantly elevated lactate levels are observed at time 102.0.",
            "Early tachycardia is present in the patient's condition.",
            "The patient presents with a complaint of \"BLOOD IN VOMIT.\"",
            "The combination of early tachycardia and the complaint of \"BLOOD IN VOMIT\" suggests possible sepsis.",
            "The patient has a high immature granulocyte percentage.",
            "The patient has a low arterial pH.",
            "The patient experiences dyspnea.",
            "The additional clues of high immature granulocyte percentage, low arterial pH, and dyspnea increase the likelihood of sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "High heart rates are observed throughout the time series data.",
            "Episodes of low blood pressure occur at later timestamps.",
            "Significantly elevated lactate levels are observed at time 102.0.",
            "Early tachycardia is present in the patient's condition.",
            "The patient presents with a complaint of \"BLOOD IN VOMIT.\"",
            "The combination of early tachycardia and the complaint of \"BLOOD IN VOMIT\" suggests possible sepsis.",
            "The patient has a high immature granulocyte percentage.",
            "The patient has a low arterial pH.",
            "The additional clues of high immature granulocyte percentage, low arterial pH, and dyspnea increase the likelihood of sepsis risk within 12 hours."
        ],
        "alignment_scores": [
            0.5,
            0.8,
            1.0,
            0.7,
            0.3,
            0.7,
            0.4,
            0.3,
            0.7
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "High heart rates can indicate hemodynamic instability, which is one of the factors associated with an elevated shock index. However, the claim does not mention systolic blood pressure, which is necessary to calculate the shock index directly. Thus, it is only partially aligned with the concept of Elevated Shock Index, reflecting a moderate level of alignment.",
            "The claim refers to episodes of low blood pressure, which is a key indicator of sepsis-associated hypotension. This category specifies systolic blood pressure <90 mmHg or MAP <70 mmHg, or a significant drop in blood pressure, as part of sepsis progression. Although the exact measurements are not provided in the claim, the mention of low blood pressure episodes strongly aligns with this category, though not perfectly due to the lack of specific numerical data.",
            "The claim directly identifies the observation of significantly elevated lactate levels, which aligns perfectly with the category of Elevated Serum Lactate. This category explicitly references serum lactate\u202f\u2265\u202f2\u202fmmol/L as an indicator of tissue hypoperfusion, which markedly elevates sepsis mortality risk. There is a direct and precise match between the claim and the category, leading to a perfect alignment rating.",
            "Tachycardia (heart rate > 90 bpm) is one of the criteria for SIRS, indicating systemic inflammation consistent with early sepsis. The claim aligns well with this category, as tachycardia directly meets a SIRS criterion, hence the relatively high rating. However, without additional SIRS criteria being mentioned, full alignment isn't achieved.",
            "The claim of \"blood in vomit\" suggests a potential serious underlying condition, possibly warranting further investigation or intervention. Although this directly does not specify any sepsis criteria, it raises clinical suspicion of a significant problem that might lead to infection-related complications and could prompt a clinician to consider early antibiotic or culture orders. The alignment is low because the presence of blood in vomit is not directly an indicator of sepsis or its associated risk factors according to the listed categories.",
            "Tachycardia, or a high heart rate (>90 bpm), is directly listed as one of the criteria for SIRS, which indicates systemic inflammation potentially consistent with early sepsis. The complaint of \"BLOOD IN VOMIT\" suggests a serious underlying condition that could relate to sepsis but is not explicitly part of the SIRS criteria. The combination of tachycardia and potential internal bleeding increases the risk perception, aligning somewhat well with SIRS criteria due to the presence of early tachycardia. Hence, the alignment rating is moderately strong at 0.7.",
            "A high immature granulocyte percentage is an indicator of infection or inflammation, suggesting the body is mounting a response to a possible sepsis-causing pathogen. While this is not a direct match to any specific sepsis prediction category, it could prompt clinical suspicion similar to that which leads to early antibiotic orders or blood cultures. However, since there's no direct action mentioned, like the administration of antibiotics or ordering cultures, the alignment is moderate.",
            "A low arterial pH typically indicates metabolic acidosis, often associated with elevated lactate levels due to tissue hypoperfusion. While low pH isn\u2019t directly listed under the Elevated Serum Lactate category, elevated lactate is a common cause of metabolic acidosis. Therefore, the alignment is indirect and somewhat meaningful but not explicit.",
            "The claim includes low arterial pH and dyspnea, which align with the concept of organ dysfunction seen in SOFA criteria; low pH suggests metabolic acidosis, and dyspnea relates to respiratory issues. While the mention of immature granulocytes is more indicative of infection/inflammation and doesn't directly correlate with SOFA, the combination points toward risk of organ dysfunction and potential sepsis, hence the moderate alignment."
        ],
        "final_alignment_score": 0.6000000000000001,
        "accuracy": 0
    },
    {
        "input": "1: HR, 79.882; 1: RR, 18.0; 1: SpO2, 92.348; 1: Perf, 2.965; 1: 1min HRV, 16.865; 2: HR, 79.475; 2: RR, 17.102; 2: SpO2, 92.459; 2: Perf, 3.261; 2: 1min HRV, 12.250; 2: 5min HRV, 13.874; 2: SBP, 91.0; 2: DBP, 56.0; 2: MAP, 67.667; 3: HR, 79.603; 3: RR, 17.552; 3: SpO2, 92.167; 3: Perf, 4.201; 3: 1min HRV, 9.150; 3: SBP, 89.0; 3: DBP, 54.0; 3: MAP, 65.667; 4: HR, 80.017; 4: RR, 19.814; 4: SpO2, 91.797; 4: Perf, 4.437; 4: 1min HRV, 7.918; 5: HR, 79.483; 5: RR, 17.897; 5: SpO2, 92.466; 5: Perf, 4.719; 5: 1min HRV, 19.889; 6: HR, 77.898; 6: RR, 17.203; 6: SpO2, 93.034; 6: Perf, 4.849; 6: 1min HRV, 8.734; 7: HR, 77.305; 7: RR, 17.915; 7: SpO2, 94.172; 7: Perf, 4.749; 7: 1min HRV, 29.252; 7: 5min HRV, 20.200; 7: SBP, 82.0; 7: DBP, 58.0; 7: MAP, 66.0; 8: HR, 77.603; 8: RR, 19.879; 8: SpO2, 94.845; 8: Perf, 4.85; 8: 1min HRV, 15.192; 9: HR, 77.932; 9: RR, 18.898; 9: SpO2, 95.729; 9: Perf, 5.131; 9: 1min HRV, 12.593; 10: HR, 77.845; 10: RR, 16.397; 10: SpO2, 96.293; 10: Perf, 4.86; 10: 1min HRV, 16.278; 10: SBP, 82.0; 10: DBP, 56.0; 10: MAP, 64.667; 11: HR, 77.458; 11: RR, 19.085; 11: SpO2, 96.492; 11: Perf, 5.061; 11: 1min HRV, 23.636; 12: HR, 77.441; 12: RR, 19.458; 12: SpO2, 96.0; 12: Perf, 4.676; 12: 1min HRV, 26.166; 12: 5min HRV, 19.846; 13: HR, 77.086; 13: RR, 19.672; 13: SpO2, 96.517; 13: Perf, 4.590; 13: 1min HRV, 27.453; 14: HR, 78.068; 14: RR, 20.780; 14: SpO2, 97.119; 14: Perf, 4.273; 14: 1min HRV, 29.638; 15: HR, 78.259; 15: RR, 18.069; 15: SpO2, 96.017; 15: Perf, 4.582; 15: 1min HRV, 26.424; 16: HR, 77.0; 16: RR, 21.712; 16: SpO2, 95.831; 16: Perf, 4.953; 16: 1min HRV, 21.531; 17: HR, 74.655; 17: RR, 19.983; 17: SpO2, 96.0; 17: Perf, 5.045; 17: 1min HRV, 32.942; 17: 5min HRV, 30.473; 18: HR, 76.627; 18: RR, 18.644; 18: SpO2, 96.881; 18: Perf, 4.553; 18: 1min HRV, 42.603; 18: SBP, 86.0; 18: DBP, 56.0; 18: MAP, 66.0; 19: HR, 76.746; 19: RR, 20.695; 19: SpO2, 96.085; 19: Perf, 4.913; 19: 1min HRV, 22.919; 20: HR, 75.914; 20: RR, 19.672; 20: SpO2, 96.810; 20: Perf, 4.996; 20: 1min HRV, 15.346; 21: HR, 75.695; 21: RR, 21.186; 21: SpO2, 96.068; 21: Perf, 4.31; 21: 1min HRV, 18.165; 22: HR, 75.0; 22: RR, 19.897; 22: SpO2, 96.0; 22: Perf, 5.584; 22: 1min HRV, 15.242; 22: 5min HRV, 26.758; 23: SpO2, 95.627; 23: Perf, 6.732; 24: SpO2, 95.847; 24: Perf, 6.377; 25: SpO2, 95.103; 25: Perf, 5.538; 26: SpO2, 95.271; 26: Perf, 4.859; 27: SpO2, 94.431; 27: Perf, 3.054; 28: SpO2, 97.0; 28: Perf, 3.627; 29: SpO2, 95.644; 29: Perf, 3.088; 30: SpO2, 96.862; 30: Perf, 2.077; 31: SpO2, 96.068; 31: Perf, 2.325; 32: SpO2, 97.759; 32: Perf, 1.248; 33: SpO2, 97.068; 33: Perf, 0.830; 33: SBP, 110.0; 33: DBP, 71.0; 33: MAP, 84.0; 34: SpO2, 97.949; 34: Perf, 0.764; 34: NORMOSOL-R IV BOLUS -, 1000 ML; 35: HR:, 75.0; 35: RR, 20.0; 35: SpO2, 96.828; 35: Perf, 0.739; 35: SBP, 110.0; 35: DBP, 71.0; 35: MAP, 84.0; 36: POC PH (V) ISTAT, 7.42; 36: POC PCO2 (V) ISTAT, 35.1 mmHg; 36: POC PO2 (V) ISTAT, 37 mmHg; 36: POC HCO3 (V) ISTAT, 22.7 mmol/L; 36: POC O2 SATURATION ISTAT VENOUS, 73 %; 36: POC LACTATE ISTAT, 1.78 mmol/L; 36: POC TCO2 (V) ISTAT, 24 mmol/L; 36: POC BASE EXCESS ISTAT, -2 mmol/L; 36: HR, 73.935; 36: RR, 26.932; 36: SpO2, 95.593; 36: Perf, 1.088; 36: 1min HRV, 15.067; 37: HR, 76.224; 37: RR, 22.655; 37: SpO2, 97.5; 37: Perf, 1.012; 37: 1min HRV, 13.381; 37: 5min HRV, 18.055; 38: HR, 78.051; 38: RR, 28.356; 38: SpO2, 97.932; 38: Perf, 0.629; 38: 1min HRV, 16.546; 39: HR, 80.0; 39: RR, 25.254; 39: SpO2, 98.390; 39: Perf, 0.600; 39: 1min HRV, 21.224; 40: HR, 81.121; 40: RR, 23.741; 40: SpO2, 98.810; 40: Perf, 0.593; 40: 1min HRV, 13.943; 41: HR, 83.542; 41: RR, 26.373; 41: SpO2, 98.0; 41: Perf, 0.600; 41: 1min HRV, 19.886; 42: HR, 83.897; 42: RR, 29.414; 42: SpO2, 98.086; 42: Perf, 0.639; 42: 1min HRV, 17.444; 42: 5min HRV, 26.739; 43: HR, 84.475; 43: RR, 28.780; 43: SpO2, 98.661; 43: Perf, 0.669; 43: 1min HRV, 13.889; 44: HR, 85.712; 44: RR, 26.424; 44: SpO2, 98.644; 44: Perf, 0.677; 44: 1min HRV, 17.314; 47: 5min HRV, 16.253; 62: INR, 1.3; 62: PROTHROMBIN TIME, 15.6 seconds; 63: PART. THROMBOPLASTIN TIME, 35.1 seconds; 71: PIPERACILLIN-TAZOBACTAM-DEXTRS, 4.5 GRAM/100 ML IV PGBK; 74: LIPASE:, 3 U/L; 77: EGFR REFIT WITHOUT RACE (2021), 71 mL/min/1.73 m2; 77: ALT (SGPT), 20 U/L; 77: PROTEIN TOTAL, 5.4 g/dL; 77: CREATININE, 1.01 mg/dL; 77: POTASSIUM, 4.2 mmol/L; 77: GLOBULIN, 2.7 g/dL; 77: AST (SGOT), 62 U/L; 77: ALKALINE PHOSPHATASE, 362 U/L; 77: GLUCOSE, 194 mg/dL; 77: BILIRUBIN TOTAL, 2.1 mg/dL; 77: EGFR FOR AFRICAN AMERICAN, 82 mL/min/1.73 m2; 77: CORRECTED CALCIUM, 8.5 mg/dL; 77: ANION GAP, 11 mmol/L; 77: ALBUMIN, 2.7 g/dL; 77: SODIUM, 133 mmol/L; 77: CALCIUM, 7.5 mg/dL; 77: BLOOD UREA NITROGEN (BUN), 23 mg/dL; 77: CO2, 23 mmol/L; 77: CHLORIDE, 99 mmol/L; 118: HEMOGLOBIN (HGB), 11.1 g/dL; 118: WHITE BLOOD CELLS (WBC), 2.9 K/uL; 118: PLATELET COUNT (PLT), 47 K/uL; 118: HEMATOCRIT (HCT), 33.3 %; 118: RED CELL DISTRIBUTION WIDTH (RDW), 15.4 %; 118: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.3 g/dL; 118: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 32.4 pg; 118: RED BLOOD CELLS (RBC), 3.43 MIL/uL; 118: MEAN CORPUSCULAR VOLUME (MCV), 97.1 fL; 118: LYMPHOCYTES % (MANUAL DIFF), 6.0 %; 118: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 118: MONOCYTES % (MANUAL DIFF), 0.0 %; 118: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 2.75 K/uL; 118: NEUTROPHILS BANDS % (MANUAL DIFF), 16.0 %; 118: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 0.18 K/uL; 0: Age, 80; 0: Gender, M; 0: Race, Asian; 0: Means of arrival, EMS; 0: Triage Temp, 38.2; 0: Triage HR, 77.0; 0: Triage RR, 16.0; 0: Triage SBP, 92.0; 0: Triage DBP, 53.0; 0: Triage acuity, 3-Urgent; 0: CC, GENERAL WEAKNESS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "First, assess vital signs indicating organ dysfunction or infection, like low systolic blood pressure (SBP) at 89-92 mmHg and increased respiratory rate of 25-29 breaths/min, suggesting potential septic shock. Then, analyze laboratory indicators of sepsis, including the low platelet count (47 K/uL), low WBC count (2.9 K/uL), and high body temperature (38.2\u00b0C). Finally, consider age and comorbidities, as this 80-year-old patient shows significant physiological stress and potential anemia, leading to a high sepsis risk label within 12 hours.",
        "claims": [
            "Vital signs should be assessed for indications of organ dysfunction or infection.",
            "Low systolic blood pressure (SBP) is identified as 89-92 mmHg.",
            "An increased respiratory rate of 25-29 breaths/min suggests potential septic shock.",
            "Laboratory indicators of sepsis should be analyzed.",
            "A low platelet count of 47 K/uL is an indicator of sepsis.",
            "A low white blood cell (WBC) count of 2.9 K/uL is an indicator of sepsis.",
            "A high body temperature of 38.2\u00b0C is an indicator of sepsis.",
            "Age and comorbidities should be considered in the assessment of sepsis risk.",
            "The patient is 80 years old.",
            "The 80-year-old patient shows significant physiological stress.",
            "The 80-year-old patient may have potential anemia.",
            "The combination of factors leads to a high sepsis risk label within 12 hours."
        ],
        "relevant_claims": [
            "Vital signs should be assessed for indications of organ dysfunction or infection.",
            "Low systolic blood pressure (SBP) is identified as 89-92 mmHg.",
            "An increased respiratory rate of 25-29 breaths/min suggests potential septic shock.",
            "A low platelet count of 47 K/uL is an indicator of sepsis.",
            "A low white blood cell (WBC) count of 2.9 K/uL is an indicator of sepsis.",
            "A high body temperature of 38.2\u00b0C is an indicator of sepsis.",
            "Age and comorbidities should be considered in the assessment of sepsis risk.",
            "The patient is 80 years old.",
            "The 80-year-old patient shows significant physiological stress.",
            "The 80-year-old patient may have potential anemia."
        ],
        "alignment_scores": [
            0.4,
            0.9,
            0.9,
            1.0,
            1.0,
            0.9,
            0.6,
            1.0,
            0.9,
            0.7
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "High qSOFA Score (\u22652)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elderly Susceptibility (Age \u226565 years)",
            "Elderly Susceptibility (Age \u226565 years)",
            "Elderly Susceptibility (Age \u226565 years)",
            "Elderly Susceptibility (Age \u226565 years)"
        ],
        "alignment_reasonings": [
            "The claim implies the need for monitoring vital signs, which aligns with the purpose of the NEWS score\u2014to identify potential clinical deterioration indicative of sepsis. However, the claim is vague and doesn't specifically mention NEWS or detail parameters that make up the scoring. Therefore, the alignment is indirect and weak, representing a general alignment with the category.",
            "The claim identifies low systolic blood pressure (SBP) in the range of 89-92 mmHg, which squarely highlights a potential sign of sepsis-associated hypotension. This condition, defined as an SBP <90 mmHg, is a direct indicator of progression towards septic shock. The SBP of 89 mmHg falls directly under this category\u2019s definition, while an SBP of 90-92 mmHg still suggests instability associated with sepsis risk. The alignment is strong and nearly full because part of the range (89 mmHg) fits exactly with the category\u2019s criteria.",
            "The claim focuses on an increased respiratory rate, specifically 25-29 breaths/min, which aligns with a component of the qSOFA score (respiratory rate \u226522/min). This heightened respiratory rate suggests a high risk of sepsis-related complications, fitting closely with the qSOFA category. The reference to potential septic shock reinforces the severity, emphasizing a strong alignment (though septic shock itself directly pertains to hypotension criteria).",
            "A low platelet count, specifically below 100\u202f\u00d7\u202f10\u2079/L (equivalent to 100 K/uL), is directly indicated as a criterion in the SOFA score for recognizing organ dysfunction related to sepsis. The platelet count of 47 K/uL is significantly below this threshold, making it a strong indicator of sepsis per the SOFA criteria. Therefore, the alignment is perfect.",
            "A low white blood cell count (<4,000/\u00b5L) is explicitly listed as one of the criteria for Systemic Inflammatory Response Syndrome (SIRS), which is used to identify systemic inflammation consistent with early sepsis. Therefore, the claim aligns perfectly with this category.",
            "The claim mentions a high body temperature of 38.2\u00b0C, which exceeds the SIRS criteria threshold for fever (>38\u00b0C). However, SIRS requires the presence of at least two criteria for full confirmation, such as altered respiratory rate, heart rate, white blood cell count, etc. While this single criterion strongly aligns with the concept of SIRS Positivity, it does not entirely confirm it as additional criteria are needed, reducing the alignment slightly from perfect.",
            "The claim suggests considering age and comorbidities in assessing sepsis risk. The elderly are specifically outlined as having markedly increased susceptibility to sepsis, capturing part of the claim's focus. However, comorbidities are not directly addressed in the listed categories, so the alignment is partial rather than complete.",
            "The claim directly states that the patient is 80 years old, which falls under the category of advanced age (\u2265\u202f65 years). Advanced age significantly increases the risk of rapid sepsis progression and higher mortality after infection, and thus perfectly aligns with the \"Elderly Susceptibility\" category.",
            "The claim emphasizes the age of the patient (80 years old), which falls under the \"Elderly Susceptibility\" category (age \u226565 years). This age factor is a significant indicator of increased risk for sepsis. However, the mention of \"significant physiological stress\" does not directly correlate with any single category, leading to a slight reduction from a perfect alignment score. Nevertheless, the advanced age itself is a strong risk factor, justifying the high alignment rating.",
            "The claim involves an 80-year-old patient, directly linking to the category of Elderly Susceptibility due to the age factor. However, the mention of potential anemia is not directly related to sepsis susceptibility or risk, which slightly reduces the alignment. The main element aligning with the category is the patient\u2019s age, hence the moderate alignment rating."
        ],
        "final_alignment_score": 0.8300000000000001,
        "accuracy": 1
    },
    {
        "input": "24: HR, 67.0; 24: RR, 21.0; 24: SpO2, 100.0; 24: SBP, 150.0; 24: DBP, 75.0; 24: MAP, 100.0; 24: Pain, 4.0; 24: Temp, 98.1; 72: SpO2, 96.85; 73: HR, 73.429; 73: SpO2, 97.448; 73: 1min HRV, 39.770; 74: HR, 76.576; 74: RR, 24.111; 74: SpO2, 97.847; 74: 1min HRV, 79.227; 74: 5min HRV, 75.764; 75: HR, 73.879; 75: RR, 24.069; 75: SpO2, 99.052; 75: 1min HRV, 64.406; 76: HR, 72.508; 76: RR, 22.203; 76: SpO2, 100.0; 76: 1min HRV, 40.756; 77: HR, 73.593; 77: RR, 22.881; 77: SpO2, 100.0; 77: 1min HRV, 84.321; 78: HR, 71.828; 78: RR, 26.414; 78: 1min HRV, 66.034; 79: HR, 71.915; 79: RR, 24.475; 79: SpO2, 99.0; 79: 1min HRV, 68.889; 79: 5min HRV, 66.426; 80: HR, 73.241; 80: RR, 26.810; 80: 1min HRV, 49.479; 81: HR, 72.729; 81: RR, 27.203; 81: 1min HRV, 70.379; 82: HR, 70.390; 82: RR, 27.136; 82: SpO2, 88.647; 82: 1min HRV, 80.163; 83: HR, 72.052; 83: RR, 27.034; 83: SpO2, 100.0; 83: 1min HRV, 56.723; 84: HR, 72.051; 84: RR, 24.610; 84: SpO2, 100.0; 84: 1min HRV, 74.728; 84: 5min HRV, 68.300; 85: HR, 71.586; 85: RR, 24.569; 85: SpO2, 99.909; 85: 1min HRV, 38.538; 86: HR, 70.627; 86: RR, 23.847; 86: SpO2, 100.0; 86: 1min HRV, 67.076; 87: POC PH (V) ISTAT, 7.30; 87: POC PCO2 (V) ISTAT, 51.4 mmHg; 87: POC O2 SATURATION ISTAT VENOUS, 30 %; 87: POC PO2 (V) ISTAT, 21 mmHg; 87: POC BASE EXCESS ISTAT, -1 mmol/L; 87: POC LACTATE ISTAT, 1.03 mmol/L; 87: POC TCO2 (V) ISTAT, 27 mmol/L; 87: POC HCO3 (V) ISTAT, 25.2 mmol/L; 87: HR, 70.966; 87: RR, 24.017; 87: SpO2, 100.0; 87: 1min HRV, 47.630; 88: HR, 70.305; 88: RR, 24.085; 88: SpO2, 100.0; 88: 1min HRV, 27.826; 89: HR, 70.034; 89: RR, 21.017; 89: SpO2, 100.0; 89: 1min HRV, 54.584; 89: 5min HRV, 49.265; 90: HR, 72.414; 90: RR, 21.862; 90: SpO2, 100.0; 90: 1min HRV, 61.558; 91: HR, 71.169; 91: RR, 22.051; 91: 1min HRV, 60.250; 92: HR, 71.121; 92: RR, 29.707; 92: SpO2, 99.957; 92: 1min HRV, 82.983; 93: HR, 71.661; 93: RR, 28.237; 93: SpO2, 99.569; 93: 1min HRV, 52.021; 94: HR, 72.932; 94: RR, 27.034; 94: SpO2, 99.322; 94: 1min HRV, 61.645; 94: 5min HRV, 65.404; 95: HR, 70.897; 95: RR, 23.328; 95: SpO2, 97.931; 95: 1min HRV, 83.476; 96: HR, 70.915; 96: RR, 22.610; 96: SpO2, 96.0; 96: 1min HRV, 129.629; 97: HR, 73.069; 97: RR, 22.310; 97: 1min HRV, 81.351; 98: HR, 70.983; 98: RR, 26.610; 98: SpO2, 96.923; 98: 1min HRV, 77.855; 99: HR, 72.441; 99: RR, 24.322; 99: SpO2, 97.844; 99: 1min HRV, 65.983; 99: 5min HRV, 85.807; 100: HR, 72.948; 100: RR, 31.707; 100: 1min HRV, 60.048; 101: HR, 70.661; 101: RR, 28.932; 101: SpO2, 96.357; 101: 1min HRV, 75.586; 102: HR, 71.569; 102: RR, 29.517; 102: SpO2, 98.471; 102: 1min HRV, 50.917; 103: HR, 71.983; 103: RR, 29.288; 103: SpO2, 98.017; 103: 1min HRV, 37.331; 104: HR, 72.390; 104: RR, 24.695; 104: SpO2, 96.373; 104: 1min HRV, 57.989; 104: 5min HRV, 58.190; 105: HR, 72.534; 105: RR, 29.086; 105: SpO2, 97.172; 105: 1min HRV, 42.429; 106: HR, 72.576; 106: RR, 29.508; 106: SpO2, 97.254; 106: 1min HRV, 54.927; 107: HR, 73.741; 107: RR, 26.862; 107: SpO2, 97.0; 107: 1min HRV, 34.070; 108: WAM DIFTYP, AUTO; 108: HEMATOCRIT (HCT), 32.9 %; 108: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 27.0 pg; 108: NRBC PERCENT (HEMATOLOGY), 0.0 %; 108: RED CELL DISTRIBUTION WIDTH (RDW), 14.5 %; 108: MONOCYTE % (AUTO DIFF), 7.9 %; 108: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.50 K/uL; 108: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 108: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.91 K/uL; 108: LYMPHOCYTE % (AUTO DIFF), 35.1 %; 108: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 108: WHITE BLOOD CELLS (WBC), 7.1 K/uL; 108: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 108: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 108: EOSINOPHIL % (AUTO DIFF), 1.5 %; 108: RED BLOOD CELLS (RBC), 4.08 MIL/uL; 108: BASOPHIL % (AUTO DIFF), 0.4 %; 108: NEUTROPHIL % (AUTO DIFF), 54.8 %; 108: BASOPHIL ABSOLUTE (AUTO DIFF), 0.03 K/uL; 108: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.4 g/dL; 108: HEMOGLOBIN (HGB), 11.0 g/dL; 108: PLATELET COUNT (PLT), 181 K/uL; 108: MEAN CORPUSCULAR VOLUME (MCV), 80.6 fL; 108: HR, 73.237; 108: RR, 24.119; 108: SpO2, 96.424; 108: 1min HRV, 72.738; 109: HR, 73.610; 109: RR, 23.203; 109: SpO2, 96.0; 109: 1min HRV, 54.247; 109: 5min HRV, 53.550; 110: HR, 75.207; 110: RR, 22.914; 110: SpO2, 96.0; 110: 1min HRV, 47.829; 111: HR, 80.424; 111: RR, 25.814; 111: 1min HRV, 65.162; 112: HR, 81.845; 112: RR, 25.655; 112: SpO2, 96.0; 112: 1min HRV, 56.303; 113: HR, 79.576; 113: RR, 24.695; 113: SpO2, 96.405; 113: 1min HRV, 69.113; 114: HR, 79.864; 114: RR, 23.610; 114: SpO2, 97.0; 114: 1min HRV, 58.916; 114: 5min HRV, 62.870; 114: SBP, 162.0; 114: DBP, 89.0; 114: MAP, 113.333; 114: LPM O2, 2.0; 114: Pain, 4.0; 115: HR, 75.241; 115: RR, 26.397; 115: SpO2, 97.0; 115: 1min HRV, 74.272; 115: SBP, 162.0; 115: DBP, 89.0; 115: MAP, 113.333; 116: HR, 76.746; 116: RR, 30.831; 116: SpO2, 96.932; 116: 1min HRV, 60.360; 117: HR, 76.017; 117: RR, 29.034; 117: SpO2, 97.771; 117: 1min HRV, 54.618; 118: HR, 75.661; 118: RR, 28.203; 118: SpO2, 97.812; 118: 1min HRV, 64.985; 119: HR, 75.379; 119: RR, 25.707; 119: SpO2, 97.86; 119: 1min HRV, 44.094; 119: 5min HRV, 60.569; 0: Age, 90; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 67.0; 0: Triage RR, 21.0; 0: Triage SBP, 150.0; 0: Triage DBP, 75.0; 0: Triage acuity, 2-Emergent; 0: CC, MULTIPLE COMPLAINTS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The first step is to look for signs such as elevated HR, RR, and abnormal SpO2, which could indicate sepsis risk. The patient's HR and RR are moderately elevated but not critically high, and SpO2 mostly remains normal, with a few dips not sustained. Next, examine the lactate, blood pH, and other lab results, which are within normal range, indicating adequate perfusion and no major physiological derangements. Finally, note the patient's age and comorbid factors but, overall, there is no significant trend toward instability or organ dysfunction pointing towards sepsis. Thus, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "Signs such as elevated heart rate (HR), respiratory rate (RR), and abnormal oxygen saturation (SpO2) could indicate sepsis risk.",
            "The patient's heart rate is moderately elevated.",
            "The patient's respiratory rate is moderately elevated.",
            "The patient's heart rate is not critically high.",
            "The patient's respiratory rate is not critically high.",
            "The patient's SpO2 mostly remains normal.",
            "The patient's SpO2 has a few dips that are not sustained.",
            "Lactate levels are within normal range.",
            "Blood pH is within normal range.",
            "Other lab results are within normal range.",
            "Normal lab results indicate adequate perfusion.",
            "Normal lab results indicate no major physiological derangements.",
            "The patient's age and comorbid factors should be considered.",
            "There is no significant trend toward instability.",
            "There is no significant trend toward organ dysfunction.",
            "The patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's SpO2 mostly remains normal.",
            "There is no significant trend toward organ dysfunction."
        ],
        "alignment_scores": [
            0.2,
            0.3
        ],
        "alignment_category": [
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The claim that the patient's SpO2 mostly remains normal suggests adequate oxygenation, indirectly implying the absence of hypoxia. While SpO2 levels are related to respiratory function and oxygenation, they are not specifically measured within the SOFA score. Thus, there is only a minimal and indirect relationship to the SOFA category, which involves indicators like PaO\u2082/FiO\u2082 ratios. The alignment is weak, as normal SpO2 itself does not suggest sepsis risk or organ dysfunction.",
            "The claim suggests that there is no significant trend toward organ dysfunction, which conceptually relates to the SOFA score used to assess organ dysfunction. Although the claim implies that the SOFA score might not have increased by \u22652 points, indicating low sepsis risk, there is a weak indirect alignment since SOFA scores are specifically used to detect organ dysfunction."
        ],
        "final_alignment_score": 0.25,
        "accuracy": 1
    },
    {
        "input": "4: HR, 106.0; 4: RR, 16.0; 4: SpO2, 98.0; 4: SBP, 131.0; 4: DBP, 64.0; 4: MAP, 86.333; 4: Pain, 5.0; 4: Temp, 99.7; 21: POC PH (V) ISTAT, 7.51; 21: POC HCO3 (V) ISTAT, 23.9 mmol/L; 21: POC BASE EXCESS ISTAT, 1 mmol/L; 21: POC PCO2 (V) ISTAT, 30.3 mmHg; 21: POC LACTATE ISTAT, 1.29 mmol/L; 21: POC O2 SATURATION ISTAT VENOUS, 55 %; 21: POC PO2 (V) ISTAT, 26 mmHg; 21: POC TCO2 (V) ISTAT, 25 mmol/L; 45: WAM DIFTYP, AUTO; 45: MONOCYTE % (AUTO DIFF), 1.4 %; 45: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.3 %; 45: BASOPHIL % (AUTO DIFF), 0.2 %; 45: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.02 K/uL; 45: MONOCYTE ABSOLUTE (AUTO DIFF), 0.09 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.7 pg; 45: HEMATOCRIT (HCT), 42.6 %; 45: RED CELL DISTRIBUTION WIDTH (RDW), 12.9 %; 45: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 45: NRBC PERCENT (HEMATOLOGY), 0.0 %; 45: RED BLOOD CELLS (RBC), 4.98 MIL/uL; 45: WHITE BLOOD CELLS (WBC), 6.6 K/uL; 45: NEUTROPHIL ABSOLUTE (AUTO DIFF), 5.91 K/uL; 45: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.52 K/uL; 45: BASOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 45: EOSINOPHIL % (AUTO DIFF), 0.2 %; 45: NEUTROPHIL % (AUTO DIFF), 90.0 %; 45: HEMOGLOBIN (HGB), 14.3 g/dL; 45: LYMPHOCYTE % (AUTO DIFF), 7.9 %; 45: MEAN CORPUSCULAR VOLUME (MCV), 85.5 fL; 45: PLATELET COUNT (PLT), 137 K/uL; 45: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.6 g/dL; 49: SpO2, 96.216; 50: HR, 97.929; 50: RR, 21.923; 50: SpO2, 97.105; 50: Perf, 2.812; 50: 1min HRV, 29.329; 50: SBP, 116.0; 50: DBP, 63.0; 50: MAP, 80.667; 51: HR, 96.559; 51: RR, 33.831; 51: SpO2, 97.361; 51: Perf, 2.605; 51: 1min HRV, 34.380; 52: HR, 96.328; 52: RR, 30.379; 52: SpO2, 97.172; 52: Perf, 3.327; 52: 1min HRV, 24.923; 52: 5min HRV, 30.085; 53: HR, 96.034; 53: RR, 25.712; 53: SpO2, 97.627; 53: Perf, 3.753; 53: 1min HRV, 25.405; 54: HR, 95.763; 54: RR, 37.576; 54: SpO2, 96.458; 54: Perf, 3.767; 54: 1min HRV, 28.660; 55: HR, 95.948; 55: RR, 28.862; 55: SpO2, 96.862; 55: Perf, 3.849; 55: 1min HRV, 23.770; 56: HR, 95.759; 56: RR, 34.759; 56: SpO2, 96.776; 56: Perf, 3.85; 56: 1min HRV, 25.753; 57: HR, 97.542; 57: RR, 29.661; 57: SpO2, 96.407; 57: Perf, 3.858; 57: 1min HRV, 28.382; 57: 5min HRV, 26.741; 58: HR, 96.424; 58: RR, 28.407; 58: SpO2, 96.051; 58: Perf, 3.928; 58: 1min HRV, 26.958; 59: HR, 98.508; 59: RR, 28.729; 59: SpO2, 96.322; 59: Perf, 4.044; 59: 1min HRV, 27.299; 59: NS IV BOLUS -, 1000 ML; 60: HR:, 97.828; 60: RR, 26.603; 60: SpO2, 96.483; 60: Perf, 3.747; 60: 1min HRV, 30.139; 61: HR, 96.102; 61: RR, 33.576; 61: SpO2, 95.220; 61: Perf, 3.977; 61: 1min HRV, 21.766; 62: HR, 95.276; 62: RR, 34.759; 62: SpO2, 95.103; 62: Perf, 4.003; 62: 1min HRV, 13.770; 62: 5min HRV, 26.118; 63: PART. THROMBOPLASTIN TIME, 28.5 seconds; 63: HR, 95.186; 63: RR, 32.966; 63: SpO2, 95.458; 63: Perf, 3.943; 63: 1min HRV, 18.218; 64: HR, 96.898; 64: RR, 28.034; 64: SpO2, 96.017; 64: Perf, 3.907; 64: 1min HRV, 26.648; 65: HR, 95.466; 65: RR, 26.655; 65: SpO2, 96.534; 65: Perf, 3.322; 65: 1min HRV, 19.805; 66: HR, 94.085; 66: RR, 35.492; 66: SpO2, 98.0; 66: Perf, 3.414; 66: 1min HRV, 27.787; 67: HR, 96.259; 67: RR, 24.069; 67: SpO2, 97.586; 67: Perf, 3.469; 67: 1min HRV, 20.987; 67: 5min HRV, 24.017; 68: HR, 101.203; 68: RR, 24.712; 68: SpO2, 98.627; 68: Perf, 3.187; 68: 1min HRV, 42.194; 69: HR, 102.483; 69: RR, 25.672; 69: SpO2, 98.466; 69: Perf, 2.435; 69: 1min HRV, 24.507; 70: HR, 98.305; 70: RR, 35.390; 70: SpO2, 97.797; 70: Perf, 3.664; 70: 1min HRV, 24.606; 71: HR, 97.966; 71: RR, 34.407; 71: SpO2, 97.0; 71: Perf, 4.119; 71: 1min HRV, 25.309; 72: HR, 97.552; 72: RR, 34.431; 72: SpO2, 96.897; 72: Perf, 4.384; 72: 1min HRV, 22.467; 72: 5min HRV, 30.756; 73: HR, 97.474; 73: RR, 32.919; 73: SpO2, 97.322; 73: Perf, 4.642; 73: 1min HRV, 24.391; 74: SpO2, 97.0; 74: Perf, 4.79; 75: BNP NT-PRO, 454 pg/mL; 75: HR, 98.0; 75: RR, 30.0; 75: SpO2, 97.0; 75: LPM O2, 2.0; 76: INR, 1.3; 76: PROTHROMBIN TIME, 15.8 seconds; 77: 5min HRV, 24.391; 82: HR, 95.0; 82: RR, 31.0; 82: SpO2, 96.0; 82: SBP, 104.0; 82: DBP, 58.0; 82: MAP, 73.333; 82: LPM O2, 2.0; 82: Pain, 0.0; 90: CREATININE, 1.38 mg/dL; 90: EGFR REFIT WITHOUT RACE (2021), 58 mL/min/1.73 m2; 90: EGFR FOR AFRICAN AMERICAN, 67 mL/min/1.73 m2; 90: ANION GAP, 15 mmol/L; 90: AST (SGOT), 42 U/L; 90: CO2, 23 mmol/L; 90: GLUCOSE, 131 mg/dL; 90: CORRECTED CALCIUM, 8.4 mg/dL; 90: ALT (SGPT), 17 U/L; 90: SODIUM, 138 mmol/L; 90: GLOBULIN, 2.9 g/dL; 90: BILIRUBIN TOTAL, 0.9 mg/dL; 90: POTASSIUM, 3.6 mmol/L; 90: BLOOD UREA NITROGEN (BUN), 21 mg/dL; 90: ALBUMIN, 4.1 g/dL; 90: CALCIUM, 8.5 mg/dL; 90: CHLORIDE, 100 mmol/L; 90: PROTEIN TOTAL, 7.0 g/dL; 90: ALKALINE PHOSPHATASE, 72 U/L; 93: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 109: SpO, 2: 97.0; 110: SpO2, 97.0; 110: Perf, 3.739; 111: SpO2, 97.0; 111: Perf, 3.808; 112: SpO2, 97.0; 112: Perf, 3.783; 113: SpO2, 97.0; 113: Perf, 3.796; 114: SpO2, 96.862; 114: Perf, 3.921; 115: PH, URINE (UA): 5.0; 115: KETONE, URINE (UA): Negative; 115: NITRITE, URINE (UA): Positive; 115: GLUCOSE, URINE (UA): Negative; 115: SPECIFIC GRAVITY, URINE (UA): 1.011; 115: SpO2, 96.593; 115: Perf, 6.781; 116: HR, 97.333; 116: RR, 34.308; 116: SpO2, 97.310; 116: Perf, 7.19; 116: 1min HRV, 16.514; 117: HR, 97.136; 117: RR, 32.847; 117: SpO2, 97.339; 117: Perf, 7.19; 117: 1min HRV, 11.804; 117: 5min HRV, 13.074; 118: HR, 96.881; 118: RR, 33.305; 118: SpO2, 97.0; 118: Perf, 7.1; 118: 1min HRV, 12.584; 119: HR, 96.310; 119: RR, 32.103; 119: SpO2, 96.759; 119: Perf, 6.88; 119: 1min HRV, 3.420; 0: Age, 56; 0: Gender, M; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 37.6; 0: Triage HR, 106.0; 0: Triage RR, 16.0; 0: Triage SBP, 131.0; 0: Triage DBP, 64.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER,BREATHING PROBLEM",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To predict sepsis risk, we need to assess key indicators such as altered vital signs, abnormal laboratory results, and clinical symptoms. The patient in question presents with an elevated heart rate (tachycardia), moderate oxygen saturation, and slightly increased respiratory rate, which can suggest systemic stress but not definitively sepsis. Laboratory results, such as lactate levels and white blood cell count, are not significantly abnormal. Additionally, while the patient presents with fever and breathing issues, which can be concerning, there is no clear evidence of severe hypoperfusion or organ dysfunction that would indicate a high likelihood of sepsis. Thus, based on available data, the risk of developing sepsis within 12 hours seems low.",
        "claims": [
            "To predict sepsis risk, we need to assess key indicators.",
            "Key indicators for assessing sepsis risk include altered vital signs.",
            "Key indicators for assessing sepsis risk include abnormal laboratory results.",
            "Key indicators for assessing sepsis risk include clinical symptoms.",
            "The patient presents with an elevated heart rate (tachycardia).",
            "The patient has moderate oxygen saturation.",
            "The patient has a slightly increased respiratory rate.",
            "An elevated heart rate, moderate oxygen saturation, and slightly increased respiratory rate can suggest systemic stress.",
            "The presence of elevated heart rate, moderate oxygen saturation, and slightly increased respiratory rate does not definitively indicate sepsis.",
            "Laboratory results such as lactate levels and white blood cell count are not significantly abnormal.",
            "The patient presents with fever.",
            "The patient presents with breathing issues.",
            "Fever and breathing issues can be concerning.",
            "There is no clear evidence of severe hypoperfusion in the patient.",
            "There is no clear evidence of organ dysfunction in the patient.",
            "The lack of severe hypoperfusion or organ dysfunction reduces the likelihood of sepsis.",
            "Based on available data, the risk of developing sepsis within 12 hours seems low."
        ],
        "relevant_claims": [
            "The patient presents with an elevated heart rate (tachycardia).",
            "An elevated heart rate, moderate oxygen saturation, and slightly increased respiratory rate can suggest systemic stress.",
            "The presence of elevated heart rate, moderate oxygen saturation, and slightly increased respiratory rate does not definitively indicate sepsis.",
            "There is no clear evidence of organ dysfunction in the patient.",
            "The lack of severe hypoperfusion or organ dysfunction reduces the likelihood of sepsis."
        ],
        "alignment_scores": [
            0.7,
            0.7,
            0.7,
            0.7,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)"
        ],
        "alignment_reasonings": [
            "Tachycardia, or an elevated heart rate (>90 bpm), is one of the criteria used in SIRS to identify systemic inflammation consistent with early sepsis. While only one SIRS criterion is mentioned, and not a complete set to fully meet SIRS positivity, the claim directly relates to this criterion, indicating a moderate alignment.",
            "The claim discusses an elevated heart rate and slightly increased respiratory rate, both of which are components of the SIRS criteria. While the claim mentions \"moderate oxygen saturation,\" it is more closely related to stress than directly matching SIRS positivity. The alignment is significant but not complete, given the lack of specific SIRS thresholds being met explicitly in the claim.",
            "The claim mentions an elevated heart rate and a slightly increased respiratory rate, which are both components of the SIRS criteria. While moderate oxygen saturation is not directly a SIRS criterion, the combined presence of elevated heart rate and increased respiratory rate suggests systemic inflammation, aligning significantly, though not definitively, with SIRS positivity.",
            "The claim indicates an absence of organ dysfunction, which directly relates to the SOFA score's purpose of detecting new organ dysfunction. Although there is no increase in the SOFA score, the claim's content is highly relevant to this category, as the SOFA score measurement confirms or rules out organ dysfunction relevant to sepsis risk. The alignment is relatively strong because lack of organ dysfunction directly impacts the SOFA assessment.",
            "The claim's mention of \"lack of severe hypoperfusion\" indirectly relates to serum lactate levels, as elevated lactate is an indicator of tissue hypoperfusion. However, the claim is phrased in the negative, stating what is absent rather than present, and does not directly mention lactate levels. Thus, the alignment is weak but present due to the conceptual linkage between hypoperfusion and lactate."
        ],
        "final_alignment_score": 0.6199999999999999,
        "accuracy": 0
    },
    {
        "input": "6: HR, 113.0; 6: RR, 18.0; 6: SpO2, 100.0; 6: SBP, 129.0; 6: DBP, 99.0; 6: MAP, 109.0; 6: Pain, 8.0; 6: Temp, 97.5; 14: SpO2, 98.0; 14: Perf, 3.832; 15: SpO2, 98.0; 15: Perf, 2.722; 16: SpO2, 97.828; 16: Perf, 2.920; 17: SpO2, 98.797; 17: Perf, 4.697; 18: SpO2, 97.949; 18: Perf, 5.500; 19: SpO2, 97.776; 19: Perf, 4.514; 20: SpO2, 98.186; 20: Perf, 3.809; 21: SpO2, 98.0; 21: Perf, 5.181; 22: POC, HCG, ISTAT QUALITATIVE: Negative; 22: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 22: SpO2, 97.237; 22: Perf, 5.756; 23: POC PH (V) ISTAT, 7.44; 23: POC O2 SATURATION ISTAT VENOUS, 76 %; 23: POC BASE EXCESS ISTAT, 0 mmol/L; 23: POC LACTATE ISTAT, 1.46 mmol/L; 23: POC PO2 (V) ISTAT, 39 mmHg; 23: POC PCO2 (V) ISTAT, 36.1 mmHg; 23: POC HCO3 (V) ISTAT, 24.6 mmol/L; 23: POC TCO2 (V) ISTAT, 26 mmol/L; 23: SpO2, 98.051; 23: Perf, 3.662; 24: SpO2, 97.190; 24: Perf, 4.291; 25: SpO2, 97.559; 25: Perf, 2.529; 26: SpO2, 97.534; 26: Perf, 2.696; 27: SpO2, 98.780; 27: Perf, 3.376; 28: SpO2, 98.85; 28: Perf, 4.125; 38: HR, 96.0; 38: SpO2, 99.0; 38: SBP, 130.0; 38: DBP, 89.0; 38: MAP, 102.667; 38: Pain, 8.0; 40: SpO2, 98.781; 40: HYDROMORPHONE, 1 MG/ML INJ SYRG; 40: ONDANSETRON HCL (PF), 4 MG/2 ML INJ SOLN; 41: SpO2, 98.552; 41: Perf, 1.926; 42: SpO2, 97.983; 42: Perf, 1.936; 43: SpO2, 97.793; 43: Perf, 1.598; 44: SpO2, 98.186; 44: Perf, 1.330; 45: SpO2, 97.627; 45: Perf, 4.355; 46: SpO2, 95.948; 46: Perf, 6.526; 47: SpO2, 95.814; 47: Perf, 7.211; 48: SpO2, 94.897; 48: Perf, 7.489; 49: SpO2, 94.949; 49: Perf, 7.38; 50: SpO2, 95.288; 50: Perf, 6.922; 51: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 29.4 pg; 51: RED CELL DISTRIBUTION WIDTH (RDW), 15.7 %; 51: PLATELET COUNT (PLT), 237 K/uL; 51: RED BLOOD CELLS (RBC), 4.69 MIL/uL; 51: WHITE BLOOD CELLS (WBC), 14.3 K/uL; 51: HEMOGLOBIN (HGB), 13.8 g/dL; 51: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.8 g/dL; 51: HEMATOCRIT (HCT), 40.8 %; 51: MEAN CORPUSCULAR VOLUME (MCV), 87.0 fL; 51: SpO2, 95.534; 51: Perf, 6.612; 52: SpO2, 95.136; 52: Perf, 6.263; 53: SpO2, 95.724; 53: Perf, 5.561; 54: SpO2, 96.712; 54: Perf, 4.76; 55: SpO2, 97.237; 55: Perf, 5.833; 56: SpO2, 96.362; 56: Perf, 4.918; 57: SpO2, 95.847; 57: Perf, 3.894; 58: SpO2, 97.052; 58: Perf, 3.035; 59: SpO2, 97.932; 59: Perf, 1.960; 60: SpO2, 97.508; 60: Perf, 1.363; 61: SpO2, 98.621; 61: Perf, 0.817; 62: SpO2, 98.441; 62: Perf, 0.831; 63: SpO2, 97.811; 63: Perf, 0.81; 64: SpO2, 97.457; 64: Perf, 0.933; 65: SpO2, 98.0; 65: Perf, 1.696; 66: SpO2, 97.017; 66: Perf, 2.477; 67: SpO2, 97.0; 67: Perf, 2.975; 68: SpO2, 96.293; 68: Perf, 3.856; 69: SpO2, 97.017; 69: Perf, 2.624; 70: BILIRUBIN TOTAL, 0.8 mg/dL; 70: BLOOD UREA NITROGEN (BUN), 16 mg/dL; 70: EGFR FOR AFRICAN AMERICAN, 83 mL/min/1.73 m2; 70: CALCIUM, 8.7 mg/dL; 70: EGFR REFIT WITHOUT RACE (2021), 72 mL/min/1.73 m2; 70: ALT (SGPT), 35 U/L; 70: CHLORIDE, 104 mmol/L; 70: PROTEIN TOTAL, 6.4 g/dL; 70: GLOBULIN, 3.0 g/dL; 70: SODIUM, 137 mmol/L; 70: CO2, 23 mmol/L; 70: ANION GAP, 10 mmol/L; 70: POTASSIUM, 4.2 mmol/L; 70: CORRECTED CALCIUM, 9.2 mg/dL; 70: GLUCOSE, 197 mg/dL; 70: CREATININE, 1.04 mg/dL; 70: AST (SGOT), 58 U/L; 70: ALBUMIN, 3.4 g/dL; 70: ALKALINE PHOSPHATASE, 152 U/L; 70: SpO2, 96.458; 70: Perf, 3.956; 71: SpO2, 95.983; 71: Perf, 3.871; 72: SpO2, 97.136; 72: Perf, 2.959; 73: SpO2, 97.552; 73: Perf, 1.859; 74: SpO2, 96.831; 74: Perf, 1.531; 75: SpO2, 96.672; 75: Perf, 2.519; 76: SpO2, 96.034; 76: Perf, 4.384; 77: SpO2, 96.068; 77: Perf, 5.572; 78: SpO2, 96.259; 78: Perf, 5.864; 79: SpO2, 96.339; 79: Perf, 4.983; 80: SpO2, 95.948; 80: Perf, 4.156; 81: SpO2, 96.0; 81: Perf, 6.151; 82: SpO2, 95.322; 82: Perf, 6.860; 83: SpO2, 95.569; 83: Perf, 6.102; 84: SpO2, 97.542; 84: Perf, 2.928; 85: SpO2, 97.603; 85: Perf, 2.236; 86: SpO2, 97.407; 86: Perf, 1.993; 87: SpO2, 97.763; 87: Perf, 2.127; 88: SpO2, 98.517; 88: Perf, 1.963; 89: SpO2, 98.163; 89: Perf, 2.272; 90: SpO2, 97.983; 90: Perf, 1.775; 91: SpO2, 98.712; 91: Perf, 1.189; 92: SpO2, 98.136; 92: Perf, 1.692; 93: SpO2, 98.0; 93: Perf, 1.553; 94: SpO2, 97.695; 94: Perf, 1.424; 95: SpO2, 97.828; 95: Perf, 1.935; 96: SpO2, 97.864; 96: Perf, 2.417; 97: SpO2, 97.424; 97: Perf, 3.952; 98: SpO2, 97.948; 98: Perf, 2.007; 98: Pain, 8.0; 98: HYDROMORPHONE, 1 MG/ML INJ SYRG; 99: SpO, 2: 97.407; 99: Perf, 1.745; 100: SpO2, 97.207; 100: Perf, 2.058; 101: SpO2, 98.475; 101: Perf, 1.515; 102: SpO2, 96.559; 102: Perf, 4.064; 103: SpO2, 95.672; 103: Perf, 6.009; 104: SpO2, 95.797; 104: Perf, 6.499; 105: LIPASE, 3 U/L; 105: SpO2, 96.690; 105: Perf, 6.050; 106: SpO2, 96.085; 106: Perf, 4.536; 107: HR, 100.0; 107: RR, 16.0; 107: SpO2, 96.103; 107: Perf, 3.992; 107: SBP, 122.0; 107: DBP, 83.0; 107: MAP, 96.0; 107: Pain, 7.0; 107: LR IV BOLUS -, 1000 ML; 108: SpO, 2: 95.830; 108: Perf, 4.809; 109: SpO2, 96.593; 109: Perf, 2.287; 110: SpO2, 96.862; 110: Perf, 3.286; 111: SpO2, 96.814; 111: Perf, 5.008; 112: SpO2, 96.155; 112: Perf, 6.273; 113: SpO2, 96.0; 113: Perf, 7.343; 114: SpO2, 96.0; 114: Perf, 8.217; 115: SpO2, 96.0; 115: Perf, 8.392; 116: SpO2, 96.0; 116: Perf, 8.23; 117: SpO2, 96.0; 117: Perf, 7.856; 118: SpO2, 96.186; 118: Perf, 7.616; 119: SpO2, 96.254; 119: Perf, 5.937; 0: Age, 30; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.4; 0: Triage HR, 113.0; 0: Triage RR, 18.0; 0: Triage SBP, 129.0; 0: Triage DBP, 99.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "The initial assessment of the patient shows an elevated heart rate (113 bpm) but overall stable vital signs, including normal respiratory rate, oxygen saturation, and blood pressure, though the patient reports significant abdominal pain. Over the next several hours, despite variations, vital signs remain within generally stable ranges. There is no evidence of marked hypoxemia, hyperlactemia, or organ dysfunction, and laboratory values do not strongly suggest sepsis. Therefore, the patient is not at high risk of developing sepsis within the next 12 hours.",
        "claims": [
            "The initial assessment of the patient shows an elevated heart rate of 113 bpm.",
            "The patient has overall stable vital signs.",
            "The patient has a normal respiratory rate.",
            "The patient has normal oxygen saturation.",
            "The patient has normal blood pressure.",
            "The patient reports significant abdominal pain.",
            "Vital signs remain within generally stable ranges over the next several hours.",
            "There is no evidence of marked hypoxemia.",
            "There is no evidence of hyperlactemia.",
            "There is no evidence of organ dysfunction.",
            "Laboratory values do not strongly suggest sepsis.",
            "Therefore, the patient is not at high risk of developing sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The initial assessment of the patient shows an elevated heart rate of 113 bpm.",
            "There is no evidence of hyperlactemia.",
            "There is no evidence of organ dysfunction.",
            "Laboratory values do not strongly suggest sepsis."
        ],
        "alignment_scores": [
            0.5,
            0.8,
            0.6,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "SOFA Score Increase (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The elevated heart rate of 113 bpm exceeds the SIRS criterion of a heart rate >90 bpm, which indicates systemic inflammation consistent with early sepsis. Since elevated heart rate is one of the SIRS criteria, this claim aligns reasonably well with the category, but only addresses one of the necessary multiple criteria (\u22652) for the full SIRS positivity definition, resulting in a moderate alignment rating.",
            "The claim directly references the absence of hyperlactatemia, which is relevant to the expert category of elevated serum lactate (\u22652 mmol/L). The category specifically uses elevated lactate levels as a marker for sepsis risk. Since the claim mentions the lack of this condition, this strongly relates to the category, even though it suggests low risk rather than high. Hence, the alignment is high but not perfect due to the negative result.",
            "The claim indicates an absence of organ dysfunction, which indirectly points to a scenario where there is no increase in SOFA score. While it doesn't match the category's specific focus on a score increase, understanding organ function is central to SOFA evaluations. The alignment is not direct, but the concept of assessing organ function is related.",
            "The claim that laboratory values do not strongly suggest sepsis implies a lack of clinical suspicion or urgency\u2014contrary to ordering early antibiotics or cultures. While this indirectly hints at the absence of indicators prompting early sepsis intervention, it doesn't align with any specific action or clear clinical criterion from the categories provided. Thus, the alignment is weak."
        ],
        "final_alignment_score": 0.5499999999999999,
        "accuracy": 0
    },
    {
        "input": "6: Pain, 3.0; 11: HR, 110.0; 11: RR, 16.0; 11: SpO2, 98.0; 11: SBP, 101.0; 11: DBP, 71.0; 11: MAP, 81.0; 11: Temp, 100.6; 72: HR, 92.222; 72: RR, 21.875; 72: 1min HRV, 43.704; 73: HR, 89.305; 73: RR, 17.288; 73: SpO2, 98.8; 73: 1min HRV, 29.523; 73: 5min HRV, 33.011; 74: HR, 90.915; 74: RR, 18.271; 74: SpO2, 99.339; 74: 1min HRV, 25.600; 75: HR, 91.966; 75: RR, 12.310; 75: SpO2, 99.067; 75: 1min HRV, 33.168; 76: HR, 92.542; 76: RR, 11.017; 76: SpO2, 98.478; 76: 1min HRV, 25.871; 77: HR, 90.724; 77: RR, 11.052; 77: 1min HRV, 46.247; 78: HR, 91.0; 78: RR, 13.983; 78: 1min HRV, 41.994; 78: 5min HRV, 36.581; 79: HR, 89.271; 79: RR, 21.220; 79: SpO2, 98.630; 79: 1min HRV, 38.635; 80: HR, 90.362; 80: RR, 17.621; 80: SpO2, 98.793; 80: 1min HRV, 25.565; 81: HR, 89.724; 81: RR, 16.879; 81: SpO2, 99.707; 81: Perf, 1.096; 81: 1min HRV, 23.929; 82: HR, 91.424; 82: RR, 17.610; 82: SpO2, 98.949; 82: Perf, 1.005; 82: 1min HRV, 24.082; 83: HR, 88.458; 83: RR, 18.373; 83: SpO2, 98.864; 83: Perf, 0.826; 83: 1min HRV, 38.059; 83: 5min HRV, 31.944; 83: ACETAMINOPHEN, 500 MG PO TABS; 83: OXYCODONE, 5 MG PO TABS; 83: KETOROLAC, 15 MG/ML INJ SOLN; 84: HR:, 90.254; 84: RR, 16.983; 84: SpO2, 99.051; 84: Perf, 0.804; 84: 1min HRV, 30.058; 85: HR, 90.534; 85: RR, 12.517; 85: SpO2, 98.579; 85: Perf, 0.836; 85: 1min HRV, 27.375; 86: HR, 96.610; 86: RR, 15.678; 86: SpO2, 98.797; 86: Perf, 0.833; 86: 1min HRV, 31.678; 87: HR, 91.914; 87: RR, 20.276; 87: SpO2, 99.5; 87: Perf, 0.746; 87: 1min HRV, 29.713; 88: HR, 91.593; 88: RR, 20.780; 88: SpO2, 99.339; 88: Perf, 0.707; 88: 1min HRV, 20.362; 88: 5min HRV, 31.524; 89: HR, 88.186; 89: RR, 24.390; 89: SpO2, 99.847; 89: Perf, 0.611; 89: 1min HRV, 28.514; 90: HR, 86.017; 90: RR, 24.776; 90: SpO2, 99.0; 90: Perf, 0.495; 90: 1min HRV, 31.844; 91: HR, 86.780; 91: RR, 23.254; 91: SpO2, 99.339; 91: Perf, 0.51; 91: 1min HRV, 45.691; 92: HR, 89.655; 92: RR, 23.328; 92: SpO2, 98.966; 92: Perf, 0.562; 92: 1min HRV, 34.010; 93: HR, 90.207; 93: RR, 21.879; 93: SpO2, 99.862; 93: Perf, 0.567; 93: 1min HRV, 20.106; 93: 5min HRV, 35.050; 93: Pain, 2.0; 94: POC PH (V) ISTAT, 7.42; 94: POC BASE EXCESS ISTAT, 3 mmol/L; 94: POC PO2 (V) ISTAT, 21 mmHg; 94: POC TCO2 (V) ISTAT, 29 mmol/L; 94: POC PCO2 (V) ISTAT, 42.8 mmHg; 94: POC O2 SATURATION ISTAT VENOUS, 35 %; 94: POC LACTATE ISTAT, 0.65 mmol/L; 94: POC HCO3 (V) ISTAT, 27.7 mmol/L; 94: HR, 90.55; 94: RR, 17.9; 94: SpO2, 98.942; 94: Perf, 0.58; 94: 1min HRV, 31.606; 95: HR, 88.534; 95: RR, 22.086; 95: SpO2, 99.622; 95: Perf, 0.550; 95: 1min HRV, 26.931; 96: HR, 91.017; 96: RR, 22.576; 96: SpO2, 98.847; 96: Perf, 0.441; 96: 1min HRV, 25.494; 96: NORMOSOL-R IV BOLUS -, 2000 ML; 97: HR:, 85.966; 97: RR, 27.155; 97: SpO2, 99.810; 97: Perf, 0.425; 97: 1min HRV, 25.770; 98: HR, 86.593; 98: RR, 22.780; 98: SpO2, 99.559; 98: Perf, 0.628; 98: 1min HRV, 36.433; 98: 5min HRV, 32.757; 99: HR, 84.576; 99: RR, 19.424; 99: SpO2, 99.763; 99: Perf, 1.418; 99: 1min HRV, 43.134; 100: HR, 88.603; 100: RR, 20.328; 100: SpO2, 99.517; 100: Perf, 0.829; 100: 1min HRV, 28.072; 101: HR, 88.305; 101: RR, 22.542; 101: SpO2, 99.288; 101: Perf, 0.703; 101: 1min HRV, 62.987; 102: HR, 87.517; 102: RR, 19.776; 102: SpO2, 99.259; 102: Perf, 0.7; 102: 1min HRV, 30.948; 103: HR, 90.356; 103: RR, 20.305; 103: SpO2, 99.288; 103: Perf, 0.7; 103: 1min HRV, 20.254; 103: 5min HRV, 41.813; 104: HR, 89.086; 104: RR, 18.121; 104: SpO2, 99.362; 104: Perf, 0.7; 104: 1min HRV, 24.861; 105: HR, 90.034; 105: RR, 20.847; 105: SpO2, 99.305; 105: Perf, 0.7; 105: 1min HRV, 22.729; 106: HR, 91.475; 106: RR, 18.712; 106: SpO2, 99.542; 106: Perf, 0.7; 106: 1min HRV, 11.326; 107: HR, 90.534; 107: RR, 21.293; 107: SpO2, 99.45; 107: Perf, 0.7; 107: 1min HRV, 20.989; 108: HR, 91.729; 108: RR, 18.898; 108: SpO2, 99.390; 108: 1min HRV, 17.928; 108: 5min HRV, 21.353; 109: HR, 90.345; 109: RR, 19.448; 109: SpO2, 99.034; 109: 1min HRV, 23.798; 110: HR, 90.932; 110: RR, 20.780; 110: SpO2, 99.492; 110: 1min HRV, 14.083; 111: HR, 90.237; 111: RR, 21.593; 111: SpO2, 98.932; 111: 1min HRV, 14.092; 112: HR, 93.510; 112: RR, 25.067; 112: SpO2, 99.034; 112: 1min HRV, 24.214; 113: HR, 93.155; 113: RR, 25.04; 113: SpO2, 98.797; 113: Perf, 3.01; 113: 1min HRV, 17.315; 113: 5min HRV, 21.145; 114: HR, 89.483; 114: RR, 25.684; 114: SpO2, 99.362; 114: Perf, 3.138; 114: 1min HRV, 30.205; 115: HR, 94.583; 115: RR, 22.361; 115: SpO2, 98.712; 115: Perf, 2.212; 115: 1min HRV, 17.856; 116: HR, 89.814; 116: RR, 19.729; 116: SpO2, 98.864; 116: Perf, 2.262; 116: 1min HRV, 43.068; 117: HR, 86.914; 117: RR, 15.966; 117: SpO2, 99.069; 117: Perf, 2.278; 117: 1min HRV, 71.766; 118: HR, 82.414; 118: RR, 12.276; 118: SpO2, 98.690; 118: Perf, 2.049; 118: 1min HRV, 73.083; 118: 5min HRV, 61.493; 119: HR, 86.949; 119: RR, 17.169; 119: SpO2, 98.915; 119: Perf, 1.853; 119: 1min HRV, 53.403; 0: Age, 25; 0: Gender, M; 0: Race, White; 0: Means of arrival, Other/Unknown; 0: Triage Temp, 38.1; 0: Triage HR, 110.0; 0: Triage RR, 16.0; 0: Triage SBP, 101.0; 0: Triage DBP, 71.0; 0: Triage acuity, 3-Urgent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The easiest subquestion to consider is whether there are immediate signs of severe sepsis, such as elevated heart rate (tachycardia), fever, low blood pressure, or respiratory distress, within the first two hours. The presenting HR of 110, fever at 38.1\u00b0C, and normal/near-normal blood pressure do suggest some risk factors, but beyond the initial 2 hours, we see stabilization and improvement. The subsequent data over the next period do not show significant deterioration; instead, the heart rate largely remains stable in the 80s-90s, RR stabilizes below the critical threshold, SpO2 is consistently high, and HRV shows variability but not consistently decreasing, thus indicating no high risk for sepsis within 12 hours.",
        "claims": [
            "There may be immediate signs of severe sepsis within the first two hours.",
            "Signs of severe sepsis can include elevated heart rate, fever, low blood pressure, or respiratory distress.",
            "The presenting heart rate is 110.",
            "A fever of 38.1\u00b0C is present.",
            "The blood pressure is normal or near-normal.",
            "The presenting heart rate, fever, and normal/near-normal blood pressure suggest some risk factors.",
            "Beyond the initial 2 hours, stabilization and improvement are observed.",
            "Subsequent data do not show significant deterioration.",
            "The heart rate largely remains stable in the 80s-90s.",
            "The respiratory rate stabilizes below the critical threshold.",
            "The SpO2 is consistently high.",
            "Heart rate variability shows variability but is not consistently decreasing.",
            "This data indicates no high risk for sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The presenting heart rate is 110.",
            "A fever of 38.1\u00b0C is present.",
            "The presenting heart rate, fever, and normal/near-normal blood pressure suggest some risk factors."
        ],
        "alignment_scores": [
            0.9,
            0.8,
            0.8
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "A heart rate greater than 90 bpm is one of the criteria for SIRS, which indicates the presence of systemic inflammation and aligns with an increased risk of sepsis. Since the claim directly provides a heart rate over this threshold, it is strongly aligned, but SIRS positivity requires two criteria, so the alignment isn't perfect.",
            "A fever of 38.1\u00b0C meets the SIRS criterion for temperature, which is >38\u00b0C. This directly aligns with one of the SIRS criteria used to identify systemic inflammation consistent with early sepsis. The alignment is strong because it exactly matches one part of the requirement for SIRS positivity.",
            "The claim mentions a heart rate and fever, both of which are part of the SIRS criteria (heart rate\u202f>\u202f90\u202fbpm and temperature\u202f>\u202f38\u202f\u00b0C or\u202f<\u202f36\u202f\u00b0C). While normal/near-normal blood pressure doesn't align with SIRS directly, the presence of two potential SIRS criteria is central to the evaluation. This makes the alignment quite strong, but without exact values, it's not definitive, thus a 0.8 rating."
        ],
        "final_alignment_score": 0.8333333333333334,
        "accuracy": 1
    },
    {
        "input": "4: HR, 82.0; 4: RR, 16.0; 4: SpO2, 100.0; 4: SBP, 146.0; 4: DBP, 98.0; 4: MAP, 114.0; 4: Pain, 7.0; 4: Temp, 98.1; 7: Pain, 7.0; 33: WAM DIFTYP, AUTO; 33: NEUTROPHIL % (AUTO DIFF), 62.5 %; 33: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.31 K/uL; 33: NRBC PERCENT (HEMATOLOGY), 0.0 %; 33: MONOCYTE % (AUTO DIFF), 7.0 %; 33: PLATELET COUNT (PLT), 367 K/uL; 33: HEMATOCRIT (HCT), 38.3 %; 33: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.6 pg; 33: BASOPHIL % (AUTO DIFF), 0.3 %; 33: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 33: HEMOGLOBIN (HGB), 13.4 g/dL; 33: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 33: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.5 %; 33: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 33: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.79 K/uL; 33: NEUTROPHIL ABSOLUTE (AUTO DIFF), 8.63 K/uL; 33: MONOCYTE ABSOLUTE (AUTO DIFF), 0.96 K/uL; 33: EOSINOPHIL % (AUTO DIFF), 2.2 %; 33: MEAN CORPUSCULAR VOLUME (MCV), 90.3 fL; 33: RED CELL DISTRIBUTION WIDTH (RDW), 11.2 %; 33: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.0 g/dL; 33: LYMPHOCYTE % (AUTO DIFF), 27.5 %; 33: WHITE BLOOD CELLS (WBC), 13.8 K/uL; 33: RED BLOOD CELLS (RBC), 4.24 MIL/uL; 38: HR, 80.0; 38: SpO2, 99.0; 38: SBP, 162.0; 38: DBP, 101.0; 38: MAP, 121.333; 39: HR, 83.0; 39: SpO2, 98.407; 39: Perf, 2.286; 39: SBP, 159.0; 39: DBP, 107.0; 39: MAP, 124.333; 40: SpO2, 98.793; 40: Perf, 1.983; 41: SpO2, 99.017; 41: Perf, 1.678; 42: SpO2, 98.831; 42: Perf, 1.288; 43: SpO2, 99.103; 43: Perf, 1.572; 44: SpO2, 98.773; 44: Perf, 2.47; 44: SBP, 142.0; 44: DBP, 97.0; 44: MAP, 112.0; 45: SpO2, 99.310; 45: Perf, 2.105; 46: SpO2, 98.525; 46: Perf, 2.503; 47: PH, URINE (UA): 6.0; 47: KETONE, URINE (UA): Negative; 47: SPECIFIC GRAVITY, URINE (UA): 1.010; 47: PROTEIN, URINE (UA): Negative; 47: LEUKOCYTE ESTERASE, URINE (UA): Negative; 47: NITRITE, URINE (UA): Negative; 47: GLUCOSE, URINE (UA): Negative; 47: SpO2, 98.169; 47: Perf, 2.853; 48: HR, 79.0; 48: RR, 18.0; 48: SpO2, 98.138; 48: Perf, 2.775; 48: SBP, 142.0; 48: DBP, 97.0; 48: MAP, 112.0; 49: SpO2, 98.695; 49: Perf, 3.093; 50: SpO2, 98.621; 50: Perf, 3.136; 51: SpO2, 97.881; 51: Perf, 3.083; 52: SpO2, 98.222; 52: Perf, 2.428; 60: SODIUM, 137 mmol/L; 60: BLOOD UREA NITROGEN (BUN), 9 mg/dL; 60: ALT (SGPT), 95 U/L; 60: BILIRUBIN TOTAL, 0.4 mg/dL; 60: ALBUMIN, 4.5 g/dL; 60: PROTEIN TOTAL, 8.5 g/dL; 60: CALCIUM, 9.7 mg/dL; 60: CHLORIDE, 101 mmol/L; 60: CORRECTED CALCIUM, 9.3 mg/dL; 60: GLOBULIN, 4.0 g/dL; 60: GLUCOSE, 167 mg/dL; 60: CREATININE, 0.44 mg/dL; 60: ALKALINE PHOSPHATASE, 96 U/L; 60: AST (SGOT), 58 U/L; 60: POTASSIUM, 3.7 mmol/L; 60: ANION GAP, 12 mmol/L; 60: CO2, 24 mmol/L; 60: EGFR REFIT WITHOUT RACE (2021), 132 mL/min/1.73 m2; 66: SpO2, 98.273; 66: SBP, 138.0; 66: DBP, 91.0; 66: MAP, 106.667; 67: SpO2, 98.119; 67: Perf, 1.559; 68: HR, 79.0; 68: SpO2, 98.776; 68: Perf, 2.141; 68: SBP, 138.0; 68: DBP, 91.0; 68: MAP, 106.667; 69: SpO2, 98.102; 69: Perf, 2.627; 70: SpO2, 97.431; 70: Perf, 2.77; 71: SpO2, 97.424; 71: Perf, 2.602; 72: SpO2, 98.138; 72: Perf, 1.685; 73: SpO2, 98.203; 73: Perf, 1.359; 74: SpO2, 98.542; 74: Perf, 1.387; 75: SpO2, 97.017; 75: Perf, 1.193; 76: SpO2, 99.658; 76: Perf, 1.508; 77: SpO2, 99.052; 77: Perf, 4.531; 78: SpO2, 99.458; 78: Perf, 3.426; 79: SpO2, 98.797; 79: Perf, 3.575; 80: SpO2, 98.276; 80: Perf, 2.550; 81: SpO2, 97.102; 81: Perf, 2.810; 82: SpO2, 95.966; 82: Perf, 2.693; 83: SpO2, 98.203; 83: Perf, 1.976; 84: SpO2, 97.356; 84: Perf, 2.381; 85: SpO2, 97.362; 85: Perf, 2.297; 86: SpO2, 95.390; 86: Perf, 2.546; 87: SpO2, 95.190; 87: Perf, 2.503; 88: SpO2, 95.932; 88: Perf, 2.038; 89: SpO2, 95.593; 89: Perf, 1.964; 90: SpO2, 98.121; 90: Perf, 1.987; 91: SpO2, 98.593; 91: Perf, 1.973; 92: SpO2, 99.121; 92: Perf, 2.620; 93: SpO2, 97.0; 93: Perf, 3.478; 94: SpO2, 93.322; 94: Perf, 3.164; 95: SpO2, 98.707; 95: Perf, 1.441; 96: SpO2, 97.729; 96: Perf, 1.631; 97: SpO2, 99.0; 97: Perf, 1.952; 98: SpO2, 99.102; 98: Perf, 2.415; 99: SpO2, 98.695; 99: Perf, 2.855; 100: SpO2, 98.5; 100: Perf, 3.036; 101: SpO2, 98.237; 101: Perf, 2.378; 102: SpO2, 98.241; 102: Perf, 2.211; 103: SpO2, 98.797; 103: Perf, 3.313; 104: SpO2, 98.845; 104: Perf, 2.617; 105: SpO2, 98.559; 105: Perf, 2.219; 106: SpO2, 98.492; 106: Perf, 1.441; 107: SpO2, 98.483; 107: Perf, 1.413; 108: SpO2, 98.356; 108: Perf, 1.123; 109: HIGH SENSITIVITY TROPONIN, <4 ng/L; 109: SpO2, 97.897; 109: Perf, 1.762; 110: SpO2, 97.966; 110: Perf, 2.066; 111: SpO2, 98.339; 111: Perf, 4.271; 112: SpO2, 98.724; 112: Perf, 4.038; 113: SpO2, 98.678; 113: Perf, 3.599; 114: SpO2, 98.879; 114: Perf, 5.345; 115: SpO2, 99.169; 115: Perf, 4.547; 116: SpO2, 98.627; 116: Perf, 4.874; 117: INFLUENZA B, Not Detected; 117: RSV, Not Detected; 117: SARS-COV-2 RNA, Not Detected; 117: INFLUENZA A, Not Detected; 117: SpO2, 98.397; 117: Perf, 2.488; 118: HR, 74.0; 118: RR, 16.0; 118: SpO2, 99.339; 118: Perf, 2.690; 118: SBP, 138.0; 118: DBP, 90.0; 118: MAP, 106.0; 119: SpO2, 98.897; 119: Perf, 4.056; 0: Age, 33; 0: Gender, F; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 82.0; 0: Triage RR, 16.0; 0: Triage SBP, 146.0; 0: Triage DBP, 98.0; 0: Triage acuity, 3-Urgent; 0: CC, HEADACHE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, we evaluate signs such as abnormal vital signs, elevated White Blood Cell (WBC) count, and clinical indicators like low blood pressure, high heart rate, or signs of infection. The patient maintains stable blood pressure and heart rate, normal respiratory rate, and SpO2 levels. Although the WBC count is slightly elevated, there is no significant trend or additional clinical signs indicating a high risk of sepsis. Consequently, the data does not strongly suggest a high risk of sepsis within the next 12 hours.",
        "claims": [
            "To determine the sepsis risk, we evaluate signs such as abnormal vital signs, elevated White Blood Cell (WBC) count, and clinical indicators like low blood pressure, high heart rate, or signs of infection.",
            "The patient maintains stable blood pressure and heart rate.",
            "The patient has a normal respiratory rate.",
            "The patient has normal SpO2 levels.",
            "The WBC count is slightly elevated.",
            "There is no significant trend in the WBC count.",
            "There are no additional clinical signs indicating a high risk of sepsis.",
            "The data does not strongly suggest a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient maintains stable blood pressure and heart rate.",
            "The WBC count is slightly elevated.",
            "There is no significant trend in the WBC count.",
            "There are no additional clinical signs indicating a high risk of sepsis.",
            "The data does not strongly suggest a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.3,
            0.7,
            0.2,
            0.2,
            0.0
        ],
        "alignment_category": [
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "None of the provided categories"
        ],
        "alignment_reasonings": [
            "The claim indicates stability in blood pressure and heart rate, which suggests an absence of hemodynamic instability, the opposite of what the Elevated Shock Index category would typically indicate (a shock index \u22651.0 denotes instability). The claim's information is indirectly related, as it verifies the absence of criteria that would contribute to an elevated shock index. This indirect association gives a low alignment rating, as the information only weakly informs the category by indicating what's not happening rather than providing positive evidence.",
            "The claim mentions an elevated white blood cell (WBC) count, which directly relates to one of the SIRS criteria (WBC > 12,000/\u00b5L). However, the term \"slightly elevated\" suggests it might not fully meet the threshold defined in the SIRS criteria. Nevertheless, it indicates a potential inflammatory response, making it relevant to SIRS, although possibly not meeting all explicit criteria, hence the rating of 0.7.",
            "The claim about no significant trend in WBC count doesn\u2019t strongly or directly relate to any specific category. However, WBC count is one of the criteria used for SIRS Positivity. Given that SIRS requires elevated or decreased WBC counts as part of its criteria, the lack of a significant trend weakly relates to the SIRS Positivity category. The alignment is minimal because the claim suggests neither increase nor decrease to meet the SIRS threshold.",
            "The claim suggests the absence of specific clinical signs for high sepsis risk, hinting at a scenario where a clinician might be cautious but not yet compelled to take immediate action like ordering antibiotics or cultures. This is weakly related to the \"Early Antibiotic/Culture Orders\" category, which implies clinical suspicion of infection. The alignment is very indirect and tenuous since no specific actions or signs are mentioned.",
            "The claim indicates that there is no strong suggestion of high sepsis risk, which does not specifically align with any of the expert categories geared towards identifying sepsis risk factors or criteria. Each provided category pertains to explicit criteria or indicators of increased sepsis risk, none of which appear to be met according to the claim. Therefore, there is no alignment with the current claim."
        ],
        "final_alignment_score": 0.27999999999999997,
        "accuracy": 1
    },
    {
        "input": "6: SpO2, 100.0; 6: 1min HRV, 0.0; 6: 5min HRV, 0.0; 7: HR, 89.619; 7: RR, 22.685; 7: SpO2, 99.944; 7: 1min HRV, 11.931; 7: SBP, 121.0; 7: DBP, 79.0; 7: MAP, 93.0; 7: Pain, 0.0; 7: Temp, 99.2; 8: HR, 85.983; 8: RR, 17.322; 8: SpO2, 98.407; 8: Perf, 1.51; 8: 1min HRV, 15.479; 9: HR, 85.186; 9: RR, 17.966; 9: SpO2, 99.610; 9: Perf, 1.854; 9: 1min HRV, 12.859; 10: HR, 82.138; 10: RR, 21.569; 10: SpO2, 99.983; 10: Perf, 3.417; 10: 1min HRV, 8.644; 10: SBP, 121.0; 10: DBP, 79.0; 10: MAP, 93.0; 11: HR, 80.610; 11: RR, 20.407; 11: SpO2, 98.983; 11: Perf, 3.693; 11: 1min HRV, 9.208; 11: 5min HRV, 28.237; 12: HR, 80.879; 12: RR, 20.310; 12: SpO2, 99.724; 12: Perf, 3.354; 12: 1min HRV, 7.965; 12: SBP, 126.0; 12: DBP, 74.0; 12: MAP, 91.333; 13: HR, 80.627; 13: RR, 19.339; 13: SpO2, 99.407; 13: Perf, 4.203; 13: 1min HRV, 21.634; 14: HR, 83.407; 14: RR, 19.881; 14: SpO2, 100.0; 14: Perf, 3.270; 14: 1min HRV, 14.516; 15: HR, 83.828; 15: RR, 20.741; 15: SpO2, 100.0; 15: Perf, 2.916; 15: 1min HRV, 13.868; 16: HR, 82.780; 16: RR, 20.559; 16: SpO2, 100.0; 16: Perf, 3.216; 16: 1min HRV, 14.416; 16: 5min HRV, 18.190; 17: HR, 83.379; 17: RR, 19.776; 17: SpO2, 99.914; 17: Perf, 3.048; 17: 1min HRV, 12.498; 18: HR, 83.593; 18: RR, 18.475; 18: SpO2, 99.780; 18: Perf, 3.221; 18: 1min HRV, 9.845; 19: HR, 83.483; 19: RR, 18.414; 19: SpO2, 100.0; 19: Perf, 3.773; 19: 1min HRV, 15.395; 20: HR, 82.102; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 4.452; 20: 1min HRV, 12.347; 21: HR, 80.983; 21: RR, 21.644; 21: SpO2, 100.0; 21: Perf, 4.297; 21: 1min HRV, 8.791; 21: 5min HRV, 14.222; 22: HR, 81.534; 22: RR, 22.586; 22: SpO2, 100.0; 22: Perf, 4.374; 22: 1min HRV, 10.385; 23: HR, 81.695; 23: RR, 21.814; 23: SpO2, 100.0; 23: Perf, 4.000; 23: 1min HRV, 8.485; 24: HR, 84.0; 24: RR, 18.103; 24: SpO2, 99.828; 24: Perf, 3.904; 24: 1min HRV, 17.086; 25: HR, 80.932; 25: RR, 21.949; 25: SpO2, 99.898; 25: Perf, 2.998; 25: 1min HRV, 14.699; 26: HR, 79.661; 26: RR, 23.542; 26: SpO2, 100.0; 26: Perf, 3.536; 26: 1min HRV, 11.626; 26: 5min HRV, 18.159; 27: HR, 80.069; 27: RR, 19.241; 27: SpO2, 100.0; 27: Perf, 3.759; 27: 1min HRV, 11.552; 28: HR, 81.407; 28: RR, 21.831; 28: SpO2, 100.0; 28: Perf, 4.380; 28: 1min HRV, 42.345; 29: HR, 80.741; 29: RR, 23.379; 29: SpO2, 99.281; 29: Perf, 4.449; 29: 1min HRV, 15.668; 30: HR, 86.542; 30: RR, 24.441; 30: SpO2, 98.974; 30: Perf, 4.22; 30: 1min HRV, 10.281; 31: HR, 80.729; 31: RR, 22.153; 31: SpO2, 99.068; 31: Perf, 4.201; 31: 1min HRV, 41.651; 31: 5min HRV, 37.735; 32: HR, 77.362; 32: RR, 20.603; 32: SpO2, 98.741; 32: Perf, 4.049; 32: 1min HRV, 74.029; 33: HR, 78.610; 33: RR, 22.712; 33: SpO2, 99.0; 33: Perf, 3.340; 33: 1min HRV, 21.139; 34: HR, 79.241; 34: RR, 20.379; 34: SpO2, 99.793; 34: Perf, 2.175; 34: 1min HRV, 30.534; 35: HR, 77.492; 35: RR, 22.356; 35: SpO2, 100.0; 35: Perf, 1.999; 35: 1min HRV, 34.039; 36: HR, 78.0; 36: RR, 15.576; 36: SpO2, 100.0; 36: Perf, 2.634; 36: 1min HRV, 21.351; 36: 5min HRV, 41.722; 37: HR, 78.241; 37: RR, 23.914; 37: SpO2, 100.0; 37: Perf, 2.585; 37: 1min HRV, 27.046; 38: HR, 78.254; 38: RR, 23.542; 38: SpO2, 100.0; 38: Perf, 2.801; 38: 1min HRV, 22.826; 38: NS IV BOLUS -, 1000 ML; 39: HR:, 80.776; 39: RR, 20.483; 39: SpO2, 100.0; 39: Perf, 2.416; 39: 1min HRV, 23.835; 39: ACETAMINOPHEN, 500 MG PO TABS; 40: HR:, 82.458; 40: RR, 18.847; 40: SpO2, 100.0; 40: Perf, 1.982; 40: 1min HRV, 21.585; 41: HR, 83.915; 41: RR, 22.644; 41: SpO2, 99.203; 41: Perf, 1.928; 41: 1min HRV, 31.481; 41: 5min HRV, 34.632; 42: HR, 80.259; 42: RR, 25.103; 42: SpO2, 99.586; 42: Perf, 1.913; 42: 1min HRV, 22.326; 42: SBP, 127.0; 42: DBP, 98.0; 42: MAP, 107.667; 43: HR, 77.593; 43: RR, 25.203; 43: SpO2, 100.0; 43: Perf, 3.700; 43: 1min HRV, 23.540; 44: HR, 77.241; 44: RR, 23.707; 44: SpO2, 100.0; 44: Perf, 4.000; 44: 1min HRV, 17.694; 45: HR, 78.949; 45: RR, 19.847; 45: SpO2, 99.746; 45: Perf, 3.578; 45: 1min HRV, 71.802; 46: 5min HRV, 40.598; 54: WAM DIFTYP, AUTO; 54: MONOCYTE % (AUTO DIFF), 17.1 %; 54: NEUTROPHIL ABSOLUTE (AUTO DIFF), 1.40 K/uL; 54: PLATELET COUNT (PLT), 251 K/uL; 54: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.20 K/uL; 54: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.2 %; 54: HEMATOCRIT (HCT), 30.9 %; 54: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.04 K/uL; 54: MONOCYTE ABSOLUTE (AUTO DIFF), 0.56 K/uL; 54: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 54: LYMPHOCYTE % (AUTO DIFF), 36.6 %; 54: BASOPHIL % (AUTO DIFF), 1.8 %; 54: EOSINOPHIL % (AUTO DIFF), 0.6 %; 54: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 35.3 g/dL; 54: WHITE BLOOD CELLS (WBC), 3.3 K/uL; 54: MEAN CORPUSCULAR VOLUME (MCV), 86.3 fL; 54: RED BLOOD CELLS (RBC), 3.58 MIL/uL; 54: NEUTROPHIL % (AUTO DIFF), 42.7 %; 54: RED CELL DISTRIBUTION WIDTH (RDW), 16.8 %; 54: NRBC PERCENT (HEMATOLOGY), 0.0 %; 54: HEMOGLOBIN (HGB), 10.9 g/dL; 54: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 54: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.4 pg; 54: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 95: HR, 89.0; 95: RR, 20.0; 95: SpO2, 99.0; 95: SBP, 135.0; 95: DBP, 73.0; 95: MAP, 93.667; 95: GABAPENTIN, 600 MG PO TABS; 111: TROPONIN I: <., 017 ng/mL; 0: Age, 71; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 37.3; 0: Triage HR, 81.0; 0: Triage RR, 18.0; 0: Triage SBP, 121.0; 0: Triage DBP, 79.0; 0: Triage acuity, 3-Urgent; 0: CC, RAPID HEART RATE",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To predict the risk of sepsis, important indicators include vital signs, heart rate variability, and inflammation markers. The patient's vitals (HR, RR, BP, SpO2) remain stable within normal ranges. No significant deterioration in heart rate variability or acute changes in temperature suggest systemic infection. Hematology results like white blood cell count and neutrophil count (both indicators of infection response) are not elevated but rather low, suggesting no active infection. These factors combined indicate a low risk of sepsis in the next 12 hours.",
        "claims": [
            "To predict the risk of sepsis, important indicators include vital signs, heart rate variability, and inflammation markers.",
            "The patient's vital signs remain stable within normal ranges.",
            "The heart rate variability has not significantly deteriorated.",
            "There are no acute changes in temperature suggesting systemic infection.",
            "The white blood cell count is low.",
            "The neutrophil count is low.",
            "Low white blood cell and neutrophil counts suggest no active infection.",
            "These factors combined indicate a low risk of sepsis in the next 12 hours."
        ],
        "relevant_claims": [
            "There are no acute changes in temperature suggesting systemic infection.",
            "Low white blood cell and neutrophil counts suggest no active infection."
        ],
        "alignment_scores": [
            0.3,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "The claim pertains to temperature changes, a criterion for SIRS that is used to identify systemic inflammation and early sepsis. The absence of changes suggests no current indication of SIRS, making the alignment indirect and weak.",
            "The claim refers to low white blood cell counts, which are explicitly mentioned under the SIRS criteria (<4,000/\u00b5L). While a low WBC count can be indicative of a lack of infection, it is also a component of SIRS, which is used to assess systemic inflammation in early sepsis. The alignment is not perfect because the low WBC is interpreted as suggesting the absence of infection, but it still conceptually aligns with the SIRS criteria."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 1
    },
    {
        "input": "2: HR, 117.0; 2: RR, 18.0; 2: SpO2, 97.0; 2: SBP, 127.0; 2: DBP, 74.0; 2: MAP, 91.667; 2: Temp, 101.0; 11: Pain, 4.0; 25: RR, 18.0; 28: POC PH (V) ISTAT, 7.45; 28: POC BASE EXCESS ISTAT, 6 mmol/L; 28: POC PO2 (V) ISTAT, 20 mmHg; 28: POC O2 SATURATION ISTAT VENOUS, 33 %; 28: POC LACTATE ISTAT, 1.05 mmol/L; 28: POC HCO3 (V) ISTAT, 30.4 mmol/L; 28: POC PCO2 (V) ISTAT, 44.3 mmHg; 28: POC TCO2 (V) ISTAT, 32 mmol/L; 30: ACETAMINOPHEN, 500 MG PO TABS; 55: INR:, 1.0; 55: PROTHROMBIN TIME, 14.0 seconds; 56: PART. THROMBOPLASTIN TIME, 30.6 seconds; 61: SARS-COV-2 RNA, Not Detected; 72: HR, 109.543; 72: RR, 14.92; 72: 1min HRV, 10.910; 72: SBP, 125.0; 72: DBP, 77.0; 72: MAP, 93.0; 73: HR, 108.661; 73: RR, 20.322; 73: SpO2, 98.0; 73: 1min HRV, 9.919; 73: 5min HRV, 10.791; 73: SBP, 125.0; 73: DBP, 77.0; 73: MAP, 93.0; 73: Pain, 6.0; 73: Temp, 97.2; 74: HR, 109.780; 74: RR, 15.373; 74: 1min HRV, 9.975; 75: HR, 107.241; 75: RR, 18.914; 75: 1min HRV, 13.266; 76: HR, 105.356; 76: RR, 21.169; 76: 1min HRV, 8.440; 77: CREATININE, 0.89 mg/dL; 77: PROTEIN TOTAL, 8.4 g/dL; 77: BLOOD UREA NITROGEN (BUN), 11 mg/dL; 77: AST (SGOT), 46 U/L; 77: CO2, 27 mmol/L; 77: ALT (SGPT), 31 U/L; 77: BILIRUBIN TOTAL, 0.8 mg/dL; 77: ANION GAP, 11 mmol/L; 77: CHLORIDE, 95 mmol/L; 77: POTASSIUM, 4.2 mmol/L; 77: EGFR REFIT WITHOUT RACE (2021), 102 mL/min/1.73 m2; 77: GLUCOSE, 112 mg/dL; 77: CALCIUM, 8.8 mg/dL; 77: GLOBULIN, 4.1 g/dL; 77: CORRECTED CALCIUM, 8.6 mg/dL; 77: SODIUM, 133 mmol/L; 77: ALBUMIN, 4.3 g/dL; 77: ALKALINE PHOSPHATASE, 73 U/L; 77: LIPASE, 27 U/L; 77: HR, 107.517; 77: RR, 19.690; 77: 1min HRV, 13.170; 78: HR, 104.915; 78: RR, 19.475; 78: 1min HRV, 7.905; 78: 5min HRV, 13.380; 79: HR, 106.678; 79: RR, 23.237; 79: 1min HRV, 10.356; 80: HR, 106.966; 80: RR, 19.397; 80: 1min HRV, 10.673; 81: HR, 107.102; 81: RR, 21.559; 81: 1min HRV, 22.506; 82: HR, 105.466; 82: RR, 19.345; 82: 1min HRV, 10.033; 83: HR, 105.288; 83: RR, 18.017; 83: 1min HRV, 16.411; 83: 5min HRV, 15.158; 84: HR, 104.847; 84: RR, 18.441; 84: 1min HRV, 15.242; 85: HR, 105.603; 85: RR, 12.879; 85: 1min HRV, 14.937; 86: HR, 103.780; 86: RR, 20.780; 86: 1min HRV, 11.609; 87: HR, 105.857; 87: RR, 17.079; 87: 1min HRV, 23.708; 88: HR, 106.169; 88: RR, 18.333; 88: 1min HRV, 11.407; 88: 5min HRV, 16.147; 89: HR, 104.897; 89: RR, 20.810; 89: 1min HRV, 18.039; 90: HR, 104.621; 90: RR, 15.621; 90: 1min HRV, 10.529; 91: HR, 105.695; 91: RR, 19.712; 91: 1min HRV, 22.887; 92: HR, 106.069; 92: RR, 21.328; 92: 1min HRV, 19.021; 93: HR, 104.0; 93: RR, 17.542; 93: 1min HRV, 7.265; 93: 5min HRV, 17.503; 94: HR, 102.845; 94: RR, 21.983; 94: 1min HRV, 10.541; 95: HR, 102.102; 95: RR, 21.593; 95: 1min HRV, 11.068; 96: HR, 104.576; 96: RR, 23.237; 96: 1min HRV, 11.313; 97: HR, 104.759; 97: RR, 21.138; 97: 1min HRV, 19.620; 98: HR, 102.559; 98: RR, 21.288; 98: 1min HRV, 11.768; 98: 5min HRV, 14.812; 99: HR, 103.246; 99: RR, 22.807; 99: 1min HRV, 22.341; 100: HEMATOCRIT (HCT), 43.7 %; 100: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.0 pg; 100: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.1 g/dL; 100: RED CELL DISTRIBUTION WIDTH (RDW), 10.9 %; 100: WHITE BLOOD CELLS (WBC), 7.0 K/uL; 100: RED BLOOD CELLS (RBC), 4.80 MIL/uL; 100: MEAN CORPUSCULAR VOLUME (MCV), 91.0 fL; 100: PLATELET COUNT (PLT), 199 K/uL; 100: HEMOGLOBIN (HGB), 14.9 g/dL; 100: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 35.7 %; 100: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: EOSINOPHILS % (MANUAL DIFF), 0.9 %; 100: NEUTROPHILS BANDS % (MANUAL DIFF), 36.4 %; 100: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 5.08 K/uL; 100: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.73 K/uL; 100: BASOPHILS % (MANUAL DIFF), 0.9 %; 100: MONOCYTES % (MANUAL DIFF), 10.4 %; 100: LYMPHOCYTES VARIANT % (MANUAL DIFF), 0.9 %; 100: LYMPHOCYTES % (MANUAL DIFF), 14.8 %; 100: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: BASOPHILS ABSOLUTE (MANUAL DIFF), 0.06 K/uL; 100: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.04 K/uL; 100: HR, 103.576; 100: RR, 20.627; 100: 1min HRV, 14.543; 101: HR, 102.746; 101: RR, 25.254; 101: 1min HRV, 13.129; 102: HR, 108.08; 102: RR, 20.714; 102: 1min HRV, 31.538; 103: HR, 105.153; 103: RR, 10.763; 103: 1min HRV, 17.801; 103: 5min HRV, 22.944; 104: HR, 101.862; 104: RR, 16.569; 104: 1min HRV, 9.539; 104: SBP, 122.0; 104: DBP, 83.0; 104: MAP, 96.0; 105: HR, 102.441; 105: RR, 18.356; 105: 1min HRV, 22.460; 106: HR, 100.254; 106: RR, 22.322; 106: 1min HRV, 10.142; 107: HR, 104.276; 107: RR, 26.655; 107: 1min HRV, 19.422; 108: HR, 99.552; 108: RR, 17.017; 108: 1min HRV, 14.436; 108: 5min HRV, 19.297; 109: HR, 100.879; 109: RR, 17.431; 109: 1min HRV, 18.475; 110: HR, 100.983; 110: RR, 15.661; 110: 1min HRV, 17.022; 111: HR, 102.424; 111: RR, 16.0; 111: 1min HRV, 21.414; 111: LR IV BOLUS -, 1000 ML; 112: HR:, 101.5; 112: RR, 19.879; 112: 1min HRV, 23.754; 113: HR, 99.153; 113: RR, 18.525; 113: 1min HRV, 11.421; 113: 5min HRV, 19.897; 114: HR, 99.812; 114: RR, 16.667; 114: 1min HRV, 11.782; 118: 5min HRV, 11.782; 0: Age, 53; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 38.3; 0: Triage HR, 117.0; 0: Triage RR, 18.0; 0: Triage SBP, 127.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To predict the sepsis risk, we need to assess the patient's vital signs, laboratory results, and clinical presentation. Initially, the patient had an elevated heart rate (HR 117), elevated temperature (38.3\u00b0C), and was triaged as emergent, suggesting a potential risk. Over time, despite fluctuations, key indicators like HR, respiratory rate (RR), blood pressure, white blood cell count (WBC), and lactate levels remained stable and not critically abnormal. The lactate, an important sepsis marker, was low (1.05 mmol/L). Also, the patient's condition seems stable without significant deterioration or additional sepsis indicators, hence the label \"No\" is appropriate.",
        "claims": [
            "To predict the sepsis risk, we need to assess the patient's vital signs, laboratory results, and clinical presentation.",
            "The patient had an elevated heart rate of 117.",
            "The patient had an elevated temperature of 38.3\u00b0C.",
            "The patient was triaged as emergent.",
            "An elevated heart rate and elevated temperature suggest a potential risk for sepsis.",
            "Key indicators like heart rate, respiratory rate, blood pressure, white blood cell count, and lactate levels remained stable over time.",
            "The key indicators were not critically abnormal.",
            "The lactate level was low at 1.05 mmol/L.",
            "The lactate level is an important sepsis marker.",
            "The patient's condition appears stable.",
            "There has been no significant deterioration in the patient's condition.",
            "There were no additional indicators suggesting sepsis.",
            "The label \"No\" is appropriate for predicting sepsis risk."
        ],
        "relevant_claims": [
            "The patient had an elevated heart rate of 117.",
            "An elevated heart rate and elevated temperature suggest a potential risk for sepsis.",
            "The key indicators were not critically abnormal."
        ],
        "alignment_scores": [
            0.8,
            1.0,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim mentions an elevated heart rate of 117, which meets one of the SIRS criteria (heart rate > 90 bpm). This directly relates to systemic inflammation consistent with early sepsis, indicating a strong alignment with this category. However, full compliance with SIRS requires meeting at least two criteria, so it's not a complete match, warranting a slightly less than perfect rating.",
            "The claim indicates an elevated heart rate and elevated temperature, both of which fall under the SIRS criteria. The presence of \u22652 SIRS criteria is used to identify systemic inflammation consistent with early sepsis. Consequently, there is perfect alignment between the claim and this category.",
            "The claim suggests that the indicators were not critically abnormal, meaning there likely wasn't significant clinical deterioration typically flagged by a high NEWS score. However, the NEWS score involves evaluating multiple vitals and clinical indicators for risk assessment, so the absence of critical abnormalities might relate slightly to a lower NEWS score suggesting reduced sepsis risk. The alignment is weak because it does not specifically reference the criteria or a result that clearly connects to the NEWS score or other categories."
        ],
        "final_alignment_score": 0.7000000000000001,
        "accuracy": 1
    },
    {
        "input": "4: HR, 107.811; 4: RR, 20.453; 4: SpO2, 97.875; 4: 1min HRV, 98.468; 5: HR, 103.660; 5: RR, 17.604; 5: SpO2, 95.154; 5: 1min HRV, 130.891; 5: 5min HRV, 117.559; 5: SBP, 109.0; 5: DBP, 67.0; 5: MAP, 81.0; 5: Temp, 97.7; 6: HR, 103.808; 6: RR, 18.712; 6: SpO2, 94.0; 6: 1min HRV, 119.633; 7: HR, 101.774; 7: RR, 22.0; 7: SpO2, 94.0; 7: 1min HRV, 106.343; 8: HR, 102.558; 8: RR, 17.635; 8: SpO2, 98.775; 8: 1min HRV, 142.784; 9: HR, 106.604; 9: RR, 20.283; 9: SpO2, 98.818; 9: 1min HRV, 114.243; 10: HR, 110.170; 10: RR, 19.623; 10: SpO2, 97.115; 10: 1min HRV, 130.733; 10: 5min HRV, 125.114; 11: HR, 105.981; 11: RR, 21.327; 11: SpO2, 97.545; 11: 1min HRV, 110.793; 12: HR, 97.075; 12: RR, 18.962; 12: SpO2, 99.139; 12: 1min HRV, 154.971; 13: HR, 105.923; 13: RR, 19.308; 13: SpO2, 98.674; 13: 1min HRV, 121.821; 14: HR, 102.08; 14: RR, 23.057; 14: SpO2, 99.053; 14: Perf, 0.24; 14: 1min HRV, 127.983; 15: HR, 107.358; 15: RR, 19.962; 15: SpO2, 99.729; 15: Perf, 0.255; 15: 1min HRV, 142.063; 15: 5min HRV, 135.303; 16: HR, 105.404; 16: RR, 19.48; 16: SpO2, 99.654; 16: Perf, 0.268; 16: 1min HRV, 131.069; 16: SBP, 108.0; 16: DBP, 72.0; 16: MAP, 84.0; 17: HR, 102.113; 17: RR, 21.333; 17: SpO2, 99.5; 17: Perf, 0.287; 17: 1min HRV, 118.922; 18: HR, 107.404; 18: RR, 22.25; 18: SpO2, 99.25; 18: Perf, 0.292; 18: 1min HRV, 136.870; 19: HR, 105.396; 19: RR, 19.660; 19: SpO2, 99.020; 19: Perf, 0.297; 19: 1min HRV, 112.584; 20: HR, 104.755; 20: RR, 18.279; 20: SpO2, 99.06; 20: Perf, 0.268; 20: 1min HRV, 145.764; 20: 5min HRV, 130.300; 21: HR, 105.942; 21: RR, 22.827; 21: SpO2, 99.913; 21: Perf, 0.25; 21: 1min HRV, 160.123; 22: HR, 107.887; 22: RR, 24.566; 22: SpO2, 99.0; 22: Perf, 0.25; 22: 1min HRV, 97.245; 23: HR, 107.404; 23: RR, 18.673; 23: Perf, 0.25; 23: 1min HRV, 100.277; 24: HR, 107.16; 24: RR, 22.472; 24: Perf, 0.25; 24: 1min HRV, 50.432; 25: HR, 109.396; 25: RR, 19.453; 25: SpO2, 98.679; 25: 1min HRV, 151.744; 25: 5min HRV, 130.502; 26: HR, 98.442; 26: RR, 18.8; 26: SpO2, 98.312; 26: 1min HRV, 145.506; 27: HR, 104.396; 27: RR, 18.717; 27: SpO2, 96.943; 27: Perf, 0.498; 27: 1min HRV, 123.708; 28: HR, 104.385; 28: RR, 23.7; 28: SpO2, 98.282; 28: Perf, 0.492; 28: 1min HRV, 128.235; 29: HR, 104.660; 29: RR, 17.019; 29: SpO2, 98.0; 29: Perf, 0.49; 29: 1min HRV, 135.629; 30: HR, 107.936; 30: RR, 26.5; 30: SpO2, 97.933; 30: Perf, 0.481; 30: 1min HRV, 148.137; 30: 5min HRV, 137.295; 31: HR, 102.453; 31: RR, 19.388; 31: SpO2, 97.849; 31: Perf, 0.506; 31: 1min HRV, 146.413; 31: SBP, 107.0; 31: DBP, 76.0; 31: MAP, 86.333; 32: HR, 106.038; 32: RR, 19.491; 32: SpO2, 97.226; 32: Perf, 0.482; 32: 1min HRV, 113.776; 33: HR, 101.851; 33: RR, 21.538; 33: SpO2, 99.419; 33: Perf, 0.433; 33: 1min HRV, 146.124; 34: HR, 107.151; 34: RR, 17.962; 34: SpO2, 98.293; 34: Perf, 0.418; 34: 1min HRV, 115.549; 35: HR, 106.904; 35: RR, 18.519; 35: SpO2, 98.0; 35: Perf, 0.41; 35: 1min HRV, 112.346; 35: 5min HRV, 126.538; 36: HR, 100.914; 36: RR, 22.019; 36: Perf, 0.41; 36: 1min HRV, 61.116; 37: HR, 108.041; 37: RR, 15.395; 37: Perf, 0.41; 37: 1min HRV, 132.412; 38: HR, 105.7; 38: RR, 21.02; 38: SpO2, 98.682; 38: Perf, 0.412; 38: 1min HRV, 134.087; 39: HR, 103.717; 39: RR, 19.906; 39: SpO2, 97.769; 39: Perf, 0.465; 39: 1min HRV, 134.831; 40: HR, 98.962; 40: RR, 19.744; 40: SpO2, 98.636; 40: Perf, 0.478; 40: 1min HRV, 183.842; 40: 5min HRV, 150.445; 41: WAM DIFTYP, AUTO; 41: LYMPHOCYTE % (AUTO DIFF), 7.7 %; 41: NRBC PERCENT (HEMATOLOGY), 0.0 %; 41: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 28.4 pg; 41: BASOPHIL % (AUTO DIFF), 0.1 %; 41: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.01 K/uL; 41: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.4 %; 41: PLATELET COUNT (PLT), 195 K/uL; 41: HEMOGLOBIN (HGB), 11.5 g/dL; 41: BASOPHIL ABSOLUTE (AUTO DIFF), 0.02 K/uL; 41: WHITE BLOOD CELLS (WBC), 16.4 K/uL; 41: NEUTROPHIL % (AUTO DIFF), 87.1 %; 41: NEUTROPHIL ABSOLUTE (AUTO DIFF), 14.27 K/uL; 41: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.07 K/uL; 41: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.6 g/dL; 41: HEMATOCRIT (HCT), 37.6 %; 41: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 41: RED BLOOD CELLS (RBC), 4.05 MIL/uL; 41: RED CELL DISTRIBUTION WIDTH (RDW), 16.4 %; 41: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 41: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 41: MONOCYTE ABSOLUTE (AUTO DIFF), 0.76 K/uL; 41: EOSINOPHIL % (AUTO DIFF), 0.1 %; 41: MONOCYTE % (AUTO DIFF), 4.6 %; 41: HR, 103.824; 41: RR, 19.275; 41: SpO2, 96.981; 41: Perf, 0.493; 41: 1min HRV, 149.126; 45: 5min HRV, 149.126; 68: ALT (SGPT), 63 U/L; 68: BLOOD UREA NITROGEN (BUN), 31 mg/dL; 68: CO2, 21 mmol/L; 68: PROTEIN TOTAL, 6.4 g/dL; 68: CHLORIDE, 106 mmol/L; 68: ALKALINE PHOSPHATASE, 107 U/L; 68: ANION GAP, 12 mmol/L; 68: EGFR FOR AFRICAN AMERICAN, 62 mL/min/1.73 m2; 68: AST (SGOT), 82 U/L; 68: BILIRUBIN TOTAL, 0.4 mg/dL; 68: SODIUM, 139 mmol/L; 68: GLUCOSE, 239 mg/dL; 68: POTASSIUM, 4.3 mmol/L; 68: CORRECTED CALCIUM, 10.5 mg/dL; 68: EGFR REFIT WITHOUT RACE (2021), 54 mL/min/1.73 m2; 68: CREATININE, 0.88 mg/dL; 68: GLOBULIN, 3.2 g/dL; 68: CALCIUM, 9.9 mg/dL; 68: ALBUMIN, 3.2 g/dL; 89: SARS-COV-2 RNA, Not Detected; 91: LIPASE, 25 U/L; 91: BNP NT-PRO, 28823 pg/mL; 107: TROPONIN I, 0.665 ng/mL; 107: TROPONIN I, 0.665 ng/mL; 0: Age, 90; 0: Gender, F; 0: Race, Other; 0: Means of arrival, EMS; 0: Triage Temp, 36.5; 0: Triage HR, 91.0; 0: Triage RR, 13.0; 0: Triage SBP, 109.0; 0: Triage DBP, 67.0; 0: Triage acuity, 2-Emergent; 0: CC, FATIGUE,IRREGULAR HEART BEAT,ARM SWELLING",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess the sepsis risk, we need to evaluate signs such as abnormal vital signs, lab results, and clinical features indicating infection or organ dysfunction. The patient, aged 90 with symptoms like fatigue and irregular heartbeat, presents with relatively stable vital signs, normal to slightly elevated heart rate and respiratory rate, and sufficient SpO2 levels. Laboratory data show elevated white blood cells (16.4 K/uL) and BNP NT-PRO (28823 pg/mL), but no significant markers suggest severe infection or organ failure, such as very high lactate or CRP levels. The troponin level is elevated, pointing to potential cardiac stress, but this alone doesn't indicate a high risk for sepsis within 12 hours. Given these observations, the risk of sepsis appears low.",
        "claims": [
            "To assess the sepsis risk, we need to evaluate signs such as abnormal vital signs, lab results, and clinical features indicating infection or organ dysfunction.",
            "The patient is aged 90.",
            "The patient presents with symptoms like fatigue and irregular heartbeat.",
            "The patient's vital signs are relatively stable.",
            "The patient's heart rate is normal to slightly elevated.",
            "The patient's respiratory rate is normal to slightly elevated.",
            "The patient has sufficient SpO2 levels.",
            "Laboratory data show elevated white blood cells at 16.4 K/uL.",
            "Laboratory data show BNP NT-PRO at 28823 pg/mL.",
            "There are no significant markers suggesting severe infection or organ failure.",
            "Lactate levels are not very high.",
            "CRP levels are not very high.",
            "The troponin level is elevated.",
            "Elevated troponin points to potential cardiac stress.",
            "Elevated troponin alone does not indicate a high risk for sepsis within 12 hours.",
            "Given these observations, the risk of sepsis appears low."
        ],
        "relevant_claims": [
            "Laboratory data show elevated white blood cells at 16.4 K/uL.",
            "Laboratory data show BNP NT-PRO at 28823 pg/mL.",
            "There are no significant markers suggesting severe infection or organ failure."
        ],
        "alignment_scores": [
            1.0,
            0.2,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated SOFA Score (\u22652 points)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "The claim directly references an elevated white blood cell count (16.4 K/uL), which exceeds the SIRS criterion of >12,000 WBC/\u00b5L. This is directly aligned with the criteria for identifying systemic inflammation consistent with early sepsis, resulting in perfect alignment.",
            "BNP (Brain Natriuretic Peptide) is not explicitly part of the SOFA criteria but can be related to cardiac function and stress. An elevated BNP suggests heart strain or failure, which might indicate hemodynamic instability or organ dysfunction. However, BNP is not a direct component of SOFA or a typical sepsis marker, so the alignment is weak.",
            "The claim emphasizes the absence of significant markers for severe infection or organ failure. While this loosely aligns with the concept that no action (like antibiotics or cultures) was deemed necessary, it lacks direct reference to any specific category condition. The alignment is indirect and weak because the statement primarily highlights the absence of indications for sepsis-related interventions."
        ],
        "final_alignment_score": 0.5,
        "accuracy": 0
    },
    {
        "input": "8: Pain, 7.0; 27: HR, 120.0; 27: RR, 22.0; 27: SpO2, 95.0; 27: SBP, 81.0; 27: DBP, 55.0; 27: MAP, 63.667; 27: LPM O2, 3.0; 27: Temp, 98.1; 56: POC, HCG, ISTAT QUALITATIVE: Negative; 56: POC, BHCG, ISTAT QUANTITATIVE: <5.0 IU/L; 65: SpO2, 87.3; 65: SBP, 88.0; 65: DBP, 64.0; 65: MAP, 72.0; 66: SpO2, 86.370; 66: SBP, 94.0; 66: DBP, 62.0; 66: MAP, 72.667; 67: SpO2, 92.661; 67: Perf, 0.203; 68: HR, 118.385; 68: RR, 15.385; 68: SpO2, 94.729; 68: Perf, 0.220; 68: 1min HRV, 64.080; 69: HR, 117.793; 69: RR, 22.241; 69: SpO2, 95.897; 69: Perf, 0.259; 69: 1min HRV, 9.480; 69: SBP, 94.0; 69: DBP, 62.0; 69: MAP, 72.667; 69: LPM O2, 4.0; 69: Temp, 98.3; 70: HR, 117.559; 70: RR, 24.136; 70: SpO2, 96.492; 70: Perf, 0.284; 70: 1min HRV, 10.843; 70: 5min HRV, 30.738; 71: HR, 116.224; 71: RR, 27.121; 71: SpO2, 97.017; 71: Perf, 0.290; 71: 1min HRV, 14.608; 72: HR, 114.831; 72: RR, 30.288; 72: SpO2, 97.966; 72: Perf, 0.360; 72: 1min HRV, 4.378; 73: HR, 116.862; 73: RR, 27.328; 73: SpO2, 97.0; 73: Perf, 0.743; 73: 1min HRV, 5.068; 74: HR, 117.119; 74: RR, 22.373; 74: SpO2, 96.746; 74: Perf, 0.788; 74: 1min HRV, 9.255; 75: HR, 117.373; 75: RR, 23.390; 75: SpO2, 96.3; 75: Perf, 0.743; 75: 1min HRV, 16.879; 75: 5min HRV, 11.855; 76: HR, 117.175; 76: RR, 25.877; 76: SpO2, 96.035; 76: Perf, 0.527; 76: 1min HRV, 4.554; 77: HR, 117.167; 77: RR, 22.95; 77: SpO2, 96.417; 77: Perf, 0.435; 77: 1min HRV, 7.411; 78: HR, 117.983; 78: RR, 23.345; 78: SpO2, 97.534; 78: Perf, 0.455; 78: 1min HRV, 8.065; 79: HR, 118.559; 79: RR, 18.492; 79: SpO2, 97.610; 79: Perf, 0.357; 79: 1min HRV, 1.958; 80: HR, 119.051; 80: RR, 19.610; 80: SpO2, 97.508; 80: Perf, 0.352; 80: 1min HRV, 2.552; 80: 5min HRV, 6.305; 80: SBP, 93.0; 80: DBP, 64.0; 80: MAP, 73.667; 80: LPM O2, 4.0; 81: HR, 118.448; 81: RR, 22.879; 81: SpO2, 96.759; 81: Perf, 0.407; 81: 1min HRV, 5.158; 81: SBP, 93.0; 81: DBP, 64.0; 81: MAP, 73.667; 82: HR, 117.492; 82: RR, 24.661; 82: SpO2, 96.712; 82: Perf, 0.428; 82: 1min HRV, 11.514; 83: HR, 115.707; 83: RR, 28.534; 83: SpO2, 96.966; 83: Perf, 0.454; 83: 1min HRV, 2.751; 84: HR, 115.661; 84: RR, 26.186; 84: SpO2, 97.797; 84: Perf, 0.500; 84: 1min HRV, 20.359; 85: PART. THROMBOPLASTIN TIME, 31.0 seconds; 85: HR, 115.559; 85: RR, 29.542; 85: SpO2, 96.966; 85: Perf, 0.760; 85: 1min HRV, 4.553; 85: 5min HRV, 11.994; 86: HR, 115.690; 86: RR, 27.034; 86: SpO2, 96.414; 86: Perf, 0.943; 86: 1min HRV, 2.962; 87: HR, 116.339; 87: RR, 26.288; 87: SpO2, 96.0; 87: Perf, 1.029; 87: 1min HRV, 4.366; 88: HR, 116.362; 88: RR, 23.948; 88: SpO2, 96.448; 88: Perf, 0.671; 88: 1min HRV, 4.347; 89: HR, 116.237; 89: RR, 24.593; 89: SpO2, 97.610; 89: Perf, 0.564; 89: 1min HRV, 8.873; 90: HR, 116.915; 90: RR, 25.898; 90: SpO2, 97.169; 90: Perf, 0.406; 90: 1min HRV, 5.612; 90: 5min HRV, 6.027; 91: HR, 116.603; 91: RR, 22.534; 91: SpO2, 96.862; 91: Perf, 0.308; 91: 1min HRV, 8.173; 92: HR, 115.4; 92: RR, 25.944; 92: SpO2, 97.702; 92: Perf, 0.309; 92: 1min HRV, 2.095; 93: POC PH (V) ISTAT, 7.32; 93: POC O2 SATURATION ISTAT VENOUS, 76 %; 93: POC HCO3 (V) ISTAT, 10.5 mmol/L; 93: POC LACTATE ISTAT, 0.73 mmol/L; 93: POC PCO2 (V) ISTAT, 20.6 mmHg; 93: POC BASE EXCESS ISTAT, -16 mmol/L; 93: POC TCO2 (V) ISTAT, 11 mmol/L; 93: POC PO2 (V) ISTAT, 43 mmHg; 95: 5min HRV, 7.487; 96: INR, 1.4; 96: PROTHROMBIN TIME, 16.8 seconds; 102: BILIRUBIN TOTAL, 1.0 mg/dL; 102: GLUCOSE, 105 mg/dL; 102: CREATININE, 2.37 mg/dL; 102: POTASSIUM, 5.5 mmol/L; 102: ALKALINE PHOSPHATASE, 99 U/L; 102: AST (SGOT), 95 U/L; 102: GLOBULIN, 4.4 g/dL; 102: BLOOD UREA NITROGEN (BUN), 41 mg/dL; 102: CHLORIDE, 105 mmol/L; 102: EGFR REFIT WITHOUT RACE (2021), 27 mL/min/1.73 m2; 102: CORRECTED CALCIUM, 9.3 mg/dL; 102: ALBUMIN, 3.5 g/dL; 102: SODIUM, 131 mmol/L; 102: ALT (SGPT), 395 U/L; 102: PROTEIN TOTAL, 7.9 g/dL; 102: CO2, 12 mmol/L; 102: CALCIUM, 8.9 mg/dL; 102: ANION GAP, 14 mmol/L; 102: BNP NT-PRO, 16041 pg/mL; 106: RBC MORPHOLOGY (SLIDE REVIEW), Abnormal; 106: HEMOGLOBIN (HGB), 10.4 g/dL; 106: RED BLOOD CELLS (RBC), 4.59 MIL/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 19.9 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 75.4 fL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: WHITE BLOOD CELLS (WBC), 11.4 K/uL; 106: PLATELET COUNT (PLT), 292 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 22.7 pg; 106: HEMATOCRIT (HCT), 34.6 %; 106: NEUTROPHILS ABSOLUTE (MANUAL DIFF) (SEGS+BANDS), 9.25 K/uL; 106: LYMPHOCYTES VARIANT ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 106: NEUTROPHILS SEGMENTED % (MANUAL DIFF), 78.0 %; 106: LYMPHOCYTES VARIANT % (MANUAL DIFF), 1.0 %; 106: NEUTROPHILS BANDS % (MANUAL DIFF), 3.0 %; 106: LYMPHOCYTES ABSOLUTE (MANUAL DIFF), 1.26 K/uL; 106: MONOCYTES ABSOLUTE (MANUAL DIFF), 0.69 K/uL; 106: LYMPHOCYTES % (MANUAL DIFF), 11.0 %; 106: EOSINOPHILS % (MANUAL DIFF), 1.0 %; 106: EOSINOPHILS ABSOLUTE (MANUAL DIFF), 0.11 K/uL; 106: MONOCYTES % (MANUAL DIFF), 6.0 %; 112: IOPAMIDOL, 76 % IV SOLN (RADIOLOGY) 500 ML; 0: Age:, 32; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 120.0; 0: Triage RR, 22.0; 0: Triage SBP, 81.0; 0: Triage DBP, 55.0; 0: Triage acuity, 2-Emergent; 0: CC, ABDOMINAL PAIN,SHORTNESS OF BREATH",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "To assess the risk of sepsis, we look for vital signs and lab markers indicative of potential sepsis. The patient's initial low blood pressure (SBP: 81.0, DBP: 55.0, MAP: 63.667), high heart rate (HR: consistently above 100, reaching 120), and high respiratory rate suggest hemodynamic instability. Low SpO2 readings below 90% at times, high pro-BNP (16041 pg/mL), and a significantly low eGFR (27 mL/min/1.73 m^2) point to organ dysfunction. A pH of 7.32 alongside a lactate level, although not critically high, suggests metabolic changes often seen in sepsis. These factors collectively indicate a high risk of sepsis development within 12 hours.",
        "claims": [
            "To assess the risk of sepsis, vital signs and lab markers are evaluated.",
            "The patient's initial blood pressure is low.",
            "The systolic blood pressure (SBP) is 81.0.",
            "The diastolic blood pressure (DBP) is 55.0.",
            "The mean arterial pressure (MAP) is 63.667.",
            "The patient's heart rate is consistently above 100.",
            "The heart rate reaches 120.",
            "The patient's high respiratory rate suggests hemodynamic instability.",
            "The patient's SpO2 readings are low at times, below 90%.",
            "The high pro-BNP level is 16041 pg/mL.",
            "The significantly low eGFR is 27 mL/min/1.73 m^2.",
            "The pH level of the patient is 7.32.",
            "The lactate level is not critically high.",
            "The pH and lactate level suggest metabolic changes often seen in sepsis.",
            "These factors collectively indicate a high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's initial blood pressure is low.",
            "The systolic blood pressure (SBP) is 81.0.",
            "The diastolic blood pressure (DBP) is 55.0.",
            "The mean arterial pressure (MAP) is 63.667.",
            "The patient's heart rate is consistently above 100.",
            "The heart rate reaches 120.",
            "The patient's high respiratory rate suggests hemodynamic instability.",
            "The patient's SpO2 readings are low at times, below 90%.",
            "The high pro-BNP level is 16041 pg/mL.",
            "The significantly low eGFR is 27 mL/min/1.73 m^2.",
            "The pH and lactate level suggest metabolic changes often seen in sepsis.",
            "These factors collectively indicate a high risk of developing sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            1.0,
            0.5,
            1.0,
            0.9,
            1.0,
            0.3,
            0.7,
            0.3,
            0.7,
            0.8,
            0.2
        ],
        "alignment_category": [
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Shock Index (\u22651.0)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Shock Index (\u22651.0)",
            "SOFA Score Increase (\u22652 points)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The claim that the patient's initial blood pressure is low aligns with the category of Sepsis-Associated Hypotension. This category specifically looks for low blood pressure as an indicator of sepsis progression toward shock. Although the claim does not provide specific values or confirm if thresholds like SBP <90 mmHg or MAP <70 mmHg are met, it still significantly indicates a possibility of haemodynamic instability related to sepsis, thus justifying a high alignment rating.",
            "The claim directly states that the patient's systolic blood pressure (SBP) is 81.0, which is below the threshold of 90 mmHg. This condition is a clear indicator of sepsis-associated hypotension as defined in the category, denoting progression towards septic shock. The alignment is perfect due to the precise match with the category\u2019s criteria.",
            "Diastolic blood pressure (DBP) of 55.0 is low and relevant in assessing overall blood pressure, contributing to a low mean arterial pressure (MAP). While DBP alone is not a direct criteria under sepsis-associated hypotension, it is indirectly related, as DBP contributes to MAP calculation, which if <70 mmHg, can indicate hypotension associated with sepsis. The alignment is moderate due to this indirect but notable connection.",
            "The claim directly references a mean arterial pressure (MAP) of 63.667. This value is below the threshold of <70 mmHg specified in the Sepsis-Associated Hypotension category. The direct match of the MAP value to the criteria for sepsis-associated hypotension indicates strong alignment, making this category the most appropriate with perfect alignment.",
            "The claim states that the patient's heart rate is consistently above 100 beats per minute, which aligns closely with the SIRS criteria of heart rate >90 bpm. This is a direct indication of systemic inflammation consistent with early sepsis, thus having a high alignment with the SIRS category.",
            "A heart rate of over 90 bpm is one of the explicit criteria for SIRS. Since the given heart rate of 120 bpm exceeds the threshold, it directly aligns with this category, identifying systemic inflammation consistent with early sepsis.",
            "The claim emphasizes a high respiratory rate and links it to hemodynamic instability. While a high respiratory rate can be part of both SIRS and qSOFA criteria, the mention of hemodynamic instability aligns more specifically with the Elevated Shock Index category, which involves hemodynamic factors. However, the claim does not provide information on the heart rate or systolic BP required to compute the shock index, resulting in a weak alignment.",
            "Low SpO\u2082 readings suggest hypoxemia, which can be related to impaired oxygenation\u2014a concept evaluated by the PaO\u2082/FiO\u2082 ratio in the SOFA score. While SpO\u2082 itself isn't a direct measure in this category, it aligns with the concept of respiratory dysfunction assessed by the SOFA score, representing a meaningful connection to sepsis risk.",
            "Pro-BNP is not directly listed in any of the expert sepsis prediction categories, as it is primarily a marker for cardiac stress and heart failure rather than sepsis. However, elevated pro-BNP can suggest cardiac dysfunction, which may accompany haemodynamic instability\u2014a concept somewhat consistent with the Elevated Shock Index category. The alignment is indirect and weak because while both BNP and shock index involve cardiovascular assessment, pro-BNP is not utilized directly in sepsis prediction criteria.",
            "A significantly low eGFR of 27 mL/min/1.73 m\u00b2 indicates potential kidney dysfunction, which relates to creatinine levels assessed in the SOFA score. SOFA score considers renal function through creatinine levels, and a decline in eGFR suggests potential organ dysfunction, aligning moderately with SOFA criteria. However, since eGFR isn't directly mentioned under SOFA, the alignment, while relevant, is not direct and thus scores 0.7.",
            "The mention of lactate levels directly pertains to the Elevated Serum Lactate category, as an increase in lactate is a significant marker for tissue hypoperfusion and sepsis risk. The reference to pH changes suggests metabolic alterations but is not explicitly covered by any category. Therefore, the alignment is strong due to the lactate reference but not perfect due to the additional mention of pH without a direct tie-in to a specific category.",
            "The claim is nonspecific and doesn't directly reference concrete clinical indicators or actions related to sepsis risk. The idea of collective factors points vaguely towards a comprehensive score-based assessment like NEWS, but without specific values or criteria mentioned, the alignment is weak. The range of categories is broad, suggesting some measured risk without indicating which one specifically."
        ],
        "final_alignment_score": 0.6833333333333332,
        "accuracy": 1
    },
    {
        "input": "3: HR, 99.0; 3: RR, 20.0; 3: SpO2, 100.0; 3: SBP, 140.0; 3: DBP, 85.0; 3: MAP, 103.333; 3: Pain, nan; 3: Temp, 98.0; 4: SpO2, 100.0; 5: HR, 96.625; 5: RR, 26.391; 5: SpO2, 100.0; 5: 1min HRV, 65.045; 6: HR, 93.655; 6: RR, 13.828; 6: SpO2, 81.8; 6: 1min HRV, 14.901; 6: SBP, 140.0; 6: DBP, 85.0; 6: MAP, 103.333; 7: HR, 95.102; 7: RR, 16.983; 7: SpO2, 100.0; 7: 1min HRV, 27.905; 8: HR, 92.271; 8: RR, 19.763; 8: SpO2, 100.0; 8: Perf, 3.422; 8: 1min HRV, 26.209; 8: 5min HRV, 33.677; 9: HR, 87.948; 9: RR, 14.483; 9: SpO2, 100.0; 9: Perf, 3.304; 9: 1min HRV, 14.298; 10: HR, 88.508; 10: RR, 14.475; 10: SpO2, 100.0; 10: Perf, 3.767; 10: 1min HRV, 24.175; 11: HR, 87.966; 11: RR, 17.793; 11: SpO2, 100.0; 11: Perf, 2.893; 11: 1min HRV, 14.373; 12: HR, 90.017; 12: RR, 16.220; 12: SpO2, 100.0; 12: Perf, 1.955; 12: 1min HRV, 14.858; 13: HR, 88.322; 13: RR, 13.339; 13: SpO2, 100.0; 13: Perf, 1.784; 13: 1min HRV, 16.979; 13: 5min HRV, 18.750; 14: HR, 85.466; 14: RR, 13.983; 14: SpO2, 100.0; 14: Perf, 1.337; 14: 1min HRV, 41.162; 15: HR, 85.915; 15: RR, 8.089; 15: SpO2, 100.0; 15: Perf, 1.305; 15: 1min HRV, 47.027; 16: HR, 87.034; 16: RR, 14.241; 16: SpO2, 99.034; 16: Perf, 1.554; 16: 1min HRV, 13.824; 17: HR, 86.881; 17: RR, 19.322; 17: SpO2, 99.780; 17: Perf, 1.531; 17: 1min HRV, 16.674; 18: HR, 88.424; 18: RR, 22.508; 18: SpO2, 100.0; 18: Perf, 1.917; 18: 1min HRV, 18.220; 18: 5min HRV, 32.184; 19: HR, 86.328; 19: RR, 17.862; 19: SpO2, 99.879; 19: Perf, 2.174; 19: 1min HRV, 30.876; 19: SBP, 132.0; 19: DBP, 94.0; 19: MAP, 106.667; 20: HR, 84.864; 20: RR, 17.627; 20: SpO2, 100.0; 20: Perf, 2.211; 20: 1min HRV, 12.137; 21: HR, 84.966; 21: RR, 18.914; 21: SpO2, 99.879; 21: Perf, 2.119; 21: 1min HRV, 16.061; 22: HR, 87.203; 22: RR, 17.814; 22: SpO2, 100.0; 22: Perf, 1.934; 22: 1min HRV, 19.905; 23: HR, 91.586; 23: RR, 16.621; 23: SpO2, 100.0; 23: Perf, 1.638; 23: 1min HRV, 33.288; 23: 5min HRV, 29.349; 24: HR, 85.695; 24: RR, 20.085; 24: SpO2, 100.0; 24: Perf, 2.043; 24: 1min HRV, 43.239; 25: HR, 89.186; 25: RR, 16.644; 25: SpO2, 100.0; 25: Perf, 1.875; 25: 1min HRV, 20.964; 26: HR, 91.586; 26: RR, 17.0; 26: SpO2, 100.0; 26: Perf, 1.781; 26: 1min HRV, 12.019; 27: HR, 95.576; 27: RR, 16.966; 27: SpO2, 100.0; 27: Perf, 1.809; 27: 1min HRV, 24.570; 28: HR, 95.207; 28: RR, 20.759; 28: SpO2, 99.914; 28: Perf, 2.004; 28: 1min HRV, 12.423; 28: 5min HRV, 36.506; 29: HR, 93.038; 29: RR, 21.583; 29: SpO2, 99.966; 29: Perf, 2.114; 29: 1min HRV, 17.322; 30: SpO2, 99.763; 30: Perf, 2.112; 31: SpO2, 100.0; 31: Perf, 1.998; 32: SpO2, 100.0; 32: Perf, 2.940; 33: SpO2, 100.0; 33: Perf, 4.336; 33: 5min HRV, 17.322; 34: SpO2, 100.0; 34: Perf, 3.641; 34: SBP, 141.0; 34: DBP, 128.0; 34: MAP, 132.333; 35: SpO2, 100.0; 35: Perf, 3.437; 36: SpO2, 100.0; 36: Perf, 2.395; 37: SpO2, 100.0; 37: Perf, 1.783; 38: SpO2, 100.0; 38: Perf, 1.336; 39: WAM DIFTYP, AUTO; 39: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.2 pg; 39: PLATELET COUNT (PLT), 212 K/uL; 39: NEUTROPHIL ABSOLUTE (AUTO DIFF), 3.26 K/uL; 39: BASOPHIL % (AUTO DIFF), 0.9 %; 39: HEMOGLOBIN (HGB), 13.0 g/dL; 39: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 34.7 g/dL; 39: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 39: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 39: MONOCYTE ABSOLUTE (AUTO DIFF), 0.72 K/uL; 39: RED BLOOD CELLS (RBC), 4.17 MIL/uL; 39: LYMPHOCYTE % (AUTO DIFF), 32.2 %; 39: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 39: NEUTROPHIL % (AUTO DIFF), 51.2 %; 39: MEAN CORPUSCULAR VOLUME (MCV), 89.9 fL; 39: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 39: WHITE BLOOD CELLS (WBC), 6.4 K/uL; 39: RED CELL DISTRIBUTION WIDTH (RDW), 13.3 %; 39: MONOCYTE % (AUTO DIFF), 11.3 %; 39: NRBC PERCENT (HEMATOLOGY), 0.0 %; 39: EOSINOPHIL % (AUTO DIFF), 4.2 %; 39: HEMATOCRIT (HCT), 37.5 %; 39: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.05 K/uL; 39: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.27 K/uL; 39: SpO2, 99.864; 39: Perf, 1.502; 40: SpO2, 100.0; 40: Perf, 1.656; 41: SpO2, 100.0; 41: Perf, 1.606; 42: SpO2, 100.0; 42: Perf, 1.024; 43: SpO2, 100.0; 43: Perf, 0.829; 44: SpO2, 100.0; 44: Perf, 0.882; 45: SpO2, 100.0; 45: Perf, 0.867; 46: SpO2, 100.0; 46: Perf, 0.679; 47: SpO2, 100.0; 47: Perf, 0.640; 48: SpO2, 100.0; 48: Perf, 0.650; 49: SpO2, 99.943; 49: Perf, 0.674; 49: SBP, 142.0; 49: DBP, 95.0; 49: MAP, 110.667; 56: BLOOD TYPE VERIFICATION-AUTOMATION, O Positive; 56: ANTIBODY SCREEN 3, NEG; 56: ABO/RH (AUTOMATION), O Positive; 60: PART. THROMBOPLASTIN TIME, 30.7 seconds; 61: INR, 1.2; 61: PROTHROMBIN TIME, 14.5 seconds; 83: HR, 84.0; 83: SpO2, 100.0; 83: SBP, 141.0; 83: DBP, 95.0; 83: MAP, 110.333; 83: Pain, 8.0; 91: MORPHINE, 4 MG/ML IV SYRG; 96: LR IV BOLUS -, 1000 ML; 97: CEFAZOLIN IV PUSH (, 1 GRAM VIAL + NS VIAL); 108: HR:, 85.0; 108: RR, 16.0; 108: SpO2, 100.0; 108: SBP, 170.0; 108: DBP, 98.0; 108: MAP, 122.0; 108: Pain, 0.0; 108: Pain, 0.0; 0: Age, 60; 0: Gender, M; 0: Race, Black or African American; 0: Means of arrival, EMS; 0: Triage Temp, 36.7; 0: Triage HR, 99.0; 0: Triage RR, 20.0; 0: Triage SBP, 140.0; 0: Triage DBP, 85.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG INJURY",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The time series data shows stable vital signs such as heart rate, respiratory rate, and oxygen saturation with no significant abnormalities or instability, which are typically indicators of sepsis risk. Although there is a potential indication of concern with some variability in Heart Rate Variability (HRV) and periodic decrease in perfusion index values, these alone, without other significant signs of hemodynamic instability or fever, are insufficient to indicate a high sepsis risk within the next 12 hours. Additionally, the administration of cefazolin and a morphine painkiller aligns with management of a non-sepsis-related condition, likely the leg injury, further supporting a \"No\" label for high sepsis risk.",
        "claims": [
            "The time series data shows stable vital signs.",
            "Stable vital signs include heart rate, respiratory rate, and oxygen saturation.",
            "There are no significant abnormalities or instability in the vital signs.",
            "Stable vital signs are typically indicators of sepsis risk.",
            "There is some variability in Heart Rate Variability (HRV).",
            "There is a periodic decrease in perfusion index values.",
            "Variability in HRV and decrease in perfusion index values alone are insufficient to indicate high sepsis risk.",
            "Other significant signs of hemodynamic instability or fever are not present.",
            "The absence of other significant signs supports a lower risk of sepsis.",
            "Cefazolin has been administered.",
            "Morphine has been administered as a painkiller.",
            "The administration of cefazolin and morphine aligns with management of a non-sepsis-related condition.",
            "The treatment is likely for a leg injury.",
            "The treatment further supports a \"No\" label for high sepsis risk."
        ],
        "relevant_claims": [
            "The time series data shows stable vital signs.",
            "Variability in HRV and decrease in perfusion index values alone are insufficient to indicate high sepsis risk.",
            "The absence of other significant signs supports a lower risk of sepsis.",
            "The administration of cefazolin and morphine aligns with management of a non-sepsis-related condition."
        ],
        "alignment_scores": [
            0.2,
            0.3,
            0.3,
            0.3
        ],
        "alignment_category": [
            "Elevated NEWS Score (\u22655 points)",
            "Elevated Shock Index (\u22651.0)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)"
        ],
        "alignment_reasonings": [
            "Stable vital signs suggest that there is no immediate clinical deterioration, which is contrary to an elevated NEWS score (\u22655), a predictor of imminent deterioration. Therefore, it minimally aligns with the elevated NEWS score category. However, it is relevant as NEWS is based on changes in vital signs, even though it does not indicate an actual elevation or issue in this instance.",
            "The claim mentions heart rate variability (HRV) and a decrease in perfusion index values, which relate to hemodynamic parameters. The Elevated Shock Index category involves heart rate and perfusion elements (systolic BP), though not directly addressing HRV or perfusion index. The connection is weak, as the claim notes these parameters alone are insufficient indicators of sepsis risk, hinting only indirectly at hemodynamic instability related to the Elevated Shock Index category.",
            "The claim suggests a lower risk of sepsis due to the absence of significant signs. This indirectly aligns with the SIRS Positivity category, as the lack of systemic inflammation indicators (such as abnormal temperature, heart rate, respiratory rate, or WBC count) would suggest the criteria for SIRS are not met. However, the claim doesn't mention specific SIRS criteria, resulting in a weak alignment.",
            "The administration of cefazolin, an antibiotic, can relate to sepsis management if it's part of early sepsis treatment; however, the claim specifically states it aligns with a non-sepsis-related condition. This makes the connection to sepsis weak but still marginally relevant due to the involvement of antibiotics, albeit for another purpose."
        ],
        "final_alignment_score": 0.275,
        "accuracy": 1
    },
    {
        "input": "4: HR, 94.0; 4: RR, 18.0; 4: SpO2, 97.0; 4: SBP, 149.0; 4: DBP, 80.0; 4: MAP, 103.0; 4: Temp, 98.1; 5: Pain, 10.0; 35: SBP, 156.0; 35: DBP, 95.0; 35: MAP, 115.333; 36: SpO2, 96.429; 37: SpO2, 97.121; 37: Perf, 7.669; 38: SpO2, 97.576; 38: Perf, 8.638; 39: SpO2, 97.0; 39: Perf, 9.328; 40: SpO2, 97.0; 40: Perf, 9.307; 41: SpO2, 97.0; 41: Perf, 8.818; 42: SpO2, 97.0; 42: Perf, 8.903; 43: SpO2, 97.153; 43: Perf, 8.949; 44: SpO2, 96.810; 44: Perf, 8.050; 44: SBP, 148.0; 44: DBP, 87.0; 44: MAP, 107.333; 45: SpO2, 97.220; 45: Perf, 6.380; 46: SpO2, 97.898; 46: Perf, 4.710; 47: SpO2, 97.759; 47: Perf, 5.927; 48: SpO2, 97.186; 48: Perf, 5.645; 49: SpO2, 97.672; 49: Perf, 6.817; 50: SpO2, 98.237; 50: Perf, 7.622; 51: SpO2, 98.051; 51: Perf, 6.411; 52: SpO2, 97.534; 52: Perf, 6.707; 53: SpO2, 97.305; 53: Perf, 6.303; 54: SpO2, 97.776; 54: Perf, 5.712; 55: SpO2, 97.305; 55: Perf, 6.576; 56: SpO2, 97.237; 56: Perf, 7.164; 57: SpO2, 97.724; 57: Perf, 6.803; 58: SpO2, 98.407; 58: Perf, 6.343; 59: SpO2, 97.913; 59: Perf, 7.230; 60: SpO2, 97.667; 60: Perf, 6.017; 61: SpO2, 98.0; 61: Perf, 6.329; 62: SpO2, 98.0; 62: Perf, 5.887; 63: SpO2, 98.169; 63: Perf, 4.860; 64: SpO2, 98.0; 64: Perf, 4.885; 65: SpO2, 98.390; 65: Perf, 4.871; 66: SARS-COV-2 RNA, Not Detected; 66: SpO2, 97.914; 66: Perf, 3.335; 67: SpO2, 97.729; 67: Perf, 4.893; 68: SpO2, 97.847; 68: Perf, 4.188; 69: SpO2, 98.155; 69: Perf, 3.854; 70: SpO2, 97.661; 70: Perf, 4.066; 71: SpO2, 98.0; 71: Perf, 3.812; 72: SpO2, 98.0; 72: Perf, 3.116; 73: SpO2, 97.814; 73: Perf, 3.468; 74: SpO2, 97.310; 74: Perf, 4.189; 75: SpO2, 97.881; 75: Perf, 4.555; 76: SpO2, 97.810; 76: Perf, 4.746; 77: SpO2, 97.576; 77: Perf, 4.867; 78: SpO2, 97.763; 78: Perf, 5.017; 79: SpO2, 98.0; 79: Perf, 3.619; 80: WAM DIFTYP, AUTO; 80: RED BLOOD CELLS (RBC), 3.98 MIL/uL; 80: HEMATOCRIT (HCT), 37.6 %; 80: PLATELET COUNT (PLT), 330 K/uL; 80: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 0.93 K/uL; 80: NRBC PERCENT (HEMATOLOGY), 0.0 %; 80: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 80: MONOCYTE % (AUTO DIFF), 7.6 %; 80: NEUTROPHIL % (AUTO DIFF), 75.6 %; 80: EOSINOPHIL % (AUTO DIFF), 1.7 %; 80: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 33.2 g/dL; 80: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.2 %; 80: NEUTROPHIL ABSOLUTE (AUTO DIFF), 4.91 K/uL; 80: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.11 K/uL; 80: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 31.4 pg; 80: BASOPHIL % (AUTO DIFF), 0.6 %; 80: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 80: MEAN CORPUSCULAR VOLUME (MCV), 94.5 fL; 80: HEMOGLOBIN (HGB), 12.5 g/dL; 80: LYMPHOCYTE % (AUTO DIFF), 14.3 %; 80: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.01 K/uL; 80: MONOCYTE ABSOLUTE (AUTO DIFF), 0.49 K/uL; 80: WHITE BLOOD CELLS (WBC), 6.5 K/uL; 80: RED CELL DISTRIBUTION WIDTH (RDW), 13.1 %; 80: SpO2, 98.0; 80: Perf, 5.174; 81: SpO2, 98.0; 81: Perf, 5.211; 82: SpO2, 98.0; 82: Perf, 5.194; 83: SpO2, 98.0; 83: Perf, 5.017; 84: SpO2, 97.983; 84: Perf, 5.164; 85: SpO2, 97.373; 85: Perf, 5.423; 86: SpO2, 97.448; 86: Perf, 5.285; 87: SpO2, 98.203; 87: Perf, 4.216; 88: SpO2, 98.0; 88: Perf, 4.705; 89: SpO2, 98.0; 89: Perf, 4.904; 90: INR, 1.0; 90: PROTHROMBIN TIME, 13.6 seconds; 90: SpO2, 97.797; 90: Perf, 4.908; 91: PART. THROMBOPLASTIN TIME, 34.5 seconds; 91: SpO2, 97.966; 91: Perf, 5.132; 92: SpO2, 97.759; 92: Perf, 4.758; 93: SpO2, 97.0; 93: Perf, 4.934; 94: SpO2, 97.220; 94: Perf, 4.892; 95: SpO2, 97.305; 95: Perf, 5.384; 96: SpO2, 97.241; 96: Perf, 4.886; 97: SpO2, 97.492; 97: Perf, 4.839; 98: SpO2, 97.310; 98: Perf, 4.930; 99: SpO2, 97.102; 99: Perf, 4.921; 100: SpO2, 97.254; 100: Perf, 4.941; 101: SpO2, 98.0; 101: Perf, 4.536; 102: HR, 64.0; 102: SpO2, 97.373; 102: Perf, 4.608; 102: SBP, 180.0; 102: DBP, 75.0; 102: MAP, 110.0; 103: SpO2, 97.931; 103: Perf, 4.404; 104: CHLORIDE, 100 mmol/L; 104: AST (SGOT), 18 U/L; 104: PROTEIN TOTAL, 6.9 g/dL; 104: ALBUMIN, 4.2 g/dL; 104: SODIUM, 137 mmol/L; 104: GLOBULIN, 2.7 g/dL; 104: CALCIUM, 9.0 mg/dL; 104: ALT (SGPT), 10 U/L; 104: EGFR REFIT WITHOUT RACE (2021), 83 mL/min/1.73 m2; 104: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 104: GLUCOSE, 118 mg/dL; 104: BILIRUBIN TOTAL, 0.3 mg/dL; 104: CREATININE, 0.66 mg/dL; 104: CORRECTED CALCIUM, 8.8 mg/dL; 104: ALKALINE PHOSPHATASE, 68 U/L; 104: ANION GAP, 10 mmol/L; 104: POTASSIUM, 4.3 mmol/L; 104: CO2, 27 mmol/L; 104: SpO2, 97.214; 104: Perf, 4.583; 104: SBP, 180.0; 104: DBP, 75.0; 104: MAP, 110.0; 105: SpO2, 97.138; 105: Perf, 3.575; 106: SpO2, 98.0; 106: Perf, 4.002; 107: SpO2, 97.407; 107: Perf, 4.150; 108: SpO2, 97.948; 108: Perf, 4.002; 109: SpO2, 97.373; 109: Perf, 4.398; 110: SpO2, 97.458; 110: Perf, 4.330; 111: SpO2, 97.707; 111: Perf, 4.44; 112: SpO2, 97.475; 112: Perf, 4.413; 113: SpO2, 97.121; 113: Perf, 4.282; 114: SpO2, 97.102; 114: Perf, 4.464; 115: SpO2, 97.136; 115: Perf, 4.567; 116: SpO2, 97.586; 116: Perf, 4.080; 117: SpO2, 98.441; 117: Perf, 3.871; 118: SpO2, 98.207; 118: Perf, 4.447; 119: SpO2, 97.932; 119: Perf, 4.550; 0: Age, 90; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, 36.7; 0: Triage HR, 94.0; 0: Triage RR, 18.0; 0: Triage SBP, 149.0; 0: Triage DBP, 80.0; 0: Triage acuity, 3-Urgent; 0: CC, HEMORRHOIDS",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "To determine the sepsis risk, assess vital signs, overall health indicators, and any signs of infection or organ dysfunction. The patient, a 90-year-old female with hemorrhoids, has consistent vital signs and oxygen saturation levels within normal ranges. There are no significant deviations or indications of infection, such as fever, hypotension, or elevated heart rate, and her lab results do not show alarming values. As these do not suggest signs of sepsis, the patient is not at high risk of developing sepsis within 12 hours.",
        "claims": [
            "To determine the sepsis risk, assess vital signs, overall health indicators, and any signs of infection or organ dysfunction.",
            "The patient is a 90-year-old female.",
            "The patient has hemorrhoids.",
            "The patient has consistent vital signs.",
            "The patient's oxygen saturation levels are within normal ranges.",
            "There are no significant deviations in the patient's vital signs.",
            "The patient does not show indications of infection, such as fever.",
            "The patient does not show indications of infection, such as hypotension.",
            "The patient does not show indications of infection, such as elevated heart rate.",
            "The patient's lab results do not show alarming values.",
            "The absence of signs of infection and abnormal lab results do not suggest sepsis.",
            "The patient is not at high risk of developing sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient does not show indications of infection, such as fever.",
            "The patient does not show indications of infection, such as hypotension.",
            "The patient does not show indications of infection, such as elevated heart rate.",
            "The patient's lab results do not show alarming values."
        ],
        "alignment_scores": [
            0.7,
            0.3,
            0.4,
            0.2
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The absence of fever is directly relevant to the SIRS criteria, which include a specific threshold for temperature. Without fever, one of the key SIRS criteria for systemic inflammation and early sepsis is not met, indicating low risk. This aligns significantly with this category, as lack of fever reduces the likelihood of meeting the SIRS criteria.",
            "The claim states the absence of hypotension as an indicator of infection, suggesting awareness of its significance in sepsis, specifically the progression toward septic shock. However, it reflects an absence rather than presence, aligning weakly with the category focused on hypotension as a risk factor.",
            "The claim focuses on the absence of an elevated heart rate, which is one of the SIRS criteria for systemic inflammation and potential early sepsis. While the claim concerns a SIRS criterion, the absence of an elevated heart rate reduces the likelihood of meeting SIRS positivity, thus indicating a lower alignment with this category.",
            "The absence of alarming lab values suggests no significant increase in SOFA components, which are used to confirm new organ dysfunction. The claim only indirectly relates to a lack of severity for sepsis risk through lab results, indicating a low but somewhat relevant alignment."
        ],
        "final_alignment_score": 0.39999999999999997,
        "accuracy": 1
    },
    {
        "input": "16: Pain, 0.0; 18: HR, 117.0; 18: RR, 16.0; 18: SpO2, 100.0; 18: SBP, 103.0; 18: DBP, 74.0; 18: MAP, 83.667; 18: LPM O2, 2.0; 18: Temp, 97.7; 67: POC PH (V) ISTAT, 7.33; 67: POC PCO2 (V) ISTAT, 61.8 mmHg; 67: POC HCO3 (V) ISTAT, 32.6 mmol/L; 67: POC BASE EXCESS ISTAT, 7 mmol/L; 67: POC O2 SATURATION ISTAT VENOUS, 20 %; 67: POC TCO2 (V) ISTAT, 34 mmol/L; 67: POC PO2 (V) ISTAT, 17 mmHg; 67: POC LACTATE ISTAT, 2.77 mmol/L; 71: SpO2, 100.0; 71: Perf, 0.388; 72: HR, 114.091; 72: RR, 27.833; 72: SpO2, 100.0; 72: Perf, 0.453; 72: 1min HRV, 5.252; 72: SBP, 116.0; 72: DBP, 90.0; 72: MAP, 98.667; 72: LPM O2, 2.0; 73: HR, 113.862; 73: RR, 27.0; 73: SpO2, 99.943; 73: Perf, 0.43; 73: 1min HRV, 4.683; 74: HR, 114.983; 74: RR, 26.542; 74: SpO2, 100.0; 74: Perf, 0.382; 74: 1min HRV, 6.631; 75: HR, 115.356; 75: RR, 25.407; 75: SpO2, 100.0; 75: Perf, 0.301; 75: 1min HRV, 2.988; 76: HR, 115.224; 76: RR, 25.172; 76: SpO2, 100.0; 76: Perf, 0.226; 76: 1min HRV, 3.239; 76: 5min HRV, 5.415; 76: SBP, nan; 76: DBP, nan; 76: MAP, nan; 77: HR, 115.627; 77: RR, 25.254; 77: SpO2, 100.0; 77: Perf, 0.193; 77: 1min HRV, 8.700; 78: HR, 115.305; 78: RR, 27.966; 78: SpO2, 100.0; 78: Perf, 0.199; 78: 1min HRV, 5.428; 79: HR, 121.586; 79: RR, 29.397; 79: SpO2, 100.0; 79: 1min HRV, 6.808; 80: HR, 126.0; 80: RR, 33.339; 80: SpO2, 100.0; 80: Perf, 0.239; 80: 1min HRV, 11.828; 81: HR, 121.310; 81: RR, 27.914; 81: SpO2, 100.0; 81: Perf, 0.251; 81: 1min HRV, 11.118; 81: 5min HRV, 19.998; 82: HR, 117.305; 82: RR, 28.763; 82: SpO2, 100.0; 82: Perf, 0.367; 82: 1min HRV, 9.659; 83: HR, 117.017; 83: RR, 26.627; 83: SpO2, 99.915; 83: Perf, 0.396; 83: 1min HRV, 5.729; 84: HR, 116.534; 84: RR, 25.293; 84: SpO2, 99.674; 84: Perf, 0.363; 84: 1min HRV, 6.921; 85: HR, 116.833; 85: RR, 29.647; 85: SpO2, 99.085; 85: 1min HRV, 9.961; 86: HR, 116.741; 86: RR, 27.552; 86: SpO2, 100.0; 86: Perf, 0.321; 86: 1min HRV, 4.353; 86: 5min HRV, 7.542; 87: HR, 114.610; 87: RR, 23.576; 87: SpO2, 100.0; 87: Perf, 0.332; 87: 1min HRV, 7.569; 88: HR, 114.831; 88: RR, 25.373; 88: SpO2, 100.0; 88: Perf, 0.202; 88: 1min HRV, 13.931; 89: HR, 117.069; 89: RR, 30.741; 89: SpO2, 100.0; 89: Perf, 0.278; 89: 1min HRV, 16.662; 90: WAM DIFTYP, AUTO; 90: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.13 K/uL; 90: LYMPHOCYTE % (AUTO DIFF), 19.4 %; 90: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 90: MONOCYTE ABSOLUTE (AUTO DIFF), 1.26 K/uL; 90: EOSINOPHIL % (AUTO DIFF), 1.2 %; 90: RED CELL DISTRIBUTION WIDTH (RDW), 18.2 %; 90: NEUTROPHIL ABSOLUTE (AUTO DIFF), 11.82 K/uL; 90: NEUTROPHIL % (AUTO DIFF), 70.8 %; 90: MONOCYTE % (AUTO DIFF), 7.6 %; 90: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 31.5 g/dL; 90: NRBC PERCENT (HEMATOLOGY), 0.0 %; 90: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.20 K/uL; 90: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 26.6 pg; 90: HEMATOCRIT (HCT), 44.7 %; 90: PLATELET COUNT (PLT), 472 K/uL; 90: MEAN CORPUSCULAR VOLUME (MCV), 84.3 fL; 90: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 3.23 K/uL; 90: WHITE BLOOD CELLS (WBC), 16.7 K/uL; 90: HEMOGLOBIN (HGB), 14.1 g/dL; 90: BASOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 90: BASOPHIL % (AUTO DIFF), 0.2 %; 90: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 90: RED BLOOD CELLS (RBC), 5.30 MIL/uL; 90: HR, 115.475; 90: RR, 23.610; 90: SpO2, 100.0; 90: Perf, 0.508; 90: 1min HRV, 6.293; 91: HR, 111.569; 91: RR, 21.431; 91: SpO2, 100.0; 91: Perf, 0.309; 91: 1min HRV, 21.705; 91: 5min HRV, 17.493; 92: HR, 111.254; 92: RR, 22.220; 92: SpO2, 100.0; 92: Perf, 0.163; 92: 1min HRV, 30.123; 93: HR, 116.879; 93: RR, 23.310; 93: SpO2, 100.0; 93: Perf, 0.206; 93: 1min HRV, 22.858; 94: HR, 108.288; 94: RR, 20.068; 94: SpO2, 100.0; 94: Perf, 0.269; 94: 1min HRV, 42.586; 95: HR, 117.898; 95: RR, 23.373; 95: SpO2, 100.0; 95: Perf, 0.270; 95: 1min HRV, 9.268; 96: HR, 110.034; 96: RR, 21.431; 96: SpO2, 100.0; 96: Perf, 0.355; 96: 1min HRV, 31.907; 96: 5min HRV, 32.721; 97: HR, 116.644; 97: RR, 24.763; 97: SpO2, 100.0; 97: Perf, 0.210; 97: 1min HRV, 12.208; 98: HR, 115.414; 98: RR, 21.086; 98: SpO2, 100.0; 98: Perf, 0.311; 98: 1min HRV, 13.967; 99: HR, 110.627; 99: RR, 21.593; 99: SpO2, 100.0; 99: Perf, 0.155; 99: 1min HRV, 30.190; 100: HR, 114.186; 100: RR, 23.339; 100: SpO2, 100.0; 100: Perf, 0.215; 100: 1min HRV, 10.330; 101: HR, 109.569; 101: RR, 22.655; 101: SpO2, 100.0; 101: Perf, 0.227; 101: 1min HRV, 24.137; 101: 5min HRV, 22.116; 102: HR, 117.085; 102: RR, 25.593; 102: SpO2, 100.0; 102: Perf, 0.183; 102: 1min HRV, 12.517; 103: HR, 115.603; 103: RR, 22.310; 103: SpO2, 100.0; 103: Perf, 0.356; 103: 1min HRV, 8.259; 104: HR, 114.559; 104: RR, 20.492; 104: SpO2, 100.0; 104: Perf, 0.360; 104: 1min HRV, 6.277; 105: HR, 114.542; 105: RR, 22.119; 105: SpO2, 100.0; 105: Perf, 0.311; 105: 1min HRV, 8.614; 106: HR, 114.483; 106: RR, 20.293; 106: SpO2, 100.0; 106: Perf, 0.302; 106: 1min HRV, 6.211; 106: 5min HRV, 9.837; 107: HR, 113.763; 107: RR, 20.237; 107: SpO2, 100.0; 107: Perf, 0.289; 107: 1min HRV, 7.220; 108: HR, 113.638; 108: RR, 21.931; 108: SpO2, 100.0; 108: Perf, 0.341; 108: 1min HRV, 6.759; 109: HR, 113.373; 109: RR, 21.864; 109: SpO2, 100.0; 109: Perf, 0.333; 109: 1min HRV, 5.955; 110: HR, 114.121; 110: RR, 20.603; 110: SpO2, 100.0; 110: Perf, 0.326; 110: 1min HRV, 8.640; 111: HR, 115.678; 111: RR, 24.254; 111: SpO2, 100.0; 111: Perf, 0.299; 111: 1min HRV, 4.160; 111: 5min HRV, 7.704; 112: HR, 113.322; 112: RR, 23.966; 112: SpO2, 100.0; 112: Perf, 0.428; 112: 1min HRV, 8.932; 113: HR, 114.017; 113: RR, 21.207; 113: SpO2, 100.0; 113: Perf, 0.405; 113: 1min HRV, 6.271; 114: HR, 112.797; 114: RR, 21.695; 114: SpO2, 100.0; 114: Perf, 0.374; 114: 1min HRV, 8.015; 115: HR, 113.288; 115: RR, 21.085; 115: SpO2, 100.0; 115: Perf, 0.393; 115: 1min HRV, 7.768; 116: HR, 113.586; 116: RR, 23.466; 116: SpO2, 100.0; 116: Perf, 0.332; 116: 1min HRV, 10.202; 116: 5min HRV, 8.462; 117: HR, 112.898; 117: RR, 20.695; 117: SpO2, 100.0; 117: Perf, 0.350; 117: 1min HRV, 5.507; 118: HR, 112.552; 118: RR, 20.552; 118: SpO2, 100.0; 118: Perf, 0.328; 118: 1min HRV, 9.157; 119: HR, 112.424; 119: RR, 20.814; 119: SpO2, 100.0; 119: Perf, 0.293; 119: 1min HRV, 7.331; 0: Age, 56; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.5; 0: Triage HR, 117.0; 0: Triage RR, 16.0; 0: Triage SBP, 103.0; 0: Triage DBP, 74.0; 0: Triage acuity, 2-Emergent; 0: CC, ABNORMAL LAB",
        "answer": true,
        "llm_answer": "No",
        "llm_explanation": "To assess sepsis risk, key indicators include heart rate, respiratory rate, oxygen saturation, and blood pressure. The heart rate is consistently elevated, but within a range expected for stress. Respiratory rates are mostly elevated but decrease before time 120.0. SpO2 remains at 100%, indicating stable oxygenation. Even with the elevated lactate level, other signs of sepsis, such as significant changes in blood pressure or low oxygen saturation, are absent. Laboratory data, while showing some abnormalities, do not overwhelmingly indicate sepsis risk in conjunction with the vital signs. Overall, there aren't enough abnormal diagnostic criteria to predict high sepsis risk within 12 hours.",
        "claims": [
            "Key indicators for assessing sepsis risk include heart rate, respiratory rate, oxygen saturation, and blood pressure.",
            "The heart rate is consistently elevated.",
            "The heart rate is elevated within a range expected for stress.",
            "Respiratory rates are mostly elevated.",
            "Respiratory rates decrease before time 120.0.",
            "SpO2 remains at 100%.",
            "A SpO2 reading of 100% indicates stable oxygenation.",
            "There is an elevated lactate level.",
            "Other signs of sepsis, such as significant changes in blood pressure, are absent.",
            "Other signs of sepsis, such as low oxygen saturation, are absent.",
            "Laboratory data show some abnormalities.",
            "Laboratory data do not overwhelmingly indicate sepsis risk in conjunction with the vital signs.",
            "Overall, there aren't enough abnormal diagnostic criteria to predict high sepsis risk within 12 hours."
        ],
        "relevant_claims": [
            "The heart rate is consistently elevated.",
            "There is an elevated lactate level.",
            "Other signs of sepsis, such as significant changes in blood pressure, are absent.",
            "Other signs of sepsis, such as low oxygen saturation, are absent.",
            "Overall, there aren't enough abnormal diagnostic criteria to predict high sepsis risk within 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.9,
            0.8,
            0.3,
            0.3
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated Serum Lactate (\u22652 mmol/L)",
            "Sepsis-Associated Hypotension (SBP <90 mmHg or MAP <70 mmHg, or \u226540 mmHg drop)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)"
        ],
        "alignment_reasonings": [
            "An elevated heart rate is a specific criterion under SIRS, which identifies systemic inflammation consistent with early sepsis. Although the claim does not specify the heart rate exceeding 90 bpm (the threshold in SIRS), \"consistently elevated\" strongly implies a value that meets or exceeds this level, providing strong alignment with the SIRS category.",
            "The claim directly references \"elevated lactate level,\" which aligns strongly with the \"Elevated Serum Lactate (\u22652 mmol/L)\" category. Elevated lactate is a critical indicator of tissue hypoperfusion and sepsis mortality risk. The specific value isn't given, but the mention of elevation closely aligns with this category's focus, with a very high, but not perfect, alignment due to the lack of specific quantitative detail.",
            "The claim indicates the absence of significant changes in blood pressure, which directly relates to the category of Sepsis-Associated Hypotension. Since the claim specifically mentions blood pressure and notes the absence of hypotension or significant changes, it directly aligns with the criteria of this category, although in a negative context. Therefore, the alignment is quite strong because the claim directly discusses the criteria outlined in this category.",
            "The claim mentions the absence of low oxygen saturation, which relates to an aspect of the SOFA score (PaO\u2082/FiO\u2082 ratio). While it indicates that a specific indicator of sepsis severity related to oxygenation is not present, it indirectly ties to the SOFA score criteria. Therefore, the alignment is marginally relevant but weak, as it highlights the absence rather than the presence of sepsis indicators.",
            "The claim discusses the absence of abnormal diagnostic criteria, suggesting a lack of indicators for conditions like systemic inflammation consistent with early sepsis, which could be captured by SIRS. The absence of sufficient criteria implies that thresholds from categories like SIRS Positivity or others are not met, but the alignment is indirect and weak since the claim doesn't specify which criteria are lacking."
        ],
        "final_alignment_score": 0.6199999999999999,
        "accuracy": 0
    },
    {
        "input": "5: SBP, 154.0; 5: DBP, 59.0; 5: MAP, 90.667; 6: HR, 109.0; 6: RR, 24.0; 6: SpO2, 86.4; 6: SBP, 154.0; 6: DBP, 59.0; 6: MAP, 90.667; 6: LPM O2, 2.0; 6: Pain, 10.0; 6: Temp, 102.7; 7: SpO2, 93.186; 7: Perf, 0.338; 8: SpO2, 95.897; 8: Perf, 0.303; 9: SpO2, 99.492; 9: Perf, 0.292; 10: SpO2, 99.833; 10: Perf, 0.281; 11: SpO2, 99.667; 11: Perf, 0.23; 12: SpO2, 100.0; 12: Perf, 0.244; 13: SpO2, 100.0; 13: Perf, 0.268; 14: SpO2, 99.853; 14: Perf, 0.239; 15: SpO2, 99.0; 15: Perf, 0.23; 17: SpO2, 98.833; 18: SpO2, 99.25; 18: Perf, 0.273; 19: SpO2, 96.306; 19: Perf, 0.232; 20: SpO2, 98.294; 20: Perf, 0.191; 24: SpO2, 99.0; 24: Perf, 0.15; 25: SpO2, 98.481; 25: Perf, 0.146; 26: SpO2, 99.667; 26: Perf, 0.157; 29: SpO2, 94.727; 29: Perf, 0.12; 30: SpO2, 97.0; 30: Perf, 0.13; 31: SpO2, 97.643; 31: Perf, 0.14; 32: SpO2, 98.333; 32: Perf, 0.143; 33: SpO2, 97.047; 33: Perf, 0.167; 34: SpO2, 94.625; 34: Perf, 0.175; 35: SpO2, 98.143; 35: Perf, 0.149; 36: SpO2, 98.321; 36: Perf, 0.145; 38: SpO2, 97.625; 38: Perf, 0.195; 39: SpO2, 97.818; 39: Perf, 0.2; 40: SpO2, 98.5; 40: Perf, 0.228; 41: SpO2, 96.922; 41: Perf, 0.204; 42: SpO2, 96.756; 42: Perf, 0.2; 43: SpO2, 98.595; 43: Perf, 0.2; 44: SpO2, 97.765; 44: Perf, 0.2; 45: SpO2, 99.407; 46: SpO2, 99.776; 46: Perf, 0.282; 47: SpO2, 99.362; 47: Perf, 0.349; 48: SpO2, 98.814; 48: Perf, 0.31; 49: SpO2, 99.424; 49: Perf, 0.279; 50: SpO2, 99.690; 50: Perf, 0.335; 50: ACETAMINOPHEN, 500 MG PO TABS; 51: POC PH (V), ISTAT: 7.37; 51: POC HCO3 (V) ISTAT, 28.5 mmol/L; 51: POC LACTATE ISTAT, 2.34 mmol/L; 51: POC TCO2 (V) ISTAT, 30 mmol/L; 51: POC BASE EXCESS ISTAT, 3 mmol/L; 51: POC PCO2 (V) ISTAT, 49.8 mmHg; 51: POC PO2 (V) ISTAT, 19 mmHg; 51: POC O2 SATURATION ISTAT VENOUS, 28 %; 51: SpO2, 97.780; 51: Perf, 0.297; 52: SpO2, 99.08; 52: Perf, 0.267; 53: SpO2, 99.224; 53: Perf, 0.257; 54: SpO2, 99.679; 54: Perf, 0.240; 55: SpO2, 99.26; 55: Perf, 0.221; 56: SpO2, 99.244; 56: Perf, 0.211; 57: SpO2, 97.9; 57: Perf, 0.213; 58: SpO2, 98.714; 58: Perf, 0.22; 59: SpO2, 99.0; 59: Perf, 0.22; 60: SpO2, 99.0; 60: Perf, 0.19; 61: SpO2, 99.12; 61: Perf, 0.205; 62: SpO2, 99.727; 62: Perf, 0.21; 63: SpO2, 98.524; 63: Perf, 0.206; 64: SpO2, 98.727; 64: Perf, 0.224; 65: SpO2, 98.981; 65: Perf, 0.262; 66: SpO2, 98.644; 66: Perf, 0.277; 67: SpO2, 99.667; 67: Perf, 0.278; 68: SpO2, 99.254; 68: Perf, 0.27; 69: POC, BHCG, ISTAT QUANTITATIVE: 17.6 IU/L; 69: SpO2, 99.537; 69: Perf, 0.286; 70: SpO2, 99.169; 70: Perf, 0.317; 71: SpO2, 98.068; 71: Perf, 0.315; 72: SpO2, 99.328; 72: Perf, 0.351; 73: SpO2, 99.797; 73: Perf, 0.553; 74: SpO2, 99.345; 74: Perf, 0.623; 75: SpO2, 98.288; 75: Perf, 0.858; 79: HR, 96.0; 79: RR, 22.0; 79: SpO2, 100.0; 79: SBP, 139.0; 79: DBP, 76.0; 79: MAP, 97.0; 82: NORMOSOL-R IV BOLUS -, 1000 ML; 106: WAM, DIFTYP: AUTO; 106: EOSINOPHIL ABSOLUTE (AUTO DIFF), 0.04 K/uL; 106: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 2.17 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 25.4 pg; 106: RED BLOOD CELLS (RBC), 4.06 MIL/uL; 106: MONOCYTE ABSOLUTE (AUTO DIFF), 0.74 K/uL; 106: NEUTROPHIL % (AUTO DIFF), 85.0 %; 106: MEAN CORPUSCULAR VOLUME (MCV), 84.2 fL; 106: WHITE BLOOD CELLS (WBC), 21.5 K/uL; 106: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 30.1 g/dL; 106: MONOCYTE % (AUTO DIFF), 3.4 %; 106: BASOPHIL ABSOLUTE (AUTO DIFF), 0.06 K/uL; 106: HEMATOCRIT (HCT), 34.2 %; 106: PLATELET COUNT (PLT), 209 K/uL; 106: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 1.0 %; 106: HEMOGLOBIN (HGB), 10.3 g/dL; 106: LYMPHOCYTE % (AUTO DIFF), 10.1 %; 106: EOSINOPHIL % (AUTO DIFF), 0.2 %; 106: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 106: RED CELL DISTRIBUTION WIDTH (RDW), 17.2 %; 106: BASOPHIL % (AUTO DIFF), 0.3 %; 106: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.22 K/uL; 106: NEUTROPHIL ABSOLUTE (AUTO DIFF), 18.31 K/uL; 106: NRBC PERCENT (HEMATOLOGY), 0.0 %; 112: CEFEPIME, 2 GRAM/20 ML IV PUSH; 115: POTASSIUM:, 3.6 mmol/L; 115: BLOOD UREA NITROGEN (BUN), 10 mg/dL; 115: BILIRUBIN TOTAL, 1.2 mg/dL; 115: EGFR FOR AFRICAN AMERICAN, 64 mL/min/1.73 m2; 115: CORRECTED CALCIUM, 8.8 mg/dL; 115: ANION GAP, 10 mmol/L; 115: PROTEIN TOTAL, 7.0 g/dL; 115: ALT (SGPT), 17 U/L; 115: CHLORIDE, 95 mmol/L; 115: CO2, 24 mmol/L; 115: AST (SGOT), 30 U/L; 115: GLOBULIN, 3.4 g/dL; 115: CREATININE, 1.14 mg/dL; 115: ALKALINE PHOSPHATASE, 83 U/L; 115: ALBUMIN, 3.6 g/dL; 115: GLUCOSE, 97 mg/dL; 115: SODIUM, 129 mmol/L; 115: CALCIUM, 8.5 mg/dL; 115: EGFR REFIT WITHOUT RACE (2021), 55 mL/min/1.73 m2; 115: C-REACTIVE PROTEIN (CRP), 21.1 mg/dL; 116: NORMOSOL-R IV BOLUS -, 500 ML; 0: Age:, 51; 0: Gender, F; 0: Race, White; 0: Means of arrival, EMS; 0: Triage Temp, 39.3; 0: Triage HR, 109.0; 0: Triage RR, 24.0; 0: Triage SBP, 154.0; 0: Triage DBP, 59.0; 0: Triage acuity, 2-Emergent; 0: CC, LEG PAIN,FEVER,CHILLS",
        "answer": true,
        "llm_answer": "Yes",
        "llm_explanation": "The patient's elevated temperature (39.3\u00b0C), high heart rate (109 bpm), high respiratory rate (24 breaths/min), low blood pressure (DBP: 59 mmHg), high white blood cell count (21.5 K/uL), and high C-reactive protein (21.1 mg/dL) indicate systemic inflammation and possible sepsis. The presence of severe leg pain with fever, chills, and administration of IV antibiotics (Cefepime) also support this assessment. These clinical features combined suggest a high risk of sepsis within 12 hours.",
        "claims": [
            "The patient's temperature is elevated at 39.3\u00b0C.",
            "The patient's heart rate is high at 109 bpm.",
            "The patient's respiratory rate is high at 24 breaths/min.",
            "The patient's blood pressure is low with a DBP of 59 mmHg.",
            "The patient's white blood cell count is high at 21.5 K/uL.",
            "The patient's C-reactive protein level is high at 21.1 mg/dL.",
            "The patient's clinical features indicate systemic inflammation.",
            "The patient's clinical features indicate possible sepsis.",
            "The patient has severe leg pain.",
            "The patient has a fever.",
            "The patient has chills.",
            "The patient is receiving IV antibiotics (Cefepime).",
            "The presence of severe leg pain, fever, chills, and IV antibiotics supports the assessment of sepsis.",
            "These clinical features combined suggest a high risk of sepsis within 12 hours."
        ],
        "relevant_claims": [
            "The patient's temperature is elevated at 39.3\u00b0C.",
            "The patient's heart rate is high at 109 bpm.",
            "The patient's respiratory rate is high at 24 breaths/min.",
            "The patient's white blood cell count is high at 21.5 K/uL.",
            "The patient's C-reactive protein level is high at 21.1 mg/dL.",
            "The patient's clinical features indicate systemic inflammation.",
            "The patient's clinical features indicate possible sepsis.",
            "The patient has a fever.",
            "The patient has chills.",
            "The patient is receiving IV antibiotics (Cefepime).",
            "The presence of severe leg pain, fever, chills, and IV antibiotics supports the assessment of sepsis.",
            "These clinical features combined suggest a high risk of sepsis within 12 hours."
        ],
        "alignment_scores": [
            0.9,
            0.5,
            0.8,
            1.0,
            0.5,
            0.8,
            0.3,
            0.6,
            0.3,
            1.0,
            0.8,
            0.4
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Elevated NEWS Score (\u22655 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The elevated temperature of 39.3\u00b0C exceeds the SIRS threshold of >38\u00b0C, making it a direct indicator of systemic inflammation that aligns well with the SIRS criteria for early sepsis identification. Although the claim only presents one SIRS criterion rather than two, the alignment with a key aspect of SIRS positivity is strong.",
            "The claim states a high heart rate of 109 bpm, which meets one of the SIRS criteria (heart rate > 90 bpm) used to identify systemic inflammation related to early sepsis. However, the alignment is partial as a single SIRS criterion is insufficient to determine positivity; thus, the alignment rating is moderate.",
            "A high respiratory rate is specifically listed as one of the SIRS criteria, which include a respiratory rate\u202f>\u202f20\u202f/min. The patient's rate of 24 breaths/min clearly meets this specific criterion, indicating systemic inflammation consistent with early sepsis. The alignment is strong, as it directly matches one of the criteria under SIRS positivity.",
            "The claim directly references an elevated white blood cell count (>12,000/\u00b5L), which is explicitly one of the SIRS criteria. This is used to identify systemic inflammation consistent with early sepsis, indicating perfect alignment with the SIRS Positivity category.",
            "A high C-reactive protein (CRP) level is indicative of systemic inflammation, which is conceptually related to the systemic inflammatory response syndrome (SIRS) criteria. While CRP is not one of the specific SIRS criteria, it suggests an inflammatory state that may be consistent with early sepsis, warranting a moderate alignment rating.",
            "The claim mentions \"systemic inflammation,\" which aligns with the presence of SIRS criteria indicative of early sepsis. While the claim does not specify which SIRS criteria are met, the mention of systemic inflammation strongly suggests relevance to the SIRS category. The alignment is high because systemic inflammation is central to SIRS, though it is not precise enough to rate a perfect score without specific criteria being cited.",
            "The claim broadly mentions \"clinical features\" indicating possible sepsis but lacks specific details about type and severity of symptoms or vital sign derangements that would align with a single category. While this statement is vague, it loosely aligns with the Elevated NEWS Score category, as the NEWS score is used to predict deterioration compatible with sepsis based on a combination of clinical features and vital signs. However, due to the non-specific and generic nature of the claim, the alignment is weak.",
            "The claim of having a fever aligns with the SIRS criteria, specifically \"temperature >38\u00b0C,\" which is used to identify systemic inflammation indicative of early sepsis. However, the claim does not specify the fever's exact temperature to confirm meeting the SIRS threshold (>38\u00b0C), so the alignment is partial rather than full.",
            "Chills can accompany fever, which is one of the SIRS criteria (temperature >38\u00b0C). However, chills alone do not explicitly meet any specific SIRS criterion like a fever threshold. Therefore, while it suggests a potential systemic response, the direct alignment is weak.",
            "The administration of IV antibiotics, specifically Cefepime, indicates a direct clinical action reflecting suspicion of a serious infection, which aligns perfectly with the category of early antibiotic/culture orders. This demonstrates strong alignment with the expert category focused on sepsis risk assessment.",
            "The claim mentions the administration of IV antibiotics, which aligns well with the Early Antibiotic/Culture Orders category, indicating a suspicion of severe infection or sepsis. However, specific timing within the first 2 hours is not mentioned, hence reducing the alignment rating slightly from a perfect score. Fever and chills support systemic infection but are not enough on their own to confirm this category without explicit timing of the antibiotics.",
            "The claim refers to \"clinical features combined\" suggesting a sepsis risk, which is generally in line with a scoring system approach like the NEWS score, as it aggregates various physiological parameters to assess deterioration risk. However, the claim lacks specific details on vital signs or an explicit NEWS score threshold, thereby resulting in a partial indirect alignment with the NEWS category."
        ],
        "final_alignment_score": 0.6583333333333333,
        "accuracy": 1
    },
    {
        "input": "11: Pain, 8.0; 18: HR, 114.0; 18: RR, 22.0; 18: SpO2, 95.0; 18: SBP, 101.0; 18: DBP, 62.0; 18: MAP, 75.0; 18: LPM O2, 2.0; 18: Temp, 102.2; 21: ACETAMINOPHEN, 500 MG PO TABS; 29: POC PH (V), ISTAT: 7.44; 29: POC PCO2 (V) ISTAT, 45.7 mmHg; 29: POC HCO3 (V) ISTAT, 30.9 mmol/L; 29: POC O2 SATURATION ISTAT VENOUS, 57 %; 29: POC LACTATE ISTAT, 1.00 mmol/L; 29: POC PO2 (V) ISTAT, 29 mmHg; 29: POC TCO2 (V) ISTAT, 32 mmol/L; 29: POC BASE EXCESS ISTAT, 7 mmol/L; 40: SpO2, 89.769; 40: Perf, 1.475; 40: SBP, 110.0; 40: DBP, nan; 40: MAP, nan; 41: HR, 109.95; 41: SpO2, 88.828; 41: Perf, 1.977; 41: 1min HRV, 14.576; 42: HR, 110.525; 42: SpO2, 90.525; 42: Perf, 2.646; 42: 1min HRV, 16.205; 43: HR, 109.678; 43: SpO2, 91.881; 43: Perf, 3.402; 43: 1min HRV, 21.374; 43: 5min HRV, 18.328; 44: HR, 109.672; 44: SpO2, 95.172; 44: Perf, 3.964; 44: 1min HRV, 21.182; 45: HR, 108.390; 45: SpO2, 95.153; 45: Perf, 4.616; 45: 1min HRV, 21.246; 46: HR, 108.569; 46: SpO2, 94.914; 46: Perf, 4.833; 46: 1min HRV, 17.993; 47: HR, 107.085; 47: SpO2, 95.017; 47: Perf, 5.151; 47: 1min HRV, 18.946; 48: HR, 108.356; 48: SpO2, 95.373; 48: Perf, 5.283; 48: 1min HRV, 19.931; 48: 5min HRV, 20.167; 49: HR, 107.138; 49: SpO2, 95.155; 49: Perf, 5.190; 49: 1min HRV, 17.870; 50: HR, 106.424; 50: SpO2, 96.0; 50: Perf, 5.102; 50: 1min HRV, 19.279; 51: HR, 106.241; 51: SpO2, 96.0; 51: Perf, 4.463; 51: 1min HRV, 16.673; 52: HR, 107.186; 52: SpO2, 96.068; 52: Perf, 4.564; 52: 1min HRV, 20.341; 53: HR, 105.525; 53: RR, 17.0; 53: SpO2, 96.0; 53: Perf, 5.102; 53: 1min HRV, 18.524; 53: 5min HRV, 18.733; 54: HR, 106.276; 54: SpO2, 96.0; 54: Perf, 5.207; 54: 1min HRV, 18.691; 55: HR, 108.814; 55: SpO2, 94.339; 55: Perf, 5.860; 55: 1min HRV, 19.011; 56: HR, 108.017; 56: SpO2, 93.828; 56: Perf, 5.531; 56: 1min HRV, 17.191; 57: HR, 108.102; 57: SpO2, 93.831; 57: Perf, 5.456; 57: 1min HRV, 20.965; 58: HR, 107.322; 58: SpO2, 93.627; 58: Perf, 5.796; 58: 1min HRV, 18.570; 58: 5min HRV, 19.512; 59: HR, 107.897; 59: SpO2, 93.328; 59: Perf, 5.545; 59: 1min HRV, 18.361; 60: HR, 107.508; 60: SpO2, 95.729; 60: Perf, 4.673; 60: 1min HRV, 16.617; 61: HR, 106.672; 61: SpO2, 95.310; 61: Perf, 4.716; 61: 1min HRV, 18.259; 62: HR, 106.797; 62: SpO2, 95.678; 62: Perf, 4.453; 62: 1min HRV, 17.616; 63: HR, 107.831; 63: SpO2, 96.322; 63: Perf, 3.808; 63: 1min HRV, 23.819; 63: 5min HRV, 19.307; 64: HR, 105.172; 64: SpO2, 96.0; 64: Perf, 4.299; 64: 1min HRV, 23.239; 65: HR, 106.254; 65: RR, 22.056; 65: SpO2, 95.915; 65: Perf, 4.105; 65: 1min HRV, 17.162; 66: HR, 104.517; 66: SpO2, 95.828; 66: Perf, 4.427; 66: 1min HRV, 18.875; 67: HR, 104.085; 67: SpO2, 96.0; 67: Perf, 4.424; 67: 1min HRV, 17.668; 68: HR, 105.525; 68: SpO2, 95.017; 68: Perf, 5.536; 68: 1min HRV, 17.378; 68: 5min HRV, 19.579; 69: HR, 104.914; 69: SpO2, 94.0; 69: Perf, 5.951; 69: 1min HRV, 15.239; 70: HR, 104.695; 70: SpO2, 93.797; 70: Perf, 6.006; 70: 1min HRV, 14.047; 71: HR, 104.810; 71: SpO2, 93.224; 71: Perf, 5.726; 71: 1min HRV, 12.730; 72: HR, 103.288; 72: RR, 29.375; 72: SpO2, 93.661; 72: Perf, 5.810; 72: 1min HRV, 10.750; 73: HR, 103.431; 73: RR, 14.259; 73: SpO2, 94.0; 73: Perf, 5.949; 73: 1min HRV, 15.137; 73: 5min HRV, 14.475; 74: HR, 102.508; 74: RR, 18.593; 74: SpO2, 93.576; 74: Perf, 5.645; 74: 1min HRV, 18.665; 75: HR, 104.203; 75: RR, 18.559; 75: SpO2, 94.085; 75: Perf, 5.729; 75: 1min HRV, 19.603; 76: HR, 104.931; 76: RR, 19.655; 76: SpO2, 94.828; 76: Perf, 6.026; 76: 1min HRV, 17.125; 77: HR, 102.932; 77: RR, 20.729; 77: SpO2, 95.627; 77: Perf, 5.371; 77: 1min HRV, 16.380; 78: HR, 101.224; 78: RR, 20.241; 78: SpO2, 96.0; 78: Perf, 5.247; 78: 1min HRV, 17.340; 78: 5min HRV, 19.426; 79: HR, 100.607; 79: RR, 20.898; 79: SpO2, 95.424; 79: Perf, 4.697; 79: 1min HRV, 12.174; 80: HR, 100.847; 80: RR, 21.186; 80: SpO2, 95.136; 80: Perf, 4.427; 80: 1min HRV, 16.551; 83: INFLUENZA B, Not Detected; 83: SARS-COV-2 RNA, Not Detected; 83: RSV, Not Detected; 83: INFLUENZA A, Not Detected; 83: 5min HRV, 14.374; 98: PART. THROMBOPLASTIN TIME, 37.6 seconds; 103: INR, 1.3; 103: WAM DIFTYP, AUTO; 103: PROTHROMBIN TIME, 16.4 seconds; 103: MONOCYTE ABSOLUTE (AUTO DIFF), 1.80 K/uL; 103: LYMPHOCYTE ABSOLUTE (AUTO DIFF), 1.45 K/uL; 103: RED BLOOD CELLS (RBC), 2.91 MIL/uL; 103: IMMATURE GRANULOCYTE ABSOLUTE (AUTO DIFF) WAM, 0.14 K/uL; 103: NEUTROPHIL % (AUTO DIFF), 64.1 %; 103: LYMPHOCYTE % (AUTO DIFF), 8.7 %; 103: HEMOGLOBIN (HGB), 8.8 g/dL; 103: EOSINOPHIL % (AUTO DIFF), 15.1 %; 103: BASOPHIL % (AUTO DIFF), 0.5 %; 103: MEAN CORPUSCULAR VOLUME (MCV), 92.8 fL; 103: NRBC ABSOLUTE (HEMATOLOGY), 0.00 K/uL; 103: NEUTROPHIL ABSOLUTE (AUTO DIFF), 10.63 K/uL; 103: EOSINOPHIL ABSOLUTE (AUTO DIFF), 2.50 K/uL; 103: IMMATURE GRANULOCYTE % (AUTODIFF) WAM, 0.8 %; 103: NRBC PERCENT (HEMATOLOGY), 0.0 %; 103: WHITE BLOOD CELLS (WBC), 16.6 K/uL; 103: PLATELET COUNT (PLT), 637 K/uL; 103: HEMATOCRIT (HCT), 27.0 %; 103: MEAN CORPUSCULAR HEMOGLOBIN (MCH), 30.2 pg; 103: MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC), 32.6 g/dL; 103: MONOCYTE % (AUTO DIFF), 10.8 %; 103: RED CELL DISTRIBUTION WIDTH (RDW), 13.5 %; 103: BASOPHIL ABSOLUTE (AUTO DIFF), 0.08 K/uL; 0: Age, 39; 0: Gender, F; 0: Race, White; 0: Means of arrival, Self; 0: Triage Temp, nan; 0: Triage HR, 114.0; 0: Triage RR, 22.0; 0: Triage SBP, 101.0; 0: Triage DBP, 62.0; 0: Triage acuity, 2-Emergent; 0: CC, FEVER",
        "answer": false,
        "llm_answer": "Yes",
        "llm_explanation": "To determine the risk of sepsis, we look for indicators of infection and organ dysfunction. The patient has a high temperature (102.2\u00b0F), which suggests a potential fever. The heart rate is elevated (tachycardia) throughout the time series, and the respiratory rate is slightly elevated initially. Laboratory results show leukocytosis (WBC count of 16.6 K/uL) and anemia (hemoglobin of 8.8 g/dL), both of which can signal infection or sepsis. Despite the absence of a positive microbiological test, these clinical signs and laboratory abnormalities suggest a high risk of sepsis within the next 12 hours.",
        "claims": [
            "To determine the risk of sepsis, we look for indicators of infection and organ dysfunction.",
            "The patient has a high temperature of 102.2\u00b0F.",
            "A temperature of 102.2\u00b0F suggests a potential fever.",
            "The heart rate is elevated throughout the time series.",
            "Elevated heart rate indicates tachycardia.",
            "The respiratory rate is slightly elevated initially.",
            "Laboratory results show leukocytosis with a WBC count of 16.6 K/uL.",
            "A WBC count of 16.6 K/uL indicates leukocytosis.",
            "Laboratory results show anemia with a hemoglobin level of 8.8 g/dL.",
            "A hemoglobin level of 8.8 g/dL indicates anemia.",
            "Both leukocytosis and anemia can signal infection or sepsis.",
            "Despite the absence of a positive microbiological test, clinical signs and laboratory abnormalities suggest a high risk of sepsis.",
            "The clinical signs and laboratory abnormalities suggest a high risk of sepsis within the next 12 hours."
        ],
        "relevant_claims": [
            "The patient has a high temperature of 102.2\u00b0F.",
            "A temperature of 102.2\u00b0F suggests a potential fever.",
            "The heart rate is elevated throughout the time series.",
            "Elevated heart rate indicates tachycardia.",
            "The respiratory rate is slightly elevated initially.",
            "Laboratory results show leukocytosis with a WBC count of 16.6 K/uL.",
            "A WBC count of 16.6 K/uL indicates leukocytosis.",
            "Laboratory results show anemia with a hemoglobin level of 8.8 g/dL.",
            "A hemoglobin level of 8.8 g/dL indicates anemia.",
            "Both leukocytosis and anemia can signal infection or sepsis.",
            "Despite the absence of a positive microbiological test, clinical signs and laboratory abnormalities suggest a high risk of sepsis.",
            "The clinical signs and laboratory abnormalities suggest a high risk of sepsis within the next 12 hours."
        ],
        "alignment_scores": [
            0.8,
            0.9,
            0.8,
            1.0,
            0.6,
            1.0,
            1.0,
            0.4,
            0.3,
            0.7,
            0.7,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)",
            "SOFA Score Increase (\u22652 points)",
            "SIRS Positivity (\u22652 Criteria)",
            "Early Antibiotic/Culture Orders (within 2 hours)",
            "Elevated NEWS Score (\u22655 points)"
        ],
        "alignment_reasonings": [
            "The given temperature of 102.2\u00b0F is equivalent to approximately 39\u00b0C, which clearly exceeds the SIRS criteria threshold of >38\u00b0C for fever. This strongly suggests the presence of systemic inflammation consistent with early sepsis, making it highly aligned, though on its own, temperature is just one criterion of the SIRS, and full SIRS positivity requires at least two criteria.",
            "The temperature of 102.2\u00b0F (approximately 39\u00b0C) is above the SIRS threshold (>38\u00b0C), which directly indicates a systemic inflammatory response. This aligns strongly, though not perfectly, with the SIRS criteria, as fever is only one of the required criteria for a positive SIRS identification.",
            "An elevated heart rate (>90 bpm) is one of the specific criteria for SIRS, which identifies systemic inflammation consistent with early sepsis. The claim aligns directly with this aspect of the SIRS criteria, though only one criterion is mentioned, so the alignment is strong but not absolutely complete.",
            "Tachycardia is specified as a heart rate\u202f>\u202f90\u202fbpm, which is one of the criteria used in the Systemic Inflammatory Response Syndrome (SIRS) criteria to identify systemic inflammation consistent with early sepsis. The claim directly refers to this condition (elevated heart rate), resulting in perfect alignment with the category.",
            "The claim mentions an elevated respiratory rate, which aligns with one of the SIRS criteria (respiratory rate\u202f>\u202f20/min). However, as the description says \"slightly elevated\" and does not provide an exact number, it suggests a potential but uncertain match to the criteria for systemic inflammation, which slightly reduces direct relevance.",
            "The claim directly mentions leukocytosis with a WBC count of 16.6 K/uL, which is explicitly listed as one of the SIRS criteria (WBC > 12,000/\u00b5L). This aligns perfectly with the category, as elevated WBC is a direct indicator of systemic inflammation consistent with early sepsis.",
            "An elevated white blood cell (WBC) count of 16.6 K/uL fits directly with the SIRS criteria, where WBC > 12,000/\u00b5L is used to identify systemic inflammation consistent with early sepsis. Therefore, this claim fully aligns with the specified category.",
            "Anemia, signified by a low hemoglobin level, can be indirectly related to organ dysfunction, one of the aspects associated with an increase in the SOFA score. However, hemoglobin levels are not directly part of SOFA scoring components, such as PaO\u2082/FiO\u2082 ratio, platelet count, bilirubin, or creatinine levels. Thus, there\u2019s a conceptual connection, but it is not direct or strong, resulting in a moderate alignment rating.",
            "Anemia, indicated by low hemoglobin, isn't directly assessed in the SOFA score. However, anemia may indirectly affect SOFA components like cardiovascular status and organ oxygenation. The relationship to sepsis risk is minor and indirect, hence a low alignment rating.",
            "Leukocytosis (elevated white blood cell count) is explicitly a part of the SIRS criteria, making it relevant to the SIRS Positivity category. Anemia, while not a direct SIRS criterion, may suggest a need for further investigation, indirectly supporting the presence of an inflammatory or infectious process. Therefore, the alignment is relatively strong with the SIRS category but not perfect, due to the partial relevance of anemia.",
            "The claim indicates that there is a clinical suspicion of sepsis based on signs and laboratory abnormalities, despite not having a positive microbiological test. This suspicion typically prompts early interventions such as the administration of antibiotics or the drawing of cultures, which is captured under the category of \"Early Antibiotic/Culture Orders (within 2 hours).\" The alignment is fairly strong as the claim implies similar reasoning that would often trigger such actions, although it doesn't explicitly mention them.",
            "The claim mentions \"clinical signs and laboratory abnormalities,\" implying a general assessment leading to a high sepsis risk, similar to NEWS. Elevated NEWS considers vital sign derangements to anticipate clinical deterioration compatible with sepsis. Lacking details, this suggests alignment but not perfectly with NEWS or another specific category."
        ],
        "final_alignment_score": 0.7416666666666666,
        "accuracy": 0
    },
    {
        "input": "4: HR, 110.0; 4: RR, 18.0; 4: SpO2, 100.0; 4: SBP, 157.0; 4: DBP, 87.0; 4: MAP, 110.333; 4: Temp, 97.0; 12: Pain, 8.0; 52: SpO2, 98.0; 53: SpO2, 94.484; 53: Perf, 0.343; 54: SpO2, 93.154; 54: Perf, 0.300; 55: SpO2, 91.959; 55: Perf, 0.278; 56: SpO2, 93.019; 56: Perf, 0.450; 57: SpO2, 96.132; 57: Perf, 0.738; 58: SpO2, 97.0; 58: Perf, 0.945; 59: SpO2, 95.849; 59: Perf, 0.823; 60: SpO2, 94.981; 60: Perf, 0.576; 61: SpO2, 96.528; 61: Perf, 0.527; 62: SpO2, 95.509; 62: Perf, 0.607; 63: SpO2, 95.346; 63: Perf, 0.519; 64: SpO2, 95.604; 64: Perf, 0.626; 65: SpO2, 95.537; 65: Perf, 0.59; 66: SpO2, 94.458; 66: Perf, 0.586; 67: SpO2, 94.265; 67: Perf, 0.579; 68: SpO2, 95.0; 68: Perf, 0.574; 69: SpO2, 95.774; 69: Perf, 0.547; 70: SpO2, 95.774; 70: Perf, 0.425; 71: SpO2, 96.192; 71: Perf, 0.397; 72: HR, 111.0; 72: SpO2, 97.226; 72: Perf, 0.378; 72: SBP, 158.0; 72: DBP, 100.0; 72: MAP, 119.333; 73: SpO2, 97.0; 73: Perf, 0.373; 73: SBP, 158.0; 73: DBP, 100.0; 73: MAP, 119.333; 74: SpO2, 96.906; 74: Perf, 0.377; 75: SpO2, 96.5; 75: Perf, 0.406; 75: Pain, 0.0; 76: SpO2, 96.192; 76: Perf, 0.429; 77: SpO2, 96.415; 77: Perf, 0.455; 78: SpO2, 96.75; 78: Perf, 0.47; 79: SpO2, 97.377; 79: Perf, 0.436; 80: SpO2, 96.0; 80: Perf, 0.454; 81: SpO2, 95.308; 81: Perf, 0.439; 82: SpO2, 97.547; 82: Perf, 0.467; 83: SpO2, 97.942; 83: Perf, 0.528; 84: HR, 108.562; 84: RR, 23.333; 84: SpO2, 97.415; 84: Perf, 0.52; 84: 1min HRV, 6.283; 84: SBP, 146.0; 84: DBP, 95.0; 84: MAP, 112.0; 85: HR, 107.315; 85: RR, 18.796; 85: SpO2, 98.148; 85: Perf, 0.52; 85: 1min HRV, 9.190; 86: HR, 107.75; 86: RR, 22.269; 86: SpO2, 98.308; 86: Perf, 0.52; 86: 1min HRV, 7.709; 87: HR, 106.396; 87: RR, 16.415; 87: SpO2, 97.094; 87: Perf, 0.487; 87: 1min HRV, 8.475; 87: 5min HRV, 9.826; 88: HR, 106.115; 88: RR, 17.192; 88: SpO2, 96.75; 88: Perf, 0.403; 88: 1min HRV, 8.518; 89: HR, 108.278; 89: RR, 20.204; 89: SpO2, 95.852; 89: Perf, 0.376; 89: 1min HRV, 7.594; 90: HR, 109.377; 90: RR, 17.302; 90: SpO2, 95.321; 90: Perf, 0.383; 90: 1min HRV, 3.874; 91: HR, 109.135; 91: RR, 17.923; 91: SpO2, 96.673; 91: Perf, 0.398; 91: 1min HRV, 6.186; 92: HR, 105.509; 92: RR, 17.604; 92: SpO2, 97.0; 92: Perf, 0.399; 92: 1min HRV, 2.008; 92: 5min HRV, 10.216; 93: HR, 107.769; 93: RR, 18.365; 93: SpO2, 97.0; 93: Perf, 0.384; 93: 1min HRV, 5.526; 94: HR, 108.642; 94: RR, 19.679; 94: SpO2, 96.396; 94: Perf, 0.349; 94: 1min HRV, 5.896; 95: HR, 107.615; 95: RR, 19.865; 95: SpO2, 96.827; 95: Perf, 0.360; 95: 1min HRV, 6.318; 96: HR, 107.811; 96: RR, 19.604; 96: SpO2, 96.887; 96: Perf, 0.342; 96: 1min HRV, 9.593; 97: HR, 107.833; 97: RR, 17.630; 97: SpO2, 96.926; 97: Perf, 0.343; 97: 1min HRV, 8.945; 97: 5min HRV, 7.989; 98: HR, 109.115; 98: RR, 16.962; 98: SpO2, 96.365; 98: Perf, 0.352; 98: 1min HRV, 4.041; 99: HR, 108.132; 99: RR, 17.679; 99: SpO2, 96.057; 99: Perf, 0.367; 99: 1min HRV, 8.423; 100: HR, 111.019; 100: RR, 15.231; 100: SpO2, 96.442; 100: Perf, 0.388; 100: 1min HRV, 3.575; 101: HR, 110.585; 101: RR, 16.189; 101: SpO2, 96.943; 101: Perf, 0.372; 101: 1min HRV, 3.269; 102: HR, 110.226; 102: RR, 14.868; 102: SpO2, 96.472; 102: Perf, 0.343; 102: 1min HRV, 7.359; 102: 5min HRV, 7.762; 103: HR, 110.192; 103: RR, 17.404; 103: SpO2, 96.904; 103: Perf, 0.35; 103: 1min HRV, 6.722; 104: HR, 110.660; 104: RR, 18.623; 104: SpO2, 96.113; 104: Perf, 0.352; 104: 1min HRV, 5.132; 105: HR, 110.288; 105: RR, 17.885; 105: SpO2, 96.5; 105: Perf, 0.466; 105: 1min HRV, 7.060; 106: HR, 111.434; 106: RR, 16.811; 106: SpO2, 98.094; 106: Perf, 0.522; 106: 1min HRV, 29.379; 107: HR, 109.887; 107: RR, 16.623; 107: SpO2, 97.943; 107: Perf, 0.512; 107: 1min HRV, 6.777; 107: 5min HRV, 14.634; 108: HR, 111.75; 108: RR, 19.442; 108: SpO2, 97.981; 108: Perf, 0.464; 108: 1min HRV, 4.427; 108: SBP, 138.0; 108: DBP, 96.0; 108: MAP, 110.0; 109: HR, 110.113; 109: RR, 16.415; 109: SpO2, 96.811; 109: Perf, 0.469; 109: 1min HRV, 4.230; 110: HR, 108.358; 110: RR, 17.170; 110: SpO2, 97.642; 110: Perf, 0.568; 110: 1min HRV, 7.919; 111: HR, 109.226; 111: RR, 17.925; 111: SpO2, 97.472; 111: Perf, 0.575; 111: 1min HRV, 4.075; 112: HR, 109.340; 112: RR, 13.604; 112: SpO2, 96.887; 112: Perf, 0.533; 112: 1min HRV, 5.584; 112: 5min HRV, 7.998; 113: HR, 109.566; 113: RR, 12.717; 113: SpO2, 97.113; 113: Perf, 0.497; 113: 1min HRV, 6.331; 113: SBP, 139.0; 113: DBP, 88.0; 113: MAP, 105.0; 114: HR, 108.962; 114: RR, 18.830; 114: SpO2, 97.415; 114: Perf, 0.552; 114: 1min HRV, 10.085; 115: LACTATE.WHOLE BLD, 1.6 mmol/L; 115: HR, 109.115; 115: RR, 22.096; 115: SpO2, 94.069; 115: Perf, 0.574; 115: 1min HRV, 5.739; 116: HR, 109.038; 116: RR, 20.528; 116: SpO2, 95.778; 116: 1min HRV, 3.933; 117: HR, 109.774; 117: RR, 19.698; 117: 1min HRV, 5.480; 117: 5min HRV, 6.848; 118: HR, 109.154; 118: RR, 22.981; 118: 1min HRV, 4.851; 119: HR, 110.434; 119: RR, 22.302; 119: 1min HRV, 4.683; 0: Age, 59; 0: Gender, M; 0: Race, Other; 0: Means of arrival, Self; 0: Triage Temp, 36.1; 0: Triage HR, 110.0; 0: Triage RR, 18.0; 0: Triage SBP, 157.0; 0: Triage DBP, 87.0; 0: Triage acuity, 3-Urgent; 0: CC, MALE GENITAL PROBLEM,SHORTNESS OF BREATH",
        "answer": false,
        "llm_answer": "No",
        "llm_explanation": "The key to predicting sepsis risk involves assessing vital signs such as heart rate (HR), respiratory rate (RR), blood pressure (BP), temperature, and other clinical indicators. The patient's HR is consistently elevated (>100 bpm), which could raise concerns if isolated. However, other vital signs like RR, oxygen saturation (SpO2), and temperature do not show critical deviations from normal ranges. Additionally, lactic acid levels are within normal limits (1.6 mmol/L). Although the patient presents with shortness of breath, there is no clear indication of hemodynamic instability or organ dysfunction typically associated with sepsis onset within 12 hours.",
        "claims": [
            "The key to predicting sepsis risk involves assessing vital signs.",
            "Important vital signs include heart rate (HR), respiratory rate (RR), blood pressure (BP), and temperature.",
            "The patient's heart rate (HR) is consistently elevated at over 100 bpm.",
            "An elevated heart rate (HR) could raise concerns if isolated.",
            "Other vital signs like respiratory rate (RR), oxygen saturation (SpO2), and temperature do not show critical deviations from normal ranges.",
            "Lactic acid levels are within normal limits at 1.6 mmol/L.",
            "The patient presents with shortness of breath.",
            "There is no clear indication of hemodynamic instability.",
            "There is no clear indication of organ dysfunction typically associated with sepsis onset within 12 hours."
        ],
        "relevant_claims": [
            "The patient's heart rate (HR) is consistently elevated at over 100 bpm.",
            "There is no clear indication of organ dysfunction typically associated with sepsis onset within 12 hours."
        ],
        "alignment_scores": [
            0.7,
            0.7
        ],
        "alignment_category": [
            "SIRS Positivity (\u22652 Criteria)",
            "SOFA Score Increase (\u22652 points)"
        ],
        "alignment_reasonings": [
            "The claim states that the patient's heart rate is consistently elevated at over 100 bpm, which aligns with the SIRS criteria of a heart rate > 90 bpm. While elevated heart rate alone does not meet the full definition of SIRS (which requires \u22652 criteria), the claim is strongly relevant to this category because an elevated heart rate is one component of SIRS. Hence, the alignment is substantial but not complete.",
            "The claim refers to a lack of clear organ dysfunction, which directly relates to the SOFA score used to evaluate organ dysfunction and determine sepsis risk. While it indicates what is not present, the SOFA score's focus on organ dysfunction means any absence thereof would be most relevant to this category. The alignment is not absolute since the claim does not mention specific SOFA criteria or points, but the connection is strong conceptually."
        ],
        "final_alignment_score": 0.7,
        "accuracy": 1
    }
]
